Volker Schumpelick Robert J. Fitzgibbons (Eds.) Hernia Repair Sequelae
Volker Schumpelick Robert J. Fitzgibbons (Eds.)
Hernia Repair Sequelae In Collaboration with Joachim Conze
With 236 Figures and 97 Tables
1 23
Prof. Dr. Volker Schumpelick
Prof. Dr. Robert J. Fitzgibbons
Chirurgische Klinik Universitätsklinikum Aachen Pauwelsstraße 30 52074 Aachen Germany e-mail:
[email protected]
Department of Surgery Creighton University 601 North 30th Street Suite 3740 Omaha, NE 68131 USA e-mail:
[email protected]
ISBN 978-3-642-04552-3 Springer-Verlag Berlin Heidelberg New York Bibliografische Information der Deutschen Bibliothek The Deutsche Bibliothek lists this publication in Deutsche Nationalbibliographie; detailed bibliographic data is available in the internet at http://dnb.ddb.de. This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer-Verlag. Violations are liable to prosecution under the German Copyright Law. Springer Medizin Springer-Verlag GmbH ein Unternehmen von Springer Science+Business Media springer.de © Springer-Verlag Berlin Heidelberg 2010 The use of general descriptive names, registered names, trademarks, etc. in this publications does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature.
Planning: Hanna Hensler-Fritton, Heidelberg Projectmanagement: Ulrike Dächert, Heidelberg Design and Cover: deblik Berlin Cover Image: friesischAdvertising GmbH Typesetting: TypoStudio Tobias Schaedla, Heidelberg SPIN: 12765003 Printed on acid free paper
5135 – 5 4 3 2 1 0
V
Preface At the last Suvretta meeting in 2006 on recurrent hernia prevention and treatment, we demonstrated that with the wide range of available techniques, materials, and meshes at our disposal today, an experienced hernia surgeon will be able to prevent or at least treat a recurrent hernia. But whereas recurrences can be treated successfully in most cases, some other hernia repair sequelae can result in severe, sometimes untreatable problems, e.g. pain, infection, adhesion, or infertility. That was the reason to focus the 5th Suvretta meeting in 2008 on hernia repair sequelae. We are convinced that such sequelae can be a more serious problem for the patient than the mostly treatable recurrent hernia. Therefore, it was appropriate to focus the 5th Suvretta meeting on these longterm problems. During a four-day meeting, we discussed all technical aspects of the various operations and materials to generate a consensus concerning the best techniques and meshes. We explored methods to improve surgical techniques to look into the multifactorial causes of post hernia repair sequelae. In the seclusion of the Swiss plateau valley we had a perfect setting to discuss these important hernia repair problems in detail with the top hernia specialists in the world. With this book, the results of this exceptional 5th Suvretta meeting have been made accessible for every surgeon who is interested in hernia surgery and its sequelae. V. Schumpelick
VII
List of First Authors Alfieri, S.
Bachman, S. L.
Champault, G. G.
Department of Digestive Surgery Catholic University of Sacred Heart Largo Agostino Gemelli 8 00168 Rome Italy
[email protected]
University of Missouri Department of Surgery Missouri Hernia Institute University of Missouri–Columbia 414 McHaney Hall Columbia, MO 65211 USA
Paris University XIII – Medical School »Léonard de Vinci« Department of Digestive Surgery University Hospital Jean Verdier Avenue du 14 Juillet 93140 Bondy France
[email protected]
Amid, P. K. Department of Surgery David Geffen School of Medicine at UCLA Lichtenstein Hernia Institute at UCLA 1260 15th Street, Suite 1200 Santa Monica, CA 90404 USA
[email protected]
Bellows, C. Associate Professor of Surgery Chief, General Surgery Director of Surgical Research General and Laparoscopic Surgery Tulane University New Orleans, LA USA
Chowbey, P. K. Minimal Access, Metabolic and Bariatric Surgery Centre Sir Ganga Ram Hospital Room No. 200 (IInd floor) New Delhi 110060 India
[email protected]
Berger, D. Arlt, G. D. Department of Surgery Park-Klinik Weissensee Schönstrasse 80 13086 Berlin Germany
[email protected]
Department of Surgery Stadtklinik Balgerstrasse 50 76532 Baden-Baden Germany
[email protected]
Conze, J. Department of Surgery University Hospital RWTH Pauwelsstrasse 30 52074 Aachen Germany
[email protected]
Binnebösel, M. Aufenacker, T. J. Department of Surgery (C22) Canisius Wilhelmina Ziekenhuis (CWZ) Postbus 9015 6500 GS Nijmegen The Netherlands
[email protected]
Aydede, H. Associate Professor of Surgery Celal Bayar University Medical Faculty Department of Surgery Manisa Turkey
[email protected]
Department of Surgery RWTH Aachen University Hospital Pauwelsstrasse 30 52074 Aachen Germany
[email protected]
Demirer, S. D. Ankara University School of Medicine Department of Surgery Ankara Turkey
[email protected]
Bringman, S. Clintec, Karolinska Institutet Stockholm, Sweden Departments of Surgery, Södertälje Hospital Södertälje Sweden
[email protected]
Deysine, M. Professor of Surgery Winthrop University Hospital Mineola, NY USA
[email protected]
VIII
List of First Authors
Diaz, J. J., Jr.
Flament, J. B.
Hegarty, D.
Division of Trauma and Surgical Critical Care Department of Surgery Vanderbilt University Medical Center Nashville, TN USA
[email protected]
Department of Surgery Faculty of Medicine University of Reims ChampagneArdenne General Surgery Service Hôpital Robert Debré Rue Serge Kochman 51100 Reims France
[email protected]
Department of Anaesthesia, Intensive Care & Pain Medicine Cork University Hospital Cork Ireland
[email protected]
Dilek, O. N. Professor of General Surgery School of Medicine Kocatepe University PK:70 03100 Afyonkarahisar Turkey
[email protected]
Falagas, M. E. Department of Medicine, Henry Dunant Hospital, Athens, Greece Department of Medicine, Tufts University School of Medicine, Boston, MA, USA Alfa Institute of Biomedical Sciences (AIBS) 9 Neapoleos Street, 151 23 Marousi Athens, Greece
[email protected]
Franz, M. G. Associate Professor of Surgery Chief, Minimally Invasive Surgery University of Michigan Department of Surgery 2214F Taubman Center 1500 East Medical Center Drive Ann Arbor, MI 48109 USA
[email protected]
Goldenberg, A. Associate Professor Department of Surgery Federal University of Sao Paulo Brazil
[email protected]
Gryska, P. vR. Fawole, A. S. Department of Academic Surgery St. James’s University Hospital Beckett Street Leeds LS9 7TF UK
[email protected]
Tufts University School of Medicine Boston, MA Department of Surgery Newton-Wellesley Hospital Suite 365, 2000 Washington Street Newton, MA 0246 USA
[email protected]
Hansson, B. Department of Surgery Canisius Wilhelmina Hospital Nijmegen The Netherlands
Honigsberg, E. Mount Sinai Medical Center 1010 5th Avenue New York, NY 10028 USA
Hopf, H. W. Department of Anesthesiology, University of Utah Medical Director, Urban Central Region Wound Care Services LDS Hospital 8th Avenue and C Street Salt Lake City, UT 84132 USA
[email protected]
Jansen, M. Department of Surgery University Hospital RWTH Aachen Pauwelsstrasse 30 52074 Aachen Germany
[email protected]
Jansen, P. L. Department of Surgery University Hospital RWTH Aachen Pauwelsstrasse 30 52074 Aachen Germany
[email protected]
IX List of First Authors
Junge, K.
Kolbe, T.
Montgomery, A.
Department of Surgery Technical University of Aachen Pauwelsstrasse 30, 52057 Aachen Germany
[email protected]
Biomodels Austria, University of Veterinary Medicine Veterinärplatz 1 1210 Vienna Austria
[email protected]
Department of Surgery Malmö University Hospital 20502 Malmö Sweden
[email protected]
Kaemmer, D.
Kukleta, J. F.
Department of Surgery RWTH Aachen Pauwelsstr. 30 52074 Aachen Germany
[email protected]
Klinik Im Park Seestrasse 220 8027 Zurich Switzerland
[email protected]
Morales-Conde, S.
Muschaweck, U. Kurzer, M.
Kavvadias, T. Department of Obstetrics and Gynaecology Lucerne Cantonal Hospital Lucerne Switzerland
Kehlet, H. Section for Surgical Pathophysiology 4074 Rigshospitalet Copenhagen University Blegdamsvej 9 2100 Copenhagen Denmark
[email protected]
Klinge, U. Institute for Applied Medical Engineering Helmholtz Institute for Applied Medical Technology RWTH Aachen University Pauwelsstraße 20-30 52074 Aachen Germany
[email protected]
University Hospital Virgen del Rocío. Betis-65, 1º 41010 Sevilla Spain
[email protected]
British Hernia Centre 87 Watford Way London NW4 4RS UK
[email protected]
Hernienzentrum Dr. Muschaweck – München Arabellastrasse 5 81925 Munich Germany
[email protected]
Lammers, B. J.
Neumayer, L.
Department for Colorectal and Hernia Surgery Lukaskrankenhaus Neuss Neuss Germany
[email protected]
Professor of Surgery Department of Surgery University of Utah Salt Lake City VA Healthcare System 1950 Circle of Hope Room 6540 Salt Lake City, UT 84132 USA
[email protected]
Matthews, B. D. Chief, Section of Minimally Invasive Surgery Department of Surgery Washington University School of Medicine 660 S. Euclid Ave., Campus Box 8109 St. Louis, MO 63110 USA
[email protected]
Nordin, P. Head of the Swedish Hernia Register Department of Surgery Östersund Hospital 831 83 Östersund Sweden
[email protected]
Otto, J. Miserez, M. Department of Abdominal Surgery University Hospitals Herestraat 49 3000 Leuven Belgium
[email protected]
Department of Surgery University Hospital RWTH Aachen Pauwelsstrasse 30 52074 Aachen Germany
[email protected]
X
List of First Authors
Page, B. P.
Schug-Paß, C.
Stroh, C.
University Department of Surgery Western Infirmary Glasgow G11 6NT Scotland
[email protected]
Department of Surgery Center for Minimally Invasive Surgery Vivantes Hospital Spandau Neue Bergstrasse 6 13585 Berlin Germany
[email protected]
Department of General, Abdominal and Paediatric Surgery Municipal Hospital (Teaching Hospital of the Friedrich-Schiller University at Jena, Germany) Strasse des Friedens 122 07548 Gera Germany
[email protected]
Pascual, G. Department of Medical Specialities Alcalá University Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BNN) Madrid Spain
Peiper, C. Surgical Clinic Evangelisches Krankenhaus Werler Strasse 110 58455 Hamm Germany
[email protected]
Penkert, G. Friederikenstift Hannover Department of Neurosurgery Humboldtstrasse 5 30169 Hannover Germany
[email protected]
Read, R. C. Emeritus Professor of Surgery 304 Potomac Street Rockville, MD 20850 USA
[email protected]
Schippers, E. Surgical Clinic Department of General and Visceral Surgery Juliusspital Juliuspromenade 19 97070 Würzburg Germany
[email protected]
Schumpelick, V. Department of Surgery University Hospital RWTH Pauwelsstrasse 30 52074 Aachen Germany
[email protected]
Simons, M. P. Department of Surgery Onze Lieve Vrouwe Gasthuis Postbus 95500 1090 HM Amsterdam The Netherlands
[email protected]
Smeds, S. The Sergel Clinic Department of Clinical and Experimental Medicine Faculty of Health Sciences University Hospital Linköping University 58185 Linköping Sweden
[email protected]
Stanton-Hicks, M. Vice Chairman, Anesthesiology Institute Consulting Staff, CCF Shaker Children’s Pain Rehabilitation Cleveland Clinic Pain Management Department 9500 Euclid Avenue – C-25 Cleveland, OH 44195 USA
[email protected]
Stumpf, M. Department of Surgery RWTH Aachen Pauwelsstrasse 30 52074 Aachen Germany michale.stumpf@ klinikum-pforzheim.de
van der Kolk, B. M. Department of Surgery, Division of Abdominal Surgery Radboud University Nijmegen Medical Center Nijmegen The Netherlands
Witkowski, P. Department of Surgery Division of Abdominal Organ Transplantation Columbia University 177 Fort Washington Ave, 7HS, Room 200C New York, NY 10032 USA
[email protected]
XI
Contents 15
I Risk for the Spermatic Cord 16 17 1 2
3
4 5 6 7
8
9 10
Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion? . . . . . . . . . . 3 The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model– Preliminary Results . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats . . . . . . . . . . . . . . . . . 29 The Effects of a Mesh Bioprosthesis on the Spermatic Cord Structures . . . . . . . . . . . . . . 39 Influence of Prosthetic Implants on Male Fertility in Rats . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 What Can We Do To Decrease the Risk of Vas Deferens Injury due to Inguinal Hernioplasty? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis Used for Inguinal Hernia Repair . . . . . . . . . . . . . . . . . . . . . . 57 Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like? . . . . . . . . . 65 Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review . . . . . . . . . . . . . . 71
18
19
III 20
21 22
23
24
II
Risk for Infection 25
11 12
13 14
Mesh Infection Following Hernia Repair: A Frequent Problem? . . . . . . . . . . . . . . . . . . . . . . . 79 Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 Mesh-Related Infections After Hernia Repair . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh . . . . . . .113 Mesh Infection–Therapeutic Options . . . . . . .119 Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery? . . . . . . . . . . . . . . . . . . . . . . . . . . . .125 Infection Control in a Hernia Clinic: 24-Year Results of Aseptic and Antiseptic Measure Implementation in 4,620 »Clean Cases« Based on Up-To-Date Microbiological Research . . . . . . . . . . . . . . . . . . . . . . . .135 Components Separation Technique: Pros and Cons . . . . . . . . . . . . . . . . . . . . . . . . . . . . .143
26 27
28 29
Risk for Pain
Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair: A Reflection of Both Individual Pain Propensity and Surgical Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . .155 Chronic Pain After Inguinal Hernia Repair . . .163 What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .169 Surgical Trauma of Nerves–Causes of Neuropathic Pain, Classification, and Options in Surgical Therapy . . . . . . . . . . . . . . . .177 Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves? . . . . . . . .185 What To Consider as Clinicians About Chronic Postoperative Pain and Inguinal Herniorrhaphy . . . . . . . . . . . . . . . . . . . . . . . . . . . . .191 Risk Factors for Chronic Pain After Groin Hernia Surgery . . . . . . . . . . . . . . . . . . . . . .199 Ischemic Inflammatory Response Syndrome as an Alternative Explanation for Postherniorrhaphy Pain . . . . . . . . . . . . . . . . .207 Postoperative CRPS in Inguinal Hernia Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .213 Chronic Pain After Open Mesh Repair of Incisional Hernia . . . . . . . . . . . . . . . . . . . . . . . .221
XII
30 31 32
33
34
35
36
37
38
39
40 41
Contents
Clinical Results After Open Mesh Repair . . . .227 Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair . . . . . . . . . . . . . . . . . . . .233 Effect of Nerve Identification on the Rate of Postoperative Chronic Pain Following Inguinal Hernia Surgery . . . . . . . . . . . . . . . . . . . .239 Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair: A Report from the SMIL Study Group . . . . . . .245 Recurrence or Complication: The Lesser of Two Evils? A Review of Patient-Reported Outcomes from the VA Hernia Trial . . . . . . . . .251 Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique . . . . . . . . . . . . . .257 The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia . . . . . . . . . . . . . . . . . . . . .265 Lightweight Macroporous Mesh vs. Standard Polypropylene Mesh in Lichtenstein Hernioplasty . . . . . . . . . . . . . . . . . .275 Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .279 New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy Inguinodynia and Orchialgia . . . . . . . . . . . . . . .287 Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both? . . . 293 Results of Tailored Therapy for Patients with Chronic Inguinal Pain . . . . . . . . . . . . . . . . .299
47 48
49 50 51 52
V
53
54 55 56
57 58 59
IV 42
43 44 45
46
Risk for Adhesion
Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .305 Biological Tissue Graft: Present Status . . . . . .317 IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis . . . . . . . . . . . . . 323 Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual . . . . . . . . . . . . . . . . . . . . . . .331 Tissue Ingrowth, Adhesion, and Mesh Contraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .345
Effect of Different Mesh Materials on Adhesion Formation . . . . . . . . . . . . . . . . . . . . . . .353 Tissue Ingrowth and Laparoscopic Ventral Hernia Mesh Materials: An Updated Review of the Literature . . . . . . . . . . . . . . . . . . . .365 Porosity and Adhesion in an IPOM Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .375 Benefit of Lightweight and/or Titanium Meshes? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .381 ePTFE Prostheses and Modifications . . . . . . . .393 The Role of Stem Cells in Abdominal Wall Repair . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .401
Risk for Migration and Erosion
Safety and Durability of Prosthetic Repair of the Hiatal Hernia: Lessons Learned from a 15-Year Experience . . . . . . . . . . . . . . . . . . . . . . .413 Mesh Migration into the Esophageal Wall After Mesh Hiatoplasty . . . . . . . . . . . . . . . .421 Complications After Gastric Banding– Results in Germany . . . . . . . . . . . . . . . . . . . . . . . .429 Alloplastic Implants for the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse . . . . . . . . . . . . . . . . . . . . . . . . . . . .439 Prophylactic IPOM Mesh To Prevent Parastomal Hernias . . . . . . . . . . . . . . . . . . . . . . . .445 Laparoscopic Parastomal Hernia Repair: Pitfalls and Complications . . . . . . . . . . . . . . . . . .451 Concept of Visible Mesh and Possibilities for Analysis of Mesh Migration and Shrinkage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .457
VI Strategy to Improve Results 60 61
Who Has the Major Role in Hernia Surgery: The Surgeon or the Material? . . . . . . . . . . . . . . .463 Two Controversial Concepts: Standard Procedure in a Standard Patient Versus Tailored Surgery with Procedures Adjusted to Individual Patients . . . . . . . . . . . . . . . . . . . . . .467
XIII Contents
VII 62 63
64 65 66 67
68
Pro and Contra
In Support of a Standard Technique for Inguinal Hernia Repair . . . . . . . . . . . . . . . . . . . . .475 In Support of Individual Selection of Technique as Related to the Patient– Improvement by Better Selection of Patients Who Can Be Offered a Less Risky Technique: Groin Hernia . . . . . . . . . . . . . . . . . . .479 In Support of Standard Procedure in Abdominal Hernia Repair . . . . . . . . . . . . . . . . . .485 In Support of Individualized Procedures in Abdominal Wall Hernia Repair . . . . . . . . . . .493 In Support of Standard Procedure in Hiatal Hernia Repair . . . . . . . . . . . . . . . . . . . . . . . .503 Strategy To Improve the Results? In Support of Individualized Procedures in Hiatal Hernia Repair . . . . . . . . . . . . . . . . . . . . .513 Questionnaire . . . . . . . . . . . . . . . . . . . . . . . . . . . . .521 Subject Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .525
I
I
Risk for the Spermatic Cord
1
Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion? – 3
2
The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model – 13
3
Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model–Preliminary Results – 21
4
Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats – 29
5
The Effects of a Mesh Bioprosthesis on the Spermatic Cord Structures – 39
6
Influence of Prosthetic Implants on Male Fertility in Rats – 43
7
What Can We Do To Decrease the Risk of Vas Deferens Injury due to Inguinal Hernioplasty? – 49
8
The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis Used for Inguinal Hernia Repair – 57
9
Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like? – 65
10
Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review – 71
1
Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion? O. N. Dilek
4
Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
Introduction
1 The spermatic cord anatomy has been well studied because of its important role in testicular physiology and surgery. The spermatic cord is composed of the vas deferens; testicular vessels, including the testicular artery and veins; autonomous nerves; spermatic muscle; and fascia [1]. Each of these structures can have various effects on testicular perfusion. The testicular arteries arise from the abdominal aorta just below the renal artery and travel in the intermediate stratum of the retroperitoneum to reach the internal inguinal ring and become a component of the spermatic cord [1]. In an intraoperative dissection study of over 100 spermatic cords, Beck et al. identified a single internal spermatic artery in 50% of cases, with two arteries in 30% of spermatic cords and three arteries in 20% [1]. At the internal ring, the vessels are joined by the genital branch of the genitofemoral nerve, the ilioinguinal nerve, the cremasteric artery, the vas deferens, and its artery. The testicular artery branches into an internal artery and an inferior testicular artery and into a capital artery to the head of the epididymis [1]. Human testicular parenchyma receives approximately 9 ml of blood per 100 g of tissue per minute. Silber showed that an interruption of the testicular blood supply may result in testicular atrophy [2]. The spermatic veins (testicular veins) collect the blood from the testis, epididymis, and scrotum. The testicular veins form several highly anastomotic channels that surround the testicular artery as the pampiniform plexus. This arrangement allows countercurrent heat exchange, which cools the blood in the testicular artery [1]. The vascular arrangement in the pampiniform plexus–with the counterflowing artery and veins separated only by the thickness of their vascular wall in some areas– facilitates the exchange of heat and small molecules. For example, testosterone is transported from the vein to the artery via a concentrationlimited passive diffusion process. The countercurrent exchange of heat in the spermatic cord provides blood to the testis, which is a specialized structure that functions optimally at 2–4°C lower than the rectal temperatures in normal men [3, 4]. A loss of the temperature differential is associated
with testicular dysfunction [1, 3]. At the level of the inguinal canal, the vein joins to form two or three channels and then a single vein that drains into the inferior vena cava on the right and the renal vein on the left [1, 5]. The cremasteric muscle is one of the parts of the spermatic cord. When this muscle contracts, the cord is shortened, and the testicle is moved closer up toward the body, a position that provides slightly more warmth to maintain optimal testicular temperature. When cooling is required, the cremasteric muscle relaxes, and the testicle is lowered away from the warm body and is able to cool. This phenomenon is known as the cremasteric reflex [6]. The dartos muscle is a sympathetically innervated dermal muscle layer within the scrotum, distinct from the somatically innervated cremasteric muscle. Abnormalities of dartos and cremasteric muscle innervation may impact testis thermoregulation and spermatogenesis [6]. Autonomous nerves reach the testis accompanying the testicular artery and pampiniform plexus. The vast majority of testicular nerves are sympathetic axons with vasomotor function. They innervate the small vessels supplying clusters of Leydig cells and regulate testicular luteinizing hormone receptors and blood flow [7, 8]. About 10% of people develop some type of hernia during their lifetime, and more than 750,000 hernia operations are performed in the United States each year. Hernias are seven times more common in males than in females [9]. Abramson et al. reported that the overall current risk for a male to have an inguinal hernia is 18%, and the lifetime risk is 24% [10]. Anatomically, a close relation exists between the spermatic cord and inguinal hernias. Inguinal hernias can carry the risk of ischemia of the testis by intermittent mechanical compression (pressure) on the testicular vessels [11, 12]. In some reports, color Doppler ultrasonography showed that, preoperatively, the sonographic resistive index (RI) was significantly elevated in the affected (hernia) side compared with the normal side [13]. On the other hand, Muñoz Sánchez et al. concluded that uncomplicated inguinal hernias cause no significant alterations in the arterial circulation of the testicle [14].
5 Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
The laparoscopic totally extraperitoneal preperitoneal (TEP) hernia repair technique, which is based on the concept of tension-free high ligation of the sac, has become widely popular in surgical practice [15–18]. Lichtenstein hernia repair (LHR) is one of the most comfortable effective methods of inguinal hernia repair, and it has similarities with TEP because of the prosthetic mesh used [19]. Despite the frequency of open and laparoscopic herniorrhaphy, the effects of a hernia and its subsequent repair on testicular perfusion and function are unknown. It is presently unclear what the best method is for reconstructing the deep inguinal ring in hernia surgery with mesh implantation. Testicular dysfunction (atrophy) is one of the most dreaded sequelae of inguinal hernioplasty. However, literature findings show that testicular atrophy occurs in 0–2% of patients after herniorrhaphy [9, 20]. Yavetz et al. reported that among 8,500 patients attending a fertility clinic because of infertility, 565 men (6.65%) reported an incidence of inguinal hernioplasty with or without subsequent atrophy of the testis [21]. The preoperative and postoperative use of color Doppler ultrasound (CDUS) to evaluate the spermatic cord structure and scrotal structure has been well documented in testicular pathologies and hernias [22–24]. CDUS is extremely helpful in all cases to investigate extratesticular vascularization and testicular perfusion, with parameters optimized to display low-flow velocities, including peak systolic velocity (PSV) and end diastolic velocity (EDV). Lefort and colleagues showed that color Doppler examination of the scrotum should include measurement of intratesticular RI, as an elevated RI can be suggestive of ischemia [25]. However, most of these conditions have not been well documented using CDUS after TEP or LHR. We have discussed the previously unreported use of testicular CDUS in patients who underwent TEP or LHR. Damage to the spermatic cord structures, testicular atrophy, and dysfunction levels as a consequence of mesh application are not well known in adults. The purpose of this study was to evaluate the efficacy of prosthetic meshes on testis perfusion and testis volume with Lichtenstein and TEP hernia repair techniques.
1
Materials and Methods In our prospective randomized series of 82 patients, 26 of them (age 24–71 years) fulfilled the inclusion criteria and underwent elective herniorrhaphy for groin hernia [26]. In patients with an American Society of Anesthesiologists (ASA) score of more than II, having a hydrocele and/or a varicocele could alter the testicular function independent of the hernia repair [27, 28]. For this reason, patients with the following conditions were excluded from the study: hernia types Ia, IIb, III, or IV according to the Nyhus classification [16, 29]; ASA scores of III, IV, or V; or hydrocele and/or varicocele. Other exclusion criteria were recurrence, conversion to an open procedure, or the inability to provide informed consent. Scrotal hernias or large hernias are predisposing factors for testicular atrophy (type IIb or larger), and very small hernias (type Ia) are not suitable for TEP or LHR methods. Thus, giant scrotal hernias were also excluded in our study [26]. Each patient was randomly assigned to one of two groups: TEP (n=13, mean age 46.7±1.6 years) or LHR (n=13, mean age 54.2±2.7 years). Six of the patients had bilateral hernias (n=3 for each group). CDUS of the testes was performed on all patients the day before operation and 3 months after operation. The scrotum was examined with a linear (5 MHz) transducer (ATL Ultramark 9, USA). Color Doppler settings were optimized to detect slow flow, with the highest color gain setting allowing an acceptable signal-to-noise ratio, the lowest wall filter, and the lowest velocity scale. Ultrasound of the scrotum was performed in the supine position, and the patient was asked to hold the penis suprapubically. Blood flow parameters of the spermatic artery were evaluated and noted as PSV, EDV, and calculated RI. The investigation protocol was approved by the ethics committee of our institution. Patient groups were compared with each other, and the nonoperated side was compared with the operated side. Kruskal–Wallis and Mann–Whitney U–tests were used to evaluate the differences. A two-sided p-value <0.05 was considered significant [26].
6
Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
Results
1 In our series, the mean patient age was 49.6±1.7 (range 24–71) years; in the LHR group, 54.2±2.6 (range 26–71) years; and in the TEP group, 46.7±1.7 (range 32–62) years. We found no significant changes in blood flow parameters (PSV, EDV, RI) when comparing the two groups preoperatively and postoperatively (⊡ Tables 1.1 and 1.2). Also, there were no significant changes in the blood flow parameters when the TEP and LHR groups were compared with each other [26].
⊡ Table 1.1. Peak systolic velocity (PSV), end diastolic velocity (EDV), and resistive index (RI) measurements in the totally extraperitoneal group (NS not significant) Preoperative
Postoperative
PSV
18.18±1.03
17.84±1.11
EDV
6.68±0.48
6.07±0.37
RI
0.62±0.017
0.63±0.018
p
NS
⊡ Table 1.2. Peak systolic velocity (PSV), end diastolic velocity (EDV), and resistive index (RI) measurements in the Lichtenstein repair group (NS not significant)
Discussion All inguinal hernia repair techniques aim to close the internal ring with a suture or a biomaterial such as polypropylene mesh. Concern has been raised about whether the spermatic cord structures are compromised with these techniques The spermatic cord structures may be exposed to invasive surgical intervention during inguinal hernia reconstruction. Surgical dissection, division, or mechanical trauma to the spermatic artery and veins accounts for serious trophic changes in the testis. Lee et al. have explained that surgical manipulation of the spermatic cord imparts a small but statistically significant morphological change in testicular size without a deleterious effect on testicular development, fertility, or fecundity [20]. Many factors can lead to decreased or interrupted testicular perfusion. In some reports, inguinal hernia may impair testicular blood flow, which may be attributable to the effect of intermittent mechanical compression on the funiculus spermaticus in the inguinal canal [11–13, 25]. Testicular artery and vein injuries, thrombosis of the spermatic vein plexus, and testicular torsion are the major factors influencing testicular perfusion. Furthermore, the implantation of a nonabsorbable polypropylene mesh during hernia repair causes a chronic foreign body reaction involving the surrounding tissue. In cases of inguinal hernia repair using different mesh techniques, the spermatic cord structures are potentially affected by this chronic inflammatory tissue remodeling [30].
Preoperative
Postoperative
PSV
17.30±0.98
17.24±0.78
EDV
5.51±0.29
5.70±0.29
RI
0.65±0.017
0.66±0.014
p
NS
However, many authors have reported that the testes have more vessels than expected. Testicular arterial anatomy has been well studied because of its important role in testicular physiology and testicular surgery. Anatomically, the spermatic artery divides into two branches near the testis. Jarow et al. showed that the frequent early branching of the internal spermatic artery prevents inadvertent interruption of testicular arterial blood flow during operations performed on the spermatic cord within the inguinal canal [31]. The testicular artery penetrates the tunica albuginea at the lower pole, proceeding as the capsular artery. Using CDUS, a transmediastinal artery is visible in the upper third of the testis in 50%. Branches from the capsular artery course through the parenchyma in the testicular septations as afferent arteries and are directed to the gonadal hilum. The testicular veins are not consistently visible with CDUS [23]. Many studies suggest an unknown or alternative (collateral) connection between vessels of the cord and other vessels that supply blood to the testis [14, 32–34]. Zomorrodi and Buhluli explained that they isolated and ligated the spermatic cord at the internal ring of the inguinal canal for transfixation and placed the allografted
7 Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
Thrombosis Ligating /Cutting Hematoma Inflammation Fibrosis
1
Ischemic orchitis Testicular ischemia
Testicular atrophy
kidney in the retroperitoneal position with anastomoses of the iliac vessels, and that mass ligation of the spermatic cord did not lead to any ischemic problems in the follow-up period [33]. Zát’ura et al. concluded that in the great majority of men, the blood supply of the testis is ensured by collateral circulation [34]. It is well known that thrombosis, ligation, and/ or cutting of the spermatic vessels may lead to ischemia, ischemic orchitis, and testicular atrophy (⊡ Fig. 1.1). Ischemic orchitis typically presents 2–3 days after inguinal hernia surgery and can progress to infarction. This ischemic injury is likely due to thrombosis of the venous plexus rather than to iatrogenic arterial injury or inappropriate closure of the inguinal canal [32]. Venous outflow obstruction secondary to thrombosis of the pampiniform plexus can also cause testicular infarction as a result of overzealous dissection of the cord or excessive use of diathermy; it may also be the result of pressure from a large hematoma in the groin [35]. Testicular torsion significantly reduces testicular vascular perfusion. Turner et al. reported that in an experimental study, experimental torsion significantly reduced testicular vascular perfusion. Five minutes after torsion repair, the mean flow values had returned to approximately 70% of the pretorsion values. Testicular torsion significantly reduced the venous plasma testosterone concentrations at both 3 and 30 days after torsion repair. These authors suggest that reperfusion/oxidative stress may play a role in Leydig cell dysfunction, as well as acting directly in germ cell apoptosis [36].
⊡ Fig. 1.1. Ischemic conditions and their relationship to testicular perfusion and testicular atrophy
Testis perfusion can be maintained for a prolonged period in the presence of testicular torsion. Anatomical variability may account for differences in the duration of viability of the torsed testis [37]. It is clear that impairment of testicular perfusion can lead to testicular damage (atrophy). Other causes also exist, such as obstruction of the vas deferens, inguinal hematoma, infections, and immunological reactions [21, 38]. For about 25 years, the use of prosthetic materials for repairing inguinal hernias has been routine in general surgery. An estimated 80% of inguinal hernia operations involve placement of a prosthetic mesh to form a »tension-free« herniorrhaphy. The prosthetic mesh induces a chronic foreign body fibroblastic response, creating scar tissue that imparts strength to the floor and leads to fewer recurrences [38]. The use of prosthetic materials for inguinal hernia markedly reduces the recurrence rates, postoperative hospital stay, pain, and discomfort. But the prosthesis frequently adheres to the cord structures in most cases. The disadvantages include local wound complications, technical difficulties in hernia repair, restriction of mobility by the rigid shell (⊡ Fig. 1.2), contraction of the mesh, and complications related to the cord structures, such as varicocele, hydrocele, ischemic orchitis, testicular atrophy, and, finally, infertility [39]. In our study, we aimed to study the effects of the TEP and LHR techniques on testicular circulation [26]. We did not find any significant differences between the techniques regarding blood flow in the testes. Our previous report included
8
Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
1
⊡ Fig. 1.2. Prosthetic mesh induces a chronic foreign body reaction involving the surrounding tissue and the spermatic cord structures, which could impair testicular perfusion and lead to testicular atrophy
the same population, and neither TEP nor LHR affected testicular function; TEP did decrease testicular volume, but by normal limits [40]. The influence of the Lichtenstein and Shouldice operations on the cord structures was investigated in a canine model. Similar to our results, no significant differences with regard to testicular volume and blood flow were found between the operation groups or between the preoperative and postoperative results [41, 42]. Many clinical studies have reported similar results in which the choice of either the Lichtenstein or TEP hernia repair technique did not significantly alter testicular function. Patients with inguinal hernia have an elevated testicular vascular resistance, which is reversed after repair. The choice of laparoscopic or open herniorrhaphy did not affect reversal of this surrogate of testicular function [13, 42, 43]. Laparoscopic inguinal hernia repair using suture closure of the internal inguinal ring does not impair testicular perfusion. Advantages of the laparoscopic approach also include its technical ease and the fact that it is an outpatient procedure, the cord structures remain untouched, the type of hernia is obvious, and clear visualization of the anatomy can be achieved [44]. However, some clinical and experimental studies revealed a dense fibroblastic response encompassing the polypropylene mesh that either
trapped or obliterated the testicular vessels and vas deferens [30, 38]. Peiper et al. [45] reported that implantation of a nonabsorbable polypropylene mesh in the inguinal region during hernia repair causes a chronic foreign body reaction involving the surrounding tissue and the spermatic cord structures in pigs. They observed that venous thrombosis of the spermatic veins occurred in five of 15 cases. The mesh repair may also lead to decreases in arterial perfusion, testicular temperature, and the rate of regular spermatogenesis in seminiferous tubules. Therefore, they recommend strict indications for implanting a prosthetic mesh during inguinal hernia repair [45]. Prosthetic meshes can contract by 20–75% of their original size within a year after implantation in the inguinal region. Taylor et al. set out to determine whether this contraction has any effect on testicular or femoral vessel blood flow following open or laparoscopic hernia repair. They found that mesh contraction following inguinal hernioplasty does not adversely affect the testis or femoral vessels and that mesh can be used safely for both anterior and preperitoneal approaches [46]. With Doppler, the flow in the spermatic artery and testicular artery and its branches is of low resistance, with a relatively broad systolic part and holodiastolic flow. CDUS enables a definitive diagnosis of ischemia and decreased testicular
9 Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
circulation. A pitfall to remember in the diagnosis is that hypervascularity can occur [47]. Testicular and epididymal swelling along with a slightly decreased echogenicity have been reported to develop in the first hours, although in most cases the hypoechogenicity occurs later, so examining the testis 3 months after the operation seems to be more rational, as was done in our study [48, 49]. There are many clinical and experimental study results concerning whether testicular perfusion is adversely affected. We thought it would be difficult to impair testicular perfusion after hernia repair because of the rich arterial supply and collateral capacity. Arterial input and venous drainage of the testis are assured by many anastomoses that protect it from ischemic injury [50–52]. Careful dissection and preservation of the vessels are important to protect these anastomoses during hernia repair. The idea that deep ring repair that is too tight may cause testicular ischemia is erroneous. There are also many ways to protect testicular perfusion. Surgeons should be trained to repair all inguinal hernias at diagnosis, even if asymptomatic. This treatment practice will decrease and prevent complications such as incarceration and strangulation; moreover, herniorrhaphy becomes more difficult the longer that repair is delayed [9, 11]. Trauma to spermatic cord structures should be minimized and the incidence of testicular atrophy reduced by limiting dissection trauma to the spermatic cord, by never dissecting beyond the pubic tubercle, by leaving distal indirect hernia sacs attached to the cord, and, as in recurrent hernias, by avoiding dissection of the spermatic cord altogether by employing a posterior preperitoneal approach [35]. Preserving the cremasteric muscle fibers and reconstructing the fascia can protect the structures of the spermatic cord from the inflammatory reaction [45]. Overzealous dissection of a distal hernia sac, dislocation of the testis from the scrotum into the wound, and concomitant scrotal surgery should be avoided [50]. Patients considering polypropylene mesh herniorrhaphy need to be carefully advised about potential obstruction and compromise to future fertility in men, especially those of young reproductive age or with a solitary testicle [38].
1
Preperitoneal repairs should be considered for repairs of recurrent hernias, not only to reduce further recurrences but also to avoid testicular complications [53]. Using an intraperitoneal composite mesh onlay and assuring safe fixation with fibrin glue could be an alternative when treating recurrent and complicated inguinal hernias [54]. In conclusion, neither TEP nor LHR affected testicular circulation in our study [26]. The total number of patients in our study was a limitation. It is clear that fine surgical dissection and reconstruction with respect for anatomy and the use of proper prosthetic material could lead to the best results. To be consistent, future animal and clinical studies must be performed in large groups and focus on the use of mesh, which may increase the intensity of the mesh reaction to the cord structures.
References 1. Brooks JD (2007). Anatomy of the lower urinary tract and male genitalia. In: Wein AJ (ed) Campbell–Walsh urology, 9th edn. Saunders Elsevier, China, pp 38–77 2. Silber SJ (2000). Microsurgical TESE and the distribution of spermatogenesis in non-obstructive azoospermia. Hum Reprod 15(11):2278–2284 3. Mieusset R, Bujan L, Mansat A, Pontonnier F, Grandjean H (1987). Hyperthermia and human spermatogenesis: enhancement of the inhibitory effect obtained by »artificial cryptorchidism.« Int J Androl10(4):571–580 4. Kurz KR, Goldstein M (1986). Scrotal temperature reflects intratesticular temperature and is lowered by shaving. J Urol 135(2):290–292 5. Mihalache G, Indrei A, Mihalache GD (1996). The vasa vasorum in the veins of the spermatic cord. Rev Med Chir Soc Med Nat Iasi 100(3–4):180–182. [Romanian with English abstract] 6. Yilmaz U, Yang CC, Berger RE (2006). Dartos reflex: a sympathetically mediated scrotal reflex. Muscle Nerve 33(3):363–368 7. Wrobel KH, Abu-Ghali N (1997). Autonomic innervation of the bovine testis. Acta Anat (Basel) 160(1):1–14 8. Schlegel PN, Hardy MP, Goldstein M (2007). Male reproductive physiology. In: Wein AJ (ed) Campbell–Walsh urology, 9th edn. Saunders Elsevier, Philadelphia, pp 577–608 9. Fitzgibbons RJ, Filipi CJ, Quinn TH (2005). Inguinal hernias. In: Brunicardi FC (ed) Schwartz’s principles of surgery, 8th edn. McGraw-Hill, New York, pp 1353–1394 10. Abramson JH, Gofin J, Hopp C, et al. (1978). The epidemiology of inguinal hernia. A survey in western Jerusalem. J Epidemiol Community Health 27:300
10
1
Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
11. Hager J, Menardi G (1986). Ischemic damage of the testis as a complication of incarcerated hernia in the infant. Padiatr Padol 21(1):17–24 [German with English abstract] 12. Turgut AT, Ölçücüoğlu E, Turan C, et al. (2007). Preoperative ultrasonographic evaluation of testicular volume and blood flow in patients with inguinal hernias. J Ultrasound Med 26(12):1657–1666 13. Beddy P, Ridgway PF, Geoghegan T, Peirce C, Govender P, Keane FB, Torreggiani WC, Conlon KC (2006). Inguinal hernia repair protects testicular function: a prospective study of open and laparoscopic herniorrhaphy. J Am Coll Surg 203(1):17–23 14. Muñoz Sánchez MJ, Muñoz Fernández L, Prados Olleta N, Vara Thorbeck R (2005). Testicular-epididymal hemodynamics and inguinal hernia. Eur Surg Res 37(4):257–264 15. Stoppa RE, Waarlaumont CR (1989). The preperitoneal approach and prosthetic repair of groin hernia. In: Nyhus LM, Condon RE (eds) Hernia, 3rd edn. Lippincott, Philadelphia 16. Nyhus LM, Condon RE, Harkins HN (1960). Clinical experiences with preperitoneal hernial repair for all types of hernia of the groin, with particular reference to the importance of transversalis fascia analogues. Am J Surg 100:239–244 17. Kingsley D, Vogt DM, Nelson T, et al. (1998). Laparoscopic intraperitoneal onlay inguinal herniorrhaphy. Am J Surg 176:548–553 18. McKernan JB, Laws HL (1993). Laparoscopic repair of inguinal hernia using a totally extraperitoneal prosthetic approach. Surg Endosc 7:26–28 19. Collaboration EH (2000). Laparoscopic compared with open methods of groin hernia repair: systematic review of randomized controlled trials. Br J Surg 87:860–867 20. Lee SL, DuBois JJ, Rishi M (2000). Testicular damage after surgical groin exploration for elective herniorrhaphy. J Pediatr Surg 35(2):327–330 21. Yavetz H, Harash B, Yogev L, Homonnai ZT, Paz G (1991). Fertility of men following inguinal hernia repair. Andrologia 23(6):443–446 22. Ponka JL (1980). Early and late postoperative complications and their management. In: Ponka JL (ed) Hernias of the abdominal wall. Saunders, Philadelphia, pp 605–618 23. Oyen RH (2002). Scrotal ultrasound. In: Baert AL (ed) Syllabus ultrasound. Springer, Berlin, pp 280–295 24. Hostman WG (1997). Scrotal imaging. Uroradiology 24:653–671 25. Lefort C, Thoumas D, Badachi Y, Gobet F, Pfister C, Dacher JN, Benozio M (2001). Ischemic orchiditis: review of 5 cases diagnosed by color Doppler ultrasonography. J Radiol 82(7):839–842 26. Dilek ON, Yücel A, Akbulut G, Değirmenci B (2005). Are there adverse effects of herniorrhaphy techniques on testicular perfusion? Evaluation by color Doppler ultrasonography. Urol Int 75:167–169 27. Segenreich E, Israilov SR, Shmueli J, Niv E, Servadio C (1997). Correlation between semen parameters and ret-
28.
29. 30.
31.
32.
33.
34.
35. 36.
37.
38.
39.
40.
41.
42.
43.
rograde flow into the pampiniform plexus before and after varicocelectomy. Eur Urol 32(3):310–314 Sigman M, Jarow JP (1997). Ipsilateral testicular hypotrophy is associated with decreased sperm counts in infertile men with varicoceles. J Urol 158(2):605–607 Wantz GE (1986). Testicular atrophy as a sequela of inguinal hernioplasty. Int Surg 71:159–163 Peiper C, Junge K, Klinge U, Strehlau E, Krones C, Ottinger A, Schumpelick V (2005). The influence of inguinal mesh repair on the spermatic cord: a pilot study in the rabbit. J Invest Surg 18(5):273–278 Jarow JP, Ogle A, Kaspar J, Hopkins M (1992). Testicular artery ramification within the inguinal canal. J Urol 147(5):1290–1292 Moore JB, Hasenboehler EA (2007). Orchiectomy as a result of ischemic orchitis after laparoscopic inguinal hernia repair: case report of a rare complication. Patient Saf Surg 1(1):3 Zomorrodi A, Buhluli A (2008). Viable testis after retroperitoneal mass cord ligation in internal ring of inguinal canal in 15 kidney recipients: five years of experience. Transplant Proc 40(1):208–209 Zát’ura F, Student V, Fiala R, Vrtal R (1997). Personal experience with peroperative study of testicular blood flow in laparoscopic surgery of varicocele. Rozhl Chir 76(9):419– 420 Wantz GE (1982). Testicular atrophy as a risk inguinal hernioplasty. Surg Gynecol Obstet 154(4):570–571 Turner TT, Bang HJ, Lysiak JJ (2005). Experimental testicular torsion: reperfusion blood flow and subsequent testicular venous plasma testosterone concentrations. Urology 65(2):390–394 Bentley DF, Ricchiuti DJ, Nasrallah PF, McMahon DR (2004). Spermatic cord torsion with preserved testis perfusion: initial anatomical observations. J Urol 172(6 Pt 1):2373–2376 Shin D, Lipshultz LI, Goldstein M, et al (2005). Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia. Ann Surg 241(4):553–558 Homonnai ZT, Fainman N, Paz GF, David MP (1980). Testicular function after herniotomy. Herniotomy and fertility. Andrologia 12:115–120 Akbulut G, Serteser M, Yücel A, et al. (2003). Can laparoscopic hernia repair alter function and volume of testis? Randomized clinical trial. Surg Laparosc Endosc Percutan Tech 13:377–381 Uzzo RG, Lemack GE, Morrissey KP, Goldstein M (1999). The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 161:1344–1349 Ersin S, Aydin U, Makay O, et al. (2006). Is testicular perfusion influenced during laparoscopic inguinal hernia surgery? Surg Endosc 20(4):685–689 Zieren J, Beyersdorff D, Beier KM, Müller JM (2001). Sexual function and testicular perfusion after inguinal hernia repair with mesh. Am J Surg 181(3):204–206
11 Chapter 1 · Are There Adverse Effects of Herniorrhaphy Techniques on Testicular Perfusion?
44. Schier F (2006). Laparoscopic inguinal hernia repair–a prospective personal series of 542 children. J Pediatr Surg 41(6):1081–1084 45. Peiper C, Junge K, Klinge U, Strehlau E, Ottinger A, Schumpelick V (2006). Is there a risk of infertility after inguinal mesh repair? Experimental studies in the pig and the rabbit. Hernia 10(1):7–12 46. Taylor SG, Hair A, Baxter GM, O’Dwyer PJ (2001). Does contraction of mesh following tension free hernioplasty effect testicular or femoral vessel blood flow? Hernia 5(1):13–15 47. Leung WYM, Poon M, Fan TW, et al. (1999): Testicular volume of boys after inguinal herniotomy: combined clinical and radiological follow-up. Pediatr Surg Int 15: 40–41 48. Oyen RH (2002). Scrotal ultrasound. In: Baert AL (ed) Syllabus ultrasound. Springer, Berlin, pp 280–295 49. Hostman WG (1997). Scrotal imaging. Uroradiology 24:653-671 50. Reid I, Devlin HB (1994). Testicular atrophy as a consequence of inguinal hernia repair. Br J Surg 81:91–93 51. Fong Y, Wantz GE (1992). Prevention of ischemic orchitis during inguinal hernioplasty: experience with 6454 hernioplasties in male patients. Surg Gynecol Obstet 174:399–402 52. Koontz AR (1965). Atrophy of the testicle as a surgical risk. Surg Gynecol Obstet 120:511–513 53. Wantz GE (1993). Testicular atrophy and chronic residual neuralgia as risks of inguinal hernioplasty. Surg Clin North Am 73(3):571–581 54. Olmi S, Scaini A, Erba L, Bertolini A, Croce E (2007). Laparoscopic repair of inguinal hernias using an intraperitoneal onlay mesh technique and a Parietex composite mesh fixed with fibrin glue (Tissucol). Personal technique and preliminary results. Surg Endosc 21(11):1961–1964
Discussion Fitzgibbons: Your technique with color Doppler is very good, investigating the circulation of the testis. How good is it for testing the venous? Dilek: I don’t have additional information about that because this part of the study was done by the radiologist. Smeds: At first, do you have an idea if there is a change of the testicular temperature, and second, do you know if there is a connection between decrease of temperature and sperm production? Dilek: That was not our topic, so I can’t give you more information about that. Schumpelick: How can we decide about testicular function that may be influenced by this method if we don’t analyze the function? I mean, temperature is not a function.
1
2
The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model A. Montgomery and F. Berndsen
14
Chapter 2 · The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model
Introduction
2
According to the Swedish Hernia Register [1], an estimated 80% of inguinal hernia operations involve placement of a polypropylene mesh, with a majority performed as a Lichtenstein procedure. The Lichtenstein technique is regarded as the gold standard in Sweden; this is probably in accordance with most other countries. A prosthetic mesh induces a chronic foreign body reaction with fibroblastic ingrowth into the mesh and subsequent scar plate formation. This is believed to reinforce the abdominal wall and thereby decrease the risk of recurrence by 50–70% [2]. The foreign body reaction leads to chronic inflammation, which can cause retraction of the mesh area and shrinkage of the scar plate. As a result, tension can be put to the anchoring points of the mesh, which might cause chronic pain. Patients might also have individual reactions to meshes with different properties. These might be some of the factors causing chronic pain in up to 15–30% of patients operated on for inguinal hernias in whom mesh is used [3, 4]. It has been suggested that the foreign body reaction is proportionate to the weight and structure of the mesh and that commonly used meshes contain too much material, producing an exaggerated response [5, 6]. To minimize these effects, composite meshes have been introduced that contain one absorbable and one nonabsorbable part. By the use of composite meshes, the reinforcement and manageability properties desired at operation and in the early phase can thereby be satisfied together with a reduction in the total amount of mesh left permanently in the patient. Problems other than chronic pain that might be associated with chronic inflammation caused by mesh include sexual dysfunction and infertility. These problems are not well understood. Infertility can be related to the handling of the spermatic cord during inguinal herniorrhaphy. Injury to the vas as well as the spermatic vessels can result in infertility. Ischemic injury to the testicle that eventually leads to atrophy is reported to occur in about 0.5% of patients having primary hernia repair and 5% with recurrent hernia repairs [7, 8]. Another potential mechanism for infertility is a foreign
body reaction resulting from the use of mesh that comes into contact with the spermatic cord. Bilateral hernia surgery in children is a known risk factor for infertility [9]. In men investigated for infertility, 6.4% are reported to have had an iatrogenic injury to the vas after hernia surgery [10]. To try to minimize some of the inflammatory effects, a composite mesh has been introduced that contains 61% absorbable (polyglactin) and 39% nonabsorbable material (polypropylene; Vypro II). The total weight of polypropylene is 32 g/m2. The aim of this study was to compare a heavyweight polypropylene mesh with a lightweight composite mesh to note the effect on spermatic cord structures and testosterone production in an experimental setting.
Materials and Methods Thirty male Sprague Dawley rats were randomly divided into three groups. A 3-cm long incision was made in the groin, and the spermatic cord was exposed and dissected free. The cremaster muscle was split but not divided. In group I, a suture repair was performed using 5.0 polypropylene sutures (Prolene, Ethicon, Somerville, NJ, USA) in the transversalis fascia, imitating open suture repair. In group II, a 2×3.5-cm heavyweight polypropylene mesh (Prolene, Ethicon, Somerville, NJ, USA) was placed, imitating the Lichtenstein repair. A slit was made in the mesh for the spermatic cord. The mesh was fixed with 5.0 Prolene sutures, and the tails were approximated with one suture. In group III, a large-pore lightweight polypropylene/polyglactin composite mesh, Vypro II (Ethicon, Norderstedt, Germany), was placed as in group II. After 90 days, vasography was performed, and blood samples were taken from the venous plexus of the spermatic cord on both sides. Analysis of stestosterone from the spermatic veins was carried out using competitive radioimmunoassay. Testicles from both sides were weighed. The inguinal areas on both sides were dissected en bloc, including the spermatic cord, the mesh, and the underlying abdominal wall. Light microscopy was performed
2
15 Chapter 2 · The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model
for a cross-section of specimen obtained from the middle of the 3-cm long sample stained with hematoxylin–eosin and van Gieson’s stain. Inflammation and fibrosis were graded separately using a scale from 0 to 3. The sections of the spermatic cord were captured using a camera, and the images were reduced in pixels to obtain a cross-sectional area of the vas deferens from both sides. Continuous and nonparametric data were calculated as the median (interquartile range) and compared using the Mann–Whitney U-test. For comparing operated and control sides, the Wilcoxon signed-rank test was used.
vas deferens in all animals on both sides (⊡ Fig. 2.1). There was no significant difference in testicular weight between the groups or between sides. There was no difference in s-testosterone values between the operated and the control sides in group I or II. However, in group III, s-testosterone values were significantly lower in the operated compared with the control side (⊡ Table. 2.1). There was no significant difference in vas deferens cross-sectional area between the operated and the control side in group I or II, but a difference was seen in group III.
Group I (Suture Repair) vs. Groups II and III (Mesh Repairs)
Results All rats survived the 90-day study period with no wound complications. Vasography revealed patent
There was no difference in s-testosterone from the spermatic vein between the operated sides or between the control sides between the groups (⊡ Table. 2.2). The median grade of inflammation and fibrosis was significant lower in the suture repair group compared with the mesh groups. The inflammation in group I was concentrated around the sutures; no inflammation was seen in sections not including sutures. There was no difference in the cross-sectional area of the vas deferens between the groups.
Group II (Prolene Mesh) vs. Group III (Vypro II Mesh) There was no difference in s-testosterone from the spermatic vein between the operated and the control side between the groups (⊡ Table. 2.3). There
⊡ Fig. 2.1. Vasography showing patent vas deferens
⊡ Table 2.1. Testicular weight, s-testosterone, and vas deferens diameter: operated vs. control side (medians are presented) Group I: suture repair
Group II: Prolene mesh
Group III: Vypro II mesh
Operated side
Control side
p
Operated side
Control side
p
Operated side
Control side
p
s-testosterone (nmol/l)
127
179
0.176
202
260
0.214
83
127
0.008
Vas deferens cross-sectional area (pixels)
157
183
0.753
109
173
0.260
158
187
0.022
16
Chapter 2 · The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model
⊡ Table 2.2. Group I (suture repair) vs. groups II and III (mesh repairs); medians are presented
2
Group I: suture repair
Groups II and III: mesh repairs
p
Testosterone (nmol/l): Operated side Control side
127 179
176 174
0.849 0.935
Inflammation: grade 0–3
1.0 (0–1.3)
2.0 (2.0–2.0)
0.001
Fibrosis: grade 0–3
1.0 (0.8–2.0)
2.0 (1.0–2.5)
0.046
Vas deferens cross-sectional area: Operated side Control side
157 183
152 176
0.400 0.809
⊡ Table 2.3. Group II (Prolene mesh) vs. group III (Vypro II mesh); medians are presented Group II: Prolene mesh
Group III: Vypro II mesh
p
Testosterone (nmol/l): Operated side Control side
202 260
83 127
0.052 0.123
Inflammation: grade 0–3
2.0 (1.5–2.0)
2.0 (2.0–2.0)
0.481
Fibrosis: grade 0–3
2.0 (1.8–2.0)
2.0 (1.0–3.0)
0.696
Vas deferens cross-sectional area: Operated side Control side
109 173
173 187
0.143 0.243
was no difference in the grade of inflammation or fibrosis between the groups. In both groups the inflammation was chronic, with histiocytes concentrated around the mesh material. Giant cells were, however, more prominent in group III (Vypro II), and remaining polyglactin fibres were observed. There was no difference in the cross-sectional area of the vas deferens between the groups.
Conclusion Vasography revealed a patent vas in all animals. The only effects on the cord structures in a rat model were impaired s-testosterone production and a reduced cross-sectional area of the vas after the use of a low-weight composite mesh compared with the control side. This was not demonstrated in the suture repair or heavy polypropylene mesh
groups. No statistical difference in inflammation or fibrosis was seen between heavyweight polypropylene mesh and the low-weight composite mesh. Remaining polyglactin was observed in the lowweight composite mesh group after 90 days.
Discussion Polypropylene meshes have been used in hernia surgery for decades, but their use has increased dramatically the last 10 years. A Cochrane metaanalysis comparing open mesh repairs and conventional repairs revealed a decreased risk of recurrence by 50–75% if mesh were used [2]. The connection between childhood vas injury in inguinal hernia repair has been documented [9]. In adult inguinal hernia surgery, this connection has not been thoroughly studied. This might be of
17 Chapter 2 · The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model
clinical importance because almost 30% of the patients are operated on for bilateral hernias. There could be an injury to the duct structures by dissection, but theoretically, a foreign body reaction around the mesh could also affect the spermatic cord structures because the mesh lies in contact with the spermatic cord. Interest in the latter situation has increased over the last years, and experimental studies have now been performed on dogs, pigs, rabbits, and rats. Uzzo et al. were the first to compare heavyweight polypropylene mesh to conventional (Shouldice) repair in dogs [11]. In their study, all vasograms demonstrated patency, and sperm morphology and motility did not differ between the groups or between the operated and control sides. The patency of the vas was also confirmed in our study. However, Uzzo et al. found morphologic changes of the testis in three out of six animals in the mesh group. No evidence of testicular impairment was seen. They also found a decrease in the cross-sectional diameter of the vas deferens on the operated side compared with the control side in both the suture repair and mesh groups. We reported a cross-sectional reduction only in the Vypro II group and not in the Prolene or the suture repair group. In a later report by Taneli et al., a polypropylene mesh was compared to a sham-operated group in rats [12]. It was concluded that mesh implantation has no effect on testicular hormonal function and only a limited effect on nitric oxide levels, which was not sufficient to cause testicular apoptosis that could lead to infertility. Maciel et al. reported on a study in rats in which bilateral vas deferens dissection was performed and a polypropylene mesh placed on one side [13]. There were no testicular changes, but changes in the vas that caused functional obstruction with dilatation and spermatozoid repression were seen. Two experimental studies from the Aachen group concern findings in pigs and rabbits. The first study consisted of two series, one on pigs and one on rabbits [14]. Preperitoneal Shouldice and Lichtenstein repair were performed, and a polypropylene mesh was used preperitoneally and in a Lichtenstein repair. The mesh repairs resulted in a
2
decrease of arterial perfusion, testicular temperature, and spermatogenesis. The conclusion was that a strict indication for implantation of a prosthetic mesh during hernia repair is recommended. In the second study, low-weight and heavyweight polypropylene mesh were compared in rabbits [15]. Vasography revealed relevant obstructions located at the mesh margins in 50% of the heavyweight and 22% in the lightweight mesh groups after 6 months. This is in contrast to our results, in which all vasograms were normal at 3 months. In another study on rats, Kolbe and Lechner wrapped heavyweight versus low-weight polypropylene mesh around the vas [16]. Fertility was tested and was found to be slightly restricted 4 weeks after surgery in both groups. Some rats in the heavyweight mesh group revealed sperm granulomas due to lesions to the spermatic cord. The conclusion was, however, that neither type of hernioplastic implant indicates a negative influence on male fertility. In a prospective study of 73 patients operated on with the plug-and-patch technique, Zieren et al. measured testicular perfusion and testicular volume preoperatively and at 3 and 6 months postoperatively [17]. No differences between the contralateral side and operated side were seen at follow-up. In the present report, the study period of 90 days was chosen for two reasons. First, the manufacturer claims that the polyglactin part of the Vypro II mesh is totally absorbed in 56–70 days, thus not participating in the inflammation/fibrosis reaction at 90 days. Second, the 90-day period has previously been used and accepted in studies of foreign body reactions [6, 18, 19]. Surprisingly, though, we found remaining polyglactin fibres in the Vypro II specimens after 90 days. This might explain the impaired testosterone production and smaller cross-sectional area of the vas deferens in the Vypro II group compared with the control side. There was, however, no difference in inflammation or fibrosis between the two mesh groups. It is well known that polypropylene mesh induces a foreign body reaction, with chronic inflammation existing even years after implantation [20], but despite millions of mesh implants, only a few reports describe serious adverse effects. Klosterh-
18
2
Chapter 2 · The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model
alfen et al. studied the connection between mesh weight and foreign body reaction, and according to their studies, the level of inflammatory response depends on the weight and texture of the mesh material [20]. The large-pore, lightweight mesh (Vypro II), which has only 30% polypropylene compared with standard meshes, has been suggested as leading to less foreign body reaction [21]. Our study did not confirm these findings. It must be stated that animal studies have their limitations, and the results cannot be directly transferred to humans. This type of study, though, is not possible to do in human patients. The overall effect of meshes in reducing the frequency of recurrence, and thereby reducing the frequency of a second, more complicated hernia operation in which the spermatic cord could be in danger by dissection, might well exceed the potential negative effect of the mesh per se.
10.
11.
12.
13.
14.
15.
References 16. 1. The Swedish Hernia Register (Nationellt kvalitetsregister för bråckkirurgi). http://www.svensktbrackregister.se/.2 2. The EU Hernia Trialist Collaboration (2002) Open mesh versus non-mesh repair of groin hernia meta-analysis of randomized trials based on individual patient data. Hernia 6: 130–136 3. Berndsen FH, Petersson U, Arvidsson D, Leijonmarck C-E, Rudberg C, Smedberg S, Montgomery A (2007) Discomfort five years after laparoscopic and Shouldice inguinal hernia repair: a randomised trial with 867 patients. A report from the SMIL study group. Hernia 11(4):307–313 4. Fränneby U, Sandblom G, Nordin P, Nyrén O, Gunnarsson U (2006) Risk factors for long-term pain after hernia surgery. Ann Surg 244(2):212–219 5. Vrijland WW, van der Tol MP, Luijendijk RW, Hop WCJ, Busschbach JJV, de Lange DCD, van Geldere D, Rottier AB, Vegt PA, Ijzermans JNM, Jeekel J (2002) Randomized clinical trial of non-mesh versus mesh repair of primary inguinal hernia. Br J Surg 89:293–297 6. Klosterhalfen B, Klinge U, Schumpelick V(1998) Functional and morphological evaluation of different polypropylene-mesh modifications for abdominal wall repair. Biomaterials 19:2235–2246 7. Wantz GE (1993) Testicular atrophy and chronic residual neuraligia as risk of inguinal hernioplasty. Surg Clin North Am 73:571–581 8. Fitzgibbons RJ (2005) Can we be sure polypropylene mesh causes infertility? Ann Surg 241(4):559–561 9. Matsuda T, Horii Y, Yoshida O (1992) Unilateral obstruction of the vas deferens caused by childhood inguinal
17.
18.
19.
20.
21.
herniorrhaphy in male infertility patients. Fertil Steril 58:609–613 Sheynkin YR, Hendin BN, Schlegel PN, Goldstein M (1999) Microsurgical repair of iatrogenic injury to the vas deferens. J Urol 159:139–141 Uzzo RG, Lemack GE, Morrissey KP, Godstein M (1999 The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 161:1344–1349 Taneli F, Aydede H, Vatansever S, Ulman C, Ari Z, Uyanik BS (2005) The long-term effect of mesh bioprosthesis in inguinal hernia repair on testicular nitric oxide metabolism and apoptosis in rat testis. Cell Biochem Funct 23(3):213–220 Maciel LC, Glina S, Palma PC, Nascimento LF, Netto NR Jr (2007) Histopathological alterations of the vas deferens in rat exposed to polypropylene mesh. BJU Int 100(1):187– 190 Peiper C, Junge K, Klinge U, Strehlau E, Ottinger A, Schumpelick V (2006) Is there a risk of infertility after inguinal mesh repair? Experimental studies in the pig and the rabbit. Hernia 10(1):7–12 Junge K, Binnebösel M, Rosch R, Ottinger A, Stumpf M, Muhlenburch G, Schumpelick V, Klinge U (2008) Influence of mesh materials on the integrity of the vas deferens following Lichtenstein hernioplasty: an experimental model. Hernia 12(6):621–626 Kolbe T, Lechner W (2007) Influence of hernioplastic implants on male fertility in rats. J Biomed Master Res B Appl Biomater 81(2):435–440 Zieren J, Beyersdorff D, Beier KM, Müller JM (2001) Sexual function and testicular perfusion after inguinal hernia repair with mesh. Am J Surg 181:204–206 Baykal A, Onat D, Rasa K, Renda N, Sayek I (1997) Effects of polyglycolic acid and polypropylene meshes on postoperative adhesion formation in mice. World J Surg 21:579–583 Bellón JM, Contreras LA, Buján J, Palomares D, CarreraSan Martin A (1998) Tissue response to polypropylene meshes used in the repair of abdominal wall defects. Biomaterials 19:669–675 Klosterhalfen B, Klinge U, Hermanns B, Schumpelick V (2000) Pathology of traditional surgical nets for hernia repair after long-term implantation in humans. Chirurg 71:43–51 [German with English abstract] Junge K, Klinge U, Rosch R, Klosterhalfen B, Scumpelick V (2002) Functional and morphologic properties of a modified mesh for inguinal hernia repair. World J Surg 26:1472–1480
)
Discussion Kukleta: Do you think that Vypro II is a good rep-
resentative for a lightweight mesh? The Vypro II has a bigger inflammatory impact than any other lightweight mesh, doesn’t it?
19 Chapter 2 · The Effects of Mesh Bioprosthesis on the Spermatic Cord Structures in a Rat Model
Montgomery: Of course. Indeed, this study was performed in 2003 and published in 2004, and the available meshes at that time were scientifically the most interesting ones. Köckerling: In our various studies with partially resorbable meshes, we always found after the time given by the company some remaining resorbable material in the animals with a high grade of inflammatory reaction around it. We should learn from this to take longer observation periods because the absorption process obviously takes longer than given by the company. Montgomery: That’s why we chose a 90-day interval in our study, but it wasn’t enough. Conze: I just want to make a remark on the animal models used in this context. The diameter of the spermatic cord of small animals differs from human ones, and therefore, the ratio of the diameter of mesh fibers and spermatic cord differs. So the effect of the fibrotic reaction on a very tiny rat vas is much stronger than it might be on a human vas.
2
3
Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model–Preliminary Results K. Junge, M. Binnebösel, C. Kauffmann, R. Rosch, J. Otto, D. Kämmer, F. Schoth, G. Mühlenbruch, U. Klinge, V. Schumpelick
22
3
Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model–Preliminary Results
Introduction
Material and Methods
An estimated 75–80% of inguinal hernia operations involve placing a mesh prosthesis, either laparoscopically or using an open technique, to patch the defect in the floor of the inguinal canal. Foreign body reactions, with fibroblastic ingrowth and chronic inflammation, are believed to reinforce the abdominal wall and decrease the risk of recurrence. It has been proven that this foreign body reaction is proportionate to the weight, structure, and polymer of the mesh and that commonly used meshes contain too much material, producing an exaggerated foreign body reaction/tissue response and leading to clinical complications [1–3]. To minimize the foreign body reaction and clinical complications, new types of mesh materials have been introduced that have a decreased amount of material and larger pores, resulting in a nearby physiologic tissue ingrowth [2, 4, 5]. Further improvement of biocompatibility has been achieved using polyvinylidene fluoride (PVDF) as the polymer [3]. PVDF is a polymer with improved textile and biological properties [6]. Compared with polyester, PVDF is more resistant to hydrolysis and degradation. Furthermore, ageing does not increase the stiffness that is evidently seen in polypropylene. Although it has been used in vascular surgery for some years, there have been limited types of surgical meshes until now. Whereas these so-called lightweight, large-pore, and elastic mesh materials are known to show a favourable outcome considering postoperative pain [7–10] compared with conventional heavyweight, small-pore, and stiff mesh materials, just a few experimental studies have focused on the influence of different mesh materials on the integrity of the vas deferens. With the widespread acceptance and ease of placement, mesh repair is being increasingly offered to young patients whose fertility status may well be an issue in the future. To further elucidate the impact of different mesh materials following Lichtenstein hernia repair, an animal study in the pig was conducted to investigate the long-term effect on integrity of the vas deferens and testicular function.
Mesh Materials Two different mesh materials were investigated: a large porous and elastic mesh made of PVDF monofilaments and Marlex, a small-pore, stiff mesh made of polypropylene (PP) monofilaments (⊡ Fig. 3.1).
Animals Six male uncastrated male pigs were housed under conditions of constant light and temperature and received a complete diet of feed and water ad libitum throughout the entire study, which was performed according to the National Institutes of
a
b ⊡ Fig. 3.1. a A large-pore, elastic mesh made of polyvinylidene fluoride monofilaments. b A small-pore, stiff mesh made of polypropylene monofilaments
23 Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure
Health guidelines for the use of laboratory animals. All animals received bilateral Lichtenstein hernia repair (n=12).
Surgical Procedure Operations were carried out under general anaesthesia. Following premedication using 4 mg/ kg azaperone, 44 μg/kg atropine, and 15 mg/kg ketamine intramuscularly, an intravenous catheter was placed into an ear vein. Anaesthesia was induced by injection of 10–15 mg pentobarbital. Anaesthesia was continued by isoflurane/oxygen as well as continuous infusion of fentanyl (45–90 μg/ kg/h). Following anaesthesia, the skin was shaved and disinfected with a povidone–iodine solution. An inguinal incision was performed and the external oblique fascia dissected. Following exploration of the inguinal canal, a Lichtenstein procedure was carried out using a 7×10-cm slitted mesh sample (PVDF mesh on one side, PP mesh on the contralateral side). Mesh samples were fixed at the inguinal ligament and the mesh slit was closed using 4/0 Prolene sutures. Afterwards, the external oblique fascia and skin were closed. No antibiotic treatment was given before or during the experiments. Throughout the whole observation period, all animals were objectively controlled and underwent daily clinical investigation to assess local and systemic complications. Six
3
months after mesh implantation, all animals (n=6) underwent thermographic investigation of the inguinal region and the testes. Thermographic measurements were performed as a parameter of local perfusion using a VarioCAM basic camera (InfraTec, Dresden, Germany). Following measurement of testicular size by ultrasound, the animals were sacrificed for morphologic observations. The abdomen was opened for complete exploration. The intraabdominal part of the vas deferens was dissected 2 cm before entering the inguinal canal at both sides, and 10 ml of x-ray solution was injected for vasography (13.3 g gelatin, 16.6 g Bleimennige =Pb2PbO4, 100 ml water). Following ligation of the vas deferens, the whole inguinal canal–including the mesh sample as well as the testis–was resected and fixed in 10% formaldehyde (⊡ Fig. 3.2).
Assessment of Integrity of the Vas Deferens Integrity of the vas deferens was assessed semiquantitatively using x-ray vasography. Obstructions of the vas deferens were classified as minor (0–25% reduction in lumen diameter), medium (25–75% reduction), or major (>75% reduction) and were examined at the margins of the mesh samples as well as within the mesh area.
Histological Analysis
⊡ Fig. 3.2. Explanted inguinal area including testis with injected x-ray solution
Tissue specimens were embedded in paraffin. Histological investigation was performed on 3-μm sections after haematoxylin and eosin staining. All sections were processed at the same time to reduce internal staining variations. Spermatogenesis as the main testicular function was estimated histologically using the Johnsen score (⊡ Table 3.1) [11]. Immunohistochemistry was done according to the manufacturer’s instructions. For detection of proliferating cells (Ki67), we used mouse monoclonal antibody MIB-1, 1:10, from Dako (Glostrup, Denmark) and rabbit antimouse antibody 1:300 from Dako (Glostrup, Denmark) as secondary antibody. TUNEL histochemistry for the detection of apop-
24
Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model–Preliminary Results
⊡ Table 3.1. Johnsen score [11] 10
Complete spermatogenesis with many spermatozoa
Thermography Investigating the mean inguinal temperature at the initial incision, no differences were found comparing the PVDF mesh (34.9±0.9°C) with the PP mesh (34.7±0.9°C). Furthermore, no difference was found in testis temperature (PVDF 29.0±1.1°C; PP 29.1±1.1°C; see ⊡ Figs. 3.3 and 3.4).
9
Many spermatozoa present but germinal epithelium
8
Only few spermatozoa (<5–10) present in section
7
No spermatozoa but many spermatids present
6
No spermatozoa and only few spermatids (<5–10) present
Integrity of the Vas Deferens
5
No spermatozoa, no spermatids but several or many spermatocytes present
4
Only few spermatocytes (<5) and no spermatids or spermatozoa present
3
Spermatogonia are the only germ cells present
2
No germ cells but Sertoli cells are present
1
No cells in tubular section
Following explantation, x-ray vasography showed analysable results for all mesh implantations. Overall, relevant obstructions (>75% of lumen diameter; ⊡ Fig. 3.5) were located only at the mesh margins. Whereas four PVDF explants showed no or minor obstructions, one out of six PVDF explants had an obstruction 25–75% of the lumen diameter. The PP mesh group explants were found to have significant obstructions of more than 75% of the lumen diameter in two specimens, as well as obstructions of 25–75% of the lumen diameter in another two. Histologically, no direct infiltration of the mesh fibres into the vas deferens was found. Obstructions were more or less due to compression of the wall of the vas deferens, inducing an inflammatory and fibroblastic reaction in the wall of the vas.
3
totic cells was performed by an in situ apoptosis detection kit (Apoptag, Oncor, cat. no. S7100, Germany). Sections were examined by standard light microscopy (Olympus BX51, Hamburg, Germany). For each sample, five regions within the interface (×400; area 100×100 μm) were captured by a digital camera (Olympus C-3030, Hamburg, Germany). The expression of immunohistochemical parameters was classified by two independent, blinded observers. The extent of staining was graduated as a percentage of positive-stained cells in the specimen (0–100%).
Results Macroscopic Observation The surgical procedure was well tolerated by all animals, and the postoperative period was uneventful. None of the animals developed signs of ischaemic orchitis or testicular atrophy. No differences were seen in testicular volume between the PP (18.9±2.2 cm3) and the PVDF mesh groups (18.1±4.0 cm3).
Histological Analysis Testicular function was estimated histologically. Each testicular sample of 10 seminiferous tubules was classified according to the Johnson score. Following PP mesh implantation, a mean Johnson score of 8.5±0.1 was estimated, which was not significantly different from that for the PVDF mesh samples (8.5±0.3, ⊡ Fig. 3.6). Analysing three out of six mesh explants, each group microscopic investigation of the mesh–hosttissue interface showed typical formation of foreign body granulomas. Investigating the percentage of apoptotic (TUNEL) and proliferating (Ki67) cells, no significant differences were found between the PP (TUNEL 12.7±8.0%; Ki67 7.4±1.8%) and the PVDF mesh samples (TUNEL 3.4±3.3%; Ki67 6.0±2.5%; ⊡ Fig. 3.7).
25 Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure
⊡ Fig. 3.3. Example of temperature measurement using thermography camera
3
⊡ Fig. 3.5. Vasography following mesh implantation; note obstruction of the vas deferens at the margin following polypropylene mesh implantation
⊡ Fig. 3.4. Temperatures (mean ± standard deviation) measured using the thermography system (PP polypropylene, PVDF polyvinylidene fluoride)
⊡ Fig. 3.6. Johnsen score, showing mean ± standard deviation (PP polypropylene, PVDF polyvinylidene fluoride)
26
3
Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model–Preliminary Results
⊡ Fig. 3.7. Percentage (mean ± standard deviation) of (a) proliferating and (b) apoptotic cells at the interface of mesh and the host tissue (PVDF polyvinylidene fluoride, PP polypropylene)
Discussion Obstructive azoospermia is a rare but serious complication following inguinal hernia repair. Although an incidence of iatrogenic perioperative injury to the vas deferens during inguinal hernia repair of 0.3% in adults and 0.8–2.0% in childhood has been described [12], little is known about the long-term effects of different mesh prostheses on the integrity of the vas deferens. Because almost 30% of the patients are operated on for bilateral hernias, and because mesh repair is being increasingly offered to young patients whose fertility status may well be an issue in the future, this item is of major clinical importance. Aside from case reports, just one larger clinical series has been reported. Shin et al. investigated 14 cases of azoospermia secondary to inguinal vasal obstruction related to previous mesh herniorrhaphy [13]. Following open or laparoscopic hernia mesh repair, they reported on nine patients with bilateral obstruction as well as five patients with unilateral obstruction. Surgical exploration revealed a dense fibroblastic response encompassing the polypropylene mesh, with either a trapped or obliterated vas in all patients. The first experimental study investigating this matter was performed by Uzzo et al., comparing six dogs operated with a polypropylene mesh to six dogs operated with conventional (Shouldice) repair [14]. They found a decrease in the cross-sectional diameter of the vas deferens on the operated side compared with the control side in both the suture repair and the mesh groups. Furthermore, mor-
phologic changes of the testis were found in three of six animals in the mesh group. Goldenberg et al. investigated 18 dogs with a follow-up of 60 days and found a chronic inflammatory reaction in 100% on the mesh side, a reduction in spermatogenesis, and a reduction in lumen diameter of the vas deferens on the mesh side [15]. However, studies comparing the effect of different mesh prostheses are rather limited. Peiper et al. investigated spermatic cord perfusion and spermatogenesis in rabbits, comparing Lichtenstein hernia repair using UltraPro (a lightweight, largepore, and elastic mesh) and Marlex (a heavyweight, small-pore, and stiff mesh of polypropylene) with the Shouldice repair [16]. They found a more obvious decrease in spermatic cord perfusion after Marlex mesh repair than after Shouldice repair. In contrast, in our study the analysed temperature (as a parameter of perfusion) showed no differences between the mesh samples in the inguinal region or in the testis. In evaluating spermatogenesis, Peiper’s group noted a decrease in Johnsen score in the seminiferous tubules after Lichtenstein repair independent of the kind of mesh. In our study, a mean Johnsen score of 8.5±0.1 was estimated following PP mesh implantation, which was not significantly different from the group of PVDF mesh samples (8.5±0.3). No control group had been analysed until now. Berndsen et al. compared a low-weight composite mesh (Vypro II) and a heavyweight mesh (Prolene) used for Lichtenstein repair in rats [17]. Ninety days after implantation, a median crosssectional area of the vas deferens was 109 pixels
27 Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure
for the Prolene and 158 pixels for the Vypro II side, with no significant difference. In our study, obstructions were analysed semiquantitatively using vasography. Investigations revealed obstructions that were mainly located at the mesh margins. The stiff PP mesh group showed an overall higher amount and degree of stenosis compared with the smooth PVDF mesh. Next to a significantly reduced inflammatory foreign body reaction of the PVDF (TUNEL 3.4±3.3%; Ki67 6.0±2.5%) compared with the PP mesh (TUNEL 12.7±8.0%; Ki67 7.4±1.8%), the lower number of obstructions was probably due to the elastic textile properties of the PVDF mesh. In contrast to the study by Shin et al., we could find no direct infiltration of the mesh fibres into the vas deferens. Obstructions were mainly due to compression of the wall at the mesh side, with an induced inflammatory and fibrotic reaction in the wall of the vas deferens. To summarize, great effort has been put into the challenge of creating a mesh material that optimises patients’ outcomes. The introduction of improved mesh materials has led to superior outcomes with regard to postoperative pain and foreign body sensation. However, the influence of different mesh materials on spermatic cord structures has not been studied thoroughly. For the first time, the construction of a large-pore and elastic monofilamentous PVDF mesh showed a beneficial effect on the integrity of the vas deferens in an experimental setting. However, no differences were observed in testicular function (temperature, volume, spermatogenesis).
References 1. Klosterhalfen B, Klinge U, Schumpelick V. Functional and morphological evaluation of different polypropylenemesh modifications for abdominal wall repair. Biomaterials 1998; 19(24):2235–2246 2. Junge K, Klinge U, Rosch R, Klosterhalfen B, Schumpelick V. Functional and morphologic properties of a modified mesh for inguinal hernia repair. World J Surg 2002; 26(12):1472–1480 3. Klinge U, Klosterhalfen B, Ottinger AP, Junge K, Schumpelick V. PVDF as a new polymer for the construction of surgical meshes. Biomaterials 2002; 23(16): 3487–3493
3
4. Junge K, Klinge U, Prescher A, Giboni P, Niewiera M, Schumpelick V. Elasticity of the anterior abdominal wall and impact for reparation of incisional hernias using mesh implants. Hernia 2001; 5(3):113–118 5. Klinge U, Klosterhalfen B, Conze J, Limberg W, Obolenski B, Ottinger AP et al. Modified mesh for hernia repair that is adapted to the physiology of the abdominal wall. Eur J Surg 1998; 164(12):951–960 6. Urban E, King MW, Guidoin R, Laroche G, Marois Y, Martin L et al. Why make monofilament sutures out of polyvinylidene fluoride? ASAIO J 1994; 40(2):145–156 7. Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Heikkinen TJ. Three-year results of a randomized clinical trial of lightweight or standard polypropylene mesh in Lichtenstein repair of primary inguinal hernia. Br J Surg 2006; 93(9):1056–1059 8. O’Dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G. Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 2005; 92(2):166–170 9. Horstmann R, Hellwig M, Classen C, Rottgermann S, Palmes D. Impact of polypropylene amount on functional outcome and quality of life after inguinal hernia repair by the TAPP procedure using pure, mixed, and titaniumcoated meshes. World J Surg 2006; 30(9):1742–1749 10. Nienhuijs S, Staal E, Strobbe L, Rosman C, Groenewoud H, Bleichrodt R. Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J Surg 2007; 194(3):394–400 11. Johnsen SG. Testicular biopsy score count–a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones 1970; 1:2–25 12. Pollak R, Nyhus LM. Complications of groin hernia repair. Surg Clin North Am 1983; 63(6):1363–1371 13. Shin D, Lipshultz LI, Goldstein M, Barme GA, Fuchs EF, Nagler HM et al. Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia. Ann Surg 2005; 241(4):553–558 14. Uzzo RG, Lemack GE, Morrissey KP, Goldstein M. The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 1999; 161(4):1344–1349 15. Goldenberg A, Matone J, Marcondes W, Herbella FA, Farah JF. Comparative study of inflammatory response and adhesions formation after fixation of different meshes for inguinal hernia repair in rabbits. Acta Cir Bras 2005; 20(5):347–352 16. Peiper C, Junge K, Klinge U, Strehlau E, Krones C, Ottinger A et al. The influence of inguinal mesh repair on the spermatic cord: a pilot study in the rabbit. J Invest Surg 2005; 18(5):273–278 17. Berndsen FH, Bjursten LM, Simanaitis M, Montgomery A. Does mesh implantation affect the spermatic cord structures after inguinal hernia surgery? An experimental study in rats. Eur Surg Res 2004; 36(5):318–322
28
Chapter 3 · Damage to the Spermatic Cord by the Lichtenstein Procedure in a Pig Model–Preliminary Results
Discussion Kehlet: If we see these very good pictures and
3
compare them to other studies concerning this problem, we should have an agreement using only one model to investigate this problem. Smeds: My question is, you have animals with damage and without damage in both groups with both types of meshes. Did you make a deeper analysis of this damage, and what is the reason for it? Junge: At this point we didn’t perform deeper analysis. We have to look on the histological sections to find out what is the detailed cause for this damage.
4
Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats C. Peiper, K. Junge, A. Oettinger, M. Binnebösel
30
Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
Introduction
4
Modern concepts for treating inguinal hernias always include prosthetic mesh repairs. Some surgeons use the mesh repair exclusively [1]. Reported results are promising concerning recurrence rates [2] and return to physical activity [3]. On the other hand, there is a certain risk of complications due to the mesh that are difficult to detect. Alterations of fertility, if observable, may be recorded only in very large series. We know that prosthetic meshes implanted into the abdominal wall cause chronic inflammatory changes of the surrounding tissue [4]. Because of the close contact between mesh and the structures of the spermatic cord after inguinal mesh repair, these changes may also alter the reproductive structures in male patients. Case reports have been published about spermatic granuloma [5] and spermatoceles [6] after Lichtenstein hernia repair. Especially after mesh implantation in younger patients, these findings may be of great importance. In a rabbit experimental model, we investigated the interaction between mesh and the adjacent spermatic cord concerning the extent of inflammatory changes and their relationship to the material used, the integrity of the deferent duct, and the influence on the testicular function.
Materials and Methods These experiments were officially approved by the district president of North Rhine-Westphalia, Germany (AZ 50.203.2-AC 18, 3/01). All animals received humane care in accordance with the requirements of the German Animal Protection Act. All operations were carried out under general anesthesia. An intravenous catheter was placed into an ear vein. After premedication using subcutaneous buprenorphine 0.3 ml/kg, anesthesia was induced by injection of Domitor 0.3 ml/kg and ketamine 10% 0.2 ml/kg. Anesthesia was continued by repeated injections of these medications. Additionally, the animals were ventilated by isoflurane/air after endotracheal intubation. All animals received pulse oximetry and electrocardiographic monitoring during the operation. The animals were fixed in the supine position. After the fur was
cleaned and shaved, the skin was disinfected using Braunoderm, and the operating field was covered by sterile cloths. All operations were carried out under aseptic and sterile surgical conditions.
Rabbit Study 1 Eight chinchilla rabbits underwent unilateral inguinal hernia repair following the Lichtenstein approach [7]. All rabbits received implantation of a Marlex mesh (Bard, Cranston, RI, USA). This is a small-pore, heavyweight polypropylene mesh. Shouldice repair was carried out on the contralateral side [8]. Another three rabbits served as controls. Under aseptic conditions, the inguinal canal was opened by dividing the external oblique fascia, and the spermatic cord was secured by a loop. We preserved the cremasteric muscle. The Lichtenstein repair was performed with fixation of the mesh at the inguinal ligament and the internal oblique muscle using interrupted Miralene sutures (Miralene 0 HRT 26, Braun-Dexon). The lateral end of the mesh was slit into two tails and closed against the lateral aspect of the internal inguinal ring using Miralene sutures. Afterwards, the contralateral inguinal region was prepared. Here, a simple Shouldice repair was performed following the same extensive preparation using running Miralene sutures. Thus, every animal served as its own control. Animals were kept in standard rabbit cages of 60×60×60 cm at a temperature range of 20–22°C and a light circle of 12 h. They were fed dry pellets (Ssniff, 40 g/animal/day). Three months later, we evaluated testicular changes. The testicular volume was measured by ultrasound and calculated using the formula of a rotating ellipsoid [9]. Testicular temperature was evaluated using a digital thermometer (Voltcraft 300K) with a needle sensor. Arterial perfusion of the spermatic cord and testicles was investigated using the IC-VIEW system (Pulsion Medical Systems, Munich, Germany). Skin and subcutaneous tissue were removed from the lower abdomen, and the scrotal skin was removed completely (⊡ Fig. 4.1a). A 0.5 mg/kg bolus
31 Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
4
⊡ Table 4.1. Johnsen score for qualitative evaluation of spermatogenesis [10]
a
1
No cells in tubular section
2
No germ cells, but Sertoli cells present
3
Spermatogonia are the only germ cells present
4
Only a few spermatocytes (<5) and no spermatids or spermatozoa present
5
No spermatozoa and no spermatids, but several or many spermatocytes present
6
No spermatozoa and only a few spermatids (<5–10) present
7
No spermatozoa, but many spermatids present
8
Only a few spermatozoa (<5–10) present in section
9
Many spermatozoa present, but germinal epithelium disorganized, with marked sloughing or obliteration of lumen
10 b
c ⊡ Fig. 4.1. Testicles and spermatic cord of a rabbit after preparation and before evaluation of arterial perfusion (a), during flush of indocyanine green and under excitation of nearinfrared light (b), and after transfer of the fluorescence intensity into colors (c)
of indocyanine green (ICG) was injected intravenously into the ear vein. Excitation light was provided by an IC-VIEW system camera-mounted near a near-infrared (NIR) light source (780 nm). ICG-derived fluorescence was detected by a digital camera using the super-night-shot mode
Complete spermatogenesis with many spermatozoa (late spermatids)
(⊡ Fig. 4.1b) and was transferred to a computer for further quantification of perfusion-related fluorescence intensity (IC-CALC; ⊡ Fig. 4.1c). We calculated the difference between the intensity before and the maximum intensity after injection as an index for maximum perfusion. This parameter was recorded at the spermatic cord and at the testicles. Spermatogenesis as the main testicular function was estimated histologically using the Johnsen score [10] (⊡ Table. 4.1). The spermatic cords were excised, including the deep inguinal ring. Representative crosssections were obtained at this area and analyzed histologically using hematoxylin and eosin stains, focusing on the inflammatory response to the prosthetic mesh.
Rabbit Study 2 To differentiate among the results of different mesh materials, we conducted an additional animal study using the same conditions and techniques
32
4
Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
mentioned above. We included 20 male chinchilla rabbits. All animals underwent bilateral Lichtenstein repair with a Prolene mesh (Ethicon, Norderstedt, Germany) on one side and Ultrapro mesh (Ethicon, Norderstedt, Germany) on the other side. Analysis followed after 6 months. After explantation of the inguinal region of the abdominal wall, we analyzed the patency of the vas deferens by injecting x-ray solution into the vas (⊡ Fig. 4.2). Additionally, we used light microscopy to measure the size of the foreign body granulomas induced by the meshes. Global statistical analysis was carried out using the Kruskal–Wallis test. For statistics among the groups, we used the Mann–Whitney test.
Injection of x-ray solution ligation of ductus
ductus mesh
testicle
⊡ Fig. 4.2. Vasography after resection of the inguinal region of the abdominal wall
⊡ Fig. 4.3. Testicular volume (ml) 3 months after groin mesh implantation in the rabbit
Results Rabbit Study 1 In the postoperative period, we observed an increased testicular volume (⊡ Fig. 4.3), with no difference between the kinds of repair (p=0.53), and a decreased testicular temperature compared with the controls (⊡ Fig. 4.4). Here, too, the differences among the operations were small (p=0.246). A cause for these findings may be the reduced arterial perfusion that exists after any repair (p<0.05). In comparison to the controls, this decrease in spermatic cord perfusion was more obvious after Lichtenstein repair (p=0.03; ⊡ Fig. 4.5) than after the Shouldice operation. The testicular perfusion was also significantly reduced after Lichtenstein mesh implantation (p<0.05; ⊡ Fig. 4.6). Evaluation of spermatogenesis revealed a decrease in the Johnsen 10 score in seminiferous tubules after Lichtenstein repair. Following Shouldice repair, the testicles showed regular spermatogenesis (p=0.20; ⊡ Fig. 4.7). During histological evaluation of the surrounding tissue, we observed a characteristic foreign body reaction to the mesh (⊡ Fig. 4.8), which we did not find after the Shouldice repairs. Destruction of the vas deferens wall or venous thrombosis was not detected. The duct was patent in all specimens. Obviously, the preserved cremasteric muscle protected the structures of the spermatic cord in this model.
33 Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
4
⊡ Fig. 4.4. Testicular temperature (°C) 3 months after groin mesh implantation in the rabbit
⊡ Fig. 4.5. Spermatic cord perfusion (a.u.) 3 months after groin mesh implantation in the rabbit, analyzed by the IC-VIEW system
⊡ Fig. 4.6. Testicular perfusion (a.u.) 3 months after groin mesh implantation in the rabbit, analyzed by the IC-VIEW system
⊡ Fig. 4.7. Percentage of mature spermatogenesis (Johnsen 10) 3 months after groin operation in the rabbit
34
Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
Rabbit Study 2
4
⊡ Fig. 4.8. Inflammatory changes of the spermatic cord 3 months after Marlex mesh implantation in the rabbit (mesh fiber right upper, deferent duct left lower; hematoxylin and eosin, 100×)
During vasography, several specimens showed significant reduction of the vas deferens diameter (⊡ Fig. 4.9). Most of the obstructions were observed at the margin of the mesh. Severe obstruction (>75%) was found in 50% of the Prolene margins and 22.2% of the Ultrapro mesh edges. Within the mesh area, we saw no severe obstruction. Moderate obstruction (25–75%) also occurred more often in the Prolene group (⊡ Table. 4.2). Analysis of spermatogenesis revealed the same postoperative decrease in spermatozoa counted as Johnsen 10 after mesh implantation as was observed in the first study. Because of the different mesh material, the difference in the controls did not reach
⊡ Fig. 4.9. Vasography 6 months after inguinal Prolene mesh implantation in the rabbit
⊡ Table 4.2. Obstruction of the vas deferens 6 months after mesh implantation in the rat Obstruction at mesh margin
Obstruction within mesh area
0/+ (<25%)
++ (25–75%)
+++ (>75%)
0/+ (<25%)
++ (25–75%)
+++ (>75%)
Prolene
43.75% (7/16)
6.25% (1/16)
50% (8/16)
75% (12/16)
25% (4/16)
0% (0/16)
Ultrapro
77.8% (14/18)
0% (0/18)
22.2% (4/18)
83.3% (15/18)
16.7% (3/18)
0% (0/18)
35 Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
4
⊡ Fig. 4.10. Percentage of mature spermatogenesis (Johnsen 10) 6 months after groin mesh implantation in the rabbit
⊡ Fig. 4.11. Size of foreign body granuloma 6 months after groin mesh implantation in the rabbit
statistical difference. The decrease was also not different in the different material types (⊡ Fig. 4.10). Histological analysis revealed larger foreign body granulomas after Prolene mesh implantation than after Ultrapro mesh implantation (p<0.05, ⊡ Fig. 4.11).
Results in Rat Experiments Berndsen and colleagues conducted groin mesh implantation in 30 rats and analyzed the animals after 90 days. They found reduced s-testosterone
levels in the spermatic veins compared with the controls. Furthermore, the cross-sectional area of the vas deferens was also reduced after mesh implantation [11]. Taneli and colleagues published a study in 2005 that included 40 animals. Analysis was conducted 6 months after groin mesh implantation. An inducible nitric oxide synthase expression was detected in the ipsilateral testis after mesh implantation. Apoptotic cells were not detected. The authors concluded that long-term polypropylene mesh implantation has no effect on testicular hormonal function and only a limited effect on nitric oxide
36
4
Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
levels and that this effect is not sufficient to cause testis apoptosis that could lead to infertility [12]. Kolbe and Lechner also investigated the effect of hernioplastic implants on male rat infertility, comparing the results after Prolene mesh implantation to the effects after Vypro II and with control animals. They observed some sperm granulomas in the Prolene group but saw no negative influence on male fertility in juvenile or adult rats [13]. The effect of the mesh on the vas deferens of the rat was investigated by Maciel and colleagues, with results published in 2007. They observed a foreign body reaction of the spermatic cord, including histological changes of the vas deferens, functional obstruction and dilatation of the duct, spermatozoid repression, and a loss of mucosal folding proximal to the mesh. In epididymides and testicles, no changes were found [14].
Discussion The effect on the surrounding soft tissue of longterm implantation of a mesh bioprosthesis for hernia repair is under current discussion and investigation. A persisting, inflammatory, proliferative foreign body reaction with increased cell turnover in the recipient tissues even years after implantation has been described [4]. These major inflammatory responses to mesh implantation have been mostly reported after incisional hernia repair, but also after bioprosthesis implantation in inguinal hernia operations. Therefore, we investigated the effect of this inflammatory reaction on the spermatic cord and testicular function in a rabbit model. We observed only minor inflammatory changes. Perhaps this reduced reaction was due to the short postoperative period. Despite this small morphological response, we found a significant influence on testicular perfusion and function. Testicular temperature was reduced in the postoperative phase after any repair, while testicular perfusion was lowest following the Lichtenstein operation. Spermatogenesis also showed a reaction to the implanted mesh. The amount of regular spermatogenesis classified as Johnsen 10 was reduced in comparison to that after Shouldice repair and in the controls, but this
difference did not reach statistical significance. No differences between the mesh materials were observed. Further experiments with larger groups seem to be necessary after this study. At first glance, the observed changes might be of no major clinical relevance in unilateral repair and could be important only in bilateral repairs. However, the literature contains several reports of serum antisperm antibody production after unilateral ischemic injury to the testis or the spermatic cord [15]. This has also been reported in patients after inguinal hernia repair [16, 17]. These antibodies may lead to male infertility even after unilateral changes and are therefore of major relevance. Further research on this topic is mandatory. The influence on humoral conditions will also be a topic of further investigations. Akbulut et al. observed decreased levels of testosterone after laparoscopic hernia repair (totally extraperitoneal repair) [18]. This finding is supported by animal experiments by Uzzo and colleagues in a canine model [19] and by Berndsen et al. in the rat [11]. One explanation for the morphological and functional changes observed in our study may be adhesion formation between the mesh and the structures of the spermatic cord as a result of the foreign body reaction. These adhesions were also described by Fitzgibbons et al. [20] in the pig. They found adhesions between the mesh and structures of the spermatic cord even after intraperitoneal placement of the mesh. LeBlanc et al. [21] placed a heavyweight polypropylene mesh into the preperitoneal space and also observed severe adhesions to the spermatic cord 30 days after implantation. Ninety days after operation, adhesions to the spermatic vessels and the spermatic cord as well as venous congestion of the testis were described. This may also serve as an explanation for the observed deferent duct obstruction in our experiments. One additional aspect is the protection of the structures of the spermatic cord by the cremasteric muscle. These structures were protected from inflammation if the cremasteric muscle was preserved, as we did in this rabbit model. Perhaps this strategy might be advisable instead of complete resection of the cremasteric muscle during mesh implantation.
37 Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
There are also reports about reactions to inguinal prosthetic mesh in men. The most important publication on this topic is by Shin and colleagues, published in 2005. They reported on 14 young male patients undergoing open or laparoscopic groin mesh implantation. Nine of them presented bilateral vas deferens obstruction, and the other five suffered from unilateral obstruction with contralateral testicular atrophy. The authors suggested that men–especially those of young reproductive age or with a solitary testicle–should be carefully advised of the potential for obstruction and compromise to future fertility before undergoing polypropylene mesh herniorrhaphy [22]. Valenti et al. reported a case of fibrotic vas deferens obstruction due to direct contact of an implanted plug with the vas [23]. Wingenbach et al. reported long-lasting pain during copulation in 3.9% of all cases after laparoscopic hernia repair [24]. Langenbach et al. found painful ejaculation in 10%, 12 weeks after laparoscopic repair [25], which correlated with the kind of mesh. Hetzer et al. reported spermatoceles requiring operation after Lichtenstein repairs in 0.8% [6]. Silich and McSherry reported a case of a spermatic granuloma requiring operation 2 years after mesh repair of an inguinal hernia [5]. Aasvang et al. conducted a questionnaire-based analysis of 1,015 patients 1 year after mesh-based inguinal hernia repair. They found relevant pain during physical activity in 18.4% and pain during sexual activity in 22.1%. Genital or ejaculatory pain occurred in 12.3%, and 2.8% of the patients complained about moderate or severe impairment of their sexual activity [26]. Out of this population, the authors intensified analysis in 10 selected patients with postherniotomy ejaculatory pain and pain-related sexual dysfunction. After this analysis, the authors concluded that postherniotomy genital and ejaculatory pain that impairs sexual activity is of neuropathic origin and is anatomically related to the vas deferens and related structures [27]. Summarizing these publications and our experimental results, we suggest some negative influence by the foreign body reaction to the prosthetic mesh on the structures of the spermatic cord. Therefore, we caution against implanting poly-
4
propylene mesh into the inguinal region without a good indication.
Conclusion Until more data are available, we see a limited indication for mesh implantation during inguinal hernia repair in young patients, as an effect on testicular function and spermatogenesis is possible. Preserving the cremasteric muscle fibers may protect the spermatic cord.
Acknowledgements Parts of these experiments were supported by the Deutsche Forschungsgemeinschaft (AZ KON 709/2002, PE 718/4-1).
References 1. Bittner R, Schmedt CG, Schwarz J, Kraft K, Leibl BJ. Laparoscopic transperitoneal procedure for routine repair of groin hernia. Br J Surg 2002; 89:1062–1066 2. Wara P, Bay-Nielsen M, Juul P, Bendix J, Kehlet H. Prospective nationwide analysis of laparoscopic versus Lichtenstein repair of inguinal hernia. Br J Surg 2005; 92:1277–1281 3. Fenoglio ME, Bermas HR, Haun WE, Moore JT. Inguinal hernia repair: results using an open preperitoneal approach. Hernia 2005; 9:160–161 4. Klosterhalfen B, Klinge U, Hermanns B, Schumpelick V. Pathology of traditional surgical nets for hernia repair after long-term implantation in humans. Chirurg 2000; 71:43–51 5. Silich RC, McSherry CK. Spermatic granuloma. An uncommon complication of the tension-free repair. Surg Endosc 1996; 10:537–539 6. Hetzer FH, Hotz T, Steinke W, Schlumpf R, Decurtins M, Largiader F. Gold standard for inguinal hernia repair: Shouldice or Lichtenstein? Hernia 1999; 3:117–120 7. Lichtenstein IL, Shulman AG, Amid PK, Montllor MM. The tension-free hernioplasty. Am J Surg 1989; 157:188–193 8. Shouldice EE. Surgical treatment of hernia. Ontar Med Rev 1945; 4:43 9. Peiper Ch, Ponschek N, Truong S, Schumpelick V. Ultrasound-based volumetric evaluation of fluid retention after inguinal hernia repair. Surg Endosc 2000; 14:666–669 10. Johnsen SG. Testicular biopsy score count–a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones 1970; 1:2–25
38
4
Chapter 4 · Influence of Prosthetic Implants on Male Fertility in Rabbits and Rats
11. Berndsen FH, Bjursten LM, Simanaitis M, Montgomery A. Does mesh implantation affect the spermatic cord structures after inguinal hernia surgery? An experimental study in rats. Eur Surg Res 2004; 36:318–322 12. Taneli F, Aydede H, Vatansever S, Ulman C, Ari Z, Uyanik BS. The long-term effect of mesh bioprosthesis in inguinal hernia repair on testicular nitric oxide metabolism and apoptosis in rat testis. Cell Biochem Funct 2005;23:213– 220 13. Kolbe T, Lechner W. Influence of hernioplastic implants on male fertility in rats. J Biomed Mater Res B Appl Biomater 2007; 81:435–440 14. Maciel LC, Glina S, Palma PC, Nascimento LF, Netto NR Jr. Histopathological alterations of the vas deferens in rats exposed to polypropylene mesh. BJU Int 2007; 100:187– 190 15. Lewis-Jones DI, Moreno de Marval M, Harrison RG. Impairment of rat spermatogenesis following unilateral experimental ischemia. Fertil Steril 1982; 38:482–490 16. Kapral W, Kollaritsch H, Stemberger H. Correlation of inguinal hernia and agglutinating sperm antibodies. Zentralbl Chir 1990; 115:369–377 17. Matsuda T, Muguruma K, Horii Y, Ogura K, Yoshida O. Serum antisperm antibodies in men with vas deferens obstruction caused by childhood inguinal herniorrhaphy. Fertil Steril 1993; 59:1095–1097 18. Akbulut G, Serteser M, Yucel A, Degirmenci B, Yilmaz S, Polat C, San O, Dilek ON. Can laparoscopic hernia repair alter function and volume of testis? Randomized clinical trial. Surg Laparosc Endosc Percutan Tech 2003; 13:377–381 19. Uzzo RG, Lemack GE, Morrissey KP, Goldstein M. The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 1999; 161:1344–1349 20. Fitzgibbons RJ Jr, Salerno GM, Filipi CJ, Hunter WJ, Watson P. A laparoscopic intraperitoneal onlay mesh technique for the repair of an indirect inguinal hernia. Ann Surg 1994; 219:144–156 21. LeBlanc KA, Booth WV, Whitaker JM, Baker D. In vivo study of meshes implanted over the inguinal ring and external iliac vessels in uncastrated pigs. Surg Endosc 1998; 12:247–251 22. Shin D, Lipshultz LI, Goldstein M, Barme GA, Fuchs EF, Nagler HM, McGallum SW, Niederberger CS, Schoor RA, Brugh VM 3rd, Honig SC. Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia. Ann Surg 2005; 241:553–558 23. Valenti G, Baldassarre E, Torino G. Vas deferens obstruction due to fibrosis after plug hernioplasty. Am Surg 2006; 72:137–138 24. Wingenbach O, Waleczek H, Kozianka J. Laparoscopic hernioplasty by transabdominal preperitoneal approach. Analysis and review in 267 cases. Zentralbl Chir 2004; 129:369–373 25. Langenbach M, Schmidt J, Lazika M, Zirngibl H. Urological symptoms after laparoscopic hernia repair. Reduction
with a variant of polypropylene mesh. Urologe A 2003; 42:375–381 26. Aasvang EK, Møhl B, Bay-Nielsen M, Kehlet H. Pain-related sexual dysfunction after inguinal herniorrhaphy. Pain 2006; 122:258–263 27. Aasvang EK, Møhl B, Kehlet: Ejaculatory pain: a specific postherniotomy pain syndrome? Anesthesiology 2007; 107:298–304
5
The Effects of a Mesh Bioprosthesis on the Spermatic Cord Structures A. Goldenberg
40
Chapter 5 · The Effects of a Mesh Bioprosthesis on the Spermatic Cord Structures
Introduction
Experimental Study 2
We performed two experimental studies in a dog model [1, 2] and one clinical research study on the effects of synthetic mesh on fertility.
In the second investigation we studied the effects of polypropylene mesh implanted by inguinotomy in the spermatic cord, epididymis, and testis of dogs [2].
Experimental Study 1 Methods
5
The first work developed by our group concerned application of the mesh by video laparoscopy without dissection of the inguinal region. The aim of this study [1] was to investigate the effects of the synthetic mesh on the ductus deferens and testicle of dogs.
Methods Ten adult male dogs were anesthetized, and a 2.5×3.5 cm2 polypropylene mesh was fixed in the inguinal region in direct contact with the ductus deferens, using metallic staples without dissection of the region and, therefore, without manipulation. The right side, with no mesh, was the control. The operating time was 15 min. The animals were observed for 30 days, and then they were again anesthetized and underwent new surgery, during which the ductus deferens and testicle were removed and sent for histological analysis.
Results The histological sections of the testicle showed a focal reduction of spermatogenesis in 20% of the animals and a degenerative process in 20%. In the epididymis, chronic inflammation and seminiferous tubule dilatation were observed in 70%. A chronic inflammatory process was found in 60% of the vasa deferentia.
Conclusion The polypropylene mesh in direct contact with the spermatic funiculus in dogs caused histological alterations, with minimal reduction of spermatogenesis.
Eighteen dogs were included (12–23 kg), separated into three groups: -Group A (n=7): left side (with mesh) vs. right side (without mesh) -Group B (n=7): left side (without mesh) vs. right side (with mesh) -Group C (n=4): no surgical manipulation (control group) After being observed for 60 days, the animals were subjected to bilateral removal of the spermatic cord, epididymis, and testis, which were submitted for histological analysis. During the reoperation, a macroscopic evaluation was performed.
Results On the mesh side, we noted 100% mesh adherence to the posterior wall of the inguinal canal, as well as adherence of the spermatic cord to the mesh. Congestion of the pampiniform plexus was noted in three animals. Chronic inflammation and foreign body reactions in the spermatic cord were observed in 100% of the animals. On the side that was not implanted with mesh, a chronic inflammatory reaction was observed in 71% of the animals. All of the animals presented a chronic inflammatory reaction in the deferent duct on the mesh side, and such a reaction was also present in 11 animals in the side without the mesh. These alterations were not found in group C. There was a considerable statistical reduction in the average lumen diameter of the deferent duct on the mesh side. In the epididymis and testis, macroscopic and microscopic alterations were not significant, although one animal showed a marked reduction of spermatogenesis on the mesh side.
41 Chapter 5 · The Effects of a Mesh Bioprosthesis on the Spermatic Cord Structures
5
Conclusion
Acknowledgments
When in contact with the spermatic cord of dogs, the polypropylene mesh caused an intense chronic inflammatory reaction and a significant reduction in the diameter of the lumen of the deferent duct.
I am grateful for the collaboration in my research to Jaques Matone, Joaquim Ferreira de Paula, and Edgar Valente Lima Neto.
Clinical Study
1.
We performed one more study to evaluate testicular volume and arterial flow in patients undergoing surgical correction for inguinal hernia with a polypropylene prosthesis [3].
References
2.
3.
Methods This was an observational prospective clinical study of 39 male patients with unilateral inguinal hernia of Nyhus types IIIa and IIIb who underwent surgical correction with implantation of a polypropylene prosthesis by means of the Lichtenstein technique. The patients were evaluated using Doppler ultrasound before the operation and selectively 3 and 6 months after the operation. The variables studied were testicular volume, systolic and diastolic velocity, resistance index, and pulsatility index.
Results No statistically significant alterations in the studied variables were observed over the course of time: testicular volume (p=0.197), systolic velocity (p=0.257), diastolic velocity (p=0.554), resistance index (p=0.998), and pulsatility index (p=0.582).
Conclusion No alterations in testicular volume or arterial flow were observed over a 6-month period in patients who underwent surgical correction for inguinal hernia using a polypropylene prosthesis.
Goldenberg A, Matone J, Marcondes W, Focchi G. Effects of the polypropylene mesh in the testicle, epididymis and ductus deferens of dogs. Acta Cir Bras 2001; 16(4) Goldenberg A, Ferreira de Paula J. Effects of the polypropylene mesh implanted through inguinotomy in the spermatic funiculus, epididium and testis of dogs. Acta Cir Bras 2005; 20(6):461–467 Lima Neto EV, Goldenberg A, Jucá MJ. Prospective study on the effects of a polypropylene prosthesis on testicular volume and arterial flow in patients undergoing surgical correction for inguinal hernia. Acta Cir Bras 2007; 22(4): 266–271
Discussion Amid: Is there any direct contact between mesh
and the vas deferens during your laparoscopic approach? Goldenberg: No, there was no dissection and therefore no direct contact.
6
Influence of Prosthetic Implants on Male Fertility in Rats T. Kolbe and W. Lechner
44
Chapter 6 · Influence of Prosthetic Implants on Male Fertility in Rats
Introduction
6
In an effort to find a suitable material for tensionfree repair of inguinal hernias, a variety of natural and synthetic materials have been used [1]. Currently, three prosthetic materials are widely used for repairing inguinal hernias: polyester, polypropylene, and expanded polytetrafluoroethylene [2]. Despite their wide acceptance and use in countless surgeries worldwide, little data exist regarding the effects of the mesh bioprosthesis on the adjacent spermatic cord structure and function, particularly the ductus deferens. Since it was shown that the weight of the implanted material corresponds to the postsurgical inflammatory reaction [3–5], partially absorbable meshes have been developed to reduce the amount of foreign material staying in the patient’s body. This study explored the vulnerability of the ductus deferens to mesh-induced inflammation and shrinkage after hernia repair in a rodent model. In our study we tested the influence on male fertility of a widely used mesh of 100% polypropylene (Prolene) and a mesh containing a mixture of 50% polypropylene and 50% polyglactin (Vypro II). The polyglactin component, which should be resorbed within 56–70 days, makes the mesh more flexible and reduces the implant’s weight. The bigger pores are regarded to be advantageous concerning the inflammatory reaction after implantation [6–8]. Due to the ethical constraints of studies in humans, we used rats as an animal model to test the vulnerability of the ductus deferens to the materials mentioned above. Because there are reports of special sensitivity of the premature male reproductive organs to surgical manipulations [9, 10], we tested both mature and premature male rats for short-term and long-term histological reactions and for subsequent reproductive performance.
Material and Methods Two types of implants (Prolene and Vypro II, both Ethicon, Germany) in the size of 2.25 cm2 were used in juvenile and adult Hsd:Sprague Dawley SD rats (8 weeks and 12 weeks, respectively). In two control groups (juvenile and adult male rats), the ducti were only bluntly separated from adherent
⊡ Fig. 6.1. Reproductive tract of male rat and implantation of meshes
tissue. Each of the six groups (Prolene juvenile, Pj; Prolene adult, Pa; Vypro II juvenile, Vj; Vypro II adult, Va; control juvenile, Cj; control adult, Ca) consisted of 10 animals. The meshes were surgically wrapped around the ductus deferens on each side to ensure direct contact with the spermatic cord and were fixed with sutures to remain in position (⊡ Fig. 6.1).
45 Chapter 6 · Influence of Prosthetic Implants on Male Fertility in Rats
6
4 Weeks After Start: Histology The implants and the adjacent part of the ductus deferens from one side of each male rat were removed surgically for histological examination of acute inflammatory reaction. Staining was achieved with mouse antihuman proliferating cell nuclear antigen (PCNA) for detection of cell proliferation, rabbit antihuman factor VIII (Von Willebrand factor) for detection of angiogenic proliferation, and mouse antihuman bcl-2 (oncoprotein) for cancerogenic reaction. Counterstaining was done with Hemalaun.
a
3–4 Months After Start: Mating Test Three months after implantation, each male was mated with two or three adult females. Two days after positive vaginal plug control, the females were euthanized, and oocytes or embryos were flushed from the oviducts and uteri. The relationship of unfertilized and degenerated oocytes to morphologically intact embryos was recorded.
b
4 Months After Start: Histology The implant on the opposite side was removed after euthanasia for histological examination of chronic inflammatory reactions using the same methods as described above.
c
Results Histological Examination Hemalaun Staining Four weeks after treatment, two animals in the Pj group showed granulomatous inflammatory reactions with sperm deposits in the connective tissue due to injuries of the wall of the ductus deferens. Other rats in groups Pj and Pa showed incisions of the muscularis. There was enhanced production of collagen fibers at the edges of the Prolene im-
d ⊡ Fig. 6.2. a The two different implants. b Sperm granuloma. c Minor inflammation around a Prolene fiber (arrow). d Lumen of the ductus slightly depressed by Vypro II fibers (arrows)
46
6
Chapter 6 · Influence of Prosthetic Implants on Male Fertility in Rats
plants. Areas of inflammation were visible around the Vypro II implants in groups Vj and Va, with many multinuclear giant cells (⊡ Fig. 6.2). There was no visible inflammatory reaction in the mucosa or blockage of the spermatic cord. In the samples taken after 4 months, we observed no profound differences from the first examination after 4 weeks. In the Prolene groups, there were incisions of the muscularis due to implant fibers, but no enhanced cellular reaction or inflammation-associated changes occurred. Two rats in the Pj group and three in the Pa group showed multinuclear giant cells. In the Vypro II groups, only the nonabsorbable component of the meshes was present. In some cases, the round lumen of the ductus deferens was slightly deformed, comparable to the Prolene groups, but without the incisions seen in the Pj and Pa groups.
PCNA Reaction Serosa Cells The staining for proliferative cells revealed increased inflammatory reactions after 4 months compared with the values after 4 weeks after treatment (⊡ Fig. 6.3a). While there was only a tendency in the Vypro and Prolene groups for more PCNApositive cells after 4 weeks, this difference was significant after 4 months (⊡ Fig. 6.3b). There was no significant difference between the mesh groups. We did not observe an age effect.
Mucosal Cells Between the mesh groups and controls, there was no significant difference in the percentage of PCNA-positive cells either after 4 weeks or after 4 months. Several groups showed high variation among individuals and thus a high standard of group values.
Von Willebrand Factor Staining Staining for Von Willebrand factor revealed an increase in the mean number of blood vessels in all groups between sampling points (⊡ Fig. 6.4). This proliferation ranged from 1.6% (Cj group) to 36% (Pj group). However, due to high individual variation, there was no statistically significant difference (as shown by analysis of variance) between the experimental groups.
⊡ Fig. 6.3. Proliferating cell nuclear antigen (PCNA)-positive cells in different cell layers 4 weeks and 4 months after implantation of meshes around the spermatic cord (mean and SE). a After 4 weeks. b After 4 months
Bcl-2 Staining There was no sign of oncogenic activity by expression of bcl-2 after either 4 weeks or after 4 months compared with positive controls.
6
47
No. of blood vessels per area counted
Chapter 6 · Influence of Prosthetic Implants on Male Fertility in Rats
25 20 15
after 4 weeks
10
after 4 months
5 0 Cj
Ca
Pj
Pa
Vj
Va
Experimental Groups ⊡ Fig. 6.4. Number of blood vessels per area counted at 4 weeks and 4 months (mean and range; minimum to maximum)
Mating Test The flushing of embryos resulted in mean embryo numbers from 7.7 to 14.7 in the experimental groups. These were compared to the total number of unfertilized or fragmented oocytes and embryos (range 13.0–16.3). All groups exhibited one to three males with decreased or restricted fertility, but there were no differences between groups. There was no indication of a negative influence on male fertility due to one of the implanted meshes (analysis of variance).
Discussion Open and laparoscopic mesh-based techniques dominate inguinal hernia repairs today. Research is currently focusing on the search for suitable mesh materials with regard to inflammatory response, chemical properties, and applicability [2]. The more rigid polypropylene mesh is preferred for laparoscopic hernia repair because it unfolds easily after introduction into the abdomen through the endoscope. A disadvantage is the heavy shrinkage of this material in vivo, which has been reported both in humans [4] and in animal experiments [5]. In contrast, other authors reported an even greater shrinkage of the more flexible Vypro II mesh (28%) compared with a heavyweight polypropylene mesh (Atrium, 12%) [11].
In our investigation, we used both materials in both juvenile and adult male rats. A direct mating test revealed no statistically significant differences between the two different materials or the different ages. Histological examination of spermatic cord explants stained with PCNA showed long-term inflammatory reactions in the adjacent serosa but not in the mucosa. This effect was independent of the material applied. This effect might be induced by the smaller pore size of the Prolene mesh, resulting in enhanced colonization with macrophages after 90 days [12, 13] and resorption of the polyglactin part in the Vypro II mesh. However, in both cases the mucosa was not involved. This result is in contrast to that found by Rosch et al. [14], but it confirms Berndsen et al. [15]. By measuring testicular hormonal function, the latter authors also confirmed that polypropylene and polypropylene/polyglactin meshes did not influence male fertility in the rat model, as had been concluded in another study [16]. The sharp edges and the unusual mode of application (wrapping around the spermatic cord) might be responsible for the observed sperm granulomas in two male rats and for the mesh incisions into the muscularis and granulosa in some rats of the Prolene group. From this point of view, the 50% absorbable Vypro II mesh with softer material properties seems to be more difficult to apply, but according to the results of other investigations [17], it causes less irritation to the surrounding tissue.
48
Chapter 6 · Influence of Prosthetic Implants on Male Fertility in Rats
In summary, we did not observe a reduction in fertility of male rats compared with the controls, even after direct wrapping of synthetic meshes of two different types around the ducti deferentia. Therefore, we conclude that neither mesh has a negative influence on male fertility.
References
6
1. The EU Trialists Collaboration (2002) Repair of groin hernia with synthetic mesh: meta analysis of randomized controlled trials. Ann Surg 235:322–332 2. Nathan JD, Pappas TN (2003) Inguinal hernia: an old condition with new solutions. Ann Surg 238:148–157 3. Prior MJ, Williams EV, Shukla HS, Phillips S, Vig S, Lewis M (1998) Prospective randomized controlled trial comparing Lichtenstein with modified Bassini repair of inguinal hernia. J R Coll Surg Edinb 43:82–86 4. Schumpelick V, Arlt G, Schlachetzki A, Klosterhalfen B (1997) Chronic inguinal pain after transperitoneal mesh implantation. Case report of net shrinkage. Chirurg 68:1297–1300 5. Klinge U, Klosterhalfen B, Muller M, Ottinger AP, Schumpelick V (1998) Shrinking of polypropylene mesh in vivo: an experimental study in dogs. Eur J Surg 164:965–969 6. Klinge, U, Klosterhalfen B, Conze J, Limberg W, Obolenski B, Ottinger AP, Schumpelick V (1998) A modified mesh for hernia repair that is adapted to the physiology of the abdominal wall. Eur J Surg 164:951 7. Klosterhalfen B, Junge K, Klinge U (2005) The lightweight and large porous mesh concept for hernia repair. Expert Rev Med Devices 2:103–117 8. Hagerty RD, Salzmann DL, Kleinert LB, Williams SK (2000) Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoro-ethylene and polyethyleneterephthalate. J Biomed Mater Res 49:489–497 9. Shandling B, Janik JS (1981) The vulnerability of the vas deferens. J Ped Surg 16:461–464 10. Barrat C, Seriser F, Arnoud R, Trouette P, Champault G (2004) Inguinal hernia repair with beta glucan-coated mesh: prospective multicenter study (115 cases)–preliminary results. Hernia 8:33–38 11. Scheidbach H, Tamme C, Tannapfel A, Lippert H, Kockerling F (2004) In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: an experimental study in pigs. Surg Endosc 18:211–220 12. Rosch R, Junge K, Schachtrupp A, Klinge U, Klosterhalfen B, Schumpelick V (2003) Mesh implants in hernia repair. Inflammatory cell response in a rat model. Eur Surg Res 35:161–166 13. Schumpelick V, Klinge U (2003) Prosthetic implants for hernia repair. Br J Surg 90:1457–1458
14. Rosch R, Junge K, Quester R, Klinge U, Klosterhalfen B, Schumpelick V (2003) Vypro II mesh in hernia repair: impact of polyglactin on long-term incorporation in rats. Eur Surg Res 35:445–450 15. Berndsen FH, Bjursten LM, Simanaitis M, Montgomery A (2004) Does mesh implantation affect the spermatic cord structures after inguinal hernia surgery? An experimental study in rats. Eur Surg Res 36:318–322 16. Taneli F, Aydede H, Vatansever S, Ulman C, Ari Z, Uyanik BS (2005) The long-term effect of mesh bioprosthesis in inguinal hernia repair on testicular nitric oxide metabolism and apoptosis in rat testis. Cell Biochem Funct 23:213–220 17. Friis E, Lindahl F (1996) The tension-free hernioplasty in a randomized trial. Am J Surg 172:315–319
Discussion Schumpelick: I think this is the first study dealing
with fertility. Kolbe: Let me give at first one short comment on
this animal model. I believe that the rat model is a very good model to investigate tissue reaction. That seems to be comparable to the human situation. It seems not to be a good model for investigating testicular function because there are some differences from the human being. The rodent can retract the testicles into the body cave with different temperatures and conditions for spermatogenesis.
7
What Can We Do To Decrease the Risk of Vas Deferens Injury due to Inguinal Hernioplasty? P. Witkowski
50
Chapter 7 · What Can We Do To Decrease the Risk of Vas Deferens Injury due to Inguinal Hernioplasty?
Introduction
7
The implantation of polypropylene mesh in inguinal hernia repair surgery has been a tremendous breakthrough. It has significantly reduced the hernia recurrence rate from 15–20% to 0.5–5% and therefore has decreased the rate of spermatic cord, vas deferens, and testicular artery injury due to reoperation for recurrence [1]. We have only limited information, however, about the long-term effects of polypropylene mesh implantation on the vas deferens, especially with regard to fertility. Despite new developments, polypropylene mesh remains the optimal and most commonly used material for inguinal hernioplasty. This mesh stimulates a pronounced chronic inflammatory reaction with connective tissue formation that incorporates the prosthesis into surrounding tissue. Although such scar formation fills out the hernia defect and effectively prevents hernia recurrence, it may ultimately cause damage to the adherent organs. This inflammatory process is clinically relevant because it remains active even years after mesh implantation [2].
Is There a Risk for a Vas Deferens Injury After Mesh Hernioplasty? In my opinion, we have enough clinical as well as experimental data from animal studies to confirm this risk. Injury may occur in the postoperative period because of a chronic foreign body reaction involving tissue surrounding the implanted mesh, which may also include the spermatic cord and vas deferens. Clinical experience indicates that a polypropylene mesh cannot be safely implanted in contact with any visceral or retroperitoneal organs, especially if placed under pressure or tension. Extensive fibrosis around the mesh can trap and damage inguinal nerves, the intestine, or the urinary bladder [3–5]. The mesh can even erode into the wall or lumen of those organs, leading to pain, infection, small bowel obstruction, or enterocutaneous fistula formation [3–7]. The same process may even lead to stenosis or obstruction of the urethra after polypropylene tape suspension for the treatment
of stress urinary incontinence [4]. Erosion of the vagina has also been reported [8, 9]. As a remedy, a new polypropylene sling with an absorbable central suburethral part was developed to separate the polypropylene part of the sling from the urethra and vagina [10]. All of the complications described above are recognizable on obvious clinical presentation and result from placement of the mesh in close proximity to the organs. Therefore, it is reasonable to expect that a structure as delicate as the vas deferens could also be damaged or occluded if a mesh were placed close enough to it, especially if left under tension or pressure. Animal studies provide more arguments for an increased risk of vas injury when polypropylene mesh is used for the repair. In several studies, mesh was found to be adherent to the spermatic cord throughout its inguinal course, leading to significant foreign body reaction in all animals [2, 11–13]. Histology showed fibrosis, extensive skeletal muscle degeneration, and histiocytic inflammation along the outer part of the cord [11, 14]. Additionally, the thick muscular layer of the vas was more prominently attenuated after mesh hernia repair than after Shouldice repair in a canine experiment [11]. This attenuation is important because the vas is no longer considered a passive conduit through which the ejaculate travels. The rich adrenergic innervation, the complexity of the muscle layers of the vas, and the metabolically active vasal epithelium all suggest a very active role in sperm transport, which may be altered by the perivasal fibrosis attributable to the mesh [11]. When a mesh was placed in proximity, the lumen of the vas was narrowed compared with nonsurgical controls [12]. Other studies also suggest that even if fibrosis around the vas deferens and within its wall does not lead to reduction of the lumen of the vas, it may cause functional obstruction with dilatation of the proximal segment along with degenerative changes in mucosa and repression of spermatozoa [11, 14]. Foreign body reaction around the mesh may compromise blood flow within the cord and eventually compromise fertility [15]. Congestion of the pampiniform plexus was noted in 20%
51 Chapter 7 · What Can We Do To Decrease the Risk of Vas Deferens Injury
7
of animals after a Lichtenstein procedure, with spermatic cord vein thrombosis in up to 33% of cases after an open preperitoneal approach [2, 14]. Mesh repair led to decreases in arterial perfusion and testicular temperature and also reduced the proportion of seminiferous tubules with regular spermatogenesis [2]. Focal fibrinoid necrosis of the deferent duct wall was also reported [2]. The above results were observed in animals shortly after mesh implantation (weeks or months), whereas in humans, the mesh stays in the body for years and may cause much more extensive degenerative changes. Finally, several clinical reports conclude that occlusive injury to the vas deferens resulted from mesh implantation [7, 16–20]. Because these reports represent only single cases, until recently they had only anecdotal value. But a recent multicenter study has drawn attention to the possibility that vas deferens injury may take place more commonly than we think [21]. The authors presented 14 cases of obstructive azoospermia leading to infertility because of bilateral or unilateral vas occlusion, with simultaneous, but different, pathology of the reproductive organs on the contralateral side. Mesh-related fibrosis as a cause of vas occlusion was verified during surgical revision of the inguinal region [21]. Mechanical injury of the vas by the edge of the mesh has also been blamed as a possible cause of spermatic granuloma [20]. Further reports suggest that vas obstruction may lead to increased serum levels of antisperm antibody even without sperm granulomas, which can additionally compromise fertility [15, 22].
by that fact that most patients do not test their fertility before or after surgery, and occlusion can develop not only shortly after surgery but also years later, when a patient has finished his procreative activity. Furthermore, we do not have any noninvasive methods to detect vas injury or obstruction or to screen asymptomatic patients. Because we have animal experimental data indicating that fibrosis around the implanted mesh compromises vas deferens function, and knowing that the vas can be occluded when mesh is placed in proximity, as seen with urethral or small bowel obstruction, we cannot exclude the possibility that symptomatic patients from case reports are only the tip of the iceberg and that there are asymptomatic patients with vas deferens injury and occlusion after inguinal hernioplasty. The majority of patients may have this complication and may be completely unaware of it because they either do not test their fertility or they remain fertile because of an uncompromised contralateral sex organ.
How Great Is the Risk of Vas Injury After Mesh Hernioplasty?
Some surgeons may choose not to change anything and to continue using current surgical techniques until the actual risk rate is known. For the time being, I think that for patients whose procreative ability is of great concern, we should tailor our surgical approach to minimize the risk of vas injury without compromising repair results. These candidates would include young patients with bilateral hernia and those with compromised sex organs and contralateral hernia. Careful handling of the spermatic cord, including the vas deferens, in order to avoid direct
Today we cannot estimate the risk because we do not know how many patients are affected. This is mainly because of poor clinical presentation of the injury. Isolated, unilateral occlusion of the vas is completely asymptomatic. Infertility is the only potential symptom, and it occurs only with bilateral occlusion or with unilateral injury in a patient with contralateral sex organ pathology. Diagnosis of mesh-related vas injury is further complicated
How Can We Assess the Risk? Autopsies of patients who received inguinal mesh repair might give some estimates. Unfortunately, prospective studies with fertility monitoring before and after the procedure put a significant burden on patients and do not seem feasible at the moment [23].
What Can We Do Now?
52
7
Chapter 7 · What Can We Do To Decrease the Risk of Vas Deferens Injury due to Inguinal Hernioplasty?
intraoperative injury of this structure remains a constant principle of safe and efficient surgical technique [15]. To minimize the risk of vas occlusion, the general rule would be to avoid direct contact between the mesh and the vas deferens [24]: ▬ In the preperitoneal space the vas deferens is bare, so we may choose to avoid implanting mesh there, both in the posterior (laparoscopic, Nyhus, Stoppa, transabdominal preperitoneal, totally extraperitoneal repair) and anterior preperitoneal approaches (Rives, Kugel, Prolene Hernia System repair). ▬ Mesh plug insertion in the deep inguinal ring for indirect defects causes extensive fibrosis and may also involve the bare vas deferens; therefore, the plug is not advised in this location (Rutkow technique) [24]. ▬ In the course of the inguinal canal, the vas runs in the spermatic cord and is better protected by the surrounding internal spermatic fascia and cremaster. Therefore, it seems reasonable not to excise the cremaster but instead to spare it and close it with absorbable suture after hernia sac dissection and reduction. ▬ Placement of the mesh on the posterior wall of the inguinal canal is better (Lichtenstein or Trabucco technique) because the transversalis fascia can separate the mesh from bare vas running in the preperitoneal space. The disadvantage of the Lichtenstein operation, however, is that the spermatic cord is placed within the inguinal canal, where it is usually compressed between the mesh and the aponeurosis of the external oblique abdominal muscle. In such limited space, fibrosis around the mesh may still involve the spermatic cord and compromise the vas deferens. Therefore, we may modify our technique; after placing the mesh on the posterior wall of the inguinal canal, we can reapproximate the aponeurosis of the external oblique muscle with the sutures below (instead of above) the spermatic cord, as described in the Trabucco repair [25] (⊡ Figs. 7.1–7.3). This modification can be easy applied to the Lichtenstein operation, as has been previously suggested [26]. In this way, the spermatic cord is separated from the mesh with additional fascia and
⊡ Fig. 7.1. Placement of the mesh on the posterior of the inguinal canal
placed freely in subcutaneous tissue. Therefore, the risk of damage due to fibrosis surrounding the prosthesis is eliminated. Additionally, polypropylene mesh is placed flat between two fascial layers, the transversalis fascia and the oblique aponeurosis, which limits fibrotic tissue ingrowth only to the intrafascial space. Fibrosis penetrating the mesh glues the fascial layers together, creating a uniform, triple-layer (fascia– mesh–fascia) solid scar, which effectively reinforces the abdominal wall around the deep inguinal ring and prevents recurrence. After such repair, oblique passage of the spermatic cord through the inguinal canal can thus be avoided; it is not essential for effectiveness of the repair, as in traditional suture operations. This approach was developed by Trabucco in his sutureless technique, in which a preshaped polypropylene mesh with flat-shape memory is placed without suture fixation on the posterior wall of the inguinal canal [25]. Longterm results of this approach indicate that it is as effective as any other tension-free technique [27–30]. This technique is especially popular in Italy, with thousands of patients and years of experience. A randomized study could be organized to
53 Chapter 7 · What Can We Do To Decrease the Risk of Vas Deferens Injury
⊡ Fig. 7.2. Closure of the aponeurosis of the external oblique muscle below (instead of above) the spermatic cord
⊡ Fig. 7.3. Closure of the lateral part of the aponeurosis of the external oblique muscle; the medial part of the aponeurosis is already closed below the spermatic cord
assess the effectiveness of such modification of the Lichtenstein technique, but in our opinion, a sufficient amount of indirect confirmatory evidence exists. Professor Smeds from Sweden started using this approach after our recent publication [26] a year ago and found only one (0.3%) recurrence after 300 repairs (personal communication). In my opinion, a shutter-valve effect of mesh tails sutured together and wrapping the cord is dangerous because it unnecessarily enhances contact between the surface of the mesh with the cord, creating a cuff that contracts substantially around the spermatic cord in the postoperative
7
period as the mesh contracts. It may compromise the vas as well as blood vessels within the cord. Moreover, the sharp edge of the mesh on which the spermatic cord directly kinks upon entering the inguinal canal from the deep inguinal ring is considered a common place for vas injury. A flat, preshaped onlay mesh with a hole for the spermatic cord decreases contact between the mesh and the cord without compromising the effectiveness of the Lichtenstein technique. The efficacy of this approach was clearly proven by the Trabucco technique and other repairs using a preshaped onlay mesh with a preformed hole for the spermatic cord. In the above proposed approach, direct kinking of the cord over the mesh is avoided, and the cord instead folds over the fascia of the external aponeurosis while entering the subcutaneous space. The proposed surgical techniques comply with the principles of the tension-free operation and can be easily implemented. In summary, although the actual rate of vas deferens injury due to fibroblastic inflammation around polypropylene mesh is not yet known, there is strong experimental and clinical evidence that such processes can and do take place. Therefore, until the risk is fully investigated, all patients with any known compromise to their reproductive health or with concerns about fertility can be offered a surgical technique that minimizes the potential risk without diminishing all the advantages of tension-free hernia repair. Isolating the spermatic cord from the mesh by placing it above (not below) the aponeurosis of the oblique abdominal muscle seems to be an easy, applicable, and effective solution.
References 1. Fitzgibbons RJ Jr. (2005) Can we be sure polypropylene mesh causes infertility? Ann Surg 241:55–561 2. Peiper Ch, Klinge U, Junge K, Schumpelick V (2006) Is there a risk of infertility after inguinal mesh repair? Experimental study in pig and the rabbit. Hernia 10:7–12 3. Amid PK (2004) Radiologic images of meshoma: a new phenomenon causing chronic pain after prosthetic repair of abdominal wall hernias. Arch Surg 139:1297–1298 4. Chuback JA, Singh RS, Sills C, et al. (2000) Small bowel obstruction resulting from mesh plug migration after open inguinal hernia repair. Surgery 127:475–476
54
7
Chapter 7 · What Can We Do To Decrease the Risk of Vas Deferens Injury due to Inguinal Hernioplasty?
5. Agrawal A, Avill R (2005) Mesh migration following repair if inguinal hernia: a case report and review of literature. Hernia 10:79–82 6. Jeans S, Williams GL, Stephenson BM (2007) Migration after open mesh plug inguinal hernioplasty: a review of the literature. Am Surg 73:207–209 7. Weber-Sánchez A, García-Barrionuevo A, Vázquez-Frias JA, Cueto-Garcia J (1999) Laparoscopic management of spermatic cord entrapment after laparoscopic inguinal herniorrhaphy. Surg Laparosc Endosc Percutan Tech 9:296-9 8. Sweat SD, Itano NB, Clemens JQ, et al. (2002) Polypropylene mesh tape for stress urinary incontinence: complications of urethral erosion and outlet obstruction. J Urol 168:144–146 9. Dunn JS Jr, Bent AE, Ellerkman RM et al. (2004) Voiding dysfunction after surgery for stress incontinence: literature review and survey results. Int Urogynecol J Pelvic Floor Dysfunct 15:25–31 10. Trabucco AF, Blitstein J (2004) T-sling for the treatment of stress urinary incontinence. Am J Urol Rev 12:583–588 11. Uzzo RG, Lemack GE, Morrissey KP, Goldstein M (1999) The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 161(4):1344–1349 12. Goldenberg A, Paula JF (2005) Effects of the polypropylene mesh implanted through inguinotomy in the spermatic funiculus, epididium and testis of dogs. Acta Cir Bras 20(6):461–467 13. Berndsen FH, Bjursten LM, Simanaitis M, Montgomery A (2004) Does mesh implantation affect the spermatic cord structures after inguinal hernia surgery? An experimental study in rats. Eur Surg Res 36(5):318–322 14. Maciel LC, Glina S, Palma PC, Nascimento LF, Netto NR Jr. (2007) Histopathological alterations of the vas deferens in rats exposed to polypropylene mesh. BJU Int 100:187–190. Erratum in: Costa Nascimento FC [corrected to Nascimento, Luiz FC] (2007) BJU Int 100:481 15. Ridgway PF, Shah J, Darzi AW (2002) Male genital tract injuries after contemporary inguinal hernia repair. BJU Int 90:272–276 16. Valenti G, Baldassarre E, Torino G (2006) Vas deferens obstruction due to fibrosis after plug hernioplasty. Am Surg 72:137–138 17. Nagler HM, Belletete BA, Gerber E, Dinlenc CZ (2005) Laparoscopic retrieval of retroperitoneal vas deferens in vasovasostomy for postinguinal herniorrhaphy obstructive azoospermia. Fertil Steril 83:1842 18. Meacham RB (2002) From androlog. Potential for vasal occlusion among men after hernia repair using mesh. J Androl 23:759-761 19. Aasvang EK, Kehlet H (2008) Postherniotomy dysejaculation: successful treatment with mesh removal and nerve transection. Hernia 12:645–647 20. Silich RC, McSherry CK (1996) Spermatic granuloma. An uncommon complication of the tension-free hernia repair. Surg Endosc 10:537–539
21. Shin D, Lipshultz LI, Goldstein M, Barmé GA, Fuchs EF, Nagler HM, McCallum SW, Niederberger CS, Schoor RA, Brugh VM 3rd, Honig SC (2005) Herniorrhaphy with polypropylene mesh causing inguinal vassal obstruction: a preventable cause of obstructive azoospermia. Ann Surg 241:553–558 22. Matsuda T, Muguruma K, Horii Y, Ogura K, Yoshida O (1993) Serum antisperm antibodies in men with vas deferens obstruction caused by childhood inguinal herniorrhaphy. Fertil Steril 59:1095–1097 23. Agarwal BB, Sinha BK, Mahajan KC (2008) The risk of communicating TEP-related infertility risk is an opportunity and not a »Cinderella concern« anymore. Surg Endosc 22:1557–1558 24. Valenti G, Baldassarre E (2006) Vasal obstruction after hernioplasty: the importance of surgical strategy in preventing azoospermia. Ann Surg 244:160; author reply 160 25. Trabucco EE, Trabucco AF (2002) Tension-free, sutureless, preshaped mesh hernioplasty. In: Nyhus LM, Condon RE (eds) Hernia, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 159–164 26. Witkowski P, Trabucco EE (2007) Is there an increased risk of the vas deferens occlusion after meshes inguinal hernioplasty and what can we do about it? Ann Surg. 245:153–154 27. Trabucco EE, Trabucco AF (1998) Flat plug and mesh hernioplasty in the »inguinal box«: description of the surgical technique. Hernia 2:133–138 28. Adamonis W, Witkowski P, Smietanski M, et al. (2006) Is there a need for a mesh plug in inguinal hernia repair? Randomized, prospective study of the use of Herta 1 mesh compared to PerFix Plug. Hernia 10:223–228 29. Cucci M, De Carlo A, Di Luzio P, et al. (2002) The Trabucco technique in the treatment of inguinal hernias: a six-year experience. Minerva Chir 57:457– 459 30. Testini M, Miniello S, Piccinni G, et al. (2002) Trabucco versus Rutkow versus Lichtenstein techniques in the treatment of groin hernia: a controlled randomized clinical trial. Minerva Chir 57:371–376
Discussion Deysine: The previous study did not show much damage caused by the mesh. The differences were not statistically significant in most cases. So we don’t have any hard data to prove anything at this time. I would suggest that until we have more hard data, human hard data, we should restrain the kind of language that we use when we express our impressions. Köckerling: I have to speak for the endoscopic procedure. At the moment, we really have no data,
55 Chapter 7 · What Can We Do To Decrease the Risk of Vas Deferens Injury
even no clinical data, showing that there is really a higher problem for vas deferens injury or any other influence on that system due to endoscopic inguinal hernia repair. So I wouldn’t go so far as to exclude this technique in younger patients who are fertile. Maybe we will have some problems. We should carefully look at those problems, learn how to avoid them, and choose the right mesh, but we shouldn’t go so far as to exclude all mesh procedures. Kehlet: I think we are at the state where we can say that we should not dissect the cremaster from the cord. Amid: We have to understand that if we use a mesh and we don’t remove the cremastic muscle, none of these potential problems will occur.
7
8
The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis Used for Inguinal Hernia Repair H. Aydede
58
Chapter 8 · The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis Used for Inguinal Hernia Repair
Introduction
8
Polypropylene mesh currently finds widespread use throughout the world in hernia repair, as it is well tolerated by the body and allows tissue ingrowth into the prosthesis [1]. Experimentally, all meshes cause an initial inflammatory tissue response in the recipient after implantation [2]. Interestingly, in most clinical studies in humans, these meshes are described as inert materials, but systematic morphological examinations of the long-term effects of meshes commonly used for hernia repair in humans are rare [3]. Nitric oxide (NO), a freely diffusible, water- and lipid-soluble molecule, is formed from L-arginine and molecular oxygen by a family of nitric oxide synthases [4]. In the testis, nitric oxide synthase (NOS) from endothelial cells (eNOS) is expressed in the Leydig cell, Sertoli cell, spermatocyte, and spermatid [5]. Expression of inducible NO synthase (iNOS) requires transcriptional activation, which is induced by various combinations of cytokines [6]. The upregulation of NOS leads to excessive NO production for prolonged periods of time and accounts for oxyradical-mediated damage [6]. Although little is known about the mechanism of its toxicity in germ cell injury from testicular ischemia, NO is an important mediator of cell death through either apoptosis or necrosis, depending on the intensity and duration of injury [7]. The aim of the present study was to investigate long-term effects of mesh implantation on testicular hormone function and NO metabolism [8]. Testicular hormone function was evaluated by assessments of serum luteinizing hormone (LH) and folliclestimulating hormone (FSH) levels. Testicular NO metabolism was investigated by testicular NO levels, iNOS, and eNOS expressions. Testicular ischemic damage impairing spermatogenesis with the possibility of leading to male infertility was assessed by germ-cell-specific apoptosis in the rat testis.
Material and Methods Animals and Surgical Technique The study comprised 40 male Swiss albino rats, 10–12 weeks old and 200–220 g in weight. The rats
were housed in a temperature- and light-controlled environment with ad libitum access to water and rat food pellets for 3 days before the study. All experimental procedures were approved by the Experimental Animal Research Ethics Committee of the Faculty of Medicine. All surgical procedures were performed under general anesthesia administered by intramuscular injection of ketamine and xylazine hydrochloride, employing sterile techniques.
Experimental Design The animals were randomly allocated into two groups, each containing 20 rats. In group 1, the operation was performed using an infrainguinal incision above the scrotum, and the inguinal anatomy was explored. The left spermatic cord was elevated, and a 0.5×1.0-cm polypropylene mesh (Surgipro, United States Surgical, Norwalk, CT, USA) was placed behind the left inguinal spermatic cord. To avoid displacement, the mesh was sutured to aponeurotic tissue behind the spermatic cord using 4/0 polypropylene. In group 2, the sham-operated controls, the left inguinal spermatic cord was elevated and left in place with no further manipulations. An intracardiac blood sample (1 ml) was obtained for biochemical analysis from both groups during the preoperative period. All animals were housed in standard conditions in the experimental research laboratory for 6 months. After 6 months, before the rats were sacrificed, a 2-ml sample of intracardiac blood was taken, and both testes were removed for examination. All testes were divided into two halves. One half of each testicular sample was placed in Bouin’s fixative solution for histological evaluation, and the other halves were snap-frozen in liquid nitrogen and stored at -70ºC for biochemical evaluation.
Assessment of Hormonal Function of the Testes Serum samples were frozen at -70ºC for batch analysis. Serum LH and FSH levels were assessed by immunoradiometric assay methods with DPC (Diagnostic Products, Los Angeles, CA, USA) re-
59 Chapter 8 · The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis
agents. The method sensitivities were 0.15 mIU/ ml-1 and 0.06 mIU/ml-1. Intra-assay precisions were 1.6 and 7.1%, and interassay precisions were 3.8% and 5.7% for LH and FSH, respectively.
Concentration of NO in Testes In estimating the tissue NO production, biochemical assessments of stable NO oxidative metabolite (nitrite and nitrate) levels were analyzed. Assessments of tissue nitrite and nitrate levels were based on the Griess method. The absorbance of the reaction mixture was measured at 545 nm with a spectrophotometer (Shimadzu, Japan). A standard curve was obtained with concentrations of 2–10 mmol/l-1 sodium nitrate. Data in this study present the total nitrite and nitrate, which are NO metabolites and are expressed as mmol/g-1 wet tissue.
8
a terminal deoxynucleotidyl transferase-mediated biotin nick end–labeling (TUNEL) method. Fragmentation of DNA in the nucleus is one of the first morphological changes in the apoptotic process and can be detected in histological sections using the TUNEL method performed with a commercial kit, such as the DeadEnd Colorimetric TUNEL system (Promega G7130), according to the manufacturer’s instructions. The quantification of apoptosis was carried out in a blind fashion by two independent observers.
Statistical Evaluation Statistical analyses were performed with SPSS 10.0 software. Groups were compared using a twotailed Student’s t-test, one-way ANOVA test, and Mann–Whitney U-test. Values of p<0.05 were considered to indicate statistical significance.
Immunohistochemical Evaluation Results All specimens were fixed in Bouin’s solution for 24 h. Sections (5 mm thick) from paraffin blocks were incubated in a solution of 3% H2O2 for 15 min to inhibit endogenous peroxidase activity. Then sections were washed with phosphate base solution (PBS) and incubated for 18 h at 4ºC with primary antibodies: anti-iNOS at a 1/100 dilution (Zymed 61-7700) and anti-eNOS at a 1/200 dilution (Biomol SA-258). Afterwards, sections were washed three times for 5 min each with PBS, followed by incubation with biotinylated IgG and then with streptavidin–peroxidase conjugate (Dako). They were incubated with DAB (3.3’-diaminobenzidine) substrate for detection of immunoreactivity. Control samples were processed in an identical manner, but the primary antibody step was omitted. Staining intensity was graded as mild (+), moderate (++), or strong (+++).
Detection of Apoptotic Cell Death In Situ Using the TUNEL Method To obtain evidence for induction of programmed cell death, apoptotic cells were identified using
Testicular tissue NO levels in ipsilateral and contralateral testes in the mesh-implanted group and sham-operated control groups are shown in ⊡ Table 8.1. We found significant increases in the ipsilateral testicular NO level compared with the contralateral NO level in the mesh-implanted group and the control group (p=0.0001, p=0.002, respectively). Comparison of the mesh-implanted group and the control group revealed significantly (p=0.015) higher NO levels in the ipsilateral mesh group. The results of hormonal evaluation of testicular function of the study groups preoperatively and 6 months postoperatively are given as mean ± standard deviation. Serum LH and FSH levels are summarized in ⊡ Table 8.2 for preoperative serum samples and 6-month postoperative serum samples in the mesh-implanted group and the sham-operated control group. No significant statistical differences between preoperative and postoperative samples were seen in serum LH or FSH levels. We found mild (+) eNOS activity in ipsilateral and contralateral specimens of the mesh-implanted and sham-operated groups. However, (+)
60
Chapter 8 · The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis Used for Inguinal Hernia Repair
⊡ Table 8.1. Testicular tissue nitric oxide (NO) levels in ipsilateral and contralateral testes in the mesh and sham-operated control groups (values given as mean ± standard deviation) NO (μmol-1 wet tissue)
Ipsilateral testis a
Mesh group
230.3±90.9
Sham-operated control group
166.56±32.0a
Contralateral testis
P
180.6±74.8
0.0001
140.88±29.3
0.002
a
P=0.015
⊡ Table 8.2. Serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels in the preoperative and postoperative periods in the mesh-implanted and sham-operated control groups (values given as mean ± standard deviation) Mesh-implanted group
-1)
LH (mIU/ml
8
-1)
FSH (mIU/ml
Sham-operated control group
Preoperative
Postoperative
Preoperative
Postoperative
0.582±0.065
0.571±0.084
0.626±0.086
0.636±0.088
0.362±0.050
0.353±0.041
0.385±0.043
0.340±0.050
iNOS activity was observed only in the ipsilateral testis of the mesh-implanted study group, and no expression was detected in the remaining samples (⊡ Fig. 8.1). TUNEL (+) apoptotic germ cells were not detected in any of the samples.
Discussion The major finding of the present study was that no apoptotic TUNEL (+) cells were present in the mesh-implanted study group. Therefore, we believe that mesh implantation does not cause secondary ischemic changes in testicular function over the long term. It has been shown that acute graded reductions in testicular blood flow affect the early stages of spermatogenesis, which may have a major impact on sperm production [9]. In my study in 2003, we evaluated the longterm effect of mesh and its localization (i.e., anterior or posterior) on testicular perfusion and function in groin hernia patients. Testicular function was evaluated with spermiograms and testicular perfusion with color Doppler ultrasonography. Group I consisted of 30 posterior preperitoneal mesh repair patients, and group II consisted of an-
terior tension-free repair patients. There were no statistically significant differences between the preoperative and postoperative spermiogram results for either group. No statistically significant difference was found between the two groups in terms of Doppler flow parameters (peak systolic velocity, end diastolic velocity, resistive index, pulsatility index) for preoperative, early, or late postoperative periods. When Doppler flow parameters were compared for group I, a statistically significant difference was found between preoperative and early postoperative values. No statistically significant difference was found between preoperative and late postoperative values. This was also true for early postoperative values versus late postoperative values. When Doppler flow parameters were compared for group II, a statistically significant difference was found between preoperative and early postoperative values. No statistically significant difference was found between preoperative and late postoperative values. This was also true for early postoperative values versus late postoperative values. No statistically significant difference was observed between preoperative and late postoperative Doppler flow parameters, nor was a statistically significant difference seen between the preoperative and day-75 postoperative spermio-
8
61 Chapter 8 · The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis
Ipsilateral
Mesh
Control
Contralateral
Mesh
Control
⊡ Fig. 8.1. Mild positive (+) iNOS immunostaining is shown in the stroma of the ipsilateral testis (a) of the mesh-implanted study group. Negative (-) iNOS immunostaining is shown in
the contralateral (b) testis of the mesh-implanted study group and ipsilateral (c) and contralateral (d) testes of the shamoperated control group. ×400 original magnifications
gram results for either mesh repair group. Bearing in mind the experimentally proven chronic inflammatory tissue reaction against mesh, these results indicate that chronic tissue inflammation has no adverse effect on testicular perfusion or spermatogenetic function over time [10]. The production of NO as well as its injurious metabolite peroxynitrite and other reactive nitrogen species may result in a cascade of events leading to DNA fragmentation and apoptosis. It is well known that the early stages of spermatogenesis are very sensitive to a moderate, acute reduction in blood flow, and consistent reductions in blood flow may interfere with sperm production and adversely affect fertility [11]. NO is one of many inflammatory mediators, which include the adhesion molecules and cytokines that contribute to the inflammatory cell adherence of testicular microvascular endothelium and lead to microcirculatory failure. Apoptosis is directly linked to the recruitment of neutrophils to subtunical venules [11]. NO is important in increasing blood flow and inhibiting leukocyte accumulation [12]. In addi-
tion, NO has a dual effect. On the one hand, it is vasodilatory in modest increases and potentially protective of testicular tissue, but on the other hand, excessive amounts can exert cytotoxic effects in combination with other cytokines and may result in testicular germ-cell-specific apoptosis. In the present study, we observed a significant increase in NO level and mild (+) iNOS expression in the ipsilateral side of the mesh-implanted group, which suggests ischemic/inflammatory injury of the mesh-implanted testis; however, this injury was not sufficient to cause germ cell apoptosis in the testicular tissue. In a study investigating the eNOS immunostaining and apoptosis in testicular ischemia, it was reported that acute (3 h) testicular ischemia resulted in germ cell apoptosis, and strong eNOS immunostaining was detected in the cytoplasm of degenerating germ cells [13]. The authors suggest that strong eNOS immunostaining is associated with germ cell apoptosis. Similarly, in our observations in the present study, the long-term results of mesh implantation revealed mild (+) eNOS
62
8
Chapter 8 · The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis Used for Inguinal Hernia Repair
expressions in all samples, and no apoptotic germ cells were observed in testicular tissue. In the present study we found no statistical difference in serum hormone levels between the mesh-implanted study groups and the sham-operated controls. Thus, long-term mesh implantation does not cause biochemical alteration of the hormonal functions of the testes. Part of this study was presented at the 13th European Microscopy Congress in 2004. Our presented results demonstrated that cells with pyknotic nuclei, which indicate apoptotic cells, were observed less in the mesh group than in the control group when analyzed both by light and electron microscopy [14]. In conclusion, using prosthetic mesh in humans did not cause any defects in testicular perfusion or spermatogenetic function. In this experimental model, NO level as an oxidative damage indicator was found to be increased in rat testes, and iNOS overexpression was detected immunohistochemically. The increased level of NO is one of the apoptotic promoters. However, finding no difference for apoptosis and no ultrastructural difference in electron microscopy emphasizes that this oxidative damage is compensated for by testicular tissue. Thus, prosthetic mesh repair in patients undergoing infertility treatment can be meticulously reevaluated.
7. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with Nmethy-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162–7166 8. Taneli F, Aydede H, Vatansever S, Ulman C, Arı Z, Uyanık BS (2005) The long-term effect of mesh bioprosthesis in inguinal hernia repair on testicular nitric oxide metabolism and apoptosis in rat testis. Cell Biochem Funct 23:213–220 9. Berg A, Collin O, Lissbrant E (2001) Effect of acute graded reduction in testicular blood flow on testicular morphology in the adult rat. Biol Reprod 64:13–20 10. Aydede H, Erhan Y, Sakarya A, Kara E, Iklgül O, Can M (2003) Effect of mesh and its localisation on testicular flow and spermatogenesis in patients with groin hernia. Acta Chir Belg 103:607–610 11. Lysiak JJ, Turner SD, Nguyen QAT, Singbarth K, Ley K, Turner TT (2001) Essential role of neutrophils in germ cell-specific apoptosis following ischemia/reperfusion of mouse testis. Biol Reprod 65:718–725 12. Lissbrant E, Lofmark U, Collin O, Berg A (1997) Is nitric oxide involved in the regulation of rat testicular vasculature? Biol Reprod 56:1221–1227 13. Zini A, Abitbol J, Girardi SK, Schulsinger D, Goldstein M, Schegel PN (1998) Germ cell apoptosis and endothelial nitric oxide synthase (eNOS) expression following ischemiareperfusion injury to testis. Arch Androl 41:57–65 14. Vatansever HS, Taneli F, Kayma F, Köse CF, Müftüoğlu S, İlgül O (2004) Testicular nitric oxide levels and apoptosis in rat testes during inguinal hernia repair after using long-term mesh bioprosthesis. In: Proceedings of the13th European Microscopy Congress, Antwerp, Belgium, 22–27 August 2004
References
Discussion
1. DeBorg JR (1998) The historical development of prosthetics in hernia surgery. Surg Clin North Am 78:973–1006 2. Klinge U, Klosterhalfen B, Müller M, Schumpelick V (1999) Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur J Surg 165:665–673 3. Bendavid R (1998) Complications of groin hernia surgery. Surg Clin North Am 78:1080–1103 4. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142 5. Zini A, O’Bryan MK, Magid MS, Schlegel PN (1996) Immunohistochemical localisation of endothelial nitric oxide synthase in human testis, epididymis and vas deferens suggest a possible role for nitric oxide in spermatogenesis, sperm maturation and programmed cell death. Biol Reprod 55:935–941 6. Nathan C (1997) Inducible nitric oxide synthase: what differences does it make? J Clin Invest 100:2417–2423
Schumpelick: I looked for your spermiograms.
Did you see any differences in motility or in any other analysis of testicular function besides the spermiograms according to the investigation period? Aydede: You are right. In our study we found no statistical significant difference between the different investigation time points. Klinge: The point I want to address is the method of statistical analysis. You frequently said that some differences were statistically significant or not significant. I’m not sure whether many of these data were really normal distributed. If you compare just the means between two groups, I’m not sure if some single details, such as a complete constric-
63 Chapter 8 · The Long-Term Effect on Testicular Function of a Mesh Bioprosthesis
tion of the vas, will be detected by this test. Did you use some other statistical tests for subgroups in your entire cohort? Aydede: At this time I can’t give you more information about statistical analysis than the Mann– Whitney U-test. We should do a more detailed analysis. Gryska: In the very first clinical study, how many patients did you have in each group? Aydede: We had about 30 patients in each group.
8
9
Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like? U. Muschaweck
66
Chapter 9 · Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like?
Introduction Lichtenstein repair is recommended in national guidelines as the first choice for uncomplicated primary inguinal hernia. It is known as easy to perform, has a short learning curve, and is said to have the smallest risk for recurrent hernia and other complications. However, in the year 2007 we had to reoperate on 232 patients with recurrent hernia, making up 20% of all our operations. Of these, 31 had had a previous Lichtenstein repair. In all 31 cases, the intraoperative findings showed complete incorporation of at least one nerve, mesh shrinkage and migration, and excessive scar tissue in the area of the external oblique fascia, the internal oblique muscle, and the groin ligament. We always had to remove the mesh completely because of the tissue damage in the groin canal. Also, neurectomy of at least one nerve always had to be done.
⊡ Fig. 9.1. Case 1: hardened mesh with stiff, sharp edges; vas adherent to mesh edge
9 Case Reports We have selected six cases of patients with severe chronic groin pain resulting in reoperation with impressive intraoperative findings. Two of these had a severed vas that was caused by the mesh.
Case 1: DL, 62-Year-Old Man from Wales
⊡ Fig. 9.2. Case 1: ilioinguinal nerve thickened; surface rough, not shiny; surrounded by fibrotic tissue. Recurrent hernia 3×3 cm
History: Lichtenstein repair in Cardiff, Wales, in October 2006. After 1 year, massive pain in the groin and radiating, burning pain to the scrotal area and penis. Unable to walk more than 30 m. Applied surgical technique: Removal of the mesh, neurectomy of the ilioinguinal nerve, Lichtenstein repair with UltraPro mesh (⊡ Figs. 9.1 and 9.2). Patient immediately free of pain. Electron microscopy and histological findings: Heavyweight small-pore polypropylene mesh; ingrowth of nerve with marked perineural fibrosis; posttraumatic neuroma (⊡ Fig. 9.3).
⊡ Fig. 9.3. Case 1: heavyweight small-pore polypropylene mesh; ingrowth of nerve with marked perineural fibrosis; posttraumatic neuroma
67 Chapter 9 · Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like?
Case 2: HB, 61-Year-Old Man from Germany
9
Electron microscopy and histological findings: Large-pore polypropylene mesh (⊡ Fig. 9.6), moderate foreign body reaction (epithelioid cell type).
History: Lichtenstein repair in Oldenburg, Germany, in October 2006. After 8 months, new bulge was present, with pressure and pain in the groin and severe pain during ejaculation.
Case 3: MR, 26-Year-Old Man from Denmark
Intraoperative findings: Excessive scar tissue; mesh surrounding vas at the internal ring (⊡ Figs. 9.4 and 9.5).
History: Lichtenstein repair in September 2007, with pain starting immediately afterward. Reoperation in December 2007.
Applied surgical technique: Removal of the mesh, neurectomy of the ilioinguinal nerve, minimal repair (suture repair). Patient immediately free of pain.
Intraoperative findings: Mesh covering the ilioinguinal nerve completely; nerve partly growing into the mesh (⊡ Fig. 9.7).
⊡ Fig. 9.4. Case 2: excessive scar tissue; mesh surrounds vas at the internal ring
⊡ Fig. 9.6. Case 2: large-pore polypropylene mesh, moderate foreign body reaction (epithelioid cell type)
⊡ Fig. 9.5. Case 2: ilioinguinal nerve thickened and grown into the upper edge of the mesh, surrounded by fibrotic tissue; lateral recurrent hernia 8×2 cm
⊡ Fig. 9.7. Case 3: mesh covers the ilioinguinal nerve completely; nerve partly growing into the mesh; small medial recurrent hernia
68
Chapter 9 · Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like?
⊡ Fig. 9.8. Case 3: heavyweight small-pore polypropylene mesh, foreign body granuloma, perineural fibrosis
9
⊡ Fig. 9.9. Case 4: inguinal nerve ingrowth into mesh; lateral edge of mesh rolled up and penetrating through the fascia and subcutaneous tissue; palpable through skin. No recurrent hernia
Applied surgical technique: Removal of the mesh with neurectomy and minimal repair. Electron microscopy and histological findings: Heavyweight small-pore polypropylene mesh (⊡ Fig. 9.8), foreign body granuloma, perineural fibrosis. Low-grade infection with neutrophilic granulocytes.
Case 4: GM, 40-Year-Old Man from Italy History: Lichtenstein repair in 2005, with pain starting immediately afterward. Reoperation in February 2008. Intraoperative findings: Inguinal nerve ingrowth into mesh; lateral edge of mesh rolled up and penetrating through the fascia and subcutaneous tissue; palpable through the skin (⊡ Fig. 9.9). No recurrent hernia.
⊡ Fig. 9.10. Case 4: double-layered, heavyweight, small-pore polypropylene mesh
Case 5: JC, 66-Year-Old Man from England
Applied surgical technique: Removal of the mesh with only a neurectomy done.
History: Lichtenstein repair in 2001, reoperation in 2008.
Electron microscopy and histological findings: Double-layered, heavyweight, small-pore polypropylene mesh, bulky board of scar, beginnings of calcification (⊡ Fig. 9.10).
Intraoperative findings: Mesh corrugated, only partial ingrowth (⊡ Fig. 9.11). Ilioinguinal nerve adherent to mesh over 2 cm. Lateral recurrent hernia 3×2 cm.
69 Chapter 9 · Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like?
⊡ Fig. 9.11. Case 5: mesh corrugated; only partial ingrowth. Ilioinguinal nerve adherent to mesh over 2 cm. Lateral recurrent hernia 3×2 cm
9
⊡ Fig. 9.12. Case 5: mesh type uncertain, chronic inflammation (giant cells)
Applied surgical technique: Removal of the mesh, neurectomy, Lichtenstein repair with UltraPro mesh. Electron microscopy and histological findings: Mesh type uncertain (⊡ Fig. 9.12), chronic inflammation (giant cells).
Case 6: HW, 29-Year-Old Woman from Germany History: Lichtenstein repair in March 2006. Pain started in August 2007; reoperation in February 2008.
⊡ Fig. 9.13. Case 6: Vypro mesh with ingrowth of ilioinguinal nerve. Medial recurrent hernia 3×2.5 cm
Intraoperative findings: Small amount of Vypro mesh with ingrowth of ilioinguinal nerve (⊡ Fig. 9.13). Medial recurrent hernia 3×2.5 cm. Applied surgical technique: Removal of the mesh (⊡ Fig. 9.14), followed by neurectomy and minimal repair. Electron microscopy and histological findings: Vypro mesh with posttraumatic neuroma and marked perineural fibrosis. ⊡ Fig. 9.14. Case 6: removal of the mesh, followed by neurectomy and minimal repair
70
Chapter 9 · Reoperation Following Lichtenstein Repair: What Do Vas and Nerves Look Like?
Is the Mesh Type Important? This sample of six patients whom we looked at in greater detail is certainly very small. But there is only a slight tendency that heavyweight mesh might be more often involved (see ⊡ Table 9.1).
Summary In these six patients, heavyweight small-pore meshes were slightly more predominant than heavyweight large-pore or lightweight meshes. But more important than the choice of mesh is the surgical handling of the nerve. (Is a primary resection better than keeping the nerve?) Therefore, the indication for mesh repair must be carefully considered, particularly in young patients.
9
⊡ Table 9.1. Mesh types encountered in the six cases and examined by electron microscopy Polypropylene
4
Heavyweight small-pore
3
Heavyweight large-pore
1
Vypro
1
Unknown (could not be analyzed)
1
Discussion Schumpelick: You mentioned that the nerve has
grown into the mesh, but it may be that the mesh has grown into the nerve. Muschawek: You are right; during the explantation you are not able to see which direction was the right one. Miserez: Two questions on the six patients you operated on for pain and recurrence. First, is it enough to do a single neurectomy, and second, do we need to remove the mesh for pain? Muschawek: I’m sure, because the mesh always covers the nerve, and if you lift up the mesh you can see the nerve going into the mesh. And in
most cases there is only one nerve left. So I prefer resecting the mesh and the mesh in this case. Uzzo: In the literature you find up to a 10% chronic pain rate after Lichtenstein repair. I think we should stop saying that Lichtenstein repair is easy to perform. You said it during your slides. Obviously, it’s not easy. Muschawek: You are right. It looks easy, but there are many details you have to think about. Heniford: I think we should put all these problem patients together with a standard study protocol, and we will get very quickly large numbers of patients through which we can answer questions. Klinge: You have a lot of experience with recurrent hernias. Do you think that it makes a difference in reoperating after 2 years or after 10 years? Muschawek: No. You will have the adhesion within a few weeks after operation. Kehlet: I just remember the first reports about pain after Lichtenstein repair. Now we are sitting here for a full meeting discussing chronic pain. So I think we have to be careful also with this fertility problem. We have to look at it, and we cannot say it is probably not a real problem.
10
Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review R. C. Read
72
Chapter 10 · Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review
Introduction
10
Complications following repair of inguinal herniation have historically been attributed to poor surgical technique and blamed on inexperience. Those related to the spermatic cord, testicular atrophy and occlusion of the vas deferens, are dreaded because the patient, angry that his manhood has been threatened, often resorts to litigation. Ischemia of the testicle was said to be the result of a too-tight reconstruction of the internal inguinal ring [1]. Injury to the vas deferens is presumed to arise after harsh separation of the hernial sac. The former may be ligated, divided, or devascularized. Considered rare, it is underreported because most men undergoing groin repair tend to be older and are no longer concerned about their reproductive capacity. Because most inguinal herniae are unilateral, younger men rarely face sterility. Nevertheless, a significant minority have bilateral repairs. Further, cryptorchidism or later epididymitis can eliminate the spermatic contribution from the contralateral groin.
Sutured Repair During the latter half of the 20th century, the Shouldice–Bassini procedure became the gold standard for groin hernioplasty. In the early 1980s, Wantz and Bendavid, two pioneers in herniology, separately focused attention on testicular ischemia and vasal narrowing. In 1982, Wantz [2, 3] reported that 11 of 1,682 patients developed orchitis within a week. All had had complete removal of their scrotal sacs. After the same operation was performed on 311 men for recurrence, seven progressed to testicular atrophy. Wantz blamed dissection through scarred tissue. The common feature was thrombosis affecting the pampiniform plexus and leading to venous infarction. Wantz pointed out that constriction at the internal inguinal ring was not responsible because ligation of testicular veins at this level, which is standard treatment for varicocele, does not cause testicular infarction. To avoid this complication, he recommended that in a complete indirect inguinal hernia, dissection of the hernial sac should not proceed beyond the level
of the pubic tubercle. Division of the peritoneal sac there allows for reduction and inversion of its proximal portion into the preperitoneal space. In cases of recurrent herniation, a posterior preperitoneal approach to repair should be employed, thereby avoiding dissection of a scarred spermatic cord. Adopting these ideas for his next group of 4,000 Shouldice hernioplasties resulted in only one case of ischemic orchitis. In 1983, Bendavid encountered a patient who complained of episodes of brief, severe pain in the groin during ejaculation. He had previously been operated on using the Shouldice procedure. By 1991, another 16 cases had been identified, two of whom had not received surgery but suffered from chronic epididymitis or cancer of the prostate treated with radiotherapy. The next year, Bendavid labeled this new syndrome »dysejaculation« [4]. Another 13 cases were reported in 1995 [5]. Symptomatology began 1 month to 2 years postoperatively. Reoperation showed either separation of the vas deferens from its blood supply, adherence to the transversalis fascial floor of the inguinal canal, kinking, abrasions, stricture, or scarring. Bendavid considered that the mechanism for pain was retrograde distension of a blocked vas deferens, since ejaculation begins with peristalsis in the epididymis, passing down to the seminal vesicles and prostate. Delay in onset postoperatively indicated scarring secondary to the dissection that had been required to remove both the cremasteric musculature and the hernial sac. Because some of Bendavid’s patients became pain free over time, conservative treatment was recommended.
Prosthetic Repair [6] Reinforcement of sutured hernioplasties began in the last decade of the 19th century, a few years after Bassini’s cure became well known. In 1894, Phelps employed silver coils. Later, filigrees of other metals were used. However, rigidity, fibrosis, sinuses, radiopacity, and both patient and surgeon discomfort discouraged their use. In 1944, Aquaviva and Bounet introduced Nylon mesh. Their prosthetic design remains, but polypropylene, which was first used by Usher in 1963, is now the most popular
73 Chapter 10 · Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review
mesh. Nevertheless, it was not until the final decade of the 20th century that a majority of groin repairs became prosthetic and the Lichtenstein procedure was the new gold standard. This change resulted from a significant reduction in the rate of recurrent herniation. LeBlanc et al. [7], using endoscopy, placed mesh preperitoneally overlying the internal inguinal ring of pigs. Examples of venous congestion in the pampiniform plexus were found, indicating that the posterior preperitoneal approach to the groin does not preclude venous infarction of the testicle. In 1999, Uzzo et al. [8] claimed to be the first to examine the effects of mesh-induced fibrosis on components of the spermatic cord. Using dogs, unilateral inguinal defects were created and repaired using either polypropylene mesh or the Shouldice technique. The contralateral groin served as a control. A year later, autopsies revealed patent but significantly narrowed vasa deferentia in both repair groups. Hydroceles and testicular atrophy were found in half of the dogs treated with mesh; none followed sutured repair. Taylor et al. [9] studied patients who had undergone repair of unilateral inguinal herniation with either the laparoscopic or anterior prosthetic (polypropylene) technique 3 years previously. There was no significant effect on testicular blood flow. Zieren et al. [10] reported in 2001 that testicular perfusion remained unchanged 6 months after patients received plug-and-patch repairs for inguinal herniation. Aydede et al. [11] obtained similar results, long term, after randomly assigning patients to anterior or preperitoneal prosthetic repair. Laparoscopic mesh repair of inguinal herniae was found to result in dysejaculation that began an average of 3 months postoperatively in 10% [12] or 3.9% [13] of patients. Thus, as with damage to the pampiniform plexus, the preperitoneal approach does not confer exemption from injury to the vas deferens. Its incidence appears to increase with the use of mesh. Silich and McSherry [14] reported a patient with a sperm granuloma 4 years after a Lichtenstein repair. They believe it arose from erosion of the vas deferens by the cut edge of the mesh at the medial end of the slit made to recreate the internal inguinal ring. Berndsen et al. [15] compared the effects of heavy or lightweight
10
polypropylene mesh on the spermatic cords of rats 3 months after Lichtenstein repair, using the Shouldice procedure as control. Interestingly, they found impaired testosterone production and narrowing of the vas deferens only with low-weight composite mesh. There was no difference in the inflammation or fibrosis evoked by the different meshes, contrary to results from previous studies [16, 17]. Dilek et al. [18] measured testicular blood flow before and 3 months after patients were randomly assigned to laparoscopic or Lichtenstein repair of inguinal herniation. Neither technique affected testicular blood flow. Taneli et al. [19] studied testicular metabolism in rats whose spermatic cord was exposed to a layer of polypropylene mesh. Findings were compared to those for sham-operated controls 6 months later. There was no significant difference in serum hormone levels or apoptosis in the testes. Their results support the 2001 results of Zieren et al. [10] and Taylor et al. [9]. Shin et al. [20] presented their multi-institutional experience of 14 younger men previously repaired for inguinal herniae, mainly using the Lichtenstein procedure, who reported infertility. Nine had bilateral vasal obstruction, and five had unilateral obstruction with contralateral testicular atrophy or epididymitis. The mechanism was dense fibrosis. All had normal blood hormone levels. The authors point out that the vasal narrowing described by Uzzo et al. [8] at 1 year postoperatively could, over time, become an occlusion. Iatrogenic injury to the vas deferens such as ligation, cauterization, incision, or vascular compromise could also be a factor. Goldenberg and de Paula [21] studied the 2-month effect of simulated polypropylene mesh repair in the groin of dogs. Observations were compared with contralateral dissected or unoperated controls. The inflammatory response–100% with mesh, 71% without–involved the vas deferens in all subjects in the mesh group, causing statistically significant narrowing. A third of the animals that received mesh showed congestion of the pampiniform plexus. Peiper et al. [22] experimented on pigs and rabbits to determine whether a risk of infertility exists after inguinal mesh repair. In the former, transinguinal preperitoneal repair with polypropylene mesh, after resection of the cre-
74
10
Chapter 10 · Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review
master, was compared to a contralateral Shouldice procedure. Within a month, one-third of those receiving mesh demonstrated venous thrombosis in the pampiniform plexus even though the spermatic cord was exposed to the prosthesis only at the internal inguinal ring. The rabbits underwent unilateral Lichtenstein repair with preservation of the cremaster muscle, and contralateral Shouldice repair was also undertaken. Testicular parameters were compared with those of unoperated controls. Each repair reduced perfusion, more so with Lichtenstein. Kolbe and Lechner [23] wrapped the vasa deferentia of rats with either heavyweight or lightweight polypropylene mesh. After 3 months, their fertility was determined by mating them and counting the oocytes or embryos. Some sperm granulomas were observed in the heavyweight mesh group, but neither prosthesis reduced fertility compared with controls, which had simply undergone isolation of the vas deferens. Interestingly, both meshes induced a similar inflammatory reaction, supporting the work of Berndsen et al. [15] but not that of others [16, 17]. Witkowski and Trabucco [24] questioned the reported increased risk of vas deferens occlusion after mesh inguinal hernioplasty. They cite Fitzgibbons [25], who has argued that »no correlation between fibrosis and vasal obstruction has been proven.« Witkowski and Trabucco [24] stated, as did Shin et al. [20], that it is therefore possible that intraoperative damage from dissection or fixation is responsible. Regardless, they suggest separating the mesh from the spermatic cord by placing it subcutaneously à la Halsted–Bassini. In 2008 Gventatadze [26] tested the effect of such isolation on sperm morphology in patients undergoing the modified bilateral Lichtenstein repair. Comparison was made with others receiving the classic procedure. A statistically significant deterioration (p<0.01) in sperm parameters was found in the latter.
Conclusions In summary, venous infarction of the testicle (atrophy) and narrowing of the vas deferens (dysejaculation) were rarely reported following su-
tured repair (Shouldice). The risk to the spermatic cord increases after its isolation by excision of the cremaster muscle and scrotal sacs. Reoperation requiring dissection through scar tissue jeopardizes the cord, and tissue reaction to prostheses augments damage to cord structures. Lightweight mesh cannot be relied upon to evoke less fibrosis than heavyweight mesh. Spermatic cord complications are not avoided by preperitoneal placement of prostheses. Pathology, secondary to groin dissection and the use of mesh, has been shown to affect the vas deferens more often than the pampiniform plexus. Arterial flow to the testis is affected little by prosthetic repair unless, in a minority, venous thrombosis supervenes. Vasal occlusion is underreported since most inguinal herniorrhapies are performed on the elderly, who usually are not concerned about fertility. In younger men, sterility is generally not a problem because most repairs are unilateral. However, contralateral diseases or bilateral hernioplasties can result in sterility. It has been reported that subcutaneous placement of the spermatic cord in men after bilateral Lichtenstein repair, as recommended by Witkowski and Trabucco, significantly improves fertility compared with the classic Lichtenstein procedure.
References 1. Koontz AR (1965) Atrophy of the testicle as a surgical risk. Surg Gynecol Obstet 120:511–513 2. Wantz GE (1982) Testicular atrophy as a risk of inguinal hernioplasty. Surg Gynecol Obstet 154:570–571 3. Fong Y, Wantz GE (1992) Prevention of ischemic orchitis during inguinal hernioplasty. Surg Gynecol Obstet 174:399–402 4. Bendavid R (1992) »Dysejaculation«: an unusual complication of inguinal herniorrhaphy. Postgrad Gen Surg 4(2):139–141 5. Bendavid R (1995) Dysejaculation. Probl Gen Surg 12(2):237–238 6. Read RC (2004) Milestones in the history of hernia surgery: prosthetic repair. Hernia 8:8–14 7. LeBlanc KA, Booth WV, Whitaker JM et al. (1998) In vivo study of meshes implanted over the inguinal ring and external iliac vessels in uncastrated pigs. Surg Endosc 12:247–251 8. Uzzo RG, Lemack GE, Morrissey KP et al. (1999) The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 161(4):1344– 1349
75 Chapter 10 · Damage to the Spermatic Cord from Groin Herniorrhaphy: A Review
9. Taylor SG, Hair A, Baxter GM et al. (2001) Does contraction of mesh following tension-free hernioplasty affect testicular or femoral vessel blood flow? Hernia 5:13–15 10. Zieren J, Beyersdorff D, Beier KM et al. (2001) Sexual function and testicular perfusion after inguinal hernia repair with mesh. Am J Surg 181:204–206 11. Aydede H, Erhan Y, Sakarya A et al. (2003) Effect of mesh and its localization on testicular flow and spermatogenesis in patients with groin hernia. Acta Chir Belge 103 (6):607–610 12. Langenbach M, Schmidt J, Lazika M et al. (2003) Urological symptoms after laparoscopic hernia repair. Reduction with a variant of polypropylene mesh. Urologe 42:375–381 13. Wingenbach O, Waleczek H, Kozianka J (2004) Laparoscopic hernioplasty by transabdominal preperitoneal approach. Analysis and review in 267 cases. Zentralbl Chir 129:369–373 14. Silich RC, McSherry CK (2006) Spermatic granuloma. An uncommon complication of the tension-free hernia repair. Surg Endosc 10(5):537–539 15. Berndsen FH, Bjursten LM, Simanaitis M et al. (2004) Does mesh implantation affect the spermatic cord structures after inguinal hernia surgery? An experimental study in rats. Eur Surg Res 36:318–322. 16. Klosterhalfen B, Klinge U, Schumpelick V (1998) Functional and morphological evaluation of different polypropylene mesh modifications for abdominal wall repair. Biomaterials 19:2235–2246 17. Junge K, Klinge U, Rosch R et al. (2002) Functional and morphological properties of a modified mesh for inguinal hernia repair. World J Surg 26:1472–1480 18. Dilek ON, Yucel A, Akbulut G et al. (2005) Are there adverse effects of herniorrhaphy techniques on testicular perfusion? Evaluation by color Doppler ultrasonography. Urol Int 75:167–169 19. Taneli F, Aydede H, Vatansever S et al. (2005) The longterm effect of mesh bioprosthesis in inguinal hernia repair on testicular nitric oxide metabolism and apoptosis in rat testis. Cell Biochem Funct 23:213–220 20. Shin D, Lipshultz LI, Goldstein M et al. (2005) Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction. A preventable cause of obstructive azoospermia. Ann Surg 241(4):553–558 21. Goldenberg A, de Paula JF (2005) Effects of polypropylene mesh implanted through inguinotomy on the spermatic funiculus, epididymis and testis of dogs. Acta Cir Bras 20(6):461–467 22. Peiper C, Junge K, Klinge U et al. (2006) Is there a risk of infertility after inguinal mesh repair? Experimental studies in the pig and rabbit. Hernia 10(1):7–12 23. Kolbe T, Lechner W (2007) Influence of hernioplastic implants on male fertility in rats. J Biomed Mater Res B Appl Biomater 81B:435–440 24. Witkowski P, Trabucco EE (2007) Is there an increased risk of vas deferens occlusion after mesh inguinal hernioplasty and what we can do about it? [letter] Ann Surg 245(1):153–154
10
25. Fitzgibbons RJ Jr (2005) Can we be sure polypropylene mesh causes infertility? Ann Surg 241:559–561 26. Gvenetadze T (2008) Method of spermatic cord isolation from the mesh. In: Proceedings of the American Hernia Society annual meeting, Scottsdale, Arizona, 12–16 March 2008, poster 23
II
II
Risk for Infection
11
Mesh Infection Following Hernia Repair: A Frequent Problem? – 79
12
Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery – 87
13
Mesh-Related Infections After Hernia Repair – 97
14
Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field – 103
15
Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh – 113
16
Mesh Infection–Therapeutic Options – 119
17
Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery? – 125
18
Infection Control in a Hernia Clinic: 24-Year Results of Aseptic and Antiseptic Measure Implementation in 4,620 »Clean Cases« Based on Up-To-Date Microbiological Research – 135
19
Components Separation Technique: Pros and Cons – 143
11
Mesh Infection Following Hernia Repair: A Frequent Problem? B. J. Lammers, A. Baer, T. Sauer, P. Pohl, P. E. Goretzki
80
Chapter 11 · Mesh Infection Following Hernia Repair: A Frequent Problem?
Introduction
11
Wound and mesh infections after hernia repair are very severe complications. On the one hand, today it is well established to repair hernias with meshes in very different ways, but on the other hand, knowledge of the incidence of severe infections, including mesh infection, is quite rare [1, 2]. In this chapter we aim to define which kinds of infections we can recognise. The rate of infection after mesh repair differs, of course, between inguinal hernia repair and incisional hernia repair. In the United States it is very common to use the group of ventral hernias of the abdominal wall (including incisional, epigastric, Spigelian, and umbilical hernias). According to the infection, we will look at infections in this group as well as in inguinal hernias, including femoral hernias. Therefore, we will address just two groups: ventral hernias (laparoscopic and open) and inguinal hernias (open and laparoscopic procedures). Using new techniques and new materials, it is impossible to define detailed risk factors for wound and mesh infection that are related to each procedure and each material. The literature includes some references on this; these will be remarked upon in this chapter regarding some special topics. Further investigations are necessary, and the authors of other chapters will also comment on this topic.
Definition of Surgical Site Infection Using the definition of the Centers for Disease Control and Prevention, infections are divided into superficial and deep infections. Superficial infection occurs in the first 30 days after an intervention, and deep infection occurs within 1 year and involves the fascia, the muscle layers, and the graft. We must recognise that there are early infections within the first 30 days after implantation and late infections that may occur years after implantation. Furthermore, we may encounter further intraabdominal problems, such as abscess formation, bowel injury, peritonitis, and so on, with both early and late onset.
Looking through the literature, no definitions of mesh infection are available. But at the very least, there is a risk of infection of the mesh with any kind of wound infection, so we should be alert for signs of deep infection, including the mesh (onlay, intraperitoneal onlay, sublay, etc.): ▬ Fever ▬ Signs of infection (swelling, oedema) ▬ C-reactive protein and leucocytosis ▬ Contaminated mesh Inguinal hernia surgery is primarily sterile surgery with low contamination. In abdominal wall surgery, the infection rate is higher, so it must be regarded as contaminated surgery.
Materials and Methods We did a literature review of papers involving more than 100 patients with ventral hernia repair and incisional hernia repair, and we also included our own data. The main topic of this investigation was the rate of infections, including mesh-related infections, if these data were available. However, many papers lacked information on this problem. The group of inguinal hernia repairs was covered by an overview of inguinal hernia repair in the North Rhine region of Germany for a period of 10 years with almost 200,000 operations [3]. This period included the development of a reporting system and the new video-assisted technologies (transabdominal preperitoneal and totally extraperitoneal repair). There are very few papers on mesh infection in inguinal hernia repair. Fistula formation is also very rare, so this was not discussed in this overview. Obviously, the problem in inguinal hernia repair nowadays is not evident.
Results Ventral Hernias and Incisional Hernia Repairs Without Mesh Repair This operation, which is done in many countries using direct suture or doubling of the fascia (called the Mayo repair in Germany), is not standard
81 Chapter 11 · Mesh Infection Following Hernia Repair: A Frequent Problem?
therapy today because mesh repair is accepted. However, many patients need a nonmesh repair. The infection rate with antibiotic prophylaxis is about 6–10 % [4–6]. Our own experiences with a long-term run of 20 years show an infection rate of 12%, including complete wound rupture. These data show the general problem of incisional hernia repair: contaminated surgery. The rate of postoperative infections is over 10%. The bacteria stay in the wound for a long time.
Incisional Hernias with Mesh Repair We analysed the publications involving more than 100 patients. Many of them are multicentre studies; there is just one randomised multicenter study, from Conze [7]. Leber et al. showed in a retrospective study in 1998 that in open mesh repair, many early and late postoperative problems occur. Particularly significant was the high rate of infections and fistulas [1]. They showed that at that time it was not clear which positions of the meshes related to the material were possible. The infection rate reported in the older papers is higher than in the papers published in the last 3 years [8–12]. Obviously, surgeons are gaining experience and are able to manage the problems better. Another possibility
11
might be the evolution of new meshes. Ramshaw et al. [13] and Stoppa [14] have had very high rates of wound infections, 15–25% (⊡ Table 11.1). In the last years, open mesh repairs have usually been associated with a lower rate of wound infections, 0.6–7% [4, 15–17]. But the main topic of these papers is usually not the infection rate. Mesh infections and the rate of mesh removal must be mentioned, although this topic is difficult to discuss because data on this are not available in every study. Finan et al. [16] found some risk factors for infection: immunosuppression, smoking, intraoperative bowel injury, bowel resection emergency procedures, complicated hernia surgery (incarcerated, obstructed, or strangulated), and operating time. The variation in rates among different hospitals reported in this paper is very interesting– from 1% to 9%. The mesh infection rate was between 0.3% and 6%. So the rate of mesh infection differed, and not every infected mesh was removed, but the data on this problem are very sparse [16].
Tailored Incisional Hernia Surgery – Our Results In our experience since 1996 of using a tailored concept for all operations with mesh (494 of 798),
⊡ Table 11.1. Literature overview of mesh infections in open incisional hernia treatment (minimum 100 cases) First author
Year
N
Wound infections (%)
Mesh infections (%)
Mesh removal (%)
Iannitti [15]
2008
455
0.3
0.3
?
Lammers [17]
2008
774
7
2
0.5
Israelsson [4]
2006
349
9.6
Mahmoud Uslu [18]
2006
291
3.3
0.6
Finan [16]
2005
1505
5
?
Conze [7]
2005
165
17.8
-
Basoglu [32]
2004
264
21.5
2 fistulas
McGreevy [9]
2003
71
8.4
Korenkov [30]
2002
160
13
Ramshaw [13]
1999
174
15.5
6
Stoppa [14]
1989
368
15
ß
?
2
6
82
11
Chapter 11 · Mesh Infection Following Hernia Repair: A Frequent Problem?
we have had a general wound infection rate of 8.9%. For intraperitoneal onlay mesh (IPOM) repair (222 operations), we have had a mesh infection rate of 4%, and only 2.3% of the meshes were removed (only expanded polytetrafluoroethylene, or ePTFE, meshes must be removed). In the onlay repair group (223 operations), we have had a 2.2% mesh infection rate, and just one of 223 meshes had to be removed. We have seen no fistula formation and no intraperitoneal abscesses (⊡ Table 11.2). The rate of fistula to the bladder, colon, or other intestinal organs is very rarely reported in the literature, usually occurring when meshes were used that should not be placed intraperitoneally (heavyweight meshes without a composite structure, polypropylene and polyester). The data on mesh removal are also very rare. We know that infected ePTFE is very difficult to handle, but in our experience, not every infected mesh must be removed in open hernia surgery. Infected polyester meshes are quite difficult to handle, but lightweight polypropylene meshes are not especially difficult to treat. In general, they do not need to be removed. Mahmoud Uslu et al. described only two cases of 291 patients (modified onlay technique) in which it was necessary to reoperate and remove the mesh, whereas the infection rate was 2.7% [18]. The wound infection rate in the study of Conze et al. [7] was very high, up to 18%, with one-third of the affected patients needing surgery. The authors did not define mesh infection, but these must have been deep infections; however, mesh removal was not necessary. At least, there was no significant
difference between composite and regular meshes. All patients had sublay repair (⊡ Table 11.1).
Wound and Mesh Infections in Laparoscopic Hernia Repair One of the main advantages of laparoscopic IPOM is the lower mesh infection rate. The wound infection rate is about 2%, and the mesh infection rate is between 1% and 5%. But one point is very important: Quite often, the data on IPOM are based on a lot of very easy umbilical and epigastric hernias; the patients whose procedures were converted are not included in these data. Also, when a bowel injury is reported, it is not clear whether this means a mesh infection. One of the authors, Finan, stated, »This study had an 8% rate of laparoscopic hernia repairs with a 3.3% wound infection rate compared to a 4.5% rate in open permanent mesh repairs, demonstrating no meaningful difference« [16]. Berger, who reports on only incisional hernia repairs without any selection, has a very low rate of mesh and wound infections–about 1%. We have seen no wound infections but saw one mesh infection caused by an unknown bowel leakage with peritonitis [9, 19–24] (⊡ Table 11.3).
Infections in Inguinal Hernia Repair In almost all studies, infection occurring with an open and laparoscopic inguinal hernia repair is no problem. Mesh infections are very rare, so they are
⊡ Table 11.2. Our data from 1986 to 2008: infection rates (IPOM intraperitoneal onlay mesh) N
Wound infections (%)
Mesh infections (%)
Mesh removal (%)
Unknown bowel injury (%)
Incisional hernia total
798
8.9
1.9
0.9
0.1
With mesh
494
6.2
2.8
1.2
0.2
IPOM
222
6.8
4
2.3
0
Onlay
223
7
2.2
0.4
0
Laparoscopic IPOM
49
0
2
2
2
11
83 Chapter 11 · Mesh Infection Following Hernia Repair: A Frequent Problem?
usually not reported; that is why we looked for a large prospective series. In the years 1991 to 1999 in the North Rhine area of Germany, there was a program to collect all the data on inguinal hernia repair. Nearly 200,000 operations were documented. In the data collection, we discovered that the postoperative complication rate was much higher in general than in randomised studies [3, 25–29]: We found a complication rate of between 5.1% and 9.7%. This
rate decreased as the laparoscopic management of hernias increased up to 29%. The seroma rate was between 3% and 5%, but there were documented wound infections of 0.79–1.55%, swelling of the scrotum in about 0.7%, and swelling of the testes in 0.24–0.52% (as a sign for testicular atrophy in the future). The reoperation rate was a bit higher than 1%. These patients are always at risk for a mesh infection. The mortality rate was 0.1% (⊡ Table 11.4).
⊡ Table 11.3. Literature overview of mesh infections in laparoscopic ventral hernia therapy First author
Year
N
Wound infections (%)
Mesh infections (%)
Mesh removal (%)
Ferrari [20]
2007
99
1
1
1
Heniford [21]
2000
407
1.23
0.98
0.98
McGreevy [9]
2003
65
–
4.6
4.6
Olmi [31]
2007
85
–
1
1
LeBlanc [23]
2000
100
2
1
1
Berger [22]
2002
150
1.3
1
1
Lammers [own data]
2008
49
0
2
2
⊡ Table 11.4. Results of inguinal hernia surgery in the North Rhine district of Germany [3] Year
1999
1998
1997
1996
1995
1994
1993
1992
1991
Total
Patients
19,266
18,619
19,732
20,940
19,646
19,907
19,740
18,738
17,605
173,923
Operations
22,015
21,162
22,212
23,245
21,639
21,888
21,354
20,203
19,000
192,718
Postoperative complications (%)
5.9
5.6
5.5
5.1
6.4
7.6
7.9
8.1
9.7
Reoperation (%)
1.10
1.16
1.13
1.12
1.17
1.48
1.42
–
–
Seroma, haematoma (%)
3.85
3.27
3.11
2.8
3.54
4.46
4.39
4.27
5.08
Wound infection (%)
0.89
0.84
0.90
0.79
1.19
1.31
1.51
1.48
1.55
Swelling of scrotum (%)
0.55
0.58
0.56
0.44
0.58
0.75
0.77
0.74
0.81
Swelling of testes (%)
0.26
0.28
0.32
0.24
0.34
0.53
0.49
0.42
0.52
–
84
Chapter 11 · Mesh Infection Following Hernia Repair: A Frequent Problem?
Discussion
11
The problem of mesh infection in hernia repair does not occur very often, but when it does, there is always the question of whether the mesh has to be removed. Some studies found that in the case of an infection with ePTFE, the mesh should be removed. Most of the meshes that were developed within the last 7 years (light meshes, composite meshes) did not have this problem. Fistula formation is not so rare when the wrong mesh is used intraperitoneally; the rate could be as high as 3.5% [1, 19]. Therefore, it is very important to use only approved meshes intraabdominally and perhaps even avoid intraperitoneal meshes. Mesh infection in laparoscopic hernia repair is often associated with mesh removal, but the data are very sparse. When studying the literature, it is very difficult to discover the complication rates because many studies involved a mixture of ventral and incisional hernias. When looking back at older data, it can be seen that incisional hernia treatment formerly had a high wound infection rate. When prophylactic antibiotics were used, the rate decreased to 5–7%. The infection rate seems to be higher in large series; the studies on antibiotics suggest this [25–29]. But the incidence of mesh-associated infections, including fistula formation, is not clear in inguinal hernia repair. In general, a higher complication rate is noted when many hospitals are involved in a study. Deep infection, including infection of the mesh, has a high risk of recurrence and reoperation. In the future, more studies are necessary to look for the advantages related to laparoscopic incisional hernia repair.
4. 5.
6.
7.
8.
9.
10.
11. 12. 13.
14. 15.
16.
17. 18.
References 19. 1. Leber GE, Gar JL, Aleander AL, et al. Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 1998; 133:378–382 2. Lammers BJ, Voos S, Witt M, Goretzki PE. Results of conventional mesh-augmented incisional hernia repair. Chir Gastroenterol 2003; suppl 2:24–28 3. Lammers BJ, Meyer HF, Huber HG, et al. Developments in inguinal hernia surgery based on newly introduced inter-
20.
21.
vention techniques in the North Rhine district. Chirurg 2001; 72:448–452 Israelsson LA, Smedberg S, Montomery A, et al. Incisional hernia repair in Sweden 2002. Hernia 2006; 10:258–261 Perez A, Roxas MF, Hilvano SS. A randomized, doubleblind, placebo-controlled trial to determine effectiveness of antibiotic prophylaxis for tension-free mesh herniorrhaphy. J Am Coll Surg 2005; 200:393–398 Yerdel MA, Akin EB, Dolalan S, et al. Effect of singledose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh. The randomized, double-blind, prospective trial. Ann Surg 2001; 233:26–33 Conze J, Kingsnorth AN, Flament JB, et al. Randomized clinical trial comparing lightweight composite mesh with polyester or polypropylene mesh for incisional hernia repair. Br J Surg 2005; 92:1488–1493 Lammers BJ, Goretzki PE, Witt M, Röher WM. e-PTFE IPOM versus onlay-repair–results of a prospective randomised controlled trial. Chir Forum 2001; 30:563–566 McGreevy JM, Goodney PP, Birkmeyer CM, et al. A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. Surg Endosc 2003; 17:1778–1780 Arroyo A, Garcia P, Pérez F, et al. Randomized clinical trial comparing suture and mesh repair of umbilical hernia in adults. Br J Surg 2001; 88:1321–1323 Cassar K, Munro A. Surgical treatment of incisional hernia. Br J Surg 2002; 89:534–545 Langer C, Liersch T, Kley C, et al. 25 Jahre Erfahrung in der Narbenhernienchirurgie. Chirurg 2003; 74:638–645 Ramshaw BJ, Esartia P, Schwab J, et al. Comparison of laparoscopic and open ventral herniorrhaphy. Am Surg 1999; 65:827–832 Stoppa RE. The treatment of complicated groin and incisional hernias. World J Surg 1989; 13:545–554 Iannitti DA, Hope WW, Norton HJ, et al. Technique and outcomes of abdominal incisional hernia repair using a synthetic composite mesh: a report of 455 cases. J Am Coll Surg 2008; 206:83–88 Finan KR, Vick CC, Kiefe CI, Neumayer L, Hawn MT. Predictors of wound infection in ventral hernia repair. Am J Surg 2005; 190:676–681 Lammers BJ, Goretzki PE, Otto T. New aspects in hernia surgery. Urologe 2005; 44:774–779 Mahmoud Uslu HY, Erkek AB, Cakmak A, et al. Incisional hernia treatment with polypropylene graft: results of 10 years. Hernia 2006; 10:380–384 Benhidjeb T, Bärlehner E, Anders S. Laparoscopic incisional hernia repair. Chir Gastroenterol 2003; 19(suppl):16–22 Ferrari GC, Mirando A, Di Lernia S, et al. Laparoscopic repair of incisional hernia: outcomes of 100 consecutive cases comprising 25 wall defects larger than 15 cm. Surg Endosc 2008; 22:1173–1179 Heniford BT, Park A, Ramshaw BJ, Voeller G. Laparoscopic ventral and incisional hernia repair in 407 patients. J Am Coll Surg 2000; 190:645–650
85 Chapter 11 · Mesh Infection Following Hernia Repair: A Frequent Problem?
22. Berger D, Bientzle M, Müller A. Postoperative complications after laparoscopic incisional hernia repair. Surg Endosc 2002; 16:1720–1723 23. LeBlanc KA, Booth WV, Whitaker JM, Bellanger DE. Laparoscopic incisional and ventral herniorrhaphy in 100 patients. Am J Surg 2000; 180:193–197 24. O’Dwyer PJ, Kingsnorth AN, Molloy RG, et al. Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 2005; 92:166–170 25. Sanabria A, Dominguez LC, Valdivieso E, Gabriel G. Prophylactic antibiotics for mesh inguinal hernioplasty: a meta-analysis. Ann Surg 2007; 245:392–396 26. Kuzu M, Hazinedaroglu S, Dolalan S, et al. Prevention of surgical site infection after open prosthetic inguinal hernia repair: efficacy of parenteral versus oral prophylaxis with amoxicillin-clavulanic acid in a randomized clinical trial. World J Surg 2005; 29:794–799 27. Perez A, Roxas MF, Hilvano SS. A randomized, doubleblind, placebo-controlled trial to determine effectiveness of antibiotic prophylaxis for tension-free mesh herniorrhaphy. J Am Coll Surg 2005; 200:393–398 28. Yerdel MH, Akin EB, Dolalan S, et al. Effect of singledose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh. The randomized, double-blind, prospective trial. Ann Surg 2001; 233:26–33 29. Terzi C, Kilic D, Ünek T, et al. Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study. J Hosp Infect 2005; 60:340–347 30. Korenkov M, Sauerland S, Arndt M, et al. Randomized clinical trial of suture repair, polypropylene mesh or autodermal hernioplasty for incisional hernia. Br J Surg 2002; 89:50–56 31. Olmi S, Scaini A, Cesana GC, et al. Laparoscopic versus open incisional hernia repair. An open randomized controlled study. Surg Endosc 2007; 21:555–559 32. Basoglu M, Yildirgan MI, Yilmaz I, et al. Late complications of incisional hernias following prosthetic mesh repair. Acta Chir Belg 2004; 104:425–428 33. Bingener J, Buck L, Richards M, et al. Long-term outcomes in laparoscopic vs open ventral hernia repair. Arch Surg 2007; 142:562–567
Discussion Read: You mentioned bacteria. Are there any viral infections of mesh? Lammers: It may be possible, but I have never seen it, and I have never heard about this. Schumpelick: Do you know where the bacteria come from?
11
Lammers: First of all, we know that patients who
have had an infection in former times from the first operation—for example, for bowel with anastomosis leakage, they have bacteria even years after the first operation in the wound. That’s the advantage of laparoscopic hernia repair because you don’t open the same wound again. On the other hand, during open hernia repair there is the possibility to bring bacteria inside the wound, such as from the patient’s skin. But there are no studies available on this problem at the moment.
12
Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery H. W. Hopf
88
Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery
Introduction
12
Despite major advances in the management of patients undergoing surgery–including aseptic technique, prophylactic antibiotics, and advances in surgical approaches such as laparoscopic surgery– surgical wound infection remains among the most common complications of surgery [1]. Wound complications are associated with prolonged hospitalization and increased resource consumption. More than 300,000 surgical site infections occur each year in the United States at an estimated cost of more than $1 billion [1]. A growing body of literature supports the concept that patient factors are a major determinant of wound outcome following surgery. Comorbidities such as diabetes and cardiac disease clearly contribute, but environmental stressors as well as the individual’s response to stress are equally important. In particular, wounds are exquisitely sensitive to hypoxia, which is both common and preventable. Perioperative management can be adapted to promote postoperative wound healing and resistance to infection. Along with aseptic technique and prophylactic antibiotics, maintenance of perfusion and oxygenation of the wound is paramount. There is strong clinical evidence that once perfusion is assured, the addition of increased inspired oxygen substantially reduces surgical site infections in at-risk patients. It is becoming clear that the intraoperative care of patients has repercussions far into the postoperative period. The impact of anesthetic technique on postoperative pain, perioperative myocardial ischemia, and vascular graft patency is now well established. Similarly, anesthetic technique can be adapted to promote postoperative wound healing and resistance to infection. The most important factors include temperature management, increased arterial oxygen tension (PaO2), pain control, fluid management, and, as has been long recognized, appropriate sterile technique and administration of prophylactic antibiotics. All but the last relate particularly to maintaining perfusion and oxygenation of the wound. Even when the best care possible is provided, surgical wounds may become infected or fail to heal. The progress of wounds healing by secondary
intention can also be optimized. The most important factors include attention to perfusion and oxygenation, as with acute wounds; moist wound care; control of bacterial load; nutrition; edema control; and prevention of ongoing trauma.
Wound Repair Injury damages the local circulation and causes platelets to aggregate and release a variety of substances, including chemoattractants and growth factors. The initial result is coagulation, which prevents exsanguination, but also widens the area that is no longer perfused. Inflammatory cells (polymorphonuclear leukocytes immediately and macrophages by 24–48 h) migrate to the wound and are activated in response to endothelial integrins, fibrin, lactate, hypoxia, foreign bodies, and growth factors. In turn, macrophages and lymphocytes produce more growth factors and lactate [2]. Activated inflammatory cells consume oxygen at a high rate, and, coupled with the impaired microcirculation, this results in hypoxia, especially at the center of the wound [3]. Lactate is produced both anaerobically and aerobically, and this results in concentrations of 5–15 mM even in well-oxygenated wounds. Lactate is a strong stimulus for collagen secretion and angiogenesis [4, 5]. Antiinflammatory steroids impair healing by suppressing inflammation at this step. Angiogenesis is required to replace the injured microcirculation. Platelets release a number of angiogenic factors, including platelet-derived growth factor, insulin-like growth factor 1, and others. Angiogenic growth factor levels remain high because of continued production by macrophages and fibroblasts (particularly of fibroblast growth factor and vascular endothelial growth factor) in response to hypoxia and lactate, among other things [6]. The capillary endothelial response to angiogenic agents (i.e., migration into the wound, tubule formation, and connecting to sources of blood flow) requires oxygen, so angiogenesis progresses proportionally to blood perfusion and arterial PO2 [7]. New blood vessels grow into matrix that is produced by fibroblasts. Fibroblasts replicate and migrate mainly in response to growth factors and
89 Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection
chemoattractants. Lactate and some growth factors induce collagen mRNA synthesis and procollagen production. Posttranslational modification by prolyl and lysyl hydroxylases is required to allow collagen peptides to aggregate into triple helices. Collagen can be exported from the cell only when it is in this triple helical structure. The helical configuration is also primarily responsible for tissue strength. The activity of the hydroxylases is critically dependent on vitamin C and tissue oxygen tension [8]. Wound strength, which results from collagen deposition, is, therefore, highly vulnerable to wound hypoxia. Angiogenesis and extracellular matrix (primarily collagen) production are closely linked. Fibroblasts cannot produce mature collagen in the absence of mature blood vessels that deliver oxygen to the site. On the other hand, new blood vessels cannot mature without a strong collagen matrix. Mice kept in a hypoxic environment (13% inspired oxygen) develop some new blood vessels in a test wound, but these vessels are immature, with little surrounding matrix, and demonstrate frequent areas of hemorrhage [9]. Epithelial cells move and replicate in response to growth factors and oxygen tension, and epithelization occurs most rapidly in hydrated, welloxygenated tissue [10]. Disruption of the normal skin barrier requires that wounds have the ability to clear foreign material and resist infection. Nonspecific phagocytosis and intracellular killing are the major pathways activated in wounds [11]. Conversion of oxygen to superoxide in phagocytic vacuoles is responsible for the first step in nonspecific intracellular killing, so resistance to infection is critically impaired by wound hypoxia and becomes more efficient as PO2 increases even to very high levels (500– 1,000 mmHg) [12].
Wound Perfusion and Oxygenation Wound complications include failure to heal, infection, and excessive scarring or contracture. Rapid repair has the least potential for infection and excess scarring. Repair proceeds most rapidly when wound oxygen levels are high, and this is
12
achieved only by maintaining perfusion of injured tissue [13]. Ischemic or hypoxic tissue, on the other hand, is easily infectable and heals poorly, if at all. Wound tissue oxygenation depends on the vascular anatomy, the degree of vasoconstriction, and arterial PO2. Wound tissue oxygenation is complex and depends on the interaction of blood perfusion, arterial oxygen tension, hemoglobin (Hb) dissociation conditions, carrying capacity, mass transfer resistances, and local oxygen consumption. The standard teaching that oxygen delivery depends more on hemoglobin-bound oxygen (oxygen content) than on arterial PO2 may be true of working muscle, but it is not true of wound healing. In muscle, intercapillary distances are small, and oxygen consumption is high. In subcutaneous tissue, on the other hand, intercapillary distances are large, and oxygen consumption is relatively low [14]. In uninjured subcutaneous tissue, the intercapillary distance is greater than that in muscle and other highly perfused organs. In wounds, where the microvasculature is damaged, diffusion distances increase by an order of magnitude. Peripheral vasoconstriction further increases diffusion distance [3]. The driving force of diffusion is partial pressure. Hence, a high PO2 is needed to force oxygen into injured and healing tissues, particularly in subcutaneous tissue, fascia, tendon, and bone. Although oxygen consumption is relatively low in wounds, it is consumed by processes that require oxygen at a high concentration. Inflammatory cells use little oxygen for respiration, producing energy largely via the hexose-monophosphate shunt [12]. Most of the oxygen consumed in wounds is used for oxidant production (bacterial killing), collagen synthesis, angiogenesis, and epithelization. The rate constants for oxygen for these components of repair all fall within the physiologic range of 25–100 mmHg [10, 12, 15–18]. This means that the rate at which repair proceeds varies according to tissue PO2 from zero to at least 250 mmHg. In vitro fibroblast replication is optimal at a PO2 of about 40–60 mmHg. These in vitro observations are clinically relevant. »Normal« subcutaneous PO2, measured in test wounds in uninjured, euthermic, euvolemic volunteers breathing room air,
90
12
Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery
is 65±7 mmHg [19]. Thus, any degree of hypoxia may impair immunity and repair. In surgical patients, the rate of wound infections is inversely proportional [20], while collagen deposition is directly proportional [21] to postoperative subcutaneous wound tissue oxygen tension. High oxygen tensions (>100 mmHg) can be reached in wounds but only if perfusion is rapid and arterial PO2 is high [13, 22]. This is because 1) subcutaneous tissue serves a reservoir function, so there is normally flow in excess of nutritional needs, and 2) wound cells consume relatively little oxygen, about 0.7 ml/100 ml of blood flow at a normal perfusion rate [14, 23]. At high levels of PaO2, this small volume can be carried by plasma alone. Contrary to popular belief, therefore, oxygen-carrying capacity (i.e., hemoglobin concentration) is not particularly important to wound healing provided that perfusion is normal [24]. Wound PO2 and collagen synthesis remain normal in individuals who have hematocrit levels as low as 15–18% provided they can appropriately increase cardiac output and vasoconstriction is prevented. Peripheral vasoconstriction, which results from central sympathetic control of subcutaneous vascular tone, is probably the most frequent and clinically the most important impediment to wound oxygenation. Subcutaneous tissue is both a reservoir to maintain central volume and a major site of thermoregulation. There is little local regulation of blood flow, except by local heating [22, 25]. Therefore, subcutaneous tissue is particularly vulnerable to vasoconstriction. Sympathetically induced peripheral vasoconstriction is stimulated by cold, pain, fear, and blood volume deficit [26, 27] and by various medications, including nicotine (smoking) [19], beta adrenergic antagonists, and alpha-1 agonists, all commonly present in surgical situations. Prevention and correction of hypothermia [28] and blood volume deficits [29] have been shown to decrease wound infections and increase collagen deposition in patients undergoing major abdominal surgery. Subcutaneous tissue oxygen tension is significantly higher in patients with good pain control than in those with poor pain control after knee surgery [30]. Stress also causes wound hypoxia and significantly impairs wound healing and resistance to infection [31, 32].
These effects are clearly mediated, at least in major part, by raising the partial pressure of oxygen in the injured tissue. Greif et al. demonstrated in a randomized, controlled, double-blind trial that in warm, wellhydrated patients (n=500) with good pain control (that is, in well-perfused patients) undergoing major colon surgery, administration of 80% vs. 30% oxygen intraoperatively and for the first 2 h postoperatively significantly reduced the wound infection rate by 50% [33]. Belda et al. [34] replicated these results–noting a significant 40% reduction in surgical site infection–in a randomized, controlled, double-blind trial in 300 colon surgery patients randomized to 80% vs. 30% oxygen intraoperatively and for the first 6 h postoperatively. Surgical and anesthetic management was standardized and intended to support optimal perfusion. Myles et al. demonstrated a significant reduction in major postoperative complications, as well as specific wound infections, in 2,050 major surgery patients randomized to 80% oxygen in 20% nitrogen vs. 30% oxygen in 70% nitrous oxide intraoperatively [35]. A smaller (n=165) randomized, controlled study by Pryor et al. [36] demonstrated a doubling of surgical site infection in patients randomized to 80% vs. 35% oxygen intraoperatively. The study had a number of methodological flaws, but, more importantly, the two groups of patients were not equivalent, which likely explained the increase in infections seen in the 80% oxygen group. Thus, there is substantial evidence that use of high inspired oxygen intraoperatively and the administration of supplemental oxygen postoperatively in well-perfused patients undergoing major abdominal surgery will reduce the risk of wound infection. Concerns about the risk of oxygen toxicity, including pulmonary fibrosis and atelectasis, have limited adoption of high inspired oxygen. Oxygen toxicity is not a risk in the short term (less than days) and therefore is not pertinent in the operating room. Some degree of atelectasis is inevitable in all patients undergoing major surgery. Akca et al. [37] demonstrated similar degrees of atelectasis in colon surgery patients randomized to 80% vs. 30% oxygen (balance nitrogen) intraoperatively.
91 Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection
Myles et al. found that high inspired nitrous oxide caused more atelectasis than high inspired oxygen. Use of positive end expiratory pressure appears to abrogate the problem of atelectasis [38]. Thus, these issues should not limit the use of high inspired oxygen. Contraindications to the use of FiO2 >0.8 include prematurity (retrolental fibroplasias), recent (possibly lifetime) bleomycin administration, use of cautery in the airway or other procedures in which pulmonary or laryngeal oxygen may leak into the field, and, possibly, acute pulmonary conditions. Delivery of antibiotics also depends on perfusion. Parenteral antibiotics given so that high levels are present in the blood at the time of wounding clearly diminish, but do not eliminate, wound infections [39]. In one-third of all wound infections, the bacteria cultured from the wound are sensitive to the prophylactic antibiotic given to the patient, even when the antibiotics were given according to standard procedure. The vulnerable third of patients appear to be the hypoxic and vasoconstricted group.
Intraoperative Management All anesthetics tend to cause hypothermia 1) by causing vasodilation, which redistributes heat from core to periphery in previously vasoconstricted patients and increases heat loss, and 2) by decreasing heat production [40]. Vasoconstriction is uncommon intraoperatively, as the threshold for thermoregulatory vasoconstriction is decreased, but it is often severe in the immediate postoperative period, when anesthesia is discontinued and the thermoregulatory threshold returns to normal in the face of core hypothermia. The onset of pain with emergence from anesthesia adds to this vasoconstriction. Maintenance of normothermia intraoperatively has been shown to decrease the wound infection rate by two-thirds in patients undergoing colon surgery [28]. Rapid rewarming of hypothermic patients in the postanesthesia care unit (PACU) also appears to be effective [41]. Maintenance of a high room temperature or forced air warming before, during, and after the operation are significantly more effective than other meth-
12
ods of warming such as circulating water blankets placed under the patient and humidification of the breathing circuit [42]. Preoperative systemic (forced air warmers) or local (warming bandages) warming techniques have also been shown to decrease wound infections, even in clean, low-risk surgeries such as breast surgery and inguinal hernia repair [43]. Surgical stress results in increased intravenous fluid requirements. Inflammatory mediators cause both vasodilation and an increase in vascular permeability [44]. Other known causes of perioperative hypovolemia or fluid loss include preoperative mechanical bowel preparation, lack of oral intake, fever, preexisting medical conditions, medications such as diuretics, and surgical fluid losses, including evaporation and blood loss. Optimizing the perioperative fluid administration remains a controversial challenge. Estimates of blood loss, third-space fluid losses, and maintenance requirements are inaccurate and may lead to either overreplacement or underreplacement. Currently, most practitioners rely on their clinical acumen, vital signs such as heart rate and blood pressure, and urine output to manage perioperative fluids. Due to the compensatory action of peripheral vasoconstriction, surgical patients can be markedly hypovolemic without a change in any of these variables [13, 21, 45]. Unfortunately, this peripheral vasoconstriction shunts blood away from the skin, increases wound hypoxemia, and increases the risk of surgical wound infection [20]. Current best recommendations include replacing fluid losses based on standard recommendations for the type of surgery, replacing blood loss, and replacing other ongoing fluid losses (e.g., high urine output due to diuretic or dye administration, hyperglycemia, or thermoregulatory vasoconstriction). Pain control should be addressed intraoperatively so that patients do not have severe pain upon emergence from anesthesia. Achieving the goal is more important than the technique used to do so. Although regional anesthesia/analgesia may provide superior pain relief, the effects of specific analgesic regimens on wound outcome have not yet been studied.
92
Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery
Postoperative Management
12
Wounds are most vulnerable in the early hours. Although antibiotics lose their effectiveness after the first hours, natural wound immunity (oxygenrelated) lasts longer [46]. Even a short period of vasoconstriction during the first day is sufficient to reduce oxygen supply. Correction and prevention of vasoconstriction in the first 24-48 h after surgery will have significant beneficial effects. All vasoconstrictive stimuli must be corrected simultaneously to allow optimal healing. Volume is the last to be corrected because vasoconstriction for other reasons induces diuresis and renders the patient hypovolemic (peripherally, not centrally). Assessing perfusion, especially in the PACU, is critical. Unfortunately, urine output is a poor and often misleading guide to peripheral perfusion [47]. Markedly low output may indicate decreased renal perfusion, but normal or even high urine output has little correlation to wound/tissue PO2. Many factors commonly present in the perioperative period, including hyperglycemia, dye administration, thermoregulatory vasoconstriction, adrenal insufficiency, and various drugs, may cause inappropriate diuresis in the face of mild hypovolemia. Physical examination of the patient is a better guide to dehydration and vasoconstriction. Vasoconstriction can be determined by a capillary return time of more than 1.5 s at the forehead and more than 5 s over the patella. Eye turgor is another good measure of hydration. Finally, patients can usually distinguish thirst from a dry mouth. Skin should be warm and dry. When excessive tissue fluids have accumulated, diuresis should be undertaken gently so that transcapillary refill can maintain blood volume. This applies to patients who need renal dialysis as well. The average dialysis patient vasoconstricts sufficiently to lower tissue PO2 by 30% or more during dialysis and needs about 24 h for vasomotor tone and wound/tissue PO2 to return to normal [48]. Fluid losses from the vascular system are not necessarily replaced from the tissues as rapidly as they are sustained. Tissue edema may be the price paid for adequate intravascular volume. Edema
increases intracapillary distance, so there may be a delicate balance between excessive edema and peripheral vasoconstriction (which worsens the hypoxia caused by edema).
Care of Wounds Healing by Secondary Intention Even with appropriate perioperative management, some wounds become infected or fail to heal. Frequently this may result from other causes of impaired perfusion, such as obesity, prior radiation to the area, arterial insufficiency, or excessive edema. It may also result from other problems such as malnutrition, overwhelming contamination, or ongoing trauma. If it is a simple case of infection, the wound will generally heal rapidly by secondary intention with just attention to basic care. If other complicating factors are involved, it may take more effort to achieve healing. In either case, the most modern and advanced healing devices will not succeed if proper care is not instituted, so attention to basic proper wound care is crucial to ensure success: 1. Reduce the bacterial load. The best way to achieve this is to wash the wound gently with mild soap in a warm shower. All open wounds are contaminated with bacteria. Most bacterial contamination comes from bacteria normally resident on the skin. A shower provides the volume to wash away the bacteria; rinsing with normal saline does not provide adequate volume. Moreover, saline is generally kept refrigerated or at room temperature and thus will tend to induce local vasoconstriction, whereas a warm shower will tend to induce local vasodilation. Mild soap provides sufficient detergent effect to assist in dislodging bacteria. Antibacterial agents, including antibacterial soaps, Betadine, bleach, Dakin’s solution, hydrogen peroxide, and alcohol, are effective at reducing bacterial load, but they do so at the cost of inactivating white cells and harming granulating tissue. Thus, wounds treated with these agents are very clean but frequently demonstrate minimal evidence of healing (granulation tissue).
93 Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection
2. Maintain a moist wound environment. Moist wounds heal about 50% faster than dry ones [49, 50]. Any number of products may provide the proper environment, depending on the wound. Traditional wet-to-damp dressings should be replaced as the standard of care and essentially never used. They are less cost-effective than any other dressing on the market because they have minimal ability to manage exudates and they induce maceration of the surrounding skin, thereby potentially actually enlarging the wound; they pull off granulation tissue as they debride necrotic tissue and slough, thus prolonging healing. They also provide no protection against bacterial contamination (nonocclusive), must be changed three times a day (TID), and cause more discomfort. Although a single sheet of gauze is inexpensive compared with a typical $10–20 modern dressing, more than one piece of gauze is used with each dressing change, and the dressing must be changed TID, thus raising the supply cost at least as high as more sophisticated dressings that are only changed daily or less often. The labor costs of wetto-damp dressings are therefore also higher. Moreover, home care nurses cannot provide TID dressing changes, which may delay hospital discharge. Finally, given that dressing changes often cause discomfort, less frequent changes are clearly a benefit. So use whatever you want, but don’t use wet to damp! Of note, gauze impregnated with a nonevaporating substance such as Aquaphor, silver sulfadiazine, or a hydrogel does make an excellent filler for deeper wounds. 3. Pay attention to nutrition. Recent intake (7 days) is most important [51]. Be aware of a patient’s NPO status leading to missed meals. Key elements include protein, which is required to make the extracellular matrix but is lost in potentially large quantities from exudative wounds, and vitamin C, an essential cofactor of prolyl hydroxylase (a central enzyme in collagen posttranslational modification) as well as essential for proper neutrophil function. The type of protein is relatively unimportant, although the amino acid arginine im-
12
proves wound healing at pharmacologic (more than nutritional) levels [52]. Arginine-containing protein supplements are available, and arginine capsules can be obtained at health food stores. Vitamin A and zinc deficiencies impair wound healing, and these should be repleted. A 10-day course (25,000 IU vitamin A and 220 mg zinc daily) is sufficient, as both may be toxic in excess. Vitamin A specifically reverses impaired healing resulting from steroids [53, 54]. Topical vitamin A and D ointment (sold for diaper rash over the counter) applied once daily works well. 4. Pay attention to perfusion. Patients should be instructed to quit smoking, drink plenty of fluids, manage their pain aggressively, and keep their wound covered or insulated for warmth. Stress reduction is also likely to be beneficial.
Summary In patients with moderate to high risk of surgical site infection, surgeons and anesthesiologists have the opportunity to enhance wound healing and prevent wound infections by simple, inexpensive, and readily available means [55, 56]. Intraoperatively, appropriate antibiotic use, prevention of vasoconstriction (volume, warming), and maintenance of a high PaO2 (300–500 mmHg) are key. Postoperatively, the focus should remain on preventing vasoconstriction through pain relief, warming, and adequate volume administration in the PACU.
References 1. Kaye, K.S., et al., Preoperative drug dispensing as predictor of surgical site infection. Emerg Infect Dis, 2001. 7(1): pp. 57–65 2. Dvonch, V.M., et al., Changes in growth factor levels in human wound fluid. Surgery, 1992. 112(1): pp. 18–23 3. Silver, I.A., Cellular microenvironment in healing and nonhealing wounds., in Soft and hard tissue repair, T.K. Hunt, R.B. Heppenstall, and E. Pines, eds. 1984, Praeger: New York. pp. 50–66 4. Hunt, T.K., et al., Studies on inflammation and wound healing: Angiogenesis and collagen systhesis stimulated
94
5.
6. 7.
8.
9.
10.
11. 12.
13.
14.
15.
12 16.
17.
18.
19. 20.
21.
22.
23.
Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection After Surgery
in vivo by resident and activated wound macrophages. Surgery, 1984. 96: pp. 48–54 Jensen, J.A., et al., Effect of lactate, pyruvate and pH on secretion of angiogenesis and mitogenesis factors by macrophages. Lab Invest, 1986. 54: pp. 574–578 Schultz, G. and M. Grant, Neovascular growth factors. Eye, 1991. 5: pp. 170–180 Knighton, D.R., I.A. Silver, and T.K. Hunt, Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery, 1981. 90(2): pp. 262–720 Prockop, D.J., et al., The biosynthesis of collagen and its disorders (first of two parts). N Engl J Med, 1979. 301(1): pp. 13–23 Hunt, T.K., et al., Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid Redox Signal, 2007. 9(8): pp. 1115–1124 Medawar, P.S., The behavior of mammalian skin epithelium under strictly anaerobic conditions. Q J Microsc Sci, 1947. 88: p. 27 Babior, B.M., Oxygen-dependent microbial killing by phagocytes. N Engl J Med, 1978. 198: pp. 659–668 Allen, D.B., et al., Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg, 1997. 132(9): pp. 991–996 Gottrup, F., et al., Directly measured tissue oxygen tension and arterial oxygen tension assess tissue perfusion. Crit Care Med, 1987. 15(11): pp. 1030–1036 Evans, N.T.S. and P.F.D. Naylor, Steady states of oxygen tension in human dermis. Respir Physiol, 1966. 2: pp. 46–60 Edwards, S., M. Hallett, and A. Campbell, Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J, 1984. 217: pp. 851–854 Hutton, J.J., A.L. Tappel, and S. Udenfriend, Cofactor and substrate requirements of collagen proline hydroxylase. Arch Biochem Biophys, 1967. 118: pp. 231–240. Myllyla, R., L. Tuderman, and K.I. Kivirikko, Mechanism of the prolyl hydroxylase reaction. 2. Kinetic analysis of the reaction sequence. Eur J Biochem, 1977. 80(2): pp. 349–357 DeJong, L. and A. Kemp, Stoicheiometry and kinetics of the prolyl 4-hydroxylase partial reaction. Biochim Biophys Acta, 1984. 787(1): pp. 105–111 Jensen, J.A., et al., Cigarette smoking decreases tissue oxygen. Arch Surg, 1991. 126: pp. 1131–1134 Hopf, H.W., et al., Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg, 1997. 132(9): pp. 997–1004; discussion 1005 Jonsson, K., et al., Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surg, 1991. 214: pp. 605–613 Sheffield, C., et al., Centrally and locally mediated thermoregulatory responses alter subcutaneous oxygen tension. Wound Repair Regen, 1996. 4(3): pp. 339–345 Hopf, H., T. Hunt, and J. Jensen, Calculation of subcutaneous tissue blood flow. Surg Forum, 1988. 39: pp. 33–36
24. Hopf, H. and T. Hunt, Does–and if so, to what extent–normovolemic dilutional anemia influence post-operative wound healing? Chirugische Gastroenterologie, 1992. 8: pp. 148–150 25. Rabkin, J.M. and T.K. Hunt, Local heat increases blood flow and oxygen tension in wounds. Arch Surg, 1987. 122(2): pp. 221–225 26. Derbyshire, D. and G. Smith, Sympathoadrenal responses to anaesthesia and surgery. Br J Anaesth, 1984. 56: pp. 725–739 27. Halter, J., A. Pflug, and D. Porte, Mechanism of plasma catecholamine increases during surgical stress in man. J Clin Endocrin Metab, 1977. 45(5): pp. 936–944 28. Kurz, A., et al., Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med, 1996. 334(19): pp. 1209–1215 29. Hartmann, M., K. Jonsson, and B. Zederfeldt, Effect of tissue perfusion and oxygenation on accumulation of collagen in healing wounds. Randomized study in patients after major abdominal operations. Eur J Surg, 1992. 158(10): pp. 521–526. 30. Akça, O., et al., Postoperative pain and subcutaneous oxygen tension [letter]. Lancet, 1999. 354(9172): pp. 41–42 31. Rojas, I.G., et al., Stress-induced susceptibility to bacterial infection during cutaneous wound healing. Brain Behav Immun, 2002. 16(1): pp. 74–84 32. Horan, M.P., et al., Impaired wound contraction and delayed myofibroblast differentiation in restraint-stressed mice. Brain Behav Immun, 2005. 19(3): pp. 207–216 33. Greif, R., et al., Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med, 2000. 342(3): pp. 161–167 34. Belda, F.J., et al., Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA, 2005. 294(16): pp. 2035–2042 35. Myles, P.S., et al., Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology, 2007. 107(2): pp. 221–231 36. Pryor, K.O., et al., Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA, 2004. 291(1): pp. 79–87 37. Akca, O., et al., Comparable postoperative pulmonary atelectasis in patients given 30% or 80% oxygen during and 2 hours after colon resection. Anesthesiology, 1999. 91(4): pp. 991–998 38. Duggan, M. and B.P.P. Kavanagh, Atelectasis in the perioperative patient. Curr Opin Anaesthesiol, 2007. 20(1): pp. 37–42 39. Classen, D., et al., The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med, 1992. 326(5): pp. 281–286 40. Matsukawa, T., et al., Heat flow and distribution during induction of general anesthesia. Anesthesiology, 1995. 82: pp. 662–673 41. West, J., et al., The effect of rapid postoperative rewarming on tissue oxygen. Wound Repair Regen, 1993. 1(2): p. 93
95 Chapter 12 · Patient Factors as a Major Determinant of Wound Outcome and Infection
42. Kurz, A., et al., Forced-air warming maintains intraoperative normothermia better than circulating water mattresses. Anesth Analg, 1993. 77: pp. 89–95 43. Melling, A.C., et al., Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet, 2001. 358(9285): pp. 876–880 44. Holte, K., N.E. Sharrock, and H. Kehlet, Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth, 2002. 89(4): pp. 622–632 45. Gosain, A., et al., Tissue oxygen tension and other indicators of blood loss or organ perfusion during graded hemorrhage. Surgery, 1991. 109(4): pp. 523–532 46. Knighton, D.R., B. Halliday, and T.K. Hunt, Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg, 1986. 121(2): pp. 191–195 47. Jonsson, K., et al., Assessment of perfusion in postoperative patients using tissue oxygen measurements. Br J Surg, 1987. 74(4): pp. 263–267 48. Jensen, J.A., et al., Subcutaneous tissue oxygen tension falls during hemodialysis. Surgery, 1987. 101(4): pp. 416– 421 49. Winter, G.D., Oxygen and epidermal wound healing. Adv Exp Med Biol, 1977. 94(673): pp. 673–678 50. Hinman, C. and H.I. Maibach, Effect of air exposure and occlusion on experimental human skin wounds. Nature, 1963. 200: pp. 377–378 51. Haydock, D. and G. Hill, Improved wound healing response in surgical patients receiving intravenous nutrition. Br J Surg, 1987. 74: pp. 320–323 52. Barbul, A., et al., Arginine enhances wound healing and lymphocyte immune response in humans. Surgery, 1990. 108: pp. 331–337 53. Hunt, T., et al., Effect of vitamin A on reversing the inhibitor effect of cortisone on healing of open wounds in animals and man. Ann Surg, 1969. 170: pp. 633–641 54. Wicke, C., et al., Effects of steroids and retinoids on wound healing. Arch Surg, 2000. 135(11): pp. 1265–1270 55. Hunt, T.K. and H.W. Hopf, Wound healing and wound infection. What surgeons and anesthesiologists can do. Surg Clin North Am, 1997. 77(3): pp. 587–606 56. Ueno, C., T.K. Hunt, and H.W. Hopf, Using physiology to improve surgical wound outcomes. Plast Reconstr Surg, 2006. 117(7 Suppl): pp. 59S–71S
Discussion Terzi: Is there any risk for patients in giving high
oxygen? Hopf: Giving patients 100% oxygen is largely risk-
free. If they are newborns, you should probably avoid 100% oxygen. So for everybody who is afraid
12
of oxygen toxicity, there is no evidence of any in the short term. Schumpelick: What about anemia and wound healing? Hopf: Anemia is good for wound healing as long as your heart works because the viscosity goes down and you get better blood flow in the wound. I have measured wound oxygen in a test group of volunteers, and there was no difference in patients without anemia, especially if you give them oxygen, because a better flow combined with a good oxygenation leads to good wound oxygen level.
13
Mesh-Related Infections After Hernia Repair M. E. Falagas, G. C. Makris
98
Chapter 13 · Mesh-Related Infections After Hernia Repair
Introduction Open or laparoscopic »tension-free« mesh implantation for hernia repair of abdominal wall defects has been the gold standard treatment because it appears to reduce the rate of recurrence by an average of 30–50% in comparison with the simple nonmesh herniorrhaphy. However, the use of artificial meshes within the human body is not without potential clinical problems and might lead to various complications such as seromas (fluid accumulation), adhesions, chronic severe pain, migration or even rejection of the mesh, and, of course, mesh-related infections [1, 2]. These complications may even be life-threatening and usually necessitate hospitalization and surgical removal of the troublesome mesh. Mesh-related infections, along with seroma formation, are the most common complications encountered during ventral or inguinal hernia repair, although infection is definitely the one with the most devastating consequences for the patient. Every year almost 30,000 inguinal and just as many ventral hernia repairs become infected, both in the United States and Europe. New improved techniques and stricter aseptic protocols in the operating room have contributed to a decrease in wound infection rates after hernia repair, but this still appears to be center dependent.
13 Risk Factors The risk factors for surgical site infections (SSIs) in herniorrhaphy are gender (female > male), age over 70, comorbidities (diabetes, obesity), operating time, and the prophylactic use of drainage or prostheses. Even though artificial implants pose an independent risk factor for the development of SSIs, other factors also affect the incidence of postherniorrhaphy mesh-related infection rates [1]: ▬ Type of mesh [polyester, polypropylene (PP), or polytetrafluoroethylene (PTFE)] ▬ Type of surgical technique used to apply the mesh (laparoscopic or open) ▬ Relationship of the mesh to the peritoneum (transabdominal preperitoneal or totally extraperitoneal)
▬ Perioperative administration of prophylactic antibiotics and type of sterile techniques applied in the operating room ▬ Mesh placement in contaminated tissues ▬ Other factors, such as smoking and immunosuppression
Incidence of Mesh-Related Infections Elective primary abdominal reconstruction with mesh is considered a clean surgery, with infection rates of up to 8% being reported [1]. The rate of infection may vary among centers and appears to be influenced by underlying comorbidity (diabetes, immunosuppression, obesity) and by specific factors mentioned earlier, which will be discussed in following sections.
Operating Technique and Type of Mesh Laparoscopic hernioplasty compared with open mesh procedures has been proven to induce a lower incidence of surgical wound infections, probably due to the lack or relatively limited physical contact of the mesh with the surgical wound during the operation. However, the specific type of laparoscopic technique used (transabdominal preperitoneal versus totally extraperitoneal mesh implementation) is not associated with different rates of infections, but data are still insufficient to support this statement. The type of implemented mesh is also of vital importance regarding the development (or not) of an infection [3]. Monofilament polypropylene (PP) is the most frequently used biomaterial for repair of an abdominal wall defect due to the low infection rates compared with other nonabsorbable types of meshes. The biocompatibility and the large pore size of this PP textile permit the relatively uncompromised inflammatory response of the immune system on the surface of this material. Engelsman et al. [3] reviewed the infection rates of different kinds of nonabsorbable meshes after open repair hernioplasty and noted important variations: ▬ Polypropylene meshes: 2.5–5.9% ▬ Expanded polytetrafluoroethylene (ePTFE) meshes: 0–9.2%
99 Chapter 13 · Mesh-Related Infections After Hernia Repair
▬ Polyester meshes: most polyester infection rates are quite similar to those of polypropylene meshes, but rates of up to 16% have also been documented Surgical technique and patient and mesh characteristics are responsible for the above differences. The pathophysiologic mechanisms and certain characteristics of the meshes underlying the above differences will be discussed in a following paragraph.
Antimicrobial Prophylaxis and Preoperative Aseptic/Sterilization Protocols Preoperative administration of antimicrobial agents in clean surgical procedures such as primary hernioplasty has been a matter of considerable debate for years, but a recent meta-analysis by Sanabria et al. [4] of the accumulated evidence suggests that infection rates were decreased by almost 50% in the patients who received antimicrobial prophylaxis. Stricter operative aseptic protocols in combination with proper prophylactic antibiotic coverage was also demonstrated to be effective in further restricting surgical posthernioplasty wound infections in a large series of patients who underwent »clean« surgical repair of abdominal wall defects.
Mesh Placement in Contaminated Areas Hernia repair is considered a clean operation. Nevertheless, when bowel opening or abdominal wound infection has previously occurred, this procedure becomes contaminated; thus, the implementation of an artificial material was thought for years to be contraindicated. However, recent studies suggest that minor morbidity, minimal risk of infection, and minor wound-related mortality are observed after mesh placement in contaminated tissues. Apparently, more solid evidence is required.
13
Smoking and Other Comorbidities Smoking, prolonged operating time, and patient comorbidities such as diabetes, immunosuppression, and obesity have been incriminated for a further increase in the incidence of surgical wound infections after hernioplasty.
Microbiology and Pathophysiology of Mesh-Related Infections The isolated microflora in mesh-related infections are usually associated with Staphylococcus species, especially S. aureus; Streptococcus spp., including group B streptococci; and Gram-negative (mainly Enterobacteriaceae) and anaerobic bacteria [5]. In addition, microbiological data confirm that strains of methicillin-resistant S. aureus have been isolated in mesh-related infections after hernia repair, as have Candida spp. and Mycobacterium spp., although to a far lesser extent. Microbes have an extraordinary ability to adhere to surfaces to produce colonies and maintain their functional status. In particular, certain pathogens, including S. aureus, may adhere even to artificial surfaces such as metal and cause implant-related infections. Bacteria may adhere to inanimate surfaces, produce slime (which causes stronger and irreversible adhesion), and form biofilms, which have the ability to communicate through quorum sensing and resist internal mechanisms of defense. In addition, they build tight junctions with the underlying biomaterial, creating complex, large structures that are not easily ingested by phagocytes. Highly porous material with a large surface area and numerous niches–such as the multifilament meshes–provides pathogens with an excellent environment protected from the immune system of the host. Niches function as a shelter for the pathogens’ colonies because of the large size of phagocytes. Niches are small in diameter, but at the same time, they substantially increase the total area of the mesh, raising the possibility for successful bacterial adherence [6]. Porous materials are connected with higher infection rates because they downsize the normal inflammatory response of the infected host organism.
100
Chapter 13 · Mesh-Related Infections After Hernia Repair
Finally, the hydrophobic or hydrophilic properties of implanted materials also influence the adhering pattern of bacteria upon them, since they determine protein absorption from the surface of the biomaterial. In vitro studies have shown that more hydrophobic materials, such as PTFE and ePTFE, may be associated with the development of more resistant forms of biofilms [6]. The above results may explain previous clinical findings that infections related to multifilament, hydrophobic ePTFE and PTFE meshes are expected to have the worst prognosis and demand surgical management.
Clinical Manifestation and Diagnosis The manifestations of mesh-related infections can be divided into surgical (superficial) wound infections and deep-seated mesh infections and may occur 2 weeks to 39 months from the day of mesh implantation.
Surgical Wound Infections
13
Surgical wound infections are the most commonly encountered type of infection, presenting at an early postoperative stage, usually days or a few weeks after the mesh placement. The symptoms and signs are typical of local acute inflammation: pain, erythema, swelling with locally increased temperature, and confined tenderness. Inappropriate treatment of surgical wound infections may be complicated by the formation of a discharging fistula, intraabdominal abscess, or, rarely, osteomyelitis. The emergence of systemic symptoms such as fever, chills, or rigor and malaise should urge prompt investigation and initiation of therapeutic actions before sepsis occurs.
Deep-Seated Mesh Infections Deep-seated mesh infections generally manifest in the early postoperative period, but infrequently they can also be observed as a late-onset phenomenon that is delayed for months or years (up to 4.5 years after the operation) [7]. Deep-seated in-
fections may result from persistent fluid collection (seromas) leading to chronic groin sepsis. Symptoms can be chronic, recurrent, or totally absent until the progression to sepsis.
Diagnosis The combination of clinical presentation, physical examination, laboratory values, and previous medical history is usually adequate to establish a diagnosis. However, when there are doubts regarding differential diagnosis, two noninvasive imaging techniques could provide physicians with a solution: Bedside ultrasound and computerized tomography may reveal the inflammatory process in the adipose tissue around the implant because of the different ultrasonic and density characteristics, respectively. Complications such as the presence of fistula or abscess could also be depicted. Diagnostic paracentesis of mesh-associated seromas when there are no signs of inflammation should be carefully considered and not performed routinely; there is a high risk of transforming a potentially aseptic reaction to an infectious process through the introduction of bacteria into the previously aseptic seromas.
Treatment and Antimicrobial Prophylaxis Therapeutic Options: Surgical or Conservative The therapeutic options available following the development of mesh-related infection can be separated according to the type and severity of infection and the type of implanted mesh. ▬ Posthernioplasty superficial wound infections may have a better prognosis and may be treated conservatively using proper intravenous antimicrobial coverage and drainage when signs of accumulated exudate exist. However, the use of drainage is still controversial due to insufficient evidence. ▬ In limited, deep-seated infections of the mesh, prolonged antibiotic treatment in combination with percutaneous or open drainage has
101 Chapter 13 · Mesh-Related Infections After Hernia Repair
been reported to be effective to restrain the infectious process. However, when extensive infection is present–due to biofilm formation and limited penetration of the drug in the area–mesh removal and surgical cleaning of the wound pose the best possible treatment to eradicate the infection. Unfortunately, the labeling of a mesh-related infection as limited or extensive remains empirical. Hernia recurrence could be a postoperative complication if adequate fibrous tissue had not developed earlier (early-onset, deep-seated infections). ▬ The choice between conservative and surgical treatment could also be influenced by the type of implanted mesh. Structural (monofilament or multifilament) and biochemical (hydrophobic or hydrophilic) properties influence the potential response of the infection to the administered antibiotics. Clinical findings in combination with recent in vitro experiments suggest that infected hydrophobic meshes– such as PTFE and ePTFE–are most likely to be removed in order to achieve complete cure. So far, no universal recommendations based on randomized controlled trials exist for the optimal treatment of mesh-related infections. Further data
13
are warranted to establish evidence-based algorithms for treating infections according to the type and severity of infection and the type of mesh.
Prophylaxis Due to the special features of implant devices, the best way to treat an implant-related infection without destroying the implant is to take the appropriate measures to avoid initial exposure to infectious agents. Considerable effort has been made to develop techniques that will restrain the fundamental mechanisms for implant-related infections, which are bacterial adhesion and colonization of artificial surfaces and biofilm formation. Various strategies such as antimicrobial prophylaxis and mesh coatings of antimicrobial biomaterials have been developed, but so far, comparative data are lacking. Preoperative antimicrobial prophylaxis in elective, »clean« surgical procedures such as repair of an abdominal wall defect with a mesh has been a matter of considerable controversy for years. Nevertheless, recent meta-analysis of accumulated data provides evidence of significantly lower SSI rates after proper prophylaxis. The antimicrobial
Hospital surgical site infection rate
Low (<1%)
High (>1%)
Assess individual risk factors
Preoperative prophylaxis
High-risk patient
Preoperative prophylaxis
Low-risk patient
No preoperative prophylaxis
⊡ Fig. 13.1. Proposed algorithm for preoperative antimicrobial prophylaxis
102
13
Chapter 13 · Mesh-Related Infections After Hernia Repair
agents most commonly used are cefazolin 1–2 g (or 1 g erythromycin if the patient is allergic), 1.5 g ampicillin/sulbactam , 2 g amoxicillin/clavulanic acid, or 1.5 g cefuroxime. Unfortunately, there are still no data regarding the cost-effectiveness of this approach. Infection rates can be center dependant and can be as low as 1% in some cases. Therefore, researchers have suggested that institutions revise their SSI rates and decide, according to each patient’s special risk factors, whether antimicrobial prophylaxis is justified. (See ⊡ Fig. 13.1). Mesh coating with antimicrobial agents or other biomaterials that decrease the adhesion ability of bacteria, increase host tissue ingrowth, or initiate bacterial destruction have been developed to prevent implant colonization and biofilm formation in the first place. Apart from antibiotic coatings (such as cefoxitin), silver, gold, titanium carbonitride, polyglactin, gelatin, and other biomaterials have been used as coatings, with different mechanisms of action. At present, however, evidence is based on experimental and animal studies, and the available comparative data are insufficient to draw safe conclusions Universal recommendations regarding the choice of mesh type or the best possible antimicrobial prophylaxis cannot be supplied based on the available evidence from randomized controlled trials [8]. Until further trials are completed to shed more light on these controversial issues, the choice of mesh and antibiotic coverage will be center dependent and, in particular, derived from the surgeon’s experience and the financial cost.
References 1.
2.
3.
4.
Falagas ME, Kasiakou SK. Mesh-related infections after hernia repair surgery. Clin Microbiol Infect 2005; 1:3–8 Bliziotis IA, Kasiakou SK, Kapaskelis AM, Falagas ME. Meshrelated infection after hernia repair: case report of an emerging type of foreign-body related infection Infection 2006; 1:46–48 Engelsman AF, van der Mei HC, Ploeg RJ, Busscher HJ. The phenomenon of infection with abdominal wall reconstruction. Biomaterials 2007; 14:2314–2327 Sanabria A, Domínguez LC, Valdivieso E, Gómez G. Prophylactic antibiotics for mesh inguinal hernioplasty: a meta-analysis. Ann Surg 2007; 3:392–396
5.
6.
7.
8.
Falagas ME, Velakoulis S, Iavazzo C, Athanasiou S. Meshrelated infections after pelvic organ prolapse repair surgery. Eur J Obstet Gynecol Reprod Biol 2007; 2:147–156 Engelsman AF, van der Mei HC, Busscher HJ, Ploeg RJ. Morphological aspects of surgical meshes as a risk factor for bacterial colonization. Br J Surg 2008; 8:1051–1059 Delikoukos S, Tzovaras G, Liakou P, Mantzos F, Hatzitheofilou C. Late-onset deep mesh infection after inguinal hernia repair. Hernia 2007; 1:15–17 Eriksen JR, Gögenur I, Rosenberg J. Choice of mesh for laparoscopic ventral hernia repair. Hernia 2007; 6:481–492
Discussion Heniford: When I talk to our patients about lap-
aroscopic versus open ventral hernia repair, the number one reason to recommend laparoscopic repair is not pain, and it is not cosmetics—it’s a decreased risk of infection, by far. When we look back at our patients and compare the different risk factors for infection, the number one reason is smoking.
14
Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field J. J. Diaz
104
Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field
Introduction Repair of a ventral hernia is one of the most common surgical procedures performed in the United States. Yet ventral hernia repair in the setting of a contaminated surgical field presents a very difficult surgical dilemma. Prosthetic mesh has been widely employed since the 1950s for the elective repair of ventral hernias. Beyond hernia recurrence, prosthetic mesh has known complications such as infection, contracture, and intestinal fistula formation. In the setting of a clean-contaminated and/or dirty surgical field, prosthetic mesh is contraindicated due to high complication rates [1–4]. The alternative, closing of a ventral hernia with an absorbable mesh, presents its own set of problems. Repair with absorbable mesh only serves to keep the patient from evisceration. It is a temporizing procedure for a planned ventral hernia repair, and it continues to be associated with a high rate of wound infection that is unaffected by the use of an absorbable mesh [5–7].
Patient Population
14
Patients with complex hernias remain a very difficult group to repair. Complex hernias are commonly described as follows: open abdomen after trauma/emergency; general surgery resulting in a planned ventral hernia; presence of an intestinal fistula, ostomy, or infected mesh. Patients who have a history of multiple hernia repairs, loss of domain, or loss of abdominal tissue and musculature are also labeled as having complex hernias. Patients with a previous history of infected mesh or wound infection have a high risk of developing another surgical site infection [8, 9]. In all of these cases, the use of prosthetic mesh would be considered a contraindication in hernia repair. To date, no classification system is universally accepted for defining ventral hernias. A ventral hernia can range from a simple periumbilical hernia in a patient with no comorbidities to an abdominal catastrophe with a planned ventral hernia, a split-thickness skin graft over the viscera, and an atmospheric fistula. Manufacturers have started to develop biological mesh with the intent to produce a product that
can become vascularized and resist infection. In addition, the ideal product must have the tensile strength of native fascia or be comparable to prosthetic mesh, be pliable, and be easy to implant. To date, only human acellular dermal matrix has demonstrated its ability to resist infection. The development of human acellular dermis (HADM) as a fascial graph replacement presents a potential alternative to hernia closure in a compromised surgical field. HADM is derived from human donors (LifeCell, Branchburg, NJ, USA). The donated human skin is supplied by the American Association of Tissue Banks and is approved by the U.S. Food and Drug Administration as banked human tissue. Under a proprietary process, HADM is cleansed of any immune reactive cells or cellular components. HADM is being used to reduce complications seen with prosthetic mesh, such as infection, adhesions, fistulas, seromas, bleeding, and skin erosion [10, 11].
Repair Types The most common ventral hernia repair types mesh to »bridge« the defect using a tension-free repair. A prosthetic mesh with 3–4 cm of overlap of the fascial edge has been used as an onlay or sublay [12, 13]. Interposition mesh placement is well known to have the highest recurrence rate and is not a recommended surgical technique. Luijendijk et al., in the only randomized controlled trial of mesh vs. primary suture repair, showed that the rate of hernia recurrence could be reduced by using a prosthetic mesh [12]. We hypothesized that a human acellular dermal matrix would be a suitable biological tissue alternative for repairing ventral hernia in the presence of a contaminated surgical field by better tolerance to wound infection, thereby reducing the incidence of prosthesis removal.
Methods We performed a retrospective study of a single institution’s experience with HADM (⊡ Fig. 14.1). Patients were admitted from January 2001 to
105 Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair
14
All study patients N=75
Clean-contaminated N=64
Contaminated or dirty N=11
SSI
Yes N=21
Medically managed N=9
SSI
No N=43
Surgically managed N=12
Yes N=4
No N=7
Medically managed N=2
Surgically managed N=2
Mesh removed =4
December 2004 to Vanderbilt University Medical Center and included surgical cases from the trauma, general surgery, and emergency general surgery services. Before the study began, approval was granted by the Vanderbilt University Institutional Review Board.
Study Population Patients were included if they were greater than 15 years of age and had undergone repair of a ventral hernia or traumatic anterior wall fascial defect with acellular human dermis (AHD) in a compromised surgical field. Surgical involvement of the following organ systems was required for inclusion: stomach, small bowel, colon, appendix, hepatobiliary system, urinary bladder, spleen, and ostomy formation. This also included removal of infected mesh or repair of an enterocutane-
Mesh removed =1
⊡ Fig. 14.1. Study design (SSI surgical site infection)
ous fistula. The medical center’s electronic data repository (StarPanel) and hospital administrative database were used to accurately collect patient data. Demographic data collected (⊡ Table 14.1) included age, gender, race, hospital length of stay, and comorbidities, which in turn included diabetes mellitus, hypertension, renal insufficiency (serum creatine <30 mg/h), chronic obstructive pulmonary disease, heart disease, and hepatic disease (cirrhosis). The wound classification was recorded for each patient. The Centers for Disease Control and Prevention (CDC) wound classification system was used to define surgical wounds [10] (⊡ Table 14.2). The operative technique for each hernia repair was also recorded (⊡ Table 14.3). The type of suture used for each AHD repair (absorbable vs. permanent) was also recorded in the database. The study population was divided into two groups: cleancontaminated (CC) and contaminated/dirty (CD).
106
Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field
⊡ Table 14.1. Study demographics
⊡ Table 14.2. Wound classification
n
Wound classification
Wound criteria
Clean
Elective, not emergency, nontraumatic; primarily closed; no acute inflammation; no break in technique; respiratory, gastrointestinal, biliary, and genitourinary tracts not entered
Clean-contaminated
Urgent or emergency case that is otherwise clean; elective opening of respiratory, gastrointestinal, biliary, or genitourinary tract with minimal spillage (e.g., appendectomy); no encountering of infected urine or bile; minor technique break
Contaminated
Nonpurulent inflammation; gross spillage from gastrointestinal tract; entry into biliary or genitourinary tract in the presence of infected bile or urine; major break in technique; penetrating trauma <4 h old; chronic open wounds to be grafted or covered
Dirty
Purulent inflammation (e.g., abscess); preoperative perforation of respiratory, gastrointestinal, biliary, or genitourinary tract; penetrating trauma >4 h old
75 Value
% / SD
51.5
14.5
Male
36
48.0
Female
39
52.0
Age Gender
Race (%) White
60
80.0
Black
11
14.7
Other
5
6.7
Cardiac
15
20.0
Hypertension
34
45.3
Diabetes mellitus
23
30.7
Renal
4
5.3
Chronic obstructive pulmonary disease
5
6.7
Hepatic
3
4.0
Chronic steroids
4
5.3
Length of stay
16.7
20.8
Charges
$158,183
$206,896
Died (sepsis)
1
1.3
⊡ Table 14.3. Operative repair type
Home
56
74.7
Repair type
Repair description
Transfer /rehabilitation
18
24.0
Inlay (sublay)
Reinforcing sheet of acellular human dermis is positioned deep to the anterior abdominal wall defect
Onlay
Reinforcing sheet of acellular human dermis is positioned superficial to the defect
Component separation
Releasing incisions are made in the external oblique muscle with rectus reinforcement with acellular human dermis
Interposition
The edges of the acellular human dermis graft are sutured directly to the edges of the fascial defect
Comorbidity (%)
Hospital
Disposition (%)
14
Outcomes The primary outcome measured in this study was the incidence of surgical site infection (SSI) as per the CDC definitions for nosocomial infections. Management of the wound infection was divided into medical management (intravenous antibiotic only) and surgical management (operative incision and drainage plus intravenous antibiotics). Also recorded was whether the AHD was removed.
14
107 Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair
Secondary variables included early hernia recurrence (<1 year); septic complications, including ventilator-associated pneumonia; urinary tract infection; and blood stream infection.
Statistics Statistical analysis was performed using chi-square tests to evaluate statistical significances between patient subgroups.
Results Seventy-five patients met the study criteria. The overall wound infection rate was 33.3%: 11 medically managed infections (14.7%) and 14 surgically managed infections (18.7%). The average length of hospital stay was 16.7 days (+20.8) with a mean follow-up of 275 (+209) days. With respect to the entire patient population, 25 out of 75 patients (33.3%) developed an SSI, and 12 patients had hernia recurrence (16%). The CC group (n=64) had nine wound infections that
were medically managed (14.1%) and 12 wound infections that were surgically managed (18.8%). The CD group (n=11) had two wound infections that were medically managed (18.2%) and two that were surgically managed (18.2%). Five of 14 surgically managed (35.7%) wound infections required removal of the mesh.
Subgroup Analysis The patient population was divided into two subgroups based on wound type: clean-contaminated (CC) and contaminated or dirty (CD). Sixty-four patients had CC wounds, and 11 patients had CD wounds (⊡ Table 14.4). Within the CC group, there were 21 SSI: 9/64 patients (14.1%) were medically managed, and 12/64 patients (18.8%) were surgically managed. Of the 12 surgically managed wound infections, five necessitated removal of the HADM (33.3%) either because of enterocutaneous fistula formation (n=4) or HADM infection (n=1; see ⊡ Table 14.5). Within the follow-up period (average 269 days), a total of 12 patients (16%) in the CC group experienced hernia recurrence.
⊡ Table 14.4. Clean-contaminated (CC) and contaminated/dirty (CD) subgroup analysis (HR hernia recurrence; LOS length of stay; WC wound closure during initial procedure; FUD follow-up days Groups
n
HR (%)
LOS (SD)
WC (%)
FD (SD)
Clean-contaminated
64
10
15.6
15.4
19.6
64
100
269
186
Contaminated/dirty
11
2
18.2
24.3
27.7
8
72.7
306
277
Total
75
12
16.0
19.8
23.6
72
96
275
201
⊡ Table 14.5. Inpatient infection rate (MM medical management; SM surgical management) n (%)
Inpatient Total (%)
MM (%)
SM (%)
Clean-contaminateda
64
85.3
21
32.8
9
14.1
12
18.8
Contaminated/dirty
11
14.7
4
36.4
2
18.2
2
18.2
Totals
75
100
25
33.3
11
14.7
14
18.7
aMesh
removal in five patients
108
Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field
Surgical Technique and Suture Analysis Outcomes were also evaluated with respect to the type of hernia repair implemented (⊡ Table 14.6). The ventral hernia repair type with the lowest occurrence of wound infection was the onlay technique (n=15), with 6.7% of patients developing an SSI. This was followed by inlay (n=27; 33.3%), interposition (n=23; 43.5%), and component separation (n=10; 50%). The repair method most successful at preventing hernia recurrence was the inlay method, with only 7.4% of patients developing a secondary hernia. This was followed by component separation (10%), onlay (13.3%), and interposition (30.4%). Although general trends in differences in wound infection and hernia recurrence rates are evident, none of these differences was statistically significant. Patients were also stratified by the type of suture used for the procedure, and outcomes were determined. Thirty-one percent (31.3%) of the patients who were repaired with absorbable sutures (n=32) developed a postoperative SSI, and 25% experienced hernia recurrence. Patients repaired with permanent sutures (n=38) had a slightly higher SSI rate at 34.2%, but a lower rate of her-
nia recurrence, at 10.5%. Again, the differences between infection and recurrence rates were not statistically significant. It should be noted that the type of suture used in five patients was unknown, and two developed a surgical wound infection (⊡ Table 14.7). It was concluded that wound infection in the contaminated surgical field occurred 33.3% of the time; 18.7% of the cases required surgical management, and 35.7% of these required removal of the HADM.
Discussion Because of the high rates of infection, hernia recurrence, and the occasional need for mesh removal with synthetic hernia repair in a contaminated surgical field, surgeons continue to search for other methods and materials to manage this difficult dilemma [15, 16]. One such material that has garnered attention is HADM. Studies have demonstrated that acellular grafts such as HADM have shown reduced postsurgical inflammation and rapid cellular infiltration and revascularization [17, 18]. This has been attributable to the
⊡ Table 14.6. Surgical repair technique and outcomes (WI wound infection; MM medical management; SM surgical management; HR hernia recurrence)
14
Repair type
n
WI (%)
MM (%)
SM (%)
HR (%)
Inlay
27
9
33.3
5
55.6
4
44.4
2
7.4
Onlay
15
1
6.7
1
6.7
0
0.0
2
13.3
Interpositional
23
10
43.5
3
30.0
7
70.0
7
30.4
Component separation
10
5
60.0
2
30
3
30.0
1
20.0
⊡ Table 14.7. Suture type and outcomes (WI wound infection; MM medical management; SM surgical management; HR hernia recurrence) Suture typea
n
WI (%)
Absorbable (PDS)
32
10
31.3
7
70.0
3
30.0
8
25.0
Permanent (Prolene)
38
13
34.2
4
30.8
9
69.2
4
10.5
aSuture
type unknown in five cases
MM (%)
SM (%)
HR (%)
109 Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair
macroarchitecture of the HADM, which is native human dermis. The HADM is a three-dimensional implant of tissue with an intact basement membrane, collagen fibers, elastin filaments, hyaluronan, and proteoglycans, as well as patent capillary network channels [19]. Once HADM is vascularized, the very nature of its structure allows it to resist infection when implanted into the anterior abdominal wall. Animal models have also shown that HADM offers the same tensile strength as synthetic materials, while achieving superior revascularization [20]. Our study substantiates the increasing amount of evidence demonstrating the utility of HADM in ventral hernia repairs, especially in a compromised surgical field. It is generally accepted that synthetic prostheses are contraindicated in a compromised surgical field because of unacceptably high rates of infection and hernia recurrence. However, no prospective trials have evaluated outcomes between HADM and synthetic mesh repairs. Our results and those of others suggest that ventral hernias repaired with HADM have acceptably low rates of infection and hernia recurrence compared with those repaired with nonbiological prostheses. Voyles et al. reported nine polypropylene mesh removals out of 29 (31%) surgically contaminated ventral hernia repairs due to infection or fistula formation [21]. Animal models have also shown high rates of polypropylene and polytetrafluoroethylene mesh removal due to infection [22, 23]. Geisler et al. reported hernia recurrence of 43% with synthetic mesh in compromised surgical fields [24]. The overall rates of wound infection (33.3%) and hernia recurrence (16%) in this study are consistent with studies reporting complication rates for synthetic prostheses in compromised surgical fields. Several previous studies also evaluated outcomes in hernia repair using HADM and demonstrated lower complication rates as well. Buinewicz and Rosen, in a retrospective review of 44 patients who underwent incisional hernia repair or TRAM flap surgery using HADM, reported a 7% postoperative wound infection rate and 5% hernia recurrence in clean surgical fields. No patient required reoperation or removal of the HADM [10]. Kolker et al. reported no hernia recurrences and only two
14
seromas from a pool of 16 ventral hernia patients in clean surgical settings [25]. Butler et al. evaluated the effectiveness of HADM in 13 suboptimal surgical patients in whom polypropylene mesh was contraindicated (perioperative radiation, placement of mesh directly over the bowel with bacterial contamination) [26]. Only two seromas (15%), one hematoma (8%), one occurrence of partial flap necrosis (8%), one case of enterocutaneous fistula formation (8%), and one case of wound dehiscence (8%) were noted. This study demonstrates the usefulness of HADM in compromised surgical fields. Scott et al. have also explored the application of HADM for open abdominal wound closure [27]. HADM was used to definitively close 37 open abdomens that would not have otherwise closed primarily. The results were favorable: two SSIs (5.4%), one intraabdominal abscess (2.7%), and no hernia recurrences. A prosthetic mesh infection is a complex surgical problem. In most cases, this progresses to a chronic septic state, which usually mandates removal of the mesh. Under these circumstances, immediate repair requires either autologous tissue material or a staged surgical repair. Yet these cases have a universally high wound infection rate. In our study, we had a 33% wound infection rate, but only five cases required removal of the AHD during the early experience. The revascularization of the HADM coupled with early surgical management of complex surgical wound infections allowed us to salvage the repair. It became clear that a surgical wound infection did not always equal a mesh infection. The impact of hernia repair type on patient outcomes demonstrates general agreement with the existing literature. Several studies have shown that the interposition technique yields the highest frequency of complications, whereas the inlay approach involves complications least frequently [28, 29]. Although no particular method was statistically superior in our small patient population, the numbers strongly discourage the use of interpositional hernia repair. The existing literature also favors inlay (sublay) repair, but in our study, the onlay technique proved to be less prone to infection and just as resistant to hernia recurrence as the inlay technique. Component separation repairs
110
Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair in the Compromised Surgical Field
also had a low rate of recurrence (10%) but a much higher rate of wound infection (50%). Again, the size of our patient population did not allow for statistical significance, but the results favor either inlay or onlay HADM placement. Repair of these complex ventral defects with onlay, inlay, or component separation surgical techniques commonly requires large adjacent skin flaps. This allows for mobilization of the skin and primary closure of the surgical wound. This technique results in large subcutaneous spaces that are commonly managed with drains to allow egress of collected fluid, with collapse of the space. In our study, drains were universally used for this purpose. White et al. [9] found that abnormal fluid collections are the most frequent problem in these types of hernia repairs. However, the use of drains does not reduce the incidence of complications such as wound infection or seroma formation.
Strengths and Limitations
14
This is the largest study to date using AHD in a compromised surgical field, and it was conducted at a large academic referral center. This is a retrospective review, with all the limitations and problems associated with such a study. We did not have a control arm, and the follow-up period was extremely limited. This was a heterogeneous population that included trauma, general surgery, and emergency general surgery cases. As such, no long-term analysis or conclusions can be gathered from the data. Future studies are required to directly compare the use of acellular human dermis vs. prosthetic mesh regarding the long-term success of ventral repair in a prospective fashion.
Conclusion Our analysis demonstrates the value of AHD for repairing a ventral hernia in a compromised surgical field. The relatively low rate of surgical wound infection and hernia recurrence coupled with the infrequent necessity for AHD removal favors its use over synthetic mesh for contaminated ventral hernia closure [30].
References 1. Trupka AW, Schweiberer L, Hallfeldt K, Waldner H. Management of large abdominal wall hernias with foreign implant materials (Gore-tex patch). Zentralbl Chir 1997;122:879–884 2. Bleichrodt RP, Simmermacher RKJ, Van der Lei B, Schakenraad JM. Expanded polytetrafluoroethylene patch versus polypropylene mesh for the repair of contaminated defects of the abdominal wall. Surg Gyn Obst 1993;176: 18–24 3. Voyles CR,Richardson JD, Bland KI, et al. Emergency abdominal wall reconstruction with polypropylene mesh. Short term benefits versus long term complications. Ann Surg 1981; 194:219–223 4. Temudom T, Siadati M, Sarr JG. Repair of complex giant or recurrent ventral hernias by using tension-free intraparietal prosthetic mesh (Stoppa technique): lessons learned from our initial experience (fifty patients). Surgery 1996; 120:738–744 5. Finan KR, Vick CC, Kiefe CI, Neumayer L, Hawn MT. Predictors of wound infection in ventral hernia repair. Am J Surg 2005;190(5):676–681 6. Scott BG, Feanny MA, Hirschberg A. Early definitive closure of the open abdomen: a quiet revolution. Scand J Surg 2005;94(1):9–14 7. Mayberry JC, Burgess EA, Goldman RK, et al. Enterocutaneous fistula and ventral hernia after absorbable mesh prosthesis closure for trauma: the plain truth. J Trauma 2004;57(1):157–162 8. Houck JP, Rypins EB, Sarfeh IJ, et al. Repair of incisional hernia. Surg Gynecol Obst 1989; 169:397–399 9. White TJ, Santos MC, Thompson JS. Factors affecting wound complications in repair of ventral hernias. Am Surg 1998;64(3):276–280 10. Buinewicz B, Rosen B. Acellular cadaveric dermis (acellular human dermis): a new alternative for abdominal hernia repair. Ann Plast Surg 2004; 52:188 11. Bauer JJ, Harris MT, Kreel I, et al. Twelve-year experience with expanded polytetrafluoroethylene in the repair of abdominal wall defects. Mt Sinai J Med 1999; 66: 20–25 12. Luijendijk RW, Hop WC, van den Tol MP, et al. A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 2000; 343(6):392–398 13. Burger JW, Luijendijk RW, Hop WC, et al. Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 2004; 240(4):578–583 14. The Hospital Infection Control Practices Advisory Committee. Guidelines for prevention of surgical site infection. Am J Infect Control 1999; 27:109–110 15. Diaz JJ Jr, Gray BW, Dobson JM, et al. Repair of giant abdominal hernias: does the type of prosthesis matter? Am Surg 2004;70(5):396–401; discussion 401–402 16. Leber GE, Garb JL, Alexander AI, Reed WP. Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 1998;133(4):378–382
111 Chapter 14 · Human Acellular Dermal Matrix for Ventral Hernia Repair
17. Livesey SA, Herndon DN, Hollyoak MA, et al. Transplanted acellular allograft dermal matrix. Potential as a template for the reconstruction of viable dermis. Transplantation 1995;60(1):1–9 18. Eppley BL. Experimental assessment of the revascularization of acellular human dermis for soft-tissue augmentation. Plast Reconstr Surg 2000; 107:757 19. LifeCell. AlloDerm Regenerative Tissue Matrix. http:// www.lifecell.com/products/95/ 20. Silverman RP, Singh NK, Li EN, et al. Restoring abdominal wall integrity in contaminated tissue-deficient wounds using autologous fascia grafts. Plast Reconstr Surg 2004;113(2):673–675 21. Voyles CR, Richardson JD, Bland KI, et al. Emergency abdominal wall reconstruction with polypropylene mesh: short-term benefits versus long-term complications. Ann Surg 1981;194(2):219–223 22. Bleichrodt RP, Simmermacher RKJ, van der Lei B, et al. Expanded polytetra-fluoroethylene patch versus polypropylene mesh for the repair for contaminated defects of the abdominal wall. Surg Gynecol Obstet 1993; 176:18 23. Brown GL, Richardson JD, Malangoni MA, et al. Comparison of prosthetic materials for abdominal wall reconstruction in the presence of contamination and infection. Ann Surg 1985; 201:705 24. Geisler DJ, Reilly JC, Vaughan SG, Glennon EJ, Kondylis PD. Safety and outcome of use of nonabsorbable mesh for repair of fascial defect in the presence of open bowel. Dis Colon Rectum 2003; 46(8):1118–1123 25. Kolker AR, Brown DJ, Redstone JS, Scarpinato VM, Wallack MK. Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (acellular human dermis) and component separation. Ann Plast Surg 2005;55(1):36–41; discussion 41–42 26. Butler CE, Langstein HN, Kronowitz SJ. Pelvic, abdominal and chest wall reconstruction with acellular human dermis in patients at increased risk for mesh-related complications. Plast Reconstr Surg. 2005;116(5):1263–1275; discussion 1276–1277 27. Scott BG, Scott BG, Welsh FJ, et al. Early aggressive closure of the open abdomen–a new approach. J Trauma 2006;60(1):17–22 28. Ueno T, Pickett LC, de la Fuente SG, et al. Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg 2004;8:109–112 29. de Vries Reilingh TS, van Geldere D, et al. Repair of large midline incisional hernias with polypropylene mesh: comparison of three operative techniques. Hernia 2004;8(1):56–59 30. Langer C, Liersch T, Kley C, Flosman M, et al. Twenty-five years of experience in incisional hernia surgery. A comparative retrospective study of 432 incisional hernia repairs. Chirurg 2003;74(7):638–645
14
15
Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh A. S. Fawole, R. P. C. Chaparala, N. S. Ambrose
114
Chapter 15 · Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh
Introduction
15
Over 70,000 groin hernias are repaired each year in England and Wales. Tension-free mesh hernioplasty is a commonly performed procedure for repair of inguinal hernias. It is relatively easy to perform, with one of the lowest recurrence rates of the available repairs [1], and studies have shown that this is a safe procedure with very few complications [2]. But there are concerns about infection because of the introduction of a foreign material into the body. Surgical site infection following inguinal hernia repair has been reported to be anything from 0 to 15%. The majority of these are superficial infections and do not appear to be influenced by the presence of a mesh [3]. These usually settle spontaneously with the use of antibiotics and sometimes require superficial incision and drainage. However, deep wound infection is a serious complication leading to chronic groin sepsis, which requires removal of the prosthetic mesh material to allow resolution of the infective process. Taylor and O’Dwyer [4] identified 12 cases of chronic groin sepsis following mesh repair of an inguinal hernia in Scotland over a 4-year period, all of which required complete or partial removal of the mesh to resolve the sepsis. Follow-up data were available for 11 of these 12 patients, two of whom developed hernia recurrence following mesh removal, although the duration of follow-up was not stated for the rest of the patients. One of these patients, who developed a recurrence about 2 years after initial mesh removal, had a further mesh repair that, unfortunately, once again led to groin sepsis requiring removal of the second mesh to control the infection. The other patient remained asymptomatic on follow-up, and the recurrence was thus not treated surgically [4]. Case reports have not observed hernia recurrence following removal of infected mesh material inserted by the open [5] or laparoscopic [6] techniques. A randomised controlled trial of prophylactic antibiotics in mesh hernioplasties found four cases of deep infection in the overall population of 280 patients studied (1.4%). Three of these required mesh removal for symptom control, and all three had no evidence of hernia recurrence at 1 year follow-up [7].
The aim of this study was to determine the incidence of inguinal hernia recurrence following the removal of an infected prosthetic mesh. In addition, the perioperative complications and long-term symptoms associated with removal were reviewed.
Patients and Methods Over an 8-year period from January 1, 1995, to December 31, 2002, 2,017 patients [1,892 male, 125 female; median age 60 (range 15–95) years] had repair of inguinal hernias in our university teaching hospital. Of these, 122 patients had bilateral hernias repaired, making a total of 2,139 inguinal hernias repaired in this study period; 1,955 were primary inguinal hernias, and 184 procedures were performed for a recurrent inguinal hernia. A retrospective case note review of patients who had mesh removal after inguinal hernia repair was undertaken. These notes were retrieved from records obtained from the operating theatre database system, which searched for all patients who had mesh removal. All patients with groin sepsis requiring mesh removal were included; however, two patients had removal of mesh for chronic groin pain and were excluded. Patients were further followed up by a telephone interview and were subsequently reviewed in the surgical outpatient clinic by one of the authors (NSA) to determine the outcomes after mesh removal. The main outcome measures were incidence of hernia recurrence and chronic groin pain.
Results Fourteen patients [11 male, three female; median age 60 (range 24–77) years] had mesh removal for chronic groin sepsis during this 8-year period. Only one of these patients had repair of a recurrent inguinal hernia as the initial procedure; all the others had repair of primary inguinal hernias. One patient had repair of bilateral primary inguinal hernias, but there was evidence of infection on one side, which resulted in removal of the mesh. An onlay polypropylene mesh was used in all of
115 Chapter 15 · Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh
the patients except one, who had only a polypropylene mesh plug repair. The mesh was secured with staples in five patients, and a polypropylene suture was used in the remaining nine, including the patient who had a mesh plug repair. Seven of these 14 patients had their initial hernioplasty performed as a day-case procedure. Six patients had a planned overnight stay. One patient had a delayed discharge (9 days) because of a scrotal haematoma that was treated conservatively. Six of the 14 patients received a dose of prophylactic antibiotic at the time of their operation (Table 15.1). There was no evidence of infection at the time of discharge in any of these patients. Two patients developed deep wound infection at 1 month. Another four were routinely seen at about 2 months, and none of them had evidence of infection at that time. The remaining eight patients did not have a routine postoperative clinic
15
appointment and were seen only after developing deep infection. Infection was first noticed in the groin at a mean of 11 (range 1–35) months following hernia repair (⊡ Table 15.1). There is no statistical difference between the mean times to first presentation of those patients who had prophylactic antibiotics (10 months) and those who did not (12.5 months); p=0.33. All patients were initially treated conservatively with repeated courses of antibiotics for a mean period of 10 (range 1–49) months. Mesh removals were performed at a mean of 22 (range 2–62) months following the initial hernia repair. All mesh removals were performed under general anaesthetic, and there were no perioperative complications. Eight patients had specimens sent for bacteriology at the time of operation, and six of these grew Staphylococcus aureus on culture.
⊡ Table 15.1. Use of prophylactic antibiotics, period of conservative management, and timing of operation in patients who had mesh removal Patient
Prophylactic antibiotics
Duration between initial operation and first sign of infection (months)
Period of conservative management with antibiotics (months)
Duration between initial operation and mesh removal (months)
1
Yes
1
4
5
2
None documented
3
3
6
3
None documented
28
1
29
4
Yes
13
49
62
5
None documented
35
9
44
6
None documented
9
25
36
7
None documented
7
1
8
8
None documented
4
26
30
9
Yes
8
3
11
10
None documented
13
4
17
11
Yes
7
10
17
12
Yes
25
4
29
13
Yes
6
6
12
14
None documented
1
1
2
116
Chapter 15 · Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh
All the patients who had mesh removal were followed up. After a median period of 44 (range 5–91) months, there were two recurrences, which were both asymptomatic. One of these patients noticed a lump in the groin 5 months following mesh removal, but this was asymptomatic, and he elected to have this treated conservatively. He was reviewed 10 months following recurrence and has remained asymptomatic. The other patient had a persistent minor groin discharge after mesh removal, which settled completely after 2 months. He was reviewed in the clinic 41 months after mesh removal and had remained asymptomatic, but clinical examination revealed a cough impulse suggestive of a small recurrent hernia. On questioning, none of the patients complained of pain or discomfort that interfered with their usual level of activity.
Discussion
15
Chronic groin sepsis is a dreaded complication of inguinal hernia repair using prosthetic material. Intuitively, prophylactic antibiotics would appear to be indicated in hernia repair with mesh, as this procedure involves introducing a foreign body into the groin. However, the literature is certainly divided regarding the use of prophylactic antibiotics in mesh repair of inguinal hernias. A Cochrane review of the literature [8] was unable to conclude a benefit for recommending antibiotic prophylaxis in elective primary inguinal hernia repair. A subsequent update in 2007 came to the same conclusion but suggested that antibiotics could not be argued against when high infection rates are detected. In this present series, the use of prophylactic antibiotics was documented in six out of 14 patients and did not appear to confer a benefit in preventing mesh infection. Deep infection tends to present after a delayed period following mesh repair of inguinal hernias; there was a mean period of 10 months’ delay in this group of patients. Use of prophylactic antibiotics does not appear to alter the time to presentation with deep infection (p=0.33). Available reports suggest that deep wound infection is uncommon following mesh repair of in-
guinal hernias [2, 4, 7], but it does usually require removal of the mesh to facilitate cessation of the groin sepsis [4, 5, 9]. We have shown a deep infection rate of about 0.7% (14 out of 2,017 patients). This is higher than in some reports, 0.03% [2], but is comparable to other studies that found deep infection rates of 1.4% [7] and even higher rates of superficial infection [10]. A wide range of surgeons with no particular interest in hernia repair, including mostly surgical trainees, performed the operations in this present study. This heterogeneous group of operating surgeons may partly explain the relatively higher rate of deep infections compared with specialist hernia repair centres. Inexperienced surgeons may excessively handle the mesh, which may contribute to development of deep infection. Although contamination at the time of operation is the likely source of infection in superficial infections, this is unlikely to be the aetiology in deep infections, which often present after a delayed period. These may be a result of haematogenous spread from distant sites [4]. It has been suggested that conservative treatment of groin infections with antibiotics leads to resolution of infection [11]. This is a reasonable proposition when there is only superficial infection of the subcutaneous tissue, but deep infection persists until there is surgical extirpation of the infected prosthetic material. In our series, groin sepsis did not settle even with repeated prolonged courses of antibiotics in some of the patients. Removal of infected prosthetic mesh is potentially associated with operative complications because of the concomitant inflammatory reaction that may make tissue planes more difficult to find. Meticulous surgical technique is thus necessary to ensure careful dissection and prevent intraoperative damage to structures, especially within the spermatic cord. In this study, no complications were associated with mesh removal. All mesh removals were performed by a consultant surgeon or a senior surgical trainee under the direct supervision of the consultant. For most of the patients (12 out of 14), there were no attempts to reinforce the transversalis fascia, which was thickened and fibrosed even after mesh removal. Two patients
117 Chapter 15 · Fate of the Inguinal Hernia Following Removal of Infected Prosthetic Mesh
had loose plication of the fascia with interrupted absorbable polydioxanone sutures. After a median follow-up period of 44 (5–91) months, only two of the 14 patients who had mesh removal for deep infection had developed hernia recurrence. These cases remained asymptomatic and were thus treated conservatively. Deep-seated wound infection has also been reported following laparoscopic hernia repair and also requires removal of the mesh, which can be done laparoscopically or by an open technique. Even after laparoscopic surgery, mesh removal does not appear to lead to hernia recurrence [6]. In conclusion, deep-seated wound infection following inguinal hernia repair is uncommon. When it does occur, it results in chronic groin sepsis, which in the majority of cases requires removal of the infected material before symptoms resolve. However, hernia recurrence is not inevitable, suggesting that the strength of a mesh repair lies in the fibrous reaction evoked within the transversalis fascia by the prosthetic material rather than in the physical presence of the mesh itself. With careful dissection, an infected mesh can be removed without any associated complications. Therefore, in established deep infection, physicians should not hesitate to remove an infected mesh to allow resolution of chronic groin sepsis. Patients should be warned that they may develop a recurrence. We would advise repairing this by a posterior (laparoscopic) approach after removal of mesh following an anterior (open) mesh hernioplasty.
References 1. Lichtenstein IL, Shulman AG, Amid PK, Montllor MM. (1989) The tension-free hernioplasty. Am J Surg 157:188– 193 2. Shulman AG, Amid PK, Lichtenstein IL. (1992) The safety of mesh repair for primary inguinal hernias: results of 3,019 operations from five diverse surgical sources. Am Surg 58:255–257 3. Mann DV, Prout J, Havranek E, Gould S, Darzi A. (1998) Late-onset deep prosthetic infection following mesh repair of inguinal hernia. Am J Surg 176:12–14 4. Taylor SG, O’Dwyer PJ. (1999) Chronic groin sepsis following tension-free inguinal hernioplasty. Br J Surg 86:562– 565
15
5. Ismail W, Agrawal A, Zia MI. (2002) Fate of chronically infected onlay mesh in groin wound. Hernia 6:79–81 6. Avtan L, Avci C, Bulut T, Fourtanier G. (1997) Mesh infections after laparoscopic inguinal hernia repair. Surg Laparosc Endosc 7:192–195 7. Yerdel MA, Akin EB, Dolalan S, Turkcapar AG, Pehlivan M, Gecim IE, Kuterdem E. (2001) Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: the randomized, double-blind, prospective trial. Ann Surg 233:26–33 8. Sanchez-Manuel FJ, Seco-Gil JL. (2003) Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev:CD003769 9. Hatada T, Ishii H, Ichii S, Ashida H, Yamamura T. (2000) Late infection after mesh-plug inguinal hernioplasty. Am J Surg 179:76–77 10. Taylor EW, Duffy K, Lee K, Hill R, Noone A, Macintyre I, King PM, O’Dwyer PJ. (2004) Surgical site infection after groin hernia repair. Br J Surg 91:105–111 11. Gilbert AI, Felton LL. (1993) Infection in inguinal hernia repair considering biomaterials and antibiotics. Surg Gynecol Obstet 177:126–130
Discussion Jacob: Concerning infection after groin hernia
repair, have you looked at those patients who have a local anesthetic compared to those who have general anesthesia? Fawole: We haven’t looked at this special point. But you are right; there might be a risk for bringing bacteria into the tissue during the local anesthesia.
16
Mesh Infection–Therapeutic Options E. Schippers
120
Chapter 16 · Mesh Infection–Therapeutic Options
Introduction The use of meshes in hernia repair has become standard procedure throughout the world. Implantation of a mesh has been found to reduce the rate of recurrence in the repair of incisional hernias [1–3]. However, mesh-related complications have become increasingly important. Postherniorrhaphy mesh infection, mesh bowel intrusion, fistula formation, and eventual removal and reinsertion have been induced by mesh contamination during primary surgery. Mesh-related infections following surgery occur relatively infrequently compared with other device-related infections; an incidence of mesh-related infections after incisional hernia repair up to 8% has been reported [4]. The relevance of bacterial contamination is controversial in the literature, although it is of considerable clinical importance to the patient and surgeon. Deysine describes mesh infection with consecutive migration and fistula formation as a catastrophe [5]. In vascular surgery, even more dramatic consequences of infected prostheses, including a mortality rate of 75%, were reported in earlier times. Patients with an infected prosthesis would ultimately die from massive hemorrhage or septicemia unless the prosthesis was removed [6]. However, in renal transplant recipients with immunosuppression and comorbidities such as obesity, diabetes, and chronic pulmonary diseases, surgical repair of infected or contaminated herniation with polypropylene mesh is safe and effective and yields excellent results [7].
16
Type of Mesh Shortly after introducing polyethylene mesh for replacing tissue defects, Usher [8] underscored the relevance of mechanical and biological properties of the mesh that are associated with the type of tissue structure. In experiments with infected wounds in dogs, he demonstrated that knitted material and taffeta weave were equally inert to infection. He attributed this in part to the use of a monofilament and to the structure of the knit-
ted fabric, which consists of a series of loops with no interlocking knots that might harbor serum and bacteria. With increasing recognition of the value of biomaterials for the repair of abdominal wall hernias, knowledge of biomaterial-related complications required in-depth knowledge and understanding of the physical properties of the prostheses. Consequently, Amid [9] proposed a classification of available biomaterials for hernia surgery based on their pore size: Type I: Totally macroporous prostheses containing pores larger than 75 μm, a pore size that is required for admission of macrophages, fibroblasts, blood vessels, and collagen fibers into the pores Type II: Totally microporous prostheses; these prostheses contain pores that are less than 10 μm in at least one of their three dimensions Type III: Macroporous prostheses with multifilamentous or microporous components, braided polypropylene mesh, or braided Dacron mesh Surgical infection promoted by implantation of biomaterials is caused by infection and proliferation of bacteria into and within the pores and interstices of these synthetic materials. When pores are less than 10 μm, bacteria averaging 1 μm cannot be eliminated by macrophages and neutrophilic granulocytes, which are too large to enter a 10-μm three- dimensional pore. Type I prostheses deter housing and growth of bacteria by allowing macrophages, rapid fibroplasia, and angiogenesis, which also prevents infiltration and growth of bacteria. Types II and III prostheses are similar to braided suture materials, and by harboring bacteria, they can promote their growth, likewise resulting in biomaterial-related infection. With respect to this classification and to the biomaterial-related complications, Amid concluded that in cases of infection, the totally macroporous prostheses (type I) do not have to be removed. To manage the infection, drainage and local wound care are all that is necessary. In cases of infection with type II or III mesh, total removal (II) or partial removal of type III is required. Leber et al. [10] analyzed the long-term complications associated with prosthetic repair of incisional hernia. They found that late infections appearing months or even years after surgery were
121 Chapter 16 · Mesh Infection–Therapeutic Options
more challenging. These were often combined with complex fistulas involving bowel, and the mesh had to be removed. In their study, multifilamented polyester mesh was associated with a significantly greater number of infections. Based on this clinical observation, the influence of the presence of either a monofilament or multifilament mesh material on the bacterial infection risk was studied in a rat model [11]. The extent of adherent bacteria corresponded to the estimated filament surface, thus favoring the use of monofilament materials. Robinson et al. reviewed medical device reports from the U.S. Food and Drug Administration on the use of surgical mesh for hernia repair. The analysis of 252 reports revealed a percentage of 42% related to infection. Polytetrafluoroethylene (PTFE) mesh especially tended to be associated with more infections. Another conclusion was that cases of polypropylene infections can be healed without mandatory removal of the mesh [12].
Role of Bacteria Deysine [13] categorized meshes into two groups: those that are hydrophobic, such as expanded PTFE, and those that are hydrophobic, including polyester and polypropylene. Those repelling water take more time to become integrated by the fibroblastic response. Likewise, hydrophobic materials may initially repel the fluids containing bacteria. The role of bacteria in cases of rejection was described as follows: Prostheses are rejected through the process of suppuration after becoming colonized by bacteria [5]. In order to adhere, bacteria undergo functional changes such as the production of slime, which enhances an irreversible and strong adhesion. Slime production is a major pathogenic property of bacterial strains that form biofilms on surfaces. Once the microorganisms have adhered to a biomaterial’s surface, they are protected against phagocytosis because the microorganisms and biomaterials together are too large to ingest. Although a variety of different bacteria can cause a prosthetic infection, the usual causative organ-
16
isms associated with cases of mesh infections are Staphylococcus spp., especially Staphylococcus aureus; Streptococcus spp.; gram-negative bacteria (mainly Enterobacteriaceae); and anaerobic bacteria [14]. The reported high rate of 63% of methicillin-resistant Staphylococcus aureus (MRSA) complicating intraperitoneal mesh implantation is alarming [4].
Diagnosis Patients usually present with symptoms and signs of local acute inflammation: pain, erythema, increased temperature, and tenderness and swelling in the abdominal wall in the area of the mesh. Systemic manifestations include fever, malaise, and chills or rigor. Abdominal abscesses and discharging fistulas can be the first clinical manifestation. To monitor prosthetic infections, erythrocyte sedimentation rate (ESR), C-reactive protein, and white blood cell count are well-established laboratory methods. White blood cell counts have a sensitivity of only 20% and a predictive value of 50%. The combination of ESR and C-reactive protein is a more powerful diagnostic tool; when both are negative, the possibility of infection is zero. When both are positive, the possibility of infection is 83% [15].
Imaging With the help of ultrasound, a noninvasive procedure, most mesh-related complications can be detected or ruled out. An abscess formation is seen as a hypoechogenic structure caused by cell debris, with small plump hyperechoic reflections caused by gas bubbles. The extent of incomplete fistulas within the abdominal wall can be determined. The hypoechoic structure of the fistula channel can be followed through the abdominal wall (⊡ Fig. 16.1). Computed tomography and magnetic resonance imaging allow clear identification of abdominal wall pathologies. Indications for these are sonographically uncertain results; however, the disadvantages include higher costs, limited availability, and the danger of contrast medium allergy. Fistu-
122
Chapter 16 · Mesh Infection–Therapeutic Options
Antibiotics
⊡ Fig. 16.1. Typical sonographic finding of an abscess formation and fistula channel with hypoechoic structures
lography reveals the extent, location, and relation of fistulas and is therefore a helpful tool in preoperative planning.
Treatment
16
Therapeutic options in cases of mesh infection range from prevention and intravenous antibiotics to open wound treatment and mesh removal. The essential factor in the evolution and persistence of infection is the formation of a biofilm around the implanted device [16]. The biofilm is capable of resisting antimicrobial agents due to the protective mechanism. Adequate prevention of a biomaterial-centered infection is therefore aimed at the first contact of a microorganism with a biomaterial. Bacterial adhesions on the biomaterial depend on the material surface. Mesh coated with different precious metals, such as titanium, silver, or gold, can successfully reduce bacterial attachment [17]. Because ultrasound reduces biofilm formation, several studies on the effect of ultrasound on bacterial cell growth and on the treatment of biomaterial-centered infections have been performed. A positive effect of ultrasound in addition to treatment with antibiotics has been shown. Theoretically, a phenomenon called the bioacoustic effect enhances the transportation and penetration of antibiotics within the biofilms. The contribution of low-frequency and high-intensity ultrasound in the presence of an antibiotic agent removes and kills microorganisms [18].
Bacterial susceptibility to pharmacological treatment is significantly reduced when a polymeric device is present. Possible reasons for the reduced susceptibility of biofilm-embedded organisms to antibiotic agents include a slow rate of bacterial growth within the biofilm, inhibition of antimicrobial activity by biofilm substances, and poor penetration of the biofilm by antibiotics [19]. Therefore, the strategy of monotherapy with intravenous antibiotics in cases of mesh-related infections has a poor outcome and consequently has no indication [14].
Open Wound Treatment Standard surgical practice supports removing prosthetic material when a wound infection involves the prosthesis. The removal of mesh in this situation is often technically difficult and may result in substantial additional complications. Local tissue incorporation can make removal of mesh dangerous because adjacent vascular structures or the bowel can be injured, which may result in acute bleeding or subsequent development of an enterocutaneous fistula. Because achieving closure of the fascial defect after mesh removal is usually not possible, this surgery may result in an incisional hernia that is larger than the original one. In early postoperative infections after implantation of porous mesh, it is therefore advised to introduce an open wound management strategy combined with a suction-based debridement system as an alternative to explantation of the mesh. The principle of vacuum sealing has been introduced for the treatment of complicated wounds [20]. The first step is wound opening, followed by necrosectomy, wound debridement, and irrigation. A polyvinyl vacuum foam is cut to size and placed into the wound. A vacuum-assisted closure system with transparent polyurethane foil is applied to the open portion of the wound and skin (⊡ Fig. 16.2). Permanent suction at 60–80 kPa must be established. The foam is removed at 2–5-day intervals, with the transparent foil allowing daily inspection of the wound. This treatment results in progressive
123 Chapter 16 · Mesh Infection–Therapeutic Options
16
a
⊡ Fig. 16.3. Example of a microporous mesh followed by late infection and fistula that had to be removed
b ⊡ Fig. 16.2. Steps in vacuum sealing after early mesh infection. a Cutting the foam to size. b Vacuum-assisted closure system in place
debridement and granulation of the open wound and causes a dermatotraction with approximation of the wound edges. After successful wound conditioning, a secondary closure of skin over the mesh can be achieved without mesh removal. However, mesh explantation is recommended for all type II prostheses (totally microporous) [9]. Furthermore, later infections after months or even years are more challenging and also require removal of the prosthesis [21]. They are often combined with complex fistulas involving the bowel. In these cases, preservation of the mesh is likely to fail, and sooner or later the mesh has to be removed [22] (⊡ Fig. 16.3).
Conclusion Mesh infection is a serious, but not catastrophic, complication in hernia surgery. The extent of the damage correlates with the type of mesh that was
primarily implanted. With respect to prevention and therapy, the ideal mesh is macroporous, hydrophilic, and monofilamented. Two-thirds of infections are caused by Staphylococcus spp., and methicillin-resistant staphylococci are frequent. The therapeutic options are both mesh-related and time-related. Open wound treatment, including vacuum sealing, is indicated in early postoperative infection of macroporous meshes. Explantation should be limited to microporous meshes or late and chronic infections, which are often complicated by sinus or fistula formation. Monotherapy with antibiotics should be abandoned. Interesting aspects for future research in this field include biofilm formation, bioacoustic effects, and mesh coatings.
References 1. Luijendijk RW, Hop WC, van den Tol MP, et al. (2000) A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343:392–398 2. Schumpelick V, Klosterhalfen B, Müller M, et al. (1999) Minimierte Polypropylen Netze zur präperitonealen Netzplastik (PNP): eine prospektive randomisierte klinische Studie. Chirurg 70:422–430 3. Schippers E, Harsányi A, Thumbs A, Schneider M (2001) Ergebnisse nach offener Netzplastik der Narbenhernie in Sublay-Technik. Viszeralchirurgie 36:152–156 4. Copp WS IV, Harris JB, Lokey JS, McGill ES, Klove KL (2003) Incisional herniorrhaphy with intraperitoneal composite mesh: a report of 95 cases. In: Proceedings of the Sou-
124
5.
6.
7.
8.
9.
10.
11.
12.
13. 14.
15.
16.
16
17.
18.
19. 20.
21.
Chapter 16 · Mesh Infection–Therapeutic Options
theastern Surgical Congress, 7–11 February 2003, Savannah, Georgia. Vol 69, pp. 784–787 Deysine M (2004) The catastrophe: mesh infection and migration with fistula formation–life-long risk? In: Schumpelick V, Neuhaus LM (eds) Meshes: benefits and risks. Springer, Berlin, pp 207–227 Fry WJ, Lindenauer SM, Arbor A (1967) Infection complicating the use of plastic arterial implants. Arch Surg 94:600–609 Antonopoulos IM, Nahas WC, Mazzucchi E, Piovesan AC, Birolini C, Lucon AM (2005) Is polypropylene mesh safe and effective for repairing infected incisional hernia in renal transplant recipients? Urology 66:874–877 Usher FC (1961) Knitted Marlex mesh: an improved marlex prosthesis for repairing hernias and other tissue defects. Arch Surg 82:153–155 Amid PK (1997) Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia 1:15–21 Leber GE, Garb JL, Alexander AI, Reed WP (1998) Longterm complications associated with prosthetic repar of incisional hernias. Arch Surg 133:378–382 Klinge U, Junge K, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V (2002) Do multifilament alloplastic meshes increase the infection rate? Analyses of the polymeric surface, the bacteria adherence and the in vivo consequences in a rat model. J Biomed Materials Res 63:765–771 Robinson TN, Clarke JH, Schoen J, Walsh MD (2005) Major mesh-related complications following hernia repair: events reported to the Food and Drug Administration. Surg Endosc 19:1556–1560 Deysine M (1998) Management of prosthetic infections in hernia surgery. Surg Clin North Am 78:1105–1115 Falagas A, Kasiakou SK (2004) Mesh-related infections after hernia repair surgery. European Society of Clinical Microbiology and Infectious Diseases, CMI, 11:3–8 Salvati EA, Callaghan JJ, Brause BD, et al. (1986) Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Rel Res 207:83–93 Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science; 284:1318–1322 Engelsmann AF, van der Mei HC, Ploeg RJ, Busscher HJ (2007) The phenomenon of infection with abdominal wall reconstruction. Biomaterials 28:2314–2327 Johnson LL, Peterson RV, Pitt WG (1998) Treatment of bacterial biofilms on polymeric biomaterials using antibiotics and ultrasound. J Biomater Sci Polym Ed 9:1177– 1185 Darouiche R (2004) Treatment of infections associated with surgical implants. N Engl J Med 350:1422–1429 Fleischmann W, Bacher U, Bischoff M, Hoekstra H (1995) Vacuum sealing: indication, technique and results. Eur J Orthop Surg Traumatol 5:37–40 Flament JB, Avisse C, Palot JP, Delattre JF (1999) Biomaterials–principles of implantation. In: Schumpelick V, Kings-
north AN, et al. (eds) Incisional hernia. Springer, Berlin, pp 217–227 22. Klinge U, Conze J, Krones CJ, Schumpelick V (2005) Incisional hernia: open techniques. World J Surg 29:1066–1072
17
Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery? T. J. Aufenacker
126
Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery?
Introduction
17
A mesh-based repair is, in many Western countries, the most popular technique for repairing abdominal wall hernia in order to reduce the risk of recurrence [1–7]. More than 80% of adult abdominal wall hernias occur in the groin, and in the Western world the majority are being repaired with the use of a prosthetic mesh. There is a large variation in techniques used to correct a groin hernia, with an even larger variety of meshes. Currently the most popular inguinal hernia technique is the Lichtenstein hernia repair [8], using a flat mesh to reinforce the inguinal wall. The incidence of infection after inguinal hernia repair has been reported to vary from 0% to 9% [9]. Especially when a foreign body, such as a polypropylene mesh, is used, prevention of a deep infection is of paramount importance because a deep infection of a mesh may require its removal, as reported in several cases [10]. A Cochrane Review meta-analysis for inguinal hernia [11] in 2004 concluded that »antibiotic prophylaxis for elective inguinal hernia repair cannot be firmly recommended or discarded« because the number of included patients was limited and that »further studies are needed, particularly on the use of mesh repair.« Although most studies, as discussed later in this chapter, do not support the use of antibiotic prophylaxis, its use is still widespread. The reason for this might be legislative in many cases since an American attorney, for instance, could ask a so-called expert during a court of law about a lack of antibiotic prophylaxis. In some cases, this expert might well be a psychiatrist without updated knowledge in this area, and his or her advice would be misleading to those hearing the case. Many American surgeons admit to continuing to use antibiotic prophylaxis for this reason. Both in the United States and Europe, over 1.5 million abdominal wall hernia repairs (of which 70% are groin hernia repairs) are performed annually [12]. Therefore, any improvement in their treatment could have a large medical and economic impact. A reduction in the number of wound infections would especially have a great effect on patient satisfaction, sick leave, and wound
care. Conversely, discarding the use of antibiotic prophylaxis in hernia repair could reduce costs, the risks of toxic and allergic side effects, and the possible development of bacterial resistance [13] or superinfections. To assess whether systemic antibiotic prophylaxis prevents wound infection in groin hernia repair, a systematic review and a meta-analysis of randomised controlled trials were carried out.
Material and Methods A search of Medline, EMBASE, CINAHL, DARE, ACP, LILACS, and the Cochrane Register using the terms hernia and antibiotic prophylaxis was done to identify randomised controlled trials on the subject published between 1966 and May 2008. All languages were considered. The search was performed independently by two reviewers, who selected potentially relevant papers based on title and abstract. References from the selected papers were used for search completion. Field experts were contacted for potential data, and books of the abstracts from leading hernia meetings over the last 8 years were manually checked for unpublished data. All randomised placebocontrolled trials using antibiotic prophylaxis in mesh abdominal wall hernia repair with explicit defined wound infection criteria and a minimum follow-up period of 1 month were included. Each paper was reviewed independently by three reviewers, and a quality assessment was performed according to the scoring system of Jadad et al. [14]. Discrepancies among the reviewers were resolved by consensus. Only papers with a Jadad score ≥3 were considered appropriate for further analysis. Data were extracted from the studies and pooled using the Review Manager software [15] from the Cochrane Collaboration. A χ2 test for heterogeneity of study results was performed. If heterogeneity could not be detected, data were pooled using a random effects model to correct for clinical diversity and methodological variations between studies. The effectiveness of antibiotic prophylaxis to prevent wound infection was expressed as odds ratios (ORs) for dichotomous
127 Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection
data and their 95% confidence intervals (CIs). Numbers needed to treat (NNT) and 95% CIs were calculated from the OR and the background risk of wound infection for the patients in the placebo groups. No subgroup analysis was performed. If it remained unclear from a study whether data were presented for patients or hernias, a sensitivity analysis (worst-case scenario) was done by varying the distribution of bilateral hernia between the treated and placebo groups.
Results The search resulted in a large number of potentially relevant studies, identifying nine papers reporting prospective randomised data on the use of antibiotic prophylaxis in groin hernia surgery with prosthetic reinforcement. After the Cochrane meta-analysis update in 2007, no additional trials in the area of nonmesh repairs were published. In this Cochrane analysis, one study combining three trials with unpublished data is included. Therefore, the data regarding nonmesh techniques from the Cochrane meta-analysis
17
(⊡ Table 17.1) are used to perform an analysis with the random-effect model. A nonsignificant effect of antibiotic prophylaxis in nonmesh techniques was demonstrated, OR 0.75 (0.53–1.06), NNT 85 (45–359). Regarding the mesh-based techniques, a summary of the nine papers that included randomised trials and the outcome of the assessment is given in ⊡ Table 17.2. The results of the three assessments did not differ among the three reviewers. The only laparoscopic study, by Schwetling and Barlehner [16], used an incorrect randomisation method and lacked a definition of wound infection, but in the absence of more studies on this technique, it was considered best evidence. Eight studies were, after the quality assessment, suited for meta-analysis regarding the use of antibiotic prophylaxis in mesh-based repairs. They included 2,963 open inguinal and 43 femoral hernia repairs. The patient and surgical characteristics of these eight randomised controlled trials are documented in ⊡ Table 17.3. The included studies are presented separately with their main intervention and results in ⊡ Table 17.4.
⊡ Table 17.1. Pooled data of six studies on the use of antibiotic prophylaxis for prevention of wound infection after nonmesh inguinal hernia repair Review: The effectiveness of antibiotic prophylaxis in inguinal hernia repair Comparison: 01 Antibiotic prophylaxis vs: placebo Outcome: 03 Non mesh techniques Study or sub-category
Antibiotic n/N
Placebo n/N
Evans
1/48
2/49
Anderson
5/137
Platt
OR (random) 95% Cl
Year
2.01
0.50 [0.04, 5.70]
1973
6/150
8.14
0.91 [0.27, 3.05]
1980
4/301
6/311
7.33
0.68 [0.19, 2.45]
1990
Lazorthes
0/155
7/153
1.45
0.06 [0.00, 1.11]
1992
Taylor
25/283
25/280
35.35
0.99 [0.55, 1.77]
1997
Pessaux
68/2008
20/394
45.72
0.66 [0.39, 1.09]
2006
Total (95% Cl)
2932
1337
100.00
0.75 [0.53, 1.06]
Total events: 103 (Antibiotic), 66 (Placebo) Test for heterogeneity: Chi2= 4.31, df = 5 (P= 0.51), I2 = 0% Test of overall effect: Z= 1.63 (P=0.10)
OR (random) 95% Cl
0.1 0.2 0.5 1 2 5 10 Favours treatment Favours control
Weight %
128
Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery?
⊡ Table 17.2. Results and quality of prospective randomised studies on the use of antibiotic prophylaxis in the prevention of wound infection after mesh groin hernia repair Reference
Jadad score
Number of patients
Infection %
Correct randomisation?
Doubleblind?
Wound infection definition?
Follow-up period?
Accepted in metaanalysis?
Laparoscopic inguinal hernia mesh repair (transabdominal preperitoneal) Schwetling [16] 1998
0
80
0.0%
No, alternately
No
No definition
Unknown
No; best evidence
Open inguinal and femoral hernia mesh repair
17
Morales [17] 2000
4
524
1.9%
Yes
Yes
Yes
1 year
Yes
Yerdel [18] 2001
5
269
4.8%
Yes
Yes
CDC criteria [25]
1 year
Yes
Celdran [19] 2004
4
91
4.4 %
Yes
Yes
CDC criteria [25]
2 years
Yes
Oteiza [20] 2004
3
247
0.4%
Yes
No
CDC criteria [25]
1 month
Yes
Aufenacker [21] 2004
5
1,008
1.7 %
Yes
Yes
CDC criteria [25]
3 months
Yes
Perez [22] 2005
5
360
3.1%
Yes
Yes
CDC criteria [25]
1 month
Yes
Tovaras23 2007
5
379
3,7%
Yes
Yes
Yes
1 month
Yes
Jain24 2008
5
120
1.7%
Yes
Yes
CDC criteria25
1 month
Yes
The total number of infections after groin hernia repair with a mesh-based technique was 48/1,526 patients (3.1%) in the placebo group and 24/1,480 patients (1.6%) in the antibiotic group. The pooled data for the eight studies are presented in ⊡ Table 17.5. There was no statistical heterogeneity (p=0.36). The OR for wound infection after antibiotic prophylaxis was 0.59 (95% CI 0.34–1.03), resulting in an NNT of 80 (49–1111). A sensitivity analysis was performed because the Celdran study [19] did not specify in which group the eight bilateral hernias were included (worst-case scenario: infection rate in Celdran’s placebo group 4/41=9.8%), resulting in an OR of 0.57 (95% CI 0.32–1.04). The number of deep infections after inguinal and femoral hernia repair was 6/1,050 in the placebo group (0.6%) and 3/1,053 in the antibiotic
prophylaxis group (0.3%), with an OR of 0.50 (95% CI 0.12–2.09) and an NNT of 352 (199–1961). The pooled data of six studies (the Morales and Tzovaras data were not available) are presented in ⊡ Table 17.6.
Discussion In this systematic review and meta-analysis on the effectiveness of antibiotic prophylaxis in groin hernia repair, the six randomised controlled trials concerning non-mesh-based techniques and the nine mesh-based trials demonstrate no significant benefit of antibiotic prophylaxis. For groin hernias, the wound infection rate reported in randomised controlled trials of 2.4% after
17
129 Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection
⊡ Table 17.3. Patient and study characteristics of eight randomised controlled trials on antibiotic prophylaxis in inguinal and femoral hernia mesh repair (PHS Prolene Hernia System) Morales [17] N=524a
Yerdel [18] N=269a
Celdran [19] N=99b
Oteiza [20] N=247a
Aufenacker [21] N=1,008a
Perez [22] N=360a
Tzovaras [23] N=379a
Jain [24] N=120a
Total infections (%)
1.9%
4.8%
4.4%
0.4%
1.7%
3.1%
3.7%
1.7%
Deep infection (%)
0.8%
1.5%
0%
0%
0.3%
0.6%
Not documented
0%
Mesh removal (%)
0.8%
1.1%
0%
0%
0.2%
0.6%
0%
0%
Body mass index (mean)
Not documented
25.0
26.2
Not documented
Not documented
Not documented
26.0
Not documented
Diabetes
Not documented
Study exclusion criterion
18 (18.1%)
Not documented
Study exclusion criterion
Not documented
13 (3.4%)
Study exclusion criterion
Recurrent hernia
39 (7.4%)
Study exclusion criterion
13 (13.1%)
Study exclusion criterion
Study exclusion criterion
Study exclusion criterion
Not documented
Study exclusion criterion
Duration of surgery
34 min
63 min
65 min
40 min
40 min
53 min
45 min
58 min
Surgeons (%) Residents (%)
524 (100%) 0 (0%)
0 (0%) 269 (100%)
75 (75.8%) 24 (24.2%)
247 (100%) 0 (0%)
571 (56.6%) 437 (43.4%)
Not documented
Not documented
120 (100%) 0 (0%)
Bilateral hernia
0 (0%)
0 (0%)
8 (8.8%)
Study exclusion criterion
56 (5.6%)
Study exclusion criterion
Study exclusion criterion
Study exclusion criterion
Femoral hernia
23 (4.4%)
Study exclusion criterion
Study exclusion criterion
20 (8.1%)
Study exclusion criterion
Study exclusion criterion
Study exclusion criterion
Study exclusion criterion
Use of drains
Study exclusion criterion
60 (22.3%)
Not documented
Not documented
15 (1.5%)
0 (0%)
15 (4.0%)
0 (0%)
Local anaesthetics
Not documented
111 (41.3%)
99 (100%)
226 (91.5%)
17 (1.7%)
0 (0%)
329 (86.8%)
Not documented
Day surgery
51 (9.7%)
Not documented
99 (100%)
247 (100%)
463 (45.9%)
Not documented
Not documented
0 (0%)
Mesh type
Flat, polypropylene
Flat, polypropylene
Flat, polypropylene
Flat, polypropylene
Flat, polypropylene
Flat, polypropylene
Flat, polypropylene
PHS, polypropylene
Exclusion bias [26]
30/554 (5.4)
11/280 (3.9%)
0/91 (0%)
3/250 (1.2%)
7/1,015 (0.7%)
0/360 (0%)
2/381 (0.5%)
0/120 (0%)
aN= bN=
number of patients number of hernias (91 patients)
130
Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery?
⊡ Table 17.4. Results of individual studies accepted in the systematic review on the use of antibiotic prophylaxis for preventing wound infection after mesh groin hernia repair (NNT number needed to treat) Reference
N
Mean age (years)
Males (%)
Type of antibiotic
Infection placebo group (patients, %)
p-value
NNT
0%
1.0
∞
Infection intervention group (patients, %)
Laparoscopic inguinal hernia mesh repair (transabdominal preperitoneal) Schwetling [16]
80
55
86
Cefuroxime 1.5 g
0/40
0%
0/40
Open inguinal and femoral hernia mesh repair Morales [17]
524
54
90
Cefazolin 2g
6/287
2.1%
4/237
1.7%
0.737
248
Yerdel [18]
269
56
93
Ampicillin + sulbactam 1.5 g
12/133
9.0%
1/136
0.7%
0.002
13
Celdran [19]
91
58
90
Cefazolin 1g
4/49a
8.2%
0/50a
0.0%
0.059
13
Oteiza [20]
247
57
85
Amoxicillin + clavulanic acid 2 g
0/123
0.0%
1/124
0.8%
0.318
NNH 124
Aufenacker [21]
1,008
58
96
Cefuroxime 1.5 g
9/505
1.8%
8/503
1.6%
0.813
520
Perez [22]
360
61
98
Cefazolin 1g
7/180
3.9%
4/180
2.2%
0.540
59
Tzovaras [23]
379
63
94
Amoxicillin + clavulanic acid 1.2 g
9/189
4.7%
5/190
2.6%
0.4
48
Jain [24]
120
41
100
Amoxicillin + clavulanic acid 1.2 g
1/60
1.7%
1/60
1.7%
0.500
∞
aNumber
17
of hernias (91 patients)
mesh repair is not higher than the percentage after conventional sutured repair [11] (4.0%). Because the use of antibiotics is not likely to increase the wound infection percentage, the net effect of studies designed as those that were included will almost always be zero or will be in favour of the patients’ receiving prophylaxis and therefore on the left (antibiotic-favouring) side of the forest plot. The meta-analysis of six nonmesh studies demonstrated a nonsignificant effect of antibiotic prophylaxis: OR 0.75 (0.53–1.06), NNT 85 (45–359). The meta-analysis of eight studies on the use of antibiotic prophylaxis to prevent wound infection
after mesh groin hernia repair did not favour the use of antibiotic prophylaxis: OR 0.59 (95% CI 0.34– 1.03) and NNT 80 (49–1,111). In the meta-analysis, only one study of below-average size demonstrated a large and significant benefit for the prophylaxis group, but this study can be criticised because of repeated aspiration of seromas and excessive use of drains that could cause (secondary) infections; also, it is likely that the study was underpowered because it was, unfortunately, prematurely stopped because of the high rate of wound infection. However, there can be a debate about the method used for meta-analysis in this chapter be-
17
131 Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection
⊡ Table 17.5. Pooled data of eight studies on the use of antibiotic prophylaxis for preventing wound infection after mesh inguinal hernia repair Review: The effectiveness of antibiotic prophylaxis in inguinal hernia repair Comparison: 01 Antibiotic prophylaxis vs placebo Outcome: 01 Total number of wound infections Study or sub-category
Antibiotic n/N
Placebo n/N
Morales
4/237
6/287
Yerdel
1/136
Aufenacker
OR (random) 95% Cl
Year
16.78
0.80 [0.22, 2.88]
2000
12/133
7.02
0.07 [0.01, 0.58]
2001
8/503
9/505
27.05
0.89 [0.34, 2.33]
2004
Celdran
0/50
4/49
3.51
0.10 [0.01, 1.91]
2004
Oteiza
1/124
0/123
2.97
3.00 [0.12, 74.36]
2004
Perez
4/180
7/180
17.51
0.56 [0.16, 1.95]
2005
Tzovaras
5/190
9/189
21.27
0.54 [0.18, 1.64]
2007
Jain
1/60
1/60
3.89
1.00 [0.06, 16.37]
2008
Total (95% Cl)
1480
1526
100.00
Total events: 24 (Antibiotic), 48 (Placebo) Test for heterogeneity: Chi2 = 7.70, df = 7 (P = 0.36), I2 = 9.1% Test for overall effect: Z = 1.86 (P = 0.06)
OR (random) 95% Cl
Weight %
0.59 [0.34, 1.03]
0.01 0.1 1 10 100 Favours treatment Favours control
⊡ Table 17.6. Pooled data of six studies (Morales and Tsovaras data not available) on the use of antibiotic prophylaxis for preventing deep wound infection after mesh groin hernia repair Review: The effectiveness of antibiotic prophylaxis in inguinal hernia repair Comparison: 01 Antibiotic prophylaxis vs placebo Outcome: 02 Deep infections Study or sub-category
Antibiotic n/N
Placebo n/N
Yerdel
1/136
3/133
Aufenacker
1/503
2/505
Celdran
0/50
Oteiza
OR (random) 95% Cl
Year
38.96
0.32 [0.03, 3.13]
2001
34.98
0.50 [0.05, 5.54]
2004
0/49
Not estimable
2004
0/124
0/123
Not estimable
2004
Perez
1/180
1/180
1.00 [0.06, 16.11]
2005
Jain
0/60
0/60
Not estimable
2008
Total (95% Cl)
1053
1050
Total events: 3 (Antibiotic), 6 (Placebo) Test for heterogeneity: Chi2 = 0.39, df = 2 (P = 0.82), I2 = 0% Test for overall effect: Z = 0.94 (P = 0.35)
OR (random) 95% Cl
Weight %
26.12
100.00 0.01 0.1 1 10 100 Favours treatment Favours control
0.50 [0.12, 2.09]
132
17
Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery?
cause meta-analysis is a nonperfect technique that is no substitute for a large and well-designed randomised controlled study. Nonetheless, the technique is indicated for similar situations in which the number of patients in the studies is low or when results are conflicting, as it provides pooled estimates with narrower CIs and greater statistical power. But the interpretation of a meta-analysis, especially which method to use, is essential. The choice of method should be based on the presence or absence of statistical heterogeneity within the data together with the clinical diversity and methodological diversity of the original studies. In the presence of statistical heterogeneity, it is better not to perform a meta-analysis. In the eight studies used for the current meta-analysis, there is no statistical heterogeneity (e.g. p=0.36, I2= 9.1). The studies are, unfortunately, clinically and methodologically diverse; for instance, there is large variation among the included studies regarding recurrent hernia, diabetes, bilateral repair, use of local anaesthetics, and the surgeon’s level of expertise. To correct for this clinical and methodological diversity, the random method should be used rather than fixed analysis. Especially when the results of the fixed and random analysis conflict, as in the current situation, the choice of meta-analysis method should preferably be conservative, and in these situations the random method should also be used [27, 28]. An infection percentage in low-risk patients should be below 2% [29] when performing clean inguinal or femoral hernia surgery lasting less than 1 h. Therefore, the question should be, »Should we administer antibiotics to all patients undergoing clean surgery to spare a few (sometimes a very few) superficial wound infections?« [30]. Because a relatively simple treatment of wound drainage, frequently combined with antibiotics, is required for superficial infections, and because the rare deep infections result in a low number of mesh removals (0.09% [10] –1.1% [18]) with remarkably few hernia recurrences, there remains no routine indication for antibiotic prophylaxis in low-risk patients. Discarding the use of antibiotic prophylaxis in hernia repair could reduce costs, the risks of toxic and allergic side effects, and the possible development of bacterial resistance [13] or superinfections.
If a much higher percentage of wound infections exists because of patient or surgical characteristics [28], as demonstrated by two of the inguinal hernia studies, the use of antibiotic prophylaxis could be reevaluated. In the trials with high wound infection percentages, two important differences can be seen: The duration of surgery was 1.5 times longer (64 min), and drains were used more often (22%), both known risk factors for infection [29, 31]. This review shows the lack of randomised studies of laparoscopic groin hernia repairs on the subject of wound infection. The only laparoscopic inguinal hernia (transabdominal preperitoneal) repair study discussed 80 patients without proper randomisation (alternately), but it demonstrated no infections. This study virtually excludes the presence of a high percentage of wound infections in laparoscopic repair. There is some logic in this low infection rate since the minimally invasive approach consists of small and occluded incisions, although the operating time is an average of 18 min longer compared with an open repair [32]. Considering these aspects, and as long as hard evidence is lacking, it is probably acceptable to conclude that in laparoscopic inguinal hernia repair, no antibiotic prophylaxis is needed. It is not expected that important publications were missed in our thorough search of the literature and our contacts with authorities in the field. It is, however, difficult to assess the possibility of publication bias, resulting in studies being left out that showed no effect of antibiotic prophylaxis for the procedures included in our analysis. On the other hand, if publication bias exists, the effect of antibiotic prophylaxis would be even more modest than we found in our meta-analysis, as failure to include the grey literature has been reported to overestimate a treatment effect by 15% [33]. From this meta-analysis it can be concluded that in clinical settings with low rates of infection, there will be no significant benefit from using antibiotic prophylaxis for groin hernia repair in low-risk patients. Because of an unknown impact on bacterial resistance [13], the use of routine antibiotic prophylaxis in primary inguinal hernia repair should therefore be discouraged. In the Netherlands, the cost benefit for one patient is rel-
133 Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection
⊡ Table 17.7. Patient and operation characteristics that may influence the risk of wound infections [28] Patient
Operation
Age Nutritional status Diabetes Smoking Obesity Coexistent infection at a remote body site Colonisation with microorganisms Altered immune response Length of preoperative stay
Duration of surgical scrub Skin antisepsis Preoperative shaving Preoperative skin prep Duration of operation Antimicrobial prophylaxis Operating room ventilation Inadequate sterilisation of instruments Foreign material in the surgical site Surgical drains Surgical technique
atively limited (€13.20) [34]. Nevertheless, because of the large number of inguinal hernia repairs performed in low-risk patients (an estimated 70% of all hernias) [21], discarding the use of antibiotic prophylaxis will save at least €10 million in Europe and the United States. There is, of course, not enough evidence regarding the high-risk group of patients (⊡ Table 17.7). To answer this question, another large trial would be needed, or, better yet, the source data of the separate trials should be analysed. Therefore, an attempt is currently being made to contact all authors of randomised controlled trials and ask them to deliver their source data for final analysis. Currently it can be stated that surgeons and hospitals must assess their own surgical site infection rates to define if prophylactic antibiotics must be widely used in all patients. For clinical settings with low rates of surgical site infections, selective use of antibiotics based on patients’ and surgical risk factors is probably the best therapeutic strategy.
Conclusion The meta-analysis of eight studies on the use of antibiotic prophylaxis for preventing wound infection after mesh groin hernia repair did not favour
17
the use of antibiotic prophylaxis: OR 0.59 (95% CI 0.34–1.03) and NNT 80 (49–1,111). From this meta-analysis it can be concluded that in clinical settings with low rates of infection, there will be no significant benefit from using antibiotic prophylaxis for groin hernia repair in lowrisk patients. However, if patient or surgical characteristics prove the existence of a much higher percentage of wound infections, as demonstrated by two of the inguinal hernia studies, the use of antibiotic prophylaxis could be reevaluated.
Acknowledgments The author wants to thank M. J. Koelemay, M.D., Ph.D., and M. P. Simons, M.D., Ph.D., for their help with this study.
References 1. Bay-Nielsen M, Kehlet M, Strand L, Malmstrom J, Andersen FH, Wara P, Juul P, Callesen T; Danish Hernia Database Collaboration (2001). Quality assessment of 26,304 herniorrhaphies in Denmark: a prospective nationwide study. Lancet 358:1124–1128 2. Arroyo A, Garcia P, Perez F, Andreu J, Candela F, Calpena R (2001). Randomized clinical trial comparing suture and mesh repair of umbilical hernia in adults. Br J Surg 88:1321–1323 3. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004). Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–585 4. Nilsson E, Haapaniemi S, Gruber G, Sandblom G (1998). Methods of repair and risk for reoperation in Swedish hernia surgery from 1992 to 1996. Br J Surg 85:1686–1691 5. Nyhus LM, Alani A, O’Dwyer PJ (2004). The problem: How to treat a hernia. In: Schumpelick V, Nyhus LM (eds) Meshes: benefits and risks, 1st edn. Springer, Berlin, pp 3–30 6. EU Hernia Trialists Collaboration (2000). Mesh compared with non-mesh methods of open groin hernia repair: systematic review of randomized controlled trials. Br J Surg 87:854–859 7. EU Hernia Trialists Collaboration (2002). Repair of groin hernia with synthetic mesh, meta-analysis of randomized controlled trials. Ann Surg 235:322–332 8. Lichtenstein IL, Shulman AG, Amid PK, Montller MM (1989). The tension-free hernioplasty. Am J Surg 157:188– 193 9. Stephenson BM (2003). Complications of open groin hernia repair. Surg Clin North Am 83:1255–1278
134
17
Chapter 17 · Does Antibiotic Prophylaxis Prevent the Occurrence of Wound Infection After Groin Hernia Surgery?
10. Taylor SG, O’Dwyer PJ (1999). Chronic groin sepsis following tension-free inguinal hernioplasty. Br J Surg 86:562– 565 11. Sanchez-Manuel FJ, Seco-Gil JL (2004). Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 18(4):CD003769 12. Rutkow IM (2003). Demographic and socioeconomic aspects of hernia repair in the United States in 2003. Surg Clin North Am 83:1045–1051 13. Waldvogel FA, Vaudaux PE, Pittet D, Lew PD (1991). Perioperative antibiotic prophylaxis of wound and foreign body infections: microbial factors affecting efficacy. Rev Infect Dis 13 (suppl 10):S782–789 14. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996). Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12 15. Cochrane Review Manager 4.2.7. Available at http://www. cc-ims.net/RevMan 16. Schwetling R, Barlehner E (1998). Is there an indication for general perioperative antibiotic prophylaxis in laparoscopic plastic hernia repair with implantation of alloplastic tissue? Zentralbl Chir 123:193–195 17. Morales R, Carmona A, Pagán A (2000). Utility of antibiotic prophylaxis in reducing wound infection in inguinal or femoral hernia repair using polypropylene mesh. Cir Esp 67:51–59 18. Yerdel MA, Akin EB, Dolalan S, Turkcapar AG, Pehlivan M, Gecim IE, Kuterdem E (2001). Effect of single-dose prophylactic ampicillin and sulbactam on wound infection after tension-free inguinal hernia repair with polypropylene mesh: the randomized, double-blind, prospective trial. Ann Surg 233:26–33 19. Celdran A, Frieyro O, de la Pinta JC, Souto JL, Esteban J, Rubio JM, Senaris JF (2004). The role of antibiotic prophylaxis on wound infection after mesh hernia repair under local anesthesia on an ambulatory basis. Hernia 8: 20–22 20. Oteiza F, Ciga MA, Ortiz H (2004). Antibiotic prophylaxis in inguinal herniaplasty. Cir Esp 75:69–71 21. Aufenacker TJ, van Geldere D, van Mesdag T, Bossers AN, Dekker B, Scheijde E, van Nieuwenhuizen R, Hiemstra E, Maduro JH, Juttmann JW, Hofstede D, van der Linden CT, Gouma DJ, Simons MP (2004). The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia. A multi-center double-blind randomized controlled trial. Ann Surg 240:955–961 22. Perez AR, Roxas MF, Hilvano SS (2005). A randomized, double-blind, placebo-controlled trial to determine effectiveness of antibiotic prophylaxis for tension free mesh herniorrhaphy. J Am Coll Surg 200:393–398 23. Tzovaras G, Delikoukos S, Christodoulides G., Spyridakis M, Mantzos F, Tepetes K, Athanassiou E, Hatzitheofilou C (2007). The role of antibiotic prophylaxis in elective tension-free mesh inguinal hernia repair: results of a single centre prospective randomised trial. Int J Clin Pract 61 (2):236–239
24. Jain SK, Jayant M, Norbu C (2008). The role of antibiotic prophylaxis in mesh repair of primary inguinal hernias using Prolene hernia system: a randomised prospective double-blind control trial. Trop Doct 38(2):80–82 25. Horan TC, Gaynes RP, Martone WJ, Jaris WR, Emori TG (1992). CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 20:271–274 26. Tierney JF, Stewart LA (2005). Investigating patient exclusion bias in metaanalysis. Int J Epidemiol 34:79–87 27. Alderson P, Green S. Cochrane Collaboration open learning material for reviewers, version 1.1. Available at http:// www.cc-ims.net 28. Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions, version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available at http://www.cochrane-handbook.org 29. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999). Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20:247–280 30. Sitges-Serra A (2002). Ecosurgery. Br J Surg 89:387–388 31. Simchen E, Rozin R, Wax Y (1990). The Israeli study of surgical infection of drains and the risk of wound infection in operation for hernia. Surg Gynecol Obstet 170:331–337 32. Memon MA, Cooper NJ, Memon B, Memon MI, Abrams KR (2003). Meta-analysis of randomized clinical trials comparing open and laparoscopic inguinal hernia repair. Br J Surg 90:1479–1492 33. McAuley L, Pham B, Tugwell P, Moher D (2000). Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet 356:1228–1231 34. Z-index database of Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP), The Hague, Netherlands. Available at http://www.knmp.nl [in Dutch]. Accessed December 2003
Discussion Klinge: Do you think that this problem of mesh infection and late mesh infection is an issue for meta-analysis and clinical studies? Aufenacker: It would be quite difficult to do the follow-up of such a study. If you want to prove the short-term effect of this infection, you need a large population. Simons: Do you think it would be good to use antibiotics in cases of patients with risk factors, such as smokers? Aufenacker: In our study, we do not look at smoking-related factors, so I can’t answer this question yet.
18
Infection Control in a Hernia Clinic: 24-Year Results of Aseptic and Antiseptic Measure Implementation in 4,620 »Clean Cases« Based on Up-To-Date Microbiological Research M. Deysine
136
Chapter 18 · Infection Control in a Hernia Clinic
Introduction The wound infection rate for both ventral and inguinal herniorrhaphy has remained at virtually the same unacceptable level for the last 60 years: between 3% and 4% for inguinal hernias and between 8% and 14% for ventral hernias. Thus, approximately 30,000 inguinal and 3,000 ventral repairs become infected yearly in the United States alone, and European figures may be similar [2–3]. During the last 20 years the introduction of mesh repairs has considerably changed the prognosis of these infections, whose successful treatment requires a sequence of often crippling or even life-threatening reoperations [4]. This paper reports our 25-year experience with »clean« postherniorrhaphy wound infection prevention. During this period, vast advances have been made by groups studying the biological relationships among bacteria, prostheses, and hosts [5–8]. The emerging information solidly supports the application of seasoned surgical principles that function by diminishing the number of microbes entering the wound, decreasing their available food supply, and killing them with antibiotics [9, 10]. However, recent discoveries dealing with bacterial »quorum sensing« and its inhibitors may favorably apply to the prevention and treatment of infections related to surgically implanted foreign bodies. Our results suggest that with the application of up-to-date knowledge dealing with the interaction between biomaterials and bacteria, postherniorrhaphy wound infections may become a preventable complication.
Methods and Materials
18
In 1981 we created a hernia clinic where patients were treated under a protocol that has been reported elsewhere [11–12]. At the onset, we adopted the Shouldice technique for inguinal repairs, which was progressively replaced by mesh repairs using expanded polytetrafluoroethylene (ePTFE), polypropylene, and Dacron polyester meshes. Ventral herniorrhaphy underwent a similar evolutionary pattern [10].
Initially, the operating room aseptic and antiseptic measures used were the standard ones for so-called clean cases. Wounds were not irrigated, and we did not use intravenous antibiotics. In 1982, after the occurrence of five almost consecutive postinguinal herniorrhaphy wound infections, we modified our protocol by enhancing strict aseptic measures created by others. In addition, patients received a preoperative intravenous injection of 1 g cefazolin. We also irrigated the operative sites with a solution of 80 mg gentamicin sulfate diluted into 250 ml normal saline solution, starting immediately after opening the external oblique aponeurosis and continuing intermittently until the skin was closed. (See ⊡ Table 18.1). Postoperatively, patients were seen by the author at 7 days, at 1 month, and at yearly intervals thereafter. Wound infection was defined as the appearance of pus or any other exudate anywhere in a wound, any time after surgery.
Results Since 1981 we have performed 4,300 »clean« inguinal herniorrhaphies under a published protocol. We used the Shouldice technique in 2,500 and mesh or plug repair for the rest. Five postinguinal herniorrhaphy wound infections occurred (11%), the last one in 1982. All of them occurred in patients operated with the Shouldice technique. Four of the wounds grew coagulase-positive Staphylococcus aureus. All infections were treated by opening the skin from end to end and the wound down to the infected layer, with extensive debridement of all necrotic tissue and suture material. Wounds were irrigated at daily intervals with normal saline solution, and the patients received short-term courses of specific antibiotics. All wounds healed by secondary intention. Two patients developed recurrences and were reoperated 6 weeks after the wounds were completely healed. Three hundred and thirty »clean« ventral herniorrhaphies were performed utilizing a variety of mesh techniques and materials. Three patients in whom the defects were corrected with ePTFE meshes developed wound infections (0.9%) requiring mesh removal. All of these wounds grew coagulase-positive Staphylococcus aureus. These
137 Chapter 18 · Infection Control in a Hernia Clinic
⊡ Table 18.1. Aseptic and antiseptic measures adopted in 1982 to decrease wound contamination by operating room environmental bacteria In the preoperating room: 1. Patient’s abdomen is shaved or clipped just before surgery 2. Patient receives 1 g intravenous cefazolin In the operating room: 1. Team emphasis on measures to prevent prosthesis contamination 2. Team awareness of operating room preparations: face masking, scrubbing, gowning, gloving, instrument package handling 3. Double gloving, with changes of the external glove every 45 min 4. Avoidance of nonessential personnel traffic through the operating room 5. Team awareness of all moves that may produce contamination Surgical measures 1. Ensure that skin preparation vastly exceeds the wound area; include the scrotum for inguinal herniorrhaphy 2. Drape the patient carefully 3. Emphasize scissors or scalpel dissection 4. Use electrocautery sparsely 5. Keep dissection circumscribed to relevant areas 6. As soon as the external oblique aponeurosis is opened (for inguinal or ventral hernias), start wound irrigations with a solution of 80 mg gentamicin sulfate dissolved in 250 ml normal saline 7. Irrigate as often as possible 8. Approximate tissues to themselves and to the prosthesis, using the minimum tension necessary to permit appropriate contact and avoid tissue strangulation 9. Place the prosthesis into the gentamicin solution as soon as it leaves the package; consider the operating room air to be contaminated with bacteria 10. Avoid excessive retraction, clamping, or tissue crushing with any kind of instrument 11. Avoid hand retracting or dissection 12. Excise all devitalized tissue 13. Before closing the external oblique aponeurosis, debride the wound with a dry gauze to remove clots, separated fat tissue, etc. 14. Avoid drain placement; if needed, use it for only 24 h, and keep the patient on intravenous antibiotics all of that time
patients were reoperated 6–12 months later using various techniques. No infections were observed in »clean cases« receiving either polypropylene or Dacron polyester meshes [10].
18
Since the inception of these aseptic and antiseptic measures in 1982, we have not experienced wound infections in »clean« inguinal or ventral hernia repairs
Discussion After the landmark work of Semmelweis, Pasteur, and Lister, the wound infection rate for »clean« general surgical cases fell from virtually 100% to about 10%. This rate was further reduced around 1950 to approximately 4% by improvements in operating room aseptic and antiseptic measures plus the introduction of perioperative and postoperative antibiotics. However, no further improvement in the »clean« wound infection rate has been recorded for the last 40 years [4]. This situation may be the result of less than optimal implementation of timetested aseptic measures associated with a false sense of security emerging from antibiotic availability. Furthermore, the actual wound status terminology may be deceiving because so-called clean wounds are far from sterile. Abundant evidence in the literature demonstrates that such wounds contain bacteria at the time of closure, coming from the air, bodies, or surgical instruments. Hubble et al. demonstrated that operating room air might contain up to 1,000 colony-forming units per mm3 [13]. Taylor and Bannister showed that a surgeon leaning over a wound increases the bacterial wound count by 27-fold [14], and Dillon et al. showed that 23% of »clean wounds« grew bacteria and that postoperative infections of those wounds were 10 times more common [15]. This means that during »clean« surgery, both the wound and the prosthesis will become contaminated by bacteria to various degrees. However, our knowledge of wound infection has rapidly increased because, during the last 30 years, biochemical engineers, microbiologists, and general and orthopedic surgeons have clarified the interactions among bacteria, host tissues, and prosthetic polymers [5–8, 16–19]. As demonstrated by several investigators [14–16], bacteria will enter a wound from a variety of operating theater sources. These microorganisms depend on food substrate for their survival,
138
18
Chapter 18 · Infection Control in a Hernia Clinic
and mortified tissue and plasma-coated prosthetic polymers meet this nutritional demand [20]. Subsequently, by producing high-quality adhesives that allow their survival and further colonization, bacteria rapidly hold fast to those nourishing surfaces. The forthcoming colonization is then followed by a host–immune response leading to suppuration [5, 6, 8]. In 1970, Nealson et al. [21] reported on the cellular control of the synthesis and activity of a bacterial luminescent system regulated by a system of intercellular communications. This led to a series of discoveries demonstrating that grampositive and gram-negative bacteria communicate with each other by releasing chemical molecules called autoinducers, which regulate gene expression in response to changes in population density. This process allows bacteria to build community structures and regulate biofilm and toxin production. In essence, the quorum sensum is responsible for bacterial contamination of tissues and biomaterials plus further toxin production. These landmark discoveries led to the identification of an autoinducer RAP (33–kDa autoinducer RNAIII-activating protein), which induces the phosphorylation of the target of RAP (TRAP). TRAP is a 21–kDa protein that regulates the expression of toxins. Most importantly, in the absence of TRAP expression of phosphorylation, bacteria do not produce toxins, and they fail to cause disease. Recently, the quorum-sensing inhibitor RIP [RNAIII-inhibiting peptide (YSPWTNF–NH2)] showed the capacity to inhibit TRAP phosphorylation, thereby preventing infection of implanted devices in several animal models. Finally, RIP has been found to have significant activity in treating methicillin-resistant staphylococcal infections in a rat model, suggesting its use as a therapeutic constituent. From these data, it is evident that a new era of infection control and treatment may be emerging. In 1982 we decided to test the effect of irrigating inguinal herniorrhaphy wounds with a concentrated solution of gentamicin sulfate. In addition, the prosthesis was placed in the gentamicin solution directly from the package and from there into the wound. Further to this, a preoperative intravenous injection of 1 g cefazolin was added to
the protocol. The killing effect of the gentamicin is concentration dependent and is followed by a bacteriostatic effect. Although it is most effective against gram-negative bacteria, gentamicin also has killing activity against staphylococci, both S. aureus and S. epidermidis. The empirical choice of a highly concentrated gentamicin solution may explain our results because, at the level used, gentamicin would be bactericidal and not bacteriostatic [22]. Most important, because gentamicin shows antimicrobial synergy when used in combination with beta-lactams, the cefazolin may have contributed to successful bacterial killing [23]. Gentamicin is not harmless and can produce auditory and renal damage at high serum concentrations. Concerned about such side effects, we measured gentamicin serum levels in 10 consecutive postinguinal herniorrhaphy patients 1 h postoperatively and found undetectable levels. Ventral herniorrhaphies, in contrast, present a larger surface; for those cases, we recommend avoiding peritoneal contact with the gentamicin solution because it will be rapidly absorbed by the serosal surface. Compresses soaked in the gentamicin solution can be used to protect the wound edges while or until the peritoneum is closed, at which time wound irrigations can continue. We have not encountered any cases of otic or renal toxicity. Salvati and others have monitored serum gentamicin levels after the treatment of infected orthopedic wounds with pellets containing the antibiotic, showing minimal or no detectable levels [24–27]. Recently, gentamicin irrigations have been successfully used by neurosurgeons to prevent postcraniotomy infections [28]. Additionally, Junge et al. successfully bonded gentamicin to polyvinylidene fluoride mesh material, demonstrating that the antibiotic retained its antimicrobial activity after implantation. These findings open the possibility of creating a mesh that could resist microbial colonization [29]. The use of preoperative intravenous antibiotics is a much debated issue [30–39]. In spite of the controversy, we choose to use them because we believe it could balance the infection struggle in our patients’ favor. Inguinal herniorrhaphy is one of the few surgical procedures in which the surgeon deals with
139 Chapter 18 · Infection Control in a Hernia Clinic
initially sterile tissues. Therefore, the amount of bacteria present at closure should become a controllable factor. Consequently, in addition to the antibiotic regimen, we strictly emphasized aseptic measures developed by others because we believed in their usefulness. Patients were shaved by the surgeon just before surgery, and the skin preparation vastly exceeded the operative site. Gowning, gloving, and draping were strictly supervised to diminish errors [40–43]. The literature on gloving is rich in data demonstrating that those devices routinely perforate [44–46]. Therefore, we used double gloving. Electrocautery produces a time- and energydependent coagulation necrosis indistinguishable from a full-thickness burn [47–50]. To lessen the amount of necrotic material in the wound, we used such tools sparingly. Incision and further dissection were performed with scalpel and delicate scissors. Gentle tissue handling and retracting were encouraged. The interpretation of these results is limited by the logistics of the clinical problem: These patients could have been randomized; thus, we do not know whether any of the above measures would, by themselves, have been sufficient to improve our patients’ outcomes. Moreover, our success cannot be attributed to the use of antibiotics only, as other measures were included to decrease the number of bacteria entering the wound. Additionally, the field of ventral herniorrhaphy poses additional challenges, probably related to the fact that larger wounds require larger meshes. For these operations we strongly recommend the incorporation of measures that have already yielded vastly improved results in the field of orthopedic infections, including dedicated operating rooms with HEPA-filtered laminar air flow, hooded and ventilated gowns and masks, and double gloving [51]. In our hands, the implementation of strict aseptic measures, atraumatic technique, minimal electrocautery use, intravenous preoperative antibiotics, and early and frequent wound irrigation with a gentamicin solution have eliminated postoperative herniorrhaphy infections. The validity of these results can henceforth be substantiated only by further studies.
18
New discoveries by microbiologists may further enhance the field of infection prevention and treatment.
References 1. Bendavid R (2004) Recurrences, the fault of the surgeon. In: Shumpelick V, Nyhus LM (eds) Meshes: benefits and risks. Springer, Berlin, pp 51–62 2. Deysine M (2004) Historical evolution of asepsis and antisepsis. In: Deysine M (ed) Hernia infections: pathophysiology, diagnosis treatment and prevention. Dekker, New York, pp 1–16 3. Sanchez Montes I, Sanchez Montes J, Deysine M (2004) Epidemiology and incidence of post external abdominal wall herniorrhaphy. In: Deysine M (ed) Hernia infections: pathophysiology, diagnosis treatment and prevention. Dekker, New York, pp 17–57 4. Deysine M (1998) Pathophysiology, prevention and management of prosthetic infections in hernia surgery. Surg Clin North Am 78:1105–1115 5. Gristina AG, Oga M, Well LX, et al. (1985) Adherent bacterial colonization in the pathogenesis of osteomylitis. Science 228:990–993 6. Patti JM, Allen BL, McGavin MJ, et al. (1994) MSCRAMMmediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48:585–617 7. Shive MS, Hasan SM, Anderson JM (1999) Shear stress effect on bacterial adhesion, and leukocyte oxidative capacity on polyetherurethane. J Biomed Mater Res 46:511– 519 8. Bryers JD (2000) Biofilms II–process analysis and application. Wiley Interscience, New York 9. Salvati EA, Gonzalez Della Valle A, Masri BA, Duncan CP (2003) The infected total hip arthroplasty. Instr Course Lect 52:223–245 10. Deysine M (1998) Ventral herniorrhaphy: treatment evolution in a hernia service. Hernia 2:15–18 11. Deysine M (1991) Inguinal herniorrhaphy. Reduced morbidity by service standardization. Arch Surg 126:628–630 12. Deysine M (2001) Hernia clinic in a teaching institution: creation and development. Hernia 5:65–69 13. Hubble MJ, Weale AE, Perez JV, et al. (1996) Clothing in laminar-flow operating theaters. J Hosp Infect 32:1–7 14. Taylor GJ, Bannister GC (1993) Infection and interposition between ultraclean air source and wound. J Bone Joint Surg 75B:503–504 15. Dillon ML, Postlethwait RW, Bowling KA (1969) Operative wound cultures and wound infections: a study of 342 patients. Ann Surg 170:1029–1034 16. Charnley J, Efrekhar N (1969) Postoperative infection in total prosthetic arthroplasty of the hip joint. Br J Surg 56:641–649 17. Lidwell OM, Lowbury EJ, Whyte W, et al. (1982) Effect of ultraclean air in operating rooms on deep sepsis in the
140
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
18 32.
33.
Chapter 18 · Infection Control in a Hernia Clinic
joint after total hip or knee replacement: a randomised study. Br Med J 285 :10–14 Lidwell OM, Lowbury EJL, Whyte W, et al. (1983) Airborne contamination of wounds in joint replacement operations: the relationship to sepsis rates. J Hosp Infect4:111– 131 Subcommittee of the Committee on Control of CrossInfection (1962) Operating-theatre hygiene. Design and ventilation of operating-room suites for control of infection. Lancet 2:945–951 Deysine M (2004) Prevention. In: Deysine M (ed) Hernia infections: pathophysiology, diagnosis, treatment and prevention. Dekker, New York, pp 301–324 Nealson KH, Platt T, Hastings JW (1970) Cellular control of the synthesis and activity of the bacterial luminescent system. J Bacteriol 104:313–322 Lortholary O, Tod M, Cohen Y, et al. (1995) Aminoglycosides in antimicrobial therapy II. Med Clin North Am 79:761–787 Drugeon HB, Caillon J, Juvin ME, et al. (1988) Bases theoriques de l’association de la cefazidine avec les autres antibiotiques. Recherche de synergie. Presse Med 17:1900 Salvati EA, Callaghan JJ, Brause BD, et al. (1986) Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res 207:83–93 Dirschl DR, Wilson FC (1991) Topical antibiotic irrigation in the prophylaxis of operative wound infections in orthopedic surgery. Orthoped Clin North Am 22:419–426 Wahlig H, Dingeldein E, Bergmann R, et al. (1978) The release of gentamicin from polymethylmethacrylate beads. J Bone Joint Surg 60B:270–275 Voos K, Rosenberg B, Fagrhi M, et al. (1999) Use of Tobramicin impregnated polymethylmethacrylate pin sleeves for the prevention of pin-tract infection in goats. J Orthoped Trauma 13:98–101 Yamamoto M, Jimbo M, Ide M, et al. (1996) Perioperative antimicrobial prophylaxis in neurosurgery: clinical trial of systemic Flomex administration and saline containing gentamicin for irrigation. Neurol Med Chir (Tokyo) 36:370–376 Junge K, Rosh R, Klinge U, et al. (2005) Gentamicin supplementation of polyvinylidenfluoride mesh materials for infection prophylaxis. Biomaterials 26:787–793 Waldogel FA, Vaudaux PE, Pittet D, et al. (1991) Perioperative antibiotic prophylaxis of wound and foreign body infections: microbial factors affecting efficacy. Rev Infect Dis 13 (suppl):782–789 Classen DC, Scott Evans R, Pestotnik SL, et al. (1992) The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326:281–286 Wong-Beringer A, Corelli RL, Schrock TR, et al. (1995) Influence of timing of antibiotic administration on tissue concentrations during surgery. Am J Surg 169:379–381 Hill C, Mazas F, Flamant R, et al. (1981) Prophylactic cefazolin versus placebo in total hip replacement. Lancet 1:795–797
34. Troy MG, Quan-Sheng Dong, Dobrin PB, et al. (1996) Do topical antibiotics provide improved prophylaxis against bacterial growth in the presence of polypropylene mesh? Am J Surg 171:391–393 35. Gürleyik E, Gürleyik G, Cetinkaya F, et al. (1998) The inflammatory response to open tension-free inguinal hernioplasty versus conventional repairs. Am J Surg 175:179– 182 36. Musella M, Guido A, Musella S (1998) Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernia. Eur J Surg 2001; 167:130–132 37. Hopkins CC (1991) Antibiotic prophylaxis in clean surgery, peripheral vascular surgery, non cardiovascular thoracic surgery, herniorrhaphy and mastectomy. Rev Infect Dis 13 (suppl):869–873 38. Abramov D, Jeroukhimov I, Yinnon AM (1996) Antibiotic prophylaxis in umbilical and incisional hernia repair. Eur J Surg 162:945–948 39. Gilbert AI, Felton LL (1993) Infections in inguinal hernia repair considering biomaterials and antibiotics. Surg Gynecol Obstet 177:126–130 40. Dineen P (1978) Hand-washing degerming: a comparison of povidone–iodine and chlorhexidine. Clin Pharmacol Ther 23:63–67 41. Von Bergmann E, von Bruns P, von Mikulicz J (1904) A system of practical surgery. Lea Brothers, New York 42. Watson-Jones R (1955) Fractures and joint injuries, 4th edn. Livingstone, Edinburgh, pp 191–197 43. Hochberg J, Murray GF (1997) Principles of operative surgery. In: Sabiston DC, Lyerly HK (eds) Textbook of surgery. The biological basis of modern surgical practice, 15th edn. Saunders 44. Rutkow IM (1999) The surgeon’s glove. Arch Surg 134:223– 224 45. Sohn RL, Murray MT, Franko A (2000) Detection of surgical glove integrity. Am Surgeon 66:302–306 46. Muto CA, Sistrom MG, Strain BA (2000) Glove leakage rates as a function of latex content and brand. Arch Surg 135: 982–985 47. Porter KA, O’Connor S, Rimm E, et al. (1998) Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 176:8–11 48. Onbargi LC, Hayden R, Valle RF, et al. (1993) Effects of power and electrical current density variations in an in-vitro endometrial ablation model. Obstet Gynecol 82:912–918 49. Madden JE, Edlich RF, Custer JR, et al. (1970) Studies in the management of the contaminated wound. IV. Resistance to infection of surgical wounds made by knife, electrosurgery and laser. Am J Surg 119:222–224 50. Olivar AC, Forouhar FA, Gillies CG, et al. (1999) Transmission electron microscopy: evaluation of damage in human oviducts caused by different surgical instruments. Ann Clin Lab Sci 29:281–285 51. Deysine M (2004) Post mesh herniorrhaphy control: are we doing all we can? [letter] Hernia 8:90–91 Discussion
141 Chapter 18 · Infection Control in a Hernia Clinic
Discussion Smeds: What are the reasons for your low infection rate? Deysine: It’s a combination of things I did. First of all, I try to get my operating room sterile, and I use prophylactic antibiotics because it makes sense to me. It’s only one injection; it works in orthopedic patients. Kehlet: We hear about these large personal series with zero problems in anything. And then we have these series from randomized studies with infection rates up to 9%. How can we proceed, because there is a discrepancy between these difference experiences? Deysine: I believe in technique, and I think that doing this kind of operation properly without additional damage of tissue leads to these good results.
18
19
Components Separation Technique: Pros and Cons B. M. van der Kolk, T. S. de Vries Reilingh, O. Buyne, R. P. Bleichrodt
144
Chapter 19 · Components Separation Technique: Pros and Cons
Introduction
19
of the muscles to restore the anatomy of the ventral abdominal wall. The method and its modifications have been described in detail by Bleichrodt and coworkers [5–8]. This chapter describes the relevant anatomy of the ventral abdominal wall and the surgical technique, summarizes the results, and discusses the sequelae and possible solutions to prevent them.
Prosthetic repair is still the most frequently applied method to repair ventral hernias. However, prosthetic materials have several drawbacks. First, the mechanical properties of the abdominal wall may be altered, providing less dynamic support and a less favorable cosmetic result owing to bulging of the prosthesis. Second, the prosthetic material may cause damage to the intraabdominal viscera if the peritoneum or greater omentum cannot be interposed between the prosthesis and the organs [1]. Third, biomaterials increase the risk of infection, particularly when they are used for reconstruction in a contaminated environment, such as the abdominal wall in the presence of an enterocutaneous fistula [2, 3]. In 1990, Ramirez et al. [4] described a technique for reconstructing abdominal wall defects without using prosthetic material. It is based on enlargement of the abdominal wall surface by translation of the muscle layers to bridge fascial defects of up to 28 cm at the waistline without compromising the innervation and blood supply
The anatomy in relation to the components separation technique (CST) has been described by Bleichrodt et al. [5] and is summarized here. The skin and subcutaneous tissue cover the muscles of the ventral abdominal wall. The muscles of the ventrolateral abdominal wall are the external oblique, internal oblique, and transversus abdominis, which insert into the anterior and posterior sheaths of the rectus abdominis muscle (⊡ Fig. 19.1). The arterial blood supply of the skin comes mainly from the intercostal arteries and the perforating branches of the epigastric artery (⊡ Fig. 19.2). The innerva-
⊡ Fig. 19.1. Anatomy of the abdominal wall. The skin and subcutaneous tissue cover the muscles of the ventral abdominal wall. The muscles of the ventrolateral abdominal wall are the external oblique, internal oblique, and transversus abdominis, which insert into the anterior and posterior sheaths of the rectus abdominis muscle. The aponeurosis of the external oblique muscle forms the anterior rectus sheath. The internal oblique aponeurosis divides into an anterior and posterior
part. The anterior part forms the anterior layer of the rectus sheath, together with the external oblique muscle. The posterior part fuses with the transversus abdominis, forming the posterior rectus sheath, superior to the linea semilunaris. The neurovascular bundle runs between the internal oblique and transversus abdominis muscle and penetrates the posterior rectus sheath at the posterolateral side. (Reproduced with permission from Bleichrodt et al. [5])
Anatomy
145 Chapter 19 · Components Separation Technique: Pros and Cons
19
⊡ Fig. 19.2. Blood supply of the skin and muscles of the ventral abdominal wall. The blood supply of the ventral abdominal wall stems mainly from the epigastric and intercostal arteries. The skin of the ventral abdominal wall is supplied by the (a) periumbilical musculocutaneous perforators of the (b) superior and (c) inferior epigastric arteries and the (d)
intercostal arteries, but also by branches of the superficial epigastric artery and the superficial circumflex iliac and external pudendal arteries (c). The blood supply of the muscular layers of the abdominal wall stems from the (e) superior and (f) inferior epigastric arteries, together with the intercostal arteries (g). (Reproduced with permission from Bleichrodt et al. [5])
tion of the anterolateral ventral abdominal wall is shown in ⊡ Fig. 19.3. The muscles are innervated by the 7th–12th intercostal nerves and the iliohypogastric and ilioinguinal nerves.
abdomen, 7–10 cm at the waistline, and 1–3 cm in the lower abdomen. A further gain of 2–4 cm can be achieved by separating the posterior sheath of the rectus abdominis muscle. The abdominal wall is closed in the midline with a running suture of a nonabsorbable or slowly absorbable suture material. Suction drains are placed subcutaneously, and the subcutis and skin are closed. Defects of up to 28 cm in the waistline can be bridged in this way. After closure of the linea alba, the external oblique muscle and the posterior rectus sheath are retracted laterally.
Components Separation Technique (⊡ Fig. 19.3a–e)
The skin and subcutaneous fat are dissected free from the anterior rectus sheath and the aponeurosis of the external oblique muscle. By doing this, the perforating branches of the epigastric artery are transected. The aponeurosis of the external oblique muscle is incised 1–2 cm lateral to the lateral border of the rectus abdominis muscle. The myoaponeurosis of the external oblique muscle is transected longitudinally over its full length. Transection includes the muscular part of the external oblique muscle on the thoracic wall. With this extension, the rectus abdominis muscle can be maximally shifted medially in the upper abdomen. The external oblique muscle is separated from the internal oblique muscle in the avascular plane between both muscles. With this technique, the rectus muscle can be advanced 3–5 cm in the upper
Overall Results The results of CST up to 2007 were reviewed by de Vries Reilingh et al. [8]. Operative technique, complications, and recurrence rates were the main points of interest. As of 2007, 15 series had been published on the results of abdominal wall repair using CST: one randomized controlled trial and 14 retrospective series. The technique varied among the studies. In all studies, transection of the external oblique muscle was performed; in six, a release of the posterior rectus sheath was carried out as
146
19
Chapter 19 · Components Separation Technique: Pros and Cons
⊡ Fig. 19.3. The neurovascular bundle in relation to the abdominal wall musculature. The muscles of the anterolateral ventral abdominal wall are innervated by the 7th–12th intercostal nerves and the iliohypogastric and ilioinguinal nerves. The nerves (a) run forward together with the accompanying arteries and veins between the internal oblique (b) and the transversus abdominis (c) muscle. Branches are supplied to the muscle and the overlying skin (d). The segmental neu-
rovascular bundles penetrate the internal oblique contribution to the posterior rectus sheath at the posterolateral side to supply the rectus muscle (g) and the overlying skin. The neurovascular bundles enter the rectus sheath close to the axis of the epigastric arteries, about 10–25 mm medially from the lateral border of the rectus sheath (e). (Reproduced with permission from Bleichrodt et al. [5])
well. Two studies described an extension of the original technique [6, 7]: a release of the anterior rectus sheath in one series and transection of the transverse abdominal muscle in selected patients. In three series, incidental prosthetic onlay mesh support was used. The overall quality of the studies was moderate according to the MINORS criteria. One prospective randomized trial comparing CST and prosthetic repair was performed, having a MINORS index of 12. Fourteen retrospective series including 460 patients were published, with a mean MINORS index of 7 (range 3–8). Eleven retrospective studies with a MINORS index ≥5 were pooled with the 19 patients in the randomized controlled trial, giving a total of 479 patients [9–20]. Overall mortality was 1.2% (three out of 248 patients in seven series). Wound complications were observed in 12 series that included 354 patients. Wound complications were found in 23.8% [95% confidence interval (CI) 18.3–29.8]. Wound
infection was the most common complication, found in 18.9% (95% CI 14.9–23.2); seroma in 2.4% (95% CI 1.0–4.2); hematoma in 2.4% (95% CI 1.0–4.2); and skin necrosis in 1.5% (95% CI 0.5–3.1). A follow-up period of at least 1 year after operation was reported in five series that included 134 patients; 27 patients (18.2%; 95% CI 5.4–36.2) had a recurrent hernia.
Sequelae and Prevention Hematoma, Seroma, and Wound Infection When performing CST, a very large subcutaneous wound surface, approaching 1,000 cm2, is created, extending from the thorax to the inguinal region and in the lateral direction to the midaxillary line on both sides. Hematoma (2.4%), seroma (2.4%), infection (18.9%), and skin necrosis are the most
147 Chapter 19 · Components Separation Technique: Pros and Cons
frequent complications and account for 23.8% of postoperative complications. Hematomas can be prevented by meticulous hemostasis. Seroma formation is much more difficult to prevent. The inflammatory response, which is part of the wound healing process, creates an exudate between the fascia and the subcutaneous fat layer. Many techniques such as vacuum drains, subcutaneous sutures, fibrin glue, and compression bandages are insufficient. Most seromas are asymptomatic and will disappear within 3–6 months. Some seromas become very large and endanger the wound healing process in the early phase. If not drained properly, these seromas will drain spontaneously through the skin incision, with the risk of secondary infection. Chronic seromas can be successfully punctured, and surgery is seldom required. Many CST procedures are performed under contaminated conditions, which may explain the relatively high wound infection rate. CST is often performed in the presence of wounds, enterostomies, and even bowel fistulas. Providing adequate antibiotic prophylaxis, diminishing the dissection subcutaneously, and sparing the perforating epigastric arteries may all contribute to a better result.
Skin Necrosis The blood supply of the ventral abdominal wall stems mainly from the epigastric and intercostal arteries. Transection of the epigastric perforating arteries endangers the blood supply of the skin of the ventral abdominal wall. Especially in patients in whom the intercostal arteries have been transected–such as in patients with enterotomies or laparotomies via transverse incisions– ischemia or even skin necrosis may occur. Skin necrosis has been observed in 1.5% of patients in the literature. Necrosis is mainly located in the infraumbilical region in the midline. This complication can be prevented by sparing the periumbilical epigastric perforators. In our series of patients, 5% suffered skin necrosis when the classical technique was performed. Skin necrosis did not occur in any of the patients in whom the perforating arteries were spared. In our series,
19
skin necrosis occurred in all patients who were on chronic hemodialysis.
Bulging and Abdominal Wall Rupture Bulging of the abdominal wall at the side of the relaxing incisions in the external oblique myoaponeurosis may be a cosmetic problem in patients with a thin subcutaneous fat layer. Because the cosmesis of the abdominal wall improves considerably after CST and because most patients have a prominent subcutaneous fat layer, the vast majority of patients do not complain about the distinct swelling on the lateral side of the rectus abdominis muscle. Rupture of the abdominal wall at the side of the relaxing incision is, however, a very serious complication of the technique, causing damage to the neurovascular bundle, including the intercostal nerves, which results in paralysis of at least the rectus abdominis muscle. Since 2000 we have encountered three patients (<1%) with an abdominal wall rupture at the site of incision in the external oblique muscle. In one of those patients, the rupture occurred during operation and was repaired with mesh immediately. In the second patient, the rupture occurred the day after surgery and was repaired with a mesh as well. In the third patient, bilateral ruptures occurred 1 h and 1 week after the initial operation, respectively (⊡ Fig. 19.4). The hernia was repaired by primary closure and a sublay mesh. In two of the three patients, no herniation had occurred after 1 and 6 years, respectively. In the patient with an abdominal wall rupture on both sides, the reconstruction on the left side, which was performed 6 days after the index operation, was complicated by infection and herniation. Definitive repair was done 1 year later. The cause of rupture is unknown. It is essential to properly identify the plane between the internal and external oblique muscles. Accidental transection of the internal oblique muscle may result in an abdominal wall rupture because the transversus abdominis muscle is too weak to resist the intraabdominal pressure. Some surgeons advocate an onlay mesh support to prevent recurrent hernias or abdominal wall rupture [22].
148
19
Chapter 19 · Components Separation Technique: Pros and Cons
⊡ Fig. 19.4. Components separation technique. The patient is placed in a supine position. The skin is opened via a midline incision. If a skin defect exists or if the intestine is covered with a split-thickness skin graft, the abdominal cavity is entered via an incision just lateral to the defect. The intestine and other viscera are dissected free from the ventral abdominal wall. By doing this, the lateral border of the rectus abdominal muscle can be identified properly from the inside of the abdomen. a The skin and subcutaneous fat are dissected free from the anterior rectus sheath and the aponeurosis of the external oblique muscle to about 5 cm lateral to the lateral border of the rectus sheath. Mobilization includes transection of the epigastric perforators endangering the blood supply of the skin. b The aponeurosis of the external oblique muscle is incised 1–2 cm lateral to the lateral border of the rectus abdominis muscle. The myoaponeurosis of the external oblique muscle is transected longitudinally over its full length. Transection includes the muscular part of the external oblique muscle on the thoracic wall that extends at least 7–10 cm cranially.
c The external oblique muscle is separated from the internal oblique muscle in the avascular plane between both muscles, superiorly to the midaxillary line. Mobilization is essential because the fibrous interconnections between both muscles prevent optimal medial shift of the rectus abdominis muscle. d A further gain of 2–4 cm can be achieved by separating the posterior sheath of the rectus abdominis muscle. The posterior sheath is incised posteriorly, near the midline over its full length. The rectus abdominis muscle can easily be separated from the posterior rectus sheath. e Attention must be paid to not damage the neurovascular bundle laterally. Note the entrance of the neurovascular bundle that penetrates the fascia of the internal oblique muscle at a variable distance from the lateral border of the rectus abdominis muscle, near the axis of the epigastric artery. Damage to the neurovascular bundle results in denervation of the rectus abdominis muscle. The abdominal wall is closed in the midline with a running suture of a nonabsorbable or slowly absorbable suture material (after Bleichrodt et al. [5])
Nerve Damage
between the internal oblique and the transversus abdominis muscle, and branches are given to each muscle and the overlying skin. After CST, all patients have hyposensibility of the ventral abdominal wall skin as a result of transection of the sensory nerves. Denervation of the muscles of the ventral
The muscles of the anterolateral ventral abdominal wall are innervated by the 7th–12th intercostal nerves and the iliohypogastric and ilioinguinal nerves (⊡ Fig. 19.3). The nerves run forward together with the accompanying arteries and veins
149 Chapter 19 · Components Separation Technique: Pros and Cons
a
19
abdominal wall occurs less frequently. Damage to the nerves that innervate the rectus abdominis muscle may occur after accidental transection. This may occur when dissection is performed in the wrong plane between the internal oblique muscle and the transverse abdominis muscle, but also at the entrance of the nerves into the rectus sheath at the posterolateral side of the rectus sheath. After CST, some patients have radiating pain in the ventral abdominal wall for 6–12 months postoperatively. The cause of this pain is unknown. Stretching of the nerves may be one explanation.
Reherniation
b
c
⊡ Fig. 19.5. Rupture of the abdominal wall at the site of the relaxing incision in the myoaponeurosis of the external oblique muscle. a Swelling of the abdominal wall that occurred within 1 h of repair using the components separation technique. b At operation, a complete rupture of the abdominal wall musculature was found at the lateral border of the rectus abdominis muscle. c Note that the neurovascular bundle is damaged as well, resulting in (partial) denervation of the abdominal wall musculature (adapted from de Vries Reilingh and Bleichrodt [21] with permission)
Reherniation after CST is rather frequent. After a follow-up of at least 1 year, 18.2% had a recurrent hernia. This percentage is probably actually higher and approaches the results of suture repair. Most recurrences are located in the upper abdomen and are small. Modifying the CST technique may reduce the incidence of reherniation. Tension-free repair can be achieved in most patients when complete transection of the external oblique myoaponeurosis is performed, including mobilizing the rectus abdominis muscle from the thoracic wall. Recurrences can be repaired laparoscopically in most cases. Recurrence rates in hernia surgery are lower after mesh repair. This may be the case in CST as well [21]. Placement of a mesh is simple when the posterior sheath of the rectus abdominis muscle can be closed primarily; then the mesh can be positioned between the posterior rectus sheath and the rectus abdominis muscle (⊡ Fig. 19.6a). When the posterior sheath cannot be closed, the gap in the posterior rectus sheath is bridged with a mesh, preferably with an antiadhesive layer against adhesions, such as Proceed mesh or Sepramesh (⊡ Fig. 19.6b). The anterior sheath and rectus abdominis muscles are then closed primarily and cover the mesh. In 2006, a randomized controlled trial was initiated to determine whether a preperitoneal retromuscular mesh in combination with CST lowers recurrence rates. Kingsnorth et al. [22] combine CST with onlay
150
Chapter 19 · Components Separation Technique: Pros and Cons
a
reherniation rate is still high but may be decreased by combining CST and mesh repair.
References b
⊡ Fig. 19.6. Combined components separation technique and prosthetic repair following the Stoppa–Reeves technique. a The mesh is positioned preperitoneally to separate the intestine from the mesh and is covered by the rectus abdominis muscle. b When the posterior rectus sheath cannot be closed primarily, the gap is bridged by a double-layered mesh that protects the intestine from contact with the mesh
mesh repair. They report low complication and recurrence rates.
The Remaining Fascial Gap In approximately 7% of patients, the fascia cannot be closed in the midline. Further research is needed to identify those patients in whom the abdominal wall cannot be closed primarily. If primary closure is not possible, the fascial gap is bridged with a mesh under clean or clean-contaminated conditions. Otherwise, repair with the use of autologous tissue such as free or pedicled fascia flaps is performed.
Conclusion
19
CST is an attractive technique for abdominal wall reconstruction in patients with large midline hernias, especially in a contaminated field. The technique restores the anatomy of the abdominal wall and has good cosmetic results. Postoperative complications are rather frequent. Morbidity may be decreased by sparing the epigastric perforating arteries and diminishing the wound surface. The
1. Basoglu M, Yildirgan MI, Yilmaz I, et al. Late complications of incisional hernias following prosthetic mesh repair. Acta Chir Belg 2004; 104:425–428 2. Burger JW, Luijendijk RW, Hop WC, et al. Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 2004; 240:578– 585 3. Bleichrodt RP, Simmermacher RK, van der Lei B, Schakenraad JM. Expanded polytetrafluoroethylene patch versus polypropylene mesh for the repair of contaminated defects of the abdominal wall. Surg Gynecol Obstet 1993; 176:18–24 4. Ramirez OM, Ruas E, Dellon AL. »Components separation« method for closure of abdominal-wall defects: an anatomic and clinical study. Plast Reconstr Surg 1990; 86:519–526 5. Bleichrodt RP, de Vries Reilingh TS, Malyar AW, et al. Component separation technique to repair large midline hernias. Op Tech Gen Surg 2004; 6:179–188 6. Maas SM, van Engeland M, Leeksma NG, Bleichrodt RP. A modification of the »components separation« technique for closure of abdominal wall defects in the presence of an enterostomy. J Am Coll Surg 1999; 189:138–140 7. Maas SM, de Vries Reilingh S, van Goor H, de Jong D, Bleichrodt RP. Endoscopically assisted »components separation technique« for the repair of complicated ventral hernias. J Am Coll Surg 2002; 194:388–390 8. de Vries Reilingh TS, Bodegom ME, van Goor H, et al. Autologous tissue repair of large abdominal wall defects. Br J Surg 2007; 94:791–803 9. de Vries Reilingh TS, van Goor H, Charbon J, et al. Repair of large midline abdominal wall hernias: components separation technique versus prosthetic repair. World J Surg 2007; 31:756–763 10. de Vries Reilingh TS, van Goor H, Rosman C, et al. »Components separation technique« for the repair of large abdominal wall hernias. J Am Coll Surg 2003; 196:32–37 11. Ewart CJ, Lankford AB, Gamboa MG. Successful closure of abdominal wall hernias using the components separation technique. Ann Plast Surg 2003; 50:269–273 12. Cohen M, Morales R Jr, Fildes J, Barrett J. Staged reconstruction after gunshot wounds to the abdomen. Plast Reconstr Surg 2001; 108:83–92 13. Jernigan TW, Fabian TC, Croce MA, et al. Staged management of giant abdominal wall defects: acute and longterm results. Ann Surg 2003; 238:349–355 14. Lowe JB III, Lowe JB, Baty JD, Garza JR. Risks associated with »components separation« for closure of complex abdominal wall defects. Plast Reconstr Surg 2003; 111:1276–1283
151 Chapter 19 · Components Separation Technique: Pros and Cons
15. Shestak KC, Edington HJ, Johnson RR. The separation of anatomic components technique for the reconstruction of massive midline abdominal wall defects: anatomy, surgical technique, applications, and limitations revisited. Plast Reconstr Surg 2000;105: 731–738 16. Szczerba SR, Dumanian GA. Definitive surgical treatment of infected or exposed ventral hernia mesh. Ann Surg 2003; 237:437–441 17. Vargo D. Component separation in the management of the difficult abdominal wall. Am J Surg 2004; 188:633– 637 18. DiBello JN Jr, Moore JH Jr. Sliding myofascial flap of the rectus abdominis muscles for the closure of recurrent ventral hernias. Plast Reconstr Surg 1996; 98:464–469 19. van Geffen HJ, Simmermacher RK, van Vroonhoven TJ, van derWerken C. Surgical treatment of large contaminated abdominal wall defects. J Am Coll Surg 2005; 201:206–212 20. Girotto JA, Chiaramonte M, Menon NG, et al. Recalcitrant abdominal wall hernias: long-term superiority of autologous tissue repair. Plast Reconstr Surg 2003; 112:106–114 21. de Vries Reilingh TS, Bleichrodt RP. Reply. World J Surg 2007; 31:2267–2268 22. Kingsnorth AN, Shahid MK, Valliattu AJ, et al. Open onlay mesh repair for major abdominal wall hernias with selective use of components separation and fibrin sealant. World J Surg 2008; 32(1):26–30
Discussion Franz: Can you tell us which mesh you are using in
this randomized study? Bleichrodt: We are using the Vypro II mesh be-
cause the study was running for a few years and that was the best mesh at that moment. So we had to go on with the same mesh; otherwise, we would have a problem comparing results. Deysine: Do you use antibiotic irrigation? Bleichrodt: We use antibiotic prophylaxis in every patient, and if the operation is longer than 3 hours, we give it again. Mostly we irrigate the wound with normal saline to remove, for example, blood clots and so on, but we don’t add antibacterials. We don’t have proof that it helps.
19
Conclusion of Session II, by J. Kukleta We had a quite extensive session, which can be divided into three parts: who gets the infection, how to treat the infection, and how to prevent the infection. To me, we got some take-home massages: We have to differentiate between wound infections and mesh infections and between acute mesh infections and late-onset mesh infections. We have heard interesting stuff about wound oxygen and its impact on wound healing. We have heard about biofilms and learned that it’s more difficult to fight against existing biofilms than to prevent them. But it still seems to be a complex part. The impregnation of mesh materials seems to be a good idea, but we have to learn more about that, probably with different materials. I want to close with the following remarks. Decreasing the infection rates by only 3% means thousands and thousands of people, so I would not talk about the price of €15 for antibiotics. This is our position in Switzerland. For any kind of implants, we use antibiotic prophylaxis.
III
III
Risk for Pain
20
Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair: A Reflection of Both Individual Pain Propensity and Surgical Strategy – 155
21
Chronic Pain After Inguinal Hernia Repair – 163
22
What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain? – 169
23
Surgical Trauma of Nerves–Causes of Neuropathic Pain, Classification, and Options in Surgical Therapy – 177
24
Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves? – 185
25
What To Consider as Clinicians About Chronic Postoperative Pain and Inguinal Herniorrhaphy – 191
26
Risk Factors for Chronic Pain After Groin Hernia Surgery – 199
27
Ischemic Inflammatory Response Syndrome as an Alternative Explanation for Postherniorrhaphy Pain – 207
28
Postoperative CRPS in Inguinal Hernia Patients – 213
29
Chronic Pain After Open Mesh Repair of Incisional Hernia – 221
30
Clinical Results After Open Mesh Repair – 227
31
Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair – 233
32
Effect of Nerve Identification on the Rate of Postoperative Chronic Pain Following Inguinal Hernia Surgery – 239
33
Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair: A Report from the SMIL Study Group – 245
34
Recurrence or Complication: The Lesser of Two Evils? A Review of Patient-Reported Outcomes from the VA Hernia Trial – 251
35
Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique – 257
36
The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia – 265
37
Lightweight Macroporous Mesh vs. Standard Polypropylene Mesh in Lichtenstein Hernioplasty – 275
38
Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain? – 279
39
New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy Inguinodynia and Orchialgia – 287
40
Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both? – 293
41
Results of Tailored Therapy for Patients with Chronic Inguinal Pain – 299
20
Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair: A Reflection of Both Individual Pain Propensity and Surgical Strategy S. Smeds, L. Löfström, O. Eriksson, A. Kald
156
Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
Introduction Discomfort from normal tissue healing after inguinal hernia surgery will have largely subsided at 3 months. Continued discomfort is referred to as postherniorrhaphy pain syndromes, which have diverse origins with peripheral neuropathic and nonneuropathic sources [1, 2]. In addition to the peripheral surgical trauma, pain perception is based on central nervous modulation of pain transmission. This may be influenced by age [3, 4] and other biological pain modulators [5, 6]. Expression of pain and discomfort may further be influenced by socioeconomic factors [7]. Finally, verbal eloquence and the ability to interpret assessment scales may influence final answers on self-assessment (SA) instruments. Thus, in addition to the variety of methods for inguinal herniorrhaphy, each inflicting a varying degree of peripheral tissue and nerve trauma, the variability of a number of biological and social factors possibly adds to variability in SA records. It was therefore deemed important to closely analyse the SA pattern 3 months after hernia repair. The clinic’s register gives further information on the preoperative self-assessed level of groin discomfort. This gives us an opportunity to study the degree of improvement (and impairment) following different types of repair at a point when a postoperative pain syndrome, by definition, starts.
Materials and Methods The Sergel Clinic is responsible for inguinal hernia surgery of all inhabitants in the central part of the county of Östergötland, Sweden, with a catch area of 228,000 inhabitants. The patient population covers all primary and recurrent groin hernias among elective patients older than 18 years of both genders and of American Society of Anesthesiologists (ASA) grades I–III. Since February 2004, preoperative and postoperative self-assessed levels of groin discomfort/pain have been recorded by intent by each patient.
20
Self-Assessment Instrument: Sergel Recovery Scale Self-assessment of preoperative groin problems was requested at patients’ first admission to the surgical clinic 1–4 weeks before surgery, and SA of postoperative discomfort related to the inguinal hernia repair was requested 3 months after the operation. The preoperative SA questionnaire was given before surgery in conjunction with the preoperative
⊡ Table 20.1. The lower part of column A represents the self-assessment (SA) levels (1–10) in the SA scale. The »preop« and »postop« columns give the number of patients in each SA level before and after the operation. Column B shows the number of patients whose preoperative to postoperative SAs changed by the number of steps indicated in column A. The maximum number of steps in the scale that can be registered is 9, i.e. from level 1 to level 10. This table is automatically updated when the quality follow-up database program is opened A
Preop
Postop
B
-9
0
-8
0
-7
0
-6
0
-5
1
-4
0
-3
1
-2
2
-1
5
0
29
1
36
0
49
2
55
2
65
3
112
1
63
4
82
2
68
5
69
4
75
6
72
9
81
7
50
19
74
8
53
65
33
9
43
134
29
10
10
363
SUM
582
599
575
157 Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
⊡ Table 20.2. Means and medians for preoperative and postoperative self-assessment (SA) 3 months after open hernia repair (level 10 denotes no discomfort). Fractions of patients rating themselves at level 8 and higher before and after surgery are indicated. The difference indicates the mean number of levels that the patients changed their rating from their preoperative to their postoperative SA Preop
Postop
Difference
Mean
4.877622
9.292020
4.397163
Median
5
10
5
Fraction>=8
18.2%
93.7%
an additional table showing the relative number of patients assessing themselves at levels 8–10 (⊡ Table 20.2). Those with postoperative SA at levels 7 and below were offered clinical follow-up. To analyse the validity of data collected from the primary answers, a second request for postoperative SA was sent 4–6 months after surgery to 55 patients who did not answer the first questionnaire. Analysis of difference by ordinal logistic regression showed no difference between the two groups (⊡ Fig. 20.2).
Primary and secondary self-assessment answers 10-log rel number of answers at each level
health report in the reception area, without contact with the surgeon. The postoperative SA questionnaire was given to the patient at the time of release from the clinic, with information to send it back 3 months later. The instrument consists of a visual 10-box scale in which SA level 10 represents no discomfort and level 1 represents the worst pain. A secretary routinely saved patients’ SA registrations into a database. When opened, the database automatically displayed updated information in a table, showing the number of patients at each level as registered before and 3 months after surgery as well as further numbers of patients who had moved an individually calculated number of steps in positive (improved) and negative (impaired) directions on the scale (⊡ Table 20.1). Furthermore, the updated preoperative and postoperative information was presented in two histograms (⊡ Fig. 20.1) and in
20
2
1.6
Primary answer N=599
1.2
y = 0.415x - 2.365 R 2 = 0.9906
0.8 Secondary answer N=55 y = 0.468x - 2.843 R 2 = 0.9119
0.4
0 1
2
3
4
5
6
7
8
9 10 11
Assessment levels
⊡ Fig. 20.2. Diagram demonstrating the similarity between the postoperative ratings from patients without reminders (primary answers, squares) and the ratings from patients after a reminder 1 month later (secondary answers, diamonds) at 4 months. The difference as analysed by logarithmic regression was not statistically significant. Data are presented as 10-logaritms of the relative number of patients at self-assessment levels 7–10
400 350 300 250 Preop
200
Postop
150 100 50 0 1
2
3
4
5
6
7
8
9
10
⊡ Fig. 20.1. Distribution of patients on the 10-level box scale in which 1 denotes the worst imaginable pain and 10 denotes no discomfort. White bars represent preoperative self-assessments 1–4 weeks before surgery (n=582), and black bars represent the postoperative rating 3 months after open hernia repair (n=599)
158
Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
Patients
Statistical Methods
During the years 2004–2006, 1,439 hernias in 1,369 patients with unilateral and bilateral (8% of case series) inguinal hernias were operated upon. The operations were almost exclusively performed as day surgery under general anaesthesia. Anaesthesia was induced and maintained with propofol and remifentanil. Ventilation was controlled with a laryngeal mask. One surgeon performed 92% of the operations, and 10 consultants performed the additional 109 operations. Preoperative SA was obtained from all patients except for a few with mental disorders. All male, female (8.4%), and recurrent (6.1%) inguinal hernia patients were included in the register. The report is based on 562 patients who, without notice, returned their 3-month SA (41%). Missing data necessary for comparing preoperative and postoperative ratings were noted in 21 cases. Mesh procedures dominated in primary inguinal hernia surgery (77%). Single-plug procedures (12.8%) were restricted to small medial herniations with a well-defined hernia neck (low Spigeli herniation). A combination of plug and mesh was used in Nyhus IIIb hernias with large defects at the internal orifice and in large sliding hernias. In total, prostheses were used in 484 cases (89%). Suture reinforcement of the inner inguinal orifice (annulorraphy) with additional strengthening of the dorsal wall (11%) was used in young individuals, including fertile females, in whom sutures towards the inguinal ligament aligned with the strong internal oblique muscle. Calculations are based on 484 and 57 cases with prosthesis and suture repair, respectively.
Data are presented as means with standard deviation. For continuous data, Student’s t-test was used. Two-tailed probability of less than 5% (pvalue <0.05) was considered statistically significant. Differences in ordinal data in the 10-box SA scale were analysed with ordinal logistic regression (Minitab 15 software).
Results Self-Assessment in the Register Information Distributions of SA levels prior to surgery and 3 months after the operation are shown in ⊡ Fig. 20.1. At 1–4 weeks before surgery, the distribution of patients on the scale shows a peak at level 3 with a mean at level 4.9 (⊡ Table 20.2). Ten patients (1.7%) had no pain before surgery, and 36 (6.2%) registered the worst imaginable pain (⊡ Table 20.1). At 3 months after surgery, the mean SA level in the whole set of information was 9.3, and the mean number of improvement steps was 4.4 after the performed surgical procedures (⊡ Table 20.2). The distribution of improvement in the whole set of information is shown in ⊡ Table 20.1 and ⊡ Fig. 20.3. The majority of cases, 537 out of 575 (93.4%), changed in a positive direction on the SA scale. Twenty-nine patients (5%) had the same preoperative and postoperative SA level, mainly at levels 8–10. Nine cases were impaired (1.6%). The
n 90 80
20
⊡ Fig. 20.3. This diagram is based on column B in Table 20.1 and demonstrates the number of patients in relation to the number of steps in a positive or negative direction corresponding to the level of self-assessed improvement or impairment (-) between the preoperative and postoperative ratings. The y-axis shows the number of patients
70 60 50 40 30 20 10 0 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 Difference between pre- and postoperative SA
7
8
9
20
159 Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
relative number of patients who rated themselves without discomfort changed from 1.6% (n=10) preoperatively to 60.6% (n=363) postoperatively.
Improvement with Regard to Gender and Type of Repair
Only in sutured repair were no postoperative discomfort registrations below level 7 observed. In other subgroups–i.e. all unilateral and bilateral cases, all male and female cases, and prosthesis cases–assessments lower than 7 were found (⊡ Figs. 20.4 and 20.5).
There was no significant difference in mean improvement levels between suture and prosthesis repair, in male versus female patients, or in unilateral versus bilateral cases (⊡ Table 20.3). Bilateral suture repair (performed in men only) showed the lowest improvement, 2.83±2.13 steps on the scale, whereas the largest step was observed in unilateral suture repair, 4.76±2.50 (⊡ Table 20.3).
Postoperative SA Distribution Slope
35
350
30
The relationship between the number of patients and the degree of discomfort as reported at 3 months appeared to form a slope that might fit an exponential function (⊡ Fig. 20.6). To test this, the total number of cases at each SA level in the 10-box SA scale was transformed to a relative
300
Female patients
25
Male patients
250
20
Preop
200
Preop
15
Postop
150
Postop
10
100
5
50
0
0
1
2
3
4
5
6
7
8
9 10
1
2
3
4
5
6
7
8
9 10
⊡ Fig. 20.4. Distribution of preoperative and postoperative self-assessment among female and male patients. There was no difference as calculated with ordinal logistic regression, p=0.884
350
40 35
300
Suture repair
30
Prosthesis repair 250
25 20 15
Preop
200
Preop
Postop
150
Postop
10
100
5
50
0 1
2
3
4
5
6
7
8
9 10
0
1
2
3
4
5
6
7
8
9 10
⊡ Fig. 20.5. Distribution of preoperative and postoperative self-assessment after suture and prosthesis repair, respectively. There was no significant difference as calculated with ordinal logistic regression, p=0.099. Note the presence of cases in the lower part of the scale after prosthesis repair compared with suture repair, for which no postoperative registration lower than level 7 was found
160
Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
⊡ Table 20.3. Mean (standard deviation, number) improvement steps in the 10-box self-assessment scale 3 months after open inguinal hernia surgery following suture or prosthetic repair, respectively. There was no significant difference between the improvement steps as calculated from the register data, nor between genders, nor between types of repair. Bilateral suture repair (in males only) showed the lowest mean improvement level, 2.83 steps, but showed no significant difference compared with unilateral suture repair, p=0.12, or bilateral prosthesis repair, p=0.19
Unilateral
Bilateral
Gender
Suture repair
Prostheses
Female
4.21±2.34 (n=24)
3.95±2.01 (n=23)
Male
4.76±2.50 (n=27)
4.43±2.60 (n=420)
Male
2.83±2.13 (n=6)
4.31±2.57 (n=41)
All inguinal hernia operations 2004-2006 390 363 340
Number of patients
290 240 190 140
134
90 65 40
⊡ Fig. 20.6. Number of patients at each self-assessment level on the 10level scale
1
All inguinal hernia operations 2004-2006 1.9
10-log rel number at each self assessment level
1.7 1.5
2
1 3
2
4
9
4 5 6 7 Self-assessment levels
19 8
9
10
number (percent) followed by calculation of the 10-logarithm of the relative number. The 10-logarithms were correlated to corresponding assessment levels in a diagram, and a straight line was formed, R2=0.9948 (⊡ Fig. 20.7).
1.3 1.1 0.9
y = 0.406x - 2.284 2 R = 0.9946
Discussion
2
Analyses of the register data create hypotheses rather than answering them. In contrast to randomised studies, however, they reflect the whole case mix. In routine clinical quality control on the basis of postal follow-up, only a fraction of the patients can be expected to return the first questionnaire. This is a weakness that can be defended only by a large number of cases and analysis of answers after a second request. Results of such analysis in the present paper indicate a close similarity between first and second answers. It can therefore be
0.7 0.5 0.3 0.1 -0.1 0
4
6
8
10
Self-assessment level
20
2
0
-10
⊡ Fig. 20.7. Relationship between 10-log of the relative number of cases in each self-assessment (SA) level and the corresponding SA level. A straight line with R2 =0.9948 indicates a strong correlation
161 Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
20
wards the surgical trauma. This variation among the surgical patients probably includes both varying inflammatory reaction to the surgical trauma and prostheses, when present, as well as genetically determined variation in sensitisation mechanisms [9]. The gender similarity indicates a common genetic variation of pain propensity between the sexes. There was no significant difference in the number of improvement steps after prostheses placement or suture hernia repair. This indicates that pain reaction to the surgical trauma seems to be a stronger pain determinant than the additional presence of a prosthesis. This is in concordance with previous observations in young males [10]. It was observed, however, that after suture repair, no patient indicated more discomfort than that associated with level 7 on the scale, in contrast to a number of patients receiving prostheses who rated themselves as having stronger pain. The number of cases with this important qualitative difference in their postoperative SA is probably too low to create a significant difference between the latter groups. Only a minor number of the 40% of patients who indicated some discomfort had a stronger pain reaction. Most of them indicated light discomfort at levels 9 and 8 at 3 months. One hypothesis raised after these observations is that the part of the scale that covers levels 7–10 may represent individual variation in sensitivity to the surgical trauma. The strict exponential distribution in the patient population of pain assessment in this part of the scale may support this interpretation. Patients with SA levels in the lower part of the scale,
assumed that the collected register data are representative for the register population. There was a distinct difference in the distribution of SA levels in the preoperative scale compared with postoperative ratings. The preoperative assessments were rather evenly distributed along the scale, with relatively low frequency at the extremes and with a more pronounced peak at level 3. The centre of the scale, level 5, divided the preoperative assessments into two equal parts. Only 10 out of 582 patients, 1.7%, reported no discomfort prior to surgery. This indicates that pain in addition to the inguinal herniation is a significant problem for the patient. In contrast, the postoperative ratings formed a linear-curve distribution along the scale. The slope was strictly fitted to an exponentially defined function, with approximately 60% of the cases reporting no discomfort, i.e. level 10 at 3 months. The remaining number of patients with slight discomfort to severe pain (approximately 40%) is similar to that observed in a Scottish study in which 43% had mild and 3% severe pain at 3 months [8]. The contrast between preoperative and postoperative SA levels (⊡ Fig. 20.8) reflects the wide variation of self-assessed discomfort/pain in a nonrandomised register group as compared with the intention-to-treat situation following a highly standardised surgical treatment. If one assumes only minute variations in surgical performance of the Lichtenstein repair as performed by one surgeon in several hundreds of patients, the observed SA slope in the scale may primarily be explained by individual variation in reaction patterns to-
Mean of postoperative selfassessment
10 9.8 9.6 9.4 9.2 9 8.8 8.6 8.4 1
2
3
4
5
6
7
Preoperative self-assessment
8
9
10
⊡ Fig. 20.8. Diagram demonstrating the gradual reduction in postoperative assessment of pain/discomfort (mean) in relation to preoperative selfassessment. Level 10 denotes no discomfort
162
Chapter 20 · Self-Assessment of Discomfort and Pain after Inguinal Hernia Repair
levels 1– 6, additionally expressed the presence of a stronger pain component associated with the use of mesh or plug prostheses, as observed in the present register. To reach a closer understanding of these possibly diverse pain mechanisms, the variation of discomfort/pain must be analysed over a longer time frame.
References 1. Mikkelsen T, Werner MU, Lassen B, Kehlet H (2004) Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg 99:146–151 2. Massaron S, Bona S, Fumagalli U, Battafarano F, Elmore U, Rosati R (2007) Analysis of post-surgical pain after inguinal hernia repair: a prospective study of 1,440 operations. Hernia 11:517–525 3. Ringkamp M, R Meyer (2006) Does peripheral sensitization of primary afferents play a role in neuropathic pain? In: Campbell JN, et al. (eds) Emerging strategies for the treatment of neuropathic pain. IASP Press, Seattle, pp 8–102 4. Matthews RD, Anthony T, Kim LT, Wang J, Fitzgibbons RJ Jr, Giobbie-Hurder A, Reda DJ, Itani KM, Neumayer LA; Veterans Affairs Cooperative 456 Studies Program Investigators (2007) Factors associated with postoperative complications and hernia recurrence for patients undergoing inguinal hernia repair: a report from the VA Cooperative Hernia Study Group. Am J Surg 194:611–617 5. Gordh T, Chu H, Sharma HS (2006) Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain 124:211–221 6. Tegeder I, Costigan M, Griffin RS, et al. (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12:1269–1277 7. Salcedo-Wasicek MC, Thirlby RC (1995) Postoperative course after inguinal herniorrhaphy. A case-controlled comparison of patients receiving workers’ compensation vs patients with commercial insurance. Arch Surg 130:29–32 8. Courtney CA, Duffy K, Serpell MG, O’Dwyer PJ (2002) Outcome of patients with severe chronic pain following repair of groin hernia. Br J Surg 89:1310–1314 9. Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lötsch J (2008) Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 12:1069–1077 10. Bay-Nielsen M, Nilsson E, Nordin P, Kehlet H; Swedish Hernia Data Base; the Danish Hernia Data Base (2004) Chronic pain after open mesh and sutured repair of indirect inguinal hernia in young males. Br J Surg 91:1372–1376
20
Discussion Kehlet: You suggested that there was a difference
in pain compliance comparing mesh repair and suture repair. You may remember that we have collaboration between the Danish and Swedish Hernia Data base with a very detailed questionnaire that also compared young male who are at highest risk with Shouldice repair and Lichtenstein repair. And in 2000 patients there were no differences between this two techniques regarding chronic inguinal pain. Smeds: I think that there is no difference for the majority of patients. But in this database there were only a few patients who have had mesh repair. I think that in case of suture repair the patients have had comparable postoperative pain in general. Only some of them have had more pain, what may be related to a nerve lesion. Hopf: Have you investigated whether there is a difference regarding postoperative pain comparing local to general anesthesia? Did any of the patients get ketamin, because there are some data that suggested that patients who get ketamin are of high risk to develop postoperative pain. Smeds: All patients were operated using local anesthesia. And we never used ketamin in our patients. Schumpelick: In my opinion your main message is, that you have a relation of age and pain. Why is it so? Is it because of the nerve function? Is it the tolerance to pain? Is it experience of the patients? Smeds: We have to listen to those colleagues who are working on the problem of dorsal ganglion routes. May be there are mutations in the gene that processes the enzyme that forms the tetrahydrobiopterine. This is the first hint that there may be a genetically determined level of pain. I think that we will get much more information about the process of pain, and I think that it is individually different. However, I think that the preoperative pain score is very important to identify those patients who are of high risk of developing postoperative pain.
21
Chronic Pain After Inguinal Hernia Repair H. Kehlet, E. K. Aasvang
164
Chapter 21 · Chronic Pain After Inguinal Hernia Repair
Introduction
Preop. pain intensity
21 There is now general agreement, based on data from randomised trials comparing different surgical techniques and larger amounts of epidemiological data, that chronic pain influencing daily activities may occur in 5–10% of patients [1–5]. Because little scientific data exist on evidence-based treatment of persistent postherniotomy pain, this undesirable outcome probably represents the most important one for improvement in groin hernia repair. The main focus for future research on the pathogenesis and treatment of chronic postherniotomy pain is the role of patient-related versus surgery-related factors [5] (⊡ Fig. 21.1). This report gives a short update on recent developments concerning the pathogenic mechanisms listed in ⊡ Fig. 21.1. Other factors such as age (decreased risk of chronic pain), female gender, and surgery for a recurrent hernia are other well-documented risk factors [3]; however, these cannot be altered.
Preoperative Pain The preoperative intensity of groin pain is a welldocumented risk factor for developing a persistent pain state [1, 3, 6] and corresponds to a similar documented risk following other surgeries [7]. Importantly, remote preoperative pain–i.e., pain in parts of the body other than the groin–has also been demonstrated to correlate with persistent pain, both in groin hernia repair [6, 8, 9] and other operations [7, 10]. These findings suggest that the preoperative functional level of the nociceptive system is an important risk factor, and several studies have shown a positive correlation between the pain response to a preoperative nociceptive stimulus (heat, electrical, cold) [7] and the acute postoperative pain response, which otherwise has been demonstrated to correlate with the risk of developing a persistent pain state [1, 7]. In summary, preoperative pain states and the level of nociceptive function are well documented as being important risk factors for developing a persistent pain state. They should therefore be included and assessed in all future pain trials, thereby providing possibilities for patient stratifi-
Genetics
Psyche
Acute postop. pain
Surgical trauma
Nerve injury
⊡ Fig. 21.1. Pathogenic mechanisms of persistent pain after groin hernia repair
cation into different risk groups when comparing different surgical techniques or pharmacological interventions.
Psychological Factors Preoperative anxiety and depression are wellknown characteristics of patients with chronic nonmalignant pain and have been demonstrated to be risk factors for acute pain states [7]. However, in pain after groin hernia repair, depression and anxiety were present in few (about 5%) patients [11] and may therefore not be considered important risk factors compared with other postsurgical persistent pain states in which malignancy, amputation, etc., may contribute to impaired psychosocial functioning. Nevertheless, preoperative assessment of anxiety and depression should be included in future high-level scientific studies on chronic postherniotomy pain.
Acute Postoperative Pain As mentioned above, in several operations, including groin hernia repair, a well-documented relationship exists between the intensity of the
165 Chapter 21 · Chronic Pain After Inguinal Hernia Repair
acute postoperative pain response and the risk of developing persistent pain [7]. For example, a large consecutive series with well-defined multimodal preemptive analgesia (including local anaesthesia, nonsteroidal anti-inflammatory drugs, and paracetamol) showed a threefold higher risk of chronic pain for patients with moderate to severe early postoperative pain compared to those with no or low-intensity acute postoperative pain [12]. Consequently, these and other findings [7] have led to the hypothesis that improved early postoperative pain treatment may reduce the risk of chronic pain (the concept of preemptive analgesia). However, so far the data are negative [7] and instead seem to suggest that the acute postoperative pain response is determined by the preoperative function of the nociceptive system, and thereby also the risk of persistent pain. Nevertheless, there is a need for further randomised studies, with more effective and prolonged acute pain treatment, on the risk of developing a persistent pain state.
Nerve Injury A main pathogenic mechanism for persistent postsurgical pain states is intraoperative nerve injury [7]. Obviously, with the three nerves passing the surgical field in groin hernia repair, there is a significant risk of nerve injury. Several studies have previously reported numbness after groin hernia repair; unfortunately, these reports did not use well-described, specific assessments of sensory disturbances as a sign of nerve injury, thereby limiting interpretation. This also includes studies comparing laparoscopic versus open repairs. A recent detailed study using the gold standard quantitative sensory assessment (QST) [11] in patients with and without persistent groin hernia pain, including patients who had bilateral repair, demonstrated that persistent postoperative sensory dysfunctions had a very low specificity for chronic pain, indicating that nerve damage occurs often, even in patients without chronic pain. However, signs of neuroplasticity with more frequent and intense pain after repetitive punctuate and brush stimulation were observed only in chronic pain patients
21
[11]. These findings confirm that nerve damage may be a prerequisite for developing a persistent pain state after groin hernia repair. However, corresponding to findings from other surgical procedures [7], factors other than nerve damage, including genetic factors, may contribute to persistent pain (see below). All future studies on persistent pain after groin hernia repair should include preoperative and postoperative detailed neurophysiological assessment in order to evaluate the relative importance of different pathogenic mechanisms. This is especially important for all studies comparing different surgical techniques such as laparoscopic versus open repairs, type of mesh, fixation techniques, and so on.
Surgical Trauma As mentioned above, surgical injury to one or all of the three groin nerves may occur frequently, although all efforts should be made to identify and preserve these nerves, as discussed in other chapters in this book. Consequently, the surgical technique may be important for preventing or reducing a persistent pain state. However, so far the literature is not entirely conclusive regarding laparoscopic versus open repair, type of mesh (composition, lightweight versus heavyweight), and different fixation techniques. One reason may be that for each of these topics the other variables have not been well described, which especially applies to studies comparing laparoscopic and open repairs. Ideally, the risk of nerve injury should be reduced in laparoscopic repair without mesh fixation–but most reports have insufficiently described the fixation technique and its risk in terms of nerve injury. Prospective ongoing studies that include all risk factors (preoperative, intraoperative, and postoperative) in collaboration with Copenhagen and Stuttgart and with detailed QST assessments have completed patient inclusion and 6 months of follow-up. It is hoped that the data will be able to clarify the effects of high-expertise laparoscopic repair without mesh fixation versus high-expertise open Lichtenstein repair.
166
21
Chapter 21 · Chronic Pain After Inguinal Hernia Repair
In summary, there is no doubt that the surgical technique is important for avoiding the risk of nerve damage, especially when mesh may cause compression of the nerves [13, 14]. Future trials are called for, and they need to include high-quality assessment of the signs of nerve damage when comparing different techniques.
Genetic Factors Based on the findings from a variety of surgical procedures, only a fraction of patients with documented intraoperative nerve injury develop a persistent pain state [7, 11]. Recent studies with genotype characterisation have suggested that COMT genes are important for pain sensitivity [15] and that GTP-cyclohydrolase regulates pain sensitivity in normal subjects and pain-related outcomes after spinal surgery [16]. Genes controlling the function of the voltage-gated sodium channel are also important [15]. Although this is a developing field of pain research, all future high-level scientific studies on persistent groin hernia pain should include characterisation of the genetic architecture of pain perception to provide further understanding of the mechanisms and risk factors for persistent groin hernia pain. Unfortunately, no data are available so far.
Summary The pathogenic mechanisms of chronic pain after groin hernia repair are definitely of multifactorial origin [5], and previous efforts to classify the syndromes into neuropathic versus nonneuropathic (inflammatory) pain [17] may not be founded on clear-cut diagnostic criteria. Thus, nerve injury after groin hernia repair occurs very frequently but leads to a chronic pain state in only a fraction of patients. However, since nerve injury seems to be a prerequisite for developing persistent pain, all efforts should be made to develop and characterise surgical techniques to avoid peripheral nerve injury. It is hoped that future studies will include a complete characterisation of all pathogenic mechanisms–something that has not happened before
in the large number of studies with chronic pain as an outcome [5]. Such characterisation must also be included in future trials on pharmacological treatment [7] as well as in studies on surgical treatment with neurectomy and mesh removal [14] and where preliminary data with detailed neurophysiological characterisation and functional outcomes suggest such techniques to reduce chronic pain in some, but not all, patients [18].
References 1. Aasvang E, Kehlet H. Chronic postoperative pain: the case of inguinal herniorrhaphy. Br J Anaesth 2005; 95:69–76 2. Nienhuijs S, Staal E, Strobbe L, Rosman C, Groenewoud H, Bleichrodt R. Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J Surg 2007; 194:394–400 3. Franneby U, Sandblom G, Nordin P, Nyren O, Gunnarsson U. Risk factors for long-term pain after hernia surgery. Ann Surg 2006; 244:212–219 4. Ferzli GS, Edwards E, Al-Khoury G, Hardin R. Postherniorrhaphy groin pain and how to avoid it. Surg Clin North Am 2008; 88:203–209 5. Kehlet H. Chronic pain after groin hernia repair. Br J Surg 2008; 95:135–136 6. Wright D, Paterson C, Scott N, Hair A, O’Dwyer PJ. Fiveyear follow-up of patients undergoing laparoscopic or open groin hernia repair: a randomized controlled trial. Ann Surg 2002; 235:333–337 7. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006; 367:1618–1625 8. Courtney CA, Duffy K, Serpell MG, O’Dwyer PJ. Outcome of patients with severe chronic pain following repair of groin hernia. Br J Surg 2002; 89:1310–1314 9. Aasvang EK, Mohl B, Bay-Nielsen M, Kehlet H. Pain related sexual dysfunction after inguinal herniorrhaphy. Pain 2006; 122:258–263 10. Brandsborg B, Nikolajsen L, Hansen CT, Kehlet H, Jensen TS. Risk factors for chronic pain after hysterectomy: a nationwide questionnaire and database study. Anesthesiology 2007; 106:1003–1012 11. Aasvang EK, Brandsborg B, Christensen B, Jensen TS, Kehlet H. Neurophysiological characterization of postherniotomy pain. Pain 2008; 137:173–181 12. Callesen T, Bech K, Kehlet H. Prospective study of chronic pain after groin hernia repair. Br J Surg 1999;86: 1528– 1531 13. Demirer S, Kepenekci I, Evirgen O, Birsen O, Tuzuner A, Karahuseyinoglu S, Ozban M, Kuterdem E. The effect of polypropylene mesh on ilioinguinal nerve in open mesh repair of groin hernia. J Surg Res 2006; 131:175–181 14. Amid PK, Hiatt JR. New understanding of the causes and surgical treatment of postherniorrhaphy inguinodynia and orchalgia. J Am Coll Surg 2007; 205:381–385
167 Chapter 21 · Chronic Pain After Inguinal Hernia Repair
15. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W. Genetic architecture of human pain perception. Trends Genet 2007; 23:605–613 16. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lotsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006; 12:1269–1277 17. Loos MJ, Roumen RM, Scheltinga MR. Classifying postherniorrhaphy pain syndromes following elective inguinal hernia repair. World J Surg 2007; 31:1760–1765 18. Aasvang EK, Kehlet H. The effect of mesh removal and selective neurectomy on persistent postherniotomy pain. Ann Surg 2009; 249:327–334
Discussion Deysine: Within the population that I operated
there were a lot of young people for instance teenagers. Within this population there was a lot incidence of drug intake before surgery. In my opinion this is an important factor in developing postoperative pain. Did you consider such things in your study? Kehlet: We know that the management of acute pain is very difficult in such patients. However, I have never seen such a problem of drug addiction in patients operated because of an inguinal hernia. We don´t have such patients in Denmark, but I think that this could be a risk factor as well. Schumpelick: Could you give us some more remarks about »pain genes«. This seems to be a very new story and we want to know a little bit more about that. Kehlet: I showed you the references of the two best candidates that may be important »pain genes«. In mouse and rat studies there were a lot of more possible candidate genes. But the two mentioned genes are the only genes that were also found to be of interest in humans. One of it was found in factory workers who were analyzed for chronic mandibular pain. And after some years they could predict those who are of risk to develop this chronic pain syndrome. But what we have to do in the future is to combine all the different characteristics of all »pain genes«. At the moment we were at an early stage we have not enough information that it would be relevant for clinical praxis.
21
O’Dwyer: Any statements regarding the fact that
every patient with chronic pain has some sort of sensory deficit? What is your experience with testicular pain, because 15% of our patients develop specific testicular pain? Kehlet: Specific testicular pain is quite rare. But we have not analyzed it in the current study. However, we have to do this statistical comparison, because we included all this data in our data base. Song-Zhang Ma: Chronic pain is a severe problem. In China inguinal hernia repair using mesh materials is performed 150.000 times per year. But so far I have just a very few reports on postoperative pain. What do you think is the reason? Is this because of the tolerance of pain? Kehlet: There could be several explanations. One could be that patients in China have a different genetic profile. Another reason could be that you really have not asked your patients about discomfort and postoperative pain. We have had this hernia meeting several times before, and we have never talked about chronic postoperative pain. We didn’t talk about it because we didn´t realized such problems. Song-Zhang Ma: I totally agree. Before the operation we talk about recurrence and infection, but we didn’t talk about chronic postoperative pain in detail. Amid: Few patients following inguinal hernia repair develop specific testicular pain. We did an investigation that this problem could be related to the fact that the nerves were involved in the lamina propria of the vas deference. We have just 12 cases, therefore it is not enough to make a conclusion, but it is a very significant finding. Kehlet: I agree. Schumpelick: Is there a correlation between income and development of postoperative pain? Kehlet: There are many factors to consider, however actually I cannot comment on this. But this is the reason why we should have a detailed characterization of our patients.
22
What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain? P. L. Jansen, K. Bas, D. Kämmer
170
Chapter 22 · What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain?
Introduction
22
After hernia surgery, severe chronic pain is reported in up to 10% of the patients. The treatment of these patients using neurectomy, mesh explantation, and symptom control by administration of analgesics frequently fails and hints at a neuropathic pain syndrome, at least in a subgroup of patients. Neuropathic pain syndromes are caused by irreversible changes of the nervous system. For postoperative neuropathic pain, inflammation as well as nerve degeneration and pathological regeneration are the underlying pathological mechanisms that precede these central nervous changes. Advances in understanding the peripheral pathophysiological mechanisms are necessary to develop sufficient tools for preventing and treating neuropathic pain. A pathophysiological reclassification could provide a new basis for targeted and individualized therapy of patients with chronic pain after hernia therapy.
Neuropathic Pain Neuropathic pain is defined as chronic, not selflimiting pain that can occur after any lesion or dysfunction of the peripheral or central nervous system. In contrast to nociceptive and inflammatory pain, neuropathic pain has no protective function and arises by inadequate stimulation of the peripheral sensory endings [1]. Etiology-based classifications of painful peripheral neuropathies include syndromes caused by generalized lesions of the peripheral nervous system (e.g., polyneuropathies), complex neuropathic disorders (e.g., complex regional pain syndromes), and syndromes caused by focal or multifocal lesions of peripheral nerves (e.g., postsurgical pain syndromes) [2]. Based on this definition, we can expect neuropathic pain after any surgical intervention, at least in a subgroup of patients, and even when the operating field is in close proximity to peripheral nerves. Indeed, we can observe neuropathic pain syndromes after Shouldice, Lichtenstein, and even laparoscopic hernia repair [3]. Neuropathic pain has to be clearly separated from chronic pain caused by neuroma formation following nerve injury or affec-
tion of nerves due to mesh-induced foreign body reaction. For the latter, surgical intervention can be successful. In contrast, neuropathic pain is associated with irreversible neuronal changes; therefore, surgical treatment by neurectomy or mesh explantation may be insufficient [4].
Pathophysiology of Neuropathic Pain Inflammation, degeneration of nerve fibers, reparatory mechanisms of neural tissue, and the reaction of the connective tissue lead to hyperexcitability in primary afferent nociceptors [2]. The hyperactivity in nociceptors that is called peripheral sensitization induces secondary changes in processing neurons in the spinal cord and brain that amplify the state of hyperexcitability and lead to central sensitization. Normally, these sensitization phenomena are limited until the tissue heals and the inflammation subsides. However, when primary afferent function is altered permanently, the state of hyperexcitability persists (⊡ Fig. 22.1). The resulting clinical signs are the spontaneous pain, allodynia, and hyperalgesia that are characteristic for patients with neuropathic pain. A simple focal peripheral nerve injury causes a variety of changes in the nervous system, which can all contribute to the persistence of pain and abnormal sensation. We can observe changes in the peripheral primary afferent neurons as well as in the central nervous system. These changes include upregulation of sodium channels and specific receptors as well as synthesis and secretion of cytokines and neurotransmitters, leading to ectopic impulse generation, reduced activation threshold, or increased synaptic transmission. At the central nervous system, the loss of intraspinal inhibition due to the death of inhibitory interneurons plays a crucial role [2, 5]. These neuronal changes are independent from the underlying disease, and the same neuronal mechanisms are responsible for neuropathic pain after hernia repair as for other pain syndromes. Because several mechanisms can cause a specific pain symptom, a combined therapy is often more promising than a single one. Peripheral and central neuronal changes are the common track for neu-
171 Chapter 22 · What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain?
22
⊡ Fig. 22.1. Pathophysiology of neuropathic pain (BMI body mass index)
ropathic pain syndromes, but pathophysiological changes at the site of peripheral nerve injury precede these neuronal changes.
Inflammation in Neuropathic Pain Recent publications hint at a pivotal role of the inflammatory reaction for the development of neuropathic pain. After tissue injury, mast cells, macrophages, T-cells, neutrophils, and Schwann cells are activated and infiltrate from endoneural blood vessels into the nerve (⊡ Fig. 22.2) [6]. They secrete huge amounts of cytokines, nerve growth factors, and proteases. These mediators induce ectopic activity via receptor-mediated actions on afferent nerve fibers. Although the impact of nerve inflammation on neuronal changes has not been clarified in detail, it is known that the inflammatory reaction after nerve injury initiates and maintains sensory abnormalities [2, 6]. Macrophages are key cells after nerve injury. Barclay et al. found that the depletion of macrophages attenuates the mechanical hyperalgesia after peripheral nerve lesions in rats [7]. In a
preliminary study, we investigated a potential role of macrophages for neuropathic pain in hernia patients. In contrast to healthy nerves obtained from pigs, infiltrating macrophages were frequently detected in neurectomy specimens from hernia patients with chronic pain (⊡ Fig. 22.2). The expression of matrix metalloproteinase 2 (MMP-2), a pivotal mediator of macrophages, is also enhanced, especially in the endoneurium. A role of MMPs in the development of neuropathic pain after spinal nerve ligation was demonstrated recently in rats and mice by Kawasaki et al. [8]. MMP-9 showed rapid upregulation in injured dorsal route ganglions, whereas MMP-2 was responsible for the late phase of neuropathic pain and was upregulated in primary afferent neurons as well as in the dorsal horn. This study demonstrated for the first time that peripheral processes do not occur in isolation from central neuroinflammation. The separation between early-phase and late-phase neuropathic pain mechanisms can lead to important clinical implications, such as the development of tools for preventing and treating neuropathic pain. Kawasaki et al. [8] demonstrated that the develop-
172
Chapter 22 · What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain?
22
⊡ Fig. 22.2. Immunohistochemistry of CD68 (macrophages) and MMP-2 in ilioinguinal nerve specimens from pigs and chronic pain patients after hernia therapy. Magnification ×200
ment of pain hypersensitivity could be inhibited by the administration of MMP inhibitors and small interfering RNA in MMP knockout mice. Interestingly, a role of MMP-2 is also well known to support mesh-induced chronic foreign body reaction. Mesh implantation in animal models induces excessive MMP-2 gene transcription and activity mediated by infiltrating macrophages, and this pathway may also contribute to the development of neuropathic pain.
The Role of Fibrosis in Neuropathic Pain Next to the inflammatory reaction, nerve injury activates Schwann cells and fibroblasts. These cells synthesize fibronectin and, later on, collagens and are responsible for changes in the extracellular matrix. The common understanding is that the fibrotic reaction around the nerve can affect nerve fibers and lead to the retraction or compression of
nerves by compromising proper function of this so-called perineurium. Additionally, the fibrotic reaction can lead to obliteration of Schwann cell tubes and block axon regeneration or lead to missprouting of axons, resulting in the formation of neuromas at the end of injured nerve fibers or even intraneurally. The extraneural conditions can be successfully treated by surgical intervention. In contrast, the composition of the endoneurium can be disturbed after nerve injury. Salonen et al. analyzed the fibrotic reaction after sciatic nerve transaction in rats. They found increased expression of fibronectin and collagens, especially type III collagen in the endoneurium [9]. Similarly, we could detect a distinct expression of type I and type III in nerve specimens from chronic pain patients (⊡ Fig. 22.3). Although the impact of a disturbed endoneuronal collagen expression on neuronal changes is not yet clarified, these changes may be involved in the induction of ectopic activity of injured primary afferent nociceptors as well as of spared fibers.
173 Chapter 22 · What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain?
22
⊡ Fig. 22.3. Endoneural distribution of type I collagen (red) and type III collagen (green) in neurectomy specimens of chronic pain patients after hernia therapy. Sirius red staining, magnification ×200
Furthermore, our preliminary data hint at an individual reaction to nerve injury.
The Impact of Risk Factors on Neuropathic Pain In some but not all patients, the nerve lesion triggers molecular changes in nociceptive neurons, which become abnormally sensitive and develop pathological spontaneous activity. Several studies have shown that individual risk factors have an impact on the development of neuropathic pain. Major risk factors are age younger than 40 years, preexisting preoperative pain, severe postoperative pain, and male gender [10–14]. We confirmed these results in patients who had mesh explantation either because of chronic pain or reoperation for hernia recurrence. In our cohort, we found that age under 50 and body mass index less than 25 were significantly associated with chronic pain. To determine the tissue reaction in these two groups, we further analyzed the inflammatory reaction and found that the young patients who were at risk for developing chronic pain had significantly enhanced infiltration of macrophages after mesh implantation compared with older patients.
Summary and Outlook Inflammation, fibrosis, and neuronal regeneration can lead to complex changes in the function, chemistry, and structure of neurons and glial cells. These mechanisms are independent from the underlying disease and can occur after any surgical intervention, even after hernia therapy. Patientrelated risk factors can be additional disturbing factors in the complex system of pain perception. Though major progress has been made in the understanding of cellular and molecular changes after nerve injury, their relevance for the pathophysiology of pain in neuropathies after hernia therapy has yet to be determined. A mechanism-based approach for treating neuropathic pain provides hope for safer and more specific therapies.
References 1. Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J: Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630– 1635 2. Baron R: Mechanisms of disease: neuropathic pain–a clinical perspective. Nat Clin Pract Neurol 2006, 2:95–106
174
22
Chapter 22 · What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain?
3. Franneby U, Sandblom G, Nordin P, Nyren O, Gunnarsson U: Risk factors for long-term pain after hernia surgery. Ann Surg 2006, 244:212–219 4. Kehlet H: Chronic pain after groin hernia repair. Br J Surg 2008, 95:135–136 5. Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959–1964 6. Thacker MA, Clark AK, Marchand F, McMahon SB: Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 2007, 105:838–847 7. Barclay J, Clark AK, Ganju P, Gentry C, Patel S, Wotherspoon G, Buxton F, Song C, Ullah J, Winter J, Fox A, Bevan S, Malcangio M: Role of the cysteine protease cathepsin S in neuropathic hyperalgesia. Pain 2007, 130:225–234 8. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR: Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331–336 9. Salonen V, Lehto M, Vaheri A, Aro H, Peltonen J: Endoneurial fibrosis following nerve transection. An immunohistological study of collagen types and fibronectin in the rat. Acta Neuropathol 1985, 67:315–321 10. Kehlet H, Jensen TS, Woolf CJ: Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625 11. Aasvang E, Kehlet H: Chronic postoperative pain: the case of inguinal herniorrhaphy. Br J Anaesth 2005, 95:69–76 12. Matthews RD, Anthony T, Kim LT, Wang J, Fitzgibbons Jr RJ, Giobbie-Hurder A, Reda DJ, Itani KMF, Neumayer LA: Factors associated with postoperative complications and hernia recurrence for patients undergoing inguinal hernia repair: a report from the VA Cooperative Hernia Study Group. Am J Surg 2007, 194:611–617 13. Poobalan AS, Bruce J, Smith WC, King PM, Krukowski ZH, Chambers WA: A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 2003, 19:48–54 14. Nienhuijs S, Staal E, Strobbe L, Rosman C, Groenewoud H, Bleichrodt R: Chronic pain after mesh repair of inguinal hernia: a systematic review. Am J Surg 2007, 194:394– 400
Discussion Penkert: Do you agree that we have no data that
a certain number of patients develop neuropathic pain? And please comment on what has been mentioned before: Influences the kind of preoperative drug medication – especially morphium like medicaments – the incidence of chronic postoperative pain following groin hernia repair? Lynen-Jansen: I totally agree. In the literature concerning the pathophysiology of neuropathic pain, the authors focus on just one special mechanism.
They focus on fibrosis, they focus on inflammation or they focus on neuronal changes. Unfortunately I have no personal experience of preoperative drug medication and the development of postoperative pain. Deysine: You mentioned that there were pathologically changes in nerves occurring at this kind of surgery. But this would mean that the surgeon physically contacts the nerves. Neurosurgeons particularly touch nerves just with glass-electrodes. And we retract nerves while the operation and touch them with metal instruments. In my opinion the physical contact to the nerves has to be avoided. Lynen-Jansen: I totally agree. But I also think it is a lucky situation if you can avoid contact to a nerve physically. But injury to the nerves are also possible by stretching them, especially if you don´t see them while the operation. Kehlet: What you mentioned about continuous development of chronic pain is in contrast to what we have published. In our studies the pain incidence increases. We have very few prospective data concerning chronic pain however can you comment on your different findings. Lynen-Jansen: In my opinion these were only data in case of mesh implantation. Additionally it was a retrospective study and therefore it was not so easy to determine the time point when the pain occured exactly for the first time. Köckerling: In case of a patient in later course after an endoscopic hernia repair, you have to watch carefully for a recurrence or another morphological reason for the pain. I have never seen a patient with chronic pain without a morphological cause of chronic pain. Lynen-Jansen: I totally agree, again this study has its natural limitations because it was a retrospective study. Smeds: Do you have any biological data that would explain the correlation between pain and age? Lynen-Jansen: At the moment we just have the preliminary immunohistochemical investigations and therefore no satisfying answer for your question. But we have some data that the inflammatory reaction in young patients is different compared to elder patients. A lot of biological reactions in younger people are more aggressive, even the in-
175 Chapter 22 · What Do We Know About the Pathophysiology and Pathology of Neuropathic Pain?
flammatory reaction. But the main question is, why do some young patients develop postoperative chronic pain and why other not. The answer could be that we have a multifactorial impaired disease. Stumpf: I want to comment on your immunohistochemical data and on what Dr. Deysine said. It is not a problem of how to handle the nerve, because we did this investigation in nerves that we have never touched before explanation. We explanted the nerves in case of retroperitoneal neurectomies. In my opinion it is rather a preexisting disorder than a consequence of a physical never contact. Schumpelick: Are there any differences comparing the two groups in getting a recurrence of developing postoperative chronic pain? Lynen-Jansen: In case of the explanted mesh material we saw significant differences in the infiltration of macrophages in patients with chronic pain. Franz: If you exclude the patients with a recurrence, where did you get the nerves from in the pain free patients? Lynen-Jansen: The two mentioned studies were completely different.
22
23
Surgical Trauma of Nerves–Causes of Neuropathic Pain, Classification, and Options in Surgical Therapy G. Penkert
178
Chapter 23 · Surgical Trauma of Nerves–Causes of Neuropathic Pain, Classification, and Options in Surgical Therapy
Introduction
23
With the introduction of microsurgical methods applied to peripheral nerve lesions such as entrapment syndromes, pseudoneuroma, and neuroma formations, as well as lesions with nerve discontinuity, the results of nerve surgery have significantly improved over the last three to four decades. But no real mental connection exists between these successful microsurgical methods for improving or even restoring nerve function and theories of the origin of neuropathic pain. This type of hardly treatable and, until now, not fully explained pain often causes complete social disintegration of the patient. By means and results of microsurgery, we were encouraged to apply these surgical improvements to pain related to nerve trauma, but we faced limitations that were difficult to overcome until today. Experiences in neuromodulation continue to offer new aspects, and quite recent reports on intraabdominal laparoscopic neuromodulation even seem to offer a solution to painful pelvic nerves.
Microscopic Anatomy of the Peripheral Nerve System We regard the nerve axon as the smallest anatomical unit. The myelin sheath and its Swann cells are located around the axon membrane. These structures are enclosed in two or more layers: one layer with latticed and the other with longitudinal collagen and elastic fiber elements–the endoneurium. A certain number of such nerve fibers together with their individual endoneural sheath are again surrounded by connective tissue– the perineurium. Again, a certain number of such bundles (fascicles) are grouped parallel to each other, and they are again surrounded by connective tissue–the epineurium. This group arrangement within peripheral nerves changes its distribution from central levels to the periphery. Additionally, individual crossconnections between these fascicles and groups of fascicles exist. Nerve roots consist of few but thicker fascicles divided into sectors by small membranes, whereas in the periphery, limb nerve
segments have a typical group arrangement with three to five or more groups of fascicles. Closer and closer to the periphery, these groups further subdivide into many small single fascicles. This special multifascicular structure is the one we also find within the often painful inguinal nerves, including the iliohypogastric, ilioinguinal, and genitofemoral nerves. Following nerve damage or even transection, all of the elements constituting the nerve fiber, axon, and myelin sheath degenerate from the level of the lesion to the periphery. Our surgical efforts now normally aim at establishing the best conditions as possible so that these axons can sprout again into the periphery and achieve their former targets. Unfortunately, reconstructions of those multifascicular and small nerves have tended to result in secondary neuromas at the coaptation sites; the reason was aberration of all the small fascicles at the coaptation site because of technical difficulties despite magnification under the microscope.
Types and Degrees of Nerve Lesions As the result of destructive effects on nerve tissue, we can distinguish between lesions with and without loss of continuity. In almost all cases, the question of continuity of the involved nerve remains unanswered. Two systems were therefore developed to describe the potential degrees of nerve tissue lesion. In 1943, Seddon established the concepts of neurapraxia, axonotmesis, and neurotmesis according to the degree of destructive forces on the nerve tissue [18]. Neurapraxia refers to myelin sheath degeneration within the affected nerve segment. Axonotmesis is defined as a complete interruption of the axon’s continuity. Neurotmesis, in contrast to the other types of lesion, means a complete nerve interruption. Cases of neurapraxia recover within a few weeks if the forces that compress the nerve are removed. Cases of axonotmesis recover within several months depending on the distance between lesion and target. Cases of neurotmesis cannot recover, and the targets remain paralyzed. But the prognosis of axonotmesis cases depends on additional factors. In light of this, in
179 Chapter 23 · Surgical Trauma of Nerves–Causes of Neuropathic Pain
1951 Sunderland distinguished five degrees of lesion [20]. Today we consider his classification to be more detailed and more suitable than Seddon’s earlier one: Grade 1: This grade is identical to Seddon’s neurapraxia, and it refers to myelin sheath degeneration restricted on a nerve segment due to a slight trauma. Grade 2: As a result of higher compressing forces, the axons undergo Wallerian degeneration, but each axon remains enclosed by its basal membrane and endoneurium, and it is able, by axon sprouting, to regain its former target. Grade 3: Because of destructive forces on the endoneurium, the process of axon resprouting is partially hindered. On the other hand, mis-sprouting leads to more extensive functional deficits: Without endoneurium, motor axons may sprout into a sensory pathway, or vice versa, and thus achieve no function. Grade 4: Because of disarranged perineurium, the amount of mis-sprouting increases so extensively that the recovery results after microneurolysis are even more disappointing than with grades 2 and 3 lesions. Especially in cases of small skin nerves as well as inguinal nerves, the intraneural destructive effects are easily able to completely block the axon sprouts, a situation that results in a neuroma in continuity. This kind of lesion is comparable to a total nerve interruption, with no good prognosis as far as spontaneous recovery is concerned. Grade 5: This lesion is identical to Seddon’s neurotmesis, a complete interruption of nerve trunk continuity. It is associated with a terminal neuroma at the proximal nerve stump 6–8 weeks after the nerve trauma.
Secondary Connective Tissue Reactions Following a nerve injury, not only nerve destruction but also secondary connective tissue reactions start; histologically, these are well-known processes referred to as fibrosis. The ensuing scar tissue develops compressing forces and blocks the axon-sprouting process. Considering all of these secondary effects, in 1992 Millesi established a
23
classification of different fibrosis types [8]. It was conceived from a surgical point of view, as Millesi noted that the fibrosis could originate from quite different parts of the connective tissue within nerves. He classified fibrosis into types A–C, regarding the fact that only the epineurium, or the interfascicular connective tissue, or even the intrafascicular connective tissue (the endoneurium) could be involved in the fibrosis. This differentiation became important because, due to this fibrosis, surgical limitations arise during microneurolysis. An epineural fibrosis can be easily released by a longitudinal incision. In contrast, an endoneural fibrosis limits our surgical efforts completely. Nerve segments with intrafascicular fibrosis have to be resected and reconstructed by grafting. Consequently, the surgeon’s task during each operation is to estimate the type of fibrosis and decide which microsurgical method is suitable [13].
Microsurgical Options In general, we distinguish between neurolysis and nerve reconstruction, with the latter consisting of either direct nerve suture or nerve grafting. Both techniques today require a microscope to guarantee gentle handling of the nerve tissue. With magnification, the epineurium in intact parts of the nerve proximal and distal to the injured area can be incised longitudinally. After that, the external sheath of the epineurium can be removed. As a next step, individual groups of fascicles are exposed and slightly separated from each other. When approaching the injured nerve segment, the surgeon should try to continue; if that is not possible, he or she has to switch over to repair. But at first, at the separated fascicle groups, the surgeon should try to incise the perineurium if scarred. These microneurolysis steps are referred to as epineurotomy, epineurectomy, and interfascicular neurolysis. These different surgical steps can be applied to limb nerves of sufficient caliber; however, the smaller in diameter the nerve is and the more multifascicular, the greater the number of limitations that will arise, particularly in cases of skin nerves and inguinal nerves.
180
23
Chapter 23 · Surgical Trauma of Nerves–Causes of Neuropathic Pain, Classification, and Options in Surgical Therapy
Nerves with loss of continuity or untreatable intraneural fibrosis should be reconstructed if possible. The approach to nerve repair that must be implemented for these lesions changed in the 1960s [9]. The former nerve repair techniques involved the epineural end-to-end suture, but histological studies showed that fibrosis and neuromas developed on the suture side [3]. The development of microsurgical grafting resulted in two advantages: A more accurate approximation of corresponding fascicles could be achieved [8, 16], and restoration of nerve continuity without tension significantly reduced the amount of fibrosis at the coaptation sites [10]. Despite the fact that the axons had to overcome two coaptation sites after grafting, the end results 40 years ago were so encouraging that grafting became the method of choice from then on [9]. In the meantime, all of the mentioned principles of microsurgery became well known.
Pain Associated with Nerve Lesions In former decades, nerve surgeons were convinced that these microsurgical principles could successfully be applied to pain related to nerve injury. They believed that removal of the neuroma had to be the solution in pain relief; resprouting of sensory axons would sufficiently help nociceptive afferents become stabilized by achieving their former targets. But this concept did not reliably work. In 1981, a study on this subject described the high failure rate of nerve resection and grafting to cure the associated chronic nerve-related pain [12]. All of the patients reported in this study underwent reconstruction of the injured and painful nerve segment by grafting of the sural nerve. Although motor or sensory nerve function was successfully restored in all seven patients, their pain returned in the precise state and location as experienced preoperatively. Today, mechanisms proximal to the nerve lesion are recognized as responsible for the recurrence of nerve-related pain, and we are even aware of the risk of duplicating the pain [23]. Entrapment syndromes of limb nerves usually cause a more or less bearable pain. The pain does not remain restricted to the autonomous distribu-
tion area of the affected nerve; rather, it is diffuse, and it disappears after nerve decompression [13]. This type of nerve-trunk-related pain is not a matter of discussion because a substantial intraneural nerve lesion usually does not arise in an entrapment situation. Instead, we have to deal with nerves that (1) are small in diameter, (2) predominantly contain sensory fibers, (3) easily react with intraneural severe fibrosis, and (4) additionally limit our microsurgical efforts while often being unfavorably localized. In particular, these nerves tend to develop intractable pain, and we need to strictly avoid attaching the label »psychologically peculiar« to persons with resistant pain of those nerves. We are thus confronted with three potential levels of pain: 1. Neuroma pain, a normally nonexistent pain that occurs when triggered by palpation at the location where sensory nerve fibers are blocked from regrowing. Palpation thereby causes an electric-current-like pain that the patient localizes in the distribution area of the injured nerve. 2. Hyperpathic pain, a normally nonexistent pain of unbearable intensity if the skin in the distribution area of the injured nerve is repeatedly stimulated 3. Allodynia, a pain that is permanently present as a burning sensation and that is triggered by an innocuous stimulus Both of the last two types of pain are also referred to as neuropathic pain. Neuroma pain appears about 6 weeks following the nerve lesion because a neuroma needs this time to develop. Consequently, neuroma pain starts slowly and achieves a steady state weeks later. In contrast, neuropathic pain (1) has a sudden onset, (2) appears rather early after the nerve lesion, and (3) immediately achieves a steady state. Therefore, it is very important to evaluate all the details of the patient’s anamnesis to estimate his or her individual type of pain. It may be of additional importance to assess the patient because in the case of allodynia, you should be able to apply a quite light stimulus to a small skin area to provoke
181 Chapter 23 · Surgical Trauma of Nerves–Causes of Neuropathic Pain
a highly painful sensation that spreads away from the actual stimulus location. This special attribute, by the way, may be the reason that we sometimes cannot exactly differentiate which one of the inguinal nerves is really affected. Unfortunately, the distribution areas of the iliohypogastric, ilioinguinal, and genitofemoral nerves are located side by side, and variations also exist [17, 21]. According to animal models and clinical studies, the following pathophysiological mechanisms presumably contribute to the occurrence of neuropathic pain: ▬ Continuous abnormal excitation of afferent fibers due to ongoing compressing forces [1] ▬ Impaired intraneural microcirculation that might induce ensuing ischemia and nerve damage [11] ▬ An abnormal excitatory coupling between sympathetic fibers and afferent nociceptive fibers, especially within the spinal ganglion [6] ▬ Hindered or interrupted axonal transport in both directions in the nerve fibers that may result in loss of control of the biochemical activity in the nerve cell body [4] ▬ Central alterations of electrophysiological activities in an afferent neuron that may spread transsynaptically to second-order and higher-order neurons in the spinal cord and brain [2] In conclusion, the effects of nerve injury and nerve damage are not confined to the site of the lesion, as previously expected. Instead, neuropathic pain seems to be a result of an earlier unexpected central nervous plasticity [23], and it is additionally influenced by individually different dispositions. We have no theoretical basis to explain why some patients, but not all, develop neuropathic pain. Thus, different individual dispositions seem to be responsible for the fact that identical nerve lesions cause varying reactions. Experiments in 1980 on different types of rats revealed different measurable amounts of autotomy following identical procedures on nerves. The authors concluded that different genetic dispositions must exist [5]. The experience in hernia surgery presumably will be that only some patients will sustain real neuropathic pain following surgery [21].
23
Treatment Modalities for Painful Nerves Microsurgery The above-mentioned microsurgical principles of neurolysis and nerve repair are relevant only if neuroma pain is present. As far as possible, the type of pain has to be estimated preoperatively. Nevertheless, there is a risk of about 30% of inducing an ensuing neuropathic pain. This holds true if nerves of trunk caliber are affected. But considering the particular difficulties with the small abdominal wall nerves encountered in hernia surgery, microsurgery on these nerves is more and more out of discussion. If a neuropathic pain is initially presented, microsurgery even carries the danger of duplicating the pain level in the patient. Thus, regarding neuropathic pain, our experience today is that touching a nerve at the damaged site almost always induces additional central nervous plasticity. This experience holds true independent of the nerve caliber.
Neurotomy We understand neurotomy as nerve transection proximal to the primary nerve lesion. Of course, recurrent neuroma formation will always start and stop about 6–8 weeks later. If the regrown neuroma at the proximal nerve end is imbedded within soft tissue, the risk of ongoing repeated triggering may be reduced. If, for example, we operate on Morton’s neuralgia, neurotomy via a dorsal approach will be the only way to succeed [13]. But patients with Morton’s neuralgia never present with a neuropathic pain syndrome. On the other hand, 27 of 29 laparoscopic »triple neurotomies« of all three inguinal nerves have been quite successful (N. Kleemann, personal communication). Considering the experience with a greater number of hyperpathic pain syndromes in the inguinal area, these results seem to be in contrast to the above-mentioned thesis. The actual impression, therefore, is that neurotomy at least remains under discussion.
182
Chapter 23 · Surgical Trauma of Nerves–Causes of Neuropathic Pain, Classification, and Options in Surgical Therapy
Neuromodulation
23
The idea of achieving pain relief by electrically stimulating the dorsal columns of the spinal cord (known as spinal cord stimulation or SCS) was derived from the gate control theory by Melzack and Wall in 1965 [7]. According to this concept, stimulation of large afferent A-fibers of peripheral nerves should reduce the pain input to the brain via the small unmyelinated and thinly myelinated C-fibers. Because the conduction velocity of A-fibers is faster than that of the C-fibers, A-fibers were said to have the capacity to »gate out« pain stimuli from transmission to the cortex [7]. Currently, this technique is not only applied on dorsal columns of the spinal cord but also on peripheral nerves [19]. If technically possible, the epineurium of the nerve is pierced, and a quadripolar electrode is pushed slightly into the subepineural space a few centimeters distal or proximal, depending on the affected nerve and its availability [13]. After a test stimulation period of a few days, the external screener is changed to an internal subcutaneously placed pacemaker. In cases of painful involvement of very small nerve branches that are not surgically accessible for the above-mentioned direct nerve stimulation (dPNS), and in cases of excessive scarring, the treatment can consist of subcutaneous peripheral nerve stimulation (sPNS). Here, the electrode is percutaneously advanced to the location of the assumed nerve damage. The intraoperative test stimulation should induce pleasing paresthesias in the distribution of the affected nerve. This method often achieves a good response to painful conditions of injured inguinal nerves and even has an effect on the frequently associated localized tenderness in the area of the scar tissue [22]. But the gold standard in the future may perhaps be a laparoscopic approach. Possover and colleagues reported on their recent experiences applying these techniques to the intrapelvic course of the inguinal nerves by a laparoscopic approach [14, 15]. The great advantages of intraabdominal or pelvic neuromodulation compared with neurotomy are the following:
▬ No additional sensory loss, particularly if intraabdominal »triple neurotomies« (neurotomy of all three inguinal nerves) are used ▬ No risk of inducing a neuropathic pain or duplicating the preexisting pain level
Conclusion The scientific considerations of different types of nerve lesions, secondary fibrosis, microsurgical procedures, and the regeneration process after microsurgery were insufficient for solving the problem of nerve-related pain until today. A differentiation of whether the patient presents with either neuroma pain or neuropathic pain is of great importance. Microsurgical methods, with their risks, can be applied to neuroma pain, and neuromodulation, which carries less risk but is dependent on technical details, can be used for neuropathic pain. In cases of affected inguinal nerves, laparoscopic neuromodulation seems to be a reasonable technical solution in the future, whereas neurotomy is under discussion as a high-risk procedure as far as pain relief is concerned.
References 1. Bennett GJ, Xie Y-K (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87–107 2. Devor M (1988) Central changes mediating neuropathic pain. In: Dubner R, Gebhart GF, Bond MR (Eds) Proceedings of the 5th World Congress on Pain, vol 3. Elsevier, Amsterdam, pp 114–128 3. Edshage S (1964) Peripheral nerve suture. Acta Chir Scand (suppl) 331:1–104 4. Herdegen T, Fiallos-Estrada CE, Bravo R, Zimmermann M (1993) Colocalisation and covariation of c-JUNtranscription factor with galanin in primary afferent neurons with CGRP in spinal motoneurons following transection of rat sciatic nerve. Mol Brain Res 17:147–154 5. Inbal R, Devor M, Tuchendler O, Lieblick (1980) Autotomy following nerve injury: genetic factors in the development of chronic pain. Pain 9:327-337 6. Jänig W (1991) Sympathetic activity during peripheral nerve injury. In: Besson JM, Guilbaud G (eds) Lesions of primary afferent fibers as a tool for the study of clinical pain. Elsevier, Amsterdam, pp 65–82 7. Melzack R, Wall P (1965) Pain mechanisms: a new theory. Science 150:971–979
183 Chapter 23 · Surgical Trauma of Nerves–Causes of Neuropathic Pain
8. Millesi H (1992) Chirurgie der peripheren Nerven. Urban & Schwarzenberg, Munich 9. Millesi H, Meissl G, Berger A (1976) Further experiences with interfascicular grafting of the median, ulnar, and radial nerves. J Bone Joint Surg 58A:209–218 10. Millesi H, Meissl G (1981) Consequences of tension at the suture site. In: Gorio A (ed) Posttraumatic peripheral nerve regeneration; experimental basis and clinical implication. Raven Press, New York, pp 277–279 11. Myers RR, Yamamoto T, Yaksh TL, Powell HC (1989) The role of focal ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia. Anesthesiology 78:308–316 12. Noordenbos W, Wall PD (1981) Implications of the failure of nerve resection and graft to cure chronic pain produces by nerve lesion. J Neurol Neurosurg Psychiat 44:1068–1073 13. Penkert G, Fansa H (2004) Peripheral nerve lesions. Springer, Berlin 14. Possover M, Baekelandt J, Chiantera V (2007) The laparoscopic approach to control intractable pelvic neuralgia: from laparoscopic pelvic neurosurgery to the LION technique. Clin J Pain 23(9):821–825 15. Possover M, Baekelandt J, Chiantera V (2007) The laparoscopic implantation of neuroprothesis–LION technique–to control intractable abdomino-pelvic neuralgia. Neuromodul 10:18–23 16. Samii M, Penkert G (1998) Traumatic disorders of the peripheral nervous system. In: Cruz J (ed) Neurological and neurosurgical emergencies. Saunders, Philadelphia, pp 349–362 17. Schumpelik V, Kingsnorth G (1999) Incisional hernia of the abdominal wall. Springer, Berlin 18. Seddon HJ (1943) Three types of nerve injury. Brain 66:237–288 19. Shetter AG, Racz GB, Lewis R, Heavner JE (1997) Peripheral nerve stimulation. In: North RB, Levy RM (eds) Neurosurgical management of pain. Springer, New York, pp 261–270 20. Sunderland S (1951) A classification of peripheral nerve injuries producing loss of function. Brain 74:491–516 21. Töns CH, Schumpelik V (1990) Das Ramus-genitalis-Syndrom nach Hernienoperation. Chir 61:441–443 22. Winkelmüller M (2005) Which nerve is suitable for peripheral nerve stimulation? Presentation at the 15th Workshop, Pain Section, German Society of Neurosurgery 23. Zimmermann M (1994) Basic neurophysiological mechanisms of pain and pain control. In: Horsch S, Claeys L (eds) Spinal cord stimulation. Springer, Berlin, pp 3–18
Discussion Amid: We do a lot of triple-neurectomies in pa-
tients with chronic pain. Our neurosurgeons told us that we should ligate the cut ends in order to
23
prevent neuroma formation. I reviewed the literature and I have not found any data concerning this question. What do you think is the better to prevent pain, to ligate the cut ends of the nerve or to implant them in the muscle? What is your personal recommendation? Penkert: There are no conclusive data until now what to do with a nerve when you have cut it. However there are some reports which recommend the implantation of a cut nerve in fatty tissue, others recommend the ligation of a cut nerve. However, we do not have significant data what to do with a nerve end after transsection. In my opinion any additional harm to the nerve is not good. May be after the transsection of a nerve the implantation in a muscle is the best way. But another important thing is that neuropathic pain occurs within a few days after the harm to the nerve, whereas chronic pain occurs within weeks after the damage of a nerve. Schumpelick: The anesthesiologists told us that we should give local anesthesia to the nerve before we cut it, because there is a kind of pain memory. Can you comment on this? And what is the best method to dissect a nerve, better to do it with a scissor or with a scalpel? Penkert: As a neurosurgeon we try to avoid a dissection a nerve. However if necessary you should try minimize the harm to the nerve. May be local anesthesia can be beneficial, but only if there is no additional harm to the nerve. And it doesn’t matter whether you use a scissor or a scalpel. At least it is said, that there is a pain memory. Miserez: You mentioned local neuromodulation. What is about pharmacological neuromodulation? Penkert: Mostly those medicaments have notable side effects. And the most young patients doesn’t accept those side effects. Jacob: Are locally applied steroids justified in case of neuropathic pain? Penkert: The first step should be the field stimulation in the area of the neuropathic pain. If it doesn’t work the second step could be the laparoscopic approach. These are the only things that you can do in case of neuropathic pain following surgery. However it is different in case of chronic pain.
24
Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves? D. Kaemmer, R. Rosch, M. Stumpf, J. Otto, K. Junge, U. Klinge V. Schumpelick
186
Chapter 24 · Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves?
Introduction
24
In hernia surgery, interest has been focused more and more on pain, a problem that remained underestimated because only relatively few patients seemed to be affected. Chronic pain evolves in a high percentage after surgery with the need to mobilize or even compress nerves [1]; however, after groin hernia repair, symptoms vary to a high degree [2]. Pain character is mostly neuropathic, but due to overlapping distribution areas it is not clearly related to certain nerves [3]. The neuropathic pain character is accompanied by an inflammatory pain for some time after operation, which is understandable, especially when a mesh was used and foreign material remains in the body. Nerve damage during and chronic pain after hernia repair have been poorly evaluated in the past, but clinical studies illuminate clinical consequences and symptoms [4]. Nevertheless, little experimental data exist to give clear advice on how to handle healthy or damaged nerves in the groin. In groin hernia repair, it is necessary to mobilise the groin nerves traversing the operating field and retract them during the procedure. Furthermore, in recurrent groin hernia repair it is sometimes necessary to resect nerves incorporated in scar tissue. We therefore conducted two pilot studies to evaluate how to handle nerves during groin hernia repair and to advocate for further research. Intraneural fibrosis as a mechanism for nerve dysfunction was of obvious interest, as well as the presence of inflammatory cells revealed by Giemsa staining and markers for inflammation such as COX-2, MMP-2, and CD64 as a marker for activated macrophages.
Materials and Methods In uncastrated male pigs (n=6, control n=1), bilateral Lichtenstein repair was performed using a common technique. Each animal received repair with a small-pore polypropylene mesh (mesh M) on one side and a large-pore polyvinylidene mesh (mesh P) contralaterally. A nerve specimen from an untouched nerve served as control. The follow-up
was 6 months. Iliohypogastric, ilioinguinal, and genitofemoral nerves were explanted bilaterally via a retroperitoneal approach. Nerves were stored in paraformaldehyde 4% and were processed for histology, cross-polarisation microscopy, and immunohistochemistry. Antibodies against MMP-2 (1:1000, Biomol, Hamburg, Germany), CD64 (Helmholtz Institute for Applied Medical Engineering, Aachen, Germany), and COX-2 (DCS Innovative Diagnostic-Systeme, Hamburg, Germany) were applied for immunohistochemical analyses. Collagen I/III ratios were analysed as described previously [5]. Mast cells were detected by Giemsa staining. Histological findings were evaluated using a semiquantitative score ranging from 0 to 4 (0: 0% positive cells; 1: 5% positive cells, 2: 5–30% positive cells; 3: 30–80% positive cells, 4: >80% positive cells), and scores of nerves were pooled. In a second series we evaluated pigs (n=3, control n=1) receiving a neurotomy with cauterisation of the iliohypogastric, ilioinguinal, and genitofemoral nerves on one side and neurotomy without cauterisation contralaterally. The operating procedure included bilateral exploration of the groin region, opening of the inguinal canal, and identification of the nerves. After neurotomy with or without cauterisation, the inguinal canal was closed without using a hernia repair technique. A nerve specimen from an untouched nerve served as control. The follow-up was 8 weeks. Iliohypogastric, ilioinguinal, and genitofemoral nerves were explanted bilaterally via a retroperitoneal approach. Nerves were stored in paraformaldehyde 4% and were processed for histology, cross-polarisation microscopy, and immunohistochemistry as described above.
Results Six months after bilateral Lichtenstein repair, expression of MMP-2, COX-2, and CD64 was increased compared with controls. Collagen I/III ratios were also slightly elevated, implying that a higher relative amount of collagen I was present. No mast cells were detected in either group (Giemsa staining). Altogether, there were no differences between the large-pore and the small-pore meshes (⊡ Fig. 24.1).
187 Chapter 24 · Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves?
24
10 9 8
score/ratio
7 6 5 4 3 2 1 0 MMP-2
COX-2 Mesh M
CD 64
Collagen I/III
Mesh P
⊡ Fig. 24.1. Results of first series 6 months after bilateral Lichtenstein repair (Mesh M small-pore polypropylene mesh; Mesh P large-pore polyvinylidene mesh)
10 9 8
score/ratio
7 6 5 4 3 2 1 0
MMP-2
COX-2 cauter
CD 64
Collagen I/III
scissor
Eight weeks after bilateral groin exploration, higher numbers of MMP-2, COX-2, and CD64positive cells were observed compared with control nerves. Expression of MMP-2 was higher than 6 months after Lichtenstein repair. Again, the collagen I/III ratio was increased, and no mast cells were found. This effect at 8 weeks after groin exploration was independent of the method by which neurotomy was performed. The elevations were similar for neurotomy with cauterisation and neurotomy alone (⊡ Fig. 24.2). Neither inflammatory markers nor collagen ratios changed in these two groups, but they were clearly elevated compared with control values.
⊡ Fig. 24.2. Results of second series 8 weeks after bilateral groin exploration
Discussion Patients suffering pain after groin hernia repair have been an underestimated collective in clinical research so far. This is mirrored by the confusion about how to handle intact or damaged nerves during surgery. It is known that cutaneous afferent neurons react more sensibly to damage [6]. Although experimental knowledge exists that little damage is caused by simply mobilising nerves [7], stretching [8] or compressing [9] them leads to detectable and sustaining dysfunction. There has been discussion about the amount of distension that is tolerable [8]; nevertheless, almost always during hernia repair,
188
24
Chapter 24 · Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves?
nerves are at risk for damage because the upper stretching limit is ~15% of nerve length. It has been shown that even without clear detectable nerve damage, pain and measurable dysfunction of the nerves can persist independent of the use of a mesh prosthesis [10]. This supports our finding that no differences exist between different transection methods or between different large-pore meshes. Even after hernia repair, nerves are at risk because compression, such as that caused by hematoma or seroma, can compromise intraneural blood flow. Experimental analyses in the rabbit sciatic nerve revealed a complete interruption of intraneural blood flow at pressures of about 50–70 mmHg [9]. Whether these pressures are evoked by seroma or hematoma formation, for instance, remains to be elucidated, but possible nerve damage should be taken into account when deciding whether and to what extent seromas or hematomas should be treated. It should also be mentioned that a small impairment of nerve integrity and function could possibly be aggravated by continuous or rising pressure.
Conclusion During hernia repair, nerves should be identified and carefully mobilised if necessary to protect nerves traversing the operating field from damage. Stretching of nerves by hooks should be minimised whenever possible. Compression of nerves after hernia repair by hematoma or seroma as a possible source of (further) damage should be avoided. Although 6 months after Lichtenstein repair no clear difference existed between large-pore and small-pore meshes in our model, the impact of alloplastic prostheses on chronic pain remains to be elucidated. This pilot study constitutes a very small sample and lacked a control group using Shouldice repair. Regarding the need for nerve resection during surgery, we observed no difference between neurotomy with and neurotomy without cauterisation in our model. To prevent neuroma formation with the possibility of neuropathic pain, the proximal nerve stump must be provided with the most appropriate
surgical method. If a neuroma is already present, or if resection is necessary for other reasons, the existing literature seems to favour burying the proximal nerve end into muscle, with or without ligation or capping [11, 12]. A general standard procedure is difficult to suggest because of small trial sizes. In the case of inguinal nerves, further research is needed to establish rational treatment.
Acknowledgments We are grateful to Mrs. Ellen Krott for her excellent and careful assistance during this investigation.
References 1. H. Kehlet, T.S. Jensen, C.J. Woolf, Persistent postsurgical pain: risk factors and prevention. Lancet 367 (2006) 1618–1625 2. A.S. Poobalan, J. Bruce, W.C. Smith, et al., A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 19 (2003) 48–54 3. T. Mikkelsen, M.U. Werner, B. Lassen, H. Kehlet, Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg 99 (2004) 146–151 4. E.K. Aasvang, B. Brandsborg, B. Christensen, et al., Neurophysiological characterization of postherniotomy pain. Pain 137 (2008) 173–181 5. R. Rosch, K. Junge, M. Knops, et al., Analysis of collageninteracting proteins in patients with incisional hernias. Langenbecks Arch Surg 387 (2003) 427–432 6. P. Hu, E.M. McLachlan, Selective reactions of cutaneous and muscle afferent neurons to peripheral nerve transection in rats. J Neurosci 23 (2003) 10559–10567 7. D.G. Kline, E.R. Hackett, G.D. Davis, M.B. Myers, Effect of mobilization on the blood supply and regeneration of injured nerves. J Surg Res 12 (1972) 254–266 8. J. Haftek, Stretch injury of peripheral nerve. Acute effects of stretching on rabbit nerve. J Bone Joint Surg Br 52 (1970) 354–365 9. K. Ogata, M. Naito, Blood flow of peripheral nerve effects of dissection, stretching and compression. J Hand Surg [Br] 11 (1986) 10–14 10. F. Karakayali, M. Karatas, U. Ozcelik, et al., Influence of synthetic mesh on ilioinguinal nerve motor conduction and chronic groin pain after inguinal herniorrhaphy: a prospective randomized clinical study. Int Surg 92 (2007) 344–350 11. J. Lewin-Kowalik, W. Marcol, K. Kotulska, et al., Prevention and management of painful neuroma. Neurol Med Chir (Tokyo) 46 (2006) 62–67 12. J. Wu, D.T. Chiu, Painful neuromas: a review of treatment modalities. Ann Plast Surg 43 (1999) 661–667
189 Chapter 24 · Risks for Pain–Neuropathic Pain: How Should We Handle the Nerves?
Discussion Gryska: How do you exactly handle the nerve in
case of implanting it in a muscle? Rosch: We just have done a simple dissection of
the nerves. However there are studies showing that there might be a benefit for the patients if you implant the nerve end in a muscel. And additionally we didn´t see any differences if we have ligated or coagulated the nerve in the retroperitoneal space. However there might be changes in the dorsal route ganglion. Peiper: In Lichtenstein hernia repair the ilioinguinal nerve runs through the operation field and following mesh implantation you achieve a distant contact between the mesh and the nerve. Is there any place in routine to dissect the nerve in this situation? Rosch: If you look to the studies there is no difference between the patient following Lichtenstein repair and Shouldice concerning the postoperative chronic pain. Therefore actually we would recommend any trauma to the nerves in order to avoid damage to the nerve. Amid: In some cases an adequate repair of an inguinal hernia is not possible without dissection of the ilioinguinal nerve. In those cases we dissect the nerve. But now it appears that it is important to implant the nerve in the muscle.
24
25
What To Consider as Clinicians About Chronic Postoperative Pain and Inguinal Herniorrhaphy D. Hegarty
192
Chapter 25 · What To Consider as Clinicians About Chronic Postoperative Pain and Inguinal Herniorrhaphy
Introduction
25
Inguinal hernias account for 75% of all abdominal wall hernias, with a lifetime risk of 27% in men and 3% in women [1, 2]. The rate of repair of inguinal hernia ranges from 10 per 100,000 of the population in the United Kingdom to 28 per 100,000 in the United States [3]. Of these patients, chronic postoperative inguinal pain occurs in up to 54%. The persistence of postoperative inguinal herniorrhaphy pain for longer than 3 months following surgery has gained interest during the last years, becoming the most important outcome variable besides recurrence rates [4–6] because this pain affects and impairs activities of daily life in 12% of patients [7–10]. Indeed, pain-related sexual dysfunction, including dysejaculation, is now recognised to occur in at least 2% of young men [11]. Therefore, before surgery is considered for a benign disease, complications such as severe chronic pain, with its debilitating effects, must be carefully weighed against the benefits [12]. Many studies have examined the surgical factors that contribute to development of postoperative herniorrhaphy pain. For example, the intraoperative factors shown to be associated with the lower incidence of nondisabling, mild, and moderate chronic pain include the use of lightweight meshes and the laparoscopic approach [13]. The traditional assumption that chronic pain after herniorrhaphy pain is neuropathic in origin, and is secondary to direct surgical trauma or postoperative inflammation of the nerves, has therefore been challenged [14]. As clinicians we need to consider the role of patient-related factors in the development of chronic postherniorrhaphy pain, not just the surgery-related factors. This overview seeks to examine these patient factors and to propose an assessment and management model that integrates new ideas while at the same time maintaining contact with current therapies and approaches but placing them in a more open and appropriate context.
The Biopsychosocial Model The biopsychosocial model proposed by Waddell et al. [15] draws attention to the interaction of the patient’s response to his or her situation and the
impact of the work and social environments, as well as the impact of any tissue abnormality, pain, and relevant biomedical factors on progression through the problem and eventual outcome. For example, psychosocial factors are now acknowledged to predict low back pain outcome far better than do the available physical and biomedical findings [16]. While the bulk of the recent research is still in the area of low back pain, it is reasonable to expect that psychosocial factors also significantly impact other benign musculoskeletal pain states and disabilities such as inguinal herniotomy [17]. In order to propose a clinically relevant assessment and management model that integrates new concepts, compartmentalisation of the important clinical features is required. Fundamental to this compartmentalisation strategy is the gathering of patient-relevant material that can be managed, adapted, accepted, improved, and resolved using a balanced combination of patient and clinical input [18]. Six interrelating compartments need to be assessed, with the potential for management in a parallel fashion. In this way, treatment of a patient with chronic herniotomy pain might include the following: 1. Adequate explanation of the problem, which is dominated by giving reassuring information (e.g. causes, likely course, and normal pain behaviour) 2. An explanation of the treatment and management strategy as well as the likely outcome, using the best available evidence 3. A graded exercise programme to improve muscle weakness and general fitness 4. A combination of rest and activity using principles of pacing and incrementation [19, 20] 5. Encouragement of relaxation, ergonomics, and the appropriate use of transcutaneous electrical nerve stimulation and analgesics for pain management 6. Help with preparations for a graded return to work [21] The precise integration of these compartments is not a recipe to be prescribed; rather, it is guided by the patient’s individual presentation, capacities, and negotiated goals. This article suggests that each
193 Chapter 25 · What To Consider as Clinicians About Chronic Postoperative Pain
case of chronic inguinal herniorrhaphy pain can be considered using the following six compartments: 1. Biomedical factors 2. »Flagging« of psychosocial barriers to recovery 3. Reactivation and rehabilitation 4. Identification of physical impairments 5. Encouragement of physical fitness 6. Treatment of pain
Compartment 1: Biomedical Factors When pain arises from particularly private sites or those associated with basic bodily functions, such as urination or ejaculation, the condition becomes complicated by psychological as well as unique physiological issues. These structures have innervation that converges within the central nervous system, making symptoms alone inadequate as diagnostic tools. Even a precise history and meticulous physical examination may result in diagnostic ambiguity. For example, directly asking patients to localise the epicentre of their inguinal pain on anatomical charts does not appear to be helpful [14]. Patients may contribute further to the ambiguity by omitting observations they find to be too embarrassing to describe or discuss (e.g. dysejaculation [11]). Nevertheless, clinicians have a responsibility to ensure that another underlying diagnosis is not being overlooked. Consideration should be given to the possibility of a secondary neurological, gastrointestinal, musculoskeletal, or urological diagnosis to explain the chronic symptoms. ⊡ Table 25.1 highlights some common differential diagnoses that may need to be considered in each individual case [22].
⊡ Table 25.1. Possible differential diagnoses of chronic pain localised to inguinal area structures Gastrointestinal origin Hernia: recurrent bowel obstruction Colitis: radiation enterocolitis, Crohn’s disease, ulcerative colitis Diverticular disease of the colon Irritable bowel syndrome Chronic constipation: faecal impaction Proctalgia fugax Infectious diarrhoea ▼
25
Neurological origin Postsurgical neuroma: painful scar Neuralgias (i.e. iliohypogastric, ilioinguinal, genitofemoral) Postherpetic neuralgia Peripheral neuropathy Central pain: post stroke or post spinal cord injury Neuralgias (i.e. iliohypogastric, ilioinguinal, genitofemoral) Herniated nucleus pulposus Guillain-Barré syndrome Neurofibromatosis Musculoskeletal origin Thoracic, lumbar, or sacral spinal disease Pelvic floor or abdominal muscular spasm Coccygodynia Fibromyalgia Urological Interstitial cystitis Polycystic kidney Loin pain haematuria Stag horn calculus Urethral syndrome Urethral diverticulum or caruncle Detrusor dyssynergia Male reproductive Orchialgia Prostatodynia, chronic prostatitis, or chronic pelvic pain syndrome Penile pain Female reproductive (gynaecological) pain Cyclical Mittelschmerz, other ovarian pain Primary dysmenorrhoea Secondary dysmenorrhoea (uterine abnormalities, cervical stenosis, uterine leiomyoma, adenomyosis, imperforate hymen) Noncyclical or atypical cyclical Adhesions Endometriosis Pelvic relaxation, prolapse, retroversion of the uterus Vulvodynia Ovarian remnant syndrome Dyspareunia without vulvodynia Pelvic congestion syndrome Adenomyosis Chronic pelvic pain without obvious pathology Other pain states Chronic pelvic organ ischaemia Acute intermittent porphyria Familial Mediterranean fever Systemic lupus erythematosus Psychogenic pain
194
Chapter 25 · What To Consider as Clinicians About Chronic Postoperative Pain and Inguinal Herniorrhaphy
Assessment Tool
25
Until recently there was no standardised and validated instrument to assess the severity of postoperative pain following inguinal hernia repair. The Inguinal Pain Questionnaire (IPQ) has evolved over the past number of years. It is a self-administrated questionnaire that assesses the intensity of the pain, its frequency, and the extent to which the pain interferes with daily activity [6, 22]. Evidence now supports the use of the IPQ as an instrument in clinical studies as well as in the clinical routine to assess long-term pain following inguinal hernia surgery [22].
Contribution of Genetic Factors The large interindividual variability in the experience of pain suggests that genetic variability may play an important role in chronic pain. Genetic variants modulating pain continue to be discovered, and researchers expect that genetic information may be exploited to treat pain or to predict those who are at a greater risk of developing pain. At present no clinical research is specifically examining the genetic variants that may contribute to postoperative herniorrhaphy pain. Therefore, we must rely on data from general pain-related genetic research to assess the relationship between genotype and phenotype. For example, functional genetic polymorphisms of catecholamine-O-methyltransferase (COMT) are associated with altered sensitivity to pain induced in an experimental environment [23, 24]. High COMT activity correlates with a risk of developing chronic temporomandibular joint pain [25]. Results of studies in rodents indicate that the susceptibility to develop neuropathic pain has a strong heritable component, but the genes responsible have yet to be identified [26–28]. The GTP cyclohydrolase gene has been proposed to affect pain sensitivity and pain-related outcome following spinal surgery, although this process is not completely clear [29, 30]. Given the complexity of neuropathic pain, it is likely that many genes contribute to the development of chronic pain. Studies are underway to correlate single nucleotide polymorphisms in multiple candidate genes with the risk of developing postinjury neuropathic pain [30].
Compartment 2: »Flagging« of Psychosocial Barriers to Recovery Clinicians should be encouraged to actively screen for, identify, and then appropriately manage relevant psychosocial components to identify patients at risk of developing chronic pain and associated disability problems from an early stage, perhaps even as early as the preoperative assessment [31]. This is not an attempt to label a patient’s chronic postoperative inguinal hernia pain as psychologically mediated, but rather an attempt to identify some of the barriers to recovery that might be present. The »flagging initiative« used in the management of low back pain could be usefully transferred to the area of chronic herniotomy pain. The purpose of developing flags for chronic herniotomy would be to do the following [31, 32]: ▬ Provide a method of screening for psychosocial factors ▬ Provide a systematic approach for assessing psychosocial factors ▬ Suggest strategies for better pain management for those who appear to be at high risk for chronicity The aim of this flagging initiative should be to identify a number of key psychological factors [32]: ▬ Presence of a belief that the pain is harmful or severely disabling ▬ Fear-avoidance behaviour patterns with reduced activity levels ▬ Tendency to low mood and withdrawal from social interaction ▬ Expectation that passive treatments rather than active participation will help In the management of acute and chronic pain states, enquiries about psychosocial factors and their management are highly relevant and need to be addressed. The results of early preventive programmes are persuasive and support the development of prevention programmes in primary care for first-time sufferers; such programmes have been shown to significantly–by eightfold–reduce disability and the risk of becoming chronic, as compared to »treatment as usual« [33]. The pro-
195 Chapter 25 · What To Consider as Clinicians About Chronic Postoperative Pain
gramme includes a thorough examination by a doctor and a physical therapist; information designed to reduce fear, uncertainty, and anxiety; self-care recommendations; and the recommendation to remain active and continue everyday routines [33].
Compartment 3: Reactivation and Rehabilitation Reactivation and rehabilitation are strongly linked to patient beliefs and behaviour, especially those relating to fear and avoidance (see the section on Compartment 2). Patients are often wary of moving or exercising because they lack confidence and have not been given any clear advice or guidance. In situations where they feel safe and supported, patients can find that they are able to start moving normally and without any particularly bad repercussions [34]. A process using the principles of graded exposure is suggested [35, 36]. Negotiating adequate and appropriate functional goals with patients is an important requirement [37]. By commencing with activities and activity goals in an adequate rest–activity ratio, the patient’s confidence will improve, and further activity can be built on from there. For example, being occupied diverts attention away from pain, whereas being inactive leads to deconditioning and is also associated with withdrawal from work and social activities. The consequences of this can result in feelings of hopelessness and helplessness that can lead to the onset of depression. In addition, improved circulation, exchange of metabolites, and healing are promoted by movement. Injured tissues tend to heal to the strength required by the demands put on them [38]. The case for (1) the maintenance of function, activity, or work in the acute management, (2) the early return of function and activity in acute and subacute management, and (3) the reestablishment of normal function in chronic pain-disabled patients is now strong. Patients frequently need help with pain control and pain management (see section on Compartment 6: Treatment of Pain), so this should be ensured as soon as possible.
25
Compartment 4: Identification of Physical Impairments Physiotherapists are experts at observation, examination, and correction of physical abnormalities, such as impairments found in tissue and joint anatomy, biomechanics, tension, range, mobility, strength, movement patterns, and functional activities. Physiotherapists draw on many impairment-focused skills, techniques, and approaches that may coincidentally or intentionally also help relieve pain and improve function [34]. Focused physiotherapy is important and can assist in ensuring the best possible outcome for the patient suffering chronic postoperative inguinal herniorrhaphy pain [34].
Compartment 5: Encouragement of Physical Fitness Physical activity is perhaps the most powerful component in pain management programmes. Increasing fitness is important not only in reversing the disuse syndrome but also in giving a powerful signal to patients that they are beginning to regain control over their musculoskeletal system. It is, therefore, extremely important from both the physical and the psychological points of view [37]. The detrimental effects of inactivity, immobilisation, disuse, deconditioning, and low physical fitness, and the beneficial general health effects related to increased activity and fitness are now well established and extensively reviewed elsewhere. It seems essential for clinicians, whether involved in the management of acute or chronic pain, to quickly involve the patient in the maintenance or improvement of his or her general physical health. Thankfully, a great many of the detrimental effects are, with effort, reversible.
Compartment 6: Treatment of Pain Clearly, a major goal of management is to reactivate patients. Pain management and pain control are important and are often a central feature of good therapy, ensuring the best possible outcome
196
25
Chapter 25 · What To Consider as Clinicians About Chronic Postoperative Pain and Inguinal Herniorrhaphy
for the patient. Targeting the pain source is not always essential, but understanding the antecedents for increases and decreases in the pain can often yield better treatment and management strategies. Readers are referred elsewhere for details on analgesic options, but basic analgesic management in combination with advanced interventional strategies should be considered as appropriate on an individual patient basis. Clearly, a focused and well-directed analgesic programme is critical for each case to provide appropriate pain relief while avoiding overreliance on the interventional/analgesic aspect of the treatment. As with all aspects of pain management, the emphasis is biased towards patient self-management, responsibility, and involvement rather than overdominance by passive and pain-focused treatments [18].
Summary Chronic postoperative inguinal herniorrhaphy pain occurs in up to 54% of patients and significantly impairs activities of daily life, including sexual function [2, 11]. This is particularly disappointing when a complication such as severe pain and its debilitating effects occurs after surgery for a benign disease. Unfortunately, we are unable to predict which individuals are going to develop chronic postoperative pain, a situation that impedes clinicians who need to consider treatment options. This article proposes that we compartmentalise our approach to chronic postoperative inguinal pain so as to perform clinically relevant assessments and use a management model that integrates new ideas, while at the same time maintaining contact with current therapies. By using the concept of six compartments that address the biopsychosocial aspects of the patient’s chronic pain, it is hoped that clinicians will have a model for thoroughly examining each case. In addition, evidence now supports the standardised use of the IPQ as an instrument in clinical studies and in the clinical routine to assess long-term pain following inguinal hernia surgery [22]. We propose that a flagging initiative, similar
to that used for chronic low back pain patients, be considered in inguinal hernia assessment. In the future, it is hoped that candidate pain genes can be identified and exploited to predict those who are at greater risk of developing pain and to benefit chronic postoperative inguinal pain management.
References 1. Kingnorth AN, Bowley DM, Porter C (2003) A prospective study of 1000 hernias: results of the Plymouth Hernia Service. Ann R Coll Surg Engl 85:18–22 2. Jenkins JT, O’Dwyer PJ (2008) Inguinal hernias. Br Med J 336:269–72 3. Delvin HB (1995) Trends in hernia surgery in the land of Astley Cooper. In: Soper NJ (ed) Problems in general surgery, vol 12. Lippincott-Raven, Philadelphia, pp 85–92 4. Bay-Nielsen M, Perkins FM, Kehlet H (2001) Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg 233 (1):1–7 5. Poobalan AS, Bruce J, King PM, Chambers WA, Krukowski ZH, Smith WC (2001) Chronic pain and quality of life following open inguinal hernia repair. Br J Surg 88(8):1122– 1126 6. Kehlet H (2008) Chronic pain after groin hernia repair. Br J Surg 95:135-136 7. Aasvang E, Kehlet H (2005) Chronic postoperative pain: the case of inguinal herniorrhaphy. Br J Anaesth 95(1):69–76 8. Callesen T, Bech K, Kehlet H (1999) Prospective study of chronic pain after groin hernia repair. Br J Surg 86(12):1528– 1531 9. Cunningham J, Temple WJ, Mitchell P, Nixon JA, Preshaw RM, Hagen NA (1996) Cooperative hernia study. Pain in the postrepair patient. Ann Surg 224(5):598–602 10. Poobalan AS, Bruce J, Smith WC, King PM, Krukowski ZH, Chambers WA (2003) A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 19(1):48–54 11. Aasvang EK, Mohl B, Kehlet H (2007) Ejaculatory pain: a specific postherniotomy pain syndrome? Anesthesiology 107:298–304 12. Dennis R, O’Riordan D (2007) Risk factors for chronic pain after inguinal hernia repair. Ann R Coll Surg Engl 89:218–220 13. Beldi G, Haupt N, Ipaktchi et al. (2008) Postoperative hyposthesia and pain: qualitative assessment after open and laparoscopic inguinal hernia repair. Surg Endosc 22:129–133 14. Milkkelson T, Werner MU, Lassen B, Kehlet H (2004) Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg 99:146–151 15. Waddell G, Main CJ, Morris EW et al. (1984) Chronic low back pain, psychologic distress, and illness behavior. Spine 9:209–213
197 Chapter 25 · What To Consider as Clinicians About Chronic Postoperative Pain
16. Watson PJ (1999) Psychosocial assessment. The emergence of a new fashion, or a new tool in physiotherapy for musculoskeletal pain? Physiotherapy 85(10):530–535 17. Borkan JM, Quirk M, Sullivan M (1991) Finding meaning after the fall: injury narratives from elderly hip fracture patients. Soc Sci Med 33:947–957 18. Klaber Moffett J (2002) Back pain: encouraging a selfmanagement approach. Physiother Theory Pract 18:205– 212 19. Harding V (1998) Application of the cognitive-behavioural approach. In: Pitt-Brooke J, Reid H, Lockwood J, et al. (eds) Rehabilitation of movement: theoretical bases of clinical practice. Saunders, London, p 539–583 20. Shorland S (1998) Management of chronic pain following whiplash injuries. In: Gifford LS (ed) Topical issues in pain 1. Whiplash: science and management. Fear-avoidance beliefs and behaviour. CNS Press, Falmouth, pp 115–134 21. Gibson L, Allen S, Strong J (2002) Re-integration into work. In: Strong J, Unruh A, Wright A, et al. (eds) Pain: a textbook for therapists. Churchill Livingstone, Edinburgh, p 267–287 22. Franneby U, Gunnarsson U, Andersson M, et al. (2008) Validation of an inguinal pain questionnaire for assessment of chronic pain after groin hernia repair. Br J Surg 95:488–493 23. Vlaeyen JWS, Linton SJ (2000) Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85(3):317–332 24. Zubieta JK, Heitzeg MM, Smith YR, et al. (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243 25. Diatchenko L, Slade GD, Nackley AG, et al. (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135–143 25. Mogil JS, Wilson SG, Chesler EJ, et al. (2003) The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA 100:4867–4872 27. Mogil JS, Wilson SG, Bon K, et al. (1990) Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80:67–82 28. Mogil JS, Yu L, Basbaum AI (2000) Pain genes? Natural variation and transgenic mutants. Annu Rev Neurosci 23:777–811 29. Tegeder I, Costigan M, Griffin R, Abele A, et al. (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12:1269–1277 30. Hegarty D, Shorten G (2008) Influence of a selective GTP cyclohydrolase haplotype on clinical outcome, pain intensity and pain perception thresholds following lumbar discectomy. Presented at »Plenary Speaker of the Future« at the British Pain Society 2008 [in press] 31. Watson P, Kendall N (2000) Assessing psychosocial yellow flags. In: Gifford LS (ed) Topical issues in pain 2. Biopsychosocial assessment and management. Relationships and pain. CNS Press, Falmouth, pp 111–129
25
32. Main CJ, Watson PJ (2002) The distressed and angry low back pain patient. In: Gifford LS (ed) Topical issues in pain 3. Sympathetic nervous system and pain. Pain management. Clinical effectiveness. CNS Press, Falmouth, pp 177–204 33. Linton SJ (1998) The socioeconomic impact of chronic back pain: is anyone benefiting? Pain 75:163–168 34. Gifford L, Thacker M, Jones M (2006) Physiotherapy and pain. In: McMahon S, Koltzenburg N (eds) Wall and Melzak’s textbook of pain. Churchill Livingstone, Philadelphia, pp 603–617 35. Vlaeyen JWS, Crombez G (1999) Fear of movement/(re) injury, avoidance and pain disability in chronic low back pain patients. Man Ther 4(4):187–195 36. Vlaeyen JWS, Linton SJ (2000) Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85(3):317–332 37. Watson P (2000) Psychosocial predictors of outcome from low back pain. In: Gifford LS (ed) Topical issues in pain 2. Biopsychosocial assessment and management. Relationships and pain. CNS Press, Falmouth, pp 85–109 38. Harding V (1999) The role of movement in acute pain. In: Max M (ed) Pain 1999–an updated review. Refresher course syllabus. IASP Press, Seattle, pp 159–169
Discussion Schumpelick: Can you give us a figure of your
success rates? Hegarty: This strategy is not been completely ap-
plied in a uniformed fashioned way in the moment. It has not been studied directly therefore I cannot comment on this. Stumpf: I want to stress on the things you mentioned about the psychological back ground. In our outpatient clinic we started to work with a psychiatrist in order to investigate the influence of psychosomatic reasons for chronic inguinal pain. It seems to be very important to distinguish patients with psychosomatic disorders from other patients with chronic pain. Hegarty: I totally agree with you. Also it is very important to get strategies what is going on in case of female and male patients with chronic pain. Also pain history is very important.
26
Risk Factors for Chronic Pain After Groin Hernia Surgery P. Nordin
200
Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
Introduction
26
Assessment of the outcomes of groin hernia surgery has mainly focused on recurrence. However, with modern surgical techniques and the introduction of mesh, the recurrence rate has decreased considerably [1]. More recently there has been increased attention on other outcomes such as chronic pain, convalescence, and patient satisfaction [2–8]. It is now well established from many multicentre/multinational studies that chronic pain after inguinal herniorrhaphy represents the most important and disturbing sequela; it may not only cause discomfort but also limit the individual’s activities of daily living and have a considerable impact on the person’s quality of life [7, 9]. Occurrence rates vary extensively in the literature, which can be explained by the lack of a uniform definition of such pain and of a standardised instrument for its assessment. Also, grading of pain severity and the social consequences has often been limited in studies addressing the risk of long-term pain, and it is often categorised as a dichotomous (yes/no) variable in the literature [10]. The reported prevalence rates of residual pain range between 0% and 53%, but pain impairing daily activities following groin hernia repair is reported at a level around 10% [7, 9]. Because the development of chronic pain after groin hernia repair may have major implications
⊡ Table 26.1. Levels of evidence (RCT randomised controlled trial)
for costs and quality of life, and because no treatment has been shown to be effective, a detailed analysis of potential risk factors and the influence of surgical techniques is important. This chapter contains a review of risk factors for chronic pain following herniorrhaphy. The analysis is based partly on a detailed register-based questionnaire study from the Swedish Hernia Register and partly on the European Guidelines for the Treatment of Inguinal Hernia [11, 12].
Material and Methods European Guidelines for the Treatment of Inguinal Hernia The guidelines are exclusively evidence-based on results from scientific research and are divided into different levels of evidence. The levels vary from the highest level of evidence (1A), which is based on results that have been consistently demonstrated in systematic reviews, to the lowest level (4), which is based only on the opinion of experts (see ⊡ Tables 26.1 and 26.2). This grading of scientific evidence results in different levels of conclusions and grades of recommendations [12]. As part of the European Hernia Society Guidelines for the Treatment of Inguinal Hernia, a review of published findings on risk factors for
⊡ Table 26.2. Grades of recommendation
1A
Systematic review of RCTs with consistent results from individual (homogenous) studies
A
Supported by systematic review and/or at least two randomised controlled trials of good quality
1B
RCTs of good quality
Level of evidence: 1A, 1B
2A
Systematic review of cohort or case-control studies with consistent results from individual (homogenous) studies
B
2B
RCT of poorer quality or cohort or casecontrol studies
C
2C
Outcome studies, descriptive studies
3
Cohort or case-control studies of low quality
4
Expert opinion, generally accepted treatments
Supported by good cohort studies and/or case-control studies Level of evidence: 2A, 2B Supported by case series, cohort studies of low quality, and/or »outcomes« research Level of evidence: 2C, 3
D
Expert opinion, consensus committee Level of evidence: 4
201 Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
chronic pain after groin hernia surgery was carried out. Studies of chronic pain after inguinal hernia repair were identified using the PubMed, Cochrane Library, and Ovid search engines. Any study–randomised, controlled trial, cohort, questionnaire, or follow-up–of adult (>18 years) patients with a primary or recurrent inguinal hernia (asymptomatic or symptomatic; acute or elective) was included. The search was conducted using the term pain combined with inguinal hernia, clinical trial, randomised controlled trial, chronic pain, hernia repair, and neuropathy. Chronic pain is defined by the International Association for the Study of Pain as pain lasting for 3 months or more [13].
Swedish Hernia Register The Swedish Hernia Register (SHR) has compiled detailed information on more than 160,000 groin hernia repairs since its inception in 1992. Every inguinal or femoral hernia operation in patients age 15 or older performed at participating departments is recorded prospectively according to a standardised protocol. Annual checks by external reviewers have found a validity of data of about 98% [4]. For a complete description of the SHR’s recorded data, validity checks, etc., the reader is referred to earlier publications [1, 14]. From the population-based SHR, 3,000 patients age 15–85 years from 59 hospitals were sampled from the 9,280 patients registered as having undergone a primary groin hernia operation in the year 2000. Of these, the 2,853 patients still alive in 2003 were requested to fill out a postal questionnaire to investigate the occurrence of residual pain intensity.
Inguinal Pain Questionnaire The Inguinal Pain Questionnaire (IPQ) is a selfrecording instrument for chronic pain. It has been validated and was shown to have high reliability and validity for assessment of long-term groin pain [15]. Pain intensity is rated on a seven-step fixed-point scale with steps operationally linked
26
with pain behaviour. The questionnaire consists of 18 items, with pain in the contralateral (not operated) groin used as a reference.
Results Results from the SHR-Based Questionnaire Study In the Swedish questionnaire study, 2,456 patients (86%), of whom 2,299 were men and 157 were women, responded after two reminders. In response to a question about the »worst perceived pain last week,« 758 patients (31%) reported pain to some extent. In 144 cases (6%), the pain interfered with daily activities. An age below the median, a high level of pain before the operation, and occurrence of any postoperative complications were found to significantly and independently predict long-term pain in multivariate logistic analysis when »worst pain last week« was used as the outcome variable. The same variables, along with a repair technique using an anterior approach, were found to predict long-term pain with »pain right now« as the outcome variable.
Swedish Hernia Register The SHR so far has no mandatory follow-up, but any reoperation because of chronic pain must be recorded. ⊡ Figure 26.1 presents reoperation rates because of chronic pain within 3 years for the different methods of groin hernia surgery used in Sweden. Plug techniques and open sutured repairs have the highest risk, and totally extraperitoneal (TEP), Lichtenstein, and Shouldice repairs have the lowest risk of reoperation for chronic pain.
Results from the European Guidelines The guidelines search covered all relevant literature until April 2007 and literature of all level-1A and/or level-1B studies until May 2008. The results were divided into different levels of evidence.
202
Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
0.61%
0.5%
0.46% 0.4%
0.41%
0.3% 0.25% 0.2% 0.19% 0.17%
26
0.1%
0.10%
0.0%
Lichtenstein
Shouldice
Open nonmesh
Open mesh
Open preperitoneal
Plug
TAPP
TEP
⊡ Fig. 26.1. Reoperation rates within 3 years because of chronic pain; n=142 (TAPP transabdominal preperitoneal repair; TEP totally extraperitoneal repair)
⊡ Table 26.3. Results of multivariate logistic analysis of risk factors predicting any level of pain versus no pain regarding the perception of »pain right now« (OR odds ratio; CI confidence interval) Factor
Patients perceiving pain, n (%)
Univariate model OR 95% CI
Multivariate model OR 95% CI
Age Median ≤59 years Median >59 years
345/1,026 (34%) 205/976 (21%)
1 Reference 0.55 0.45–0.68
1 Reference 0.54 0.44–0.66
Gender Male Female
517/1,878 (28%) 33/124 (27%)
1 Reference 1.11 0.71–1.73
Preoperative pain level Low High
176/966 (18%) 374/1,036 (36%)
1 Reference 2.49 2.02–3.08
1 Reference 2.43 1.97–2.99
Postoperative complications No Yes
498/1,865 (27%) 52/137 (38%)
1 Reference 1.76 1.21–2.57
1 Reference 1.77 1.22–2.57
Hernia repair Anterior approach Posterior approach
532/1,907 (28%) 18/95 (19%)
1 Reference 0.58 0.34–0.99
1 Reference 0.56 0.33–0.95
Hernia anatomy Femoral Medial Lateral
5/34 (15%) 171/602 (28%) 340/1,228 (28%)
1 Reference 2.90 1.02–8.25 2.44 0.87–6.83
203 Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
26
Gender
Nonmesh Repair
Level 2B: Females were found to have a higher risk of developing postoperative chronic pain than males did [9].
Level 1B: Most studies comparing mesh with nonmesh repair report less chronic pain with mesh repair [7, 9, 20].
Age
Standard Polypropylene Mesh
Level 2A: In a randomised controlled trial (RCT) with 319 patients comparing three open mesh techniques, chronic pain was found to be related to younger age, and two population-based questionnaire studies found that younger age significantly increased the risk [11, 16, 17].
Level 1B: In three RCTs comparing lightweight mesh with standard polypropylene mesh, two indicated that the use of lightweight mesh was associated with significantly less pain on exercise after 6 months [24] and less pain of any severity at 12 months in the lightweight group [25]. In the third study [26], there was no difference in neuralgic pain, hypoaesthesia, or hyperaesthesia between the groups.
Preoperative Pain Level 2A: Preoperative pain seems to increase the risk of developing chronic pain, according to some studies [7, 11, 17].
Mesh Fixation
Level 2B: Preoperative chronic pain conditions such as headache, back pain, and irritable bowel syndrome were found to correlate significantly with the development of chronic pain [5].
Fibrin glue and nonfixation techniques have been compared with mesh fixation with staples and tackers in laparoscopic hernia operations. Reduced early postoperative pain with the nonstapling techniques was found, but there were no differences in the risk for late chronic pain [27–29].
Strong Postoperative Pain
No Identification of Inguinal Nerves
Level 2B: In an RCT with 319 patients comparing three open mesh techniques, chronic pain was found to be related to stronger pain directly after the operation [16]. In an RCT with 867 patients and 5-year follow-up comparing transabdominal preperitoneal (TAPP) and Shouldice repair, no differences in late discomfort were found. However, severe pain during the first postoperative week was a risk factor for late discomfort in the Shouldice group [18].
Level 1A: Based on three randomised studies, chronic pain after identification and division of the ilioinguinal nerve was similar to that after identification and preservation of the nerve [30]. Level 2B: Two cohort studies suggested that the incidence of chronic pain was significantly lower after identification of all inguinal nerves compared with no identification of any nerves [30].
Preoperative Chronic Pain Conditions
Method of Repair Level 1A: The incidence of chronic pain is reported to be lower after TAPP and TEP repair compared to open anterior surgery, with or without mesh [9, 17, 19–22]. Other manifestations of nerve lesions, numbness, and paraesthesia, are also fewer following laparoscopic surgery [19, 22]. Meta-analysis of 41 trials of laparoscopic versus open groin hernia repair with 7,161 participants (individual patient data were available for 4,165) revealed less persisting pain and numbness after laparoscopic repair [23].
Intraoperative Nerve Damage Intraoperative nerve damage in relation to the development of chronic pain has been discussed. There is a lack of well-defined studies on intraoperative lesions of nerves in the inguinal region in relation to development of chronic pain [9].
Reoperation for Recurrence Level 1B: Patients undergoing reoperative surgery for recurrent hernia were at risk of developing chronic neuralgia, with a fourfold higher rate of moderate or severe chronic pain [7, 9, 17].
204
Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
Discussion
26
The risk of chronic postherniorrhaphy pain may be the most important outcome or quality variable to consider in groin hernia surgery. Variables that are most associated with an increased risk of residual postherniorrhaphy pain include nonmesh repair, techniques involving an anterior approach, younger age, preoperative pain and preoperative chronic pain conditions, strong postoperative pain, lack of intraoperative identification of inguinal nerves, and reoperation for recurrence. Postoperative complications were found to be linked to an increased risk of long-term pain in the SHR-based questionnaire study. This is in accordance with two other trials [17–31]. In most studies, however, chronic pain seems not to have been evaluated at all among the reported complications. These findings, correlating chronic pain with complications, indicate that postoperative complications may serve as an important variable for improvement of surgical quality regarding risks for long-term postherniorrhaphy pain. Among the risk factors, only the operative technique and complications can be controlled by the surgeon. Inguinal hernia repair, a relatively small operation, is followed by a substantial risk of chronic pain. At least three nerves may be damaged during the procedure. However, quantification of the level of pain, the exact cause, grading of the severity, and social consequences of the pain have not been well described. Occurrence rates vary extensively in the literature, which can be explained by the lack of a uniform definition of such pain and of a standardised instrument for its assessment [10]. Assessing chronic pain was not the primary aim of most of the available studies. In a systematic review of the literature for the years 1987–2000, the frequency of chronic pain after hernia repair, which was reported in 40 studies, ranged from 0% to 53% [7]. Pain impairing daily activities following groin hernia repair was reported by about 10% of patients when asked about it 1–2 years postoperatively [3]. These reports are predominantly from public hospitals and university institutions and are in contrast to results from dedicated hernia cen-
tres, where the incidence of reported chronic pain is 0–2% [32–34]. The incidence rates for chronic postherniorrhaphy pain derived from large register-based questionnaire studies have also varied [3, 11, 17, 35]. This may also be explained by the lack of standardised principles for assessing pain. The questionnaires used have not been uniform in the definition of pain, the length of time since surgery, and the intensity of pain. Among the strengths of register studies is the fact that many surgeons with varying backgrounds and (hernia) surgery experience are involved. The prevalence of residual pain after hernia surgery estimated in these studies is considered to mirror population-based results, and an unselected and unbiased population is involved. Furthermore, scientific studies with sufficient power to reveal risk factors for chronic postherniorrhaphy pain would require considerably large samples. In the Swedish register-based questionnaire study, references to the disabling effect of residual pain with different daily activities were explored by using the IPQ, which links pain with daily function. In the IPQ, pain intensity is rated on a sevenstep fixed-point rating scale, with steps operationally linked with pain behaviour. The questionnaire has been validated and was shown to have high reliability and validity for assessing long-term groin pain [15]. Most of the published studies on laparoscopic versus open inguinal hernia repair show a tendency towards less chronic pain after laparoscopic techniques. However, cautious interpretation is recommended. Many of the studies concerning laparoscopic treatment of inguinal hernia are of poor quality regarding pain assessment, as pain was not the primary outcome variable. But the data from the better-designed trials may suggest that the development of chronic pain is less or similar after laparoscopic hernia repair. The results from recent randomised clinical trials comparing laparoscopic TEP or TAPP repair with open tension-free mesh repair are conflicting: Some trials resulted in a lower prevalence of postoperative pain in the laparoscopic group [36–38], whereas other trials showed no difference between the treatment arms [31, 39].
205 Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
Future studies should focus on identifying preoperative risk factors; providing a detailed description of the surgical technique (e.g. nerve identification), the type and intensity of pain, and the social consequences of the pain; and incorporating a detailed postoperative follow-up with characterisation of the pain. Most of the existing treatments for chronic postherniorrhaphy pain have been unsuccessful so far and need to be further evaluated. However, prevention is better than treatment, and rational prevention and management techniques can be developed for the future only by careful studies and assessment of the causes of pain.
References 1. Nilsson E, Haapaniemi S (1998) Hernia registers and specialization. Surg Clin North Am 78:1141–1155 2. Callesen T, Bech K, Kehlet H (1999) Prospective study of chronic pain after groin hernia repair. Br J Surg 86:1528– 1531 3. Bay-Nielsen M, Perkins FM, Kehlet H (2001) Danish hernia database. Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg 223:1–7 4. Blyth FM, March LM, Brnabic AJ, Jorm LR, Williamson M, Cousins MJ (2001) Chronic pain in Australia: a prevalence study. Pain 89:127–134 5. Courtney CA, Duffy K, Serpell MG, O’Dwyer PJ (2002) Outcome of patients with severe chronic pain following repair of groin hernia. Br J Surg 89:1310–1314 6. Schwab JR, Beaird DA, Ramshaw BJ, Franklin JS, Duncan TD, Wilson RA (2002) After 10 years and 1903 inguinal hernias, what is the outcome for the laparoscopic repair? Surg Endosc 16:1201–1206 7. Poobalan AS, Bruce J, Smith WC, King PM, Krukowski ZH, Chambers WA (2003) A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 19(1):48–54 8. Winslow ER, Quasebarth M, Brunt LM (2004) Perioperative outcomes and complications of open vs extraperitoneal inguinal hernia repair in a mature surgical practice. Surg Endosc 18:221–227 9. Aasvang E, Kehlet H (2005) Chronic postoperative pain: the case of inguinal herniorrhaphy. Br J Anaesth 95(1):69–76 10. Kehlet H, Bay-Nielsen M, Kingsnorth A (2002) Chronic postherniorrhaphy pain: a call for uniform assessment. Hernia 6:178–181 11. Fränneby U, Sandblom G, Nordin P, Nyre’n O, Gunnarsson U (2006) Risk factors for long term pain after hernia surgery. Ann Surg 244:212–219 12. Simons MP, Aufenacker T, Bay-Nielsen M, et al. (2009) European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia 13:343–403
26
13. Classification of chronic pain (1986). Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl 3:S1– S226 14. SBR (Swedish Hernia Register Web site). Available at www. svensktbrackregister.se. Accessed 8 May 2005 15. Fränneby U, Gunnarsson U, Andersson M, Heuman R, Nordin P, Nyre’n O (2008) Validation of the inguinal pain questionnaire; a novel instrument for evaluation of chronic pain after hernia surgery. Br J Surg 95(4):488– 493 16. Nienhuijs SW, Boelsen OB, Strobbe LJ (2005) Pain after anterior mesh repair. J Am Coll Surg 200(6):885–889 17. Kalliomäki ML, Meyerson J, Gunnarsson U, Gordh T, Sandblom G (2008) Long-term pain after inguinal hernia repair in a population-based cohort; risk factors and interference with daily activities. Eur J Pain 12:214–225 18. Berndsen FH, Petersson U, Arvidsson D, Leijonmarck CE, Rudberg C, Smedberg S, Montgomery A; SMIL Study Group (2007) Discomfort five years after endoscopic and Shouldice inguinal hernia repair: a randomised trial with 867 patients. A report from the SMIL study group. Hernia 11:307–313 19. Bittner R, Sauerland S, Schmedt CG (2005) Comparison of endoscopic techniques vs Shouldice and other open nonmesh techniques for inguinal hernia repair: a metaanalysis of randomized controlled trials. Surg Endosc 19(5):605–615 20. The EU Hernia Trialists Collaboration (2002) Repair of groin hernia with synthetic mesh: meta-analysis of randomized controlled trials. Ann Surg 235(3):322–332 21. Koninger J, Redecke J, Butters M (2004) Chronic pain after hernia repair: a randomized trial comparing Shouldice, Lichtenstein and TAPP. Langenbecks Arch Surg 389(5):361–365 22. Schmedt CG, Sauerland S, Bittner R (2005) Comparison of endoscopic procedures vs Lichtenstein and other open mesh techniques for inguinal hernia repair: a meta-analysis of randomized controlled trials. Surg Endosc 19(2):188–199 23. Grant AM; The EU Hernia Trialsits Collaboration (2002) Laparoscopic versus open groin hernia repair: meta-analysis of randomised trials based on individual patient data. Hernia 6(1):2–10 24. Post S, Weiss B, Willer M, Neufang T, Lorenz D (2004) Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg 91(1):44–48 25. O´Dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G (2005) Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 92(2):166–170 26. Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Heikkinen TJ (2006) Three-year results of a randomized clinical trial of lightweight or standard polypropylene
206
27.
28.
29.
26
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
Chapter 26 · Risk Factors for Chronic Pain After Groin Hernia Surgery
mesh in Lichtenstein repair of primary inguinal hernia. Br J Surg 93(9):1056–1059 Lovisetto F, Zonta S, Rora E, Mazzilli M, Bardone M, Bottero L, Faillace G, Longoni M (2007) Use of human fibrin glue (Tissucol) versus staples for mesh fixation in laparoscopic transabdominal preperitoneal hernioplasty: a prospective, randomized study. Ann Surg 245(2):222– 231 Smith AI, Royston CM, Sedman PC (1999) Stapled and nonstapled laparoscopic transabdominal preperitoneal (TAPP) inguinal hernia repair. A prospective randomized study. Surg Endosc 13(8):804–806 Lau H (2005) Fibrin sealant versus mechanical stapling for mesh fixation during endoscopic extraperitoneal inguinal hernioplasty: a randomized prospective trial. Ann Surg 242:670–675 Wijsmuller AR, van Veen RN, Bosch JL, Lange JF, Kleinrensink GJ, Jeekel J, Lange JF (2007) Nerve management during open hernia repair. Br J Surg 94:17–22 Hawn MT, Itani KM, Giobbie-Hurder A, McCarthy M Jr, Jonasson O, Neumayer LA (2006) Patient-reported outcomes after inguinal herniorrhaphy. Surgery 140(2):198– 205 Kark AE, Kurzer MN, Belsham PA (1998) Three thousand one hundred seventy-five primary inguinal hernia repairs: advantages of ambulatory open mesh repair using local anesthesia. J Am Coll Surg 186:447–455 Amid PK, Lichtenstein IL (1998) Long-term results and presentation of data of the Lichtenstein open tensionfree hernioplasty. Hernia 2:89–94 Rutkow IM, Robbins AW (1998) The mesh plug technique for recurrent groin herniorrhaphy: a nine-year experience of 407 repairs. Surgery 124:844–847 Bay-Nielsen M, Nilsson E, Nordin P, Kehlet H (2004) Chronic pain after open mesh and sutured repair of indirect inguinal hernia in young males. Br J Surg 91:1372–1376 Douek M, Smith G, Oshowo A, Stoker DL, Wellwood JM (2003) Prospective randomised controlled trial of laparoscopic versus open inguinal hernia mesh repair: five year follow up. BMJ 2003;326:1012–1013 McCormack K, Scott NW, Go PM, Ross S, Grant AM; EU Hernia Trialists Collaboration (2003) Laparoscopic techniques versus open techniques for inguinal hernia repair. Cochrane Database Syst Rev 1:CD001785 Grant AM, Scott NW, O’Dwyer PJ (2004) Five-year follow-up of a randomized trial to assess pain and numbness after laparoscopic or open repair of groin hernia. Br J Surg 91:1570–1574 Wright D, Paterson C, Scott N, Hair A, O’Dwyer PJ (2002) Five-year follow-up of patients undergoing laparoscopic or open groin hernia repair: a randomized controlled trial. Ann Surg 235:333–337
Discussion Smeds: What is strong pain in these types of recommendations? How should we understand strong pain? Nordin: There is no scale in the guidelines. Miserez: The intraoperative nerve injury is a predictor for developing postoperative chronic pain? However I think that we do not have any prospective studies concerning this special question. Can you comment on this? Nordin: It is very difficult to give a comment on this, because it is not mentioned in every trial. But the balance if this is the main reason or not is very difficult to see in the trials. Köckerling: There are two reasons why TEP gives the best results regarding the development of chronic postoperative pain. One is that you never touch the nerves during that procedure. The second and very important point is that you normally do not fix the mesh. Nordin: You are right. However we have to wait for new studies comparing open a laparoscopic hernia repair. Kehlet: We cannot interpret the literature as you have done it. We should select every study were pain as outcome has been asked as a yes or no question, because it has no meaning. And additionally we should have a close look to those patients who have severe chronic pain with social consequences. Nordin: We will consider this in the next guidelines. Schumpelick: How many people of the Swedish hernia trial answered to your questionnaire? How many percent of the patients answered to your questionnaire? How representative are your data? Nordin: In a frequency of over 80% answered to the questionnaire. Penkert: I would like to give a short remark. Very often I heard about pain preoperatively as predicting factor to get chronic pain after the operation. We as neurosurgeons know that some patients feel inguinal pain which is caused by an alteration of a nerve in the L4-L5 intervertebral joint. Therefore ask your patients for such pains before you will perform an inguinal hernia repair.
27
Ischemic Inflammatory Response Syndrome as an Alternative Explanation for Postherniorrhaphy Pain M. Stanton-Hicks
208
Chapter 27 · Ischemic Inflammatory Response Syndrome as an Alternative Explanation for Postherniorrhaphy Pain
Introduction
27
In general, moderate to severe postherniorrhaphy pain occurs in 10% of patients. The incidence is higher after recurrent repair (22%) than after initial surgery (3%) [1]. Other factors increasing the risk of postherniorrhaphy pain are poor postoperative pain control, female gender, young age, and surgical nerve damage. Although abnormal inflammatory response is also proposed as a cause of chronic postherniorrhaphy pain, the specific signs and symptoms that would satisfy a diagnosis of complex regional pain syndrome (CRPS; also known as reflex sympathetic dystrophy or Sudeck’s atrophy) are lacking. In fact, a strong argument can be made that most postherniorrhaphy pain is neuropathic in nature and is a direct expression of neurogenic inflammation in the territory of an injured nerve or nerves. This article discusses the supporting literature and ideas that have been raised at this symposium. In addition, it presents the new criteria used to define CRPS, along with recent validation studies.
Literature Review Preoperative risk factors for the development of postherniorrhaphy pain include severe preexisting chronic pain at any site in the body and a surgical approach that poses a greater risk for nerve damage. In their review, Aasvang and Kehlet identified a number of hernia repair studies that specified pain as an adverse outcome [2]. While most studies of hernia surgery focus on measures to reduce the rate of recurrence, it is only during the past 10 years that chronic postsurgical pain has received increasing attention. These have taken the form of randomized controlled trials and nonrandomized studies. The role of chronic pain unassociated with hernia pain in the development of postherniorrhaphy pain is well established. Conditions such as chronic back pain, irritable bowel syndrome, headache, and peptic ulcer correlate significantly with the development of chronic pain [3, 4]. The role of surgical technique as it relates to open versus laparoscopic repair is described elsewhere in this text. With respect to neurologic ex-
amination of patients with postherniorrhaphy pain, only a small number of studies, including Aasvang and Kehlet’s review, have reported that a physical examination was done, and only one of these included a detailed neurological examination and careful sensory testing at 6 and 12 months [5–9].
Chronic Regional Pain Syndrome The definition of CRPS includes the following: 1. The presence of an initiating noxious event or cause of immobilization 2. Continued pain, allodynia, or hyperalgesia, with the pain being disproportionate to any inciting event 3. Evidence at some point of edema, changes in skin blood flow, or abnormal sudomotor activity in the region of pain 4. The diagnosis is excluded by the existence of conditions that would otherwise account for the degree of pain and dysfunction. In CRPS type I, previously known as reflex sympathetic dystrophy or RSD, there is no evidence of major nerve damage [10]. CRPS type II describes the condition in which evidence of major nerve damage exists [11]. With the introduction of a definition that is truly descriptive and does not imply any mechanistic overtones, the sensitivity for diagnosis was increased, but at the expense of specificity. At the time that the taxonomy underwent its change, it was recognized that these criteria would be revised and refined by longitudinal and epidemiological studies. An initial attempt was undertaken to provide internal validation through a multicenter study using factor analysis as a statistical technique [12]. Analysis of the data in 123 patients revealed that patients clustered in four specifically perceived groups. The first subgroup had unique signs and symptoms indicating a disorder of pain processing. The second subgroup included skin color and temperature changes, indicating vasomotor dysfunction. In the third subgroup, signs and symptoms showed evidence of edema and sudomotor dysfunction. The fourth subgroup had trophic signs and symptoms.
209 Chapter 27 · Ischemic Inflammatory Response Syndrome as an Alternative Explanation
27
⊡ Table 27.1. Modified clinical diagnostic criteria
⊡ Table 27.2. Modified research diagnostic criteria
1. Continuing pain disproportionate to any inciting event 2. Must report at least one symptom in three of the four categories: – Sensory: hyperesthesia and/or allodynia – Vasomotor: temperature asymmetry and/or skin color changes and/or skin color asymmetry – Sudomotor/edema: edema and/or sweating and/ or sweating asymmetry – Motor/trophic: decreased range of motion and/ or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin) 3. Must display at least one sign in two or more of the following categories: – Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch) and/or deep somatic pressure and/or joint movement – Vasomotor: evidence of temperature asymmetry and/or skin color changes and/or skin color asymmetry – Sudomotor/edema: evidence of edema and/or sweating and/or sweating asymmetry – Motor/trophic: evidence of a decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin) 4. There is no other diagnosis to better explain the signs and symptoms.
1. Continuing pain disproportionate to any inciting event 2. Must report at least one symptom in each of the four following categories: – Sensory: hyperesthesia and/or allodynia – Vasomotor: temperature asymmetry and/or skin color changes and/or skin color asymmetry – Sudomotor/edema: edema and/or sweating and/ or sweating asymmetry – Motor/trophic: a decreased range of motion and/ or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin) 3. Must display at least one sign at the time of evaluation in two or more of the following categories: – Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch) and/or deep somatic pressure and/or joint movement – Vasomotor: evidence of temperature asymmetry and/or skin color changes and/or skin color asymmetry – Sudomotor/edema: evidence of edema and/or sweating and/or sweating asymmetry – Motor/trophic: evidence of a decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin) 4. There is no other diagnosis to better explain the signs and symptoms.
⊡ Table 27.3. Summary of sensitivity and specificity for the proposed clinical and research criteria [13] Criterion type
Symptoms required for diagnosis
Signs required for diagnosis
Sensitivity
Specificity
Clinical
3
2
0.85
0.69
Research
4
2
0.70
0.96
External validation of the International Association for the Study of Pain (IASP) criteria compared the criteria to findings in CRPS patients, with the application of similar criteria for other types of neuropathic pain. For example, a CRPS patient group defined by the IASP criteria can be compared to patients with non-CRPS neuropathic pain such as that seen in diabetic neuropathy or posthepatic neuralgia. To test the proposed criteria further, the ability to discriminate between CRPS and non-CRPS neuropathic pain requires the iden-
tification of certain rules, which include meeting two of four sign categories and three of four symptom categories. The course of this syndrome shows extreme variability over time. Two versions of the proposed diagnostic criteria–clinical and research– have been specified (⊡ Tables 27.1–27.3) [13]. In summary, the IASP diagnostic criteria provide an objective means to make decisions concerning the identification of those conditions that represent CRPS in which there is significant autonomic dysfunction or other painful condi-
210
Chapter 27 · Ischemic Inflammatory Response Syndrome as an Alternative Explanation for Postherniorrhaphy Pain
tions, such as a type of neuropathic pain. The current CRPS criteria and now improved validity are designed to reduce the incidence of medical overutilization. The data also underscore the fact that a failure to acknowledge motor/trophic signs and symptoms in the current criteria may prevent CRPS from being distinguished from other neuropathic syndromes.
Comparison of Inflammatory and Neuropathic Pain After Herniorrhaphy
27
If one considers the three types of pain–nociceptive, inflammatory, and neuropathic–the former is clearly associated with the acute stimulation of mechanical, chemical, and thermal nociceptors. The former aspect is normally a perioperative phenomenon, and a lack of adequate control is a strong risk factor for the development of chronic postsurgical pain. Chronic inflammatory pain, on the other hand, results from ongoing tissue injury in response to a chronic stimulus, such as sensitization of nociceptors to mechanical or chemical activity. This peripheral pain may be associated with synaptic plasticity in the spinal cord, with the development of central sensitization. Normally this is self-limiting, and the associated pathophysiological response will generally run a course of days or weeks, but it could become chronic if the source of spinal input remains. Neuropathic pain occurs after injury to nerves or their transmission systems within the spinal cord and brain. The hallmark of neuropathic pain is loss of sensation in association with hypersensitivity. The partial or complete loss of sensory input is a source of positive neurological activity that is expressed by spontaneous pain and hypersensitivity, including allodynia, hyperalgesia, and disordered sensation (dysesthesia). Furthermore, light touch or gentle pressure in deeper tissues of the affected region might give rise to hyperalgesia. Neuropathic pain, in contrast to inflammatory or nociceptic pain, is associated with atopic neurologic activity in the central nervous system
that occurs spontaneously, i.e., without external evoked stimuli, a so-called ectopic pacemaker. Biochemical changes in the synaptic transmission, changes in gene transcription, and upregulation of the A2-δ subunits of voltage-gated calcium channels all play a part in injury-induced central sensitization. Tumor necrosis factor δ (TNFδ), a pain-signaling substance, sensitizes axons, and microglia in the spinal cord are activated, both of which increase the overall response at dorsal horn neurons, sensitization, and central transmission. Typically, loss of Aδ-fibers and C-fibers from peripheral nerves is associated with Aß-fiber sprouting with errant synapses to those second-order neurons vacated by the loss of the Aδ-fibers and C-fibers. The role of heritable characteristics clearly influences the expression of neuropathic pain. Animal studies have demonstrated these traits [14]. The results of future studies may allow identification of those genes responsible for the development of injury-induced neuropathic pain. With the foregoing in mind, nerve injury occurring during herniorrhaphy may in itself not cause ongoing chronic neuropathic pain. Pain preceding herniorrhaphy and other predisposing genetic factors may also be important prerequisites for the development of long-standing postherniorrhaphy pain in susceptible individuals. Given our contemporary uncertainty at predicting many of these factors, and given the technical variables of surgery (open versus laparoscopic), it would be advisable to avoid nerve injury and to certainly not deliberately resect any of the nerves in the inguinal region. Continuing improvements in morbidity with newer laparoscopic techniques should further reduce the incidence of postherniorrhaphy pain. If chronic postsurgical pain is associated with signs and symptoms that fulfill the criteria for CRPS, then its differential diagnosis should be distinct from that of neuropathic pain that is secondary to traumatic nerve injury. Obviously, prevention of neuropathic pain–which, when chronic, is a neurodegenerative disease, with maladaptive consequences in the nervous system–should be prevented at all costs. Although CRPS after hernia surgery is possible, its prevalence in the surgical hernia population is rare.
211 Chapter 27 · Ischemic Inflammatory Response Syndrome as an Alternative Explanation
27
References
Smeds: What is the incidence of CRPS I? Stanton-Hicks: I have never seen a case of CRPS I
1. Poobalan AS, Bruce J, Smith WC, et al. A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 2003; 19:48–54 2. Aasvang E, Kehlet H. Chronic postoperative pain: the case of inguinal herniorrhaphy. Br J Anaesth 2005; 95:69–76 3. Courtney CA, Duffy K, Serpell MG, et al. Outcome of patients with severe chronic pain following repair of groin hernia. Br J Surg 2002; 89:1310–4 4. Wright D, Paterson C, Scott N, et al. Five year follow-up of patients undergoing laparoscopic or open groin hernia repair: a randomized controlled trial. Ann Surg 2002; 235:333–7 5. Heikkinen T, Bringman S, Ohtonen P, et al. Five year outcome of laparoscopic and Lichtenstein hernioplasties. Surg Endosc 2004; 18:518–22 6. Liem MS, van Duyn EB, van der GY, et al. Recurrences after conventional anterior and laparoscopic inguinal hernia repair; a randomized comparison. Ann Surg 203; 237:136–41 7. Mikkelsen T, Werner MU, Lassen B, et al. Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg 2004; 99:146–51 8. Picchio M, Palimento D, Attanasio U, et al. Randomized controlled trial of preservation or elective division of ilioinguinal nerve on open inguinal hernia repair with polypropylene mesh I. Arch Surg 2004;139:755–8 9. Verstraete L, Swannet H. Long-term follow-up after Lichtenstein hernioplasty in a general surgical unit. Hernia 2003; 7:185–90 10. Stanton-Hicks M, Jänig W, Hassenbusch S, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 1995; 63:127–133 11. Merskey H, Bogduk H (eds) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. IASP Press, Seattle, 1994 12. Harden RN, Bruehl S, Galer BS, et al. Complex regional pain syndrome: are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 1999; 83:211–219 13. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007; 8(4):326–31 14. Devor M, Raber P. Heritability of symptoms in an experimental model of neuropathic pain. Pain 1990; 42:51–67
of the inguinal region. But if you have damage to the nerve it is CRPS II by definition. But we have published a case of CRPS I following breast augmentation. Therefore the inguinal region is just the same problem in another area.
Discussion Amid: What is your definition of neuroma pre-
cisely? And what is the value of mesh material in developing a neuroma? Stanton-Hicks: I find it hard to believe that the mesh acts by pressure. But I also believe that the fibers of the mesh can cut fibers of the nerves.
28
Postoperative CRPS in Inguinal Hernia Patients U. Klinge, A. Fiebeler, M. K. Tur
214
Chapter 28 · Postoperative CRPS in Inguinal Hernia Patients
Introduction
28
Chronic pain is a frequent result after surgical hernia repair and probably the most difficult complication to treat. Whereas we have several excellent options for handling a recurrence, therapy of chronic pain may be frustrating, at least in some patients, and causes a lot of trouble for the surgeon as well as for the patient. Almost the majority of patients report some kind of mild complaints following hernia repair, but some patients suffer considerably. Feeling that they cannot live with this pain, they look for any treatment to get rid of it, and they often undergo one surgical revision after another. Usually, one of the first options is a revision operation, assuming that some of the local nerves are entrapped in sutures, clips, or scar tissue. In these patients, a neurectomy is usually performed. Although in some cases it may not be possible to identify and resect all three nerves (ilioinguinal nerve, iliohypogastric nerve, and genital branch of the genitofemoral nerve), or the morphological analysis of the nerves may reveal no significant pathology, most patients show complete or partial relief of their complaints. However, in some patients the complaints remain, sometimes even getting worse, starting a series of many fruitless attempts to alleviate the discomfort. If these patients had been treated with adequate neurectomy of all three nerves, what else might be the reason for such failures, and how can we identify those patients beforehand to avoid frustrating operations?
Patients with Neuropathic Pain: Subgroup with Complex Regional Pain Syndrome Not Responding to Surgical Therapy There is no doubt that pain is related to nerves and that there are many ways to cause or intensify pain. But apart from technical reasons, which depend on the surgical procedure and the surgeon, patientrelated aspects must be considered, too. Several clinical studies have demonstrated that pain is mainly a problem of younger patients and that the risk increases with the number of previous op-
erations and the extent of local scar tissue. Each of these factors or a combination of them may favour the development of pain and, correspondingly, will influence the success of a revision operation. Whereas pain caused by entrapment through a clip may be cured causally by neurectomy [1], pain due to pathology of the wound healing process (involving age, smoking, local nerve regeneration, etc.) is more complex and difficult to address. Generally, pain is classified as either nociceptive, which represents a physiological signal from injured tissue (= wound pain), or neuropathic, in which a malfunction of a nerve leads to pain signalling to the brain. Whereas the first is assumed to disappear after healing of the wound, it is mainly the latter that is accused of causing chronic pain. Recently, Aasvang et al. [2] demonstrated that large- and small-fibre dysfunction can be detected in all patients following hernia repair but is more profound in pain patients. Correspondingly, some sort of nerve dysfunction seems to be common after surgery in the groin. However, classification as neuropathic pain seems to be too nonspecific for selecting therapeutic options. In a 1999 review in Lancet, Woolf and Mannion [3] stated the following: ▬ Pharmacotherapy for neuropathic pain has been disappointing. ▬ There is no treatment to prevent the development of neuropathic pain. ▬ There is no treatment to adequately, predictably, and specifically control established neuropathic pain. ▬ There are no predictors to indicate, which patient will develop neuropathic pain. ▬ As a tool to define treatment strategy, symptoms alone are not useful because they are not equivalent to mechanisms. Although consideration of neuropathic pain is too inaccurate, this view neglects to account for two different mechanisms that may contribute to nerval function: either direct damage or pathological triggering by perinerval stimuli. In accordance, Aasvang et al. [2], who investigated postoperative complaints after mesh repair of groin hernia, concluded that »whether the underlying pathophysiological mechanisms are related to direct intraoperative nerve in-
215 Chapter 28 · Postoperative CRPS in Inguinal Hernia Patients
jury or nerve injury due to an inflammatory (mesh) response remains to be determined.« In this context, it may be helpful to adopt the experiences of other medical fields. Stanton-Hicks published a review on the concept of complex regional pain syndrome (CRPS) [4]. CRPS is characterised by the presence of continuing pain, allodynia, or hyperalgesia after nerve injury that is not necessarily limited to the distribution of a specific nerve and is often accompanied by oedema, changes of skin blood flow, or abnormal sudomotor activity. Two types of CRPS have been recognised. Type I corresponds to reflex sympathetic dystrophy and occurs without a definable nerve lesion. Type II, formerly called causalgia, refers to cases in which a definable nerve lesion is present, but this is still controversially discussed [5]. Despite the extreme variability of the patients’ symptoms–which are quite similar to Sudeck’s atrophy–there seems to be a subgroup of patients who suffer in an outstandingly severe manner from their pain. Often, the pain is not restricted to a circumscribed area that can be related to a nerve; instead, it is characterised by intense, burning sensations and is poorly localised, appearing rather as neuropathic inflammatory pain, with an inflammatory reaction triggered by neural malfunction. It may be hypothesised that these patients may not be treatable by operations because any surgical revision might boost the local disturbance of tissue integrity [6]. In cases of nerve injury, the axonal regeneration after Wallerian degeneration fails to reinnervate the proper end organs in these patients. In an analysis of mesh samples that had been explanted because of chronic pain, some samples revealed misguided growth of the nerves directed towards the filament, indicating an inhibition of Schwann cells by foreign body reaction (⊡ Fig. 28.1). In others, the neuropathic inflammation was accompanied by fibrotic degeneration of nerves with focal axonal degeneration and regeneration of axon sprouts into the surrounding tissue (⊡ Fig. 28.2). The following patient history may be a typical example of a patient with chronic pain that can be resolved by operation. The pain started with the implantation of a mesh, with no clip fixation, in the right groin for a recurrent hernia. Immediately, the
28
patient suffered from paraesthesia, possibly caused by damage of the anterior cutaneous branch of the femoral nerve, although another neurologist suspected damage to the genitofemoral nerve. After explantation of a heavyweight polypropylene mesh that had shrunken from 15×10 cm to 13×4.5 cm, the patient showed a complete recovery. In contrast, a patient with expected CRPS, who received a suture repair of a primary hernia represents a totally different history. In this example, within the first 2 weeks the patient underwent two revisions, the first for pain and the second for hae-
⊡ Fig. 28.1. Explanted polypropylene mesh from patient with chronic pain, with growth of nerve fibre directed towards the polypropylene filament
⊡ Fig. 28.2. Explanted polypropylene mesh from patient with chronic pain, with axon sprouts regenerating into the surrounding tissue
216
28
Chapter 28 · Postoperative CRPS in Inguinal Hernia Patients
matoma. Three months later, a third revision was done with neurectomy. After transcutaneous electric stimulation for more than 1 year, retroperitoneal neurectomy of the iliohypogastric and ilioinguinal nerves followed, which resulted in temporary improvement for only 2 weeks. One year later, laparoscopic extraperitoneal revision and reneurectomy of the genitofemoral nerve did not lead to any improvement. A fourth revision 1 year later for recurrence was combined with lateral neurectomy and gave relief only for some weeks. The patient’s final status is characterised by severe pain in the entire lower abdomen, both at rest and under strain, and a demanding consumption of opioids as painkillers, and has been leading to inability to work any longer. Because several patients have experienced the same series of frustrating operations finally leading to invalidity, a specific »response« of these patients to the tissue injury of a groin hernia repair may be suspected. In this regard, the concept of CRPS may offer a valuable tool for selecting patients at high risk for poor outcomes after surgical revision–if it is possible to identify patients in this subgroup preoperatively. These patients may get a better benefit from nonsurgical therapies, such as local therapy with anti-inflammatory drugs or therapeutic injections of glucocorticoids [7]. About 30–40% of patients are considered to suffer from pain that may be classified as neuropathic [8, 9], but is not clear whether it is a part of CRPS. Which patients will probably get some benefit from an operation, and which will not?
so entrapment of a nerve had been assumed but not proven. The patients were contacted by phone, and the success of therapy was coded as follows: 1. Complete relief (CR) 2. Still experiencing intermittent attacks (IA) 3. No improvement despite revision (NI) 4. Conservative therapy (CT). All of the patients had undergone at least one surgical revision, and only three had submitted to a conservative therapy. The remaining 40 were treated with either neurectomy or explantation of a heavyweight small-pore polypropylene mesh. Results provided by telephone revealed complete relief in 13 patients, intermittent attacks in 13, and no improvement in 14. Comparing the various therapeutic outcomes, patient age did not show any significant difference among the four groups. Interestingly, the mean age of all patients was considerably lower (46.8±12.7 years) than the mean age of patients with groin hernia disease. Although males were slightly more likely to be rid of their pain, this did not reach statistical significance. As an attempt to identify patients with CRPS, we assumed that these patients do not have pain that occurs immediately after operation and then remains constant but instead have pain that develops after a considerable delay and then increases constantly (⊡ Fig. 28.3). Patients with CRPS are not
Preoperative Assessment of CRPS To find an answer, we analysed 186 patients who had been seen in our clinic for chronic pain in the abdominal wall in the years 2002–2007. In 52 patients (34%), the pain was related to previous hernia repair in the groin. Therapeutic success could be verified in 43 of them. Many of these patients had had multiple previous operations, and the causal relevance of the specific impact is hard to identify. However, they reported rather complex individual histories. The youngest patient was 16 years old. The pain occurred immediately after hernia repair and was resolved by surgical revision,
Pain
Time ⊡ Fig. 28.3. Time course of pain after hernia repair. Direct damage to the nerve, such as by entrapment in a clip or suture, is assumed to occur directly postoperatively, remaining constant afterwards. This is seen in most patients. In contrast, some patients are pain-free for some time after the operation, but then after a delay of months or even years they newly develop pain, which constantly increases
28
217 Chapter 28 · Postoperative CRPS in Inguinal Hernia Patients
expected to respond to a diagnostic pain block with local anaesthesia within 1 h, and they are not expected to show any significant relief. In patients without CRPS, it should be possible to relate the pain to the supply area of certain nerves, whereas in patients with CRPS it is not. To analyse patients, we created a CRPS scoring system consisting of the following three aspects: 1. For pain: 1= immediate postoperative pain; 2= delay/increasing pain 2. For block with local anaesthetics: 1= relief; 2= no relief 3. For anatomical relationship: 1= related to nerve area; 2= diffuse/not related to nerve area. To apply this CRPS score, we assigned 2 points to those signs assumed to indicate CRPS and only 1 point for the others (⊡ Table 28.1). Correspondingly, a sum of 6 points indicates the presence of CRPS, whereas 3 points reflects a low probability for CRPS. Therefore, the success of a surgical
⊡ Table 28.1. Complex regional pain syndrome (CRPS) scores of 43 patients with chronic pain. Pain: 1= immediate pain postoperatively; 2= delay/increasing pain. Block with local anaesthetics: 1= relief; 2= no relief. Anatomical relationship: 1= related to nerve area; 2= diffuse/not related to nerve area. Success of therapy: CR complete relief; IA intermittent attacks; NI not improved; CT conservative therapy Sum of CRPS score points
3
4
5
6
n
23
8
9
3
%
53%
19%
21%
7%
Therapeutic outcome
CRPS suspected
CR
11
3
IA
7
4
2
NI (= CRPS ?)
5
1
7
CT (= CRPS ?)
1 3
No CRPS
CRPS
5
4
3
2
1 r=0.6, p< 0.01
0 2
3
4
5
6
7
CRPS score ⊡ Fig. 28.4. Patients (n=43) treated in the surgical department of the RWTH Aachen 2002–2007 for chronic pain after groin hernia repair. Therapy success is coded as 1= complete relief, 2= intermittent attacks, 3= not improved, 4= conservative therapy. For method of scoring for complex regional pain
syndrome (CRPS), see Table 28.1. Sums vary between 3 and 6 points; 3 points are assumed to not represent CRPS, whereas 6 points are suspected to represent CRPS. The diameter of the points is related to the number of patients with a similar constellation
218
Chapter 28 · Postoperative CRPS in Inguinal Hernia Patients
therapy should be highest for patients without CRPS and lowest for patients with CRPS. Indeed, the analysis of correlation shows a statistically significant relationship between our CRPS scores and the success of therapy, confirming that patients scoring 5 and 6 should be treated conservatively (⊡ Fig. 28.4). The correlation coefficient r between the therapy index and the CRPS score was 0.6. However, six of 21 patients, whose treatment success was rated as NI or CT scored less than 5 points on the CRPS score, indicating that this scoring system needs to be improved, particularly with regard to sensitivity. Fortunately, only two of the patients with successful therapies (CR, IA) had more than 4 points in their CRPS scores, confirming the specificity of the score for excluding patients from surgical revision.
28
References 1.
2.
3.
4. 5. 6.
7.
Conclusion The concept of CRPS has proven to be helpful for understanding why some patients may fail to respond to surgical therapy. In many patients, chronic pain is caused by several different local reasons that can be influenced technically, either by neurectomy or mesh explantation. The presence of CRPS represents a systemic biological problem of tissue response that will not respond to any local repair, a concept that is already widely accepted for the treatment of causalgia or Sudeck’s atrophy, both diseases with considerable similarities. The assumption that 25% of the patients with chronic pain possibly have CRPS is well in accordance with the failure rate of 20–30% after surgical therapy. In the future, the validity of the proposed CRPS scoring system should be confirmed by comparing it with other methods and measurements. Despite the extremely complex pathogenesis of chronic pain, it appears to be possible to identify patients with CRPS preoperatively. Future studies will show whether our arbitrary CRPS score can be improved by integrating further factors, such as a history of painkillers, detectable alteration of skin temperature, modified skin reaction to heat and cold stimulus, signs of atrophy, or a pathological sweat secretion test.
8.
9.
JP Miller, F Acar, VB Kaimaktchiev, SH Gultekin, KJ Burchiel: Pathology of ilioinguinal neuropathy produced by mesh entrapment: case report and literature review. Hernia 2008, 12:213–6 EK Aasvang, B Brandsborg, B Christensen, TS Jensen, H Kehlet: Neurophysiological characterization of postherniotomy pain. Pain 2008, 137:173–81 CJ Woolf, RJ Mannion: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959–64 M Stanton-Hicks: Complex regional pain syndrome. Anesthesiol Clin North Am 2003, 21:733–44 GD Schott: Complex? Regional? Pain? Syndrome? Pract Neurol 2007, 7:145–57 H Li, W Xie, JA Strong, JM Zhang: Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology 2007, 107:469-77 S Aroori, RA Spence: Chronic pain after hernia surgery–an informed consent issue. Ulster Med J 2007, 76:136–40 S Massaron, S Bona, U Fumagalli, F Battafarano, U Elmore, R Rosati: Analysis of post-surgical pain after inguinal hernia repair: a prospective study of 1,440 operations. Hernia 2007, 11:517–25 MJ Loos, RM Roumen, MR Scheltinga: Classifying postherniorrhaphy pain syndromes following elective inguinal hernia repair. World J Surg 2007, 31:1760–1765; discussion 1766–1767
Discussion Kehlet: In my opinion you are on the wrong track.
But that is the reason why we are here to discuss this problem. How can you say that we should not operate on patients with chronic noziceptor pain? I find no evidence for that. To say that there are CRPS I and II is too simple, there are more subtypes. I ask for mulitcentre collaboration with detailed neurophysiological, psychological and genetically characterization of the patients to find out which type of chronic pain we have. We have to look at the spinal and cortical mechanisms of pain productions and separate them out to different groups. And then we should study the different types of intervention. Klinge: First of all is a question of definition. It is not precisely clear what is noziceptive pain and what is precisely CRPS. There are still a lot of
219 Chapter 28 · Postoperative CRPS in Inguinal Hernia Patients
controversial issues in this matter. Second point is that there are so many factors that are responsible. And if you include all these factors which are responsible for such a pain you have a different treatment for every patient. And probably this will not be helpful for our young surgeons in the outpatient clinics. This is such a proposal to identify subgroups. Thought this cannot reflect the specific individual situation. But the main question is whether to make a neurectomy or not. Muschaweck: You recommended a local treatment with local anesthesia. What do you think about a mixture of local anesthesia and cortisone? Klinge: First of all there is clear evidence that there is beneficial effect of combination with steroids in therapeutically injection. The other point is the diagnosis. There is difference in those patients who do not respond to the injection and feel pain even while the injection comparing to those patients who respond for instance at least for one hour to the injection of local anesthesia. Stanton-Hicks: What diagnostic criteria did you use to diagnose the CRPS? What clinical signs and symptoms? Klinge: In this preliminary study we only looked to the patients with chronic pain and grouped them to two groups. I am sure that this is not a good definition of CRPS. It is probably a sub grouping of patients with chronic pain. Probably CRPS is not the right term but it is helpful. Smeds: I want add a practical thing. As we know in 80% of the patients with chronic pain the pain will improve within the first year after the operation. Therefore we should at least wait one year before performing another operation. Klinge: There are may be different ways how to treat a decision tree to make an immediate operation or not. I am convinced that the most patients we will not see within the first 6 month after operation. Köckerling: Before we name this problem a Sudeck of the groin we absolutely should be sure that there are no morphological reasons for the chronic pain. Schumpelick: What to do now? Is there some practical advice for a practical surgeon? What to do with a patient with pain in the groin? Klinge: I want to simplify it.
28
Kehlet: There is one thing that we can conclude:
We don´t understand this problem completely. We need multicentre trials to collect enough patients, because the problem is too complicated. Amid: Two third of the patients did not have mesh repair. How can you correlate mesh repair with the pain if it is not a technical error? Klinge: Just briefly. In our laboraty we have collected about 600 mesh explants. In nearly 94% of the patients in whom the explantation was done due to chronic pain it was a heavy-weight mesh small porous polypropylene mesh.
29
Chronic Pain After Open Mesh Repair of Incisional Hernia M. Kurzer, A. Kark, S. T. Hussain
222
Chapter 29 · Chronic Pain After Open Mesh Repair of Incisional Hernia
Introduction
29
Chronic or long-term pain following open incisional hernia repair is poorly documented. Traditionally, studies of incisional hernia repair have focussed only on short-term complications (infection, haematoma), major morbidity, hospital stay, and recurrence. Chronic pain (defined as pain persisting more than 3 months postoperatively [1]) has not been perceived as a significant issue, a similar situation to that for inguinal hernia repair until recently. Indeed, a recent review of surgical treatment of incisional hernia [2] did not mention postoperative pain at all. However, with surgeons’ increasing awareness of the importance of patientreported outcomes [3], long-term pain following incisional hernia repair is increasingly recognised as a significant clinical problem. Although it can occur following open or laparoscopic repair, this article will confine itself to the problem of chronic postoperative pain after open mesh repair.
How Common Is Chronic Pain After Open Incisional Hernia Repair? McLanahan and colleagues were among the first to document chronic pain following incisional hernia repair and discuss its clinical significance [4]. At 12 months following a sublay mesh repair, 45% of
patients still had some symptoms of discomfort, although most were infrequent and mild. However, 11% of patients described the pain as moderate to severe, and 7% said it limited their activities. In addition, 34% thought they could feel the mesh. In this article, McLanahan et al. also stressed the importance of patient satisfaction and of asking patients for their assessment of the operation. Burger et al. [5] and Pajaanen and Hermunen [6] found the incidence of long-term pain to be 13% and 20%, respectively, after sublay mesh repair. Kingsnorth, using an onlay technique, reported similar figures [7]. Two of these studies [6, 7] found that in 9% or 10% of patients, respectively, this pain limited their daily activities. The list includes both onlay and sublay techniques, with an incidence of chronic pain ranging from 13% to 60%. Some of this wide variation may relate to how the pain was assessed. In a study of three different techniques reported by Korenkov et al., an extremely high proportion, 61%, of patients in the onlay mesh group reported postoperative pain [8]. Infection complications led to this multicentre study being halted, and it may be that variations in technique and other technical factors were responsible for this high incidence of pain and complications. Other groups have also recognised that pain following open incisional hernia repair is a real issue that should be addressed [9, 10]. These studies are listed in ⊡ Table 29.1.
⊡ Table 29.1. Studies addressing pain following open incisional hernia repair (nr not recorded) First author
Year
Mesh position
n
Follow-up, months
Discomfort/ some pain, %
Severe pain, %
Limitation in activities, %
Sugerman [10]
1996
Prefascial
98
20
6
nr
nr
MacLanahan [4]
1997
Sublay
106
>12
55
11
7
Müller [23]
1998
Sublay
41
17
7–30
nr
30
Martin-Duce [11]
2001
Sublay
284
72
28
nr
nr
Korenkov [8]
2002
Onlay
54
12
61
nr
nr
Paajanen [6]
2004
Sublay
84
36
20
4
10
Burger [5]
2004
Sublay
84
81
20
nr
nr
Machairas [9]
2004
Onlay
43
54
7
nr
nr
Kurzer [18]
2008
Sublay
106
95
3
0
0
Kingsnorth [7]
2008
Onlay
116
15
18
nr
9
223 Chapter 29 · Chronic Pain After Open Mesh Repair of Incisional Hernia
Aetiology of the Pain Martin-Duce et al. reported a 28% incidence of chronic postoperative pain in 152 incisional hernia patients [11]. The pain was felt laterally along the spigelian line and was thought to be related to the method of mesh attachment, with nonabsorbable sutures. Its incidence decreased when the surgeons modified their technique of mesh attachment and used absorbable sutures. Paajanen and Hermunen, too, believed that nonabsorbable peripheral sutures were the cause of postoperative pain, due to either tension in the sutures or nerve entrapment [6]. Costalat et al. [12] and Cubertafond et al. [13] held similar views. The aetiology of this pain may be similar to that seen following mesh attachment at its periphery with transfascial sutures in laparoscopic repair. The long-term follow-up of a Dutch randomised trial found the incidence of scarring or superficial pain to be similar whether a sutured or mesh repair was used [5]. However, abdominal pain was less frequent in the mesh repair patients, and the researchers concluded that much of the discomfort was due to midline tension associated with fascial closure, which is more likely in sutured-only patients.
Mesh as the Cause of Pain? Perhaps because our recent recognition of chronic pain as an important sequela of incisional hernia repair has coincided with the widespread use of mesh, the mesh itself has been thought to be a causative factor. The Aachen group, who have extensive experience with the sublay mesh repair technique, have found that a significant proportion of patients complain of paraesthesia and discomfort at the periphery of the mesh, as well as a syndrome of abdominal stiffness after open mesh incisional hernia repair. In a number of patients these symptoms are troublesome enough to require further surgery and mesh removal. Histological examination of the explanted mesh has revealed extensive scar tissue, forming what is termed a scar plate. This sensation of abdominal restriction, or corsage, had earlier
29
been recognised by French surgeons following insertion of large pieces of mesh or sublay repair of massive incisional hernias [12, 13].
Mechanism of Mesh-Associated Pain There is now ample evidence that nonabsorbable alloplastic meshes made of polypropylene or polyester excite an inflammatory foreign body reaction that progresses to chronic inflammation and fibrosis [14, 15]. This reaction is related to the size and type of the mesh fibres and is also host dependent. Most research has focused on polypropylene mesh, in which the total amount of polypropylene and the pore size are probably the chief determinants of the extent and duration of the inflammatory response [16, 17]. With small-pore (sometimes called heavyweight) meshes, the areas of scar tissue that form around individual fibres meet and coalesce, a phenomenon known as bridging. The consequent formation of a thick, rigid scar plate is responsible for the discomfort and stiffness felt by the patient. Histological examination of explanted mesh in this situation has also demonstrated nerve entrapment within the scar tissue, another factor in the aetiology of the pain. With pore sizes greater than 4 mm, there is a less acute inflammatory reaction, fibrosis is limited to the perifilamentary area, and the pores between the fibres are filled with fat rather than fibrotic scar tissue.
Other Complaints with Various Meshes A study comparing three different meshes found that 59% of patients implanted with one type of standard-weight mesh complained of paraesthesia in the region of the periphery of the mesh, compared with only 4% of patients implanted with a lightweight mesh (⊡ Table 29.2) [17]. The technique of three-dimensional stereography of the abdominal wall in postrepair patients showed an increase in stiffness, and this occurred whichever mesh was used. However, the extent of stiffness increased with mesh weight and was inversely
224
29
Chapter 29 · Chronic Pain After Open Mesh Repair of Incisional Hernia
⊡ Table 29.2. Symptoms following sublay incisional hernia repair with different meshes (from Welty et al. [17])
⊡ Table 29.3. Postoperative questionnaire to incisional hernia patients
Symptoms %
Marlex
Atrium
Vypro
Paraesthesiae
59
16
4
Complaints, heavy work
17
16
7
Complaints, daily activities
17
0
4
Complaints at rest
9
3
0
1. Can you remember if you had much pain or discomfort from the hernia before it was repaired or was there just a swelling? 2. If you had pain or discomfort before the operation, is this now better or improved? 3. Do you have abdominal or scar pain now? 4. Did you think about just leaving it? 5. Are you pleased/satisfied with the operation? 6. Is the repair still sound or do you think the hernia might have come back?
proportional to mesh pore size. Moreover, the stiffness in the lightweight (or large pore size) group diminished over time. This study also found that restricted mobility of the abdominal wall and an increase in the rate of patient complaints correlated with the morphological development of a strong scar plate [17]. The clinical evidence is, however, slightly equivocal, as a recent randomised multicentre study of 165 patients failed to show a significant difference (clinically or statistically) between standard-weight and lightweight mesh in terms of interference with daily activities.
Results from the British Hernia Centre In January 2008 we wrote to 106 patients who had undergone open mesh incisional hernia repair at our institution over the previous 10 years [18]. The technique used was an open sublay repair with standard-weight polypropylene mesh, and the overall recurrence rate was 4%. At the time of writing, 68 patients had replied to the questionnaire (⊡ Table 29.3). Before the operation, 70% of patients had some degree of pain or discomfort, and in the vast majority this was improved after operation (⊡ Table 29.4). Three patients who had not had preoperative pain had symptoms of discomfort postoperatively, although this did not interfere with their daily activities, and they were pleased to be rid of their hernia. In this retrospective study, chronic postoperative pain was not seen as a clinical problem.
⊡ Table 29.4. Questionnaire replies, 68/106 n=68
Yes
No
1
Preoperative pain?
47 (70%)
21 (30%)
2
Pain better now?
45 (95%)
2 improved
3
Any pain now?
5
63
4
How disabling?
0
68
5
No operation option?
6
Satisfied?
68
0a
7
Recurrence
0
68
aNeutral
or no response on questionnaire
Summary and Conclusion Clinically important pain following open mesh repair of incisional hernia has an incidence of approximately 10–20%. It can occur after both onlay and sublay techniques, although the nature of the pain may differ. The aetiology of the pain is probably multifactorial and includes tension in the repair, nerve entrapment in sutures, and meshassociated inflammation and scar plate formation. Whether it is related to preoperative symptoms (as in inguinal hernia) is a question that has not yet been addressed. At present we also lack data regarding what patients think about these symptoms and how much these symptoms affect daily activities. Is
225 Chapter 29 · Chronic Pain After Open Mesh Repair of Incisional Hernia
mild postoperative discomfort a price that patients are willing to pay to be rid of an uncomfortable, unsightly, enlarging, and potentially lifethreatening abdominal swelling? This information will be acquired only through accurate preoperative assessment, more assiduous follow-up, and recognition of the importance of patient-reported outcomes [19–21]. Indeed, the whole subject of incisional hernia repair is hampered by a »lack of prospective high-quality studies« [21, 22]. Future progress and improved results will come not only from technical factors (including improvements in mesh technology) but also from better understanding of the indications for surgery and the development of guidelines for appropriate patient selection.
References 1. International Association for the Study of Pain (1999). Classification of chronic pain. Description of chronic pain syndromes and definitions of pain terms. Pain Suppl 3:S1– 226 2. Cassar K, Munro A (2002). Surgical treatment of incisional hernia. Br J Surg 89:534-545. 3. Holt PJ, Poloniecki JD, Thompson MM (2008). How to improve surgical outcomes. Br Med J 336:900–901 4. McLanahan D, King L, Weems C, et al. (1997). Retrorectus prosthetic mesh repair of midline abdominal hernia. Am J Surg 173:445-449 5. Burger JW, Liujendijk RW, Hop WC, et al. (2004). Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–583; discussion 83–85 6. Paajanen H, Hermunen H (2004). Long-term pain and recurrence after repair of ventral incisional hernias by open mesh: clinical and MRI study. Langenbecks Arch Surg 389:366–370 7. Kingsnorth A (2008). Open onlay mesh repair for major abdominal wall hernias with selective use of components separation and fibrin sealant. World J Surg 32:26–30 8. Korenkov M, Sauerland S, Arndt M, et al. (2002). Randomized clinical trial of suture repair, polypropylene mesh or autodermal hernioplasty for incisional hernia. Br J Surg 89:50–56 9. Machairas A, Misiakos EP, Liakakos T, et al. (2004). Incisional hernioplasty with extraperitoneal onlay polyester mesh. Am Surg 70:726–729 10. Sugerman HJ, Kellum JMJ, Reinesm HD, et al. (1996). Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 171:80–84
29
11. Martin-Duce A, Noguerales R, Villeta R, et al. (2001). Modifications to Rives technique for midline incisional hernia repair. Hernia 5:70–72 12. Costalat G, Noel P, Vernhet G (1991). Technique de cure d’eventration par prothese parietale. Ann Chir 45:882–888 13. Cubertafond P, Sava P, Gainant A, et al. (1989). Cure chirurgical des eventrations post-operatoires par plaque prothetique. Chirurgie 115:66–71 14. Klinge U, Klosterhalfen B, Muller M, et al. (1999). Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur J Surg 165:665–673 15. Klosterhalfen B, Klinge U, Hermanns B, et al. (2000). Pathology of traditional surgical nets for hernia repair after long-term implantation in humans. Chirurg 71:43–51 16. Klosterhalfen B, Junge K, Hermanns B, et al. (2002). Influence of implantation interval on the long-term biocompatibility of surgical mesh. Br J Surg 89:1043–1048 17. Welty G, Klinge U, Klosterhalfen B, et al. (2001). Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia 5:142–147 18. Kurzer M, Kark A, Selouk S, et al. (2008). Open mesh repair of incisional hernia using a sublay technique: long-term follow-up. World J Surg 32:31–36 19. Bitzer EM, Lorenz C, Nickel S, et al. (2008). Patient-reported outcomes in hernia repair. Hernia 12:407–414 20. Nieuwenhuizen J, Kleinrensink GJ, Hop WC, et al. (2008). Indications for incisional hernia repair: an international questionnaire among hernia surgeons. Hernia 12:223–225 21. Nieuwenhuizen JA, Halm J, Jeekel J, et al. (2007). Natural course of incisional hernia and indications for repair. Scand J Surg 96:293–296 22. Muller-Riemenschneider F, Roll S, Friedrich M, et al. (2007). Long-term effectiveness of interventions promoting physical activity: a systematic review. Surg Endosc 21:2127–2136 23. Müller M, Klinge U, Conze J, Schumpelick V. (1998). Abdominal wall compliance after Marlex mesh implantation for incisional hernia repair. Hernia 2:113–117
Discussion Conze: Every large hernia was once a small hernia.
Therefore I think that there is a development of size, but you didn’t mention it in your talk. Kurzer: In my opinion the size of the hernia stays stable at one point with a scary border. Conze: Another thing is that we have to differentiate emergency cases. About 2–3% of emergency operations were done because of incarcerated hernias. Therefore it is important to differentiate who is of risk for developing an incarceration.
30
Clinical Results After Open Mesh Repair V. Schumpelick, M. Binnebösel, J. Conze
228
30
Chapter 30 · Clinical Results After Open Mesh Repair
The incidence of incisional hernia formation remains unchanged between 10% and 20%, depending on the length of follow-up [1]. It is still one of the most common complications after abdominal surgery. Today a large variety of surgical options for incisional hernia repair are available [2–4]. On the basis of data from 2006, approximately 40,000 incisional hernia repairs were performed in Germany. Although the results of conventional suture repair are known to have a recurrence rate of up to 60% depending on the time of follow-up, almost every second incisional hernia is still repaired with a suture repair. The other half are performed with the help of nonresorbable mesh prostheses. Unfortunately, the operative coding system does not facilitate differentiation of the surgical procedures. There is great variability in the placement of the mesh within the abdominal wall: intraabdominal as an intraperitoneal onlay mesh, epifascial onto the anterior fascia (onlay), or behind the muscles onto the posterior rectus sheath (retromuscular/sublay). Another important technical aspect is the intended role of the mesh–whether it is used for augmentation (reinforcement) or as a replacement (bridging of the defect) of the abdominal wall (⊡ Fig. 30.1). This shows the problem and limitations of a review of open mesh techniques: We still have no sufficient data available!
First of all, we are confronted with a mix of terms: incisional or ventral hernia? These are often used as synonyms, as well as epigastric and umbilical hernia. This does not make sense because the anatomy and pathophysiology of primary and umbilical hernias differ from that for incisional hernias. Second, within the group of incisional hernias, no differentiation is made between the different hernia locations: median, paramedian, lateral, transverse, subxiphoid oblique, or flank incisions. This is due to lack of a classification system for abdominal wall hernias. There have been several attempts in the past to develop a classification to make comparison of different surgical procedures possible. In 1998 there was a first expert meeting under the guidance of the GREPA/European Hernia Society (EHS) to create a classification for incisional hernias. Besides the location of the previous incision, the experts took defect size and reducibility into account, but no proposal resulted from this meeting [5]. Several other attempts followed, but to date, none has found its way into the clinical routine. Too many parameters need to be considered: location, defect size, width or length of the defect area, symptomatology, reducibility, number of recurrences or visibility. One parameter that all classification attempts include is the size of
onlay sublay ipom
AUGMENTATION onlay sublay
DEFECT-BRIDGING ⊡ Fig. 30.1. Role of mesh
ipom
229 Chapter 30 · Clinical Results After Open Mesh Repair
the hernia defect. But there is a vast difference between a midline hernia defect of 20 cm width and 5 cm length compared to a defect of 5 cm width and 20 cm length, though the total defect size is the same. Also, some surgical techniques open the complete scar of the previous incision, which results in a much larger defect than preoperatively described. Certainly, the total defect size is important, but the transverse diameter seems to be more relevant for the intraoperative intention to reach a tensionfree repair. Just recently, prognostic factors such as age, gender, consumption of nicotine, obesity, family history, wound contamination, and previous postoperative complications have been taken into account [6]. Under the aegis of the EHS a new attempt is on its way, but so far, no classification has reached its goal of international implementation. Another problem of comparing the existing data is the design of the follow-up period and investigation. Knowing that the incidence of incisional hernia formation shows a linear rise, the length of follow-up is of decisive significance. In the study of Luijendijk et al., the rate of recurrence after incisional hernia formation was 44% after suture repair and 24% after mesh repair [7]. The follow-up investigation of the same patient population by Burger et al. several years later revealed an increase in recurrence rate with a 10-year cumulative rate of recurrence of 63% after suture repair and 32% after mesh repair [8]. So even many years after hernia repair, there was still a steady rise in recurrence. To evaluate any technique in terms of recurrence, a follow-up of 2 years does not seem to be sufficient. Evaluation of the clinical results of the different repairs must consider early postoperative and late postoperative complications. Early postoperative complications include hematoma, seroma, and acute postoperative pain. Again, there is no international consensus on the definition of hematoma or seroma, detection by ultrasound or clinical investigation, or size (10 ml or 20 ml)? Pain is coming more and more into the focus of clinical research. But there is no standardised questionnaire being used internationally, so the existing data cannot really be compared. Infection is
30
also one of the major concerns in open incisional hernia repair, but there is usually no differentiation between superficial wound infection and deep mesh infection. Must a local erythema be considered an infection? Again, no definition has found international implementation. The same relates to late postoperative complications such as chronic pain, ileus, and fistula formation. Even the number of recurrences differs according to the method of follow-up investigation. In the Vypro I trial, the recurrences that occurred in Aachen were asymptomatic and detected only by ultrasound [9]. If the follow-up investigation had been done by telephone interview, these recurrences would have never been documented. It remains a comparison of apples with oranges, a situation that becomes obvious when one looks at the only two randomised controlled trials available on incisional hernia repair. In the study of Luijendijk et al., the mesh repair was performed in a retromuscular way, with a Marlex mesh and an overlap of 2 cm. The anterior fascia in front of the mesh was closed only when a tension-free repair could be achieved; in the other cases, a resorbable mesh was interposed, making this study a mixture of mesh augmentation and mesh bridging techniques [7]. The other study compared a large-pore lightweight mesh with three very different conventional meshes. In this international multicentre trial, the importance of a meticulous protocol can be observed: Crucial steps in the surgical procedure were left to each centre’s standard procedure, such as mesh fixation, technique for closing the anterior fascia, and the kind of suture material itself [9]. The available studies and their results are summarised in ⊡ Tables 30.1–30.3 [10–32]. A comparison of these clinical results of open mesh repair is possible only with limitations. In open mesh repair, the retromuscular mesh augmentation seems to show the best results with the least severe complications. A worldwide accepted and applicable classification is needed. Also, a differentiation between the different surgical procedures with a subdivision into augmentation and bridging techniques is urgently necessary. Only then is a comparison of clinical results in open incisional hernia repair possible and reasonable.
230
Chapter 30 · Clinical Results After Open Mesh Repair
⊡ Table 30.1. Results of onlay repair (RCT randomised controlled trial) Authors
Year
Study design
n
Follow-up (months)
Compl. %
Inf. %
Expl.
Rec. %
Vestweber et al. [10]
1997
Retrospective
36
32
?
27.7
0
6.4
Chevrel [32]
1997
Retrospective
389
1–20 years
?
10.9
0
5.5
Leber et al. [11]
1998
Retrospective
118
80
>20
?
0
14.8
Rios et al. [12]
2001
Retrospective
246
77
26
17
0
17
Korenkov et al. [ 13]
2002
RCT, stopped
70
14
?
26
0
8
San Pio et al. [14]
2003
Retrospective
67
68
?
?
?
15
Machairas et al. [ 15]
2004
Retrospective
43
54
21
?
?
9
Langer et al. [16]
2005
Retrospective
14
116
32
?
?
14
Israelsson et al. [17]
2006
Retrospective
281
>12m
?
?
?
19.3
Licheri et al. [18]
2008
Retrospective
64
?
26.5
?
0
2/64
Kingsnorth et al. [19]
2008
Prospective
116
15.2
25
8.6
0
3.4
⊡ Table 30.2. Results of retromuscular repair (RCT randomised controlled trial)
30
Authors
Year
Study design
n
follow-up (months)
Compl.
Inf.
Expl.
Rec.
Schumpelick et al. [20]
1996
Retrospective
58
54
?
3.2%
0
7%
McLanahan et al. [21]
1997
Retrospective
106
24
18%
12%
0
3.5%
Ladurner et al. [22]
2001
Retrospective
57
6–33
11%
0
0
2%
Wright et al. [23]
2002
Retrospective
90
32
36%
10%
0
6%
Paajanen and Hermunen [24]
2004
Retrospective
84
36
19%
6%
0
4%
Conze et al. [9]
2005
RCT
165
24
?
17%
0
12%
Le et al. [25]
2005
Prospective
150
>5
?
9.3%
2
2%
Israelsson et al. [17]
2006
Retrospective
228
>12 m
?
?
?
7.3%
Kurzer et al. [26]
2008
Retrospective
125
95
?
1.6%
2
4%
⊡ Table 30.3. Results of open peritoneal onlay mesh repair Authors
Year
Study design
n
Follow-up (months)
Compl.
Inf.
Expl.
Rec.
Marchal et al. [27]
1999
Retrospective
128
48
26%
14%
3
16%
Millikan et al. [28]
2003
Prospective
102
28
6%
0%
0
0%
Heartsill et al. [29]
2005
Retrospective
81
30
>20%
16%
3
15%
Bernard et al. [30]
2007
Prospective
61
35
21%
10%
2
5%
Bingener et al. [31]
2007
Prospective
233
30
15%
6%
6
9%
231 Chapter 30 · Clinical Results After Open Mesh Repair
References 1. Höer J, Lawong G, Klinge U, Schumpelick V (2002) Factors influencing the development of incisional hernia. A retrospective study of 2,983 laparotomy patients over a period of 10 years Chirurg 73:474–480 2. Conze J, Junge K, Klinge U, Schumpelick V (2006) Evidenzbasierte laparoskopische Chirurgie–Narbenhernie. Viszeralchirurgie 41:246–252 3. Conze J, Klinge U, Schumpelick V (2005) Incisional hernia. Chirurg 76:897–909 4. Klinge U, Conze J, Krones CJ, Schumpelick V (2005) Incisional hernia: open techniques. World J Surg 29:1066–1072 5. Korenkov M, Paul A, Sauerland S, et al. (2001) Classification and surgical treatment of incisional hernia. Results of an experts’ meeting. Langenbecks Arch Surg 386:65-–73 6. Dietz UA, Hamelmann W, Winkler MS, Debus ES, Malafaia O, Czeczko NG, Thiede A, Kuhfuss I (2007) An alternative classification of incisional hernias enlisting morphology, body type and risk factors in the assessment of prognosis and tailoring of surgical technique. J Plast Reconstr Aesthet Surg 60:383–388 7. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, et al. (2000) A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343:392–398 8. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–583 9. Conze J, Kingsnorth AN, Flament JB, Simmermacher R, Arlt G, Langer C, Schippers E, Hartley M, Schumpelick V (2005) Randomized clinical trial comparing lightweight composite mesh with polyester or polypropylene mesh for incisional hernia repair. Br J Surg 92:1488–1493 10. Vestweber KH, Lepique F, Haaf F, Horatz M, Rink A (1997) Mesh-plasty for recurrent abdominal wall hernias–results. Zentralbl Chir 122:885–888 11. Leber GE, Garb JL, Alexander AI, Reed WP (1998) Longterm complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382 12. Rios A, Rodriguez JM, Munitiz V, Alcaraz P, Pérez D, Parrilla P (2001) Factors that affect recurrence after incisional herniorrhaphy with prosthetic material. Eur J Surg 167:855–859 13. Korenkov M, Sauerland S, Arndt M, Bograd L, Neugebauer EA, Troidl H (2002) Randomized clinical trial of suture repair, polypropylene mesh or autodermal hernioplasty for incisional hernia. Br J Surg 89:50–56 14. San Pio JR, Damsgaard TE, Momsen O, Villadsen I, Larsen J (2003) Repair of giant incisional hernias with polypropylene mesh: a retrospective study. Scand J Plast Reconstr Surg Hand Surg 37:102–106 15. Machairas A, Misiakos EP, Liakakos T, Karatzas G (2004) Incisional hernioplasty with extraperitoneal onlay polyester mesh. Am Surg 70:726–729 16. Langer C, Liersch T, Kley C, Flosman M, Suss M, Siemer A, Becker H (2005) Twenty-five years of experience in incisi-
17.
18.
19.
20.
21.
22.
23.
24.
25. 26.
27.
28.
29.
30.
31.
32.
30
onal hernia surgery. A comparative retrospective study of 432 incisional hernia repairs. Chirurg 74:638–645 Israelsson LA, Smedberg S, Montgomery A, Nordin P, Spangen L (2006) Incisional hernia repair in Sweden 2002. Hernia 10:258–261 Licheri S, Erdas E, Pisano G, Garau A, Ghinami E, Pomata M (2008) Chevrel technique for midline incisional hernia: still an effective procedure. Hernia 12 (2):121-–126 Kingsnorth AN, Shahid MK, Valliattu AJ, Hadden RA, Porter CS (2008) Open onlay mesh repair for major abdominal wall hernias with selective use of components separation and fibrin sealant. World J Surg 32:26–30 Schumpelick V, Conze J, Klinge U (1996) Preperitoneal mesh-plasty in incisional hernia repair. A comparative retrospective study of 272 operated incisional hernias. Chirurg 67:1028–1035 McLanahan D, King LT, Weems C, Novotney M, Gibson K (1997) Retrorectus prosthetic mesh repair of midline abdominal hernia. Am J Surg 173:445–449 Ladurner R, Trupka A, Schmidbauer S, Hallfeldt K (2001) The use of an underlay polypropylene mesh in complicated incisional hernias: successful French surgical technique. Minerva Chir 56 :1111–1117 Wright BE, Niskanen BD, Peterson DJ, Ney AL, Odland MD, VanCamp J, Zera RT, Rodriguez JL (2002) Laparoscopic ventral hernia repair: are there comparative advantages over traditional methods of repair? Am Surg 68:291–295 Paajanen H, Hermunen H (2004) Long-term pain and recurrence after repair of ventral incisional hernias by open mesh: clinical and MRI study. Langenbecks Arch Surg 389:366–370 Le H, Bender JS (2005) Retrofascial mesh repair of ventral incisional hernias. Am J Surg 189:373–375 Kurzer M, Kark A, Selouk S, Belsham P (2008) Open mesh repair of incisional hernia using sublay technique: longterm follow-up. World J Surg 32:31–36 Marchal F, Brunaud L, Sebbag H, et al. (1999) Treatment of incisional hernias by placement of an intraperitoneal prosthesis: a series of 128 patients. Hernia 3:141–147 Millikan KW, Baptista M, Amin B, Deziel DJ, Doolas A (2003) Intraperitoneal underlay ventral hernia repair utilizing bilayer expanded polytetrafluoroethylene and polypropylene mesh. Am Surg 69:287–291 Heartsill L, Richards ML, Arfai N, Lee A, Bingener-Casey J, Schwesinger WH, Sirinek KR (2005) Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone. Hernia 9:162–166 Bernard C, Polliand C, Mutelica L, Champault G (2007) Repair of giant incisional abdominal wall hernias using open intraperitoneal mesh. Hernia 11:315–320 Bingener J, Buck L, Richards M, Michalek J, Schwesinger W, Sirinek K (2007) Long-term outcomes in laparoscopic vs open ventral hernia repair. Arch Surg 142:562–567 Chevrel JP, Rath AM (1997) The use of fibrin glues in the surgical treatment of incisional hernias. Hernia 1:9–14
232
Chapter 30 · Clinical Results After Open Mesh Repair
Discussion Bellows: Can you comment on the use of allogenic mesh material for instance alloderm? Schumpelick: We have never used biological meshes. Why should I use such meshes? Deysine: I totally agree that we need a better classification of incision hernias.
30
31
Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair D. Berger, M. Bientzle
234
Chapter 31 · Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair
Introduction Laparoscopic repair of incisional hernias is gaining increasing popularity because it has some advantages compared to open techniques [1, 2]. The frequency of infectious complications, for example, is significantly reduced. Previous studies also demonstrated reduced pain after laparoscopic incisional hernia repair, a finding that has also been pointed out in a very recent review [3–7]. In contrast, Pierce et al. clearly showed that early postoperative pain is a major issue [1]. The frequency of prolonged pain was nearly 2% in the laparoscopic group compared with 0.9% in the open group. A recent study found dissatisfying pain in 9% in the long run [8]. In our preliminary study, all patients who were laparoscopically treated for an incisional hernia were followed up in the early postoperative period using a visual analogue scale. Long-term follow-up was performed using a pain score similar to those used in other studies dealing with chronic pain.
Patients and Methods
31
Since 2002, all patients treated for incisional hernias have been prospectively followed up in the early postoperative period with a visual analogue scale ranging from 0 to 10. The patients are studied twice a day in reclining and upright positions until leaving the hospital. Our preliminary evaluation comprised 100 patients. Fifty patients had a mesh derived from expanded polytetrafluoroethylene (e-PTFE), and starting in May 2004, 50 patients received a mesh derived from polyvinylidene fluoride (PVDF), Dynamesh IPOM. The distribution of age, gender, and surgical parameters such as hernia size were not different between the groups. A further clinical examination was performed after 1, 3, 6, 12 months and yearly thereafter using a simplified pain score, which is shown in ⊡ Table 31.1.
Surgical Technique The surgical technique did not differ over the years. Routinely, the whole abdominal scar was covered by
⊡ Table 31.1. Classification of long-lasting postoperative pain 0 1 2 3 4
No pain at all, very satisfied Sometimes minimal pain during work, satisfied Sometimes moderate pain during work, still satisfied Often annoying pain during work, dissatisfied Strong pain at rest, very dissatisfied
the mesh, not just the obvious fascial defect. After complete adhesiolysis of the whole abdominal wall, the falciform ligament was dissected in cases with hernias or incisions reaching the upper abdomen. In patients with hernias or incisions of the lower abdomen, the fatty tissue between the plicae mediales was dissected to open the Retzius space. The meshes were fixed with six stay sutures at the corners and in the midline in the longest extension of the mesh. Furthermore, spiral tacks were used every 3–4 cm. For covering the lower abdomen, the mesh was fixed with spiral tacks at the pubic bone and the symphysis. In cases of upper abdominal hernias, the tacks were placed in the rips at the costal arch. Diclofenac and metamizole were routinely given in the postoperative period. In some cases, piritramide was added via a patient-controlled analgesia pump. Statistical analysis was done using analysis of variance tests for repeated measurements.
Results As outlined above, the two groups did not differ concerning demographic or surgical parameters. As shown in ⊡ Fig. 31.1, the patients suffered from very strong pain during the first 3 days, especially when in an upright position. The pain scores slowly decreased from a median of 7 the morning of the first postoperative day to 4 and 3 at days 3 and 4, respectively. However, there is a significant difference between the groups: Patients treated with DynaMesh IPOM showed significantly lower pain scores for 5 days than patients who received an ePTFE-derived mesh, as shown by analysis of variance testing for repeated measurements. No further correlation of pain with other parameters–such as age, gender,
235 Chapter 31 · Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair
31
8
6
4
2
0 d1ml d1ms d1el d1es d2ml d2ms d2el d2es d3ml d3ms d3el d3es d4ml d4ms d4el d4es d5ml d5ms d5el d5es
body mass index, mesh size, hernia size, duration of the procedure itself, amount and intensity of adhesions, or number of previous procedures–could be established. Chronic pain was observed only during the first 3 months of the observation period. The median pain score after 4 weeks was 1.5, which indicates minimal to moderate pain during work. Six patients were dissatisfied at that time point. Only one patient was still dissatisfied after 3 months, but the problems finally resolved without further treatment. Any correlation of chronic or persisting pain with clinical parameters could not be established because of the low number of patients. For the same reason, a differentiation between the two groups did not seem to be appropriate.
Discussion It is usually believed that a main advantage of laparoscopic procedures is reduced pain in the early
⊡ Fig. 31.1. Postoperative visual analogue scale (VAS) scores. Box plots are demonstrated. The x-axis shows the time course between day 1 and day 5, given as d1m (m morning) to d5e (e evening). The different time points differentiate between the reclining (l) and upright patient positions (s). The y-axis shows the VAS level
postoperative period, which has been proven for inguinal hernia repair [9–11]. Our own clinical experience, however, showed that after laparoscopic incisional hernia repair, the patients suffered from severe pain. The early literature described a reduced need for narcotics after laparoscopic repairs compared with conventional procedures [3–6]. Even today, a review of incisional hernia repair concluded that laparoscopy is superior compared with open techniques in terms of postoperative pain [7]. However, Pierce et al. [1] described in their analysis that »unlike most other laparoscopic procedures where incisional pain is typically minimal and relatively short lived, laparoscopic incisional hernia repair is associated with substantially more pain in the postoperative period because of the methods of mesh fixation.« Our data clearly show that our patients experienced annoying pain in the early postoperative period. The use of an elastic mesh, the properties of which are comparable to the human abdominal
236
31
Chapter 31 · Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair
wall [12], is associated with significantly reduced pain scores. For inguinal hernias, it is known that the level of pain in the early postoperative period strongly correlates with chronic pain problems [13], thus supporting the recommendation that elastic meshes should be preferred. A correlation between acute and chronic pain could not be established in our series. The number of patients studied up to now is probably too small. Some major prospective studies and reviews have observed prolonged or chronic pain in up to 9% of patients [1, 2, 8]. Unfortunately, a definition of prolonged pain is not generally given that would enable comparison among different publications. The prolonged pain is usually explained by the fixation devices, mostly transfascial sutures and tacks [4]. Local anaesthesia is recommended, followed by removal of stay sutures or tacks in otherwise untreatable cases [4]. In one series with 1.6% persistent pain, the removal of tacks or stay sutures did abolish the pain in three of six patients [14]. The success rate is not given in any other series. In our series, chronic pain resolved spontaneously after conservative treatment in all cases. However, one patient was significantly restricted in his daily activities for almost 6 months. In conclusion, laparoscopic repair of incisional hernias is a painful treatment needing subsequent analgesic postoperative therapy. Dynamesh IPOM, which exhibits a physiological elasticity [12], significantly reduces the pain level in the early postoperative period. The number of patients studied does not allow any conclusion about the nature of chronic pain. An association between acute and chronic pain could not be established for laparoscopic incisional hernia repair.
References 1. Pierce RA, Spitler JA, Frisella MM, Matthews BD, Brunt LM (2007) Pooled data analysis of laparoscopic vs. open ventral hernia repair: 14 years of patient data accrual. Surg Endosc 21:378–386 2. Carlson MA, Frantzides CT, Shostrom VK, Laguna LE (2008) Minimally invasive ventral herniorrhaphy: an analysis of 6,266 published cases. Hernia 12:9–22 3. Carbajo MA, Martin DOJ, Blanco JI, de la Cuesta C, Toledano M, Martin F, Vaquero C, Inglada L (1999) Laparoscopic treatment vs open surgery in the solution of major
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
incisional and abdominal wall hernias with mesh. Surg Endosc 13:250–252 Heniford BT, Park A, Park AF, et al. (2003) Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 238:391–400 LeBlanc KA, Booth WV, Whitaker JM, Bellanger DE (2001) Laparoscopic incisional and ventral herniorraphy: our initial 100 patients. Hernia 5:41–45 Park A, Birch DW, Lovrics P (1998) Laparoscopic and open incisional hernia repair: a comparison study. Surgery 124:816–821 Misiakos EP, Machairas A, Patapis P, Liakakos T (2008) Laparoscopic ventral hernia repair: pros and cons compared with open hernia repair. JSLS 12:117–125 Stickel M, Rentsch M, Clevert DA, Hernandez-Richter T, Jauch KW, Lohe F, Angele MK (2007) Laparoscopic mesh repair of incisional hernia: an alternative to the conventional open repair? Hernia 11:217–222 Bringman S, Ramel S, Heikkinen TJ, Englund T, Westman B, Anderberg B (2003) Tension-free inguinal hernia repair: TEP versus mesh-plug versus Lichtenstein: a prospective randomized controlled trial. Ann Surg 237:142–147 Collaboration EH (2000) Laparoscopic compared with open methods of groin hernia repair: systematic review of randomized controlled trials. Br J Surg 87:860–867 Grant AM (2002) Laparoscopic versus open groin hernia repair: meta-analysis of randomised trials based on individual patient data. Hernia 6:2–10 Junge K, Klinge U, Prescher A, Giboni P, Niewiera M, Schumpelick V (2001) Elasticity of the anterior abdominal wall and impact for reparation of incisional hernias using mesh implants. Hernia 5:113–118 Callesen T, Bech K, Kehlet H (1999) Prospective study of chronic pain after groin hernia repair. Br J Surg 86:1528– 1531 Wassenaar EB, Raymakers JT, Rakic S (2007) Removal of transabdominal sutures for chronic pain after laparoscopic ventral and incisional hernia repair. Surg Laparosc Endosc Percutan Tech 17:514–516
Discussion Flament: When you report about the hernia size
you spoke only about the diameter. But there is still another dimension: The volume of herniated bowel. Therefore we do a CT-scan before the operation to measure the volume of the bowel in the abdominal cavity and the volume of the herniated bowel to exactly estimate the size of the hernia. Berger: Your approach is very sophisticated and would be the best of course. Schippers: You use a minimal invasive approach and you use a bridging technique and you have a
237 Chapter 31 · Acute and Chronic Pain After Laparoscopic Incisional Hernia Repair
long period of postoperative pain. What is your explanation of this pain? Berger: I can only speculate. I think that a fixation trough the peritoneum is the main problem. Chowbey: A secret of good result in laparoscopic hernia repair depends on the selection of patients. In what cases laparoscopic hernia repair can be done and what cases it cannot be done laparoscopically? Another thing is the number of used tackers for the mesh fixation. If you use too much tackers the risk of pain raises. Berger: I agree concerning your remark about the number of tackers. However, I never found a recommendation of the number of tackers used in study dealing with laparoscopic hernia repair. Of course there are some hernias that cannot be repaired laparoscopically. If we cannot reach an adequate overlap – at least five centimeters on both sites – we do an open procedure.
31
32
Effect of Nerve Identification on the Rate of Postoperative Chronic Pain Following Inguinal Hernia Surgery S. Alfieri, D. Di Miceli, R. Menghi, G. Quero, C. Cina, G. B. Doglietto
240
Chapter 32 · Effect of Nerve Identification on the Rate of Postoperative Chronic Pain Following Inguinal Hernia Surgery
Introduction The ilioinguinal nerve, iliohypogastric nerve, and inguinal segment of the genital branch of the genitofemoral nerve all cross the inguinal channel and consequently are vulnerable to injury. But if they are injured, is there any evidence that they can produce pain syndromes? Should a suspected injured nerve or a nerve in the way of repair be cut (divided), resected, or left in place? Should the cut end of the nerve be left exposed or buried in the muscle? Much controversy still exists regarding how to treat these three inguinal nerves during hernia repair, with many published studies showing contrasting results. Consequently, it is right to wonder about the following: ▬ Do the inguinal nerves really play a role in the genesis of postherniorrhaphy inguinodynia and orchialgia? ▬ Is there any scientific evidence today that chronic pain is related to the different treatment reserved for the three inguinal nerves during hernia repair?
32
In trying to give scientific answers to these questions, we have evaluated not only the levels of evidence (LE) and grades of recommendation (GR) for every published study in this field, but we also read each paper in its entirety and evaluated its statistical validity and the terminology used. It is not surprising that we discovered some discrepancies between the data found in the article and the conclusions extrapolated by systematic reviews (LE, 1a; GR, A).
Definitions and Terminology An important issue is the need to provide uniform terminology to be used in this field. In fact, the terms division, resection, dissection, transection, section, and neurectomy were often used and reported incorrectly in the literature, which influenced and distorted the real results of the studies, with important and practical implications involving the treatment of chronic pain [1]. A clear example of this is demonstrated by the wrong interpretation of the study by Picchio et al.
[2], which is often cited as demonstrating that pain is not affected by elective division of the ilioinguinal nerve. However, when reading the whole paper, it is possible to learn that the authors actually performed a neurectomy (dividing the nerve lateral to the internal ring) instead of a simple division of the nerve in the operative field. Consequently, the results of this paper not only have often been distorted but also may give the erroneous message that the nerves may be sectioned during operation at any level of the inguinal canal without any consequence [3]. With the aim of providing uniform terminology, the international consensus conference held in Rome in April 2008 decided to recommend the following nomenclature: ▬ Cutting or dividing a nerve means interrupting the continuation of a nerve. It is appropriate to mention the way the cut ends were handled, such as by ligation, cauterisation, or nothing. ▬ Resection of a nerve or neurectomy means removing the segment of a nerve along the inguinal canal. It is recommended to cut the proximal end up to its intramuscular part. It is appropriate to mention the handling of the cut ends and the proximal and distal parts of the section.
Is There Any Correlation Between Chronic Pain and Identifying vs. Not Identifying the Three Inguinal Nerves? Although it has been demonstrated that preoperative identification of all inguinal nerves is almost always possible [4], the majority of surgeons continue to not detect them, as recently emphasised and confirmed for the iliohypogastric nerve (detected in only 32% of cases) and for the genital branch of the genitofemoral nerve (detected in only 36% of cases) [5]. In fact, the vast majority of the studies report data for only one nerve (generally the ilioinguinal nerve, probably because is the easiest to recognise during hernia repair) without giving any data concerning the other two nerves, neglecting the fact that all three nerves contribute to the sensory innervation of the groin.
241 Chapter 32 · Effect of Nerve Identification on the Rate of Postoperative Chronic Pain
An Italian prospective multicentre study of 973 cases and a French single-centre study of 1,332 cases are the only two published studies presenting results for all three inguinal nerves (2,305 cases altogether) with a long follow-up period (1–5 years) [6, 7]. Both studies concluded that identification and preservation of all three inguinal nerves (which occurred in 924 patients considering the two papers together) during open inguinal hernia repairs (with or without mesh) reduces chronic incapacitating groin pain to less than 1%; the mean incidence of chronic pain was 0.8% (range 0–1.6%). The Italian study also demonstrated that the risk of developing inguinal pain increased with the number of nerves concomitantly undetected. Likewise, the division of nerves strongly correlated with the presence of chronic pain [7]. According to the data in the literature, we can conclude that identifying and protecting the three inguinal nerves decreases the risk of postoperative severe chronic pain.
Should the Identified Nerve Be Preserved, Divided, or Resected (Neurectomy)? All of the published studies report data concerning division versus preservation of only a single nerve, without giving any data concerning the other two nerves. In all of these papers, the results are distorted because the nerves not considered could have been unintentionally divided or injured during operation. For these reasons, chronic pain could be generated [8]. The studies by Ravichandran et al. [9] (LE, 2b; GR, B) and Mui et al. [10] (LE, 1b; GR, A) report results of preservation versus neurectomy of only one single nerve, and these results are also limited by very small sample sizes, with only 20 patients and 50 patients in each arm. Therefore, these studies do not have substantial statistical power compared with the study of Dittrik et al. [11] (LE, 2b; GR, B), which also did not have homogeneous distribution between the two arms (66 patients versus 24 patients). In these cases, no conclusions can be evaluated, even if some studies are prospective and ran-
32
domised and apparently have the highest recommendation grade [3]. These underpowered studies are sometimes used in meta-analyses or reviews by calculating a pooled mean percentage by means of a randomised model to reach some conclusions. However, data coming out of such a model that uses small studies are completely distorted. Picchio et al. [2] (LE, 1b; GR, A) reported that pain is not affected by elective division of the ilioinguinal nerve. However, by reading the whole paper (with 400 patients in each arm), one discovers that the author actually performed more of a neurectomy (dividing the nerve lateral to the internal ring) than a simple division of the nerve in the operative field. The results of this paper have been often distorted; in fact, some authors wrongly reported that the nerve was »divided,« and others stated that the nerve was dissected, without explaining that even if Picchio et al. did not report where the nerve was divided caudally, they divided the nerve lateral to the internal ring. Merely concluding that division/dissection of the ilioinguinal nerve does not increase or reduce the risk of chronic pain not only distorts the researchers’ results, but, more importantly, it may give the erroneous message that the nerves may be sectioned during operation at any level of the inguinal canal without any consequence. Picchio et al. [2] (LE, 1b; GR, A) report that pain is not affected by elective neurectomy (according to the new nomenclature of the consensus conference) of the ilioinguinal nerve, and Pappalardo et al. [12] report this for iliohypogastric neurectomy. According to the literature, we can conclude that identification and protection of all three nerves during open inguinal hernia repair (with or without mesh) reduces the risk of chronic incapacitating pain to less than 1%.
Should the Identified Nerve Be Isolated or Left in its Natural Bed Without Manipulation, Taking Care To Not Remove the Covering Fascia of the Nerve? No published data are available regarding manipulation versus no manipulation of a preserved nerve. However, considering the anatomical stud-
242
Chapter 32 · Effect of Nerve Identification on the Rate of Postoperative Chronic Pain Following Inguinal Hernia Surgery
ies [4], we suggest (LE, 5; GR, D) leaving the the nerves in their natural bed as much as possible and not removing the covering fascia.
Should a Suspected Injured Nerve or a Nerve in the Way of Repair Be Saved by All Means or Resected?
32
The current literature is inconsistent concerning this point. Opinions differ considerably, but no published data are actually available. Some authors emphasise that when an injury has occurred, the intramuscular portion of the nerve must be resected, stating that merely dividing the nerve at the point of its emergence is inadequate [3, 5]. These data are supported by the increasing success rates of pain relief with extended versus standard neurectomy procedures, as obtained by Amid et al. [5] for patients with chronic postherniorrhaphy pain (LE, 4; GR, C) and by Alfieri et al. [6], who reported that the increased risk of developing chronic pain with the number of nerves divided could be explained by the fact that resection of the unidentified nerve has generally been performed distal to its origin; this leaves the site of the injured nerve intact–and able to continue to generate a pain signal–and exposes it to neuroma formation (LE, 5; GR, D). At the same time, there is no scientific evidence that the cut end of the nerve should be left exposed or buried in the muscle. While we await definitive results in the literature, it is reasonable to remove a suspected injured nerve or a nerve in the way of the repair during any type of repair and to implant the proximal cut end in the muscle (LE, 5; GR, D).
How Can the Inguinal Segment of the Genital Branch of the Genitofemoral Nerve Be Identified and Protected During the Open Procedure? Identifying and protecting the inguinal segment of the genital branch nerve during hernia repair is not difficult. It can be recognised, identifying and keeping the external spermatic vein (the socalled blue line) with the cord. However, the geni-
tal branch nerve can be damaged if inadvertently sectioned, entrapped, or secured (for example, if a continuous suture is introduced along the inguinal ligament), or it can be injured if the external spermatic vessels are divided to skeletonise the cord without its identification.
Should the Cremasteric Layer Be Saved or Resected? No published data are available in the literature. However, it is advisable for hernia mesh repair to save the cremasteric layer to reduce the risk of ilioinguinal and genital branch nerve damage and thus avoid possible incapacitating and chronic postoperative pain (LE, 5; GR, D).
Should the Cut Ends of the Nerve Be Left Alone, Ligated, or Cauterised? No scientific data are reported in the literature concerning the treatment of the cut ends of the nerves.
When Glue Is Used, Should We Still Identify and Protect the Nerves? No data are present in the literature concerning whether nerves should be identified and protected even if glue is used. However, it is reasonable to consider that nerves should be identified and protected in any case (LE, 5; GR, D).
Is There Convincing Evidence that Prophylactic Division or Resection of Nerves During Hernia Repair Will Reduce the Rate of Chronic Pain? Three randomised trials examined the effect of prophylactic neurectomy on chronic pain [2, 9, 10]. In all of the trials, the ilioinguinal nerve was either divided or partially resected and the patients assessed for pain, numbness, and touch and pain sensation at 1, 6, and 12 months. None of the
243 Chapter 32 · Effect of Nerve Identification on the Rate of Postoperative Chronic Pain
studies found differences in pain or numbness, although one found significant improvements in activities such as cycling and walking in favour of the nerve division group. In a prospective multicentre study of 973 patients undergoing inguinal hernia repair in which all nerves were identified [6], nerve division was associated with an increased risk of moderate to severe pain. According to the published results in the literature, we can conclude that there is no evidence that prophylactic neurectomy reduces chronic pain after inguinal hernia repair. On the contrary, indirect evidence suggests that identification and preservation of all nerves may be beneficial. However, further studies addressing this issue are required.
Conclusions The data would suggest that if one or more nerves is not detected during surgery, it is possible that they could be inadvertently sectioned, entrapped, or secured (for example, if a continuous suture is introduced along the inguinal ligament), or they could be injured (such as if the external spermatic vessels are divided to skeletonise the cord). It should not be forgotten that nerves are most often injured when the surgeon is unaware of their location and course, or when he or she fails to recognise them during surgery. Caution is stressed when teaching this common procedure to resident physicians. Finally, it is very important to develop a uniform terminology for this field in order to better analyse and compare the studies and thereby avoid giving wrong messages to the community.
4.
5.
6.
7.
8.
9.
10.
11.
12.
32
preserve the 3 inguinal nerves during hernia repair? Ann Surg 2008; 247(6) Wijsmuller, A.R., et al. Nerve-identifying inguinal hernia repair: a surgical anatomical study. World J Surg 2007; 31(2):414–420; discussion 421–422 Amid P.K., Hiatt J.R. New understanding of the causes and surgical treatment of postherniorrhaphy inguinodynia and orchialgia. J Am Coll Surg 2007; 205(2):381–385 Alfieri S., Rotondi F., Di GiorgioA., Fumagalli U., Salzano A., Di Miceli D., Ridolfini M.P., Sgagari A., Doglietto G.B., Groin Pain Trial Group. Influence of preservation versus division of ilioinguinal, iliohypogastric, and genital nerves during open mesh herniorrhaphy: prospective multicentric study of chronic pain. Ann Surg 2006; 243(4):553–558 Izard G., Gailleton R., Randrianasolo S., Houry R. Treatment of inguinal hernias by McVay’s technique in a series of 1332 cases. Ann Chir 1996; 50(9):755–756 Alfieri S., Di Miceli D., Doglietto G.B. Prophylactic ilioinguinal neurectomy in open inguinal hernia repair. Ann Surg 2007; 245(4):663 Ravichandran D., Kalambe B.G., Pain J.A. Pilot randomized controlled study of preservation or division of ilioinguinal nerve in open mesh repair of inguinal hernia. Br J Surg 2000; 87(9):1166–1167 Mui W.L., Ng C.S., Fung T.M., Cheung F.K., Wong C.M., Ma T.H., Bn M.Y., Ng E.K. Prophylactic ilioinguinal neurectomy in open ilioinguinal repair: a double-blind randomized controlled trial. Ann Surg 2006; 244(1):27–33 Dittrick G.W., Ridl K., Kuhn J.A., McCarty T.M. Routine ilioinguinal nerve excision in inguinal hernia repairs. Am J Surg 2004; 188(6):736–740 Pappalardo G., Frattaroli F.M., Mongardini M., Salvi P.F., Lombradi A., Conte A.M., Arezzo M.F. Neurectomy to prevent persistent pain after inguinal herniorrhaphy: a prospective study using objective criteria to assess pain. World J Surg 2007; 31(5):1081–1086
Discussion Amid: To present the results of the consensus con-
ference in ten minutes is not enough time. Schippers: One of your recommendations was to
References 1. Alfieri S., Di Miceli D., Doglietto G.B. Re: nerve management during open hernia repair Br J Surg 2007; 94(7):914 2. Picchio M., Palimento D., Attanasio U., Matarazzo P.F., Bambini C., Caliendo A. Randomized controlled trial of preservation or elective division of ilioinguinal nerve on open inguinal hernia repair with polypropylene mesh. Arch Surg 2004; 139(7):755–758 3. Alfieri S. Is there a consensus concerning the relationship between post-operative chronic pain and treatment to
leave the nerve where it was. You recommend not touching the nerve anyway. But with this recommendation you have problems to do the Shouldice repair properly. Alfieri: But this is just a personal comment and the evidence level is very low.
33
Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair: A Report from the SMIL Study Group A. Montgomery
246
Chapter 33 · Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair
Introduction
33
Hernia recurrence used to be the main outcome measurement when reporting on the results of inguinal hernia surgery. Today the problem of recurrence is limited as a result of standardised mesh techniques. A recurrence does not always result in a problem for the patient, and if it does, it can usually be resolved after a new repair. Chronic pain and discomfort is considered to be the most important outcome measure of inguinal hernia repair. Chronic pain and discomfort are often difficult to handle, and even small constant problems can be an annoying reminder to the patient of the former hernia. This is why the indications for surgery must be very strict. The study on »watchful waiting« in patients with very mild symptoms is therefore of great importance in this respect [1]. Chronic pain is commonly defined as pain or discomfort that lasts for more than 3 months postoperatively. The incidence of chronic pain varies widely in different publications: between 0% and 75% in open mesh repair and between 0% and 29% after laparoscopic hernia repair [2–4]. Most of the problems are described as mild discomfort. Pain affecting daily activities has been reported to be as high as 5–6% [5, 6]. Some authors claim that mesh repair results in less chronic pain than nonmesh repair and that laparoscopic repair is more favourable than open mesh repair in this regard [7–9]. The lack of description and definition of postherniorrhaphy pain and discomfort is a problem, making it impossible to compare the results from different studies. Professor Kehlet from Denmark and his colleagues have called for »uniform assessment on postherniorrhaphy pain« to facilitate interpretation of further studies [10]. Such assessment is complicated, though, and must take many aspects into account. Fränneby et al. have attempted this by constructing an 18-question form, a specific inguinal pain questionnaire called the IPQ, which has been validated [11]. Another problem is that the patients who are included in different studies often show a mixture of different techniques for both open and laparoscopic repair and for primary and recurrent hernias, and there are variations in the length of follow-up. An additional complication is the number of patient
drop-outs for the long-term follow-up. The method of follow-up is also important. A clinical examination and a standardised protocol are seldom used. Several large randomised studies comparing laparoscopic to open repair for primary unilateral inguinal hernias with a long follow-up have been performed, with a primary end point of recurrence rate. Most of these studies were initiated during the 1990s. Chronic pain is reported as a secondary end point [12–15]. The SMIL study group described below has reported on some large randomised studies. This chapter mainly concentrates on the discussion of chronic pain and discomfort from the first study–SMIL I.
SMIL Study Group The Swedish Multicentre Trial of Inguinal Hernia Repair by Laparoscopy study group (SMIL for short) was formed in 1993 to evaluate the possible benefit of laparoscopic repair compared with open techniques. The aim was to conduct well-designed large multicentre randomised controlled trials within general surgeon practices in the normal clinical setting. The group has conducted two large studies comparing laparoscopic and open repair. SMIL I started in 1993 and compares transabdominal preperitoneal (TAPP) repair with Shouldice repair for primary inguinal hernias. This study has resulted in three publications [16–18]. SMIL II was the second large study, initiated in 1996 as a result of the development of both the laparoscopic and the open inguinal hernia repair techniques. At that time, the totally extraperitoneal (TEP) technique had been introduced, avoiding the transabdominal approach. At the same time, larger meshes were recommended for a larger overlap of the hernial orifices, with the aim of reducing the risk of a recurrence. In this study, TEP was compared with the open mesh technique of Lichtenstein, which was the gold standard at that time. This study has resulted in two publications, and another two have been submitted [19, 20]. The third study is an early study of the use of small meshes in the laparoscopic group, comparing TAPP with Lichtenstein for recurrent hernias. This has resulted in one publication [21].
33
247 Chapter 33 · Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair
All three studies were designed with a primary end point of recurrence after 5 years.
TAPP vs. Shouldice–SMIL I The TAPP technique was compared to the open Shouldice operation in primary inguinal hernias in male patients between 30 and 70 years of age. A total of 25 board-certified surgeons using either tech-
Have you noticed signs of recurrence of your hernia (a bulge in the operated groin)? Yes
No
Do you have any other complaints? Yes
No
nique from seven different hospitals participated in the study. Both preoperative and perioperative variables were recorded, and short-term outcomes regarding pain were recorded on a visual analogue scale (VAS) daily during the first week. The patient’s functional status was also recorded. A clinical exam was performed at 1 and 5 years postoperatively, looking for recurrences and complaints, and a written questionnaire was answered at 1, 2, 3, and 5 years. The patient was asked to describe his experience of any discomfort after the operation according to the form depicted in ⊡ Fig. 33.1. In cases of suspected recurrence or severe complaints, the patient was examined clinically. Complaints were graded according to the definitions of discomfort described in ⊡ Fig. 33.2. Two independent and blinded observers performed the grading. A consensus discussion was held when opinions differed.
If yes, describe them here.
Results
⊡ Fig. 33.1. Form used by the patient to describe complaints after inguinal hernia surgery
Mild:
Occasional discomfort or pain that does not interfere with daily life
Moderate: Occasional discomfort or pain that interferes with daily life Severe:
Daily discomfort and pain that interferes with daily life
⊡ Fig. 33.2. Definitions of discomfort
A total of 1,068 patients were operated on within the study. Patient characteristics were similar in the two groups. A total of 867 patients (81.2%) were eligible for analysis after 5 years. Levels of discomfort and pain in the two groups at the different time points are reported in ⊡ Table 33.1. The total percentage of patients who experienced discomfort of any kind was 8.5% in the TAPP group and 11.4% in the Shouldice group, with no significant difference between the groups. Although discomfort was usually mild, it was severe in 0.2% of the laparoscopic group and 0.7% of the open repair group. Severe pain the first postoperative week was the only risk factor for late discomfort in the Shouldice group [odds ratio (OR) 2.25, P=0.022].
⊡ Table 33.1. Grade of discomfort at different time points in the SMIL I study (TAPP transabdominal preperitoneal) 1 Year
2 years
3 years
5 years
Tapp
Open
Tapp
Open
Tapp
Open
Tapp
Open
Mild
9.4
10.5
8.9
13.4
9.2
10.6
5.5
7.9
Moderate
3.1
3.4
2.2
2.8
2.3
3.8
2.8
2.8
Severe
0.2
0
0
0.2
0
0
0.2
0.7
Total
12.7
13.9
11.2
16.4
11.5
14.4
8.5
11.4
248
Chapter 33 · Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair
No other risk factor for late discomfort was found in either group.
Discomfort in SMIL I Compared with SMIL II The SMIL II study had the same protocol as SMIL I, but the operating techniques were different, as described above. A total of 1,370 patients were operated on, and 1,275 had a 5-year follow-up. Having the same protocol enables more appropriate comparison of all four techniques regarding postoperative pain. Discomfort at 1, 2, 3, and 5 years is shown in ⊡ Fig. 33.3. There was a statistically difference between Shouldice and TAPP only at the 2-year point. There was a statistically significant difference between Lichtenstein and TEP at all time points in favour of the TEP technique. The risk of having chronic pain was approximately twice as high in the Lichtenstein group as in the other groups at all time points; almost 20% in the Lichtenstein group reported discomfort at all time points.
%
*
The number of patients classified as having severe pain was low in both groups. Patients with severe or moderate pain were therefore merged, creating the moderate/severe pain group. The results are demonstrated in ⊡ Fig. 33.4. There was a statistically significant trend over time for a decrease in frequency of moderate/severe chronic pain for Lichtenstein repair but not for the other techniques. In a multivariable analysis, risk factors for chronic pain in the TEP group were impairment in the physical test after 1 week, longer recovery time than the median, and weight below the 3rd quartile. For the Lichtenstein group, the risk factor was pronounced postoperative pain.
Discussion Discomfort and chronic pain was not the primary end point in any of the large randomised studies comparing laparoscopic and open hernia inguinal hernia repair. Altogether, there are four studies on
*
*
*
20
33
*
18 16 14
TAPP Shouldice TEP Lichtenstein
12 10 8 6 4 2 0 1
2
3
5
years
⊡ Fig. 33.3. Total amount of discomfort for different techniques at different time points in the SMIL I and II studies. Significant differences between groups are indicated by an asterisk (*)
249 Chapter 33 · Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair
chronic pain besides the SMIL studies, including more than 400 patients [12–15]. There are huge differences in these studies in follow-up time, which varies between 1 and 5 years. There are also huge differences in the percentage of attendees at the last follow-up, varying between 61% and 96%. The definition of chronic pain is also difficult to compare among the studies, but all studies report less pain with the laparoscopic technique. However, this varies in the studies, too, being between 0% and 18% for the laparoscopic technique and between 1% and 20% for the open techniques. The overall percentage of chronic pain at 5 years in the SMIL I study was 8.5% for TAPP and 11.4% for Shouldice. This difference is, however, not significant. In SMIL II there was a bigger difference between chronic pain in the TEP-operated and Lichtenstein groups–9% and 19%, respectively. However, the high attendance, with clinical examination and a standardised questionnaire, at 5-year follow-up in both SMIL studies is one of the SMIL studies’ strengths. A heavy polypropylene mesh was fixated using a stapling device in both the TAPP and TEP
33
procedures. The same mesh was used for the Lichtenstein operation. In recent research, anchoring of the mesh has been discussed as one cause of chronic pain. Several randomised studies have been performed on different fixation techniques, showing advantages for the nonfixated or glued mesh in endoscopic methods [22–25]. The advantage of less pain by using a low-weight mesh with large pores has also been discussed [26, 26]. All in all, the endoscopic preperitoneal technique seems to be more favourable for patients from the aspect of preventing chronic pain and discomfort. Development of new meshes and avoidance of fixation might favour the patients even further.
References 1. Fitzgibbons RJ, Giobbie-Hurder A et al. (2006) Watchful waiting vs repair of inguinal hernia in minimally symptomatic men. A randomized clinical trial. JAMA 295:285– 292 2. Nienhuijs SW, van Oort I, Keemers-Gels ME, Strobbe LJA, Rosman C. (2005) Randomized clinical trial comparing
% 20 18 16 14 TAPP Shouldice TEP Lichtenstein
12 10
*
8
*
6 4 2 0 1
2
3
5
years
⊡ Fig. 33.4. Moderate or severe discomfort for different techniques at different time points in the SMIL I and II studies. Significant differences between groups are indicated by an asterisk (*)
250
3.
4.
5.
6.
7.
8.
9.
10.
11.
33 12.
13.
14.
15.
Chapter 33 · Discomfort 5 Years After Laparoscopic and Shouldice Inguinal Hernia Repair
the Prolene Hernia System, mesh plug repair and Lichtenstein method for open inguinal hernia repair. Br J Surg 92:33–38 Poolban AS, Bruce J, Smith WC, King PM, Krukowski ZH, Chambers WA. (2003) A review of chronic pain after inguinal herniorrhaphy. Clin J Pain 19(1):48–54 PageB, Paterson C, Young D, O´Dwyer PJ. (2002) Pain from primary inguinal hernia and the effect of repair on pain. Br J Surg 89(10):1315–1318 Kalliomäki ML, Sandblom G, Gunnarsson U, Gordh T. (2009) Persistent pain after groin hernia surgery: a qualitative analysis of pain and its consequences for quality of life. Acta Anaesthesiol Scand 53(2):236-246 Fränneby U, Sandblom G, Nordin P, Nyrén O, Gunnarsson U. (2006) Risk factors for long-term pain after hernia surgery. Ann Surg 244(2):212–219 Schmedt C-G, Sauerland S, Bittner R. (2005) Comparison of endoscopic procedures vs Lichtenstein and other open mesh techniques for inguinal hernia repair. A meta-analysis of randomized controlled trials. Surg Endosc 19:188–199 Bittner R, Sauerland S, Schmedt C-G. (2005) Comparison of endoscopic techniques vs Shouldice and other open nonmesh techniques for inguinal hernia repair. A metaanalysis of randomized controlled trials. Surg Endosc 19:605–615 McCormack K, Scott NW, Go PM, Ross S, Grant AM and the EU Hernia Trialists Collaboration. (2003) Laparoscopic techniques versus open techniques for inguinal hernia repair. Cochrane Database Syst Rev (1)CD001785 Kehlet H, Bay-Nielsen M, Kingsnorth A. (2002) Chronic postherniorrhaphy pain–a call for uniform assessment. Hernia 6:178–181 Fränneby U, Gunnarsson U, Andersson U, Heuman R, Nordin P, Nyrén O, Sandblom G. (2008) Validation of an inguinal pain questionnaire for assessment of chronic pain after groin hernia repair. Br J Surg 95(4):488–493 Grant AM, Scott NW, O´Dwyer PJ, on behalf of the MRC Laparoscopic Groin Hernia Trial Group. (2004) Fiveyear follow-up of a randomized trial to assess pain and numbness after laparoscopic or open repair of groin hernia. Br J Surg 91:1570–1574 Liem MSL, Van Der Graaf Y, Van Steensel CJ, Boelhouwer RU, Clevers GJ, Meijer WS, Stassen LP, Vente JP, Weidema WF, Schrijvers AJ, van Vroonhoven TJ. (1997) Comparison of conventional anterior surgery and laparoscopic surgery for inguinal hernia repair. N Engl J Med 336:1541– 1547 Johansson B, Hallerbäck B, Glise H, Anesten B, Smedberg S, Román J. (1999) Laparoscopic mesh versus open preperitoneal mesh versus conventional technique for inguinal hernia repair: a randomized multicenter trial (SCUR Hernia Repair Study). Ann Surg 230(2):225–231 Neumayer L, Giobbe-Hurder A, Jonasson O, Fitzgibbons R Jr, Dunlop D et al. (2004) Open mesh versus laparoscopic mesh repair of inguinal hernia. N Engl J Med 350:1819– 1827
16. Berndsen F, Arvidsson D, Enander L-K, Leijonmarck CE, Wingren U, Rudberg C, Smedberg S, Wickbom G, Montgomery A. (2002) Postoperative convalescence after inguinal hernia surgery: prospective randomised multicenter study of laparoscopic versus Shouldice inguinal hernia repair in 1042 patients. Hernia 6:56–61 17. Arvidsson D, Berndsen FH, Larsson LG, Leijonmarck CE, Rimback G, Rudberg C, Smedberg S, Spangen L, Montgomery A. (2005) Randomized clinical trial comparing 5-year recurrence rate after laparoscopic versus Shouldice repair of primary inguinal hernia. Br J Surg 92:1085–1091 18. Berndsen F, Petersson U, Arvidsson D, Leijonmarck C, Rudberg C, Smedberg S, Montgomery A. (2007) Discomfort five years after laparoscopic and Shouldice inguinal hernia repair: a randomised trial with 867 patients. A report from the SMIL study group. Hernia 11(4):307–313 19. Ekelund A, Rudberg C, Smedberg S, Enander LK, Leijonmarck CE, Österberg J and Montgomery A. (2006) Shortterm results of a randomized clinical trial comparing Lichtenstein open repair with totally extraperitoneal laparoscopic inguinal hernia repair. Br J Surg 93:1060–1068 20. Eklund A, Montgomery A, Rasmussen I, Sandbue R, Bergkvist L, Rudberg C. (2009) Low recurrence rate after laparoscopic (TEP) and open (Lichtenstein) inguinal hernia repair. Ann Surg 249(1):33–38 21. Eklund A, Rudberg C, Leijonmarck CE, Rasmussen I, Spangen L, Wickbom G, Wingren U, Montgomery A. (2007) Recurrent inguinal hernia: randomized multicenter trial comparing laparoscopic and Lichtenstein repair. Surg Endosc 21:634–640 22. Taylor C, Layani L, Liew V, Ghusn M, Crampton N, White S. (2008) Laparoscopic inguinal hernia repair without mesh fixation: early results of a large randomised clinical trial. Surg Endosc 22(3):757–762 23. Olmi S, Scaini A, Erba L, Guaglio M, Groce E. (2007) Quantification of pain in laparoscopic transabdominal preperitoneal (TAPP) inguinal hernioplasty identifies marked differences between prosthesis fixation systems. Surgery 142(1): 40–46 24. Lovisetto F, Zonta S, Rota E, Mazzilli M, Bardone M, Bottero L, Faillace G, Longoni M. (2007) Use of human fibrin glue (Tissucol) versus staples for mesh fixation in laparoscopic transabdominal preperitoneal hernioplasty: a prospective, randomized study. Ann Surg 245(2):222–231 25. Lau H. (2005) Fibrin sealant versus mechanical stapling for mesh fixation during endoscopic extraperitoneal inguinal hernioplasty. A randomised prospective trial. Ann Surg 242:670–675 26. O’Dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G. (2005) Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 92:166–170 27. Junge K, Klinge U, Rosch R, Klosterhalfen B, Scumpelick V. (2002) Functional and morphologic properties of a modified mesh for inguinal hernia repair. World J Surg 26:1472–1480
34
Recurrence or Complication: The Lesser of Two Evils? A Review of Patient-Reported Outcomes from the VA Hernia Trial L. Neumayer
252
Chapter 34 · Recurrence or Complication: The Lesser of Two Evils?
Introduction Inguinal hernia is one of the most common disease states affecting men worldwide. The direct and indirect costs of this condition, with or without repair, are great. Recent studies have questioned the need for repair in asymptomatic patients; however, in both of these studies, pain and discomfort were the main reasons for a crossover to repair from the »watchful waiting« group [1, 2]. Pain is now recognized as a common complication after hernia repair. In this review we intend to address, using previously reported data [3–5], the issue of whether a recurrence–which is viewed by most surgeons as a negative outcome–is worse for the patient in the long term than pain or other complications. Further, we review predictors of complications that may help guide surgeons in the choice of operation for individual patients.
Methods
34
The methods of the U.S. Department of Veteran Affairs (VA) hernia trial comparing laparoscopic versus open tension free hernia repair, as well as the analyses performed for evaluation of patientreported outcomes and predictors of complications, have been previously reported [3–6]. The study was designed to detect a 3% difference in recurrence at 3 years and to evaluate other surgeoncentered and patient-centered outcomes (complications/death, pain, functional status, activity levels, caregiver burden, and cost). In addition, we measured patient and surgeon satisfaction. As part of this large study, two new instruments, the Surgical Pain Scale (SPS) and the Activities Assessment Scale (AAS), were developed and validated [7, 8]. All results reported herein have been previously reported [3–6]. This report serves as an amalgamation of prior analyses. As a post hoc analysis, we also evaluated the relationship between patient-reported outcomes (PROs) and recurrence or complications [4]. In particular, we sought to determine the impact of recurrence and other complications on overall patient outcome as measured by the Medical Out-
comes Study Short Form 36 (SF-36). This analysis was limited to patients who had both preoperative and postoperative PRO assessment. Cumulative rates of recurrence and complications were used. Complications were further divided into four categories: (1) hematoma/seroma, (2) orchitis, (3) neuralgia of the leg or groin, and (4) other. Patientreported outcomes included the SF-36, the SPS, the AAS, and patient satisfaction. All of these outcomes were measured at baseline and at 2 weeks, 3 months, 6 months, and 1 and 2 years postoperatively. (Patient satisfaction, however, was not measured at 2 years.) To evaluate the relationships between preoperative and postoperative PROs, we used Pearson’s correlation coefficients. Univariate comparisons among groups were performed using analysis of variance for continuous variables and chi-square or Fisher’s exact test for categorical variables. Regression analyses were employed to determine significant predictors of postoperative PROs. As previously reported, we further analyzed predictors of short-term and long-term complications and long-term pain by initially looking for potential predictors with appropriate univariate statistics. Our initial analyses revealed different predictors for open and laparoscopic techniques, so we modeled these separately. Only outcomes with at least 50 occurrences and with p-values >0.2 in univariate comparisons were entered into regression models to ensure relative stability in the models [5].
Results As reported previously 2,134 men were randomized to Lichtenstein or laparoscopic (totally extraperitoneal or transabdominal preperitoneal) repair of their inguinal hernias [3]. Although a few patients did not undergo repair, 1,983 completed an operative intervention, and 1,696 were available for 2-year recurrence assessment. Nearly all of these patients (1,603) also had PRO data at 2 years (1,526 had PRO data at 1 year). Demographics of the patients with PRO data at 1 and 2 years were similar to those of the whole group (⊡ Table 34.1) [3, 4].
253 Chapter 34 · Recurrence or Complication: The Lesser of Two Evils?
34
⊡ Table 34.1. Demographic and outcome data, adapted from Hawn et al. [5] and Matthews et al. [6] (PRO patientreported outcome) Total study N=1,983
PRO subgroup at 2 years N=1,603
Open N (%)
Laparoscopic N (%)
Open N (%)
Laparoscopic N (%)
Recurrence
41/834 (4.9)
87/862 (10.1)
37 (4.6)
68 (8.5)
Neuralgia
99/950 (10.4)
71/943 (7.5)
67 (8.4)
53 (6.6)
Hematoma
17/950 (1.8)
50/943 (5.3)
14 (1.8)
41 (5.1)
Orchitis
7/950 (0.7)
11/943 (1.2)
6 (0.8)
11 (1.4)
Other
80/950 (8.4)
86/943 (9.1)
69 (8.6)
81 (10.1)
Patients with recurrence, a complication, or both reported scores for the AAS, SPS, and physical component portion of the SF-36 that were significantly different on univariate analyses (p<0.001) from those for patients without a recurrence or complication. Patient satisfaction also differed; 97% of patients who did not have a recurrence or complication were satisfied with their operation, whereas only 62% of those with a recurrence and 89% of those with a complication were satisfied. After adjustments were made for baseline preoperative scores and patient demographics, a recurrence did not affect the patient’s general health status as measured by the SF-36. However, patients with neuralgia or orchitis had significantly lower PCS scores than patients who did not suffer those complications. Patients with neuralgia had lower mental component scores than those without neuralgia. After open repair, patients with a recurrence had significantly more pain at rest and with activity than patients who had recurrence after laparoscopic repair. As would be expected, patients with self-reported neuralgia had higher pain scores on the SPS (10-mm difference at rest, 21-mm difference during work or exercise) compared with patients without neuralgia. Younger patients had more pain preoperatively and postoperatively than older patients did, but the magnitudes of reduction in pain scores were equivalent between younger and older patients.
Younger patients who were not actively employed prior to operation reported more limitations in activity during work or exercise as measured by the AAS. The presence of neuralgia, orchitis, or other complications also limited activity during work or exercise, but the presence of a recurrence did not limit activity during work or exercise. When operative techniques were compared, other complications after laparoscopic repair were accompanied by limitations in patient activity, whereas other complications after open repair did not seem to limit activity. Younger patients and those with a recurrence, neuralgia, or other complications were significantly less likely to be satisfied with the operation or their total hernia care when analyzed by logistic regression.
Predictors of Complications As previously reported, complications were divided into short term (occurring within 2 weeks of operation) and long term (occurring at 3 months and beyond) and occurred more frequently in patients who had undergone laparoscopic repair (39% vs. 33%, p=0.02) [3, 5]. The most common short-term complications in both the open and laparoscopic groups were wounds/scrotal hematomas/seromas and urinary retention. The most common long-term complications were seromas and chronic leg or groin pain. Wound
254
Chapter 34 · Recurrence or Complication: The Lesser of Two Evils?
⊡ Table 34.2. Predictors of complications after open repair (multivariate analysis), adapted from Matthews et al. [6] (OR odds ratio; CI confidence interval; MCS mental component score) Complications (c-index of model)
Significant predictors
Adjusted OR (95% CI)
p-value
Short-term (0.655)
Type of hernia: recurrent
2.02 (1.22, 3.32)
0.006
Hispanic ethnicity
2.94 (1.03, 8.35)
0.043
Hernia into scrotum
2.31 (1.47, 3.94)
0.0005
SF-36 MCS score: OR for each 3-unit increase
0.95 (0.92, 0.99)
0.008
Age: OR for each 5-year increase
0.90 (0.84, 0.97)
0.003
Long-term (0.624)
⊡ Table 34.3. Predictors of complications after laparoscopic repair (multivariate analysis), adapted from Matthews et al. [6] (OR odds ratio; CI confidence interval; BMI body mass index) Complications (c-index of model)
Significant predictors
Adjusted OR (95% CI)
p-value
Short-term (0.644)
Enlargement of hernia in past 6 months
1.50 (1.10, 2.05)
0.01
Duration: present for >1 year
1.59 (1.16, 2.18)
0.004
Hernia into scrotum
2.02 (1.18, 3.46)
0.011
Prostatism
1.94 (1.34, 2.81)
0.0005
Type of hernia: recurrent
2.04 (1.27, 3.27)
0.003
Prostatism
1.71 (1.14, 2.57)
0.009
BMI: OR for each 1-unit BMI increase
1.07 (1.02, 1.12)
0.006
34 Long-term (0.631)
infection was infrequent at any time for both types of repair, and no patient required mesh removal. For both techniques, having a recurrent hernia repaired increased the likelihood of short-term complications, as did the presence of a hernia extending into the scrotum (⊡ Tables 34.2 and 34.3). Prostatism was a predictor for both short-term and
long-term complications in the laparoscopic group, while younger age was associated with long-term complications in the open group. Younger age was associated with a higher likelihood of long-term pain in both open and laparoscopic groups (the adjusted odds ratio for each 5-year increase in age was 0.82 in open repairs and 0.83 in laparoscopic repairs) [5].
255 Chapter 34 · Recurrence or Complication: The Lesser of Two Evils?
Discussion The VA hernia trial comparing laparoscopic and open tension-free inguinal hernia repair in men is one of the largest ever conducted. We planned to be able to examine both surgeon-centered (recurrence, complications, and death) and patient-centered (SF-36 functional status, surgical pain, activities) outcomes for the duration of the study, which included a minimum of 2 years of follow-up. Collecting such massive amounts of data has allowed analyses of many different outcomes. Our analysis of the relationship of patient-centered outcomes to recurrences and complications is one of the few based on prospectively collected data rather than recall data from patients mailed a survey years after their herniorrhaphy. From these further analyses, we have confirmed the findings of others that chronic pain is a significant and measurable adverse effect of hernia repair and that it is more common long term after open repairs and in younger patients. We have further elucidated that for most patients, chronic pain has a deleterious effect on overall functional status, whereas recurrence, although associated with pain, in and of itself does not negatively affect functional status as measured by the physical component score of the SF-36. In our cost-effectiveness analysis, we showed that laparoscopic repair was cost-effective for a unilateral hernia; it is possible that the finding of a decreased physical component score in patients with chronic pain and no recurrence is responsible for this finding [9]. In addition, we have identified some other predictors of complications, which will require further investigation as to whether they themselves are putative risk factors or surrogates for unmeasured factors. The strength of the VA hernia trial is that it was conducted in »real-life« practices, not in highly specialized hernia or laparoscopic centers, and therefore represents the current practice of most general surgeons. As part of the trial, data were collected prospectively, allowing analyses of many secondary outcomes. A limitation is that the study was performed within the Veterans Affairs healthcare system, in which the majority of pa-
34
tients needing inguinal hernia repair are not »good risk,« thus limiting to some extent the generalizability of our results.
References 1.
2.
3.
4.
5.
6.
7.
8.
9.
Fitzgibbons RJ, Giobbie-Hurder A, Gibbs JO, Dunlop DD, Reda DJ, McCarthy M, Neumayer LA, et al. (2006) Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: a randomized clinical trial. JAMA 295(3):285–292 O’Dwyer PJ, Norrie J, Alani A, et al. (2006) Observation or operation for patients with an asymptomatic inguinal hernia. A randomized clinical trial. Ann Surg 244(2): 167–173 Neumayer L, Jonasson O, Fitzgibbons R, Henderson W, Gibbs J, Carrico CJ, Itani K, Kim L, Pappas T, Reda D, Dunlop D, McCarthy, Hynes D, Giobbie-Hurder A, London MJ, Hatton-Ward S. (2003) Tension-free inguinal hernia repair: the design of a trial to compare open and laparoscopic surgical techniques. J Am Coll Surg 196(5):743–752 Neumayer L, Giobbie-Hurder A, Jonasson O, Fitzgibbons R, Dunlop D, Gibbs J, Reda D, Henderson W. (2004) Open mesh versus laparoscopic mesh repair of inguinal hernia. N Engl J Med 350(18):1819–1827 Hawn MT, Itani K, Giobbie-Hurder A, McCarthy M, Jonasson O, Neumayer LA. (2006) Patient reported outcomes following inguinal herniorrhaphy. Surgery 140:198–205 Matthews RM, Anthony T, Kim LT, Wang J, Fitzgibbons JR, Giobbie-Hurder A, Reda DJ, Itani KMF, Neumayer LA. (2007) Factors associated with postoperative complications and hernia recurrence for patients undergoing inguinal hernia repair: a report from the VA Cooperative Hernia Study Group Am J Surg 194(5):611–617 McCarthy M, Chang CH, Pickard AS, Giobbie-Hurder A, Price DD, Jonasson O, Gibbs J, Fitzgibbons R, Neumayer L. (2005) Visual analog scales for assessing surgical pain. J Am Coll Surg 201(2):245–252 McCarthy M, Jonasson O, Chang CH, Pickard AS, GiobbieHurder A., Gibbs J, Edelman P, Fitzgibbons R, Neumayer L. (2005) Assessment of patient functional status after surgery. J Am Coll Surg 201(2):171–178 Hynes D, Sroupe K, Luo P, Giobbie-Hurder A, Reda D, Kraft M, Itani K, Fitzgibbons R, Jonasson O, Neumayer L, for the Veterans Affairs Cooperative Studies Program 456 Investigators. (2006) Cost-effectiveness of laparoscopic versus open mesh hernia operation: results from a Department of Veterans Affairs randomized clinical trial. J Am Coll Surg 203(4):447–457
35
Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique G. G. Champault
258
Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique
Introduction
35
The true incidence of chronic pain after inguinal herniorrhaphy is unknown, and until recently it was a secondary consideration, with the recurrence rate being deemed of greater importance. The incidence was reduced by the use of prostheses [1]. As recurrences have declined, though, more attention is now being focused on other measures of success, particularly quality of life. Numerous recent studies have examined the incidence of chronic pain after operations. Grant et al. [2] reported that 9.7% of their patients experienced chronic pain after surgery, and other studies [3–6] have put the figure as high as 34%. Typically, such complaints decrease over the course of the first year [7], but a significant number of patients do develop chronic and debilitating pain [8]. With the recognition that this is more common than was previously realized, numerous authors have begun to investigate the impact of pain on quality of life [9, 10]. Various factors have been examined to determine the etiology of postoperative pain. Patient age has been implicated, with the available data indicating that younger patients have a higher likelihood of postoperative pain [5, 10]. But a recent study [7] refuted this notion, finding that the incidence of chronic pain is evenly distributed among age groups. Preoperative pain seems to be a risk factor, with multiple studies [5, 6] showing that those who report pain beforehand are more likely to develop chronic pain afterward. Certain individuals can be physiologically or psychologically predisposed to develop chronic pain. Courtney et al. [8] found that patients with such symptoms after herniorrhaphy are more likely than most other people to suffer from other chronic pain conditions. Body habitus may play a role here because obese patients can have a higher incidence of postoperative inguinodynia [10]. Ferzli et al. [11] found that the probability of developing chronic pain was more than twofold higher in those undergoing ambulatory herniorrhaphy. The type of anesthetic administered has been examined as a possible factor in this problem. Nordin et al. [12] showed that local anesthesia was associated with less chronic pain than regional or general anesthesia.
Other risk factors for chronic pain include being employed and having private health insurance [5]. Direct injury to nerves, resulting in either partial or complete transection, can lead to neuroma formation and subsequent development of chronic pain. The ilioinguinal and iliohypogastric segments of the genital branch of the genitofemoral nerves are vulnerable to injury; when injured, they can produce pain syndromes that are refractory to narcotic and multidisciplinary management techniques. Some authors have also implicated the role of mesh [13, 14]. Demirer et al. [15] showed that when peripheral nerve tissue comes in contact with polypropylene mesh, myelin degeneration associated with edema and fibrosis occurs. However, multiple studies have examined this issue, and the weight of the evidence seems to indicate that mesh does not significantly increase the risk of chronic pain [8, 10, 16]. Operative technique may also play a role. No particular surgical approach has proved superior in terms of subsequent pain, although data suggest that the laparoscopic procedure [17] may be more beneficial. Douek et al. [18] found that after 5 years, the transabdominal preperitoneal procedure resulted in significantly less pain than an open tension-free mesh repair (2% vs. 10%). In contrast, the largest study [19] to date comparing open techniques with laparoscopy found no differences after 3 months. Multiple studies have examined the role of mesh. The etiological factors include irritation or damage of inguinal nerves by sutures or mesh [13], an inflammatory reaction against the mesh [20], or simply scar tissue. A recent systematic review of mesh techniques compared with nonmesh methods pointed out that no strong evidence indicated that the use of mesh increased the rate of chronic pain [1]. Recent studies [3] have pointed out that »mesh-induced pain« occurs more frequently than reported, including in tension-free techniques. Amid [21] identified »meshoma« as a radiologic entity and pathologic cause of chronic pain. Meshoma occurs when the mesh prosthesis becomes wadded into a ball because of nonfixation, insufficient fixation, or insufficient dissection to make adequate room for the prosthesis. In other situations, the weight of the evidence seems to indicate
259 Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis
that mesh does not significantly increase the risk of chronic pain [10, 16, 18]. But research into alternatives to polypropylene continues. Cobb et al. [22] have advocated the use of newer lightweight polypropylene, which may in theory result in less foreign body response and would improve operative outcomes. Post et al. [23] reported that after 6 months of follow-up, lightweight polypropylene mesh is preferable to conventional mesh for Lichtenstein repair of inguinal hernia. After this study, two randomized studies [24, 25] reported that use of a partially absorbable lightweight mesh was associated with less chronic pain than a nonabsorbable heavy mesh after 1 and 3 years. The frequency of recurrence was similar for the two meshes. A recent laparoscopic study indicated that fewer postoperative complications and an improved quality of life can be achieved by reducing the amount of polypropylene in meshes used for laparoscopic hernia repair [26]. Foreign body sensations were also fewer for lightweight meshes compared with conventional polypropylene mesh. In this study, Horstmann et al. [26] followed their patients only 1 year after surgery, when a foreign body sensation is more common than after 2 years. On the other hand, Paajanen [14] recently compared three different meshes [partially absorbable polypropylene–polyglactin mesh, lightweight polypropylene mesh (55 g/m2), and conventional densely woven polypropylene mesh] in a randomized trial of 228 patients (232 hernias) treated by Lichtenstein tension-free hernioplasty under local anesthesia in same-day surgery by the same surgeon using exactly the same surgical technique. He found no differences in pain or quality of life after 2 years of follow-up. The nature and quality of prostheses have evolved over the last 10 years, with polypropylene being the most common material. Many prostheses have offered additional refinements: anatomical molding; inclusion of elements to reduce the residual mass of nonresorbable material, thereby diminishing complications; and, recently, coatings of substances that assist in tissue acceptance and integration. We performed a study [27] to prospectively assess the results at 2-year follow-up in patients who underwent tension-free hernia repair by either the
35
Lichtenstein technique or laparoscopy, using two types of prostheses: polypropylene and beta-D-glucan-coated polypropylene (Glucamesh, Genzyme France). Glucan-coated prostheses are composed of an unwoven polypropylene mesh that is coated with beta–(1→3),(1→4)-D-glucan, a complex carbohydrate extract of oat. Oat beta-glucan is an entirely (100%) natural plant product that has been used in burn and wound care applications [28–30]. Beta-glucans have also been the subject of research regarding their roles as immunomodulators [31–34] and agents in wound healing [35, 36].
Patients and Methods Patients Between 2001 and 2003, 410 consecutive patients (396 men, 14 women) of mean age 54 years (range 18–84) underwent repair of inguinal hernias, 96 (23%) of which were bilateral and 56 (13%) recurrent. Most patients (95%) were classified as American Society of Anesthesiologists (ASA) physical status I or II [8], and 72 (17.5%) of them had a body mass index (BMI) above 30.
Methods All surgery was done under general anesthesia by four surgeons. Thrombosis prophylaxis and antibiotic prophylaxis were used in all cases. Lichtenstein repair was performed as first described [9]. The prosthesis was fixed at the inguinal ligament with five to seven stitches of polypropylene. In laparoscopic repair (totally extraperitoneal approach, or TEP), the Retzius space was developed and insufflated using three trocars. Prostheses were not fixed. This technique was preferred for bilateral hernias or for hernias that recurred after herniorrhaphy in young (20–45 years) active professionals or sportsmen or women with no anesthetic risk and a BMI under 30. All other patients underwent Lichtenstein repair. Two types of prosthesis were used: polypropylene of weight per unit area 105 g/m2 (Bard, Ethicon) and polypropylene of weight per unit area
260
Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique
50 g/m2 coated with beta-D-glucan (Glucamesh; Genzyme France), a plant derivative (oat) that promotes healing and has an immunomodulatory effect. Patients were randomly assigned to the two groups depending on whether they agreed to be included in a prospective study [10]. All patients were followed up prospectively for at least 2 years by a surgeon not involved in the study. Recurrence was confirmed by physical examination or repeat surgery. Chronic pain was assessed using a visual analog scale (VAS) and a validated questionnaire [11]. Pain was considered mild for a VAS score below 3, moderate below 5, and severe or debilitating above 5.
Statistics Quantitative values are given as means ± standard deviation. The Kruskal–Wallis test or Wilcoxon test was used for (nonparametric) comparison of the two groups. For qualitative parameters, percentages were compared using the chi-square test. Differences were considered statistically significant for p-values <0.05. The statistical analyses were done using SPSS 10.0 software for Windows.
Results
35
Lichtenstein repair was done in 273 (66.5%) patients, with polypropylene mesh in 215 (78.7%) and Glucamesh in 58 (21.3%). Laparoscopic repair was used in 137 patients, with polypropylene mesh in 80 (58.4%) and Glucamesh in 57 (41.6%). In
each of these two groups, the populations were comparable in terms of age, gender, type of hernia, ASA score, and incidence of obesity. The mean duration of hospitalization was 2.82 days (range 1–5), independent of the technique or mesh. Two-year follow-up was possible in 85.1% of patients (n=349: 117 TEP, 232 Lichtenstein) and was comparable for the two techniques used. At 2 years, recurrence had occurred in 10 cases (2.8%) and was independent of the technique [TEP n=2/117 (1.7%) vs. Lichtenstein n=8/232 (3.4%), not significant] or of the type of mesh [Glucamesh n=2/104 (1.9%) vs. polypropylene n=8/245 (2.4%), not significant]. (⊡ Table 35.1). At 2 years of follow-up, 69 patients presented with residual mild (VAS<3) or moderate (VAS<5; 19.7%) pain and 11 with intense pain (VAS>5; 3.1%). Moderate pain (⊡ Tables 35.2 and 35.3) was significantly less frequent (p=0.05) with Glucamesh than with polypropylene mesh (4.8% vs. 26.1%) irrespective of the repair technique (6.5% vs. 27.2% for laparoscopy; 3.7% vs. 25.6% for Lichtenstein). There was no significant difference between the two techniques in the Glucamesh group (6.5% vs. 3.7%) or the polypropylene mesh group (27.2% vs. 25.6%). This was also true for chronic, severe, debilitating pain (⊡ Tables 35.4 and 35.5). Pain characteristics were comparable whatever the repair technique (⊡ Table 35.6).
Discussion There is no consensus concerning the repair technique for inguinal hernia. However, it is clear that the use of prosthetic strengthening significantly
⊡ Table 35.1. Two-year recurrence (n%) as a function of technique and mesh (ns not significant) n
Recurrence
%
p
Lichtenstein
232
8
3.4
ns
Laparoscopy
117
2
1.7
ns
Glucamesh
104
2
1.9
ns
Polypropylene
245
8
2.4
ns
Total
349
10
28
35
261 Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis
repair, which is now the most widespread technique because of its advantages in terms of cost, risk, and simplicity. Nonetheless, the indications for laparoscopic repair are still subject to debate.
reduces the incidence of recurrence [37]. Tensionfree techniques may reduce the incidence of residual pain [9, 10]. This explains the preference for the laparoscopic approach and for Lichtenstein
⊡ Table 35.2. Incidence of chronic pain (n%) as a function of technique (ns not significant) Laparoscopy
Lichtenstein
Total
p
Glucamesh
3/51 (6.5%)
2/53 (3.7%)
5/104 (4.8%)
ns
Polypropylene
18/66 (27.2%)
46/179 (25.6%)
64/245 (26.5%)
ns
Total
21/117 (17.9%)
48/232 (20.6%)
69/349 (19.7%)
ns
⊡ Table 35.3. Incidence of chronic pain (n%) as a function of mesh Glucamesh
Polypropylene
p
Totally extraperitoneal approach
3/51 (6.5%)
18/66 (27.2%)
p=0.02
Lichtenstein
2/53 (3.7%)
46/179 (25.6%)
p=0.02
Total
5/104 (4.8%)
64/245 (26.5%)
p=0.02
⊡ Table 35.4. Incidence of severe pain (visual analog score >5) as a function of technique (ns not significant) Laparoscopy
Lichtenstein
Total
p
Glucamesh
1/51 (1.9%)
0/53 (0%)
1/104 (0.9%)
ns
Polypropylene
3/66 (4.5%)
7/179 (3.3%)
10/245 (4%)
ns
Total
4/117 (3.4%)
7/232 (3%)
11/349 (3.1%)
ns
⊡ Table 35.5. Incidence of severe pain (visual analog score >5) as a function of mesh Glucamesh
Polypropylene
p
Totally extraperitoneal approach
1/51 (1.9%)
3/66 (4.5%)
p=0.27
Lichtenstein
0/53 (0%)
7/179 (3.3%)
p=0.02
Total
1/104 (0.9%)
10/245 (4%)
p=0.02
Glucamesh
Polypropylene
p
Groin
67%
77%
ns
Testicle
50%
34%
ns
⊡ Table 35.6. Location of pain (ns not significant)
262
35
Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique
We used laparoscopy in young, nonobese patients with bilateral or recurrent hernia who were active professionally or in sports and who had no anesthetic risk. We applied the same indications to the laparoscopic and Lichtenstein groups, which were therefore perfectly comparable. The reported 2-year recurrence rate is comparable for Lichtenstein repair and laparoscopic repair (2–5%) [38, 39], which accords with our experience (2.8%) in which this incidence was independent of the technique or the prosthetic mesh. The choice of prosthesis is even less well defined and subject to criteria that are often costrelated and subjective or personal. The characteristics of the ideal prosthesis are well defined: large mesh, solid, flexible, low specific weight, ability to become incorporated in tissues, and biologically inert. Most meshes are made of polypropylene or polyester. Using these principles, a great variety of products have been developed and adapted to techniques or practices (laparoscopy): composite, two-faced meshes that are coated to promote healing and facilitate tissue integration. Coating with animal collagen has proved effective but carries a small biological risk (cattle) or is subject to religious restrictions (pig). Beta-Dglucan is an entirely natural plant product that promotes healing and has an immunomodulatory effect [29, 31, 33, 34]. Beta-D-glucan-coated meshes are effective in terms of recurrence, quality of life, and chronic pain [40, 41]. In the present study, we have shown that the 2-year recurrence rate was the same regardless of technique, mesh, or the mesh’s weight per unit area. Studies of lightweight meshes have yielded contrasting results [24, 42]. When they compared outcomes after laparoscopic TEP inguinal repair using new lightweight (28 g/m2) and traditional (85 g/m2) heavyweight mesh, Khan et al. [43] found less discomfort and pain in the lightweight group at 3-month follow-up. Severity of numbness was less with lightweight mesh, suggesting less nerve interference and less inflammatory response. Also, the use of lightweight mesh for Lichtenstein hernia repair did not affect the recurrence rate, but some aspects of pain and discomfort were improved 3 years after surgery [24].
Chronic pain after hernia repair has been studied extensively [3, 6, 17, 43] but is difficult to assess. Specific validated questionnaires [42, 44] have been developed to evaluate and compare quality of life as a function of technique. Numerous factors have been implicated: anatomical factors (nerves), type of hernia, technique, surgical field, and also the mesh and its fixation. In our practice, the meshes used in TEP are not fixed, and those used in Lichtenstein repair are fixed with a few sutures on the inguinal ligament. At 2-year follow-up, these techniques were identical in comparable groups of patients, whatever the type of prosthesis used. There was no difference in chronic pain, or even in pain qualified as severe, between TEP and Lichtenstein repair. There was, however, a significant difference in favor of Glucamesh compared with polypropylene mesh in the groups compared, irrespective of the repair technique. These advantages may stem from the low weight per unit area of Glucamesh but above all from the quality of the beta-D-glucan coating.
Conclusion Our findings suggest that at 2-year follow-up, the quality of hernia repair in terms of efficacy and quality of life is determined more by the characteristics of the prosthesis than by the technique used.
References 1. EU Hernia Trialist Collaboration (2000). Mesh compared with non mesh methods on open groin hernia repair. Systematic review of randomized controlled trial. Br J Surg 87, 854–859 2. Grant AM, Scott NW, O’Dwyer PJ (2004). Five-year follow-up of a randomized trial to assess pain and numbness after laparoscopic or open groin hernia. Br J Surg 91, 1570– 1574 3. Bay Nielsen M, Perkins FM, Kehlet H (2001). Danish Hernia Database. Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg 233, 1–7 4. Nienhuijs SW, Boelens OB, Strobbe LJ (2005). Pain after anterior mesh hernia repair. J Am Coll Surg 200, 885–889 5. Franneby U, Sandbloom G, Nordin P, Gunnarson U (2006). Risk factors for long term pain after hernia surgery. Ann Surg 244, 212–219
263 Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis
6. Callesen T, Beck K, Kehlet H (1999). Prospective study of chronic pain after groin hernia. Br J Surg 86, 1528–1531 7. Aasvang EK, Bay Nielsen M, Kehlet H (2006). Pain and functional impairment 6 years after inguinal herniorrhaphy. Hernia 10, 316–321 8. Courtney CA, Duffy K, Serpell MG (2002). Outcome of patients with severe chronic pain following repair of groin hernia. Br J Surg 89, 1310–1314 9. Silen W (2002). Chronic pain and quality of life following open inguinal hernia repair. Br J Surg 89, 123 10. Poobalan AS, Bruce J, King PM, Chambers WA, Krukowski ZH, Smith WCS (2001). Chronic pain and quality of life following open inguinal hernia. Br J Surg 88, 1122–1126 11. Ferzli G, Edwards E, Khoury G (2007). Chronic pain after inguinal herniorrhaphy. J Am Col Surg 205, 1, 333–341 12. Nordin P, Zetterstrom H, Guynnarson U, Nilsson E (2004). Choice of anesthesia and risk of reoperation for recurrence in groin hernia repair. Ann Surg 204, 187–192 13. Heise CP, Starling JR (1998). Mesh inguinodynia: a new clinical syndrome after inguinal herniorrhaphy. J Am Coll Surg 187, 514–518 14. Paajanen H (2007). A single surgeon randomized trial comparing three composite meshes on chronic pain after Lichtenstein hernia repair in local anesthesia. Hernia 11, 335–339 15. Demirer S, Kepenecki, Evirgen O (2006). The effect of polypropylene mesh on ilioinguinal nerve in open mesh repair of groin hernia. J Surg Res 131, 175–181 16. Koninger J, Redecke J, Butters M (2004). Chronic pain after hernia repair: a randomized trial comparing Shouldice, Lichtenstein and TAPP. Langenbecks Arch Surg 389, 361–365 17. Kumar S, Wilson RG, Nixon SJ, MacIntire IMC (2002). Chronic pain after laparoscopic and open mesh repair of groin hernia. Br J Surg 89, 1476–1479 18. Douek M, Smith G, Oshavo A (2003). Prospective randomized controlled trial of laparoscopic versus open hernia mesh repair: five years follow up. Br J Med 326, 1012– 1013 19. Neumayer L, Giobbie-Hinder A, Jonasson O (2004). Open mesh versus laparoscopic mesh repair of inguinal hernia. N Engl J Med 350, 1819–1827 20. Di Vita G, Milano S, Frazzetta M (2000). Tension free hernia repair is associated with an increase of inflammatory response markers against the mesh. Am J Surg 180, 203– 207 21. Amid PK (2004). Radiological images of meshoma: a new phenomenon after prosthetic repair of the abdominal wall hernia. Arch Surg 139, 1297–1298 22. Cobb WS, Kercher KW, Heniford BT (2005). The argument for lightweight polypropylene mesh in hernia repair. Surg Innov 12, 63–69 23. Post S, Weiss B, Willer M, Neufang T, Lorenz D (2004). Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg 91, 44–48 24. Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Heikkinen T (2006). Three years results of a randomized
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35. 36.
37.
38.
35
clinical trial of lightweight or standard polypropylene mesh in Lichtenstein repair of primary inguinal hernia. Br J Surg 96, 1056–1059 O’Dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G (2005). Randomized clinical trial assessing impact of a lightweight or heavy weight mesh on chronic pain after inguinal hernia repair. Br J Surg 92, 166–170 Horstmann R, Hellwig M, Classen C, Rottgermann S, Palines D (2006). Impact of polypropylene amount on functional outcome and quality of life after inguinal hernia repair by the TAPP procedure using pure, mixed and titanium-coated meshes. World J Surg 30, 1742–1749 Champault G, Bernard C, Rizk N, Polliand C (2007). Inguinal hernia repair: the choice of prosthesis outweighs that of the technique. Hernia 11, 125–128 Delatte SJ, Evans J, Hebra A, Adamson W, Othersen HB and Tagge EP (2001). Effectiveness of beta-glucan collagen (BGC) for treatment of partial thickness burns in children. J Ped Surg 36, 113–118 Lozano DD, Noordenbos J, Hansbrough JF (2002) The use of glucan II in the treatment of donor sites. J Burn Care Rehab 23, S81 Richards T, Azad S, Dziewulski P, Moiemen N, Dziewulski P (2000). Randomized controlled trial of dressings for partial thickness facial burns. J Burn Care Rehab 21, part 2, S219 Abel G, Czop JK (1992). Stimulation of human monocyte beta-glucan receptors by glucan particles induces production of TNF alpha and IL 1Beta. Int J Immunopharmacol 14, 1363–1373 Browder W, David W, Lucore P, Petrus H, Jones E, McNamer R (1988). Effect of enhanced macrophage function on early wound healing. Surgery 104, 224–230 de Fellippe jr J, da Rocha e Silva Jr M, Maciel FM, Soares A, Mendes NF (1993). Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). Surg Gynecol Obstet 177, 383–388 Estrada A, Yun CH, Van Kessel A, Li B, Hunta S (1997). Immunomodulatory activities of oat beta-Glucan in vitro and in vivo. Microbiol Immunol 41, 991–998 Di Pietro LA (1995). Wound healing: the role of the macrophage and others immune cells. Shock 4, 233–240 Wolk M, Danon D (1985). Promotion of wound healing by yeast glucan evaluated on single animals. Med Biol 63, 273–280 Wrigland WW, Van Den Tol MP, Luijendijih RW, Hop WCP, Busschbacht JJV, de Lange DCD, Van Geldere D, Rottier AB, Vegt PA, Ijzermans JNM and Jeekel J (2002). Randomized trial of non mesh versus mesh repair of primary inguinal hernia. Br J Surg 89, 293–297 Arvidson D, Berndsen FM, Larsson LG. Leijonmarck CE, Rimback G, Rudberg C, Smedberg S, Spangen L, Montgomery A (2005). Randomized clinical trial comparing 5 years recurrence rate after laparoscopic versus Shouldice repair of primary inguinal hernia. Br J Surg 92, 1085–1091
264
Chapter 35 · Chronic Pain After Inguinal Hernia Repair: The Choice of Prosthesis Outweighs That of Technique
39. Wara P, Bay Nielsen M, Jul P, Bendix J, Kehlet H (2005). Prospective nationwide analysis of laparoscopic versus Lichtenstein repair of inguinal hernia. Br J Surg 92, 1277– 1281 40. Barrat C, Seriser F, Arnoud R, Trouette P, Champault G (2004). Inguinal hernia repair with beta glucan coated mesh: prospective multicenter study (115 cases). Preliminary results. Hernia 8, 33–38 41. Champault G, Barrat C (2005) Inguinal hernia repair with beta glucan coated mesh: results at two years follow up. Hernia 9, 125–130 42. Conze J, Kingsnorth AN, Flament JB, Simmermacker P, Arlt G, Langer C, Shippers E, Hartley A, Schlumpelick V (2005). Randomized clinical trial comparing lightweight composite mesh with polyester or polypropylene mesh for incisional hernia repair. Br J Surg 92, 1488–1493 43. Khan LR, Kumar S, Nixon SJ (2006). Early results for new lightweight mesh in laparoscopic totally extraperitoneal inguinal hernia repair. Hernia 10, 303–308
Discussion Schumpelick: Thank you very much for this pre-
35
sentation, I think these are excellent results. How do you explain your results? How is glucan working? Champault: I think there are three explanations: First, it’s a lightweight mesh. Second, there is no fixation, because of adhesiveness. Especially in TEP hernia repair we do not fix the mesh anymore. Schumpelick: Is glucan like a glue? Champault: There is no glue on this mesh. But when you use this mesh in TEP hernia repair and you put the mesh directly on the muscle, you don’t need any fixation or tacks. And when you perform a Lichtenstein hernia repair, you only have to put in the prosthesis. In this study we used the official technique described by Amid with a running suture on the inguinal ligament. And third, with regard to the role of glucan, I have seen the use of glucan in burned patients. There it is very efficient, and you win many days in healing. Perhaps there is an action in the integration of the prosthesis in the muscle and possibly, as the experimental studies have shown, an action of the inflammatory reactions. Schumpelick: And then you mentioned in your discussion the covering of meshes with collagen. Is that not working anymore? Champault: There is a problem with collagen because you use the same product of collagen to fa-
cilitate the integration in the muscle and secondly to avoid an adherence. And that is a paradox. In the literature there is no A-level publication showing the usefulness of collagens. And the company (Covidien) have put the same prosthesis without collagen on the market – to be in the prize only! Post: You cannot differentiate the difference between the effect of lightweight and heavyweight and the glucan. So it might be hypothesized that the only difference is due to the light weight and not to glucan. In your randomized trial you started just now, do you compare the same lightweight with and without glucan? Champault: It probably will be the next trial. Smeds: Very interesting results. In order to understand the mechanisms more, I am just curious to know whether you allocated the surgeons to the different type of meshes. Did you have the polypropylene surgeons and the glucan surgeons? Because we know that there is a significant difference if you are a high-volume surgeon or a low-volume surgeon. Champault: No, the same surgeons. In a previous study we have shown that the results of trainees are the same as the results of consultants or more experienced surgeons. In this study, the repairs were performed within the whole group of our surgeons.
36
The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia S. D. Demirer, I. Kepenekci, O. Evirgen, O. Birsen, A. Tuzuner, S. Karahuseyinoglu, M. Ozban, E. Kuterdem
266
36
Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia
Introduction
Material and Methods
Open or laparoscopic mesh repair of groin hernia is one of the most common elective operations performed by general surgeons. Because of low recurrence rates, the concept of tension-free mesh repair methods has gained wide acceptance. The development of chronic pain after inguinal hernia repair is a well-known long-term complication, with the reported frequency of pain varying from 0% to 37% [1–11]. Some studies have reported a lower incidence of pain, 2–2.5%, after laparoscopic hernia repair than after open mesh repair [3, 4, 8, 11–15]. The complaint of chronic pain following inguinal hernia repair can continue for months or even years. Several risk factors associated with this have been identified, including recurrent hernia repair, the patient’s insurance status, day surgery, patient age less than 60 years, intensity of early postoperative pain, experience of the surgeon, and type of surgical procedure used [3, 6, 9, 16]. Mesh inguinodynia was described as »a new clinical syndrome« after inguinal herniorrhaphy. The development of this chronic debilitating pain after herniorrhaphy has been attributed to several mechanisms, including injury or entrapment of the sensory nerves (ilioinguinal, iliohypogastric, genitofemoral, or lateral femoral cutaneous nerves) and mesh inguinodynia [2, 3, 6–8, 17]. Partial or complete division, neuroma formation, stretching, contusion, crushing, electrical damage, or suture compression can injure sensory nerves in close proximity to the operative field and cause neuralgia. Secondary damage to a sensory nerve may also result from scar tissue compression or from irritation by an adjacent inflammatory process such as a suture granuloma or mesh. Polypropylene synthetic mesh causes inflammatory reaction and formation of scar tissue [2, 6, 8, 11, 17, 18]. The ilioinguinal nerve is a sensory nerve that is usually preserved during hernia repair, but it can interfere with placement of the mesh and may be traumatized inadvertently during operation. In this experimental study, we aimed to evaluate damage or entrapment of the ilioinguinal nerve caused by polypropylene synthetic mesh after groin hernia repair.
Our study protocol was reviewed and approved by the ethics committee of Ankara University School of Medicine. All animals received humane care in accordance with the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and published by the U.S. National Institutes of Health (NIH publication No. 85–23, revised 1985).
Experimental Design Twenty-four New Zealand rabbits weighing 2.4– 2.7 kg were included in our study. They were subjected to 1 week of preliminary conditioning during which time they received standard chow and water ad lib. They were housed in a temperatureand humidity-controlled environment, two per cage, with a 12-h light–dark cycle. Preoperative antibiotics (cefazolin 10 mg/kg) were administered intramuscularly 30 min prior to skin incision. The rabbits were anesthetized by an intramuscular injection of ketamine hydrochloride (35 mg/kg) and Xylocaine (5 mg/kg). The animals were placed in a dorsal recumbent position, followed by hair removal from the inguinal area. The inguinal and scrotal regions were shaved and prepared with Betadine solution. In all animals, the inguinal areas were explored bilaterally through an inguinal incision. The ilioinguinal nerve was identified on both sides and synthetic polypropylene mesh placed on only one side (⊡ Fig. 36.1). The ilioinguinal nerve was in touch with polypropylene mesh on this side (⊡ Fig. 36.2). We designated the right groin as the control and the left groin as the experimental side in each animal. After the operation, the inguinal incisions were closed in anatomical layers with 3-0 monofilament suture. All rabbits tolerated the surgery well, and they were followed until reexploration. Three months after surgery, the animals were anesthetized using intramuscular ketamine hydrochloride, and bilateral inguinal exploration was performed again, with samples of nerve tissue taken from both sides. The samples of nerve tissue were divided into two groups as control and experimental groups. An internation-
267 Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve
36
and examined under a light microscope (Zeiss Axio Scope photomicroscope). After double staining with uranyl acetate and lead citrate, ultrathin sections were examined and photographed using a LEO 906E transmission electron microscope. For light microscopic study, inguinal peripheral nerve tissues were fixed in 10% formaldehyde. Samples were dehydrated by immersion in a series of alcohol concentrations and embedded in paraffin; 5-μm sections were stained with hematoxylin and eosin (H&E) and Masson’s trichrome and examined under a light microscope. ⊡ Fig. 36.1. Ilioinguinal nerve of the rabbit after dissection
Morphometric Analysis
⊡ Fig. 36.2. Polypropylene mesh was laid in close proximity to the ilioinguinal nerve
For morphometric analysis, photographic color images from semithin sections of experimental and control groups were obtained with the Zeiss Axio Scope photomicroscope at ×250 magnification. The measurements were obtained using Adobe Photoshop 7.0 software. The graphic file format of the images is JPEG, and resolution was set at 500 pixels per inch. Myelinated fiber diameter, axon diameter, G-ratio (axon diameter/myelinated fiber diameter), myelin thickness, and the numbers of nerve fibers with diameters of ≤4 μm, 5–8 μm, and ≥9 μm were assessed in a blinded fashion using a semiautomated procedure [20].
Statistics ally accepted standard definition of pain persisting beyond the normal tissue healing time, assumed to be 3 months, was used in our study [19].
Histological Tissue Processing For electron microscopic study, inguinal peripheral nerve specimens from the control and experimental groups were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer and postfixed in 1% osmium tetroxide. Tissue samples were dehydrated through a graded series of ethanol and propylene oxide embedded in araldite. Semithin sections were stained with toluidine blue-Azure II
Statistical analysis was performed using the adjusted Student‘s t-test for clustered data and the adjusted chi-square test for clustered binary data, comparing the mesh-laid side of each group to the control side of the same group. A p-value <0.05 denoted a statistically significant difference.
Results No intraoperative or postoperative deaths occurred in the rabbits, and we observed no infective complications in either the control or the experimental sides during 3 months of follow-up. There was
268
Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia
a statistically significant difference between the mean operating times in the two groups (13 min in the control group vs. 24 min in the experimental group, p<0.05). During reexploration, we found macroscopically dense fibrotic tissues encompassing the polypropylene mesh and adhesions on the study side 3 months after surgery. On the experimental side, the floor of the inguinal region was very tight, and dissection as well as removal of the ilioinguinal nerve was difficult because of fibrotic changes. The nerve had thickened and adhered to the mesh and adjacent inguinal region. There was minimal fibrosis on the control side; therefore, the ilioinguinal nerve was divided and removed easily on this side.
a
Histological and Morphometric Assessment
36
H&E-stained sections from the experimental group after 3 months revealed inflammatory reaction and increased connective tissue that formed areas of fibrosis around polypropylene mesh islands (⊡ Fig. 36.3a, b). Light microscopic examination of H&E-stained and Masson’s trichrome-stained sections of peripheral nerves from the control group were normal in appearance (⊡ Fig. 36.4a, b), but the nerve fascicles in the experimental group operated with mesh showed axonal dilatation and mild to severe loss of myelinated axons (⊡ Fig. 36.5a, b). Examination of semithin sections of peripheral nerve fascicles from the control group showed almost intact myelinated and unmyelinated fibers (⊡ Fig. 36.5c). The endoneurium of closely located myelinated fibers appeared to be normal. Most of the myelin sheath layers and the thickness of equal-size fibers were the same and showed normal morphology. Electron microscopic examination of semithin and ultrathin sections of nerve morphology in the experimental group operated with mesh exhibited endoneurial edema with thickening of both the endoneurium and perineurium, causing separation of nerve fibers (⊡ Fig. 36.5d, d insert). A few extra layers of connective tissue formation in some nerve fibers of the experimental group suggested early onion-bulb formations. Myelin sheaths of fi-
b ⊡ Fig. 36.3. Experimental group at the 3rd postoperative month: interface of the mesh and recipient tissue (pmg polypropylene mesh graft). Double asterisks (**) indicate connective tissue around polypropylene mesh islands (patches) forming fibrosis and inflammatory reaction. Arrowheads show striated muscle. a Original magnification ×100. b Original magnification ×200. Hematoxylin–eosin staining
bers in the experimental group showed undulation toward the axoplasm and the endoneurium. In the experimental group we also observed separation of myelin layers from each other as a prominent feature of myelin degeneration in nerve fibers. Axoplasms also exhibited edema and crystallization (⊡ Fig. 36.6a–d).
269 Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve
36
Results of the morphometric assessment are outlined in ⊡ Table 36.1. Fiber diameter and axonal diameter were increased in the experimental group compared with the controls as a result of axonal dilatation, and this difference was statistically significant. The G-ratio, which is considered normal in the range of 0.60–0.64, increased in the experimental group compared with controls as a result of myelin sheath thinning; the difference was statistically significant. Myelin thickness was decreased moderately on the mesh side compared with the control side, but there was no statistically significant difference between them. The number of nerve fibers considered healthy, with a diameter <9 μm, was higher in the control group than in the experimental group (Pcontrol=0.783 vs. Pmesh=0.570), and the difference was statistically significant (p<0.001) with an adjusted chi-square test for clustered binary data.
a
Discussion
b ⊡ Fig. 36.4. Light microscopic images of peripheral nerves of control group. a Arrowhead axon; arrow Schwann cell nucleus; E endoneurium; P perineurium; Ep epineurium. Original magnification ×400. Masson’s trichrome staining. b Arrowheads axons; arrow Schwann cell nucleus. Original magnification ×400. Hematoxylin–eosin staining
It is usual to preserve the ilioinguinal nerve, but it can interfere with placement of the mesh and may be traumatized inadvertently during operation. The increased surface area of the mesh might allow adherence of nerves or abrasion and account for an increased risk of neuropathic pain. Using prosthetic mesh for inguinal hernia repair is well accepted. But despite favorable clinical outcomes, patients who undergo mesh hernia repair may complain of severe, debilitating pain and pose a bothersome chronic management problem [1, 21, 22]. Local analgesic or steroid injections, various pharmaceuticals, behavioral therapy, cryotherapy, alcohol or phenol injections, neurectomy, and mesh removal are frequently used in treatment [2, 18]. Delayed presentations of mesh inguino-
⊡ Table 36.1. Peripheral nerve morphometry Average fiber diameter, mean ± SD
Average axon diameter, mean ± SD
Average G-ratio, mean ± SD
Myelin thickness, mean ± SD
Mesh side
9.05±0.24a
6.17±0.11a
0.68±0.007a
1.98±0.11
Control side
6.91±0.14
4.17±0.09
0.59±0.004
2.73±0.06
ap<0.001
significant with adjusted Student’s t-test for clustered data
270
Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia
dynia may occur, possibly secondary to chronic scarring or neuroma formation. The mesh as a foreign body induces a dense fibroblastic response, creating scar tissue and imparting strength to the floor. Despite wide acceptance of this technique, there is little data regarding the effects of the mesh
a
bioprosthesis and its resulting fibrotic reaction on adjacent structures such as the spermatic cord or peripheral nerves in the inguinal region [23–28]. In our study we aimed to evaluate the local effects of mesh on the ilioinguinal nerve. Histopathological and morphometric changes of the
b
36 c
⊡ Fig. 36.5. a,b Light microscopic images of experimental group. a Asterisks axonal loss; P perineurium; Ep epineurium; arrowhead Schwann cell nucleus; arrows axons. Original magnification ×400. Hematoxylin–eosin staining. b Asterisks axonal loss; arrow axon; arrowhead Schwann cell nucleus; P perineurium; Ep epineurium; E endoneurium. Original magnification ×400. Masson’s trichrome staining. c, d, d insert Semithin
d
sections of peripheral nerves. c Arrow myelin sheath; asterisks unmyelinated nerves; P perineurium. Original magnification ×1,000. Toluidine blue staining. d, d insert Arrowheads extra collagen fiber layers (onion-bulb formation); asterisks separation of myelin sheath; arrows undulation of myelin sheath; P perineurium; Ep epineurium; double asterisks Schwann cell nucleus. Original magnification ×1,000. Toluidine blue staining
271 Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve
ilioinguinal nerve in the mesh group (mentioned in the results section of this paper), such as axonal dilatation, loss of myelinated axons, endoneurial edema, separation of myelin layers, increased fiber and axon diameters, and increased G-ratio, may be implicated in the etiology of chronic pain fol-
lowing inguinal hernia repair. But it is difficult to make a definitive statement regarding the impact of these histopathological changes on chronic pain because animal models, not human beings, were used in this experimental study. It is very well known that pain is a subjective complaint;
a
b
c
d
⊡ Fig. 36.6. Transmission electron microscopic (TEM) images of experimental group. a Axp axonal dilatations and axoplasm; double asterisks myelin sheath separation; umyn unmyelinated nerves; SCCy Schwann cell cytoplasm. TEM ×3,597. b Double asterisks extra collagen fibers around endoneurium suggesting onion-bulb formation; arrows myelin sheath degeneration and separation; asterisks myelin undulation; ms myelin
36
sheath. TEM ×2,784. c c collagen fibers; double asterisks endoneurial edema; umyn unmyelinated nerves; SCCy Schwann cell cytoplasm; myelin sheath. TEM ×4,646. d Axp crystallization of nerve fibers in axoplasm; double asterisks endoneurial edema; L lipid droplets; asterisks inclusion body in Schwann cell cytoplasm; SCCy Schwann cell cytoplasm; arrowhead degenerative inclusions between myelin layers. TEM ×12,930
272
36
Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve in Open Mesh Repair of Groin Hernia
certainly, scaling and establishment of correlation with these histopathological changes cannot be done in animal models. Polypropylene mesh serves as a flexible lattice supporting the ingrowth of connective tissues from the base of the wound and is known to incite a prompt fibroblastic response, imparting strength to the repair. An extensive inflammatory and fibroblastic granulomatous reaction occurs in response to the foreign material, which causes dense adhesions when the material is placed adjacent to visceral organs [29, 30]. According to our macroscopic and microscopic findings, the ilioinguinal nerve was affected by the resultant fibrotic reaction to the mesh (⊡ Fig. 36.3a, b). Peripheral neuropathy following mesh herniorrhaphy was most likely due to incorporation of adjacent nerve fibers in the fibroblastic reaction incited by mesh. During the reexploration, we performed extensive dissection to find and ensure adequate mobilization for the ilioinguinal nerve because of the fibrotic changes in the experimental group. It has been argued that several factors may contribute to the development of chronic groin pain; one of these factors may be nerve entrapment. The nerves may hinder the dissection or may lie across the prosthetic mesh on the posterior inguinal wall. Chronic groin pain after hernia repair can possibly be caused by the entrapment of peripheral nerves in the scar tissue formed by the mesh [2–4, 6–8, 17]. Uzzo et al. [27] demonstrated that entrapment of the ilioinguinal nerve or its branches by the mesh reaction gave rise to a traumatic neuroma. In our study, the light microscopic and ultrastructural changes seen in peripheral nerves in the experimental group operated with mesh suggest that mechanical compression of peripheral nerves is associated with myelin degeneration, endoneurial and perineurial edema, thickening of collagen layers around axons (called onion-bulb formation), and axonal loss that may cause chronic inflammatory demyelinating peripheral neuropathy. We think that inflammatory and fibrotic reactions occurring in response to the foreign material may have caused adhesions and mechanical compression of peripheral nerves, and we conclude that a similar mechanism may be responsible in part for chronic groin pain in humans.
Placement of mesh in direct contact with inguinal nerves is not recommended for avoiding groin pain [2–4, 6–8, 17]. Tsakayannis et al. [31] reported that even elective neurectomy is safe to perform and is not associated with chronic inguinal pain. Our study indicates that preservation of the inguinal nerves is important in mesh herniorrhaphy because of the mesh-induced changes that occur. We conclude that the sensory nerves in the inguinal region should be better separated from the mesh and preserved carefully in order to prevent chronic groin pain when mesh repair is performed. Further studies are needed to evaluate the effect of anatomical position and the relationship of mesh and sensory nerves to chronic pain after herniorrhaphy.
References 1. Lichtenstein IL, Shulman AG, Amid PK, Montllor MM. Cause and prevention of postherniorrhaphy neuralgia: a proposed protocol for treatment. Am J Surg 1988;155:786–790 2. Helse CP, Starling JR. Mesh inguinodynia: a new clinical syndrome after inguinal herniorrhaphy? J Am Coll Surg 1998;187:514–518 3. Bay-Nielsen M, Perkins FM, Kehlet H. Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg 2001;233:1–7 4. Callesen T, Bech K, Nielsen R, Andersen J, Hesselfeldt P, Roikjaer O, Kehlet H. Pain after groin hernia repair. Br J Surg 1998;85:1412–1414 5. Haapaniemi S, Nilson E. Recurrence and pain three years after groin hernia repair. Vallidation of postal questionnaire and physical examination as a method of follow-up. Eur J Surg 2002;168:22–28 6. Callesen T, Bech K, Kehlet H. Prospective study of chronic pain after groin hernia repair. Br J Surg 1999;86:1528– 1531 7. Ravichandran D, Kalambe BG, Pain JA. Pilot randomized controlled study of preservation or division of ilioinguinal nevre in open mesh repair of inguinal hernia. Br J Surg 2000;87:1166–1167 8. Kumar S, Wilson RG, Nixon SJ, Macintyre IMC. Chronic pain after laparoscopic and open mesh repair of groin hernia. Br J Surg 2002;89:1476–1479 9. Poobalan AS, Bruce J, King PM, et al. Chronic pain and quality of life following open inguinal hernia repair. Br J Surg 2001;88:1122–1126 10. Courtney CA, Duffy K, Serpell MG, et al. Outcome of patients with severe chronic pain following repair of groin hernia. Br J Surg 2002;89:1310–1314 11. The MRC Laparoscopic Groin Hernia Trial Group. Laparoscopic versus open repair of groin hernia: a randomized comparison. Lancet 1999;354:185–190
273 Chapter 36 · The Effect of Polypropylene Mesh on the Ilioinguinal Nerve
12. Seid AS, Amos E. Entrapment neuropathy in laparoscopic herniorrhaphy. Surg Endosc 1994;8:1050–1053 13. Liem MS, van der Graaf Y, van Steensel CJ, et al. comparison of conventional anterior surgery and laparoscopic surgery for inguinal hernia repair. N Eng J Med 1997;336:1541–1547 14. Dirksen CD, Beets GL, Go PM, et al. Bassini repair compared with laparoscopic repair for primary inguinal hernia: a randomized controlled trial. Eur J Surg 1998;164:439–447 15. Hay JM, Boudet MJ, Fingerhut A, et al. Shouldice inguinal hernia repair in the male adult: the gold standard? A multicenter controlled trial in 1,578 patients. Ann Surg 1995;222:719–727 16. Salcedo-Wasicek MC, Thirlby RC. Postoperative course after inguinal herniorrhaphy. A case controlled comparison of patients receiving workers’ compensation vs. commercial insurance. Arch Surg 1995;130:29–32 17. Bower S, Moore BB, Stephen MW. Neuralgia after inguinal hernia repair. Am Surg 1996;62:664–667 18. Wantz GE. Testicular atrophy and chronic residual neuralgia as risks of inguinal hernioplasty. Surg Clin North Am 1993;73:571–581 19. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain 1986;3 (suppl):S1–226 20. Campadelli P, Gangai C, Pasquale P. Automated morphometric analysis in peripheral neuropathies. Comput Biol Med 1999;29:147–156 21. Shulman AG, Amid PK, Lichtenstein IL. The safety of mesh repair for primary inguinal hernias: results of 3,019 operations from five diverse surgical sources. Am J Surg 1992; 58:255–257 22. Lichtenstein IL, Shulman AG, Amid PK, Montllor MM. The tension-free hernioplasty. Am J Surg 1989;157:188–193 23. Amid PK, Shulman AG, Lichtenstein IL. Critical scrutiny of the open tension free hernioplasty. Am J Surg 1993; 165:369 24. Arnould JP, Eloy R, Weill-Bousson M, et al. Resistance et tolerance biologique de 6 prostheses insertes utilizes dans la reparation de la paroi abdominale. J Chir 1977; 113:85–100 25. Usher FC, Wallace SA. Tissue reaction to plastic, a comparison of nylon, Orlon, Dacron, Teflon and Marlex. Arch Surg 1958:76:997–1003 26. Walker AP. Biomaterials in hernia repair. In: Nyhus LM, Condon RE (eds). Hernia, 4th edn. Lippincott, Philadelphia, 1995:534–540 27. Uzzo RG, Lemarck GE, Morrissey KP, et al. The effects of mesh bioprosthesis on the spermatic cord structures: a preliminary report in a canine model. J Urol 1999; 161:1344–1349 28. Shin D, Lipshultz LI, Goldstein M, Barme GA, Eugene FF, Nagler HM, McCallum SW, Niederberger CS, Schoor RA, Burgh VM, Honig SC. Herniorrhaphy with polypropylene mesh causing inguinal vassal obstruction: a preventable cause of obstructive azoospermia. Ann Surg 2005;241:553–558
36
29. Lichtenstein IL. Herniorrhaphy Am J Surg 1987;153:553 30. Wagner M. Evaluation of diverse plastic and cutis prostheses in a growing host. Surg Gynecol Obstet 1970;130:1077 31. Tsakayannis DE, Kiriakopoulos AC, Linos DA. Elective neurectomy during open tension free inguinal hernia repair. Hernia 2004;8:67–69
Discussion Amid: Many congratulations on your study. We
were inspired by your work and started doing the same thing on human subjects. We are doing exactly what you did on the nerves that you are removing from patients who have pain. And our preliminary result is completely consistent with your report. The only thing is that because we are doing it on humans, we know that these changes are causing pain, whereas in your rabbits you do not know if they are feeling pain. Your work was inspiration for our ongoing work. On a microscopic point of view, when you remove the mesh with the nerve, did you observe some adhesions of the nerves to the mesh? Demirer: Yes, of course. After 3 months we explored again. Here we observed on the experimental side a very dense fibrotic tissue and adhesion formation as compared to the control side. Smeds: Did you check how far away from the adhesion area the nerves were changed? Did you test it outside of the operation field as well? Demirer: No. Ramshaw: How would you translate this research in terms of clinical patient benefit? Demirer: In my clinic we now only use polypropylene meshes, and 2–5% of patients complain of pain. Schumpelick: What did the neuropathologists say to you about these findings? Have they seen such alterations of nerves before? Demirer: We did not ask the neuropathologists. Deysine: Have you considered conduction studies on those pieces of nerves that you took out? Demirer: In the next studies we should investigate degenerative changes by nerve physiologists. In this study we did not perform such analyses.
37
Lightweight Macroporous Mesh vs. Standard Polypropylene Mesh in Lichtenstein Hernioplasty S. Bringman
276
Chapter 37 · Lightweight Macroporous Mesh vs. Standard Polypropylene Mesh in Lichtenstein Hernioplasty
Introduction A standard polypropylene mesh used in Lichtenstein’s operation induces a strong foreign tissue reaction with potential harmful effects [1]. A mesh with less polypropylene and large pores could possibly be beneficial [2]. This chapter summarizes a randomized controlled trial comparing standard mesh and lightweight mesh [3–5].
Discussion
Six hundred men with a unilateral primary inguinal hernia were randomized through a secure Web site to be operated on with a Lichtenstein repair using either a lightweight (LW) macroporous mesh (Vypro II, Ethicon, Hamburg, Germany) or a standard polypropylene mesh (Prolene, Ethicon, Hamburg, Germany). All data were captured through the Web site. The patients were blinded to which mesh they received. Five Swedish and one Finnish hospital participated in the study. The patients completed a diary with SF-36 and visual analog (VAS) pain scales during the first 8 weeks postoperatively. After 1 year, a questionnaire was sent to all patients. Patients who indicated a lump in the groin or another complaint were examined. Three years postoperatively, the patients were examined by a blinded surgeon, and another questionnaire was completed.
In this Internet-based, multicenter study, it was demonstrated that no differences existed between Lichtenstein’s operation with LW mesh or with standard mesh up to 12 months after surgery. However, after 3 years, some aspects of pain and foreign body sensation were noted to be less in the LW group without increasing the rate of hernia recurrence. Other authors have demonstrated similar results concerning pain and foreign body sensation [6, 7]. One study showed an increased risk of recurrence in the LW group [6], which was estimated to be due to factors in the operative technique. In the present trial we used a technique with a running suture, with 1-cm intervals between the large bites in the mesh. We found no difference concerning recurrences between the groups. In conclusion, we found no difference between the group that received LW mesh and the group that received standard polypropylene mesh in Lichtenstein’s hernioplasty up to 12 months postoperatively. The LW mesh did not affect recurrence rates compared with standard mesh, but some aspects of pain and foreign body sensation were improved at follow-up 3 years after surgery.
Results
References
Of the total 600 patients, 301 were randomized to standard mesh and 299 to LW mesh, and 591 were operated on as allocated. The first patient was recruited in mid-December 2000 and the last in April 2002. The groups were comparable with regard to demographic data. There were no differences between the groups concerning return to work or normal activities, SF-36 scores, or VAS pain scores up to 8 weeks or at 12 months. The recurrence rate 3 years after surgery was 3.7% after standard mesh and 3.6% after LW mesh repair. The LW mesh group had less pain when rising from a reclining to a sitting position (p=0.03). Significantly, more men in the standard mesh group
1.
Patients and Methods
37
than in the LW mesh group (p=0.025) stated that they could feel the mesh in their groin.
2.
3.
4.
Klinge U, Klosterhalfen B, Muller M, Schumpelick V. Foreign body reaction to meshes used for the repair of abdominal wall hernias. Eur J Surg 1999; 165(7):665–673 Junge K, Klinge U, Rosch R, Klosterhalfen B, Schumpelick V. Functional and morphologic properties of a modified mesh for inguinal hernia repair. World J Surg 2002; 26(12):1472–1480 Bringman S, Heikkinen TJ, Wollert S, Osterberg J, Smedberg S, Granlund H, et al. Early results of a single-blinded, randomized, controlled, Internet-based multicenter trial comparing Prolene and Vypro II mesh in Lichtenstein hernioplasty. Hernia 2004; 8(2):127–134 Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Fellander G, et al. One year results of a randomised controlled multi-centre study comparing Prolene and Vypro II-mesh in Lichtenstein hernioplasty. Hernia 2005; 9(3):223–227
277 Chapter 37 · Lightweight Macroporous Mesh vs. Standard Polypropylene Mesh
5.
6.
7.
Bringman S, Wollert S, Osterberg J, Smedberg S, Granlund H, Heikkinen TJ. Three-year results of a randomized clinical trial of lightweight or standard polypropylene mesh in Lichtenstein repair of primary inguinal hernia. Br J Surg 2006; 93(9):1056–1059 O’Dwyer PJ, Kingsnorth AN, Molloy RG, Small PK, Lammers B, Horeyseck G. Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair. Br J Surg 2005; 92(2):166–170 Post S, Weiss B, Willer M, Neufang T, Lorenz D. Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg 2004; 91(1):44–48
Discussion Kurzer: There are three trials now. And in the European guidelines we are asking ourselves if the books are closed on this subject. The recommendation is that the use of lightweight [mesh] can be considered in inguinal hernia repair to decrease postoperative discomfort – but it is also stated that possibly [would be] at the cost of more recurrences. What would be your recommendation? Bringman: Well, I think that the Vypro II is not the best large-pore material available now. If we had UltraPro when we started the trial, we would definitely have used that one. It is true that there are only some aspects where we found a difference in our trial. I also know that the Vicryl portion of Vypro II provokes rather heavy inflammation. So I would expect the results from an UltraPro study to make it clearer in the future Post: Congratulations on the nice study. You mentioned that the design was single-blinded. Does that mean that the examiner knew which type of mesh was implanted, or was the examiner was also blinded? Bringman: The examiner was blinded. Miserez: I presume you now use lightweight in your standard daily practice—and I have two questions on that. First, does this advantage outweigh that of increased costs? Second, do you use it in all patients, or are there patients with a large direct or indirect hernia where you would not use a lightweight mesh? Bringman: In very large defects I would use a heavyweight mesh. Now I do very little Lichtenstein anymore. I focus on laparoscopic hernia surgery.
37
Jacob: There is a study that was recently pub-
lished by Dr. Heniford and Dr. Matthews, and they looked at Ki67 and the continuing cell turnover for the different mesh products—I think they used a rabbit model. They found that the heavyweight product actually had continuing cell turnover at a year compared to the lightweight mesh, where this process actually died off. And so one of the possibilities was that there is an ongoing cellular turnover with these heavyweight products that is contributing to the ongoing symptoms that you found. So the question is with this nerve information from its contact with the mesh. One of my partners opens the floor in all of his open repairs and puts the mesh in the same location as in laparoscopic repair and closes the transverse fascia over so that there is no mesh in contact with the nerves running through the canal. And I wondered if anyone else had thought of or has been doing that and what their outcomes are—so, some sort of Lichtenstein repair in the preperitoneal space. Champault: You are describing an operation described by my chief Jean Rives in 1963. Transinguinal preperitoneal prosthesis, and Volker said it was TIPP, but for me it was the Rives operation. Jacob: Maybe that is the direction where we have to go back to again to avoid the nerve problem, by putting the mesh to this place. Desine: I was very impressed by the mathematical description of your work—I was able to understand it very well—but I am concerned that you had a high incidence of testicular atrophy which I cannot explain except because of technique. And that is what has to be emphasized for the rest of his training. The percentage of testicular atrophy should be below 1%. Bringman: I agree. Schumpelick: When we first used lightweight meshes in the Lichtenstein repair, we had problems in fixing this floppy mesh in front of the pubic bone. Should we use a bigger overlap to avoid a recurrence? Bringman: We made big overlaps and a rather short distance between the stitches. Schumpelick: And additional stitches? Bringman: Additional stitches starting about 2 cm up on the medial side.
38
Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain? B. P. Page and P. J. O’Dwyer
280
Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain?
Introduction Chronic pain is the most serious long-term complication of inguinal hernia repair. Up to one-third of patients will complain of some sort of pain at 1 year postoperatively, and in 3–4% of patients this pain will be severe and disabling [1, 2]. The causes of this pain are poorly understood, but factors such as nerve and tissue injury may be important. Psychological factors are also implicated, and more recently, the type of mesh used has been considered [3]. The most frequently used mesh type in inguinal hernia repair is polypropylene based. These meshes can be monofilament or multifilament with a closed or open weave. In some patients they become very stiff over time, and patients complain that they can feel the mesh in their groin, while in others the mesh causes pain [4]. To overcome this, products have been designed that contain an absorbable and a nonabsorbable component [5]. The nonabsorbable polypropylene left in situ usually weighs about one-third that of conventional meshes. The aim of this study was to compare a partially absorbable (PA) product, Vypro II, with a conventional nonabsorbable (NA) polypropylene mesh. The primary end point of the study was pain at 1 year following surgery. This was assessed by visual analogue pain scores and a validated questionnaire [2].
Patients and Methods
38
Ethics committee approval was obtained in five surgical units to randomise patients over 18 years of age with an inguinal hernia to receive either PA or NA mesh using the Lichtenstein repair [6]. Randomisation was computer generated with block sizes that allowed balanced recruitment within each centre. Patients were excluded if the hernia was strangulated or irreducible or if they had undergone an open tension-free mesh repair previously on the same side as the current hernia. Both patients and the staff conducting the postoperative assessments were unaware of the treatment allocated. The PA mesh used in this study was constructed of multifilaments of polypropylene with additional absorbable polyglactin (Vypro II, Ethicon, Ham-
burg, Germany). This mesh has a pore size of 4 mm and weighs 82 g/m2 at implantation and 32 g/m2 after absorption of the polyglactin component, which usually takes 56–70 days. The NA mesh has a pore size of 1 mm and weighs 85 g/m2 (Atrium, Atrium Medical, Schiphol-Rijk, Netherlands). Before operation, pain scores on a visual analogue scale (VAS) were measured in all patients at rest and while moving, and all completed a short-form (SF)-36 questionnaire. Patients underwent open tension-free Lichtenstein mesh repair. Operative details recorded included the hernia type and size, any adverse events, and whether the nerves were identified and preserved or divided. All postoperative complications were recorded, and patients were telephoned with set questions at 10, 20, and 30 days after surgery to determine the incidence of wound infection and other wound-related problems. Patients who reported a wound infection or haematoma were recalled and examined clinically. Hospital stay and time to return to work and normal activities were recorded for all patients. Patients were sent a VAS pain scale at 1, 3, and 12 months, as well as a modified SF-36 questionnaire. Modifications included questions about pain of any severity at the site of hernia repair (none, very mild, mild, moderate, severe, or very severe). Patients were also asked whether the pain was present all of the time, most of the time, some of the time, a little of the time, or none of the time. In addition, they underwent clinical review and examination at 12 months for any evidence of chronic wound problem, testicular atrophy, or development of a recurrent or contralateral hernia. Patients were also asked about any pain or numbness at the site of hernia repair. A sample size of 300 evaluable patients was necessary to ensure an 80% power to detect a benefit of the PA mesh of 15% for primary efficacy (incidence of chronic pain at 12 months: NA mesh, 35%; PA mesh, 20%) at the 5% level of significance using a two-sided test. All subjects, regardless of their compliance with the protocol, were included in the analysis. For efficacy analysis, patients with missing data for pain at 12 months were analysed using the last valid observation, which was carried forward for those who did not complete a questionnaire at that time point. All statistical tests were interpreted
281 Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy
at the 5% significance level, and 95% confidence intervals (CIs) were calculated when appropriate. No adjustment for multiple testing was made.
38
graphics and the anaesthetic and operating details were similar for the two groups (⊡ Table 38.1).
Primary End Point Results Altogether, 333 patients consented to participate in the study. Two patients did not fulfil the inclusion criteria, while 10 either withdrew consent or failed to complete the preoperative assessments. This left 162 patients in the PA mesh group and 159 in the NA group (see ⊡ Fig. 38.1). The patient demo-
There were no differences in pain as rated by the VAS at any of the time points in the study (⊡ Figs. 38.2 and 38.3). Similar numbers of patients reported severe pain in both groups. Pain of any severity was found to be less in the PA group, 39.5% vs. 51.6%, a difference of 12.1% (95% CI: -23.1 to -1.0, p=0.033; see ⊡ Table 38.2).
Consenting patients: 333
Randomised: 330
Partially absorbable (PA) group:N=166
Completed postoperative assessments: 162 (97.6%)
1-month questionnaire: 142 (85.5%)
3-month questionnaire: 125 (75.3%)
12-month questionnaire: 137 (82.5%)
12-month clinic: 142 (85.5%) ⊡ Fig. 38.1. Trial profile
Nonabsorbable (NA) group:N=164
Completed postoperative assessments: 159 (97%)
1-month questionnaire: 135 (82.3%)
3-month questionnaire: 129 (78.7%)
12-month questionnaire: 129 (78.7%)
12-month clinic: 142 (86.6%)
282
Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain?
⊡ Fig. 38.2. Visual analogue pain scores at rest in both patient groups preoperatively and 1, 3, and 12 months after surgery (plots are means with 95% confidence intervals)
38
⊡ Fig. 38.3. Visual analogue pain scores on movement in both patient groups measured preoperatively and at 1, 3, and 12 months after surgery (plots are means with 95% confidence intervals)
283 Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy
38
⊡ Table 38.1. Patient demographics and anaesthesia and operating details for the partially absorbable (PA) and nonabsorbable (NA) groups PA group, n=162
NA group, n=159
55.7 (16.4)
57.3 (15.8)
156:6
154:5
25.5 (3.4)
25.7 (3.0)
Site of hernia: Right Left
80 (49.9%) 82 (50.6%)
86 (54.1%) 73 (45.9%)
Type of defect: Direct Indirect Combined
64 (39.5%) 77 (47.5%) 21 (13%)
51 (32.1%) 78 (49.1%) 30 (18.9%)
Size of defect: <1.5 cm 1.5–3 cm >3 cm
27 (16.7%) 74 (45.7%) 61 (37.7%)
24 (15.1%) 68 (42.8%) 65 (40.9%)
Type of anaesthesia: General Local Spinal
90 (55.6%) 64 (39.5%) 8 (4.9%)
94 (59.1%) 62 (39%) 3 (1.9%)
Operating time (min)a
42.5 (17.2)
42.9 (16.6)
Incision length (cm)a
7.4 (1.9)
7.4 (1.5)
Nerves identified: Ilioinguinal Genital Iliohypogastric
145 (89.5%) 74 (45.7%) 10 (6.2%)
146 (91.8%) 77 (48.4%) 68 (42.8%)
Nerves divided: Ilioinguinal Genital Iliohypogastric
32 (19.8%) 13 (8%) 10 (6.2%)
32 (20.1%) 16 (10.1%) 11 (6.9%)
Age (years)a Sex ratio (M:F) Body mass index
aValues
a
are mean (standard deviation)
⊡ Table 38.2. Pain at 12 months in the partially absorbable (PA) and nonabsorbable (NA) groups Any paina
Severe or very severe pain
PA
39.5%
3%
NA
51.6%
4%
aDifference:
12.1% (95% confidence interval -23.1 to -1.0),
common in the PA group (⊡ Table 38.4). There was no statistical difference between groups in terms of occurrence of testicular atrophy, wound sinus, or contralateral hernia when examined at 12 months.
Costs to Health Service
p=0.033
Secondary End Points Return to normal activities was the same in both groups (⊡ Table 38.3). There were six (3.7%) wound infections in the PA group and 10 (6.3%) in the NA group. Hernia recurrence was significantly more
In terms of costs, the PA mesh costs approximately £14.32 more than the NA mesh, and these costs as well as the costs of treating additional recurrences have been calculated in a United Kingdom context. Given that about 70,000 inguinal hernias are repaired each year, this translates to a cost of about £1.4 million to the United Kingdom health service. This will increase to £6.4 million when the cost of treating the extra recurrences is factored in.
284
Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain?
⊡ Table 38.3. Time to normal activities in days; values are median (interquartile range) PA group
NA group
p-value (log rank test)
Paid work
21 (14–42), n=82
26 (10–49), n=77
0.375
Housework
10 (5–24), n=161
10 (4–21), n=154
0.579
Social life
10 (5–21), n=161
10 (4–24), n=154
0.622
Sex
28 (14 to >365), n=161
28 (14 to >365), n=154
0.649
Hobbies
20 (10–40), n=161
14 (7–31), n=154
0.283
⊡ Table 38.4. Hernia recurrence at 12 months in the partially absorbable (PA) and nonabsorbable (NA) groups Number
Recurrencea
p (Fisher’s exact test)
PA
142
8 (5.6%)
0.037
NA
142
1 (0.7%)
aAnalysis
performed with respect to those who completed the postoperative assessments
Discussion
38
This study shows that there was no difference in pain scores at rest or with movement between patients randomised to PA or to NA mesh. There was also no difference in severe pain between the two groups. It is likely that the small differences in all types of pain reported in favour of the PA group reflected differences in mild and very mild pain in this study. This finding is in keeping with other studies in which patients were less likely to feel a foreign body in their groin after inguinal hernia repair with Vypro mesh [4]. One of the disappointing results of this study was a significant increase in recurrence rates in the PA group. Subsequent investigation revealed that the reason for this was that the suture pullout force in the knitted direction of the mesh was low (⊡ Fig. 38.4). This may have caused or contributed to the high recurrence rate in the PA group. The manufacturer had stressed that suture bites of at least 1 cm were required with its product. Surgeons used to taking smaller bites of mesh, as is routine with conventional polypro-
pylene mesh, underestimated the consequence of inadequate fixation with Vypro II. This may explain why most of the recurrences–five of eight– were observed in one of the participating centres. Surgeons in this centre admitted that they did not adhere to taking suture bites of at least 1 cm with the PA mesh. The PA mesh used in this study was among the first of its type to be investigated in a randomised clinical trial. The perceived advantage of leaving about one-third of the amount of polypropylene in situ after the polyglactin component is absorbed has been exploited in other products that maintain the tensile strength of the absorbable component for a longer period (e.g. Ultrapro [7]). These products may perform better than Vypro II but need to be evaluated in a similar fashion. Meshes with less polypropylene and a larger pore size, 3–4 mm, should also be evaluated in randomised clinical trials. The in vitro performance of these products may not be matched by what happens in patients. New products, such as polyvinylidene fluoride, that have a similar weight to conventional polypro-
285 Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy
38
⊡ Fig. 38.4. Suture pull-out force
pylene meshes but a larger pore size also require further careful evaluation in long-term follow-up studies [8]. Biological products that are thought to help stimulate growth of normal human blood vessels and collagen have also had limited testing in inguinal hernia repair [6]. One of the drawbacks of the many new products is the increased costs. Some of these products are several times more expensive than conventional polypropylene meshes. It follows, therefore, that a dramatic improvement in the patients’ quality of life, with similar or reduced recurrence rates, would be required to justify their routine use in inguinal hernia repair. While this seems unlikely, the cost to the health service of a product would be reduced if proven advantages resulted in increased use. This study demonstrates no clinical advantage for using a PA mesh in inguinal hernia repair. The significant reduction in mild discomfort that was observed warrants further investigation with dif-
ferent products in larger multicentre controlled clinical trials.
References 1.
2.
3.
4.
5.
Bay-Neilson M, Perkins FM, Kehlet H. Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study. Ann Surg 2001; 233:1–7 MRC Laparoscopic Groin Hernia Trial Group. Laparoscopic versus open repair of groin hernia, a randomised comparison. Lancet 1999; 354:185–190 Lagenbach MR, Schmidt J, Zirngibl H. Comparison of biomaterials in the early postoperative period. Polyprolene meshes in laparoscopic inguinal hernia repair. Surg Endosc 2003; 17:1105–1109 Post S, Weiss B, Willer M, Neufang T, Lorenz D. Randomised clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg 2004; 91:44–48 Junge K, Klinge U, Rosch R, Klosterhalfen B, Schumpelick V. Functional and morphological properties of a modified mesh for inguinal hernia repair. World J Surg 2002; 26:1472–1480
286
6.
7.
8.
Chapter 38 · Does the Choice of Prosthetic Mesh Type Make a Difference in Postherniorrhaphy Groin Pain?
Lichtenstein IL, Shulman AG, Amid PK, Willis PA. Hernia repair with polypropylene mesh, an improved method. AORN J 1990; 52:559–565 Cobb WS, Kercher KW, Heniford BT. The argument for lightweight polypropylene mesh in hernia repair. Surg Innov 2005; 12:63–69 Klinge U. Mesh for hernia repair. Br J Surg 2008; 95:539– 540
Discussion
38
Montgomery: You mentioned the mesh weight, and you said there was a middleweight mesh of 85 g. I just wondered whether this group here has a consensus on what is a lightweight mesh and what a heavyweight mesh. Should we use or call anything midweight meshes? O’Dwyer: Just out of interest, one of our group has decided that less than 40 g/m2 is truly lightweight and between 40 and 80 is middleweight, and if it’s greater than 80 it is heavyweight. But you could also say that if it is lighter than 60 g/ m2 it’s light weight, and if it’s greater than 60, it is heavyweight. Montgomery: Is anyone here having sort of a consensus on this topic? And should we count the mesh weight together with the composite part of it? Hegarty: We have to distinguish between mesh weight and pore size, don’t we? I am not bothered about how much it weighs or about the diameter of the filaments—I want a big-pore mesh. Conze: I think it is not only the weight—forget about the weight. There are meshes that are certainly more heavy than polypropylene. Say, PVDF is more heavy. If you take a PVDF mesh with the same size and the same pore size as a polypropylene mesh, it is going to be a heavyweight mesh. We should focus more on pore size and even more on surface area. And by doing that, we will get to a new classification. O’Dwyer: I think that makes sense. Pore size and filament type are perhaps more important. Unfortunately, we have gone down this route for the last 10 years. Schumpelick: The question is if we need a new technique for these lightweight flexible meshes. We have learned that with the ventral hernia we
had mistakes here, and we have to make more overlap. The question to Bringman was that without enough overlap at the pubic bone, we have problems. We need an optimized technique for these new meshes. O’Dwyer: We need a product that is forgiving. Simons: How can there be 60 randomized in one group and only 48 in the other? What kind of randomization system did you have? O’Dwyer: It was a computer-generated randomization by our statisticians. Every single patient was entered again as a new entry—it was not a block randomization.
39
New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy Inguinodynia and Orchialgia P. K. Amid
288
Chapter 39 · New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy Inguinodynia
Introduction Advances in inguinal hernia repair, such as the use of prosthetic materials and new techniques, have markedly reduced the postherniorrhaphy recurrence rate. However, chronic pain after hernia repair is of continuing concern. According to the Swedish Hernia Registry, the incidence of chronic pain postherniorrhaphy is greater than that of hernia recurrence [1]. We have previously described the causes, prevention, and surgical treatment of postherniorrhaphy chronic pain [2]. The current study of groin neuroanatomy has resulted in new understanding of certain features of postherniorrhaphy inguinodynia and orchialgia. Our series now stands at 465 patients who have undergone operation for chronic post hernia repair groin pain intractable to nonsurgical pain management treatment. Recent observations of groin neuroanatomy have prompted a modification of our neurectomy technique to include a more extensive resection of the iliohypogastric nerve and, for patients with orchialgia, resection of nerves within the lamina propria of the vas deferens as well. These observations also illustrate methods to avoid nerve injuries in the original hernia operation.
than dividing the nerve as it emerges from the internal oblique muscle, as was our practice previously, the nerve was followed and severed proximal to the surgical field of the original hernia repair. In 21 of those patients, the intramuscular segment of the iliohypogastric nerve was scarred by perineural fibrosis or entrapped by sutures placed when the so-called conjoined tendon was sutured to the inguinal ligament, plug, or flat mesh, depending on the method of the original hernia repair. In less than 5% of patients, the iliohypogastric nerve is under the internal oblique aponeurosis in the inguinal region. During hernia repair in these patients, the subaponeurotic course of the nerve must be determined by noting the
Methods
39
Between 1995 and 2008, the triple neurectomy operation was performed on 465 patients who did not respond to nonsurgical pain management treatment. These patients either did not have pain prior to their original hernia repair or, if they did, their postoperative pain was different from their preoperative pain and had the characteristic features of neuropathic pain according to the International Association for the Study of Pain. The interval between the original hernia repair and triple neurectomy was 2–5 years. In 210 patients who underwent triple neurectomy from 2004 to 2008, attention was focused on the intramuscular segment of the iliohypogastric nerve, the most vulnerable neural structure within the operative field. A slit was made in the internal oblique muscle fibers to expose the intramuscular segment of the iliohypogastric nerve (⊡ Fig. 39.1). Then, rather
⊡ Fig. 39.1. Intramuscular segment of the iliohypogastric nerve exposed by splitting the muscle fibers (with sutures retracting the edges of split)
⊡ Fig. 39.2. Point of simultaneous passage of a subaponeurotic iliohypogastric nerve from both external and internal oblique aponeurosis
289 Chapter 39 · New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy
location of its exit at the small point of attachment between the internal and external oblique aponeuroses (⊡ Fig. 39.2), and the surgeon should avoid placing sutures or staples below the abovementioned point because the course of the nerve under the internal oblique aponeurosis is inferior and lateral (⊡ Fig. 39.3). During triple neurectomy, the subaponeurotic iliohypogastric nerve can be identified by splitting the internal oblique aponeurosis immediately below the aforementioned point (⊡ Fig. 39.3). In early 2005, a patient was referred with chronic groin pain and orchialgia, and a magnetic resonance scan showed the vas deferens entrapped by a plug (⊡ Fig. 39.4). At operation, the plug completely encircled the vas deferens (⊡ Fig. 39.5). Because the patient had undergone an earlier vasectomy, the entrapped segment of the vas was resected during the triple neurectomy. Postoperatively, the patient’s groin pain and orchialgia disappeared, which was contrary to our experience with other patients with both groin pain and orchialgia who had undergone triple neurectomy alone. Histological study showed fibrosis and foreign body reaction around the paravasal nerves within the lamina propria of the vas (⊡ Fig. 39.6). In 11 subsequent patients with groin pain and orchialgia combined, a 2-cm segment of the lamina propria of the vas was resected (without resecting the vas) as proximal to the internal ring as possible. Histology showed perineural fibrosis in these patients as well.
39
⊡ Fig. 39.3. Subaponeurotic iliohypogastric nerve exposed by splitting the internal oblique aponeurosis
⊡ Fig. 39.4. Magnetic resonance image showing entrapment of vas deferens by a plug
Results From 1995 to 2008, 460 patients with chronic postherniorrhaphy pain underwent surgical treatment at the Lichtenstein Hernia Institute in Santa Monica, California. In 180 patients who had most recently undergone triple neurectomy, particular attention was paid to the intramuscular portion of the iliohypogastric nerve. Adding resection of the intramuscular segment of the iliohypogastric nerve improved the success rate of triple neurectomy compared with division of the iliohypogastric nerve at the point of its emergence from the internal oblique muscle. Furthermore, adding
⊡ Fig. 39.5. Explanted plug along with the entrapped segment of vas from Fig. 39.4
290
Chapter 39 · New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy Inguinodynia
⊡ Fig. 39.6. Perineural fibrosis of paravasal nerves corresponding to Figs. 39.4 and 39.5
resection of the lamina propria of the vas to triple neurectomy eliminated testicular pain.
Discussion
39
The definition of chronic inguinodynia, its diagnostic criteria, preoperative workup, and intraoperative verification, as well as the surgical treatment and postoperative follow-up, have been described previously [2]. Triple neurectomy is a proven surgical treatment for chronic postherniorrhaphy pain that is intractable to multidisciplinary pain management. According to three major series, the success rate of the operation ranges from 80% [3] to 95% [2, 4]. Resecting the intramuscular portion of the iliohypogastric nerve, instead of severing the nerve at the point of its emergence from the internal oblique muscle, improves the outcome of triple
neurectomy. Although a firm conclusion should not be drawn from such a small number of cases, it seems that resection of the paravasal nerves is a useful addition to triple neurectomy for patients with orchialgia associated with inguinodynia. Pain after placement of mesh in the parietal compartment of the preperitoneal space (during both open and laparoscopic hernia repair) presents special problems. The main trunk of the genitofemoral nerve, the preperitoneal segment of its genital branch, and its femoral branch located in the parietal compartment of the preperitoneal space have no fascial coverage to protect them from direct contact with nerves. This is in contrast to the nerves in front of the transversalis fascia, where the ilioinguinal and iliohypogastric nerves are covered by the investing fascia of the internal oblique muscle, and the inguinal segment of the genital branch is covered by the deep cremasteric
291 Chapter 39 · New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy
fascia. These covering layers protect the nerves by acting as a barrier against the mesh. There is experimental evidence that direct contact of mesh with the nerves leads to certain ultrastructural changes in the nerves; this evidence is consistent with the preliminary results of our ongoing study of the structural changes of nerves in patients suffering from postherniorrhaphy pain. Also, because the nerves within the preperitoneal space are not easily accessible during operative exploration, surgical treatment of inguinodynia and orchialgia after preperitoneal hernia repair is less likely to improve the patient’s symptoms. Therefore, we reserve triple neurectomy for pain after laparoscopic hernia repair for patients in whom staples or tacks were used and for those in whom computed tomography or magnetic resonance imaging shows meshoma. Recently we proposed a possible treatment for neuropathy following open and laparoscopic preperitoneal repair by transabdominal retroperitoneal transection of periinguinal nerves over the psoas muscle [5]. This approach, which can be referred to as transabdominal retroperitoneal triple neurectomy, is currently used for laparoscopic aortic surgery. In light of these new findings, the following recommendations are added to those previously suggested for preventing postherniorrhaphy inguinodynia [2]: 1. Avoid passing sutures through the internal oblique muscle. 2. Avoid suturing the upper edge of the mesh to the internal oblique muscle during Lichtenstein tension-free hernia repair. 3. Avoid mesh implantation in the parietal compartment of the preperitoneal space; within the inguinal canal a layer of fascia acts as a barrier between the nerves and the mesh, but in the parietal compartment of the preperitoneal space, there is no investing fascia to protect the nerves from direct contact with the mesh. 4. Avoid removing the cremasteric layer in order to protect the inguinal segment of genital and paravasal nerves from direct contact with the mesh and thereby avoid postherniorrhaphy inguinodynia, orchialgia, and the possibility of infertility due to direct contact between the mesh and the vas deferens.
39
Failing to identify and protect the nerves during hernia repair significantly increases the incidence of postherniorrhaphy pain [6–8]. Yet this issue has not received due attention. According to the Netherlands Hernia Registry, only 32% of surgeons identified the iliohypogastric nerve during hernia repair, and only 36% identified the genital branch of the genitofemoral nerves. As has been reported by many authors [9], identification and careful attention to the groin nerves during hernia repair reduce the incidence of chronic pain to less than 1%.
References 1.
2.
3.
4.
5. 6.
7.
8.
9.
Franneby U, Sandblom G, Nordin O, Gunnarsson U (2006) Risk factors for long-term pain after hernia surgery. Ann Surg 244:212–219 Amid PK (2004) Causes, prevention, and surgical treatment of postherniorrhaphy neuropathic inguinodynia: triple neurectomy with proximal end implantation. Hernia 8:343–349 Madura JA, Copper CM, Worth RM (2005) Inguinal neurectomy for inguinal nerve entrapment: an experience with 100 patients. Am J Surg 189:283–287 Starling JR, Harms BA (1994) Ilioinguinal, iliohypogastric, and genitofemoral neuralgia. In: Bendavid R (ed) Prostheses and abdominal wall hernia. RG Landes, Austin, pp 351–356 Amid P, Hiatt JR (2008) Surgical anatomy of the preperitoneal space. J Am Coll Surg 207:295 Alfieri S, Rotondi F, Di Giorgio A, et al. (2006) Influence of preservation versus division of ilioinguinal, iliohypogastric, and genital nerves during mesh herniorrhaphy: prospective multicentric study of chronic pain. Ann Surg 243:553–558 Wijsmuller AR, van Veen RN, Bosch JL, Lange JFM, Kleinrensink GJ, Jeekle J, Lange JF (2007) Nerve management during open hernia repair. Br J Surg 94:17–22 Aasvang EK, Mohl B, Bay-Nielson M, Kehlet H (2006) Pain related sexual dysfunction after inguinal herniorrhaphy. Pain122:258–263 Kingsnorth AN, Bowley DMG, Porter C (2003) A prospective study of 1000 hernias: results of the Plymouth Hernia Service. Ann R Coll Surg Engl 85:18–22
Discussion Klinge: Why do you believe that a proper fixation
can prevent the development of mesh shrinkage or mesh migration or meshoma? We have seen so many meshes after some times, despite thousands
292
39
Chapter 39 · New Understanding of the Causes and Surgical Treatment of Postherniorrhaphy Inguinodynia
of tacks. Why do you think that some sutures can prevent this development? Amid: You are right. This usually happens in the preperitoneal space, because the fixation is not complete and the surface is not completely smooth. Very rarely you can see these meshomas in front of the transversalis fascia. And maybe light meshes could prevent that. I do not know. But theoretically, it makes sense to assume that light meshes, by creating less fibrotic tissue, may prevent meshoma formation. Kehlet: You have operated on 460 patients now. Do you find these abnormalities every time you operate? What is the specific indication for these operations? Secondly, neurosurgeons have done neurosurgery for chronic pain for many years— always disappointing. What is the follow-up here? What happens with time? Do you really think that you have solved the problem in the long term? Amid: First, I tell you about the follow-up: We see these patients 1 week and 1 month after the operation and then up to 6 months. We contact them by phone, and that is the end of our follow-up. I admit, this is not a complete follow-up. After the last telephone conversation—and they tell us they are satisfied—if their pain comes back or becomes more, they would contact us. I agree, that is not scientific enough. How often we find these pathologies? Almost all of the time! The least thing that we find is very dense fibrotic tissue—histologically, perineural fibrosis. Now we study the structural changes of the nerves. Penkert: With your large experience in these cases, I wonder that you have success in all cases. So, we must estimate preoperatively what kind of pain it is. If it is neuroma pain, it works. But if it really is a neuropathic pain, it is quite another thing. I am in doubt. That is my comment. Amid: The best indication for this operation is when the previous operation is an anterior repair without manipulation of the preperitoneal space. If the preperitoneal space is manipulated, even by placement of a plug or by placement of a PHS or by a preperitoneal repair, then the pain could be related to the nerves in front of the transversalis fascia or behind the transversalis fascia. And there is no way to find out what part is belonging to the front and what part belongs to behind.
40
Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both? G. D. Arlt, U. Huhn, C.C. Kersten
294
Chapter 40 · Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both?
Introduction
40
Chronic inguinal pain is a rare but severe complication of inguinal hernia repair, with a prevalence of disabling pain from 3% to 9% (Kehlet et al. 2002, Aroori and Spence 2007). Its exact cause and lack of evidence-based treatment path presents problems in the effective management of this surgical complication. Most cases may be treated conservatively with repeated injections of cortisone and a local anesthetic for a permanent local nerve block. About 70–80% of the patients respond to the infiltration therapy to the point of maximum tenderness (Aroori and Spence 2007, Palumbo et al. 2007). In the others, different treatment strategies have been proposed, such as analgesics and antidepressants, transcutaneous electrical neural stimulation, or recurrent surgery with neurolysis and neurectomy with or without removal of the mesh. Although the necessity of repeated surgery for chronic pain after mesh repair may be rather low, at about 0.35% (Delikoukos et al. 2008), there is major disagreement concerning both the selection criteria for recurrent surgery and the type of surgery itself. Considering the chronic postherniorrhaphy pain syndrome in detail, two types of pain can be distinguished: 1) neuropathic pain caused by entrapment of the ilioinguinal, iliohypogastric, or genital branch of the genitofemoral nerve, and 2) nonneuropathic pain, which might be triggered by staples to the periosteum and/or compression and scar formation around the implanted mesh materials. The latter type of pain may be further differentiated into nociceptive or somatic pain induced, for example, by staples, and visceral pain such as dysejaculation or testicular pain (Loos et al. 2007, Kehlet 2008). In patients with neuropathic pain, a surgical approach with neurectomy of the involved nerves seems rational. Several studies have been published reporting the results of dual or triple neurectomy for chronic groin pain following inguinal hernia surgery. Success rates vary from about 60% to 80% in most series (⊡ Table 40.1). Unfortunately, several of these studies are judged to be of poor quality due to nonstandardized selection criteria, short follow-up, and small sample sizes.
⊡ Table 40.1. Results of neurectomy for chronic groin pain after inguinal hernia repair n
Mesh
Success
Follow-up
Stulz and Pfeiffer 1982
23
0
70%
?
Starling et al. 1987
30
0
83%
?
Kennedy et al. 1994
23
0
63%
36–144 months
Bower et al. 1996
15
0
80%
66 months
Skandalakis 1996
6
0
100%
?
Heise and Starling 1998
9
100%
56%
16 months
Amid 2004
225
100%
80%
–
Madura et al. 2005
100
27%
72%
1–60 months
Ducic et al. 2008
19
100%
84%
12 months
In cases of chronic pain after mesh repair which cannot be assigned to a distinct nerve, the considered surgical approach is mesh removal with or without additional neurectomy. Two small series of mesh removal for pain after groin hernia surgery have been published. In 1998 Heise and Starling described transinguinal mesh removal in 20 patients with severe groin pain following Lichtenstein or laparoscopic mesh repair. The outcome was excellent or good in 12 (60%) of the 20 cases. Aside from a tendency to see better results after additional neurectomy during mesh removal, they were unable to identify other factors that could improve postoperative results or help select better patients for surgery (Heise and Starling 1998). Rosen et al. presented their experience with mesh explantation on the basis of 10 cases selected from 1998 to 2004. The indication was chronic groin pain not responding to local anesthesia of the inguinal nerves. The index operation was a Lichtenstein procedure in nine of the 10 cases. In contrast to Heise and Starling, they used a combined surgical
295 Chapter 40 · Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both?
procedure with transinguinal removal of the mesh and laparoscopic repair of the hernia defect. Results were good or excellent in nine of 10 patients (Rosen et al. 2006). Our own experiences with indications, operative technique, and results of revision surgery for chronic groin pain after inguinal hernia repair are presented here.
Patients and Methods Patient Selection Patients with persistent or recurrent disabling pain interfering with daily activities 3 months after the index operation were judged as chronic pain cases. Pain of other origin, including hernia recurrence, was ruled out by pain history, clinical and ultrasound examination, and, in some cases, magnetic resonance imaging. Initial treatment was conservative and consisted of oral analgesics and infiltration therapy with local anesthetics and steroids. Those who did not respond to this treatment were candidates for surgery. Patients with neuropathic pain responding to diagnostic nerve block with local anesthetics (10 ml of Xylocaine 1% at the anterior superior iliac spine) were offered revision surgery with dual or triple neurectomy. Those with nonneuropathic pain exhibiting no significant pain relief after nerve block were candidates for mesh removal and neurectomy.
Patients From October 1998 to December 2007, 87 patients with chronic groin pain not responding to conservative treatment were referred for further surgery at the surgical department of the Park-Clinic in Berlin-Weissensee, Germany. Fifty-four patients with severe neuropathic complaints following an inguinal hernia repair were identified for recurrent surgery with double or triple neurectomy: 34 men and 20 women with an average age of 47 (range 14–77) years. Thirtyone cases presented after primary repair, and 23 patients had had several hernia repairs. A non-
40
mesh procedure had been done in 29 patients, and 25 had had a mesh repair. The nonneuropathic pain group consisted of 33 patients (26 male, seven female) with an average age of 48 (range 14–71) years. They were offered a mesh removal procedure. The mesh procedures done previously were a transabdominal preperitoneal or totally extraperitoneal repair in 23 patients, a Lichtenstein repair in five, and a mesh-plug repair in another five cases. Several attempts at conservative treatment on an outpatient basis had been made for all of the patients. In some cases, psychosomatic therapy had been recommended. Patients with mild or moderate symptoms responding to conservative therapy were not included in this series.
Operative Technique In patients dedicated for neurectomy, the lateral part of the skin scar in the groin was opened and the deep inguinal ring exposed. After exclusion of a recurrent hernia, the ilioinguinal and iliohypogastric nerves were identified lateral to the deep ring. Both nerves were resected, and a 1-cm strip of nerve tissue was harvested for histologic examination. The proximal ends of the nerves were embedded in the internus muscle. In cases with triple neurectomy, the genital branch of the genitofemoral nerve was identified at the »blue line« near the deep ring and was resected together with the external spermatic vessels. The surgical technique of mesh removal has been described before (Arlt et al. 2003).
Perioperative Care and Follow-Up Informed consent was given by all patients regarding an increased risk of intraoperative and postoperative complications (estimated percentage of ischemic orchitis about 5%, vascular injury about 5%, and recurrent hernia up to 10%). A single-shot antibiotic prophylaxis was used in all operations. All patients were mobilized within 4–6 h postoperatively. Patients were discharged according to their own wishes between days 2 and 10. Physical
296
Chapter 40 · Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both?
activity was restricted for 2 weeks after hospital discharge. All patients were followed for at least 6 months postoperatively. The last follow-up examinations with clinical assessment and ultrasound were done in June 2008, with the follow-up interval ranging from 6 to 86 months. Results were classified as good for satisfied patients with complete pain relief and no need for further analgesic medications. Satisfied patients with some pain during physical activity and the need for painkillers on demand not more than once or twice a week were classified as having a fair result. A bad outcome was quoted in dissatisfied cases with persisting or recurrent disabling pain after the revision surgery.
sified as having a fair result. In seven cases, the pain persisted or returned within 6 months after the operation. Detailed analysis of the cases with intermittent or persisting pain showed that an adverse outcome (fair or bad) was more likely in younger patients and those who had repair for a recurrent hernia (⊡ Table 40.2). Further surgery with a triple neurectomy or a secondary mesh removal was done in six patients. Consideration of the risk of further surgery with mesh removal in patients with neuropathic pain and a mesh repair in their history showed a 20% risk for additional operations in this subgroup (five of 25 cases).
Mesh Removal Results Neurectomy In the group having neurectomy surgery, no severe intraoperative or postoperative complications occurred. All 54 patients could be followed at least 6 months postoperatively. Forty-two patients showed a good result with no complaints and no analgesic medication at the follow-up examination after 6 months. Another five patients were also satisfied with the surgery but reported intermittent pain during physical activity requiring analgesics once or twice a week. They were clas-
⊡ Table 40.2. Results of neurectomy in 54 patients with neuropathic pain; cases with intermittent or persisting pain (fair or bad results of surgery) were summarized as nonresponders
40
Nonresponders
12/54 (22%)
After primary repair
3/31 (10%)
After recurrent repair
7/25 (28%)
Age >50 years
3/25 (12%)
Age <50 years
7/29 (24%)
Further surgery
6/54 (11%)
Secondary mesh removal
5/25 (2%)
In the group receiving mesh removal, complete or near total explantation of the foreign body was achieved in 32 of 33 patients. In one man with a previous Lichtenstein repair, the mesh removal was impossible due to extended scar formation at the cord, indicating a high risk for testicular atrophy. The surgery was restricted to a dual neurectomy with a fair result 6 months after the operation. In the other 32 patients, one case each of partial resection of the bladder, resection of the small bowel, suture of the femoral vein, seroma formation, and ischemic orchitis with testicular atrophy were the major intraoperative and postoperative complications. Reconstruction of the posterior wall was done with a two-layer Shouldice procedure in 25 cases and a Lichtenstein repair using a lightweight mesh (Vypro II /Ultrapro) in six cases. In a 57-year-old woman, the excision of the mesh– fascia–muscle specimen resulted in a large defect of the posterior wall, which had to be closed by a Rives procedure with a Vypro II mesh. Macroscopically, all mesh specimens showed extended folding and shrinkage of 50–70% of the surface (⊡ Figs. 40.1 and 40.2). Analysis of the mesh material and the histopathologic examination of the explanted foreign bodies showed that 30 meshes were heavyweight (>90 g/m2) polypropylene meshes and two were polyester meshes. Chronic inflammation and apoptosis were regular findings at the mesh–tissue interface.
297 Chapter 40 · Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both?
40
At follow-up 6 months to a maximum of 86 months postoperatively, two recurrent inguinal hernias were found. Twenty-two patients had no complaints and were completely satisfied (69% good results). In seven cases, the patients were satisfied but had intermittent pain during physical activity (22% fair results). In one of these patients, a recurrence was found and repaired. During further follow-up, this patient again had a fair outcome. Three patients were dissatisfied (9% bad results). One developed a testicular atrophy, another a symptomatic recurrent hernia, and another complained of persisting disabling pain (⊡ Table 40.3).
⊡ Fig. 40.1. Polypropylene Hernia System prosthesis from a 17-year-old girl 11 months after implantation
⊡ Fig. 40.2. Heavyweight small-pore polypropylene prosthesis 18 months after a transabdominal preperitoneal repair
⊡ Table 40.3. Results of mesh removal for chronic pain: follow-up at 6–86 months Follow-up in June 2008 (clinical exam/ultrasound)
n=32
Recurrent hernia
n= 2
No complaints/satisfied
n=22 (69%)
Pain during physical activity
n=7 (22%)
Dissatisfied (testicular atrophy/ recurrence/persistent pain)
n=3 (9%)
Conclusion The series of 87 patients surgically treated for chronic postherniorrhaphy pain shows that a good or fair clinical result with a satisfactory outcome can be achieved in up to 85% of cases. An important supposition is careful selection of patients. Indication should be restricted to cases with conservatively intractable symptoms. At present, the distinction between neuropathic and nonneuropathic pain on the basis of local nerve blocks can be recommended. The mesh removal operation is challenging, and the surgeon should also be experienced in hernia and vascular surgery. Informed consent from the patient concerning the increased risk of testicular and vascular complications is necessary. To develop a standardized surgical approach regarding chronic groin pain after hernia repair, a large multicenter study would be indispensable.
References Amid PK (2004) Causes, prevention, and surgical treatment of postherniorrhaphy neuropathic inguinodynia: triple neurectomy with proximal end implantation. Hernia 8:343–349 Arlt G, Lamm T, Klosterhalfen B (2003) Mesh removal in inguinal hernia repair. Eur Surg 35:42–44 Aroori S, Spence RA (2007) Chronic pain after hernia surgery–an informed consent issue. Ulster Med J 76:136– 140
298
Chapter 40 · Surgery for Chronic Inguinal Pain: Neurectomy, Mesh Explantation, or Both?
Bower S, Moore BB, Weiss SM (1996) Neuralgia after inguinal hernia repair. Am Surg 62:664–667 Delikoukos S, Fafoulakis F, Christodoulidis G et al. (2008) Reoperation due to severe late-onset persisting groin pain following anterior inguinal hernia repair with mesh. Hernia 12:593–595 Ducic I, West J, Maxted W (2008) Management of chronic postoperative groin pain. Ann Plast Surg 60:294–298 Heise CP, Starling JR (1998) Mesh inguinodynia: a new clinical syndrome after inguinal herniorrhaphy? J Am Coll Surg 187:514–518 Kehlet H (2008) Chronic pain after groin hernia repair. Br J Surg 95:135–136 Kehlet H, Bay-Nielsen M, Kingsnorth A (2002) Chronic postherniorrhaphy pain–a call for uniform assessment. Hernia 6:178–181 Kennedy EM, Harms BA, Starling JR (1994) Absence of maladaptive neuronal plasticity after genitofemoral-ilioinguinal neurectomy. Surgery 116:665–670; discussion 670–671 Loos MJA, Roumen RMH, Scheltinga MRM (2007) Classifying postherniorrhaphy pain syndromes following elective inguinal hernia repair. World J Surg 31:1760–1765 Madura JA, Madura JA II, Copper CM, Worth RM (2005) Inguinal neurectomy for inguinal nerve entrapment: an experience with 100 patients. Am J Surg 189(3):283–287 Palumbo P, Minicucci A, Nasti AG et al. (2007) Treatment for persistent chronic neuralgia after inguinal hernioplasty. Hernia 11:527–531 Rosen MJ, Novitsky YM, Cobb WS, Kercher KW, Heniford BT (2006) Combined open and laparoscopic approach to chronic pain following open inguinal hernia repair. Hernia 10:20–24 Skandalakis JE, Skandalakis LJ, Colborn GL (1996) Testicular atrophy and neuropathy in herniorrhaphy. Am Surg 62:775–782 Starling JR, Harms BA, Schroeder ME, Eichman PL (1987) Diagnosis and treatment of genitofemoral and ilioinguinal entrapment neuralgia. Surgery 102:581–586 Stulz P, Pfeiffer KM (1982) Peripheral nerve injuries resulting from common surgical procedures in the lower portion of the abdomen. Arch Surg 117:324–327
Discussion
40
Deysine: It is evident that these are sometimes true catastrophes, implying very difficult surgery. I am not surprised about the complications that you have. Referring to your paper and the paper of Dr. Amid, there is an alternative thing that we can teach to our residents when we do this hernia surgery: that you do not need to tie knots extremely hard so that you strangulate the tissue. If you teach
your residents to just approximate the mesh to whatever structure you are using, if you have the poor luck of having a nerve in between, it is not going to be strangled, and the patient will not have pain. Because otherwise, going after those nerves is difficult. Again, the technique is a very important aspect for having good results. Schumpelick: I congratulate you. I think it is one of the ugliest operations of all. You must inform your patients about the loss of sensitivity, bleeding of the vein, about the big hole you left and that you have to close maybe with a new mesh. And you must give him the message that at least 20% will have pain. If patients agree with that, he really must have pain. Even in younger people. In my personal experience, they will even come if you say that they might lose their testes. We have at least once a month such a patient. Champault: Two years ago, I saw a young man with pain. I explained the risk of infertility because he had a hernia on the other side when he was 2 years old. So he said okay, and he came back 2 weeks ago with a young boy. To sum up, he postponed the operation for one girl and one boy. Kehlet: Apparently you did a local anesthetic block to divide your indication toward neurectomy or mesh removal. What is the rationale for that, because if you think the pain is coming from the mesh, a local anesthetic block should also help? Arlt: I do not believe that the pain always originates from the mesh. Kehlet: Why did you remove it? Arlt: Only in those cases where they had a meshoma, because when we started this series we followed strictly the idea of having responders to local anesthesia [receive] nerve cutting and nonresponders [receive] mesh removal. We saw that we had five patients with pain responding to local anesthesia who had to have a third operation to take out the meshoma. Kehlet: But my question is, if you believe that the pain is coming from the mesh or the meshoma, why shouldn’t a good anesthetic block work? Arlt: Yes, it works, but only for some hours. It was a diagnostic local anesthesia. We also do this injection therapy, and we have at least 60–70% of patients we do not have to operate on. Thirty percent come again and again, despite injection therapy.
41
Results of Tailored Therapy for Patients with Chronic Inguinal Pain M. Stumpf, D. Kämmer, U. Klinge
300
41
Chapter 41 · Results of Tailored Therapy for Patients with Chronic Inguinal Pain
The onset of chronic inguinal pain has been increasing in recent years, but therapeutic options for these patients remain unclear. Different methods apart from conservative management have been described for dealing with this problem. These options include local revision of the scar and the inguinal nerves, with the next step being retroperitoneal triple neurectomy. Patients with an implanted mesh have the option to have the mesh material explanted, but this can sometimes be a rather difficult operation. We analyzed patients treated surgically for chronic inguinal pain in the surgical clinic of the University of Aachen (Germany) between 2005 and 2008. Thirty-three of these patients were included in the study. All patients had to fill out a structured pain questionnaire (Deutscher Schmerzfragebogen). In addition, immunohistochemical investigations of explanted nerves and meshes were done. Most patients had experienced complaints for more than 2 years. Seventy-five percent of patients with chronic inguinal pain had had a mesh repair in the past, mainly Lichtenstein or a laparoscopic procedure. The aim of the study was to analyze which patients would benefit from an operative approach and to learn whether it is possible to distinguish between two types of chronic inguinal pain and whether there are any clinical implications for the therapeutic strategy. For treatment, we chose three different types of surgery: local revision of the scar and nerves, retroperitoneal triple neurectomy (⊡ Fig. 41.1), or explantation of the mesh. The explanted meshes were mainly heavyweight flat meshes and plugs (⊡ Fig. 41.2). The best results were achieved for patients treated by complete mesh explantation: 75% were pain free or had real improvement in their pain. No patient was pain free after local revision, and 50% had persistent pain (⊡ Table 41.1). We then hypothesized that two types of chronic inguinal pain exist. Type I is not curable with operative intervention, but type II will possibly benefit from operative intervention. Therefore, a differentiation was made among the patients: Group 1 patients were pain free or had an improvement in their pain after operation, and
⊡ Fig. 41.1. Retroperitoneal triple neurectomy
⊡ Fig. 41.2. Explanted mesh plug and flat mesh
⊡ Table 41.1. Results after different operations Local revision
Explantation
Neurectomy
Pain-free
0%
50%
25%
Improvement
50%
25%
50%
Persistent pain
50%
25%
25%
those in group 2 had persistent pain after operation. Seventy percent of the male patients improved, but only 55% of the female patients did. There were no statistically significant differences between the two groups with regard to age, obesity, duration of pain, days of hospital stay, or number of previous operations (⊡ Table 41.2). Looking at the types of explanted meshes, it is interesting that all patients
301 Chapter 41 · Results of Tailored Therapy for Patients with Chronic Inguinal Pain
⊡ Table 41.2. Differences between patients who improved after surgery and those with persistent pain Improvement
Persistent
Age
51.16±13.93
43.17±13.97
Obese
8
4
Duration of pain (months)
25±19.4
45±51.5
Days at hospital
12.9±14.2
11.42±6.5
Former operations (n)
1.8±1.0
1.58±1.0
with plug repairs were pain free after mesh explantation. Both groups showed significant differences in the immunohistochemical expression of CD68 and matrix metallopeptidase 2 (MMP2) at the nerve tissue, which may hint at existing differences in the ultrastructure of the two types of patients. In conclusion, patients receive only minor benefits from local revision of the scar and inguinal nerves. The best results, yielding a high number of pain-free patients after the revision, were reached after mesh explantation. All patients who underwent plug removal were pain free. There might be a correlation between the type of patient and the benefit experienced; patients who were pain free after their operation showed differences in immunohistochemical markers compared with the patients who did not benefit from surgery. Further investigation will be necessary to elucidate these interesting findings concerning chronic inguinal pain after hernia surgery.
Discussion Gryska: When you do an explantation, are not also
doing at least a partial neurectomy? Stumpf: Indeed, if you are doing a reoperation fol-
lowing a Lichtenstein hernia repair to also remove the ilioinguinal nerve while the mesh explantation if the nerve wasn’t dissected while the first operation. Gryska: What are you doing with the hernia after explantation of the mesh?
41
Stumpf: We fix the hernia as well. It depends on the age of the patients. If you have a young patient with comparable stable tissue we do a Shouldice repair. But after a TAPP or TEP hernia repair you mainly have a large defect of the abdominal wall. In those cases we usually use large pore and low weight meshes to fix it again. Köckerling: How do exclude a recurrence? And do you use a diagnostic laparoscopy? Stumpf: We use the ultrasound in every patient with inguinal pain. However at first we try to diagnose a recurrence clinically followed by an ultrasound. In case of an experienced investigator you can objectify a recurrence very exactly. A diagnostic laparoscopy was used in some cases, but we didn’t use it routinely.
IV
IV
Risk for Adhesion
42
Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions? – 305
43
Biological Tissue Graft: Present Status – 317
44
IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis – 323
45
Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual – 331
46
Tissue Ingrowth, Adhesion, and Mesh Contraction
47
Effect of Different Mesh Materials on Adhesion Formation – 353
48
Tissue Ingrowth and Laparoscopic Ventral Hernia Mesh Materials: An Updated Review of the Literature – 365
49
Porosity and Adhesion in an IPOM Model – 375
50
Benefit of Lightweight and/or Titanium Meshes? – 381
51
ePTFE Prostheses and Modifications
52
The Role of Stem Cells in Abdominal Wall Repair – 401
– 345
– 393
42
Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions? M. Binnebösel, K. Junge, C. D. Klink, J. Serno, J. Otto, J. Conze, A. P. Öttinger, V. Schumpelick
306
Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions?
Introduction
42
Peritoneal adhesions are common and develop postoperatively in more than 90% of patients following abdominal surgery. Most adhesions are not symptomatic, however. Even years after surgery, adhesions can lead to undesirable outcomes such as small bowel obstruction, infertility, abdominopelvic pain, and difficult reoperative procedures [1–3]. In addition, adhesions have a substantial impact on the national health economy. In a current Swedish survey, the annual cost of adhesionrelated problems was estimated to be €39.9–59.5 million, and the cost of inpatient readmissions was almost equal to that for gastric cancer [4]. The peritoneum is the largest serous membrane, with a surface of 2 m2. It covers the visceral organs (visceral peritoneum) and lines the abdominal cavity (parietal peritoneum) [5]. The peritoneum is composed of a monolayer of mesothelial cells of mesenchymal origin, resting on a continuous basement membrane supported by the submesothelium. The submesothelial layer consists of the extracellular matrix made up of different types of collagen, glycoproteins, glycosaminoglycans, and proteoglycans [5]. Diffusion and resorption of fluid occur freely through the mesothelium and submesothelial stroma. The luminal surface of mesothelial cells has numerous microvilli, increasing the peritoneal surface area up to 40 m2 for exchange between mesothelial cells and the peritoneal cavity. Overall, the peritoneum must be regarded as an organ that has a protective function for the contents of the abdominal cavity. Peritoneal defects during surgical procedures result in a reduced supply of oxygen and nutrients as well as an impaired ability to remove metabolic byproducts [6]. Correspondingly, it has been suggested that adhesions may act as vascular grafts between healthy organs and areas of ischemic tissue, reflecting the body’s attempt to overcome local damage [7]. It is generally supposed that peritoneal adhesions reflect a kind of modified regeneration of the peritoneal surface, initially as tender and fibrinous bands that are transformed to inert scar tissue with fibroblasts and collagen bundles [1]. In accordance with Epstein et al. [8], we found human peritoneal adhesions to be highly cellular,
well-vascularized proliferating tissue, indicating a dynamic and persistent remodeling [8, 9]. Besides plasmin, plasminogen activator, and plasminogen activator inhibitor, other factors–including transforming growth factor beta, matrix metalloproteinases, tissue inhibitors of metalloproteinases, insulin-like growth factor 1, and platelet-derived growth factor–have been revealed to be important mediators involved in peritoneal healing, all interacting with each other (⊡ Fig. 42.1) [10]. Currently, the impact of inflammatory stimulants–including chemoattractants [interleukin (IL)-8, monocyte chemotactic protein-1] and cytokines (tumor necrosis factor alpha, IL-1β, IL-6)–as products of invaded polymorphonuclear granulocytes, monocytes, and leucocytes is increasingly discussed as an important factor in adhesiogenesis [1–13]. The aim of the first study was to investigate whether human peritoneal adhesions reveal inflammatory activity and whether persistent adhesions reflect a disturbed peritoneal cell differentiation, proliferation, and migration. To test this hypothesis, we focused on the appearance of macrophages (CD68), B-lymphocytes (CD20), and T-lymphocytes (CD45) as main representatives of the cellular immune response. Furthermore, we measured the occurrence of cyclooxygenase-2 (COX-2) as a pivotal component of inflammatory cell activity. Finally, we analyzed the expression profiles of Notch-3, ß-catenin, and c-myc as important mediators of cell differentiation, proliferation, and migration involved in wound healing. The aim of the second study was to investigate the kinetics of peritoneal adhesions in a rat model with special regard to the cellular immune response [T-lymphocytes (CD3) and macrophages (CD68)], inflammatory cell activity (COX-2), and cell differentiation, proliferation, and migration (ß-catenin and c-myc).
Patients and Methods Study I: Patient Information Adhesions were prospectively collected from 40 patients undergoing laparotomy at the surgical
307 Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration
42
⊡ Fig. 42.1. Elementary steps and complementary factors involved in the adhesion formation process according to Duron [10] (PA plasminogen activator; PAI plasminogen activator inhibitor; TGF transforming growth factor; FSP fibrin split products; MMP matrix metalloproteinase; ECM extracellular matrix)
department of the RWTH Aachen University Hospital, Germany. The study was approved by the local ethics committee, and patients gave written informed consent to participate in the trial. The clinical parameters acquired included age, gender, diagnosis, and surgical and medical history. Adhesion maturity was calculated from the date of the last previous abdominal surgery, according to Herrick et al. [14]. In each patient, one sample of 5–10 mm was excised from the visceral peritoneum close to the intestine, and another sample of 5–10 mm was excised from the parietal peritoneum distant from the peritoneum. Tissue specimens were immediately fixed in 4% paraformaldehyde and embedded in paraffin wax.
Study II: Animal Model and Surgical Procedure The animal experiment was approved by the Animal Care and Use Review Committee of the Russian State Medical University, Moscow. All animals were housed in accordance with the requirements of the German Animal Protection Act. For the experiment, 60 male Sprague–Dawley rats with a mean body weight of 380 g were used. All animals were kept under standardized conditions: temperature 22–24°C, relative humidity 50–60%, and 12 h of light following 12 h of darkness. The animals had free access to food and water. Food was withdrawn 12 h before and after surgery. All operations were carried out under general anesthe-
308
42
Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions?
sia and aseptic and sterile surgical conditions. The surgical procedure (explantation of the adhesion tissue) was done at the Joint Institute for Surgical Research of the Russian State Medical University in Moscow. After introduction by isoflurane, general anesthesia was achieved with a subcutaneous mixture of 0.3 mg/kg medetomidine and 100 mg/kg ketamine hydrochloride. The rats were weighed, and their skin was shaved and disinfected with a polyvidone–iodine solution. The animals were fixed in a supine position. Laparotomy was performed by a 4-cm midline incision, and then a standardized peritoneal defect with a diameter of 2 cm at the cecal area was created. The abdominal wall and skin were separately closed with continuous absorbable 4/0 polyglactin sutures (Vicryl). No additional antibiotic treatment was given before or during the experimental setting. On postoperative days 3, 5, 14, 30, 60, and 90, 10 animals, respectively, were sacrificed and weighed for morphological, histological, and immunohistochemical observations. In each animal the developed adhesion tissue, including parietal and visceral peritoneum, was explanted, and tissue specimens were immediately fixed in 4% paraformaldehyde and embedded in paraffin wax.
Histological Assessment Histological and immunohistochemical investigations were done at the Surgical Department of the RWTH Aachen University Hospital, Germany, and were performed on paraffin-embedded 3-μm sections using peroxidase-conjugated, affinity-isolated immunoglobulins. All sections were routinely stained with hematoxylin and eosin (H&E) and were processed at the same time to reduce internal staining variations. Briefly, immunohistochemistry was done subject to the avidin–biotin complex method and according to the manufacturer’s instructions. Macrophages (CD68) were identified by a 1:50 mouse monoclonal antibody from Dako (Glostrup, Denmark), with microwave pretreatment three times, citrate buffer pH 6, and rabbit antimouse 1:300 (Dako) as secondary antibody. For the detection of B-lymphocytes (CD20) and T-lymphocytes (CD45, CD3), we used a mouse monoclonal pri-
mary antibody 1:100 (Dako), and as secondary antibody we used rabbit antimouse 1:300 (Dako). Cyclooxygenase-2 (COX-2) detection was carried out by a 1:100 rabbit monoclonal antibody from DCS (Hamburg, Germany), with microwave pretreatment three times, citrate buffer pH 6, and goat antirabbit 1:300 (Dako) as secondary antibody. For Notch-3 staining, we used a 1:50 rabbit polyclonal antibody from Santa Cruz Biotechnology (Santa Cruz, CA, USA), with microwave pretreatment three times, citrate buffer pH 6, and goat antirabbit 1:500 (Dako) as secondary antibody. Beta-catenin was analyzed by a ready-to-use rabbit polyclonal antibody from Spring Bioscience (Pleasanton, CA, USA) and goat antirabbit 1:500 (Dako) as secondary antibody. Furthermore, c-myc expression was investigated by a 1:50 rabbit polyclonal antibody (Santa Cruz Biotechnology) and goat antirabbit 1:500 (Dako) as secondary antibody. The expression of immunohistochemical parameters was classified by two independent, blinded observers using a semiquantitative immunoreactivity score according to the method of Remmele and Stegner [15]. Intensity of staining was scored as 0 (negative), 1 (weak), 2 (medium), or 3 (intensive). The extent of staining was scored as 0 (0%), 1 (1–20%), 2 (21–50%), 3 (51–80%), or 4 (81–100%), indicating the percentage of positive staining in adhesion tissue. Multiplication of the intensity score (0–3) and the extent score (0–4) resulted in the immunoreactivity score, ranging between 0 and 12. Sections were examined by standard light microscopy (Olympus BX51, Hamburg, Germany). For each sample, six regions (×400, area 100×100 μm) were captured by a digital camera (Olympus C-3030, Hamburg, Germany).
Results Study I: Human Peritoneal Adhesion Tissue The mean patient age was 55±19 years, and 17 female and 23 male patients were included in the study. Eighteen of the 40 patients had had one previous abdominal operation, and 22 patients had had two or more. The parameters measured were
309 Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration
a
b
c
d
42
⊡ Fig. 42.2. Immunohistochemical features of peritoneal adhesion specimens demonstrating specific nuclear staining for Tlymphocytes (CD45) and macrophages (CD68). T-lymphocytes were evident in peritoneal adhesions younger than 12 months (a) and even in adhesions older than 12 months (b) without significant differences. Views c and d illustrate the specific nuclear staining of macrophages (CD68), with significantly higher expression in adhesions <12 months (c) compared with adhesions >12 months (d). (Magnification ×400)
not significantly affected by the gender or age of the patients or by the number of previous operations.
T-lymphocytes (CD45) and Macrophages (CD68) Investigation of the H&E-stained sections revealed extended infiltrates of mononuclear round cells. Subtyping of these cells by CD68 and CD45 displayed predominant macrophages and T-lymphocytes. They were colocalized within the entire specimen, and the appearance of these cells correlated significantly with each other (r=0.624, p<0.001). Adhesions with an age <12 months showed a significantly elevated expression level of CD68 (mac-
rophages) compared with adhesions >12 months (p<0.05). The expression of CD45 revealed no significant differences regarding adhesion maturity (p>0.05). (See ⊡ Fig. 42.2.)
Analysis of COX-2, ß-catenin, c-myc, and Notch-3 COX-2 showed a positive cytoplasmic staining with a mean score of 3±2.4. Similarly, ß-catenin was expressed in the cytoplasm of endothelial cells of blood vessels and fibroblasts (mean score 3.5±1.9). C-myc (mean score 3.1±1.8) showed positive nuclear staining, both in mononuclear round cells and in fibroblasts predominantly surrounding
310
Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions?
42
a
b
c
d
e
f
⊡ Fig. 42.3. Immunohistochemical features representing protein expression levels in peritoneal adhesions. Expression of Notch-3 (a), ß-catenin (b), and c-myc (c) in adhesions <12 months. Expression of Notch-3 (d), ß-catenin (e), and c-myc (f) in peritoneal adhesions >12 months. (Magnification ×400)
a
b
⊡ Fig. 42.4. Percentage of CD3-positive-stained cells representing a continuous infiltration of macrophages in visceral (a) and parietal (b) peritoneal adhesions
311 Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration
a
42
b
⊡ Fig. 42.5. a Percentage of CD68-positive-stained cells demonstrating a significantly higher expression in visceral adhesions on postoperative days 3 and 5. b A significantly higher infiltration of macrophages was measured in parietal adhesions on postoperative days 60 and 90
blood vessels. Expression of Notch-3 (mean score 6.3±3.4) was pronounced in all specimens. Positive staining was detected in the nucleus as well as in the cytoplasm of both mononuclear round cells and fibroblasts (⊡ Fig. 42.3).
Study II: Experimental Data During the observation period, none of the rats died or exhibited signs of infection. All rats developed peritoneal adhesions.
T-lymphocytes (CD3) and Macrophages (CD68) Both at the parietal and the visceral sites of the adhesions, T-lymphocytes could be detected. The expression profile of CD3 was stable even until the 90th postoperative day. Neither over the course of time nor when comparing the parietal to the visceral site were significant differences seen regarding the expression of CD3 (⊡ Fig. 42.4). Likewise, macrophages were detectable until the 90th postoperative day. At postoperative days 3 and 5, the infiltration of macrophages was significantly elevated at the visceral site of the adhesions compared
with the parietal site. At postoperative days 60 and 90, significantly more macrophages were detectable in parietal adhesions compared with visceral adhesions (⊡ Fig. 42.5).
Cyclooxygenase-2, ß-catenin, and c-myc A significant expression of COX-2 was evident in all adhesions, both at the parietal and visceral sites of the adhesions even 90 days after the operation. Over the course of time, COX-2 was significantly reduced from the 3rd to the 90th postoperative days. The expression of COX-2 at the visceral site of the adhesions was significantly higher on postoperative days 3, 5, and 14 compared with the parietal adhesion sites. The expression of COX-2 was significantly elevated at the parietal site of the adhesions on postoperative days 30, 60, and 90 compared with the visceral site (⊡ Fig. 42.6). Both ß-catenin and c-myc were detected at the visceral site of the adhesions. Over time, the expression profile of both parameters showed no significant differences even 90 days following the operative procedure (⊡ Fig. 42.7). At the parietal site of the adhesions, ß-catenin was evident without significant differences over the course of time. However, c-myc was not detectable at the parietal site (⊡ Fig. 42.7).
312
Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions?
42
a
b
⊡ Fig. 42.6. Collectively, there was a continuously marked expression of COX-2 until the 90th postoperative day. a In visceral adhesions, the expression was significantly higher on postoperative day 3, 5, and 14. b A significantly higher expression was measured in parietal adhesions on postoperative days 30, 60, and 90
a
b
⊡ Fig. 42.7. a Persistent expression of ß-catenin and its target c-myc in visceral adhesions. b A persistent expression of ß-catenin was detected in parietal adhesions, although no expression of c-myc was found distant to the intestine
Discussion Traumatic peritoneal defects are presumed to initiate adhesion formation, whereas the causation of maintaining peritoneal adhesions has not been previously revealed [16–19]. Analogous to physi-
ological wound healing and with lack of infection, a time-dependent termination of the inflammatory activity and a transformation of transient peritoneal adhesions into scar tissue has been suspected [20, 21]. Analysis of human peritoneal adhesions demonstrated that they were cell-rich, well-vascu-
313 Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration
larized, and innervated tissue. In a previous study we also found them to be high in adipose tissue, fibroblasts, and mononuclear round cells such as macrophages and T-lymphocytes, irrespective of the adhesions’ maturity [3]. In 2007 Hoshino et al. demonstrated that peritoneal macrophages trigger the development of peritoneal adhesions via the chemokine receptor 8 (CCR8) and its target, the chemokine ligand 1 (CCL1) [22]. Concordantly, we detected macrophages in long-lasting peritoneal adhesions both in a rat model and even in mature human peritoneal adhesions. The evidence of a significantly higher infiltration of macrophages in the early postoperative period supports the assumption that macrophages trigger the development of peritoneal adhesions. In quantity and quality, T-lymphocytes were found to have no significant differences regarding adhesion maturity. Consequently, an ongoing persistent inflammatory process with a functional impact of T-lymphocytes or T-lymphocytesynthesized chemokines in maintaining peritoneal adhesion may be suspected. Cyclooxygenase-2 (COX-2) is a regulatory factor in the biosynthesis of prostanoids such as prostaglandins, prostacyclin, and thromboxanes [23–25]. COX-2 expression is induced by a variety of growth factors and cytokines, and the expression increases rapidly in response to inflammatory stimuli and tissue damage [26–30]. During physiological wound healing, expression of COX-2 regularizes within weeks after injury [31]. Saed et al. measured significantly higher levels of COX-2 in vitro in adhesion fibroblasts compared with normal peritoneal fibroblasts and assumed an altered cell regulation in peritoneal wound healing [30]. In accordance with these findings, we detected an expression of COX-2 in human peritoneal adhesions that was irrespective of adhesion maturity. Although a continuous decrease in COX-2 expression was measured over the course of time in our rat model of adhesion formation, a substantial expression was evident even 90 days following the surgical trauma. The consideration of adhesions as widely areactive fibrotic bands has been challenged; actually, adhesion formation may be regarded as a defective wound healing process and as a disturbed
42
in situ regeneration of the peritoneal surface [32]. Notch-3, ß-catenin, and c-myc are well-known mediators in cell signaling pathways of proliferation and differentiation responses during normal development and wound healing [33, 34]. Notch proteins are single-pass transmembrane receptors, playing a critical role in control and cell-fate decisions during developmental processes [35]. Notch favors cell proliferation and opposing cell differentiation and is closely connected to Wnt signaling. ß-catenin and its target c-myc are crucial mediators of Wnt signaling and are thereby involved in the regulation of cell growth, cell differentiation, and tissue remodeling [36–39]. Activation of the ß-catenin/c-myc pathway contributes to impaired healing by inhibiting cell migration and altering cell differentiation [40]. In accordance, a marked expression of Notch-3, ß-catenin, and c-myc could be verified even in mature human peritoneal adhesions, indicating disturbed differentiation, migration, and proliferation of mesothelial cells. Likewise, ß-catenin and c-myc were detected in the rat model of adhesion formation, confirming the assumption of a disturbance in peritoneal wound healing. In conclusion, peritoneal adhesions should be regarded as a consequence of continuously malfunctioning cell differentiation and proliferation within a chronic inflammatory process. It remains unclear whether the chronic inflammatory process or the malfunctioning differentiation/proliferation is causative in adhesiogenesis. Influencing the individual inflammatory response to peritoneal trauma seems to be necessary to avoid or at least reduce the formation of postoperative peritoneal adhesions.
References 1. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001;18(4):260–73 2. Menzies D, Ellis H. Intestinal obstruction from adhesions–how big is the problem? Ann R Coll Surg Engl 1990;72(1):60–3 3. Hammoud A, Gago LA, Diamond MP. Adhesions in patients with chronic pelvic pain: a role for adhesiolysis? Fertil Steril 2004;82(6):1483–91
314
42
Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration, and Erosions?
4. Tingstedt B, Isaksson J, Andersson R. Long-term follow-up and cost analysis following surgery for small bowel obstruction caused by intra-abdominal adhesions. Br J Surg 2007;94(6):743–8 5. van der Wal JB, Jeekel J. Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis 2007;9 Suppl 2:9–13 6. Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 2005;83(2):405–9 7. Ellis H. The aetiology of post-operative abdominal adhesions. An experimental study. Br J Surg 1962;50:10–16 8. Epstein JC, Wilson MS, Wilkosz S, Ireland G, O’Dwyer ST, Herrick SE. Human peritoneal adhesions show evidence of tissue remodeling and markers of angiogenesis. Dis Colon Rectum 2006;49(12):1885–92 9. Binnebosel M, Klinge U, Rosch R, Junge K, Lynen-Jansen P, Schumpelick V. Morphology, quality, and composition in mature human peritoneal adhesions. Langenbecks Arch Surg 2007; 393(1):59–66 10. Duron JJ. Postoperative intraperitoneal adhesion pathophysiology. Colorectal Dis 2007;9 Suppl 2:14–24 11. Cahill RA, Wang JH, Redmond HP. Enteric bacteria and their antigens may stimulate postoperative peritoneal adhesion formation. Surgery 2007;141(3):403–10 12. Ito T, Fraser IP, Yeo Y, Highley CB, Bellas E, Kohane DS. Antiinflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 2007;28(10):1778–86 13. Cook AD, Vlahos R, Massa CM, Braine EL, Lenzo JC, Turner AL, Way KJ, Hamilton JA. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation. Thromb Haemost 2006;95(4):659–67 14. Herrick SE, Mutsaers SE, Ozua P, Sulaiman H, Omer A, Boulos P, Foster ML, Laurent GJ. Human peritoneal adhesions are highly cellular, innervated, and vascularized. J Pathol 2000;192(1):67–72 15. Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987;8(3):138–40 16. Alpay Z, Ozgonenel MS, Savasan S, Buck S, Saed GM, Diamond MP. Possible role of natural immune response against altered fibroblasts in the development of post-operative adhesions. Am J Reprod Immunol 2006;55(6):420–7 17. Roy S, Clark CJ, Mohebali K, Bhatt U, Wallace WA, Nahman NS, Ellison EC, Melvin WS, Sen CK. Reactive oxygen species and EGR-1 gene expression in surgical postoperative peritoneal adhesions. World J Surg 2004;28(3):316–20 18. Whawell SA, Scott-Coombes DM, Vipond MN, Tebbutt SJ, Thompson JN. Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells. Br J Surg 1994;81(2):214–6
19. Whawell SA, Vipond MN, Scott-Coombes DM, Thompson JN. Plasminogen activator inhibitor 2 reduces peritoneal fibrinolytic activity in inflammation. Br J Surg 1993;80(1):107–9 20. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O’Brien F, Buchan S, Crowe AM. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999;353(9163):1476–80 21. Jirasek JE, Henzl MR, Uher J. Periovarian peritoneal adhesions in women with endometriosis. Structural patterns. J Reprod Med 1998;43(3 Suppl):276–80 22. Hoshino A, Kawamura YI, Yasuhara M, Toyama-Sorimachi N, Yamamoto K, Matsukawa A, Lira SA, Dohi T. Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions. J Immunol 2007;178(8):5296–304 23. Minghetti L, Polazzi E, Nicolini A, Creminon C, Levi G. Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur J Neurosci 1997;9(5):934–40 24. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107(4):1183–8 25. DuBois RN, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 1994;266(5 Pt 1):G822–G827 26. Siegler AM, Kontopoulos V, Wang CF. Prevention of postoperative adhesions in rabbits with ibuprofen, a nonsteroidal anti-inflammatory agent. Fertil Steril 1980;34(1):46–9 27. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107(4):1183–8 28. Cofer KF, Himebaugh KS, Gauvin JM, Hurd WW. Inhibition of adhesion reformation in the rabbit model by meclofenamate: an inhibitor of both prostaglandin and leukotriene production. Fertil Steril 1994;62(6):1262–5 29. Rodgers KE, Girgis W, Campeau JD, diZerega GS. Reduction of adhesion formation by intraperitoneal administration of anti-inflammatory peptide 2. J Invest Surg 1997;10(1-2):31–6 30. Saed GM, Munkarah AR, bu-Soud HM, Diamond MP. Hypoxia upregulates cyclooxygenase-2 and prostaglandin E(2) levels in human peritoneal fibroblasts. Fertil Steril 2005;83 Suppl 1:1216–9 31. Futagami A, Ishizaki M, Fukuda Y, Kawana S, Yamanaka N. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest 2002;82(11):1503–13 32. Binnebosel M, Rosch R, Junge K, Lynen-Jansen P, Schumpelick V, Klinge U. Macrophage and T-lymphocyte infiltrates in human peritoneal adhesions indicate a chronic inflammatory disease. World J Surg 2008;32(2):296–304
315 Chapter 42 · Adhesion as a Chronic Inflammatory Problem? Risk for Adhesions, Migration
33. Hayward SD, Liu J, Fujimuro M. Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Sci STKE 2006;2006(335):re4 34. Rodewald HR. Making a Notch in the lymphocyte kit. Eur J Immunol 2006;36(3):508–11 35. Deregowski V, Gazzerro E, Priest L, Rydziel S, Canalis E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J Biol Chem 2006;281(10): 6203–10 36. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 2006; 56(3):417–25 37. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, He TC. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004;4(8):653–71 38. Dihlmann S, von Knebel DM. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer 2005;113(4):515–24 39. Bhatia N, Spiegelman VS. Activation of Wnt/beta-catenin/ Tcf signaling in mouse skin carcinogenesis. Mol Carcinog 2005;42(4):213–21 40. Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M. Molecular pathogenesis of chronic wounds: the role of betacatenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 2005;167(1):59–69
Discussion Franz: Even on the surface of the skin, it is difficult to define what a chronic wound is. One way is to look at the fibroblasts. For example, what about the fibroblast function? Binnebösel: But how should we investigate the function of the fibroblasts? We have not done it. Of course, it is a very important subject, but when we looked at these adhesions there was a small amount of fibroblasts. Franz: So when you said »cell-rich,« you mainly meant inflammatory cells? Binnebösel: Yes Schumpelick: Is the adhesion story a one-way story, or is there a way back to normal tissue? Binnebösel: At the moment, we just do not know. We do not know whether peritoneal adhesions are a reaction of everybody, and we do not know why in some patients adhesions dissolve and in some patients they do not. And we have to find a solution for this problem.
42
Smeds: From the clinical point of view, I wonder if you had information about the dynamics of the adhesions and whether there is a correlation to pain. Binnebösel: In our investigation we found no correlation to pain. Interestingly, previous publications showed that the amount of adhesions will increase with the number of previous operations— but this was different in our investigation. At the moment, it seems unpredictable. Smeds: Do you think it is a mechanical traction of the peritoneum and the adhesion that promotes the pain? Binnebösel: Yes, this is a possible explanation for the pain. Montgomery: Where did you get the biopsies? I think it is difficult to get reproductive biopsies? Binnebösel: Yes, this is a limitation of our study, because we randomly took two biopsies in every patient. It is very difficult to define macroscopically where it is best to take the biopsies.
43
Biological Tissue Graft: Present Status C. Bellows
318
Chapter 43 · Biological Tissue Graft: Present Status
Overview of the Disease
43
Reconstruction of abdominal wall defects is a challenging problem that many surgeons face, not only in the elective setting but also during emergency surgery. Deficiencies of the abdominal wall can be acute or chronic in nature and can result from trauma, cancer, infection, or hernia disease. Incisional hernias are the most common cause of a chronic abdominal wall defect. Despite advances in medical technology, treatment of these defects remains controversial. In fact, the repair of abdominal wall defects continues to be imperfect and costly, resulting in serious, chronic healthcare problems. Current practice guidelines and medical evidence support the use of a permanent prosthetic mesh for the repair of hernias as a means to reduce the risk of recurrent hernia. Patients who are not repaired with mesh, either owing to clinical complications or by surgeon choice, have a much higher incidence of recurrent hernia compared with patients who are repaired with mesh [1–3]. Consequently, multiple prosthetic meshes with a variety of characteristics have been developed. However, no single material has gained universal acceptance or preference, and a number of complications have been associated with the use of these permanent synthetic materials [4–8]. Most synthetic mesh strengthens the abdominal wall by inciting an intense fibroplastic response to form a strong scar-plate interface. Although this works well, the inflammatory response incited by the plastic meshes can lead to potentially serious complications such as bowel fistulation, mesh contraction, intraperitoneal adhesions, erosion into the abdominal viscera, a sensation of being able to feel the mesh, and increased stiffness of the abdominal wall with loss of compliance. Additionally, the U.S. Food and Drug Administration has received numerous reports of other complications associated with mesh, including chronic pain and infection [9]. Indeed, mesh infections are one of the most commonly reported complications and represent a potential nightmare. An infection is traumatic for the patient and time-consuming to treat. Bacteria adhere avidly to the mesh polymers and immediately lay down a biofilm, which protects them from host immunological defenses and
antibiotics and thereby ensures their long-term survival and leads to chronic infection of the hernia wound [10]. The increased morbidity and costs associated with infected mesh are so dire that surgeons avoid placing permanent mesh in grossly infected fields. Moreover, surgeons are now avoiding placing permanent mesh in clinical circumstances in which the risk of infection is increased, such as in patients with a prior wound infection. Predictably, strategies to address these complications related to the implantation of synthetic materials are now the focus of intense research by hernia surgeons. An extensive search is ongoing for alternative materials with which to not only achieve tension-free repair of an abdominal wall defect in a single-stage operation (especially in the setting of a contaminated wound) but also to achieve a functional abdominal wall and a better quality of life for the patient after repair. This search has led to an era of acellular biological tissue grafts (e.g., derived from natural materials).
Rationale and Indications for Using Biological Tissue Grafts The art and science of using tissue grafts from animal (xenogenic) and human (allogenic) sources for abdominal wall reconstruction is nascent. However, during the past few years, several biological tissue grafts have been introduced and are available for hernia repair. The rationale for using a biological tissue graft for abdominal wall reconstruction is to avoid acute and chronic mesh infection, unwanted chronic inflammation, and scar tissue formation, which occur frequently in response to permanent synthetic materials after implantation. The potential benefits of these new materials are extremely attractive and include superior biocompatibility (i.e., minimum inflammatory response), reduced adhesion formation, early vascular ingrowth, and decreased risk of infection in contaminated or potentially contaminated surgical fields. From a pathophysiological viewpoint, there are two different indications for biological tissue grafts: One is to repair an acute abdominal wall defect created by trauma, cancer, or infection, and the other is to repair a chronic, progressive ab-
319 Chapter 43 · Biological Tissue Graft: Present Status
dominal wall defect (i.e., hernia disease) resulting from a presumed defective collagen metabolism or impaired wound healing (such as in steroid users). Whereas acute wound defects can be repaired with a biological tissue graft as a scaffold to induce normal tissue regeneration, such an approach may lead to an inadequate and weak scar in patients with chronic abdominal wall defects after remodeling is complete. However, as is the case with any new medical device or product introduced into clinical practice, experience and time will ultimately define the utility and limitations.
Types of Biological Tissue Grafts: Distinguishing Features Biological tissue grafts are rendered acellular through various methods of preservation and fabrication and are offered as collagen-rich scaffolding that allows cellular ingrowth and tissue remodeling and revascularization, thereby setting the stage for an intact hernia repair. However, the specific manufacturing processes that yield modified collagen matrices vary significantly from one product to another. Therefore, each product can be classified according to the material source, type of tissue, presence or absence of collagen cross-linking, decellularization methods, and terminal sterilization methods. Currently, the different donor species grafts, including human and animal (porcine, bovine), are made of one of three types of tissue: dermis, small intestine, or pericardium. The various decellularization methods include physical (dissection, agitation, sonication, pressure, freeze–thaw), chemical (detergents, ionic solutions, acid/bases), and enzymatic methods. The various terminal sterilization methods include gamma irradiation, ethylene oxide gas, and hydrogen peroxide plasma. A few materials also employ a chemical cross-linking method in the preservation/processing of their collagen tissue grafts. Experimental studies have demonstrated that collagen cross-linked with glutaraldehyde imparts a high degree of stability to the collagen against the activity of the degrading enzyme, collagenase [11, 12], thereby slowing or stopping the degradation of the donor collagen. However, some investigators
43
believe that this chemical cross-linking leads to nonincorporation and preclusion of immune cell penetration, making these grafts unable to participate in normal tissue remodeling. Instead, immune cells encapsulate the grafts, consistent with a foreign body response. Based on the variety of tissue origins as well as distinct processing and sterilization procedures, experimental studies have demonstrated that currently available biological tissue grafts vary in performance characteristics, such as cellular response, strength, biodegradability, susceptibility to infection, and tendency to transmit diseases from donor to recipient after implantation [13]. Therefore, the use of biological tissue grafts for treating hernia disease needs to be considered on a product-byproduct basis as additional knowledge from clinical trials and clinical experience accumulates.
Biological Tissue Grafts: Clinical Data The first biological tissue graft was approved for soft tissue reconstruction in 1999. Since that time, the number of different products and the use of these materials in clinical practice have grown rapidly for want of a better solution for difficult hernia repairs. Currently, over 13 biological tissue grafts are commercially available. However, after many years on the market, some biological graft materials have been the subject of dozens of peerreviewed publications, whereas a number of other products have been reported on in few or no publications–clinical or preclinical–indexed in Medline. For example, a recent Medline search revealed 33 published articles on small intestinal submucosa grafts, 32 on acellular human dermis grafts, and 13 on cross-linked porcine dermis grafts [14]. Interestingly, most of this published experience with biological grafts is in clean field cases rather than in infected fields. Despite some encouraging early results, several clinical complications have been reported following the use of these biological materials to reconstruct abdominal wall defects, including degradation, laxity, lack of integration, and recurrence. Although the companies developing and marketing biological tissue grafts make various claims for
320
43
Chapter 43 · Biological Tissue Graft: Present Status
the superiority of their product over others, as of this writing, there are no prospective, randomized clinical trial data comparing one biological tissue graft to another and no data demonstrating the superiority of one particular biological tissue graft over a synthetic graft. Despite this lack of data, there is growing concern that not all biological tissue grafts perform uniformly after implantation in humans. Clinical data suggest that outcomes may be related in part to the material source and the processing method of these different biological tissue grafts. For example, a recent systematic review reported a failure rate of 8% at 19 months for small intestinal submucosa grafts when used for ventral hernia repair [14]. By comparison, an aggregate failure rate of 15% at 12 months was reported for noncross-linked acellular human dermis grafts and 8% at 15 months for cross-linked porcine dermis [14]. These results may also be related to the implant scenarios, the implantation technique, a relatively short duration of follow-up for many of these studies, and underreporting of complications related to the use of these products. For example, it is well documented that using biological tissue grafts in infected fields results in significantly higher failure rates than when they are implanted in clean fields. Not only do these patients tend to be more emergent or critically ill, but patients with infected fields also present the additional factor of material digestion by bacterial enzymes that may weaken a biological graft. Importantly, there have been more reports on acellular human dermis grafts used in infected fields compared with small intestinal submucosa grafts [14]. The techniques used are also very important in hernia repair outcomes, and implantation techniques appear to be especially important with biological grafts. Currently, several publications have reported on the use of acellular human dermal matrix in hernia repair, suggesting that recurrences are highest (80%) when the product is used as a fascial bridge to repair the defect [15]. By comparison, when the same biological tissue graft is used to reinforce a primary reapproximation of the fascia, utilizing the component separation technique, recurrence rates as low as 0–5% have been reported at 2-year follow-up [16]. Taken together,
these data suggest that the use of biological tissue grafts may not be justified unless primary wound closure can be achieved.
Summary and Conclusions Abdominal wall integrity may be lost after trauma, infection, herniation, or surgical resection. The surgical repair of these abdominal wall defects has changed considerably over the last decades. Currently, a wide variety of new implantable acellular biological tissue grafts have been developed and introduced into the clinical market for the repair of tissue defects. The sudden and rapid emergence of these grafts has provided surgeons with an important new tool in their surgical armentarium for treating abdominal wall defects, especially in contaminated or infected surgical fields. When the complexity of the patients and the implant scenarios is taken into consideration, biological grafts have demonstrated a good overall success rate. However, at present the data from prospective trials and case series are limited, with mostly short-term follow-up of patients treated with biological tissue grafts for abdominal wall reconstruction. More clinical work is necessary to determine which patients would benefit the most from repair using a biological tissue graft. To date, the best clinical outcomes reported with biological tissue grafts for abdominal wall reconstruction occur in patients in the absence of gross infection and when the graft is used as a fascial reinforcement. However, these first-generation biological tissue grafts are far from ideal. The ideal biological tissue graft may take one of a number of possible forms in the near future. The most economical and proficient graft would be one derived from a plentiful source, thus making it affordable. In addition, the ideal graft material should have an adequate shelf life so that it can be taken off the shelf and used immediately; it should be 100% biocompatible; and it should resist infection. Degradation and replacement of the graft material by host tissue should ultimately occur in a manner that maintains or increases the strength of the abdominal wall repair. It may also be hypothesized that the composition of an ideal biological
321 Chapter 43 · Biological Tissue Graft: Present Status
tissue graft is able to restore normal wound healing in hernia formers and thereby strengthens the resulting scar. No biological tissue graft has yet been shown to possess all of these ideal characteristics. There is increasing evidence that biological tissue grafts will become more customized or individually tailored for specific needs. An animal can have its own tissues (such as myofibroblasts or stem cells) harvested and seeded onto extracellular matrices prior to being transplanted back into its body. This approach primes or preconditions the biological tissue graft with the intended recipient animal’s own progenitor cells. Such an approach could add to the overall effectiveness of a biological tissue graft, making it more resistant to bacterial colonization and accelerating the deposition of collagen, which may more rapidly increase the strength profile [17]. Strategies to accelerate neovascularization of transplanted biological tissue grafts after implantation will facilitate their engraftment through the early delivery of oxygen, nutrients, host immune cells, and antibiotics. The preseeding of stem cells or progenitor cells into tissue grafts could also offer an advantage with respect to the need for rapid revascularization, as these cells are resistant to low oxygen conditions. All of these approaches to create a »designer extracellular matrix« are within reach in the near future. Perhaps such an approach will be called »smart biological tissue grafts.«
References 1. Luijendijk RW, Hop WC, van den Tol MP, et al. A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343:392–398 (2000) 2. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J. Long term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 4:578–585 (2004) 3. Sanchez LJ, Bencini L, Moretti R. Recurrence after laparoscopic ventral hernia repair: results and critical review. Hernia 8:138–143 (2004) 4. Carbonell AM, Harold KL, Mahmutovic AJ et al. Local injection for the treatment of suture site pain after laparoscopic ventral hernia repair. Am Surg 69:688–691 (2003) 5. Leber GE, Garb JL, Alexander AI, Reed WP. Long term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382 (1998)
43
6. Morris-Stiff GJ, Hughes LE. The outcomes of nonabsorbable mesh placed within the abdominal cavity: literature review and clinical experience. J Am Coll Surg 186:352– 367 (1998) 7. Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V. Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia 5:142–147 (2001) 8. Klinge U, Klosterhalfen B, Birkenhauer V, Junge K, Conze J, Schumelick V. Impact of polymer size on interface scar formation in a rat model. J Surg Res 103:208–214 (2002) 9. Robinson TN, Clarke JH, Schoen J, Walsh MD. Major mesh related complication following hernia repair: events reported to the Food and Drug Administration. Surg Endosc 19:1556–1566 (2005) 10. Jansen B, Schumacher-Perdreau F, Peters G, Pulverer G. New aspects in the pathogenesis and prevention of polymer-associated foreign-body infections caused by coagulase-negative staphylococci. J Invest Surg 2:361– 380 (1989) 11. Oliver RF, Grant RA, Cox RW, Hulme MJ, Mudie A. Histological studies of subcutaneous and peritoneal implants of trypsin prepared dermal collagen allografts in rats. Clin Orthop 115:291–302(1976) 12. Oliver RF, Barker H, Cooke A, Grant RA. Dermal collagen implants. Biomaterials 23:38–40 (1982) 13. Sandor M, Xu H, Connor J, Lombardi J, Harper JR, Silverman RP, McQuillan DJ. Host response to implanted porcine-derived biologic materials in a primate model of abdominal wall repair. Tissue Eng Part A 14:2021–231 (2008) 14. Hiles M, Record Ritchie RD, Altizer AM. Are biologic grafts effective for hernia repair? A systematic review of the literature. Surg Innov 16:26–37 (2009) 15. Jin J, Rosen MJ, Blatnik J, McGee MF, Williams CP, Marks J, Ponsky J. Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes? J Am Coll Surg 205:654–660 (2007) 16. Espinosa-de-los-Monteros A, de la Torre JI, Marrero I, Andrades P, Davis MR, Vásconez LO. Utilization of human cadaveric acellular dermis for abdominal wall reconstruction. Ann Plast Surg 58:264–267 (2007) 17. Lai JY, Chang PY, JN Lin. Body wall repair using small intestinal submucosa seeded with cells. J Pediatr Surg 38:1752–1755 (2003)
Discussion Read: This is an excellent paper. We need more of
these, and I think your suggestions are excellent. Falagas: I was impressed by the fact that there
are 13 FDA-approved biological grafts. If it were a medication or drug, the FDA would need two randomized controlled trials with about 1,000 pa-
322
43
Chapter 43 · Biological Tissue Graft: Present Status
tients to show the usefulness of the new product. But for a biological graft—how does the FDA approve them? There were no randomized controlled trials? Bellows: It takes a couple of animal experiments to show that the material is safe, not carcinogenetic….Alloderm gets away with it because it is a minimally processed tissue. But there are some companies now that are taking proactive stents, and actually they are doing prospective randomized trials, comparing the biologics to the synthetics in humans—but they are also selling the products at the same time. Falagas: Would you like to see comparisons of these materials before approval, or are you okay with a few animal experiments? Bellows: Of course not. If the companies do not have any data, I do not use such materials. Ma: Two years ago in Suvretta I presented data about biological meshes in inguinal hernia repair. But afterwards I realized two problems: First, can we use biological meshes if the patient has a collagen deficiency or a family history or a recurrent hernia? Second: What about the bowels, e.g., patients with FAP? Bellows: To your first question, yes, that is something that we need to know—whether these meshes are indicated in patients with collagen disorders. We do not have enough data. The inguinal hernia stuff is a small number of patients. Second, I think it is an indication for a biologic tissue graft. It is an individual decision for each patient, taking into account whether there might be a contamination or reoperation. Again, we do not have all the answers. That is why we need prospective trials with comparisons of the different materials. Kukleta: Among those first 250 reports to the FDA about adverse effects of artificial materials, there are quite a few on SIS. The first paper, as I remember, of 46 cases implanted in humans led to such chaos that they went back to the manufacturer and asked what was wrong with it and if it is really true that it can be used in humans. And now, all of a sudden, everybody thinks that things are getting better. Do you have any explanation? Bellows: I know Surgisis had a lot of problems, as you mentioned. And they went back to the drawing board and performed different types since the
first introduction of the material in the early ’90s. Actually, there is an FDA Web site where voluntarily reported complications with these biological tissue grafts are recorded in a database. And the number one graft that has the most reported complications was actually Permacol. Schumpelick: There was a big difference with regard to laparoscopic or open surgery. Is it because the abdomen is a black box and we do not see the results, or is it because of different milieus? Bellows: I do not think we have the answer yet. Most people are not using these products laparoscopically. Often the data is very rare and the follow-up is very short, so I cannot make any conclusions on this subject.
44
IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis D. Berger, M. Bientzle
324
Chapter 44 · IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis
Introduction
44
Incisional hernias frequently occur after major abdominal surgery [1, 2]. Today the repair should be based on mesh augmentation of the abdominal wall because suturing alone has proved to be ineffective [3–5]. Conventional techniques mainly use meshes in an onlay or sublay position and sometimes intraperitoneally. The laparoscopic approach is characterized by the intraperitoneal placement of meshes and therefore requires a special kind of mesh material. These meshes should provide strong incorporation on one side and prevent adhesions to visceral organs on the other side. One approach is the use of a material that allows the production of a foil with a smooth and a rough surface, such as expanded polytetrafluoroethylene (ePTFE), which was used in most cases of laparoscopic ventral hernia repair reported in the literature [6]. Another possibility is to cover a mesh made of polyester or polypropylene with a resorbable film that prevents adhesions [7, 8]. A third approach is represented by DynaMesh IPOM, which is made of polyvinylidene fluoride (PVDF) containing polypropylene on the parietal side. An inert material such as PVDF, which does not induce adhesions to visceral organs, can be applied as a real mesh structure, with large pores being a precondition of strong and rapid incorporation. The incorporation characteristics can be improved by adding a small amount of polypropylene on the parietal side [9, 10]. This prospective study included 297 consecutive patients with incisional hernias and 47 patients with parastomal hernias treated laparoscopically. The primary targets were the evaluation of the recurrence rate and mesh-related complications.
Patients, Materials, and Methods Patients Between May 2004 and January 2008, 297 unselected patients with incisional hernias and 47 patients with parastomal hernias were prospectively treated and followed. The demographic data are summarized in ⊡ Tables 44.1 and 44.2. The patients
⊡ Table 44.1. Demographic and surgical data of patients with incisional hernias
Median age: 65 years (22–92) Median body mass index: 29 (17–58) Median hernia size: 122.5 cm2 (2–420) Median mesh size: 600 cm2 (80–2,115) Median operating time: 77.5 min (30–230) Median hospital stay: 8 days (2–36) Median follow-up: 24 months (6–48 in 251/297=84%)
⊡ Table 44.2. Demographic and surgical data of patients with parastomal hernias
Median age: 69 years (54–92) Median body mass index: 28 (18–57) Median hernia size: 155 cm2 (12–400) Median mesh size: 825 cm2 (525–1,425) Median operating time: 115 min (65–230) Median hospital stay: 10 days (6–66) Median follow-up: 20 months (6–48 in 43/47=91%)
were clinically examined after 1, 3, 6, and 12 months and yearly thereafter.
Surgical Technique Patients were always treated in the supine position. The pneumoperitoneum was established with a Veress needle in cases with an untouched upper quadrant. In all other cases, an open approach was preferred. Usually, three trocars in one flank and one trocar on the opposite side were introduced. Adhesiolysis was performed by sharp dissection without any energy-driven device. Bleeding control was achieved by bipolar coagulation. Routinely, the whole original incision was covered by the mesh. In patients with upper midline incisions, the falciform ligament was dissected, and the space of Retzius was opened as well in cases with lower midline incisions. The mesh was fixed with six stay sutures at the corners and in the midline between the corners in the longest extension. Furthermore, spiral tacks (Protack; Covidien, Mansfield, MA, USA) were used every 3–4 cm. The overlap of the defect and the whole original incision was at least 5 cm.
325 Chapter 44 · IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis
The parastomal hernias were repaired by the recently described sandwich technique [11]. After complete adhesiolysis of the whole abdominal wall as described above, a 15×15-cm mesh was incised in a keyhole fashion and placed around the stoma. The mesh incision was closed by transfascial sutures and tacks. A further mesh covering the midline incision and the stoma loop was also used. The stoma loop was finally placed between the two meshes and lateralized for at least 5 cm. A single dose of cefuroxime and metronidazole was generally given prophylactically. DynaMesh IPOM was used in all patients. It represents a real mesh structure that is warpknitted from polyvinylidene fluoride. It contains a small amount of polypropylene on the parietal side, providing good incorporation.
44
⊡ Table 44.3. Clinical outcomes of laparoscopic repair of incisional hernias
Recurrences: 1/297 (0.3%) Trocar hernia: 1 (0.3%) Conversion: 1 (0.3%) Bladder laceration treated by Foley catheter: 1 Relaparotomy due to bleeding: 1 Bowel fistula that healed after local revision and vacuum-assisted closure therapy: 1 Punctures due to seroma: 4, with 1 infection due to the puncture Further revisions with resection of the hernia sac because of persistent seroma or hematoma: 3, with 1 postoperative wound infection and 1 patient with intraoperative enterotomy leading to mesh explantation and recurrence Delayed defecation: 5 patients Local revision of a stay suture: 1 Strong pain and additional medical treatment over 3 months: 6 patients Patient deaths: 1 due to pulmonary embolism
Results Incisional Hernia
⊡ Table 44.4. Clinical outcomes of laparoscopic repair of parastomal hernias
⊡ Table 44.1 demonstrates the demographic data, and ⊡ Table 44.3 summarizes the main surgical re-
Recurrence: 1/47 (2%) Revisions because of stenosis of the stoma: 2, with a consecutive wound infection in 1 patient Local revision because of abscess in the hernia sac after puncture of a seroma: 1 Conversion: 1 (2%) Strong pain and delayed relief: 1 patient, but no redo necessary because of pain No enterotomy No bleeding No further delayed defecation No deaths
sults. Twenty-three percent (n=67) of our patients with an incisional hernia had undergone previous repairs. Two patients developed a recurrence (0.6%). One recurrence occurred after explantation of the mesh. During surgical excision of the hernia sac, because a persistent seroma caused pain, the mesh was incised and the small bowel opened. A formal laparotomy was necessary to repair the bowel injury, and the mesh was removed. Another patient developed a hernia at the lower border of the mesh, which was originally implanted because of a hernia after an upper midline incision. The new defect was located in the midline between the umbilicus and the symphysis, despite a 5-cm overlap of the lower end of the scar. A persistent seroma was observed in seven patients (2.1%) who had in common a small fascial gap and a major hernia sac. Three of these seven patients experienced major complications after puncture or surgical removal of the sac: two infections and one mesh explantation. However, all patients with a deep wound infection as well as the patient
with an unrecognized enterotomy had a complete recovery without persistent mesh infection. The only bladder injury healed after prolonged transurethral drainage. One patient died on the 7th postoperative day because of pulmonary embolism.
Parastomal Hernia Demographic data are given in ⊡ Table 44.2, and the surgical results are shown in ⊡ Table 44.4. It should be pointed out that 26% of the patients with
326
44
Chapter 44 · IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis
a parastomal hernia were primarily admitted with a recurrent hernia. Only one patient (2%) developed a recurrent hernia. One conversion was necessary because no free abdominal cavity existed, and the pneumoperitoneum could not be established. The main problem, however, is the possibility of producing a stenosis of the stoma loop, which occurred in two patients. In both cases, a preexisting subcutaneous prolapse of the stoma loop was associated with a sharp angulation at the fascial level, which was produced by the meshes. A local revision with shortening of the subcutaneous part of the stoma loop abolished the angulation and reestablished the passage. In one of these patients, the intraabdominal part of the stoma loop was perforated digitally. A formal laparotomy was necessary for repair. The patient developed a deep wound infection around the stoma as well as in the midline incision. With subsequent vacuum-assisted closure (VAC) therapy, the infected meshes could be preserved. Another patient developed an abscess in the hernia sac after a persistent seroma was punctured. Again, VAC therapy led to final preservation of the mesh and cure of the infection.
Discussion The precondition for laparoscopic intraperitoneal onlay mesh (IPOM) repair of incisional and parastomal hernias is the availability of meshes that can be incorporated into the abdominal wall but also prevent adhesions between the visceral organs and the mesh itself [12]. Up to now, most patients reported in the literature were treated with ePTFEderived meshes [6]. The visceral side, preventing adhesions, is smooth, and the parietal side is rough or covered with polypropylene to provide strong incorporation into the abdominal wall. Experimental data, however, sometimes demonstrate strong adhesions between bowel and mesh [10, 13]. Furthermore, mesh shrinkage is pronounced, leading to a 50% reduction of the original surface area [10, 14]. Also, an overlap of two ePTFE meshes does not make any sense because the scar cannot grow through the meshes, which are in fact a real foil.
The use of meshes made from polypropylene or polyester with an antiadhesive coverage represents a different approach. These meshes are effective in terms of incorporation and prevention of adhesions. The shrinkage has been shown to amount to about 20% [10, 13, 15]. No data exist concerning the incorporation behavior when two meshes are used to overlap each other. Inert material that does not adhere to visceral organs can be used as a real mesh structure, allowing an overlap of two or more meshes. The meshes can be trimmed to the ideal size, which is not possible when covered meshes are used. PVDF is a very inert material that has long been used as a suture material. Its long-term stability is even better than that of polypropylene. The inflammation reaction on a cellular level is reduced, and the amount of fibrotic tissue is lower compared with any other mesh material. The shrinkage is comparable to that for covered polypropylene structures [9, 10, 16]. From an experimental point of view, PVDF-based meshes may be clinically useful. This prospective study demonstrating clinical results in 297 patients with incisional hernias reveals promising results. The recurrence rate was very low compared with the literature. This may be explained by the size of the meshes used throughout, which was more than double that described by other authors [6, 17]. One patient developed a recurrence after explantation of the mesh. Another recurrence can only be explained by a suture-associated fascial defect, which has not been described in the literature. The pathogenesis may be similar to the tackassociated hernias described by LeBlanc [18]. The laparoscopic repair of parastomal hernias also showed very good results. As we recently demonstrated, the sandwich technique, which was used in the patients in the present study, is superior compared with the original Sugarbaker technique [11]. Despite some promising results in the literature, our own series clearly showed that the one-mesh technique according to Sugarbaker is sufficient only for medial defects of the fascia [19–21]. In cases of lateral or combined defects, two meshes are needed to stabilize the abdominal wall. A precondition of the sandwich technique is
327 Chapter 44 · IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis
the availability of a mesh material that allows the meshes to overlap each other, with stable incorporation of both meshes; ePTFE-derived meshes are foils that completely prevent any ingrowth of scar tissue in both meshes. On the other hand, the keyhole technique seems to be an attractive and technically easier alternative. In fact, there is one study with promising results [22], but the follow-up was only 6 weeks. These results, however, could not be confirmed in other studies [21, 23, 24]. Therefore, the sandwich technique seems to be the most effective approach for the repair of parastomal hernias. The only recurrence in our series was due to a surgical correction of a preexisting subcutaneous prolapse of the stoma loop. During a local revision, the subcutaneous part of the stoma loop was shortened, and the intraabdominal part with adherent small bowel loops was pulled between the two meshes. After that procedure, the patient suffered from strong pain starting immediately after any oral intake. Another major issue concerns the resistance of meshes against infection. ePTFE-derived meshes must usually be removed if an infection occurs [25, 26]. To our knowledge, nothing is known about the behavior of infected meshes covered with an antiadhesive barrier. Four patients in our series developed a deep wound and mesh infection after puncture or early surgical revision. In all cases, the meshes were preserved. Recently we published a series of 25 patients prophylactically treated with a PVDF-derived three-dimensional mesh. One patient of this series underwent early relaparotomy because of an enterotomy leading to stercoral peritonitis. After 5 days of daily revisions, the abdominal wall could be closed, and the intraperitoneal mesh could also be preserved [27]. One patient developed a secondary bowel leak due to unrecognized small bowel laceration with a fistulization through the mesh, which healed uneventfully after VAC treatment. Enterotomies that had not been recognized during the primary procedure occurred in about 2% of patients after laparoscopic incisional hernia repair. Seroma or hematoma can be observed in almost 100% of our patients because we perform routine ultrasonography after 3–5 days. In a very few patients (n=4) in this series, these seromas
44
needed to be punctured because of complaints. Three patients underwent surgical excision of the hernia sac because of a persistent seroma. These patients had a major hernia sac and a small fascial defect less than 30 cm2. According to the literature, seroma or hematoma often occurs, but only ultrasonography reveals the real rate of that complication [6, 17, 28]. Further complications are summarized in Table 44.4 and proved to be rare. The low overall complication rate supports the view that laparoscopic repair of incisional and parastomal hernias with modern meshes such as DynaMesh IPOM is an effective and safe technique. The results seem to be better than those obtained by open approaches [17]. At the least, the open repair of parastomal hernias is much more effective compared with conventional techniques [29, 30]. In summary, DynaMesh IPOM was shown to be a safe and effective mesh for the laparoscopic repair of incisional and parastomal hernias. The possibility of overlapping two or more meshes provides an ideal overlap of the abdominal wall in almost all situations and opens the way to the sandwich technique for parastomal hernia repair, which seems to be the best approach today. Infectious complications occurring in our study demonstrated the resistance of PVDF against infections. Experimental data exhibit excellent results with regard to shrinkage and adhesion formation. Overall, the described technique for laparoscopic incisional and parastomal hernia repair using DynaMesh IPOM provided satisfying results with no mesh-related complications to date.
References 1. Franz MG (2008) The biology of hernia formation. Surg Clin North Am 88:1–15 2. Millikan KW (2003) Incisional hernia repair. Surg Clin North Am 83:1223–1234 3. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, IJzermans JN, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343:392–398 4. Vrijland WW, Jeekel J (2003) Prosthetic mesh repair should be used for any defect in the abdominal wall. Curr Med Res Opin 19:1–3
328
44
Chapter 44 · IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis
5. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–583 6. Carlson MA, Frantzides CT, Shostrom VK, Laguna LE (2008) Minimally invasive ventral herniorrhaphy: an analysis of 6,266 published cases. Hernia 12:9–22 7. Chelala E, Thoma M, Tatete B, Lemye AC, Dessily M, Alle JL (2007) The suturing concept for laparoscopic mesh fixation in ventral and incisional hernia repair: mid-term analysis of 400 cases. Surg Endosc 21:391–395 8. Palanivelu C, Rangarajan M, Parthasarathi R, Madankumar MV, Senthilkumar K (2008) Laparoscopic repair of suprapubic incisional hernias: suturing and intraperitoneal composite mesh onlay. A retrospective study. Hernia 12:251–256 9. Klinge U, Klosterhalfen B, Ottinger AP, Junge K, Schumpelick V (2002) PVDF as a new polymer for the construction of surgical meshes. Biomaterials 23:3487–3493 10. Junge K, Binnebosel M, Rosch R, Jansen M, Kammer D, Otto J, Schumpelick V, Klinge U (2008) Adhesion formation of a polyvinylidenfluoride/polypropylene mesh for intra-abdominal placement in a rodent animal model. Surg Endosc 23:327–333 11. Berger D, Bientzle M (2007) Laparoscopic repair of parastomal hernias: a single surgeon’s experience in 66 patients. Dis Colon Rectum 50:1668–1661 12. Berger D, Bientzle M (2006) Principles of laparoscopic incisional hernia repair. Eur Surg 38:393–398 13. McGinty JJ, Hogle NJ, McCarthy H, Fowler DL (2005) A comparative study of adhesion formation and abdominal wall ingrowth after laparoscopic ventral hernia repair in a porcine model using multiple types of mesh. Surg Endosc 19:786–790 14. Johnson EK, Hoyt CH, Dinsmore RC (2004) Abdominal wall hernia repair: a long-term comparison of Sepramesh and Dualmesh in a rabbit hernia model. Am Surg 70:657–661 15. Demir U, Mihmanli M, Coskun H, Dilege E, Kalyoncu A, Altinli E, Gunduz B, Yilmaz B (2005) Comparison of prosthetic materials in incisional hernia repair. Surg Today 35:223–227 16. Conze J, Junge K, Wei BC, Anurov M, Oettinger A, Klinge U, Schumpelick V (2008) New polymer for intra-abdominal meshes–PVDF copolymer. J Biomed Mater Res B Appl Biomater 87:321–328 17. Pierce RA, Spitler JA, Frisella MM, Matthews BD, Brunt LM (2007) Pooled data analysis of laparoscopic vs. open ventral hernia repair: 14 years of patient data accrual. Surg Endosc 21:378–386 18. LeBlanc KA (2003) Tack hernia: a new entity. JSLS 7:383– 387 19. Sugarbaker PH (1985) Peritoneal approach to prosthetic mesh repair of paraostomy hernias. Ann Surg 201:344– 346 20. Mancini GJ, McClusky DA, Khaitan L, Goldenberg EA, Heniford BT, Novitsky YW, Park AE, Kavic S, Le Blanc KA, Elieson MJ, Voeller GR, Ramshaw BJ (2007) Laparoscopic
21.
22.
23.
24. 25.
26.
27.
28.
29. 30.
parastomal hernia repair using a nonslit mesh technique. Surg Endosc 21:1487–1491 LeBlanc KA, Bellanger DE, Whitaker JM, Hausmann MG (2005) Laparoscopic parastomal hernia repair. Hernia 9:140–144 Hansson BM, de Hingh IH, Bleichrodt RP (2007) Laparoscopic parastomal hernia repair is feasible and safe: early results of a prospective clinical study including 55 consecutive patients. Surg Endosc 21:989–993 Muysoms F (2007) Laparoscopic repair of parastomal hernias with a modified Sugarbaker technique. Acta Chir Belg 107:476–480 Safadi B (2004) Laparoscopic repair of parastomal hernias: early results. Surg Endosc 18:676–680 Heniford BT F, Park AF, Ramshaw BJ, Voeller G (2003) Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 238:391–400 Berger D, Bientzle M, Muller A (2002) Postoperative complications after laparoscopic incisional hernia repair. Incidence and treatment. Surg Endosc 16:1720–1723 Berger D (2008) Prevention of parastomal hernias by prophylactic use of a specially designed intraperitoneal onlay mesh (Dynamesh IPST). Hernia 12:243–246 Susmalain S, Gewurtz G, Ezri T, Charuzi I (2001) Seroma after laparoscopic repair of hernia with PTFE patch: is it really a complication? Hernia 5:139–141 Carne PW, Robertson GM, Frizelle FA (2003) Parastomal hernia. Br J Surg 90:784–793 McLemore EC, Harold KL, Efron JE, Laxa BU, Young-Fadok TM, Heppell JP (2007) Parastomal hernia: short-term outcome after laparoscopic and conventional repairs. Surg Innov 14:199–204
Discussion Deysine: How did you prove the low adhesion
activity? Berger: These are only some experimental data. And the PVDF is used for bacterial filtration. And you can only use bacterial filters with low adhesions of bacteria to the filter. If you do a sterile filtration, you can use PVDF as material for the filter. Kukleta: You saw less pain after the implantation. Don’t you think it is the number of the fixation points that you use now? Do you use less than you used before? Berger: In fact, I use the same number of sutures, but I do not use as many tacks as in previous times. Klinge: Some years ago we did experimental studies with our microbiologists and looked at the
329 Chapter 44 · IPOM Results of 344 Consecutive Patients with a PVDF-Derived Prosthesis
attachment of bacteria to different materials. We quantified the amount of genetic material from the bacteria of standard meshes that had been in contact with various strains of bacteria. PVDF was not free but belonged to materials where the amount of genetic material was lowest. Schumpelick: You used fewer tacks. Why? Berger: The incorporation is better than with ePTFE. At the beginning I was convinced that we needed a permanent fixation. When I saw these incredibly shrunken dual meshes of up to 75% and all the tacks wandered with the mesh, I stopped believing in any permanent fixation. I only want to fix the mesh for a few days. Schumpelick: How does it look after 2 years? Are there long-term results available? Berger: We have done some relaparoscopies and relaparotomies and measured the mesh and found shrinkage up to 10%—not more—and the mesh was covered completely by a peritoneal layer. Peiper: The material of the mesh is one thing. The material of the fixation device is another thing. Many adhesions occur not at the mesh area but at the tacks. Do you have any experience with absorbable tacks? Berger: I have started with absorbable tacks for incisional hernia repair and always use absorbable tacks for umbilical hernias. But the company sells them for a very high price, and therefore I could not decide to completely change to absorbable tacks. Kukleta: I was using Easy tacks for 3 years. If you see adhesions, they are always at the tack, and the adhesions will even pull out the tacks. So it is exactly the same reaction that we have seen before. I use the absorbable tacks now—maybe we can afford a little more—but at the moment we do not have any results, as they have been used only for 2 or 3 months.
44
45
Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual B. D. Matthews, R. A. Pierce, M. M. Frisella, L. M. Brunt
332
Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual
Introduction
45
Incisional hernia is a common complication or consequence of abdominal surgery. In recent published series, the rate of incisional hernia after midline laparotomy has been as high as 20% [23, 26, 29, 33]. Due to recurrence rates as high as 30%, incisional hernias are not only associated with significant morbidity but may represent a significant financial strain on the healthcare system [10, 11]. Over the last decade, mesh-based repair techniques have replaced primary suture repair for most incisional hernia repairs because of an unacceptably high failure rate after primary repair [1, 6, 18, 19]. Nevertheless, open incisional hernia repair is often a major operation, with the associated risks of wound- and mesh-related infections and hernia recurrence. As an alternative approach, laparoscopic incisional hernia repair was developed and first reported in 1991 [16]. This technique is now increasingly used in the management of patients with uncomplicated as well as more complex incisional hernias. Thus far, nearly 100 studies have been published on laparoscopic ventral hernia repair, although most represent small series of patients in uncontrolled and nonrandomized trials from single institutions. The aggregate data from these studies have not been carefully analyzed on a large-scale basis, and only a single meta-analysis involving a total of eight studies has been published [13]. Prospective randomized trials comparing laparoscopic and open ventral hernia repair are ongoing in the United States and Europe. To better understand the current status of laparoscopic ventral hernia repair and critically compare it with open techniques, we examined the published literature to evaluate studies reporting on laparoscopic ventral hernia repair alone or in comparison with open ventral hernia repair.
Methods Study Selection A Medline search was performed to identify all publications involving laparoscopic ventral hernia repair from January 1996 through January 2006. Publications containing the keywords ven-
tral hernia, incisional hernia, umbilical hernia, and diastasis recti were identified and pooled. A similar search was also done on the broad-based keyword laparoscopy. These two groups were combined to isolate those references common to both and were further limited to studies conducted in humans and published in English. This final limitation produced a total of 330 publications and their accompanying abstracts. A manual review of the bibliographies of several recent publications dealing with laparoscopic ventral hernia repair did not identify any additional citations within the defined time frame that were missed. Studies were excluded from consideration if they contained fewer than 20 laparoscopic cases or if laparoscopic ventral hernia repair was not the primary focus of the article. As a result, 78 published series that contained at least 20 subjects each and dealt primarily with laparoscopic ventral hernia repair were further analyzed. These 78 studies were separated into series that compared patients who had undergone laparoscopic or open ventral hernia repair within a given institution (»paired« studies) and series that described only patients who had undergone laparoscopic ventral hernia repair (»unpaired« studies). If a single group or institution had published multiple studies, then the largest series from the group was chosen for inclusion unless the studies involved distinct, nonoverlapping patient populations. If a group had published both a paired and an unpaired study, then the paired study was chosen for analysis. Each of the 78 studies was then independently evaluated by two of three reviewers. Data extracted from each selected report included patient demographics, hernia etiology characteristics, perioperative details, postoperative complications, and hernia recurrence. All studies that provided sufficient detail regarding complications and recurrences were included in the analysis, even if some variables (e.g., mean hernia size) were missing. Any discrepancies were resolved by consensus of all investigators after reviewing the primary data again. This process led to the final selection of 45 total studies (14 paired, 31 unpaired), which are listed in Appendices 45.1 and 45.2. Intraoperative parameters that were evaluated included operating time, hernia and mesh sizes, open hernia repair technique (mesh vs. primary suture), open conversion for laparoscopic cases, and
333 Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair
complications. Postoperative information on hospital length of stay (LOS), complications, follow-up duration, hernia recurrence, mortality, and cost of hospitalization were all recorded. Complications related to the surgical procedure, including wound problems, mesh infection, trocar site hernia, seroma, and need for early reoperation, were evaluated. Other postoperative complications were classified into the following categories: cardiac, pulmonary, gastrointestinal, genitourinary, thromboembolic, septic, neurologic/psychiatric, prolonged pain, and miscellaneous. The perioperative mortality rate was analyzed independently, but the principal cause of death was also included as a complication.
Statistical Methods Statistical analysis was performed by an independent statistician. Two separate data sets were analyzed (paired studies comparing laparoscopic to open ventral hernia repair and unpaired studies of laparoscopic ventral hernia repair only). Data from the paired studies were analyzed as the primary evaluation and designated the »paired« analysis. Additionally, data from the unpaired laparoscopic ventral hernia repair studies were combined with the laparoscopic ventral hernia repair data from the paired studies to create a pooled laparoscopic ventral hernia repair group. These pooled laparoscopic ventral hernia repair data were then compared with the open ventral hernia repair data from the paired studies and designated the »pooled« analysis. In three instances, a given group had published both a paired study as well as a more recent, larger unpaired study that appeared to incorporate the laparoscopic ventral hernia repair cases from the smaller paired study. In these situations, the laparoscopic ventral hernia repair cases in the paired study were included in the paired analysis, but they were excluded from the combined analysis in lieu of the larger unpaired cohort. The strategy behind this dual analysis (paired and pooled) was that the paired analysis should have the greatest amount of internal validity, as the same groups of surgeons were performing both the open and laparoscopic cases and so it was much more likely that the patients undergoing either
45
laparoscopic or open ventral hernia repair in these studies would have been selected from the same respective patient populations. In addition, comparing the results of the paired analysis to those derived from the tenfold larger laparoscopic ventral hernia repair group used for the pooled analysis allows for external validation and extrapolation to a more global patient population. In several series, the patient populations were split into smaller subpopulations, and mean values were given for these subgroups. In these instances, a conglomerate weighted mean was calculated and used in the final analysis. Likewise, many of the studies did not report standard deviations in their statistical analyses, so weighted means were used to perform the calculations. Accordingly, a two-tailed t-test was used to compare differences in these weighted means, and any studies that had missing data points were taken into account when performing the analysis. Because the raw numbers of complications, recurrences, and deaths were available in all the studies that were evaluated, these parameters were amenable to more thorough statistical analyses. Thus, totals for these data points were calculated for both the laparoscopic and open ventral hernia repair groups, and differences between them were determined using chi-square analysis. Alternatively, Fisher’s exact test was used in the event that the number of data points was too small to allow for use of a chi-square algorithm.
Results A total of 45 reports met the inclusion criteria, including 14 paired and 31 unpaired studies. The majority of these studies were retrospective (n=33; 73%), whereas three of the paired and nine of the unpaired studies were done in a prospective fashion (12 total; 27%). These reports encompassed a total of 5,340 patients, including 4,582 (86%) who had undergone laparoscopic ventral hernia repair and 758 (14%) who had open ventral hernia repair. Of those 4,582 patients who underwent laparoscopic ventral hernia repair, 619 (14%) were reported in paired studies and 87% were from unpaired studies. Demographic data from the 45 studies are shown in ⊡ Table 45.1. The mean patient age was 55.3 years
334
45
Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual
in the pooled laparoscopic group, 52.9 years in the paired laparoscopic group, and 56.1 years in those receiving open repairs (not significant). Only 19 series reported the body mass index (BMI), five of which were paired studies. In the five paired series, the weighted mean BMI was 30.5 for laparoscopic cases and 29.5 for the open cases (not significant). In the pooled group, the laparoscopic repair patients had a somewhat higher mean BMI of 32.6 compared with the open repair patients (p=0.0026). Each study was also examined for the numbers of primary vs. incisional hernias and recurrent hernias. Few series included all three data points; however, 12 of the 14 paired and 27 of the 31 unpaired studies documented the number of recurrent hernias that were operated. Among the open group, 25.2% of the hernias were recurrent, compared to 27.5% of those done laparoscopically in only the
paired studies and 28.5% of cases from the combined laparoscopic group. Two paired studies [12, 34] that focused solely on umbilical hernias were included in the analysis. Both were paired studies, and all of their open repairs were done using mesh. Conversely, two other paired studies [15, 28] reported repairing some of their smaller ventral hernias using a primary sutured technique. However, these 24 cases of primary closure represented only 4.4% of the total number of open repairs. All laparoscopic repairs were done using intraperitoneal mesh. Operative data are shown in ⊡ Table 45.2. The mean operating time for the laparoscopic cases in the paired studies was 119.6 min, and 100.3 min when all the laparoscopic procedures are considered. The mean operating time for open repairs falls between these two times at 104.5 min. The hernia defect size (70.8 cm2) and the size of the mesh used
⊡ Table 45.1. Patient demographics p-valuea
p-valueb
Open repairs
Paired laparoscopic cases
Patient number (n)
758
619
4,582
Percent male
49
49
44
Age (years)
56.1
52.9
0.13
55.3
0.49
Body mass index
29.5
30.5
0.57
32.6
0.003
Length of stay (days)
4.3
2.4
0.015
2.4
0.0004
Follow-up time (months)
20.2
16.9
0.47
25.5
0.16
aCompares bCompares
Pooled laparoscopic cases
open group to paired laparoscopic ventral hernia repair group open group to pooled laparoscopic ventral hernia repair group
⊡ Table 45.2. Operative data Open repairs
Paired laparoscopic cases
p-valuea
Pooled laparoscopic cases
p-valueb
Operating time (min)
104.5
115.0
0.40
100.3
0.61
Recurrent hernias (%)
25.2
27.5
Hernia size
(cm2)
28.5
70.8
87.9
0.40
103.4
0.025
Mesh size (cm2)
170.1
260.9
0.27
295.2
0.009
Enterotomy rate (%)
1.2
2.9
0.022
2.1
0.11
Conversion rate (%) aCompares bCompares
3.9
open group with paired laparoscopic ventral hernia repair group open group with pooled laparoscopic ventral hernia repair group
3.5
45
335 Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair
for repair (175.5 cm2) were smallest in the patients undergoing open repair. The values are somewhat larger (87.9 cm2 and 260.9 cm2) when compared directly to the patients undergoing laparoscopic repair in the same set of paired studies. However, the larger hernia and mesh sizes become even more apparent when all the laparoscopic cases in the pooled group are considered (103.4 cm2, p=0.025 and 295.2 cm2, p=0.009, respectively). The enterotomy rate was significantly higher in paired laparoscopic ventral hernia repair cases compared to open ventral her-
nia repair (2.9% vs. 1.2%). Postoperative LOS was significantly shorter for the laparoscopic repairs, averaging 2.4 days in both paired and pooled laparoscopic ventral hernia repair groups compared with 4.3 days after open ventral hernia repair (p=0.015 and 0.0004, respectively). Total complication rates were significantly higher with open ventral hernia (41.6%) compared to laparoscopic ventral hernia repair for both pooled (22.7%) and paired (25.5%) analyses (p<0.0001; ⊡ Fig. 45.1). In the analysis of complications by or-
45 40
* p<0.0001
Incidence (%)
35 30
*
25
*
20 15 10 5 0
OPEN
PAIRED LAP
POOLED LAP
⊡ Fig. 45.1. Total complications
⊡ Table 45.3. Organ system complications (NS not significant) Open repairs (%)
Paired laparoscopic cases (%)
p-valuea
Pooled laparoscopic cases (%)
p-valueb
Gastrointestinal
5.9
4.0
0.11
2.6
<0.0001
Cardiac
0.5
0
0.13
0.2
0.10
Pulmonary
1.7
0.8
0.14
0.6
0.0013
Septic
0
0
NS
0.02
1.0
Thromboembolic
0.3
0.2
1.0
0.1
0.20
Genitourinary
1.6
1.1
0.47
0.9
0.10
Neurological
0.1
0
1.0
0.02
0.26
Prolonged pain
0.9
1.0
0.93
2.0
0.047
Miscellaneous complicationsc
1.9
1.0
0.18
0.7
0.0011
Mortality
0.3
0.3
1.0
0.1
0.32
aCompares
open group with paired laparoscopic ventral hernia repair group open group with pooled laparoscopic ventral hernia repair group cIncludes fever, superficial thrombophlebitis, and psychiatric complications bCompares
336
gan system, the pooled laparoscopic ventral hernia repair studies reported significantly fewer wound, pulmonary, and gastrointestinal complications compared to the open ventral hernia repair series (⊡ Table 45.3). Only total and wound complication rates were significantly different in the paired study comparison. No significant differences were noted for rates of cardiac, thromboembolic, urologic, or neurologic complications between any of the study groups. In the pooled laparoscopic ventral hernia repair group, prolonged postoperative pain was reported in a significantly greater percentage of patients (1.9%) compared to the open ventral hernia repair group (0.92%); however, prolonged
pain rates were similar for the open and laparoscopic ventral hernia repair paired series. Mortality rates were also similar between groups. Wound infection rates were 4.6–8-fold higher in the open versus laparoscopic ventral hernia repair series for both pooled and paired study comparisons and accounted for most of the wound-related complications (⊡ Table 45.4). The number of mesh infections was also significantly higher with open ventral hernia repair for all comparisons. Interestingly, the incidence of postoperative seroma was similar for both open and laparoscopic series. The rate of hernia recurrence (⊡ Fig. 45.2) was significantly lower with laparoscopic ventral her-
14 12 10 Incidence (%)
45
Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual
* p<0.0001
8 6
*
4
*
2 0 ⊡ Fig. 45.2. Hernia recurrence
OPEN
PAIRED LAP
POOLED LAP
⊡ Table 45.4. Wound complications Open repairs (%)
Paired laparoscopic cases (%)
p-valuea
Pooled laparoscopic cases (%)
p-valueb
Wound infection
10.4
2.3
<0.0001
1.3
<0.0001
Total wound complicationsc
16.8
5.3
<0.0001
3.8
<0.0001
Mesh infection
3.2
1.5
0.039
0.9
<0.0001
Seroma
12.0
12.1
0.95
11.5
0.66
Trocar hernia aCompares
0
0.4
open group with paired laparoscopic ventral hernia repair group Compares open group with pooled laparoscopic ventral hernia repair group cIncludes wound hematoma/bleeding, cellulitis, dehiscence, and fat necrosis in addition to wound infection b
337 Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair
nia repair for both the pooled (4.3%) and paired (3.1%) study cohorts compared to the paired open ventral hernia repair series (12.1%, both p<0.0001). Small variations existed in the length of follow-up reported in the three groups of studies (25.5 months for pooled laparoscopic ventral hernia repair, 16.9 months for paired laparoscopic ventral hernia repair, 20.2 months for open ventral hernia repair), but these differences were not significant. The reported incidence of trocar site hernia in the laparoscopic series was only 0.35%.
Discussion Large, single, and multi-institutional series have reported excellent results with few complications and recurrence rates of generally <10% after laparoscopic ventral hernia repair [3, 4, 8, 14, 17, 22, 27, 32]. However, only one prospective, randomized, controlled trial comparing laparoscopic to open incisional hernia repair [7] and one looking at laparoscopic versus open repair of Spigelian hernias have been reported [21]. Despite the growing body of knowledge in the field of laparoscopic ventral hernia repair, published overviews of the topic are largely review papers that have not pooled the data and critically analyzed it as a whole [9]. A single meta-analysis evaluating eight studies and three data sets (perioperative complications, operating time, and hospital LOS) has been published [13]. The most stringent statistical method for analyzing any published data from multiple sources is a meta-analysis, requiring completeness and uniformity in the data reporting methods. Any studies that lack a data point of interest, or that fail to report standard deviations along with their means, must be excluded from analysis. Such an approach in the area of ventral hernia repair would exclude many potentially informative studies because of the variable reporting methods used in these reports. A pooled-data analysis of laparoscopic ventral hernia repair was performed in order to encompass a broad range of papers and achieve a more complete overview of the results and outcomes. Dividing the study population into »paired« and »pooled« groups allowed us to examine one cohort that should have a high degree
45
of internal consistency for comparison with open ventral hernia repair (the paired studies only), as well as a significantly larger group (the pooled studies) that should give a broader view of the field as a whole; this approach has proven useful in similar past analyses [33]. In our analysis, we found the patient populations in both the pooled and paired laparoscopic groups, as well as in the open surgery group, to be demographically similar. All cohorts show a similar gender distribution, and the mean patient ages across the groups of studies show little variation. The vast majority of patients in the reported series were clinically overweight or obese, not surprising given that obesity is a strong predictive factor in hernia formation and recurrence [24, 30, 31]. The analysis of perioperative data showed that operative times were not significantly different for open or laparoscopic approaches. However, there was considerable variation across studies in the laparoscopic operative technique used, with some groups employing transfixion sutures routinely and others using them in a limited fashion or using only tacks. The variability in laparoscopic technique and the fact that most series included cases that were part of the institution’s early experience limit any definite conclusions about operative time comparisons. The measured size of the hernia defect and the size of mesh used, however, were greater in the laparoscopic reports than for the open patients, although these differences were significant for the pooled laparoscopic studies only. Possible explanations for these findings are that patients with larger defects are being selected for laparoscopic repair, the laparoscopic series are measuring sizes of all the combined defects whereas open reports describe the size of the largest defect only, additional defects are being detected and repaired with laparoscopic ventral hernia repair, or a combination of these variables. Similarly, it is not surprising that a larger mesh size was used with laparoscopic ventral hernia repair because of the technique of covering all defects with a single piece of mesh without needing to dissect large tissue flaps as with open ventral hernia repair. Postoperative LOS for both the pooled and paired laparoscopic groups averaged only 2.4 days compared to 4.3 days for the open group. The
338
45
Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual
reasons for shorter hospitalization with the laparoscopic approach are unclear but could be related to fewer complications, as discussed below, among other variables. A shorter hospitalization could also be a factor in the potential economic impact of laparoscopic ventral hernia repair, as recently addressed by Earle et al. [11]. The primary outcome parameters were perioperative complications and hernia recurrences. The analysis demonstrates that laparoscopic ventral hernia repair was associated with a significantly lower overall complication rate compared to open ventral hernia repair in the paired analysis. This difference was due primarily to more wound complications in the open ventral hernia repair series. Some differences were also seen in other organ system complications when the pooled laparoscopic ventral hernia repair data were compared to open ventral hernia repair for gastrointestinal, pulmonary, and miscellaneous other complications such as fever and thrombophlebitis; however, these differences did not reach statistical significance in the paired comparison because of the smaller sample size. Another explanation for the differences in other organ system complications in the pooled analysis is that groups reporting only on their laparoscopic experiences (i.e., studies included only in the pooled analysis) may have accumulated more extensive experience and achieved better outcomes with the laparoscopic procedure. One of the main potential advantages of laparoscopic incisional hernia repair is reduced wound complications and mesh infections, and the results of our meta-analysis support this. The difference in wound complication rates between laparoscopic versus open cases is largely a reflection of the decreased number of wound infections seen in the laparoscopic group. Two major factors likely contribute to a reduced infection rate. First, open incisional hernia repair typically involves extensive lateral dissection of tissue planes, with a large subcutaneous dead space and potentially altered blood flow. The mesh is often exposed to the subcutaneous space, with the potential for subsequent infection if a superficial wound infection occurs. With the laparoscopic approach, there is no flap dissection, and the mesh is placed intraperitoneally. Second, unlike laparoscopic ventral
hernia repair, during open ventral hernia repair the prosthetic mesh is more likely to contact the patient’s skin, with the potential for seeding by residual dermal flora. There was no difference in the rate of clinically significant seroma formation between the laparoscopic and open ventral hernia repair groups. One complication that occurred somewhat more frequently in the laparoscopic group in the paired analysis was enterotomy (2.9% laparoscopic vs. 1.2% open). Enterotomy during ventral hernia repair is a major complication with potentially lifethreatening consequences if unrecognized. The enterotomies recorded in this analysis included both those that were recognized at the time of surgery as well as those discovered later due to a subsequent complication. The occurrence of enterotomy is probably related to multiple variables, including surgeon experience, but most likely the primary risk variable is the extent of intraabdominal adhesions. The presence of prior mesh hernia repair may also be a factor in the risk for enterotomy during laparoscopic incisional hernia repair. In one recent series, the incidence of enterotomy during laparoscopic ventral hernia repair in patients with prior mesh placed was 11.4% compared with no enterotomies in patients who had not had previous mesh repairs [25] . Early postoperative pain was not evaluated in this analysis, but prolonged pain was recorded in a somewhat higher percentage of patients in the pooled laparoscopic series compared to open, but not in the paired analysis. These differences could be accounted for in part by variable reporting methods of prolonged pain as a »complication.« However, unlike most other laparoscopic procedures in which incisional pain is typically minimal, laparoscopic incisional hernia repair is associated with substantially more pain in the postoperative period because of the methods of mesh fixation. Specifically, the use of transfixion sutures for the mesh has been associated with increased pain after laparoscopic ventral hernia repair, but this issue was not addressed in our analysis. The most important measure of an effective hernia operation is a low recurrence rate. In the paired and pooled data sets, laparoscopic ventral hernia repair was associated with significantly
339 Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair
fewer hernia recurrences. These results do not appear to be explained on the basis of inadequate or short follow-up periods (mean 17–25 months), although longer-term studies with examination at follow-up will ultimately be necessary to verify these claims. Possible reasons for the lower recurrence rate with laparoscopic ventral hernia repair are that wide areas of tissue–prosthesis overlap can be obtained. This broad interface should allow for better tissue–mesh integration and a stronger repair with subsequent lower recurrence rates. A laparoscopic approach also provides a better opportunity to identify all hernia defects, some of which could be missed with an open approach. It is important to consider some of the limitations of the data analysis. One potential shortcoming of this study is the lack of complete statistical analysis of all data points studied. This, however, is largely due to inconsistent reporting of these data points across the studies evaluated. All the examined series reported their total number of patients; greater than 95% reported mean patient age; and approximately 85–90% gave information on gender breakdowns, operative times, hospital LOS, and duration of follow-up. In contrast, only about one-half to two-thirds of the studies gave information on hernia and mesh size, and fewer than 50% reported patient BMI values. Furthermore, only six reports, all of them paired studies, gave any information on the costs associated with the operative procedure and/or the hospital stay [2, 5, 10, 15, 20, 35]. Even in instances in which these parameters were reported, the values were sometimes given as means and sometimes as medians, and they often did not include standard deviations. Lack of such detailed information limits the statistical analyses that can be applied and precludes any formal meta-analysis of the data points unless a large number of studies with incomplete data are excluded.
Conclusions An analysis of the published literature on laparoscopic ventral hernia repair shows that this procedure is associated with lower total complication rates and fewer wound and mesh infections
45
than with open ventral hernia mesh repair. Hernia recurrence rates in short-term to medium-term follow-up are acceptably low and are significantly less than those reported in paired open ventral hernia cases. Studies with longer-term follow-up will be necessary to verify these results. Despite the limitations of this pooled-data analysis, it appears that laparoscopic incisional hernia repair has several distinct advantages over open approaches. Laparoscopic repair should be strongly considered by surgeons with appropriate advanced laparoscopic expertise for patients with noncomplex incisional hernias.
Acknowledgments The authors wish to thank Dr. Yan-Yan in the Department of Surgery and the Siteman Cancer Center, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, Missouri, for statistical support.
References 1. Anthony T, Bergen PC, Kim LT, Henderson M, Fahey T, Rege RV, Turnage RH (2000) Factors affecting recurrence following incisional herniorrhaphy. World J Surg 24:95–100 2. Beldi G, Ipaktchi R, Wagner M, Gloor B, Candinas D (2006) Laparoscopic ventral hernia repair is safe and cost effective. Surg Endosc 20:92–95 3. Ben-Haim M, Kuriansky J, Tal R, Zmora O, Mintz Y, Rosin D, Ayalon A, Shabtai M (2002) Pitfalls and complications with laparoscopic intraperitoneal expanded polytetrafluoroethylene patch repair of postoperative ventral hernia. Surg Endosc 16:785–788 4. Bencini L, Sanchez LJ (2004) Learning curve for laparoscopic ventral hernia repair. Am J Surg 187:378–382 5. Bencini L, Sanchez LJ, Boffi B, Farsi M, Scatizzi M, Moretti R (2003) Incisional hernia: repair retrospective comparison of laparoscopic and open techniques. Surg Endosc 17:1546–1551 6. Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–583 7. Carbajo MA, Martin del Olmo JC, Blanco JI, de la CC, Toledano M, Martin F, Vaquero C, Inglada L (1999) Laparoscopic treatment vs open surgery in the solution of major incisional and abdominal wall hernias with mesh. Surg Endosc 13:250–252
340
45
Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual
8. Carbajo MA, Martin del Olmo JC, Blanco JI, Toledano M, de la CC, Ferreras C, Vaquero C (2003) Laparoscopic approach to incisional hernia. Surg Endosc 17:118–122 9. Cobb WS, Kercher KW, Heniford BT (2005) Laparoscopic repair of incisional hernias. Surg Clin North Am 85:91– 103, ix 10. DeMaria EJ, Moss JM, Sugerman HJ (2000) Laparoscopic intraperitoneal polytetrafluoroethylene (PTFE) prosthetic patch repair of ventral hernia. Prospective comparison to open prefascial polypropylene mesh repair. Surg Endosc 14:326–329 11. Earle D, Seymour N, Fellinger E, Perez A (2006) Laparoscopic versus open incisional hernia repair: a singleinstitution analysis of hospital resource utilization for 884 consecutive cases. Surg Endosc 20:71–75 12. Gonzalez R, Mason E, Duncan T, Wilson R, Ramshaw BJ (2003) Laparoscopic versus open umbilical hernia repair. JSLS 7:323–328 13. Goodney PP, Birkmeyer CM, Birkmeyer JD (2002) Shortterm outcomes of laparoscopic and open ventral hernia repair: a meta-analysis. Arch Surg 137:1161–1165 14. Heniford BT, Park A, Ramshaw BJ, Voeller G (2003) Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 238:391–399 15. Holzman MD, Purut CM, Reintgen K, Eubanks S, Pappas TN (1997) Laparoscopic ventral and incisional hernioplasty. Surg Endosc 11:32–35 16. LeBlanc KA, Booth WV (1993) Laparoscopic repair of incisional abdominal hernias using expanded polytetrafluoroethylene: preliminary findings. Surg Laparosc Endosc 3:39–41 17. LeBlanc KA, Booth WV, Whitaker JM, Bellanger DE (2000) Laparoscopic incisional and ventral herniorrhaphy in 100 patients. Am J Surg 180:193–197 18. Luijendijk RW, Hop WC, van den Tol MP, de L, Braaksma MM, IJzermans JN, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343:392–398 19. Luijendijk RW, Lemmen MH, Hop WC, Wereldsma JC (1997) Incisional hernia recurrence following «vest-overpants» or vertical Mayo repair of primary hernias of the midline. World J Surg 21:62–65 20. McGreevy JM, Goodney PP, Birkmeyer CM, Finlayson SR, Laycock WS, Birkmeyer JD (2003) A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. Surg Endosc 17:1778– 1780 21. Moreno-Egea A, Carrasco L, Girela E, Martin JG, Aguayo JL, Canteras M (2002) Open vs laparoscopic repair of spigelian hernia: a prospective randomized trial. Arch Surg 137:1266–1268 22. Moreno-Egea A, Torralba JA, Girela E, Corral M, Bento M, Cartagena J, Vicente JP, Aguayo JL, Canteras M (2004) Immediate, early, and late morbidity with laparoscopic ventral hernia repair and tolerance to composite mesh. Surg Laparosc Endosc Percutan Tech 14:130–135
23. Mudge M, Hughes LE (1985) Incisional hernia: a 10 year prospective study of incidence and attitudes. Br J Surg 72:70–71 24. Novitsky YW, Cobb WS, Kercher KW, Matthews BD, Sing RF, Heniford BT (2006) Laparoscopic ventral hernia repair in obese patients: a new standard of care. Arch Surg 141:57–61 25. Perrone JM, Soper NJ, Eagon JC, Klingensmith ME, Aft RL, Frisella MM, Brunt LM (2005) Perioperative outcomes and complications of laparoscopic ventral hernia repair. Surgery 138:708–715 26. Read RC, Yoder G (1989) Recent trends in the management of incisional herniation. Arch Surg 124:485–488 27. Rosen M, Brody F, Ponsky J, Walsh RM, Rosenblatt S, Duperier F, Fanning A, Siperstein A (2003) Recurrence after laparoscopic ventral hernia repair. Surg Endosc17:123–128 28. Salameh JR, Sweeney JF, Graviss EA, Essien FA, Williams MD, Awad S, Itani KM, Fisher WE (2002) Laparoscopic ventral hernia repair during the learning curve. Hernia 6:182–187 29. Sorensen LT, Hemmingsen UB, Kirkeby LT, Kallehave F, Jorgensen LN (2005) Smoking is a risk factor for incisional hernia. Arch Surg 140:119–123 30. Sugerman HJ (1998) Increased intra-abdominal pressure in obesity. Int J Obes Relat Metab Disord 22:1138 31. Sugerman HJ (2001) Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 81:1063–75, vi 32. Ujiki MB, Weinberger J, Varghese TK, Murayama KM, Joehl RJ (2004) One hundred consecutive laparoscopic ventral hernia repairs. Am J Surg 188:593–597 33. Winslow ER, Fleshman JW, Birnbaum EH, Brunt LM (2002) Wound complications of laparoscopic vs open colectomy. Surg Endosc 16:1420–1425 34. Wright BE, Beckerman J, Cohen M, Cumming JK, Rodriguez JL (2002) Is laparoscopic umbilical hernia repair with mesh a reasonable alternative to conventional repair? Am J Surg 184:505–508 35. Wright BE, Niskanen BD, Peterson DJ, Ney AL, Odland MD, VanCamp J, Zera RT, Rodriguez JL (2002) Laparoscopic ventral hernia repair: are there comparative advantages over traditional methods of repair? Am Surg 68:291–295
Appendix 45.1 Paired Series Included in Study 1. Beldi G, Ipaktchi R, Wagner M, Gloor B, Candinas D (2006) Laparoscopic ventral hernia repair is safe and cost effective. Surg Endosc 20:92–95 2. Bencini L, Sanchez LJ, Boffi B, Farsi M, Scatizzi M, Moretti R (2003) Incisional hernia: repair retrospective comparison of laparoscopic and open techniques. Surg Endosc 17:1546–1551 3. Carbajo MA, Martin del Olmo JC, Blanco JI, de la CC, Toledano M, Martin F, Vaquero C, Inglada L (1999) Laparoscopic treatment vs open surgery in the solution of major incisional and abdominal wall hernias with mesh. Surg Endosc 13:250–252
341 Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair
4. DeMaria EJ, Moss JM, Sugerman HJ (2000) Laparoscopic intraperitoneal polytetrafluoroethylene (PTFE) prosthetic patch repair of ventral hernia. Prospective comparison to open prefascial polypropylene mesh repair. Surg Endosc 14:326–329 5. Gonzalez R, Mason E, Duncan T, Wilson R, Ramshaw BJ (2003) Laparoscopic versus open umbilical hernia repair. JSLS 7:323–328 6. Holzman MD, Purut CM, Reintgen K, Eubanks S, Pappas TN (1997) Laparoscopic ventral and incisional hernioplasty. Surg Endosc 11:32–35 7. McGreevy JM, Goodney PP, Birkmeyer CM, Finlayson SR, Laycock WS, Birkmeyer JD (2003) A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. Surg Endosc 17:1778– 1780 8. Park A, Birch DW, Lovrics P (1998) Laparoscopic and open incisional hernia repair: a comparison study. Surgery 124:816–821 9. Raftopoulos I, Vanuno D, Khorsand J, Kouraklis G, Lasky P (2003) Comparison of open and laparoscopic prosthetic repair of large ventral hernias. JSLS 7:227–232 10. Ramshaw BJ, Esartia P, Schwab J, Mason EM, Wilson RA, Duncan TD, Miller J, Lucas GW, Promes J (1999) Comparison of laparoscopic and open ventral herniorrhaphy. Am Surg 65:827–831 11. Salameh JR, Sweeney JF, Graviss EA, Essien FA, Williams MD, Awad S, Itani KM, Fisher WE (2002) Laparoscopic ventral hernia repair during the learning curve. Hernia 6:182–187 12. van’t Riet RM, de Vos van Steenwijk PJ, Bonthuis F, Marquet RL, Steyerberg EW, Jeekel J, Bonjer HJ (2003) Prevention of adhesion to prosthetic mesh: comparison of different barriers using an incisional hernia model. Ann Surg 237:123–128 13. Wright BE, Beckerman J, Cohen M, Cumming JK, Rodriguez JL (2002) Is laparoscopic umbilical hernia repair with mesh a reasonable alternative to conventional repair? Am J Surg 184:505–508 14. Wright BE, Niskanen BD, Peterson DJ, Ney AL, Odland MD, VanCamp J, Zera RT, Rodriguez JL (2002) Laparoscopic ventral hernia repair: are there comparative advantages over traditional methods of repair? Am Surg 68:291–295
Appendix 45.2 Unpaired Series Included in Study 1. Aura T, Habib E, Mekkaoui M, Brassier D, Elhadad A (2002) Laparoscopic tension-free repair of anterior abdominal wall incisional and ventral hernias with an intraperitoneal Gore-Tex mesh: prospective study and review of the literature. J Laparoendosc Adv Surg Tech A 12:263–267 2. Bageacu S, Blanc P, Breton C, Gonzales M, Porcheron J, Chabert M, Balique JG (2002) Laparoscopic repair of incisional hernia: a retrospective study of 159 patients. Surg Endosc 16:345–348 3. Bamehriz F, Birch DW (2004) The feasibility of adopting laparoscopic incisional hernia repair in general surgery
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
45
practice: early outcomes in an unselected series of patients. Surg Laparosc Endosc Percutan Tech 14:207–209 Ben-Haim M, Kuriansky J, Tal R, Zmora O, Mintz Y, Rosin D, Ayalon A, Shabtai M (2002) Pitfalls and complications with laparoscopic intraperitoneal expanded polytetrafluoroethylene patch repair of postoperative ventral hernia. Surg Endosc 16:785–788 Berger D, Bientzle M, Muller A (2002) Postoperative complications after laparoscopic incisional hernia repair. Incidence and treatment. Surg Endosc 16:1720–1723 Bingener J, Kazantsev GB, Chopra S, Schwesinger WH (2004) Adhesion formation after laparoscopic ventral incisional hernia repair with polypropylene mesh: a study using abdominal ultrasound. JSLS 8:127–131 Birgisson G, Park AE, Mastrangelo MJ, Jr., Witzke DB, Chu UB (2001) Obesity and laparoscopic repair of ventral hernias. Surg Endosc 15:1419–1422 Bower CE, Reade CC, Kirby LW, Roth JS (2004) Complications of laparoscopic incisional-ventral hernia repair: the experience of a single institution. Surg Endosc 18:672– 675 Carbajo MA, Martp del Olmo JC, Blanco JI, Toledano M, de la CC, Ferreras C, Vaquero C (2003) Laparoscopic approach to incisional hernia. Surg Endosc 17:118–122 Chelala E, Gaede F, Douillez V, Dessily M, Alle JL (2003) The suturing concept for laparoscopic mesh fixation in ventral and incisional hernias: preliminary results. Hernia 7:191–196 Chowbey PK, Sharma A, Khullar R, Mann V, Baijal M, Vashistha A (2000) Laparoscopic ventral hernia repair. J Laparoendosc Adv Surg Tech A 10:79–84 Eid GM, Prince JM, Mattar SG, Hamad G, Ikrammudin S, Schauer PR (2003) Medium-term follow-up confirms the safety and durability of laparoscopic ventral hernia repair with PTFE. Surgery 134:599–603 Franklin ME, Jr., Gonzalez JJ, Jr., Glass JL, Manjarrez A (2004) Laparoscopic ventral and incisional hernia repair: an 11-year experience. Hernia 8:23–27 Heniford BT, Park A, Ramshaw BJ, Voeller G (2003) Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 238:391–399 Kannan K, Ng C, Ravintharan T (2004) Laparoscopic ventral hernia repair: local experience. Singapore Med J 45:271–275 Kua KB, Coleman M, Martin I, O’Rourke N (2002) Laparoscopic repair of ventral incisional hernia. ANZ J Surg 72:296–299 Kyzer S, Alis M, Aloni Y, Charuzi I (1999) Laparoscopic repair of postoperation ventral hernia. Early postoperation results. Surg Endosc 13:928–931 LeBlanc KA, Whitaker JM, Bellanger DE, Rhynes VK (2003) Laparoscopic incisional and ventral hernioplasty: lessons learned from 200 patients. Hernia 7:118–124 Mizrahi S, Lantsberg L, Kirshtein B, Bayme M, Avinoah E (2003) The experience with a modified technique for laparoscopic ventral hernia repair. J Laparoendosc Adv Surg Tech A 13:305–307
342
45
Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair: 14 Years of Patient Data Accrual
20. Moreno-Egea DA, Martinez JA, Cuenca GM, Miquel JD, Lorenzo JG, Albasini JL, Jordana MC (2004) Mortality following laparoscopic ventral hernia repair: lessons from 90 consecutive cases and bibliographical analysis. Hernia 8:208–212 21. Muysoms F, Daeter E, Vander MG, Claeys D (2004) Laparoscopic intraperitoneal repair of incisional and ventral hernias. Acta Chir Belg 104:705–708 22. Parker HH, III, Nottingham JM, Bynoe RP, Yost MJ (2002) Laparoscopic repair of large incisional hernias. Am Surg 68:530–533 23. Perrone JM, Soper NJ, Eagon JC, Klingensmith ME, Aft RL, Frisella MM, Brunt LM (2005) Perioperative outcomes and complications of laparoscopic ventral hernia repair. Surgery 138:708–715 24. Reitter DR, Paulsen JK, Debord JR, Estes NC (2000) Fiveyear experience with the »four-before« laparoscopic ventral hernia repair. Am Surg 66:465–468 25. Rosen M, Brody F, Ponsky J, Walsh RM, Rosenblatt S, Duperier F, Fanning A, Siperstein A (2003) Recurrence after laparoscopic ventral hernia repair. Surg Endosc 17:123– 128 26. Sanchez LJ, Bencini L, Moretti R (2004) Recurrences after laparoscopic ventral hernia repair: results and critical review. Hernia 8:138–143 27. Szymanski J, Voitk A, Joffe J, Alvarez C, Rosenthal G (2000) Technique and early results of outpatient laparoscopic mesh onlay repair of ventral hernias. Surg Endosc 14:582– 584 28. Toy FK, Bailey RW, Carey S, Chappuis CW, Gagner M, Josephs LG, Mangiante EC, Park AE, Pomp A, Smoot RT, Jr., Uddo JF, Jr., Voeller GR (1998) Prospective, multicenter study of laparoscopic ventral hernioplasty. Preliminary results. Surg Endosc 12:955–959 29. Tsimoyiannis EC, Siakas P, Glantzounis G, Koulas S, Mavridou P, Gossios KI (2001) Seroma in laparoscopic ventral hernioplasty. Surg Laparosc Endosc Percutan Tech 11:317–321 30. Ujiki MB, Weinberger J, Varghese TK, Murayama KM, Joehl RJ (2004) One hundred consecutive laparoscopic ventral hernia repairs. Am J Surg 188:593–597 31. Verbo A, Petito L, Pedretti G, Lurati M, D’Alba P, Coco C (2004) Use of a new type of PTFE mesh in laparoscopic incisional hernia repair: the continuing evolution of technique and surgical expertise. Int Surg 89:27–31
Discussion Deysine: If I were a reviewer of this paper, I would address the need of a pooled data analysis. However, it is very difficult to compare unpaired data. So the valid comparison would be a data analysis with paired groups. In the main table you produced, there was no major difference in several
outcomes between open and laparoscopic [procedures], and you had to pull additional data without comparative analysis to make a strong point in favor of laparotomy. Matthews: If you look at the pooled data, you could say that is from laparoscopic experts, and is that really applicable to the community surgeon who does everything? So you are right. If you look at the paired analysis, everything looks very similar in terms of those patient variables. Obviously, there were some differences with the complications. You could argue that a laparoscopic ventral hernia repair should be done by an expert hernia surgeon. In a meta-analysis, you can work the data however you want it to come out. Kukleta: Concerning the prolonged pain, in the pooled group you found an increase on the laparoscopic side. Was there any possibility to take a look at the technique of transfascial sutures and the material used, because there are 25 U.S. papers where, in most, ePTFE was used. Here fixation must be stronger than everywhere else. Did you find any correlation? Matthews: You are absolutely right. Greater than 90% of our pooled data used an ePTFE mesh. So there are some additional things that we can look at. Schumpelick: Is it really justified to compare laparoscopic versus an open approach without any functional results? After a laparoscopic approach, you have a defect of the muscles covered by mesh. Sometimes there is a rectus diastasis in the midline, and in the open approach you close it. Therefore, we need a functional test of whether there are differences or not. Have you seen such a test? The story of Reeves and Flament was to close the hernia to increase the muscle stability of the abdomen. Matthews: More and more surgeons in the U.S. do not use the laparoscopic approach on every patient—and in my practice as well—because, from a functional standpoint, some patients benefit from an abdominal reconfiguration or reconstruction. Flament: I was questioned about the selection of patients. In Sevilla, Ramshaw said that hernias with loss of domain are not suitable for laparoscopic treatment. Yesterday Predeep Chowbey said we have to select our patients, as laparoscopy is not
343 Chapter 45 · Pooled Data Analysis of Laparoscopic vs. Open Ventral Hernia Repair
suitable for every patient. If so, the biggest hernias go to open surgery, and the smaller ones maybe go to laparoscopic surgery. How can you introduce that in the analysis of the results? Matthews: If you look at the results, the actual hernia size was much bigger in the laparoscopic patients. So the selectivity, in terms of bigger ones being done open and the smaller ones laparoscopically, did not really hold out in this analysis. I think one of the things that actually really came out is that, especially in the U.S., the average BMI of a ventral hernia patient is morbidly obese—about 35—and so I have to consider that we are producing more morbidity and maybe increasing the functional outcome, or is it a good trade-off? To me, a lot of times that makes sense, and these are the discussions I actually have with the patient. We never discussed these things 5 or 6 years ago with the patient. Selectivity has become more of an issue. Fitzgibbons: Actually, we are now usually reconstructing the abdominal wall laparoscopically. I routinely now close the defects. But to do that, of course, you have to pick smaller hernias to some extent. So we are individualizing. But you have an enormous advantage of laparoscopy as you decrease the infection rate. In the right patient, it is still a very good choice. And with regard to fixation with the tacks, my goal with the tacks is to seal the polypropylene side of the prosthesis so that the bowel cannot get in contact—not so much for the fixation. Deysine: You mentioned that patients were not always operated by surgeons who were up to date with the changes that have happened. You have general surgeons doing this kind of operation, sometimes with results that are not that great. The essence of this conference should be spread to the general surgical population until this becomes a specialty. Chowbey: As I mentioned yesterday, we have to select the patients that we operate laparoscopically or by conventional surgery with anatomical repair reinforced by the mesh. And what we also emphasize is that the recurrence after open surgery is generally very small, and these small recurrences can be very easily and comfortable managed laparoscopically. That has been our policy. We treat
45
the large incisional hernias by the conventional method, and when they come back with a recurrence, which is usually a small hernia recurrence, we handle it laparoscopically. That probably gives the best functional and anatomic results.
46
Tissue Ingrowth, Adhesion, and Mesh Contraction S. L. Bachman, A. Ramaswamy, B. J. Ramshaw
346
Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
Introduction
46
As is the case with almost every medical intervention, the use of surgical prosthetics for hernia repair is a double-edged sword. While mesh has allowed for tension-free repairs and low recurrence rates, there has been a long learning curve regarding how to appropriately fabricate and use these materials. The development of complications such as fistulas, pain, mesh migration, and hernia recurrences are among the complications our patients have suffered as mesh and placement techniques continue to evolve. It has become clear that mesh materials are not inert; they both stimulate a reaction in the organism and undergo changes over time while implanted [1]. This paper examines three interactions between the body and mesh: tissue ingrowth into mesh and its effects, adhesions to mesh, and mesh contraction in vivo.
Tissue Ingrowth »Ingrowth« of a mesh refers to the interdigitation of the mesh with fibrous tissue. This was historically considered a positive property of a material, as the ingrowth of collagen (scar) incorporates the mesh into the abdominal wall. However, it is also recognized that if ingrowth occurs on the visceral surface, such as on bowel or bladder, ingrowth is a negative effect that can lead to mesh contamination and fistulas. Multiple studies have examined the ingrowth of materials in animal models; the outcome measures of these studies are varied, including histologic examinations of the tissue–mesh interface, measurements of the force required to disrupt mesh from the abdominal wall, and sophisticated imaging models. Klinge et al. have demonstrated that mesh incorporation is the result of almost pure collagenous tissue deposited around and between the mesh fibers [2]. They demonstrated an acute inflammatory response after mesh insertion that peaked at 7–14 days, with concomitant fibroblast infiltration and a slow resolution of active cells in the wound bed until 90 days postoperative, when only a physiologic cell turnover of <1% was noted [2]. This study
compared monofilament heavyweight polypropylene with lightweight multifilament polypropylene prosthetics. The heavyweight material had a more intense inflammatory response with a corresponding fibrosis. A dense plate of connective tissue completely embedded the mesh. In comparison, the lightweight polypropylene material had a less pronounced inflammatory and fibrotic response, with eventual formation of a thin scar framework and fatty tissue interspersed within the mesh pores [2]. Mesh was laparoscopically inserted onto the abdominal wall in pigs and then examined at 28 days by Jacob et al. [3]. They found that threedimensional (3D) polyester mesh took more force to be disrupted from the abdominal wall (4.15 N/ cm2) than oxidized regenerated cellulose-coated lightweight polypropylene (3.11 N/cm2) or heavyweight polypropylene (2.96 N/cm2). Histology was not quantified beyond demonstrating fibrous ingrowth between all mesh types [3]. A number of studies have looked at peel strength as a proxy for integration. A comparison in swine performed by McGinty et al. evaluated heavyweight polypropylene, coated 3D polyester, and expanded polytetrafluoroethylene (ePTFE) mesh. They found that the force of disruption was 1.3 N/cm for ePTFE, 2.1 N/cm for heavyweight polypropylene, and 2.8 N/cm for polyester [4]. Additional histology demonstrated fibrous tissue between the pores of the polypropylene and polyester weaves. There was fibrous tissue noted in the micropores of the ePTFE surface, but there was no growth through the solid ePTFE [4]. Gonzalez and Ramshaw reported on the histologic differences between flat polyester, 3D polyester, and heavyweight polypropylene meshes 25 weeks after implantation [5]. They found that fibrous encapsulation of the polypropylene was twice that of the polyester meshes, although polypropylene had less foreign body reaction than either polyester mesh. However, polypropylene had significantly less connective tissue present than the polyesters did [5]. Histology demonstrated fibrous tissue within the pores of the polypropylene and the polyester. The long-term ingrowth of mesh was studied by Novitsky at al., who examined four types of mesh placed in an intraperitoneal location in rabbits [6]. Three barrier meshes–heavyweight polypropylene/
347 Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
ePTFE composite, dual-sided ePTFE, and lightweight polypropylene/oxidized regenerated cellulose (ORC) coating–were compared with macroporous, uncoated, heavyweight polypropylene. The strength of mesh incorporation into the abdominal wall was measured by three differentiated variablereluctance transducers. No significant difference was noted between the meshes in the force required to disrupt the mesh from the tissue; however, the compliance of the surrounding tissue was significantly higher in the lightweight polypropylene [6]. Examination and measurement of the abdominal wall after implantation of mesh in humans was performed by Welty et al. [7] using ultrasound and 3D stereography. Heavyweight monofilament polypropylene mesh was compared to more elastic and lowweight meshes. The patients with the heavyweight monofilament mesh had more complaints of paresthesias and abdominal discomfort, as well as more recurrences (although not statistically significant). Three-dimensional stereography demonstrated increased stiffness of all abdomens with mesh, but the extent of the stiffness increased with mesh weight and decreased pore size [7]. These findings support the concept that a florid ingrowth around the mesh can be detrimental to a hernia repair. Thus, if the sequelae of fibrous reactions to mesh are considered more detrimental (extensive fibrosis, loss of abdominal wall compliance, pain) than beneficial, it would be helpful to understand which meshes will stimulate this reaction. An interesting study by Sanders et al. [8] took the concept beyond pore size and investigated whether the size of mesh filaments affects the overall fibrotic ingrowth. Polypropylene fibers in four diameters ranging from 2.0 μm to 27.0 μm were implanted in rat soft tissue for 5 weeks. After histology slides were obtained, the thickness of the fibrous capsule surrounding each filament was calculated. Fibers that were smaller than 6.0 μm had no encapsulation in 87% of them, and overall had significantly smaller capsules than the fibers larger than 6.0 μm [8].
Mesh Adhesions The same factors that promote ingrowth of the muscular fascia of the abdominal wall, as described
46
above, are a potential problem when the mesh is exposed to the abdominal viscera. Polypropylene and polyester have been used since the 1950s [9, 10] and are two of the most frequently used types of mesh in ventral hernia repair. They are structurally macroporous and allow tissue, including chronic inflammatory tissue, to grow through the pores. Macroporous meshes have been coated with substances to place against the abdominal viscera to prevent ingrowth to bowel. However, when a microporous (or solid) barrier is lacking between the viscera and the macroporous mesh, such as when titanium is used as the coating substance, there is potential for ingrowth of bowel.
Human Studies Evidence supports the contention that macroporous mesh should not be placed into the peritoneal cavity. Halm et al. [11] showed that reoperations following intraperitoneal polypropylene mesh placement are much more difficult and dangerous than reoperations when mesh is placed outside the peritoneal cavity. There was a 76% complication rate when operating on patients with mesh previously placed in the abdominal cavity, compared to a 29% complication rate in patients who had mesh placed outside the abdominal cavity. In this retrospective study of 66 patients, all eight bowel resections and two enterocutaneous fistulas occurred in the group of patients who had mesh placed in the peritoneal cavity [11]. A common mesh used for laparoscopic ventral hernia repair is ePTFE, which is designed for intraabdominal placement with a microporous side placed toward the abdominal cavity. A retrospective review reported the findings at reoperations in patients in whom ePTFE had been placed laparoscopically for ventral hernia repair [12]. The reoperations in 65 patients showed that most patients (50/65) had adhesions to the mesh; however, the adhesions were mostly graded as easy to take down (44/50 were assigned a score of 1). It was also noted that no enterotomies occurred during lysis of adhesions [12]. Another human study evaluated postoperative adhesions using a dynamic ultrasound technique [13]. This study of 80 patients evaluated the inci-
348
46
Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
dence of adhesion formation after open or laparoscopic ventral hernia repair using a polyester mesh with an absorbable collagen coating designed for intraperitoneal placement. Adhesions were present at 1 year in 14% of patients by ultrasound examination [13]. The incidence of intestinal ingrowth when using mesh coated with a solid microporous or hydrogel-type barrier is unknown at this time. Damage may occur during mesh manipulation or fixation with tacks or sutures, which may strip off the antiadhesive barrier and expose the macroporous material to the abdominal viscera.
⊡ Fig. 46.1. Macroporous mesh being cut off the abdominal wall but left on multiple loops of bowel due to ingrowth of bowel into macroporous mesh
Animal Studies There are numerous reports comparing mesh products placed in the abdominal cavity in animal adhesion models [4, 14–28]. Various animal models, including rat, rabbit, and pig, have been studied to look at mesh adhesions. In these animal models, mesh is placed in the abdominal cavity and fixed to the peritoneal surface of the abdominal wall. The peritoneum and/or abdominal contents, such as small bowel or cecum, are abraded to induce injury that would simulate an abdominal wall hernia repair in humans. By abrading the bowel, this injury induces adhesion formation more reliably than if no peritoneal damage were induced. Although slight differences in the specific adhesion rates for each type of mesh are observed when comparing these studies, all of the studies show that the meshes designed for intraabdominal placement (either with a solid microporous PTFE barrier or an absorbable solid barrier) result in fewer adhesions compared with macroporous meshes, including lightweight macroporous meshes. An important concept when discussing adhesions to mesh is the fact that adherence alone is not a major problem for surgeons who must reoperate on a patient with a previous mesh placement. An adhesion to mesh may rarely cause pain or bowel obstruction for the patient, but long-term complications and difficult reoperations occur if there is ingrowth of the abdominal viscera into and through the mesh (⊡ Fig. 46.1). This ingrowth of viscera can lead to the difficult and dangerous re-
operations mentioned earlier and can result in late bowel obstructions and fistulas that can harm patients (⊡ Fig. 46.2a, b). There are reports of fistulas and bowel obstructions caused by intraperitoneal placement of macroporous mesh up to 30 years after implantation [28–32]. This evidence suggests that even if macroporous mesh is no longer placed into the peritoneal cavity after today, we as surgeons will continue to face difficult reoperations and will be managing enterocutaneous fistulas and bowel obstructions due to macroporous mesh placed in the abdominal cavity for many more decades.
Mesh Contraction Surgeons who have had the occasion to remove mesh from patients will be familiar with the phenomenon of mesh contraction (⊡ Fig. 46.3a–c). The acknowledgement of mesh contraction has led to important changes in hernia repair technique. An inadequate length of extension of mesh onto healthy tissue may lead to recurrence if the mesh retracts away from the hernia. The phenomenon of mesh contraction has been documented in experimental models, such as that by Klinge et al. [33]. This canine study established that mesh contraction occurs as early as within 4 weeks after implantation. They noted that heavyweight polypropylene was reduced to 54% of its original size, and a reduced-weight polypropylene mesh was
349 Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
46
a
a
b ⊡ Fig. 46.2. a A mesh designed for intraabdominal placement [heavyweight polypropylene/polytetrafluoroethylene (PTFE) composite] was used in a laparoscopic ventral hernia repair. b A stitch was placed in the center of the mesh to help position the mesh laparoscopically. The stitch apparently caused a defect in the expanded PTFE, and an enterocutaneous fistula developed a year after the operation
66% of its implantation size [33]. Many other investigators have also documented shrinkage of prosthetics in vivo. Coda et al. found that prosthetics would shrink or even expand in response to being bathed in different types of fluids [34]. Gonzalez et al. explanted mesh from swine abdominal walls 3 months postoperatively and found that the mean size of heavyweight polypropylene squares was 67% of their original size, and flat polyester mesh was 87% of its original size [35]. They also studied tissue integration and found that a higher force was necessary to distract the polyester mesh (mean 194 N) versus the polypropylene (159 N) [35].
b
c ⊡ Fig. 46.3. a A composite heavyweight/expanded polytetrafluoroethylene (ePTFE) mesh immediately after being excised from the anterior abdominal wall. Note the scalloped edges that have exposed the heavyweight component to the viscera. b An ePTFE explant after tissue has been removed. The mesh is stiff and contracted into this twisted shape. c A composite heavyweight polypropylene/ePTFE mesh after explantation and cleaning
350
46
Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
In another swine study, early explanation at 28 days demonstrated that 3D polyester mesh was 70.5% of its original size, heavyweight polypropylene was 74.7%, and lightweight polypropylene with ORC was 66.4% of the initial size [3]. A study with 4-week explants found that heavyweight polypropylene was 94% of its original size, 3D polyester was 79%, and ePTFE was 63% of the original size [4]. At 1 year postoperative, Novitsky et al. found that ePTFE had contracted by a mean of 32.1%, ePTFE/ heavyweight polypropylene composite by 8.9%, heavyweight polypropylene by 4.6%, and lightweight polypropylene coated with ORC by 8.7% [6]. The early timeline of contraction implicates the immediate wound-healing inflammatory response as the mechanism. The initial deposition of collagen by fibroblasts and the encasement of the mesh seem to have a role. We tested this theory by administering a daily low dose of steroid to swine with three types of mesh implanted on the anterior abdominal wall. A second group of animals did not receive the injection. Mesh was explanted at 3 months. There was variable contraction between the groups, but all three types of mesh in the steroid-treated animals had 10% less contraction than the corresponding untreated mesh (manuscript in preparation). Surveying the literature on mesh contraction leads to many contradictory results: Sometimes heavyweight polypropylene contracts more, sometimes ePTFE, sometimes lightweight materials. Some researchers have hypothesized that the location of the mesh in the abdominal wall will influence contraction [36]. However, there does seem to be a trend that an increased load of foreign material will incite more inflammation and possibly contraction. An increased size of mesh pore interstices also seems to reduce scar formation. This kind of analysis is helping to drive the shift to lighter-weight, lower-density prosthetics [37–39].
Conclusion Mesh prosthetics undergo changes within the body, and they incite an inflammatory response as well. A body of research is accumulating in the literature to try to better define these effects. New mesh configurations are an attempt to minimize
the sequelae of scar plate formation around the mesh while still obtaining the ingrowth that helps secure the mesh’s position, diminish contraction, and prevent adhesions to the visceral surface of the mesh. We can expect to see more refinements of the materials used in hernia repair in the future.
References 1. Costello CR, Bachman SL, Ramshaw BJ, Grant SA (2007) Materials characterization of explanted polypropylene hernia meshes. J Biomed Mater Res B Appl Biomater 83B:44–49 2. Klinge U, Klosterhalfen B, Birkenhauer V, Junge K, Conze J, Schumpelick V (2002) Impact of polymer pore size on the interface scar formation in a rat model. J Surg Res 103:208–14 3. Jacob BP, Hogle NJ, Durak E, Kim T, Fowler DL (2007) Tissue ingrowth and bowel adhesion formation in an animal comparative study: polypropylene versus Proceed versus Parietex Composite. Surg Endosc 21:629–33 4. McGinty JJ, Hogle NJ, McCarthy H, Fowler DL (2005) A comparative study of adhesion formation and abdominal wall ingrowth after laparoscopic ventral hernia repair in a porcine model using multiple types of mesh. Surg Endosc 19:786–90 5. Gonzalez R, Ramshaw BJ (2003) Comparison of tissue integration between polyester and polypropylene prostheses in the preperitoneal space. Am Surg 69:471–6; discussion 476–7 6. Novitsky YW, Harrell AG, Cristiano JA, Paton BL, Norton HJ, Peindl RD, Kercher KW, Heniford BT (2007) Comparative evaluation of adhesion formation, strength of ingrowth, and textile properties of prosthetic meshes after long-term intra-abdominal implantation in a rabbit. J Surg Res 140:6–11 7. Welty G, Klinge U, Klosterhalfen B, Kasperk R, Schumpelick V (2001) Functional impairment and complaints following incisional hernia repair with different polypropylene meshes. Hernia 5:142–7 8. Sanders JE, Stiles CE, Hayes CL (2000) Tissue response to single-polymer fibers of varying diameters: evaluation of fibrous encapsulation and macrophage density. J Biomed Mater Res 52:231–7 9. Usher FC, Ochsner J, Tuttle LL, Jr. (1958) Use of marlex mesh in the repair of incisional hernias. Am Surg 24:969–74 10. Usher FC, Wallace SA (1958) Tissue reaction to plastics; a comparison of nylon, orlon, dacron, teflon, and marlex. AMA Arch Surg 76:997–9 11. Halm JA, de Wall LL, Steyerberg EW, Jeekel J, Lange JF (2007) Intraperitoneal polypropylene mesh hernia repair complicates subsequent abdominal surgery. World J Surg 31:423–9; discussion 430
351 Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
12. Koehler RH, Begos D, Berger D, Carey S, LeBlanc K, Park A, Ramshaw B, Smoot R, Voeller G (2003) Minimal adhesions to ePTFE mesh after laparoscopic ventral incisional hernia repair: reoperative findings in 65 cases. JSLS 7:335–40 13. Aube C, Pessaux P, Tuech JJ, du Plessis R, Becker P, Caron C, Arnaud JP (2004) Detection of peritoneal adhesions using ultrasound examination for the evaluation of an innovative intraperitoneal mesh. Surg Endosc 18:131–5 14. Harrell AG, Novitsky YW, Cristiano JA, Gersin KS, Norton HJ, Kercher KW, Heniford BT (2007) Prospective histologic evaluation of intra-abdominal prosthetics four months after implantation in a rabbit model. Surg Endosc 21:1170–4 15. Bellon JM, Rodriguez M, Garcia-Honduvilla N, Gomez-Gil V, Pascual G, Bujan J (2007) [Real-time monitoring of the peritoneal behavior of composite prostheses by sequential laparoscopy: applicability in ventral hernia repair]. Cir Esp 82:290–6 16. Christoforoni PM, Kim YB, Preys Z, Lay RY, Montz FJ (1996) Adhesion formation after incisional hernia repair: a randomized porcine trial. Am Surg 62:935–8 17. Alimoglu O, Akcakaya A, Sahin M, Unlu Y, Ozkan OV, Sanli E, Eryilmaz R (2003) Prevention of adhesion formations following repair of abdominal wall defects with prosthetic materials (an experimental study). Hepatogastroenterology 50:725–8 18. Matthews BD, Pratt BL, Pollinger HS, Backus CL, Kercher KW, Sing RF, Heniford BT (2003) Assessment of adhesion formation to intra-abdominal polypropylene mesh and polytetrafluoroethylene mesh. J Surg Res 114:126–32 19. Gonzalez R, Rodeheaver GT, Moody DL, Foresman PA, Ramshaw BJ (2004) Resistance to adhesion formation: a comparative study of treated and untreated mesh products placed in the abdominal cavity. Hernia 8:213–9 20. Conze J, Rosch R, Klinge U, Weiss C, Anurov M, Titkowa S, Oettinger A, Schumpelick V (2004) Polypropylene in the intra-abdominal position: influence of pore size and surface area. Hernia 8:365–72 21. Johnson EK, Hoyt CH, Dinsmore RC (2004) Abdominal wall hernia repair: a long-term comparison of Sepramesh and Dualmesh in a rabbit hernia model. Am Surg 70:657–61 22. Matthews BD, Mostafa G, Carbonell AM, Joels CS, Kercher KW, Austin C, Norton HJ, Heniford BT (2005) Evaluation of adhesion formation and host tissue response to intraabdominal polytetrafluoroethylene mesh and composite prosthetic mesh. J Surg Res 123:227–34 23. Demir U, Mihmanli M, Coskun H, Dilege E, Kalyoncu A, Altinli E, Gunduz B, Yilmaz B (2005) Comparison of prosthetic materials in incisional hernia repair. Surg Today 35:223–7 24. Kayaoglu HA, Ozkan N, Hazinedaroglu SM, Ersoy OF, Erkek AB, Koseoglu RD (2005) Comparison of adhesive properties of five different prosthetic materials used in hernioplasty. J Invest Surg 18:89–95 25. Burger JW, Halm JA, Wijsmuller AR, ten Raa S, Jeekel J (2006) Evaluation of new prosthetic meshes for ventral hernia repair. Surg Endosc 20:1320–5
46
26. Harrell AG, Novitsky YW, Peindl RD, Cobb WS, Austin CE, Cristiano JA, Norton JH, Kercher KW, Heniford BT (2006) Prospective evaluation of adhesion formation and shrinkage of intra-abdominal prosthetics in a rabbit model. Am Surg 72:808-13; discussion 813–814 27. Bellon JM, Rodriguez M, Garcia-Honduvilla N, Pascual G, Gomez Gil V, Bujan J (2007) Peritoneal effects of prosthetic meshes used to repair abdominal wall defects: monitoring adhesions by sequential laparoscopy. J Laparoendosc Adv Surg Tech A 17:160–6 28. Majeski J (1998) Migration of wire mesh into the intestinal lumen causing an intestinal obstruction 30 years after repair of a ventral hernia. South Med J 91:496–8 29. Fernandez Lobato R, Martinez Santos C, Ortega Deballon P, Fradejas Lopez JM, Marin Lucas FJ, Moreno Azcoita M (2001) Colocutaneous fistula due to polypropylene mesh. Hernia 5:107–9 30. DeGuzman LJ, Nyhus LM, Yared G, Schlesinger PK (1995) Colocutaneous fistula formation following polypropylene mesh placement for repair of a ventral hernia: diagnosis by colonoscopy. Endoscopy 27:459–61 31. Losanoff JE, Richman BW, Jones JW (2002) Entero-colocutaneous fistula: a late consequence of polypropylene mesh abdominal wall repair: case report and review of the literature. Hernia 6:144–7 32. Costa D, Tomas A, Lacueva J, de Asis Perez F, Oliver I, Arroyo A, Sanchez A, Andreu J, Gallego JA, Calpena R (2004) Late enterocutaneous fistula as a complication after umbilical hernioplasty. Hernia 8:271–2 33. Klinge U, Klosterhalfen B, Muller M, Ottinger AP, Schumpelick V (1998) Shrinking of polypropylene mesh in vivo: an experimental study in dogs. Eur J Surg 164:965–9 34. Coda A, Bendavid R, Botto-Micca F, Bossotti M, Bona A (2003) Structural alterations of prosthetic meshes in humans. Hernia 7:29–34 35. Gonzalez R, Fugate K, McClusky D, 3rd, Ritter EM, Lederman A, Dillehay D, Smith CD, Ramshaw BJ (2005) Relationship between tissue ingrowth and mesh contraction. World J Surg 29:1038–43 36. Garcia-Urena MA, Vega Ruiz V, Diaz Godoy A, Baez Perea JM, Marin Gomez LM, Carnero Hernandez FJ, Velasco Garcia MA (2007) Differences in polypropylene shrinkage depending on mesh position in an experimental study. Am J Surg 193:538–42 37. Klinge U, Klosterhalfen B, Conze J, Limberg W, Obolenski B, Ottinger AP, Schumpelick V (1998) Modified mesh for hernia repair that is adapted to the physiology of the abdominal wall. Eur J Surg 164:951–60 38. Cobb WS, Kercher KW, Heniford BT (2005) The argument for lightweight polypropylene mesh in hernia repair. Surg Innov 12:63–9 39. Cobb WS, Burns JM, Peindl RD, Carbonell AM, Matthews BD, Kercher KW, Heniford BT (2006) Textile analysis of heavy weight, mid-weight, and light weight polypropylene mesh in a porcine ventral hernia model. J Surg Res 136:1–7
352
Chapter 46 · Tissue Ingrowth, Adhesion, and Mesh Contraction
Discussion Deysine: The degradation is usually secondary to
46
white cell proximity. I was wondering whether, in some of the specimens that you removed, you tried to analyze the contained bacteria as the orthopedists do with their prostheses. They could not find the bacteria by normal ways. Ramshaw: That is an excellent point. There will be an accelerated amount of oxidation in infection. In the infected meshes, we have not done any evaluation of the bacteria. This is one of the things we want to look at. We also want to look at the clinical correlations from infection, chronic pain, recurrence, etc., and the patient characteristics such as smoking, diabetes, and age. All we have done is assess clinical signs of infection. Franz: I particularly liked the distinction between surface adhesion and ingrowth. With regard to biologics, if patients have a contaminated abdomen or after failed synthetics, they are not interested in another synthetic. Technique aside, do you think cross-linking is good or bad? Ramshaw: I could certainly give you the marketing point of view on it: If it’s a company without cross-linking, cross-linking is bad because you want regeneration, and the cross-linking will prevent some of that cellular ingrowth or differentiation. Companies that have cross-linking say that non-cross-linking is bad because it is a risk for early degradation. I think the answer is that we have a lot of first-generation biologics, and we really have not solved the real issue of getting those cells to come in and differentiate into the right types of material in the right patient. And that is what I think the next generation of biologics may actually be better designed to do for our patients. Klinge: You described the degradation of polypropylene. Usually, pure polypropylene is not suitable to make filaments, and there are a lot of additives and other substances which are mixed to the polypropylene. Unfortunately, we do not know what these additives are. Did you see any differences in the degradation process between the various polypropylenes? Some years ago, we saw in histological analysis that some of the propylene heavyweight meshes behaved better than expected. I believe
that there is some difference, but we do not know what happens. Ramshaw: I completely agree. Polypropylenes are not the same; there are a lot of differences in the way they are constructed; there is a high variability in the degree of degradation. Potential variables are the length of time implanted, the bacterial milieu, more degradation with infection, the different types of fibers themselves. We are going to try to look at it as we start to correlate all of the variables together in this large database.
47
Effect of Different Mesh Materials on Adhesion Formation S. Morales-Conde, J. Martín-Cartes, M. Socas
354
Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
Introduction
47
Because of the necessity of placing prosthetic materials to reduce the high rate of recurrence associated with conventional hernia repair without mesh, aggressive dissection of tissues occurs during conventional open repair. Laparoscopic surgery has introduced a new technique for repairing defects of the anterior abdominal wall in order to avoid this large dissection, which is associated with discomfort, the use of drains, the possibility of contamination and infection of the meshes used, and a long hospital stay for the patient. These effects have led surgeons to accept the laparoscopic approach as a valid option for our patients [1]. Laparoscopic surgery and its application in the treatment of ventral hernia have produced a change in surgeon mentality. Before the advent of this technique, surgeons always avoided placing foreign materials in contact with intraabdominal viscera in order to avoid adhesions. Laparoscopic repair of ventral hernias is associated with the use of intraabdominal prostheses. This has improved the evolution of these materials toward better ingrowth to the anterior abdominal wall, but at the same time it has reduced the possibility of creating adhesions and their potential complications, such as fistulas and bowel occlusion [2]. The ideal mesh for intraperitoneal placement has yet to be found. It should follow the principles for any prosthetic material, such as being sterilizable, noncarcinogenic, chemically inactive, and resistant to physical manipulation, and it should cause no inflammation, change in mesh characteristics, altered tissue contact, or allergic or hypersensitivity reaction. Moreover, the optimal mesh should have certain characteristics when placed intraabdominally: minimal pain and adhesion formation, excellent tissue ingrowth with minimal shrinkage, no formation of fistula or infection, and minimal seroma formation. It is also important that the prosthetic material cause no change in abdominal compliance while at the same time being easy to manipulate.
Factors Related to Adhesion Formation with Prosthetic Materials The formation of adhesions is an extremely complex process that has not yet been completely explored. As a result, many of the studies on this phenomenon are still empirical, but the results published so far are promising. It is possible that we will be able to control this process in the near future, whether stimulating or inhibiting it, depending on the circumstances. The consequence of this could be the possibility of applying these prosthetic materials for intraabdominal use in laparoscopic surgery of the abdominal wall with no risk of creating adhesions and their subsequent consequences, such as fistulas and bowel occlusion. In the meantime, while we try to determine the different factors involved in adhesion formation, the ideal materials and substances to prevent adhesions are still far from being found. Different studies performed so far have proved that it is possible to reduce the quantity and the quality of these adhesions but not to prevent them completely. Full tissue integration without adhesion formation is still a challenge in the use of intraabdominal mesh materials. Different factors have been associated with the process of adhesion formation, but the need of the bowel and intraperitoneal organs to isolate foreign agents (prosthetic materials, sutures, bacteria, etc.) seems to play an important role. However, during laparoscopic repair of ventral hernia, the presence of intraperitoneal adhesions is a result not just of the material itself; experimental studies have related adhesions to the surgical technique used. Spiral tacks, improper placement and fixing of the mesh, and exposure of the sides of these materials to the intraabdominal viscera could be related to adhesion formation [3]. We also lack information about the healing process involved in adhesion formation. It would be interesting in the future to determine the critical moment when adhesions to prosthetic materials are formed. For that reason, some authors have designed different studies using sequential laparoscopy to monitor the real-time adhesion formation process and the critical period when most adhesions form [4, 5].
355 Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
If we analyze the factors involved in adhesion formation when a mesh in placed intraperitoneally, we can determine the following: ▬ Material: Different studies [6–12] have shown that the porosity of the material is one of the most important factors related to adhesion formation and ingrowth. Large porosity has been related to an increased number of adhesions. Polypropylene mesh (PPM) is considered a high-porosity prosthetic material that creates an important scar tissue involved in adhesion formation. On the other hand, a low-porosity material, such as expanded polytetrafluoroethylene (ePTFE) [6–9, 13, 14], produces a tissue capsule that covers the mesh with a low rate of adhesions. Therefore, we can conclude that the pore size of the mesh is critical in the development and maintenance of abdominal adhesions and tissue ingrowth. It has been demonstrated, however, that reducing the amount of material and increasing the pore size result in better mesh biocompatibility, with a potential reduction of adhesion formations [15, 16], as some have tried to demonstrate with the new lower-weight PPM. These large-pore PPMs in the intraabdominal position have shown a reduced inflammatory tissue reaction, so they could be considered an alternative for the development of intraperitoneal onlay meshes [17]. In fact, new studies with reduced-weight PPM have demonstrated less change in the adjacent tissue’s pliability/ compliance and less adhesion than conventional PPM [18]. In the future, these factors should also be analyzed with regard to the pore size of other materials, such as PTFE. The larger-pore, thinner meshes such as condensed PTFE (cPTFE) have led to better tissue integration compared with the other PTFE-based meshes or PPM. Through hydrophobic chemistry, a low profile, and increased pore size, cPTFE balances the rapid resolution of the inflammatory and wound-healing response to resist adhesion formation, with efficient integration within the surrounding abdominal tissue [19]. ▬ Surgical technique for placing the mesh: An experimental study conducted by our group
47
[20] has demonstrated the influence of the surgical technique of mesh placement during laparoscopic ventral hernia repair (LVHR). In this study, most of the adhesions to the ePTFE meshes were observed at the edges, compared with the central part of this prosthetic material. The potential reasons for these adhesions were analyzed, and it could be seen how adhesions formed to the undesired exposition of the parietal face of the prosthesis or to tacks improperly introduced into the mesh. These issues demonstrate the need for a meticulous technique to avoid complications related to adhesions, such as bowel occlusion and perforation. The mesh must be properly extended so that the parietal face is not exposed to the bowel, and tacks should be introduced all the way into the mesh to avoid their hanging from the anterior abdominal wall. ▬ Fixation: As stated previously, adhesions to spiral tacks may occur, and we have observed these in experimental studies. Recent clinical papers have even reported cases of obstruction and/or perforation of the small bowel resulting from a band adhesion caused by a displaced spiral tack [21, 22]. ▬ Surgical trauma: Surgical trauma to the bowel or to the peritoneal surface of the anterior abdominal wall during the process of adhesiolysis has some influence in adhesion formation, even if the ideal intraabdominal mesh is used. Adhesions result from the normal peritoneal wound-healing response and develop during the first 5–7 days after injury. Adhesion formation and adhesion-free reepithelialization are alternative pathways. These both begin with coagulation, which initiates a cascade of events resulting in the buildup of a fibrin gel matrix. If not removed, the fibrin gel matrix serves as the progenitor to adhesions by forming a band or bridge when two peritoneal surfaces coated with it are opposed [23]. The band or bridge becomes the basis for the organization of an adhesion, especially if a foreign body reaction is added to the process when a mesh is placed intraabdominally, becoming of great importance to the surgical trauma on the bowel surface [24].
356
Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
Analysis of the Influence of Different Prosthetic Materials on Adhesion Formation
47
Many prosthetic materials to be placed intraabdominally during LVHR are available on the market, and new meshes are introduced regularly. However, experimental and clinical documentation on safety, including information on adhesions, fistulas, bowel occlusion, infection, and efficacy, are often not available to the clinician. The choice of mesh may therefore be difficult in clinical practice. Regarding adhesion formation, different experimental studies on animals show different results (⊡ Table 47.1), and a mesh superior to another in terms of adhesion formation in one study may be inferior to the same mesh in another study. If we analyze the different studies, the problem might be related to the fact that they involved different implantation techniques and were carried out in different animal models. In addition, the different factors analyzed previously–such as manipulation of the abdominal viscera, fixation technique, size of the mesh, size of the visceral face of the mesh in relation to the parietal face (overlap), and management of the abdominal wall area where the mesh is to be placed–may influence the results of the various studies, but in most cases, these factors are not even described in the text. A current review of the literature has been published regarding safety measures such as adhesions, fistulas, and infections after LVHR [25]. The only real concern based on this analysis is about using pure PPM in the intraperitoneal position. The use of intraperitoneal PPM to repair incisional hernias has been demonstrated in clinical and experimental studies to carry the risk of adhesion and damage to the intraabdominal viscera. Polypropylene is a material widely used in surgery, but because of its association with the formation of enterocutaneous fistulae and adhesions, direct contact between mesh and intestine is avoided. But, as has been analyzed previously, the use of PPM may be reevaluated based on the new studies of lightweight macropore meshes to determine whether it could influence adhe-
sion formation. This study clearly points to very few mesh-related complications after a proper mesh is placed intraperitoneally and shows that experimental studies and theoretical considerations may argue for using a covered mesh (a composite mesh or ePTFE) for LVHR in humans, although it is stressed that no human data at the moment support this. The only clinical information available in the literature based on reoperative findings concerning adhesions to prosthetic materials placed intraabdominally was published by Koehler et al. in 2003 [26]. They reported on a multi-institutional study of adhesions to implanted ePTFE mesh at reoperation in patients who had previously undergone laparoscopic incisional hernia repair done with the same mesh implantation technique. In this large series of reoperations after LVHR, no or minimal adhesion to implanted ePTFE mesh was observed in 91% of cases, and no severe cohesive adhesions were found. Regarding the two types of prosthetic materials accepted for intraabdominal placement, it is important to consider the following factors: ▬ ePTFE: Traditionally, ePTFE is one of the most widely used prosthetic materials for repairing abdominal wall defects, but it has been suggested that its behavior with respect to the reparative process may depend on its structure and that this factor should be considered to determine the capability to form adhesions. ▬ Composite materials: Composite biomaterials designed for repairing abdominal wall defects are usually composed of a reticular component and a second component, or barrier, which is laminar (absorbable or nonabsorbable) and placed in contact with the visceral peritoneum. Results on the effectiveness of these membranes covering PPM or polyester mesh are related to the membranes’ composition, but they are contradictory: Studies with PPM covered with materials such as polyglactin 910 mesh (PGM), with the aim of avoiding contact between the PPM and the intraabdominal viscera, demonstrated that the interposition of PGM did not alter adhesion formation
357 Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
[27]. On the other hand, other studies designed to evaluate how the composition of this second component affects the biological behavior of the biomaterial and the formation of adhesions have shown that physical barriers seem to induce similar adhesions, while adhesions formed to prostheses with chemical barriers can vary considerably, possibly depending on the chemical composition of the barrier [28]. Finally, the same amount of adhesion despite the presence of different protective barriers has been demonstrated with other polypropylene-based meshes [29]. In conclusion, it is difficult to make a final statement because the results of different studies are so contradictory. Whereas some studies have demonstrated the superiority of some composite meshes over ePTFE [30–33], others showed ePTFE to be related to less adhesion formation [18, 29, 34], and there are even studies in which the two types of mesh are similar [35]. The literature cannot give general recommendations for the choice of mesh based on randomized controlled trials. The final choice of mesh for LVHR will therefore typically be based on cost and the surgeon’s preference while we await further data from randomized controlled clinical trials.
Reducing Adhesion to Prosthetic Materials As already mentioned, meticulous technique is one of the most important factors involved in reducing adhesion formation: Avoid unnecessary surgical trauma on the surface of the peritoneum and the serosa of the bowel; avoid exposing the parietal face of the mesh to the abdominal cavity; and avoid letting spiral tacks hang from the mesh because of improper introduction through the prosthetic material. But because these circumstances are not usually present, due to the process of adhesiolysis or to a defect location that makes placement of the mesh or tacks difficult, alternative methods to avoid adhesion are under investigation. Efforts
47
to prevent or reduce adhesions have largely been unsuccessful, hindered by the empirical basis, the biochemical complexities of adhesiogenesis, and the lack of good predictive animal models. The two major strategies for adhesion prevention or reduction consist of adjusting surgical technique, as already proposed, and applying adjuvants. Different studies have been published that used a variety of substances to prevent adhesion formation to the prosthetic materials, with varying results. Hyaluronic acid/carboxymethylcellulose (HA/CMC) membranes have been used as an effective measure to prevent PPM-induced adhesions; taurolidine 2% solution has been proposed as a cost-effective alternative to HA/CMC membranes when a PPM is placed in direct contact with the abdominal viscera [36]; hyaluronate sodium in the form of a bioresorbant membrane has been demonstrated to significantly reduce the development of intraabdominal adhesions found after implantation of a PPM in the context of surgical hernia repair [37]; and a collagen foil has also been used to reduce adhesion formation [38]. Looking for a cost-effective alternative to reduce adhesion formation to mesh placed intraabdominally during LVHR, we have conducted studies with two substances that can guarantee good coverage of the complete surface of the mesh, even if a large prosthetic material is used [39, 40]. These two substances are fibrin glue (Tissucol; Baxter Biosurgery, Vienna, Austria) and hyaluronidase cream. Both substances were able to decrease, in an animal model, the number and quantity of adhesions with PPM and ePTFE meshes. The adhesion reduction with hyaluronidase cream is a consequence of an acceleration in the normal healing process needed to create adhesions. This factor may also influence the reduction of adhesions with fibrin glue, but it may be related to other factors, such as the mechanical barrier that the fibrin glue produces 3–5 min after its application and the capsule of new tissue created by the fibrin glue through a healing process different from the inflammatory process necessary to create an adhesion.
47
Author
Jenkins et al. [41]
Naim et al. [42]
Bellón et al. [43]
Baykal et al. [44]
Dasika and Widmann [45]
Bellón et al. [46]
Vrijland et al. [47]
Bellón et al. [48]
Bellón et al. [49]
Zieren et al. [50]
Year
1983
1993
1996
1997
1998
1999
2000
2000
2002
2002 ▼
Rats
Rabbits
Rabbits
Rats
Rabbits
Rats
Mice
Rabbits
Rats
Rats
Animal
40
14
8
44
48
47
72
24
196
N
ePTFE (DualMesh) PolyesterComposite
ePTFE (DualMesh) ePTFE (CV-4)
ePTFE (MycroMesh) ePTFE (DualMesh) ePTFE (STP) PP (Marlex)
PP PP + Vicryl PP + Fluorosoft
ePTFE (STP) PP (Marlex) PP (Prolene) Lyodura
PP Vicryl PP +Vicryl
PGA PP
PP (Marlex) ePTFE (MycroMesh)
PP + ePTFE (STP), PP + Interceed PP + Poloxamer
PP (Marlex) Vicryl ePTFE (STP) Silastic PHD PP (Marlex) + Gelfilm
Meshes
Open
Open
Open
Open
Open
Open
Open
Open
No differences
ePTFE (DualMesh)
PP + Fluorosoft
ePTFE (STP) Lyodura
Vicryl PP +Vicryl
PGA
ePTFE (Mycromesh)
PP + Interceed
Vicryl
Open
Open
Fewer adhesions
Open / lap
No differences
ePTFE (CV-4)
PP (Marlex)
PP + Vicryl
–
PP
PP
PP (Marlex)
–
PP (Marlex ) PP (Marlex) + Gelfilm
More adhesions
14 and 90 days
14 days
3 and 7 days
60 days
14, 30, 60, and 90 days
1, 2, and 3 months
5 and 14 days
14, 30, 60, and 90 days
1, 2, 4, and 8 weeks
Time
⊡ Table 47.1. Experimental studies comparing adhesion formation of different prosthetic materials (lap laparoscopic; PP polypropylene mesh; ePTFE expanded polytetrafluoroethylene; PHD glycerol-preserved human dura mater; PGA polyglycolic acid; PVDF polyvinylidene fluoride)
358 Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
Pigs
Rats
Borrazzo et al. [52]
González et al. [53]
Butler and Prieto [54]
Kayaoglu et al. [35]
Matthews et al. [29]
Demir et al. [55]
McGinty et al. [30]
Konstantinovic et al. [56]
2004
2004
2004
2005
2005
2005
2005
2005 ▼
Rats
Rabbits
Rats
Guinea pigs
Rats
Pigs
Rabbits
Matthews et al. [14]
2003
Rats
Van ’t Riet et al. [51]
2003
48
8
30
30
60
19
80
21
30
91
PP (Marlex) Surgisis
PP (Prolene) ePTFE (DualMesh) Parietex Composite
PP (Bard Mesh) Composix E/X PP (Bard Mesh) + Interceed
ePTFE (DualMesh) Composix E/X Sepramesh
PP (Surgipro) ePTFE (DualMesh) Sepramesh Vypro II Parietex Composite
PP (Prolene) PP (Prolene) + AlloDerm
PP (Parietene) Parietex Composite Parietene Composite Composix E/X Sepramesh ePTFE (DualMesh)
PP ePTFE (DualMesh) Sepramesh
ePTFE (DualMesh) PP (Marlex)
PP PP + Icodextrine Sepramesh Parietex
Open
Lap
Open
Open
Open
Open
Open
Lap
Open
Open
PP (Marlex) (30 days) Surgisis (90 days)
Parietex Composite
PP (Bard Mesh) + Interceed
ePTFE (DualMesh)
Sepramesh ePTFE (DualMesh)
PP (Prolene) + AlloDerm
Parietex Composite Parietene Composite Composix E/X ePTFE (DualMesh)
Sepramesh
ePTFE (DualMesh)
Sepramesh Parietex
PP (Parietene) Sepramesh
PP (Marlex)
PP PP + Icodextrine
30 and 90 days
28 days
14 days
1, 3, 9, and 16 weeks
4 weeks
4 weeks
21 days
28 days
1, 3, 9, and 16 weeks
7 and 30 days
Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
359
47
Rats
Burger et al. [32]
Harrell et al. [34]
Kiudelis et al. [58]
Jacob et al. [59]
Voskerician et al. [19]
2006
2006
2007
2007
2007
▼
Pigs
Dilege et al. [57]
2006
Rabbits
Rabbits
Rats
Rats
Rats
Sikkink et al. [31]
2006
Animal
Author
10
42
60
200
30
60
N
cPTFE (MotifMESH) ePTFE (DualMesh) Composix PP (Marlex) Proceed
Proceed Parietex Composite PP
PP (Prolene) Mersilene PP + Vicryl ePTFE Bard Proceed
ePTFE (DualMesh) Composix E/X Proceed PP (Marlex)
PP (Prolene) ePTFE (DualMesh) Ultrapro Timesh Sepramesh Parietex Composite Proceed Tutomesh
PP (Prolene) PP + Interceed Sepramesh
PP (Prolene) PP (Prolene) + Hyalobarrier gel PP (Prolene) + Tissucol ePTFE (DualMesh) Sepramesh Parietene Composite
Meshes
Open
Lap
Open
Sequential lap
Open
Open
Open
Open / lap
cPTFE (MotifMESH) Composix
Parietex Composite
ePTFE Bard Proceed
ePTFE (DualMesh)
Sepramesh Parietex Composite
PP + Interceed Sepramesh
Sepramesh
Fewer adhesions
47
Year
⊡ Table 47.1. Continued
PP (Marlex)
PPL
PP (Prolene) Mersilene PP + Vicryl
PP (Marlex)
PP (Prolene)
PP (Prolene)
More adhesions
1 and 3 months
28 days
30 days
16 weeks
7 and 30 days
28 days
2 months
Time
360 Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
Marcondes et al. [60]
Junge et al. [33]
Conze et al. [17]
2008
2008
2008
40
24
24
20
co-PVDF PP (Prolene)
PVDF+PP (Dyna.Mesh) Parietene Composite ePTFE (DualMesh) PP
PP (Surgipro Mesh) Sepramesh Composix E/X
Parietex Composite Sepramesh PP-PU 99
PP (Marlex) ePTFE (DualMesh) Composix E/X Proceed
Lap
No differences
PP
PP (Surgipro Mesh)
Sepramesh
PP (Marlex)
7, 21, and 90 days
30 days
28 days
3, 7, and 14 days
1 year
Parietex Composite – Collagen-oxidized film-treated mesh (Sofradim, Trévoux, France) Poloxamer – Triblock copolymers consisting of a central hydrophobic block of polyethylene glycol flanked by two hydrophilic blocks of polyethylene glycol PolyesterComposite – Polyurethane-covered Dacron mesh (Braun, Melsungen, Germany) PP (Marlex) – PP mesh (Bard, Murray Hill, NJ, USA) PP (Surgipro) – Monofilament PP mesh (AutoSuture, Norwalk, CT, USA) PP-PU 99 – Autodesigned prosthesis composed with a reticular PP mesh and a nonabsorbable 26-μm-thick polyurethane film Proceed – PP–polydioxanone composite with oxidated cellulose coating (Ethicon, Somerville, NJ, USA) Prolene – PP mesh (Ethicon, Somerville, NJ, USA) PVDF + PP (DynaMesh) – Two-component (PP mesh and PVDF) monofilament mesh (FEG Textiltechnik, Aachen, Germany) Seprafilm – Bioabsorbable translucent membrane composed of carboxymethylcellulose and hyaluronic acid (Genzyme, Cambridge, MA, USA) Sepramesh – PP mesh coated on one side with a bioresorbable adhesion barrier (Seprafilm; Genzyme, Cambridge, MA, USA) Silastic – Polydimethylsiloxane prosthesis (Dow Corning, Midland, MI, USA) Surgipro Mesh – Single-layer PP mesh (U.S. Surgical, Norwalk, CT, USA) Surgisis – Derived from porcine small intestine submucosa (Cook, Strombeek-Bever, Belgium) Tissucol – Fibrin glue (Baxter Healthcare, Vienna, Austria) Vicryl – Polyglactin 910 (Johnson & Johnson, Somerville, NJ, USA) Vipro II – PP/polyglactin 910 composite mesh (Johnson & Johnson, Somerville, NJ, USA)
No differences
Parietene Composite
Sepramesh
Lap
Open
Parietex Composite, PPL-PU 99
ePTFE (DualMesh)
Sequential lap
Open
361
Rabbits
Rats
Rabbits
Rabbits
Rabbits
AlloDerm – Decellularized human dermis (LifeCell, Brachburg, NJ, USA) co-PVDF – Automanufactured mesh woven with PVDF polymer (Solvay, Brussels, Belgium) Composix – Nonwoven ePTFE (Davol, Cranston, RI, USA) Composix E/X – PP mesh sewn with PP stitching to a thin sheet of ePTFE (Davol, Bard, Murray Hill, NJ, USA) cPTFE (MotifMESH) – Nonwoven macroporous condensed PTFE (Proxy Biomedical, Galway, Ireland) ePTFE (CV-4) – Automanufactured mesh woven out of ePTFE suture thread CV-4 (Gore & Associates, Flagstaff, AZ, USA) ePTFE (DualMesh) – ePTFE (Gore & Associates, Flagstaff, AZ, USA) ePTFE (STP) – Gore-Tex Soft Tissue Patch, ePTFE with two laminar microporous surfaces (Gore & Associates, Flagstaff, AZ, USA). Fluorosoft – Fluoropassivated polyester (Sulzer Vascutek, Renfrewshire, Scotland) Gelfilm – Pharmacia & Upjohn, a subsidiary of Pharmacia, Kalamazoo, MI, USA Hyalobarrier gel – Sterile, transparent, and highly viscous gel obtained by condensation of hyaluronic acid (Fidia Advanced Biopolymers SRL, Abano Terme, Padova, Italy) Icodextrine – Iso-osmolar biodegradable –1,4-linked glucose polymer solution (Extraneal, Baxter Healthcare, Vienna, Austria) Interceed – Oxidized regenerated cellulose (Johnson & Johnson Medical, New Brunswick, NJ, USA) Lyo-dura – Lyophilized dura mater (Braun-Dexon, Barcelona, Spain) Mersilene – Polyethylene terephthalate (Johnson & Johnson, Somerville, NJ, USA) MycroMesh – ePTFE (Gore & Associates, Flagstaff, AZ, USA) Parietene Composite – PP mesh bonded on one side to a collagen-oxidized film (Sofradim, Trévoux, France)
Bellón et al. [4]
2007
Novitsky et al. [18]
2007
Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
47
362
Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
References
47
1. Morales-Conde S, Cadet H, Cano A, Bustos M, Martin J, Morales-Mendez S. Laparoscopic ventral hernia repair without sutures–double crown technique: our experience after 140 cases with a mean follow-up of 40 months. Int Surg. 2005; 90(3 Suppl):S56–62 2. Morales-Conde S. Laparoscopic ventral hernia repair: advances and limitations. Semin Laparosc Surg. 2004; 11(3):191–200 3. Morales-Conde S, Cadet I, Tutosaus JD, Carrasco P, Palma F, Morales-Méndez S. Macroscopic evaluation of mesh incorporation placed intraperitoneally for laparoscopic ventral hernia repair. Experimental model. Proceedings of the 7th World Congress of Endoscopic Surgery, Singapore, 1–4 June 2000. Monduzzi Editore, Bologna, Italy, 2000, pp 455–60 4. Bellón JM, Rodríguez M, García-Honduvilla N, Gómez-Gil V, Pascual G, Buján J. Real-time monitoring of the peritoneal behavior of composite prostheses by sequential laparoscopy: applicability in ventral hernia repair. Cir Esp. 2007;82(5):290–6 5. Bellón JM, Rodríguez M, García-Honduvilla N, Pascual G, Gómez Gil V, Buján J. Peritoneal effects of prosthetic meshes used to repair abdominal wall defects: monitoring adhesions by sequential laparoscopy. J Laparoendosc Adv Surg Tech A. 2007;17(2):160–6 6. Bellón JM, Buján J, Contreras LA, Hernando A. Integration of biomaterials implanted into abdominal wall: process of scar formation and macrophage response. Biomaterials 1995;16:381–7 7. Bellón JM, Buján J, Contreras LA, Hernando A, Jurado F. Macrophage response to experimental implantation of polypropylene prosthesis. Eur Surg Res. 1994;26:46–53 8. Bellón JM, Contreras LA, Buján J, Carrera-San Martín A, Gimeno MJ, Jurado F. Influence of the porosity of prosthetic biomaterials implanted in the abdominal wall on the healing process. Cir Esp. 1996;57:296–302 9. Bellón JM, Buján J, Contreras LA, Hernando A. Interface formed between visceral peritoneum and experimental polypropylene or polytetrafluoroethylene abdominal wall implants. J Mat Sci. (M-Med) 1996;7:331–6 10. Kaufman Z, Engelberg M, Zager M. Faecal fistula: a late complication of Marlex mesh repair. Dis Colon Rectum 1981;24:543–4 11. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young, RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg. 2001;18:260–73 12. Wrijland WW, Bonthius F, Sleyerberg EW, Marquet RL, Jaeckel J, Bonjer HJ. Peritoneal adhesions to prosthetic materials: choice of mesh for incisional hernia repair. Surg Endosc. 2000;14:960–3 13. Murphy JL, Freeman JB, Dionne PG. Comparison of Marlex and Gore-tex to repair abdominal wall defects in the rat. Can J Surg. 1989;32:244–7 14. Matthews BD, Pratt BL, Pollinger HS, Backus CL, Kercher KW, Sing RF, Heniford BT. Assessment of adhesion forma-
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
27.
tion to intra-abdominal PPM and polytetrafluoroethylene mesh. J Surg Res. 2003;114(2):126–32 Schug-Pass C, Tamme C, Tannapfel A, Köckerling F. A lightweight polypropylene mesh (TiMesh) for laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility with the DualMesh in an experimental study using the porcine model. Surg Endosc. 2006;20(3):402–9 Conze J, Rosch R, Klinge U, Weiss C, Anurov M, Titkowa S, Oettinger A, Schumpelick V. Polypropylene in the intraabdominal position: influence of pore size and surface area. Hernia. 2004;8(4):365–72 Conze J, Junge K, Weiss C, Anurov M, Oettinger A, Klinge U, Schumpelick V. New polymer for intra-abdominal meshes–PVDF copolymer. J Biomed Mater Res B Appl Biomater. 2008;87(2):321–8 Novitsky YW, Harrell AG, Cristiano JA, Paton BL, Norton HJ, Peindl RD, Kercher KW, Heniford BT. Comparative evaluation of adhesion formation, strength of ingrowth, and textile properties of prosthetic meshes after longterm intra-abdominal implantation in a rabbit. J Surg Res. 2007;140(1):6–11 Voskerician G, Rodriguez A, Gingras PH. Macroporous condensed poly(tetra fluoro-ethylene). II. In vivo effect on adhesion formation and tissue integration. J Biomed Mater Res A. 2007;82(2):426–35 Morales-Conde S, Cadet I, Morales-Méndez S. Management of mesh and sutures during laparoscopic ventral hernia repair: a lesson learned from an experimental model. In: Morales-Conde S (ed) Laparoscopic ventral hernia repair. Springer, Paris, 2003, pp 257–267 Peach G, Tan LC. Small bowel obstruction and perforation due to a displaced spiral tacker: a rare complication of laparoscopic inguinal hernia repair. Hernia. 2008;12(3):303–5 Ladurner R, Mussack T. Small bowel perforation due to protruding spiral tackers: a rare complication in laparoscopic incisional hernia repair. Surg Endosc. 2004;18(6):1001 Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, diZerega GS, Ellis H. Adhesions: pathogenesis and prevention-panel discussion and summary. Eur J Surg Suppl. 1997;(577):56–62 Dinsmore RC, Calton WC Jr, Harvey SB, Blaney MW. Prevention of adhesions to polypropylene mesh in a traumatized bowel model. J Am Coll Surg. 2000;191(2):131–6 Eriksen JR, Gögenur I, Rosenberg J. Choice of mesh for laparoscopic ventral hernia repair. Hernia. 2007 ec;11(6):481–92 26. Koehler RH, Begos D, Berger D, Carey S, LeBlanc K, Park A, Ramshaw B, Smoot R, Voeller G. Minimal adhesions to ePTFE mesh after laparoscopic ventral incisional hernia repair: reoperative findings in 65 cases. JSLS. 2003;7(4):335–40 de Vries Reilingh TS, van Goor H, Koppe MJ, Bodegom ME, Hendriks T, Bleichrodt RP. Interposition of polyglactin mesh does not prevent adhesion formation between viscera and polypropylene mesh. J Surg Res. 2007;140(1):27–30
363 Chapter 47 · Effect of Different Mesh Materials on Adhesion Formation
28. Bellón JM, Serrano N, Rodríguez M, García-Honduvilla N, Pascual G, Buján J. Composite prostheses for the repair of abdominal wall defects: comparative study of physical and/or chemical barriers. Cir Esp. 2005;77(6):351–6 29. Matthews BD, Mostafa G, Carbonell AM, Joels CS, Kercher KW, Austin C, Norton HJ, Heniford BT. Evaluation of adhesion formation and host tissue response to intraabdominal polytetrafluoroethylene mesh and composite prosthetic mesh. J Surg Res. 2005;123(2):227–34 30. McGinty JJ, Hogle NJ, McCarthy H, Fowler DL. A comparative study of adhesion formation and abdominal wall ingrowth after laparoscopic ventral hernia repair in a porcine model using multiple types of mesh. Surg Endosc. 2005;19(6):786–90 31. Sikkink CJ, Vries de Reilingh TS, Malyar AW, Jansen JA, Bleichrodt RP, van Goor H. Adhesion formation and reherniation differ between meshes used for abdominal wall reconstruction. Hernia. 2006;10(3):218–22 32. Burger JW, Halm JA, Wijsmuller AR, Ten Raa S, Jeekel J. Evaluation of new prosthetic meshes for ventral hernia repair. Surg Endosc. 2006;20(8):1320–5 33. Junge K, Binnebösel M, Rosch R, Jansen M, Kämmer D, Otto J, Schumpelick V, Klinge U. Adhesion formation of a polyvinylidenfluoride/polypropylene mesh for intraabdominal placement in a rodent animal model. Surg Endosc. 2009;23(2):327–33 34. Harrell AG, Novitsky YW, Peindl RD, Cobb WS, Austin CE, Cristiano JA, Norton JH, Kercher KW, Heniford BT. Prospective evaluation of adhesion formation and shrinkage of intra-abdominal prosthetics in a rabbit model. Am Surg. 2006;72(9):808–13 35. Kayaoglu HA, Ozkan N, Hazinedaroglu SM, Ersoy OF, Erkek AB, Koseoglu RD. Comparison of adhesive properties of five different prosthetic materials used in hernioplasty. J Invest Surg. 2005;18(2):89–95 36. Erpek H, Tuncyurek P, Soyder A, Boylu S. Hyaluronic acid/ carboxymethylcellulose membrane barrier versus taurolidine for the prevention of adhesions to polypropylene mesh. Eur Surg Res. 2006;38(4):414–7 37. Kramer K, Senninger N, Herbst H, Probst W. Effective prevention of adhesions with hyaluronate. Arch Surg. 2002;137(3):278–82 38. Schönleben F, Reck T, Tannapfel A, Hohenberger W, Schneider I. Collagen foil (TissuFoil E) reduces the formation of adhesions when using polypropylene mesh for the repair of experimental abdominal wall defects. Int J Colorectal Dis. 2006;21(8):840–6 39. Martín-Cartes J, Morales-Conde S, Suárez-Grau J, LópezBernal F, Bustos-Jiménez M, Cadet-Dussort H, SocasMacías M, Alamo-Martínez J, Tutosaus-Gómez JD, Morales-Mendez S. Use of hyaluronidase cream to prevent peritoneal adhesions in laparoscopic ventral hernia repair by means of intraperitoneal mesh fixation using spiral tacks. Surg Endosc. 2008;22(3):631–4 40. Martín-Cartes JA, Morales-Conde S, Suárez-Grau JM, Bustos-Jiménez M, Cadet-Dussort JM, López-Bernal F, Morcillo-Azcárate J, Tutosaus-Gómez JD, Morales-Méndez S. Role
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
47
of fibrin glue in the prevention of peritoneal adhesions in ventral hernia repair. Surg Today. 2008;38(2):135–40 Jenkins SD, Klamer TW, Parteka JJ, Condon RE. A comparison of prosthetic materials used to repair abdominal wall defects. Surgery. 1983;94(2):392–8 Naim JO, Pulley D, Scanlan K, Hinshaw JR, Lanzafame RJ. Reduction of postoperative adhesions to Marlex mesh using experimental adhesion barriers in rats. J Laparoendosc Surg. 1993;3(2):187–90 Bellón JM, Buján J, Contreras LA, Carrera-San Martín A, Jurado F. Comparison of a new type of polytetrafluoroethylene patch (Mycro Mesh) and polypropylene prosthesis (Marlex) for repair of abdominal wall defects. J Am Coll Surg. 1996;183(1):11–8 Baykal A, Onat D, Rasa K, Renda N, Sayek I. Effects of polyglycolic acid and polypropylene meshes on postoperative adhesion formation in mice. World J Surg. 1997;21(6):579–82; discussion 582–3 Dasika UK, Widmann WD. Does lining polypropylene with polyglactin mesh reduce intraperitoneal adhesions? Am Surg. 1998;64(9):817–9; discussion 820 Bellón JM, Contreras LA, Pascual G, Bujan J. Neoperitoneal formation after implantation of various biomaterials for the repair of abdominal wall defects in rabbits. Eur J Surg. 1999;165(2):145–50 Vrijland WW, Bonthuis F, Steyerberg EW, Marquet RL, Jeekel J, Bonjer HJ. Peritoneal adhesions to prosthetic materials: choice of mesh for incisional hernia repair. Surg Endosc. 2000;14(10):960–3 Bellón JM, Contreras LA, Pascual G, Buján J. Evaluation of the acute scarring response to the implant of different types of biomaterial in the abdominal wall. J Mater Sci Mater Med. 2000;11(1):25–9 Bellón JM, Jurado F, García-Honduvilla N, López R, Carrera-San Martín A, Buján J. The structure of a biomaterial rather than its chemical composition modulates the repair process at the peritoneal level. Am J Surg. 2002;184(2):154–9 Zieren J, Paul M, Osei-Agyemang T, Maecker F, Müller JM. Polyurethane-covered dacron mesh versus polytetrafluoroethylene DualMesh for intraperitoneal h